Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
1	911928	911928	G	C	exonic	PERM1	.	synonymous SNV	PERM1:NM_001291366:exon3:c.C2226G:p.T742T,PERM1:NM_001291367:exon4:c.C1944G:p.T648T	.	.	.	.	0.06703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	174	1	911928	chr1:911928	G	C	.	PASS	DP=174;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	1139047	1139047	C	A	exonic	TNFRSF18	.	nonsynonymous SNV	TNFRSF18:NM_148901:exon4:c.G692T:p.G231V	8.37E-07	0.089996444	0.91000272	.	0.03798	0.16362	.	.	185.06659	2.95295	0.0	0.912	D	0.996	0.670	D	0.907	0.627	P	.	.	.	1	0.090	N	.	.	.	1.4	0.336	T	-0.49	0.156	N	0.039	0.020	-0.993	0.319	T	0.141	0.461	T	0.051	0.647	D	3.838	0.518	23.4	0.983	0.392	0.090	0.147	N	c	-0.379	-0.646	0.337	0.195	0.706	0.609	0	-0.534	0.112	-0.052	0.117	0.068	0.175	0.002	0.151	0.001	0.043	4.128	0.095	.	.	.	0.5	102	511	1	1139047	chr1:1139047	C	A	102	PASS	DP=511;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	1139789	1139789	G	T	exonic	TNFRSF18	.	nonsynonymous SNV	TNFRSF18:NM_004195:exon3:c.C388A:p.P130T,TNFRSF18:NM_148901:exon3:c.C388A:p.P130T,TNFRSF18:NM_148902:exon3:c.C388A:p.P130T	8.37E-07	0.089996444	0.91000272	.	0.03798	0.16362	.	.	185.06659	2.95295	0.048	0.400	D	1.0	0.899	D	0.984	0.745	D	0.236	0.158	N	1	0.090	N	2.52	0.738	M	1.64	0.734	T	-5.58	0.889	D	0.539	0.586	-0.415	0.716	T	0.538	0.829	D	0.148	0.831	D	3.791	0.512	23.4	0.994	0.648	0.197	0.205	N	c	0.152	-0.066	0.985	0.308	0.646	0.450	0	3.55	0.396	1.678	0.370	1.048	0.713	0.467	0.265	0.047	0.162	10.935	0.463	TNFR/NGFR cysteine-rich region	.	.	0.5	.	67	1	1139789	chr1:1139789	G	T	.	PASS	DP=67;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	1159236	1159237	GG	-	exonic	SDF4	.	frameshift deletion	SDF4:NM_016176:exon3:c.438_439del:p.F146Lfs*5,SDF4:NM_016547:exon3:c.438_439del:p.F146Lfs*4	0.001309827	0.858724277	0.139965896	.	0.10366	0.35502	-0.598810865	18.13517339	109.15684	2.26829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	331	1	1159235	chr1:1159235	CGG	C	77	PASS	DP=331;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	1431048	1431048	A	G	exonic	ATAD3B	.	nonsynonymous SNV	ATAD3B:NM_001317238:exon14:c.A1660G:p.T554A,ATAD3B:NM_031921:exon16:c.A1798G:p.T600A	1.92E-13	0.056353554	0.943646446	.	0.08529	0.12376	2.166192036	98.0301958	6153.92777	16.40046	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.090	0.204	N	1	0.090	N	-0.69	0.019	N	-3.18	0.931	D	-0.22	0.105	N	0.032	0.029	-0.608	0.645	T	0.425	0.769	T	.	.	.	-2.193	0.006	0.001	0.224	0.009	0.006	0.026	N	c	-1.752	-1.824	0.002	0.087	0.707	0.730	0	-1.67	0.078	-0.884	0.042	-0.570	0.046	0.000	0.063	0.001	0.043	2.044	0.033	.	.	.	0.5	.	339	1	1431048	chr1:1431048	A	G	.	PASS	DP=339;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	1431060	1431060	T	C	exonic	ATAD3B	.	nonsynonymous SNV	ATAD3B:NM_001317238:exon14:c.T1672C:p.Y558H,ATAD3B:NM_031921:exon16:c.T1810C:p.Y604H	1.92E-13	0.056353554	0.943646446	.	0.08529	0.12376	2.166192036	98.0301958	6153.92777	16.40046	0.602	0.056	T	0.0	0.026	B	0.0	0.013	B	0.371	0.044	U	1	0.090	N	-0.69	0.019	N	-3.43	0.944	D	-0.05	0.078	N	0.072	0.097	-0.401	0.720	T	0.539	0.830	D	.	.	.	-1.923	0.009	0.001	0.220	0.009	0.006	0.026	N	c	-1.783	-1.863	0.002	0.089	0.707	0.730	0	-2.41	0.061	-1.313	0.028	-1.859	0.006	0.000	0.063	0.000	0.016	2.734	0.049	.	.	.	0.5	146	575	1	1431060	chr1:1431060	T	C	146	PASS	DP=575;AN=4	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/1	./.
1	1581191	1581191	G	-	intronic	CDK11B	.	.	.	0.72829444	0.271588478	0.000117082	.	.	0.14135	.	.	147.53387	2.64628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	43	1	1581190	chr1:1581190	TG	T	42	PASS	DP=43;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	1647893	1647893	-	TTTCTT	exonic	CDK11A;CDK11B	.	nonframeshift insertion	CDK11B:NM_001291345:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11A:NM_001313896:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11A:NM_001313982:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11B:NM_001787:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11A:NM_024011:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11B:NM_033486:exon5:c.379_380insAAGAAA:p.E126_R127insKE,CDK11A:NM_033529:exon5:c.349_350insAAGAAA:p.E116_R117insKE,CDK11B:NM_033489:exon6:c.277_278insAAGAAA:p.E92_R93insKE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	164	1	1647893	chr1:1647893	C	CTTTCTT	148	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	1670432	1670432	T	C	exonic	SLC35E2	.	synonymous SNV	SLC35E2:NM_182838:exon3:c.A387G:p.L129L,SLC35E2:NM_001199787:exon4:c.A387G:p.L129L	0.374305908	0.578735512	0.04695858	.	0.08723	.	.	.	124.71343	2.42805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	442	1	1670432	chr1:1670432	T	C	140	PASS	DP=442;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	2409906	2409906	C	T	intronic	PLCH2	.	.	.	1.71E-08	0.841467316	0.158532667	.	0.16736	0.10113	.	.	562.69013	4.81563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	369	1	2409906	chr1:2409906	C	T	98	PASS	DP=369;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	3379602	3379602	C	T	intronic	ARHGEF16	.	.	.	9.37E-08	0.510068048	0.489931858	.	0.16223	0.1412	0.246221394	69.56829441	336.90376	3.89866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	513	1	3379602	chr1:3379602	C	T	117	PASS	DP=513;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	3421897	3421897	A	G	exonic	MEGF6	.	nonsynonymous SNV	MEGF6:NM_001409:exon17:c.T2063C:p.L688P	4.42E-15	0.994620434	0.005379566	.	0.11042	0.09881	2.072624965	97.81198396	6730.46373	17.39874	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.237	0.158	N	1	0.090	P	-1.3	0.007	N	2.57	0.136	T	5.68	0.000	N	0.032	0.452	-0.927	0.446	T	0.000	0.000	T	.	.	.	-0.904	0.036	0.025	0.046	0.000	0.007	0.029	N	c	-1.324	-1.215	1.000	0.500	0.507	0.198	0	2.53	0.295	1.398	0.339	0.076	0.183	0.004	0.165	0.070	0.176	8.044	0.295	EGF-like domain|EGF-like, conserved site|Growth factor receptor cysteine-rich domain|Laminin EGF domain;Laminin EGF domain	.	.	0.5	121	95	1	3421897	chr1:3421897	A	G	121	PASS	DP=95;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	3542442	3542442	A	G	exonic	TPRG1L	.	synonymous SNV	TPRG1L:NM_182752:exon3:c.A459G:p.K153K	0.002845285	0.803826308	0.193328407	.	0.15732	0.10917	-0.117432389	44.89266336	7.9088	0.2904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	42	1	3542442	chr1:3542442	A	G	51	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	6209363	6209363	T	C	exonic	CHD5	.	synonymous SNV	CHD5:NM_015557:exon8:c.A1104G:p.V368V	0.999999995	4.88E-09	1.01E-23	DISEASE: Note=Defects in CHD5 may be a cause of the development of cancers from epithelial, neural and hematopoietic origin. CHD5 is one of the missing genes in the del(1p36), a deletion which is extremely common in this type of cancers. A decrease of its expression, results in increased susceptibility of cells to Ras- mediated transformation in vitro and in vivo (PubMed:17289567). {ECO:0000269|PubMed:17289567}.; 	0.29125	0.11641	-3.065544169	0.489502241	139.76253	2.5774	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	15	1	6209363	chr1:6209363	T	C	83	PASS	DP=15;AN=2	GT	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	8424165	8424165	T	G	exonic	RERE	.	nonsynonymous SNV	RERE:NM_001042682:exon5:c.A29C:p.D10A,RERE:NM_001042681:exon15:c.A1691C:p.D564A,RERE:NM_012102:exon16:c.A1691C:p.D564A	0.999995655	4.34E-06	1.54E-16	DISEASE: Note=A chromosomal aberration involving RERE is found in the neuroblastoma cell line NGP. Translocation t(1;15)(p36.2;q24).; 	0.87038	0.13942	-2.629516077	0.784383109	607.52718	4.98583	0.009	0.682	D	0.999	0.764	D	0.994	0.807	D	.	.	.	1	0.810	D	1.15	0.294	L	3.46	0.053	T	-2.91	0.630	D	0.83	0.818	-0.908	0.471	T	0.027	0.114	T	0.029	0.513	D	4.919	0.661	25.0	0.981	0.381	0.993	0.938	D	c	0.451	0.509	1.000	0.747	0.719	0.830	0	5.17	0.707	7.448	0.795	1.061	0.807	1.000	0.715	1.000	0.888	14.340	0.660	.	.	.	0.5	176	123	1	8424165	chr1:8424165	T	G	176	PASS	DP=123;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
1	10754479	10754479	C	G	intronic	CASZ1	.	.	.	0.999938476	6.15E-05	4.86E-13	.	0.71675	0.27528	-2.416721768	1.055673508	1083.53567	6.31123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	154	1172	1	10754479	chr1:10754479	C	G	154	PASS	DP=1172;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	11008497	11008497	G	C	exonic	C1orf127	.	synonymous SNV	C1orf127:NM_001170754:exon12:c.C1695G:p.G565G	1.33E-05	0.955388217	0.044598438	.	0.1648	.	0.986521626	90.48124558	1056.79352	6.24152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	15	1	11008497	chr1:11008497	G	C	87	PASS	DP=15;AN=2	GT	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	11254843	11254843	T	C	intronic	ANGPTL7;MTOR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	31	1	11254843	chr1:11254843	T	C	67	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	12853439	12853439	G	-	exonic	PRAMEF1	.	frameshift deletion	PRAMEF1:NM_023013:exon2:c.63delG:p.A22Pfs*30	0.098105164	0.866728022	0.035166815	.	0.09477	.	1.668219306	96.30219391	173.2434	2.8653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	151	367	1	12853438	chr1:12853438	AG	A	151	PASS	DP=367;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	12855740	12855740	C	A	exonic	PRAMEF1	.	synonymous SNV	PRAMEF1:NM_001294139:exon2:c.C285A:p.L95L,PRAMEF1:NM_023013:exon4:c.C1020A:p.L340L	0.098105164	0.866728022	0.035166815	.	0.09477	.	1.668219306	96.30219391	173.2434	2.8653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	320	1	12855740	chr1:12855740	C	A	131	PASS	DP=320;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	12939549	12939549	G	A	exonic	PRAMEF4	.	nonsynonymous SNV	PRAMEF4:NM_001009611:exon4:c.C1253T:p.P418L	0.074609525	0.872447591	0.052942885	.	0.14569	.	3.532159363	99.48100967	1356.98129	6.91114	0.011	0.555	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.090	N	3.12	0.881	M	2.77	0.114	T	-9.32	0.983	D	0.404	0.463	-1.116	0.026	T	0.081	0.320	T	0.001	0.014	T	3.327	0.458	22.9	0.988	0.463	0.066	0.125	N	c	-0.046	-0.380	0.000	0.012	0.487	0.133	0	1.48	0.218	3.100	0.497	0.677	0.295	0.672	0.281	0.056	0.168	6.456	0.210	.	.	.	0.5	103	218	1	12939549	chr1:12939549	G	A	103	PASS	DP=218;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	13183472	13183472	G	A	exonic	HNRNPCL2	.	nonsynonymous SNV	HNRNPCL2:NM_001136561:exon2:c.C401T:p.P134L	.	.	.	.	.	.	.	.	.	.	.	.	.	0.94	0.508	P	0.824	0.575	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.366	0.427	.	.	.	.	.	.	.	.	.	0.018	0.095	2.760	0.602	0.063	0.418	0.265	N	n	0.095	0.293	0.000	0.070	0.165	0.031	0	0.149	0.141	0.506	0.222	0.231	0.259	1.000	0.715	0.016	0.126	6.015	0.187	.	.	.	0.5	75	25	1	13183472	chr1:13183472	G	A	75	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	13183492	13183492	T	C	exonic	HNRNPCL2	.	synonymous SNV	HNRNPCL2:NM_001136561:exon2:c.A381G:p.P127P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	182	1	13183492	chr1:13183492	T	C	108	PASS	DP=182;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	13353904	13353904	A	C	intronic	PRAMEF18	.	.	.	.	.	.	.	.	.	.	.	287.00244	3.6298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	301	1	13353904	chr1:13353904	A	C	95	PASS	DP=301;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	16363158	16363158	G	A	intergenic	CLCNKA;CLCNKB	dist=2613;dist=7073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	267	1	16363158	chr1:16363158	G	A	139	PASS	DP=267;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	16812113	16812113	G	A	ncRNA_exonic	CROCCP3	.	.	.	.	.	.	.	0.06928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	304	1	16812113	chr1:16812113	G	A	148	PASS	DP=304;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	16890428	16890428	T	A	UTR3	NBPF1	NM_017940:c.*10A>T	.	.	.	.	.	.	.	.	.	.	10963.86792	22.82724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	126	1	16890428	chr1:16890428	T	A	79	PASS	DP=126;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	16945409	16945409	T	A	ncRNA_exonic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	191	1	16945409	chr1:16945409	T	A	.	PASS	DP=191;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	16945673	16945673	A	G	ncRNA_intronic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	248	1	16945673	chr1:16945673	A	G	144	PASS	DP=248;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	16952267	16952267	T	C	ncRNA_intronic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	189	1	16952267	chr1:16952267	T	C	103	PASS	DP=189;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	16953827	16953827	-	C	ncRNA_intronic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	146	1	16953827	chr1:16953827	G	GC	145	PASS	DP=146;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	16955037	16955037	C	G	ncRNA_exonic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	1546	1	16955037	chr1:16955037	C	G	116	PASS	DP=1546;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	16957374	16957374	C	T	ncRNA_intronic	CROCCP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	439	1	16957374	chr1:16957374	C	T	.	PASS	DP=439;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	17019445	17019445	G	T	ncRNA_intronic	ESPNP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	621	1	17019445	chr1:17019445	G	T	101	PASS	DP=621;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	17020506	17020526	GTACCTCCAGCCCTCGCGGGG	-	ncRNA_intronic	ESPNP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	219	1	17020505	chr1:17020505	AGTACCTCCAGCCCTCGCGGGG	A	98	PASS	DP=219;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	17084831	17084831	C	G	ncRNA_intronic	LOC102724562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	201	1	17084831	chr1:17084831	C	G	152	PASS	DP=201;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	17085030	17085030	C	T	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon11:c.G1445A:p.R482H	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	377	1	17085030	chr1:17085030	C	T	.	PASS	DP=377;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	17085791	17085791	G	A	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon8:c.C1030T:p.R344C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	424	1	17085791	chr1:17085791	G	A	.	PASS	DP=424;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	17086941	17086941	C	T	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon4:c.G383A:p.R128H	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	654	1	17086941	chr1:17086941	C	T	150	PASS	DP=654;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	17087459	17087459	A	G	exonic	MST1L	.	nonsynonymous SNV	MST1L:NM_001271733:exon2:c.T206C:p.M69T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	824	1	17087459	chr1:17087459	A	G	126	PASS	DP=824;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	17266616	17266616	A	G	intronic	CROCC	.	.	.	4.71E-20	0.643040868	0.356959132	.	.	0.15832	2.431142199	98.53149328	3783.54242	12.05321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	191	1	17266616	chr1:17266616	A	G	131	PASS	DP=191;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	17272044	17272044	A	G	exonic	CROCC	.	synonymous SNV	CROCC:NM_014675:exon15:c.A2079G:p.T693T	4.71E-20	0.643040868	0.356959132	.	.	0.15832	2.431142199	98.53149328	3783.54242	12.05321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	216	1	17272044	chr1:17272044	A	G	84	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	19018335	19018335	C	T	exonic	PAX7	.	nonsynonymous SNV	PAX7:NM_001135254:exon5:c.C674T:p.T225M,PAX7:NM_002584:exon5:c.C674T:p.T225M,PAX7:NM_013945:exon5:c.C668T:p.T223M	0.6298293	0.369864652	0.000306048	DISEASE: Rhabdomyosarcoma 2 (RMS2) [MIM:268220]: A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas. {ECO:0000269|PubMed:8187070}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving PAX7 is found in rhabdomyosarcoma. Translocation t(1;13)(p36;q14) with FOXO1. The resulting protein is a transcriptional activator. {ECO:0000269|PubMed:8187070}.; 	0.89869	0.34974	-1.109541557	6.782259967	76.81981	1.83979	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.27	0.982	H	-4.36	0.973	D	-4.96	0.829	D	0.931	0.931	1.038	0.979	D	0.977	0.993	D	0.634	0.969	D	7.067	0.940	33	0.999	0.988	0.974	0.742	D	c	1.093	0.948	1.000	0.747	0.487	0.133	0	4.98	0.655	7.871	0.854	0.935	0.490	1.000	0.715	0.997	0.653	16.819	0.855	Homeobox domain|Homeodomain-like	.	.	0.5	71	181	1	19018335	chr1:19018335	C	T	71	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	19476308	19476308	A	-	intronic	UBR4	.	.	.	1	2.43E-23	4.94E-62	.	0.25731	0.12662	-7.504914615	0.011795235	2894.47418	10.19251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	37	1	19476307	chr1:19476307	GA	G,GAA	61	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	19476308	19476308	-	A	intronic	UBR4	.	.	.	1	2.43E-23	4.94E-62	.	0.25731	0.12662	-7.504914615	0.011795235	2894.47418	10.19251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	37	1	19476307	chr1:19476307	GA	G,GAA	61	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	21754226	21754226	A	C	intergenic	ECE1;NBPF3	dist=82192;dist=12357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	142	1	21754226	chr1:21754226	A	C	64	PASS	DP=142;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	21799967	21799967	A	T	exonic	NBPF3	.	nonsynonymous SNV	NBPF3:NM_001256417:exon6:c.A619T:p.N207Y,NBPF3:NM_001256416:exon7:c.A829T:p.N277Y,NBPF3:NM_032264:exon7:c.A829T:p.N277Y,NBPF3:NM_001330381:exon11:c.A661T:p.N221Y	1.98E-11	0.378787942	0.621212058	.	0.06699	.	3.60019308	99.52819061	1664.61558	7.53254	0.093	0.682	T	0.999	0.764	D	0.986	0.754	D	.	.	.	1	0.090	N	2.255	0.644	M	3.43	0.055	T	-5.21	0.861	D	0.052	0.494	-1.044	0.162	T	0.034	0.148	T	0.001	0.005	T	1.153	0.205	11.50	0.538	0.049	0.001	0.006	N	c	-0.688	-1.038	0.006	0.111	0.615	0.372	0	-1.8	0.074	-1.030	0.037	-0.882	0.027	0.000	0.063	0.000	0.016	2.840	0.051	Neuroblastoma breakpoint family (NBPF) domain	.	.	0.5	.	76	1	21799967	chr1:21799967	A	T	.	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	22030891	22030891	-	A	intronic	USP48	.	.	.	0.999997429	2.57E-06	2.13E-16	.	0.10091	0.10216	-0.556537043	19.72753008	115.55589	2.33734	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	22	1	22030891	chr1:22030891	C	CA	55	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	22032222	22032223	TT	-	exonic	USP48	.	frameshift deletion	USP48:NM_001350164:exon18:c.2180_2181del:p.K727Tfs*8,USP48:NM_001330394:exon19:c.2381_2382del:p.K794Tfs*8,USP48:NM_001350166:exon19:c.2375_2376del:p.K792Tfs*8,USP48:NM_001350167:exon19:c.2378_2379del:p.K793Tfs*8,USP48:NM_001350168:exon19:c.2378_2379del:p.K793Tfs*8,USP48:NM_032236:exon19:c.2381_2382del:p.K794Tfs*8	0.999997429	2.57E-06	2.13E-16	.	0.10091	0.10216	-0.556537043	19.72753008	115.55589	2.33734	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	16	1	22032221	chr1:22032221	GTT	G	39	PASS	DP=16;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	22033386	22033386	A	-	intronic	USP48	.	.	.	0.999997429	2.57E-06	2.13E-16	.	0.10091	0.10216	-0.556537043	19.72753008	115.55589	2.33734	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	114	1	22033385	chr1:22033385	GA	G	57	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	22304831	22304831	C	A	intronic	CELA3B	.	.	.	2.12E-10	0.035783176	0.964216824	.	0.26327	.	1.732552414	96.59707478	690.96911	5.24243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	352	1	22304831	chr1:22304831	C	A	148	PASS	DP=352;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	22332319	22332319	G	A	intronic	CELA3A	.	.	.	9.82E-08	0.312809271	0.68719063	.	0.69428	0.10766	-0.356299879	29.31115829	985.05923	6.05314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	356	1	22332319	chr1:22332319	G	A	77	PASS	DP=356;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
1	22913150	22913150	C	T	intronic	EPHA8	.	.	.	1.14E-08	0.983030391	0.016969598	.	0.32535	0.12252	0.130330208	63.21066289	1372.14313	6.94837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	540	1	22913150	chr1:22913150	C	T	109	PASS	DP=540;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	22922560	22922560	G	A	intronic	EPHA8	.	.	.	1.14E-08	0.983030391	0.016969598	.	0.32535	0.12252	0.130330208	63.21066289	1372.14313	6.94837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	161	148	1	22922560	chr1:22922560	G	A	161	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.	./.
1	22928168	22928168	C	A	exonic	EPHA8	.	synonymous SNV	EPHA8:NM_020526:exon17:c.C2952A:p.I984I	1.14E-08	0.983030391	0.016969598	.	0.32535	0.12252	0.130330208	63.21066289	1372.14313	6.94837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	1	22928168	chr1:22928168	C	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	23695969	23695969	G	C	ncRNA_exonic	ZNF436-AS1	.	.	.	.	.	.	.	0.12418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	429	1	23695969	chr1:23695969	G	C	104	PASS	DP=429;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	23954441	23954441	C	T	UTR5	MDS2	NM_001348075:c.-1604C>T	.	.	0.042965573	0.662011892	0.295022535	.	0.06917	.	.	.	3048.37206	10.49529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	193	1	23954441	chr1:23954441	C	T	58	PASS	DP=193;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	24120833	24120833	C	-	intronic	LYPLA2	.	.	.	0.979519145	0.020463866	1.70E-05	.	0.20635	0.10011	-0.295622497	32.61972163	4.69509	0.16866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	543	1	24120832	chr1:24120832	AC	A	83	PASS	DP=543;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	24859501	24859501	C	-	intronic	RCAN3	.	.	.	0.003206422	0.823874218	0.17291936	.	0.14079	0.09206	-0.139478553	43.29440906	123.07433	2.41603	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.22	68	1	24859500	chr1:24859500	TC	T	10.22	PASS	DP=68;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	24987906	24987906	-	T	intronic	SRRM1	.	.	.	0.999999022	9.78E-07	2.02E-17	.	0.5312	0.11301	-0.929520514	9.683887709	90.5423	2.04787	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.15	47	1	24987906	chr1:24987906	G	GT	11.15	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	24999256	24999256	C	A	UTR3	SRRM1	NM_001303448:c.*479C>A;NM_005839:c.*479C>A;NM_001303449:c.*479C>A	.	.	0.999999022	9.78E-07	2.02E-17	.	0.5312	0.11301	-0.929520514	9.683887709	90.5423	2.04787	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	13	1	24999256	chr1:24999256	C	A	.	PASS	DP=13;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	26612292	26612292	C	-	intronic	UBXN11	.	.	.	1.20E-10	0.308498839	0.691501161	.	0.10438	0.20558	1.201528238	93.00542581	1513.39604	7.23123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	309	1	26612291	chr1:26612291	AC	A	84	PASS	DP=309;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	26663747	26663747	C	A	exonic	CRYBG2	.	synonymous SNV	CRYBG2:NM_001039775:exon10:c.G3768T:p.R1256R	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	240	1	26663747	chr1:26663747	C	A	80	PASS	DP=240;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	26781228	26781228	T	-	intronic	DHDDS	.	.	.	0.704700923	0.295148752	0.000150325	.	0.13611	0.82506	-0.093566408	46.7386176	3214.14466	10.80738	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	140	1	26781227	chr1:26781227	GT	G	63	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	27107159	27107159	G	A	exonic	ARID1A	.	nonsynonymous SNV	ARID1A:NM_006015:exon20:c.G6770A:p.R2257Q,ARID1A:NM_139135:exon20:c.G6119A:p.R2040Q	0.999999997	3.36E-09	9.91E-23	.	0.54895	0.15082	-2.670076378	0.743099788	409.71816	4.24329	0.001	0.784	D	1.0	0.899	D	0.996	0.832	D	0.000	0.843	D	1.000	0.588	D	2.195	0.620	M	0.86	0.468	T	-3.54	0.686	D	0.412	0.936	-0.523	0.678	T	0.277	0.649	T	0.016	0.368	T	4.965	0.668	25.1	0.999	0.994	0.973	0.739	D	c	0.804	0.774	1.0	0.983	0.707	0.730	0	4.6	0.564	9.665	0.979	0.902	0.416	1.000	0.715	1.000	0.888	17.964	0.890	Armadillo-type fold	.	.	0.5	.	123	1	27107159	chr1:27107159	G	A	.	PASS	DP=123;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	27722052	27722052	G	C	UTR3	GPR3	NM_005281:c.*757G>C	.	.	0.020935797	0.751114613	0.22794959	.	0.64069	0.11438	0.060756528	58.52795471	114.40031	2.33012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	287	1	27722052	chr1:27722052	G	C	.	PASS	DP=287;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	29189597	29189597	C	T	exonic	OPRD1	.	synonymous SNV	OPRD1:NM_000911:exon3:c.C921T:p.G307G	0.109062189	0.776662875	0.114274936	.	0.38858	0.34596	-0.139478553	43.29440906	296.04535	3.67407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	153	1	29189597	chr1:29189597	C	T	137	PASS	DP=153;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	31838651	31838651	C	A	UTR3	FABP3	NM_001320996:c.*82G>T;NM_004102:c.*82G>T	.	.	0.354913337	0.591610018	0.053476645	.	0.1867	.	0.191216164	66.57230479	91.66803	2.05891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	1	31838651	chr1:31838651	C	A	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	36203589	36203589	T	A	intronic	CLSPN	.	.	.	0.991559393	0.008440607	5.43E-12	.	0.45114	.	0.744001103	86.37650389	5854.71385	15.86316	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	174	1	36203589	chr1:36203589	T	A	58	PASS	DP=174;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	36282441	36282441	-	A	intronic	AGO4	.	.	.	0.990043812	0.009956187	9.81E-10	.	0.08477	0.14026	-0.890882376	10.30313753	19.9687	0.68036	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	157	1	36282441	chr1:36282441	G	GA	69	PASS	DP=157;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	36306854	36306854	G	C	exonic	AGO4	.	nonsynonymous SNV	AGO4:NM_017629:exon14:c.G1813C:p.A605P	0.990043812	0.009956187	9.81E-10	.	0.08477	0.14026	-0.890882376	10.30313753	19.9687	0.68036	0.001	0.784	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	4.44	0.988	H	0.99	0.418	T	-4.84	0.810	D	0.975	0.976	0.265	0.870	D	0.473	0.798	T	0.047	0.630	D	6.082	0.838	28.2	0.997	0.839	0.993	0.935	D	c	1.132	1.047	1.000	0.747	0.651	0.465	0	6.01	0.974	7.907	0.867	1.044	0.665	1.000	0.715	0.981	0.494	20.521	0.992	Piwi domain|Ribonuclease H-like domain	.	.	0.5	97	368	1	36306854	chr1:36306854	G	C	97	PASS	DP=368;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	36926898	36926898	C	T	exonic	MRPS15	.	synonymous SNV	MRPS15:NM_031280:exon4:c.G267A:p.V89V	0.000342016	0.949346717	0.050311267	.	0.10308	0.06601	-0.093566408	46.7386176	163.76941	2.79543	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	1	36926898	chr1:36926898	C	T	.	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	37958258	37958258	G	A	UTR3	MEAF6	NM_022756:c.*1442C>T;NM_001270876:c.*1112C>T;NM_001270875:c.*1442C>T	.	.	0.730388139	0.269048652	0.000563209	DISEASE: Note=A chromosomal aberration involving MEAF6 may be a cause of endometrial stromal tumors. Translocation t(1;6)(p34;p21) with PHF1. {ECO:0000269|PubMed:22761769}.; 	0.18507	0.10264	-0.09720619	46.20193442	5.77712	0.21811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	1	37958258	chr1:37958258	G	A	.	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	42776700	42776700	A	-	intronic	FOXJ3	.	.	.	0.977575009	0.022424814	1.76E-07	.	0.75216	0.14428	0.286674996	71.49681529	467.55831	4.48092	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	125	1	42776699	chr1:42776699	GA	G	75	PASS	DP=125;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	45267235	45267235	A	T	intronic	PLK3	.	.	.	6.25E-05	0.994577898	0.00535961	.	0.29709	0.18462	-1.109541557	6.782259967	54.52333	1.47654	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	210	1	45267235	chr1:45267235	A	T	.	PASS	DP=210;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	46082112	46082112	T	G	intronic	NASP	.	.	.	0.4702163	0.529737965	4.57E-05	.	0.82873	0.14655	-0.176292081	40.56381222	111.92131	2.30362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	109	1	46082112	chr1:46082112	T	G	45	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	47325354	47325354	G	A	ncRNA_exonic	CYP4Z2P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	71	1	47325354	chr1:47325354	G	A	69	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	47338888	47338888	C	A	ncRNA_intronic	CYP4Z2P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	51	1	47338888	chr1:47338888	C	A	133	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
1	49202109	49202109	C	T	exonic	BEND5	.	nonsynonymous SNV	BEND5:NM_001349793:exon4:c.G403A:p.G135R,BEND5:NM_001302082:exon5:c.G403A:p.G135R,BEND5:NM_024603:exon5:c.G910A:p.G304R,BEND5:NM_001349794:exon6:c.G403A:p.G135R,BEND5:NM_001349795:exon7:c.G655A:p.G219R	0.114990689	0.857716612	0.027292699	.	0.62579	0.11262	-0.271755481	34.31823543	38.21221	1.13413	0.002	0.721	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	1.245	0.315	L	.	.	.	-4.7	0.798	D	0.92	0.911	-0.708	0.601	T	0.236	0.603	T	0.017	0.385	T	7.505	0.952	34	0.999	0.990	0.957	0.654	D	c	0.521	0.574	1.000	0.747	0.706	0.609	0	5.35	0.762	5.787	0.684	0.935	0.490	1.000	0.715	1.000	0.888	18.038	0.892	BEN domain	.	.	0.5	.	26	1	49202109	chr1:49202109	C	T	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	51767912	51767912	-	C	intronic	TTC39A	.	.	.	0.098310255	0.901370177	0.000319568	.	0.30275	.	-0.358119787	29.16371786	40.28663	1.18371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	440	1	51767912	chr1:51767912	G	GC	122	PASS	DP=440;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	0/1	./.	./.	./.	./.
1	53308644	53308644	A	C	exonic	ZYG11A	.	nonsynonymous SNV	ZYG11A:NM_001004339:exon1:c.A89C:p.Q30P	.	.	.	.	0.11936	.	0.837848571	88.22835574	323.85912	3.82518	0.006	0.614	D	0.911	0.484	P	0.461	0.446	P	0.199	0.166	U	1	0.810	D	2.095	0.583	M	0.89	0.456	T	-1.43	0.352	N	0.626	0.650	-1.062	0.114	T	0.091	0.348	T	0.041	0.598	D	5.178	0.699	25.5	0.991	0.531	0.671	0.331	D	c	0.116	0.130	1.000	0.747	0.564	0.319	0	4.03	0.459	1.125	0.307	0.939	0.529	1.000	0.715	0.987	0.523	9.272	0.367	.	.	.	0.5	.	144	1	53308644	chr1:53308644	A	C	.	PASS	DP=144;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	53351594	53351594	-	T	intronic	ZYG11A	.	.	.	.	.	.	.	0.11936	.	0.837848571	88.22835574	323.85912	3.82518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	174	1	53351594	chr1:53351594	C	CT	59	PASS	DP=174;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	0/1	./.	./.	./.
1	54871576	54871576	C	T	intronic	SSBP3	.	.	.	0.999756196	0.000243804	3.40E-10	.	0.15537	0.08395	-0.648365105	16.35999056	29.52993	0.94347	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	65	1	54871576	chr1:54871576	C	T	.	PASS	DP=65;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	55352523	55352523	C	T	intronic	DHCR24	.	.	.	0.969136893	0.030861185	1.92E-06	.	0.19237	0.23658	-0.822919685	11.76574664	93.19943	2.07714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	1	55352523	chr1:55352523	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	61331108	61331108	C	T	intergenic	LOC101926964;NFIA-AS2	dist=39852;dist=74808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	1	61331108	chr1:61331108	C	T	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	62175139	62175139	-	T	intronic	TM2D1	.	.	.	0.042061483	0.929476013	0.028462504	.	0.34406	0.09894	.	.	115.6404	2.33925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	59	1	62175139	chr1:62175139	A	AT	63	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	62189460	62189460	-	A	intronic	TM2D1	.	.	.	0.042061483	0.929476013	0.028462504	.	0.34406	0.09894	.	.	115.6404	2.33925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.77	37	1	62189460	chr1:62189460	T	TA	14.77	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	65211089	65211089	G	A	exonic	RAVER2	.	synonymous SNV	RAVER2:NM_018211:exon1:c.G234A:p.Q78Q	1.86E-06	0.968062953	0.031935187	.	0.16139	0.09116	-0.113792788	45.25831564	48.72242	1.36171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	162	1	65211089	chr1:65211089	G	A	98	PASS	DP=162;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	65325970	65325970	C	T	intronic	JAK1	.	.	.	0.99590968	0.00409032	2.26E-11	.	0.95076	0.17388	-1.330032624	4.688605803	66.80502	1.68715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	77	1	65325970	chr1:65325970	C	T	59	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	66102431	66102431	C	T	exonic	LEPR	.	synonymous SNV	LEPR:NM_002303:exon20:c.C3231T:p.I1077I	0.999805342	0.000194658	8.04E-12	DISEASE: Leptin receptor deficiency (LEPRD) [MIM:614963]: A rare disease characterized by normal levels of serum leptin, hyperphagia and severe obesity from an early age. Additional features include alterations in immune function, and delayed puberty due to hypogonadotropic hypogonadism. {ECO:0000269|PubMed:9537324}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.55299	0.08243	-0.216746887	37.69757018	2800.90586	9.9929	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	17	1	66102431	chr1:66102431	C	T	.	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	68628198	68628198	A	G	ncRNA_intronic	GNG12-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	187	148	1	68628198	chr1:68628198	A	G	187	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.
1	70385205	70385205	C	G	ncRNA_exonic	PIN1P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	143	789	1	70385205	chr1:70385205	C	G	143	PASS	DP=789;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	70504364	70504364	C	A	exonic	LRRC7	.	nonsynonymous SNV	LRRC7:NM_020794:exon19:c.C2743A:p.R915S,LRRC7:NM_001350216:exon21:c.C2860A:p.R954S,LRRC7:NM_001330635:exon22:c.C2758A:p.R920S	0.999998533	1.47E-06	1.10E-17	.	0.42578	0.12755	-1.368693559	4.482189196	157.64981	2.74333	0.046	0.506	D	0.312	0.311	B	0.14	0.321	B	0.005	0.334	N	0.981	0.403	D	0.695	0.181	N	1.24	0.367	T	-0.55	0.168	N	0.663	0.747	-1.089	0.057	T	0.045	0.195	T	0.008	0.217	T	2.963	0.416	22.1	0.993	0.596	0.925	0.555	D	c	-0.078	0.089	0.993	0.329	0.487	0.133	0	5.67	0.876	3.398	0.521	0.892	0.403	1.000	0.715	0.986	0.517	18.749	0.917	.	.	.	0.5	.	37	1	70504364	chr1:70504364	C	A	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	74575212	74575212	-	T	exonic	LRRIQ3	.	frameshift insertion	LRRIQ3:NM_001105659:exon5:c.732dupA:p.Q245Tfs*6,LRRIQ3:NM_001322315:exon5:c.732dupA:p.Q245Tfs*6	3.22E-15	0.005170825	0.994829175	.	0.06919	.	1.379742765	94.60368011	1020.69778	6.14814	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	26	1	74575212	chr1:74575212	G	GT	51	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	74818936	74818936	-	T	intronic	FPGT-TNNI3K;TNNI3K	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	35	1	74818936	chr1:74818936	G	GT	65	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	75038228	75038228	A	C	exonic	ERICH3	.	nonsynonymous SNV	ERICH3:NM_001002912:exon14:c.T3166G:p.L1056V	.	.	.	.	0.15022	.	2.043117123	97.75300778	.	.	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-1.59	0.004	N	2.83	0.108	T	0.78	0.019	N	0.015	0.002	-0.900	0.480	T	0.003	0.010	T	.	.	.	-1.961	0.008	0.001	0.044	0.000	0.001	0.005	N	c	-1.321	-1.249	0.000	0.035	0.549	0.223	0	2.51	0.293	0.067	0.143	-0.095	0.117	0.000	0.063	0.014	0.122	7.414	0.260	.	.	.	1	147	46	1	75038228	chr1:75038228	A	C	147	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	1/1	./.	./.	./.	./.	./.
1	78414382	78414385	CATC	-	UTR3	FUBP1	NM_003902:c.*69_*66delGATG;NM_001303433:c.*69_*66delGATG	.	.	0.999972831	2.72E-05	1.62E-12	.	0.60917	0.16996	-0.291981272	33.20358575	48.41037	1.35624	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	17.95	31	1	78414381	chr1:78414381	GCATC	G	17.95	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	84355735	84355748	AGAACTTCAAGGAT	-	intronic	TTLL7	.	.	.	0.268072469	0.731927454	7.64E-08	.	0.20746	0.09426	-0.754958418	13.57631517	77.26727	1.8459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	24	1	84355734	chr1:84355734	AAGAACTTCAAGGAT	A	106	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
1	89289954	89289954	-	T	intronic	PKN2	.	.	.	0.999995223	4.78E-06	4.75E-15	.	0.52957	0.18687	-1.065444789	7.425100259	146.59854	2.63771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	27	1	89289954	chr1:89289954	A	AT	52	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	89446108	89446108	T	-	UTR3	RBMXL1	NM_019610:c.*2229delA;NM_001162536:c.*2229delA	.	.	0.119596956	0.87492457	0.005478474	.	0.20063	.	0.72761005	86.08162302	80.60629	1.89749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.93	82	1	89446107	chr1:89446107	AT	A	13.93	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	89449508	89449508	-	T	exonic	RBMXL1	.	frameshift insertion	RBMXL1:NM_019610:exon2:c.1dupA:p.M1Nfs*2,RBMXL1:NM_001162536:exon3:c.1dupA:p.M1Nfs*2	0.119596956	0.87492457	0.005478474	.	0.20063	.	0.72761005	86.08162302	80.60629	1.89749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	120	1	89449508	chr1:89449508	A	AT	69	PASS	DP=120;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	94544155	94544155	G	A	exonic	ABCA4	.	synonymous SNV	ABCA4:NM_000350:exon10:c.C1347T:p.N449N	1.27E-28	0.894718807	0.105281193	DISEASE: Fundus flavimaculatus (FFM) [MIM:248200]: Autosomal recessive retinal disorder very similar to Stargardt disease. In contrast to Stargardt disease, FFM is characterized by later onset and slowly progressive course. {ECO:0000269|PubMed:11379881, ECO:0000269|PubMed:11385708, ECO:0000269|PubMed:9781034}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:19028736, ECO:0000269|PubMed:9295268}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 3 (CORD3) [MIM:604116]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958761, ECO:0000269|PubMed:11385708, ECO:0000269|PubMed:11527935}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 19 (RP19) [MIM:601718]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP19 is characterized by choroidal atrophy. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09923	0.38763	0.736662821	86.30573248	3827.03692	12.16874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	77	1	94544155	chr1:94544155	G	A	.	PASS	DP=77;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	97981395	97981395	T	C	exonic	DPYD	.	nonsynonymous SNV	DPYD:NM_000110:exon13:c.A1627G:p.I543V	4.19E-09	0.996985954	0.003014042	.	0.29965	0.38628	1.431149089	95.02241095	1997.46528	8.23273	0.111	0.290	T	0.0	0.026	B	0.0	0.013	B	0.007	0.314	N	1.000	0.197	P	0.49	0.133	N	-0.8	0.739	T	0.73	0.021	N	0.023	0.006	-1.011	0.266	T	0.053	0.225	T	.	.	.	0.829	0.173	9.639	0.960	0.278	0.809	0.401	D	c	-1.000	-0.919	0.007	0.115	0.693	0.558	0	-3.13	0.049	1.397	0.339	-0.169	0.106	0.994	0.380	0.975	0.474	9.702	0.392	Aldolase-type TIM barrel|Dihydroorotate dehydrogenase domain	.	.	0.5	71	49	1	97981395	chr1:97981395	T	C	71	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	104116937	104116937	G	T	exonic	AMY2B	.	nonsynonymous SNV	AMY2B:NM_020978:exon7:c.G800T:p.R267L	7.65E-09	0.690335158	0.309664835	.	0.12126	0.38738	0.110306132	62.00165133	318.05085	3.78784	0.067	0.359	T	0.968	0.546	D	0.825	0.575	P	0.000	0.843	D	1.000	0.588	D	2.8	0.819	M	-4.78	0.981	D	-4.66	0.794	D	0.559	0.593	0.911	0.958	D	0.923	0.974	D	0.049	0.637	D	4.085	0.548	23.7	0.997	0.816	0.972	0.730	D	c	0.381	0.276	0.002	0.087	0.638	0.428	0	2.6	0.300	5.659	0.675	0.933	0.449	1.000	0.715	0.976	0.476	9.858	0.401	Glycoside hydrolase superfamily|Glycoside hydrolase, catalytic domain|Glycosyl hydrolase, family 13, catalytic domain|Glycosyl hydrolase, family 13, subfamily, catalytic domain	.	.	0.5	137	578	1	104116937	chr1:104116937	G	T	137	PASS	DP=578;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	110035318	110035318	-	T	UTR3	ATXN7L2	NM_001350174:c.*147_*148insT;NM_001350175:c.*96_*97insT;NM_001350177:c.*96_*97insT;NM_153340:c.*96_*97insT	.	.	0.718954812	0.280915691	0.000129497	.	0.26286	0.0743	-0.909290275	10.03184713	323.63888	3.82196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	337	1	110035318	chr1:110035318	A	AT	71	PASS	DP=337;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	110257506	110257506	G	C	intronic	GSTM5	.	.	.	0.000214167	0.736990281	0.262795552	.	0.04393	.	0.905808022	89.4373673	506.91274	4.62021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	169	1	110257506	chr1:110257506	G	C	.	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	110888159	110888159	A	T	splicing	RBM15	NM_022768:exon2:c.2864-2A>T	.	.	0.999853093	0.000146907	2.00E-11	DISEASE: Note=A chromosomal aberration involving RBM15 may be a cause of acute megakaryoblastic leukemia. Translocation t(1;22)(p13;q13) with MKL1. Although both reciprocal fusion transcripts are detected in acute megakaryoblastic leukemia (AMKL, FAB-M7), the RBM15-MKL1 chimeric protein has all the putative functional domains encoded by each gene and is the candidate oncogene. {ECO:0000269|PubMed:11344311, ECO:0000269|PubMed:11431691}.; 	0.41164	0.42963	-0.949752638	9.32413305	173.34726	2.86702	.	.	.	.	.	.	.	.	.	.	.	.	0.969	0.257	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2.828	0.401	21.5	0.952	0.258	0.126	0.172	N	c	0.597	0.331	1.000	0.747	0.123	0.025	0	3.94	0.446	0.311	0.190	1.199	0.960	0.000	0.063	0.984	0.507	8.451	0.319	.	.	.	0.5	.	32	1	110888159	chr1:110888159	A	T	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	110950493	110950493	G	T	ncRNA_exonic	LAMTOR5-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	665	1	110950493	chr1:110950493	G	T	109	PASS	DP=665;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	111026677	111026677	C	A	ncRNA_intronic	CYMP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	338	1	111026677	chr1:111026677	C	A	.	PASS	DP=338;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	112032260	112032260	G	A	intronic	TMIGD3	.	.	.	.	.	.	.	0.10089	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	37	1	112032260	chr1:112032260	G	A	78	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	112281744	112281744	C	A	intronic	FAM212B	.	.	.	0.003590517	0.84159666	0.154812824	.	0.09827	.	-0.60427181	17.74593064	22.74555	0.76057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	348	1	112281744	chr1:112281744	C	A	101	PASS	DP=348;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	113735255	113735255	T	-	intergenic	LRIG2;LOC643441	dist=67431;dist=4149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	171	1	113735254	chr1:113735254	CT	C	92	PASS	DP=171;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	114025435	114025435	-	T	intronic	MAGI3	.	.	.	0.570580157	0.429419836	7.05E-09	.	0.93064	0.10933	-0.925889687	9.754659118	136.27247	2.53739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	494	1	114025434	chr1:114025434	CT	CTT,C	107	PASS	DP=494;AN=6	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	0/1	0/2
1	114025435	114025435	T	-	intronic	MAGI3	.	.	.	0.570580157	0.429419836	7.05E-09	.	0.93064	0.10933	-0.925889687	9.754659118	136.27247	2.53739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	494	1	114025434	chr1:114025434	CT	CTT,C	107	PASS	DP=494;AN=6	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	0/1	0/2
1	114092112	114092112	T	-	intronic	MAGI3	.	.	.	0.570580157	0.429419836	7.05E-09	.	0.93064	0.10933	-0.925889687	9.754659118	136.27247	2.53739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	49	1	114092111	chr1:114092111	GT	G	66	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	115276990	115276990	C	A	intronic	CSDE1	.	.	.	0.999951564	4.84E-05	1.34E-12	.	0.71193	0.17821	-1.001120478	8.321538099	30.92563	0.97838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	42	1	115276990	chr1:115276990	C	A	39	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	121103633	121103633	-	T	ncRNA_exonic	SRGAP2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	218	1	121103631	chr1:121103631	CTT	CTTT,C	84	PASS	DP=218;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	121103632	121103633	TT	-	ncRNA_exonic	SRGAP2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	218	1	121103631	chr1:121103631	CTT	CTTT,C	84	PASS	DP=218;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	142797415	142797415	G	C	intergenic	ANKRD20A12P;LOC102723769	dist=83810;dist=337188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	165	1	142797415	chr1:142797415	G	C	.	PASS	DP=165;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	142819371	142819371	-	T	intergenic	ANKRD20A12P;LOC102723769	dist=105766;dist=315232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.52	106	1	142819371	chr1:142819371	G	GT	13.52	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	142825055	142825055	C	A	intergenic	ANKRD20A12P;LOC102723769	dist=111450;dist=309548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	512	1	142825055	chr1:142825055	C	A	130	PASS	DP=512;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	143187103	143187103	G	A	ncRNA_intronic	LOC102723769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	64	1	143187103	chr1:143187103	G	A	.	PASS	DP=64;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	143195951	143195951	G	T	ncRNA_intronic	LOC102723769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	1	143195951	chr1:143195951	G	T	.	PASS	DP=61;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	143217275	143217275	A	C	intergenic	LOC102723769;MIR6077	dist=15036;dist=455646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	76	1	143217275	chr1:143217275	A	C	97	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	143237559	143237559	C	T	intergenic	LOC102723769;MIR6077	dist=35320;dist=435362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	90	1	143237559	chr1:143237559	C	T	103	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	143378854	143378854	G	A	intergenic	LOC102723769;MIR6077	dist=176615;dist=294067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	302	1	143378854	chr1:143378854	G	A	134	PASS	DP=302;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	144676646	144676646	T	C	intronic	NBPF19;NBPF20;NBPF8;NBPF9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	146	118	1	144676646	chr1:144676646	T	C	146	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	144813743	144813743	G	A	exonic	NBPF8;NBPF9	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	c	-0.388	-0.841	0.060	0.152	0.651	0.465	0	-0.38	0.118	-0.295	0.083	-2.386	0.003	0.102	0.226	0.046	0.161	5.299	0.150	.	.	.	0.5	73	105	1	144813743	chr1:144813743	G	A	73	PASS	DP=105;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	144813824	144813824	G	C	exonic	NBPF8;NBPF9	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	555	1	144813824	chr1:144813824	G	C	135	PASS	DP=555;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	144854514	144854514	C	A	ncRNA_exonic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	560	1	144854514	chr1:144854514	C	A	84	PASS	DP=560;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	144854698	144854698	C	A	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	180	1	144854698	chr1:144854698	C	A	.	PASS	DP=180;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	144856817	144856817	T	C	exonic	PDE4DIP	.	nonsynonymous SNV	PDE4DIP:NM_001350520:exon36:c.A7154G:p.E2385G,PDE4DIP:NM_001198834:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_014644:exon40:c.A6668G:p.E2223G,PDE4DIP:NM_001350522:exon41:c.A6509G:p.E2170G,PDE4DIP:NM_001198832:exon42:c.A6350G:p.E2117G,PDE4DIP:NM_001350521:exon42:c.A6962G:p.E2321G,PDE4DIP:NM_001350523:exon42:c.A6347G:p.E2116G	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	c	0.152	0.039	1.000	0.517	0.598	0.340	0	3.39	0.378	3.846	0.554	0.183	0.247	1.000	0.715	0.636	0.296	8.617	0.328	.	.	.	0.5	137	682	1	144856817	chr1:144856817	T	C	137	PASS	DP=682;AN=4	GT	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.
1	144873811	144873811	A	G	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	124	1	144873811	chr1:144873811	A	G	91	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	144879538	144879538	C	T	exonic	PDE4DIP	.	synonymous SNV	PDE4DIP:NM_001350520:exon23:c.G4398A:p.K1466K,PDE4DIP:NM_001198834:exon27:c.G3912A:p.K1304K,PDE4DIP:NM_014644:exon27:c.G3912A:p.K1304K,PDE4DIP:NM_001198832:exon30:c.G3780A:p.K1260K,PDE4DIP:NM_001350521:exon30:c.G4323A:p.K1441K,PDE4DIP:NM_001350522:exon30:c.G4110A:p.K1370K,PDE4DIP:NM_001350523:exon30:c.G3777A:p.K1259K	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	n	0.585	-0.044	1.000	0.439	0.563	0.310	0	2.47	0.290	0.971	0.288	0.900	0.413	0.944	0.326	0.023	0.138	2.944	0.054	.	.	.	0.5	95	314	1	144879538	chr1:144879538	C	T	95	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	144879542	144879542	A	G	exonic	PDE4DIP	.	nonsynonymous SNV	PDE4DIP:NM_001350520:exon23:c.T4394C:p.L1465P,PDE4DIP:NM_001198834:exon27:c.T3908C:p.L1303P,PDE4DIP:NM_014644:exon27:c.T3908C:p.L1303P,PDE4DIP:NM_001198832:exon30:c.T3776C:p.L1259P,PDE4DIP:NM_001350521:exon30:c.T4319C:p.L1440P,PDE4DIP:NM_001350522:exon30:c.T4106C:p.L1369P,PDE4DIP:NM_001350523:exon30:c.T3773C:p.L1258P	.	.	.	DISEASE: Note=A chromosomal aberration involving PDE4DIP may be the cause of a myeloproliferative disorder (MBD) associated with eosinophilia. Translocation t(1;5)(q23;q33) that forms a PDE4DIP- PDGFRB fusion protein. {ECO:0000269|PubMed:12907457}.; 	.	.	7.985992467	99.94692144	8042.34707	19.35299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.009	0.244	T	.	.	.	.	.	.	.	.	c	-0.691	-0.660	1.000	0.431	0.563	0.310	0	2.15	0.265	1.568	0.358	0.911	0.421	0.953	0.330	0.054	0.167	8.185	0.303	.	.	.	0.5	104	146	1	144879542	chr1:144879542	A	G	104	PASS	DP=146;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	144879592	144879592	A	T	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	172	1	144879592	chr1:144879592	A	T	123	PASS	DP=172;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	144994902	144994902	G	A	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	643	1	144994902	chr1:144994902	G	A	142	PASS	DP=643;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	145014738	145014738	G	C	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	127	1	145014738	chr1:145014738	G	C	84	PASS	DP=127;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	145021228	145021228	G	C	ncRNA_intronic	LOC100996724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	1	145021228	chr1:145021228	G	C	.	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	145209153	145209155	GGC	-	UTR5	NOTCH2NL	NM_203458:c.-39704_-39702del-	.	.	0.000100623	0.575070489	0.424828889	.	0.13774	.	0.657836546	84.27105449	3.00594	0.10883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	216	1	145209152	chr1:145209152	GGGC	G	119	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	145281429	145281429	G	T	exonic	NOTCH2NL	.	nonsynonymous SNV	NOTCH2NL:NM_203458:exon4:c.G359T:p.C120F	0.000100623	0.575070489	0.424828889	.	0.13774	.	0.657836546	84.27105449	3.00594	0.10883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.468	0.946	D	.	.	.	.	.	.	.	.	c	0.726	0.548	1.000	0.747	0.675	0.547	0	2.87	0.324	3.678	0.541	0.613	0.288	1.000	0.715	0.998	0.697	11.536	0.497	EGF-like domain	.	.	0.5	94	862	1	145281429	chr1:145281429	G	T	94	PASS	DP=862;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	145290398	145290398	G	A	ncRNA_intronic	NBPF25P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	261	1	145290398	chr1:145290398	G	A	122	PASS	DP=261;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	145460233	145460233	G	A	UTR5	POLR3GL	NM_032305:c.-11C>T;NM_001330685:c.-11C>T	.	.	0.002440213	0.928303267	0.069256521	.	0.15289	0.11495	-0.095386216	46.48502005	23.8527	0.78684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	176	1	145460233	chr1:145460233	G	A	.	PASS	DP=176;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	145532995	145532995	T	-	intronic	ITGA10;NBPF10;NBPF19;NBPF20	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	40	1	145532994	chr1:145532994	GT	G	103	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	146420088	146420088	A	G	exonic	NBPF12;NBPF20	.	synonymous SNV	NBPF12:NM_001278141:exon25:c.A2736G:p.S912S,NBPF20:NM_001278267:exon100:c.A11058G:p.S3686S	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	600	1	146420088	chr1:146420088	A	G	116	PASS	DP=600;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	146420119	146420119	T	C	exonic	NBPF12;NBPF20	.	nonsynonymous SNV	NBPF12:NM_001278141:exon25:c.T2767C:p.S923P,NBPF20:NM_001278267:exon100:c.T11089C:p.S3697P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.001	0.002	T	.	.	.	.	.	.	.	.	c	-1.171	-1.403	0.000	0.012	0.693	0.558	0	-1.45	0.083	0.885	0.277	0.095	0.197	0.970	0.340	0.532	0.276	4.744	0.123	Neuroblastoma breakpoint family (NBPF) domain	.	.	0.5	131	814	1	146420119	chr1:146420119	T	C	131	PASS	DP=814;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	146494686	146494686	T	C	ncRNA_intronic	LOC728989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	75	1	146494686	chr1:146494686	T	C	122	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	148252019	148252019	G	C	exonic	NBPF14;NBPF9	.	nonsynonymous SNV	NBPF9:NM_001277444:exon25:c.C3192G:p.D1064E,NBPF14:NM_015383:exon66:c.C8316G:p.D2772E	.	.	.	.	.	.	.	.	.	.	.	.	.	0.795	0.520	P	0.739	0.573	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.164	0.198	-1.067	0.100	T	0.022	0.094	T	0.001	0.014	T	2.112	0.315	16.93	0.973	0.330	0.006	0.026	N	c	-0.547	-0.839	0.023	0.135	0.706	0.609	0	0.109	0.138	0.337	0.194	0.494	0.279	0.001	0.137	0.001	0.043	.	.	Neuroblastoma breakpoint family (NBPF) domain	.	.	0.5	105	410	1	148252019	chr1:148252019	G	C	105	PASS	DP=410;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	148882006	148882006	T	C	ncRNA_exonic	LOC101927429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	305	1	148882006	chr1:148882006	T	C	70	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	148890234	148890234	A	G	ncRNA_exonic	LOC101927429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	228	1	148890234	chr1:148890234	A	G	.	PASS	DP=228;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	149262825	149262825	C	T	intergenic	NBPF25P;FAM231D	dist=153100;dist=25410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	132	1	149262825	chr1:149262825	C	T	.	PASS	DP=132;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	149784994	149784994	C	T	exonic	HIST2H3D	.	synonymous SNV	HIST2H3D:NM_001123375:exon1:c.G243A:p.T81T	0.49893728	0.427580174	0.073482546	.	.	.	0.035072054	56.2514744	6.52563	0.24176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	952	1	149784994	chr1:149784994	C	T	.	PASS	DP=952;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	149859345	149859345	G	A	exonic	HIST2H2AB	.	nonsynonymous SNV	HIST2H2AB:NM_175065:exon1:c.C122T:p.A41V	0.216215034	0.647861978	0.135922988	.	0.94267	0.1705	-0.119252484	44.53880632	2.43929	0.08861	0.0	0.912	D	1.0	0.899	D	0.981	0.736	D	0.000	0.629	D	1	0.810	D	4.095	0.974	H	-0.53	0.708	T	-3.31	0.659	D	0.515	0.558	0.359	0.885	D	0.583	0.850	D	0.049	0.636	D	3.844	0.519	23.4	0.994	0.649	0.910	0.524	D	c	0.944	0.841	1.0	0.983	0.025	0.001	3	5.27	0.737	6.768	0.746	1.036	0.656	1.000	0.715	0.985	0.512	12.482	0.550	Histone H2A/H2B/H3|Histone-fold	.	.	0.5	104	1472	1	149859345	chr1:149859345	G	A	104	PASS	DP=1472;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	150297433	150297433	G	A	exonic	PRPF3	.	synonymous SNV	PRPF3:NM_004698:exon2:c.G33A:p.L11L	0.999998844	1.16E-06	7.41E-16	DISEASE: Retinitis pigmentosa 18 (RP18) [MIM:601414]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:11773002, ECO:0000269|PubMed:12714658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83102	0.16844	-0.560178693	19.30879925	16.61976	0.58582	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	1	150297433	chr1:150297433	G	A	.	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	150526044	150526044	G	C	exonic	ADAMTSL4	.	nonsynonymous SNV	ADAMTSL4:NM_001288607:exon6:c.G577C:p.A193P,ADAMTSL4:NM_001288608:exon6:c.G577C:p.A193P,ADAMTSL4:NM_019032:exon6:c.G577C:p.A193P,ADAMTSL4:NM_025008:exon6:c.G577C:p.A193P	7.09E-16	0.34016242	0.65983758	DISEASE: Ectopia lentis 2, isolated, autosomal recessive (ECTOL2) [MIM:225100]: An ocular abnormality characterized by partial or complete displacement of the lens from its space resulting from defective zonule formation. {ECO:0000269|PubMed:19200529}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectopia lentis et pupillae (ECTOLP) [MIM:225200]: An ocular abnormality characterized by displacement of the lenses and the pupils, associated with other ocular anomalies, but without systemic manifestations. The condition is usually bilateral, with the lenses and pupils displaced in opposite directions. Additional signs include enlarged corneal diameter, increased corneal astigmatism, increased anterior chamber depth, thinning and flattening of the iris with loss of crypts, angle malformation caused by enlarged iris processes, persistent pupillary membrane, loss of zonular fibers, tilted disk, and increased axial length. Secondary manifestations include refractive errors, glaucoma, early cataract development, and retinal detachment. Membrane formation on the posterior aspect of the iris has been observed both in histologic sections and on ultrasound biomicroscopy. {ECO:0000269|PubMed:20702823}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10654	0.09865	-0.00377668	53.51497995	1103.99507	6.3513	0.703	0.076	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-0.205	0.041	N	0.23	0.631	T	1.43	0.011	N	0.012	0.003	-1.058	0.123	T	0.031	0.132	T	.	.	.	-1.198	0.025	0.007	0.673	0.081	0.006	0.026	N	c	-1.688	-1.744	1.000	0.747	0.660	0.495	0	-4.57	0.032	-1.171	0.032	-1.198	0.016	0.000	0.063	0.007	0.100	3.170	0.061	.	ENSG00000143452.11|ENSG00000259357.1|ENSG00000163131.6|ENSG00000259357.1|ENSG00000259357.1|ENSG00000143452.11|ENSG00000259357.1|ENSG00000163131.6|ENSG00000143452.11|ENSG00000143369.10|ENSG00000259357.1|ENSG00000163131.6|ENSG00000259357.1|ENSG00000143452.11|ENSG00000237781.2|ENSG00000143382.9|ENSG00000259357.1|ENSG00000163131.6|ENSG00000143457.6|ENSG00000259357.1|ENSG00000259357.1|ENSG00000259357.1|ENSG00000259357.1|ENSG00000259357.1|ENSG00000163131.6|ENSG00000143452.11|ENSG00000259357.1|ENSG00000143457.6|ENSG00000259357.1|ENSG00000143452.11|ENSG00000259357.1|ENSG00000143457.6|ENSG00000143452.11|ENSG00000259357.1|ENSG00000143457.6|ENSG00000259357.1|ENSG00000143452.11|ENSG00000259357.1|ENSG00000259357.1	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Artery_Tibial|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Cells_EBV-transformed_lymphocytes|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Spleen|Thyroid|Thyroid|Whole_Blood	0.5	150	111	1	150526044	chr1:150526044	G	C	150	PASS	DP=111;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	150595425	150595425	C	T	intronic	ENSA	.	.	.	0.162369766	0.773694404	0.06393583	.	0.16235	.	0.413500896	76.67492333	9.50386	0.3504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	77	1	150595425	chr1:150595425	C	T	.	PASS	DP=77;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	151196702	151196702	-	T	intronic	PIP5K1A	.	.	.	0.014586299	0.985162174	0.000251527	.	0.12043	0.12792	-0.514264485	21.41424864	69.18119	1.72333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	150	1	151196702	chr1:151196702	G	GT	68	PASS	DP=150;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	152188563	152188563	G	T	exonic	HRNR	.	nonsynonymous SNV	HRNR:NM_001009931:exon3:c.C5542A:p.H1848N	5.01E-29	0.999822617	0.000177383	.	0.18527	0.10879	-0.141298762	42.87567823	4521.01702	13.5031	0.151	0.245	T	0.898	0.475	P	0.346	0.409	B	.	.	.	1	0.090	N	2.61	0.766	M	3.52	0.049	T	-1.27	0.320	N	0.224	0.275	-0.974	0.364	T	0.005	0.015	T	0.001	0.018	T	-0.810	0.040	0.041	0.563	0.054	0.050	0.107	N	c	-0.928	-1.152	0.000	0.056	0.554	0.246	0	-2.1	0.068	-0.439	0.069	0.048	0.160	0.000	0.063	0.001	0.043	0.938	0.013	.	.	.	0.5	115	980	1	152188563	chr1:152188563	G	T	115	PASS	DP=980;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	152280796	152280796	G	T	exonic	FLG	.	nonsynonymous SNV	FLG:NM_002016:exon3:c.C6566A:p.A2189E	.	.	.	DISEASE: Ichthyosis vulgaris (VI) [MIM:146700]: The most common form of ichthyosis inherited as an autosomal dominant trait. It is characterized by palmar hyperlinearity, keratosis pilaris and a fine scale that is most prominent over the lower abdomen, arms, and legs. Ichthyosis vulgaris is characterized histologically by absent or reduced keratohyalin granules in the epidermis and mild hyperkeratosis. The disease can be associated with frequent asthma, eczema or hay fever. {ECO:0000269|PubMed:16444271}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dermatitis atopic 2 (ATOD2) [MIM:605803]: Atopic dermatitis is a complex, inflammatory disease with multiple alleles at several loci thought to be involved in the pathogenesis. It commonly begins in infancy or early childhood and is characterized by a chronic relapsing form of skin inflammation, a disturbance of epidermal barrier function that culminates in dry skin, and IgE-mediated sensitization to food and environmental allergens. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. {ECO:0000269|PubMed:16550169, ECO:0000269|PubMed:16815158, ECO:0000269|PubMed:17030239, ECO:0000269|PubMed:17291859}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.08975	.	24.30246465	99.98820477	16458.42079	27.35022	0.31	0.140	T	0.053	0.211	B	0.004	0.093	B	.	.	.	1	0.090	N	2.705	0.794	M	4.62	0.019	T	-0.77	0.214	N	0.099	0.101	-0.848	0.521	T	0.002	0.005	T	0.003	0.071	T	-0.140	0.081	1.450	0.753	0.106	0.015	0.049	N	c	-1.241	-1.406	0.000	0.048	0.554	0.246	0	-3.76	0.041	-1.494	0.024	-0.831	0.030	0.000	0.063	0.000	0.016	0.388	0.004	.	.	.	0.5	112	774	1	152280796	chr1:152280796	G	T	112	PASS	DP=774;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	152285358	152285358	A	G	exonic	FLG	.	synonymous SNV	FLG:NM_002016:exon3:c.T2004C:p.A668A	.	.	.	DISEASE: Ichthyosis vulgaris (VI) [MIM:146700]: The most common form of ichthyosis inherited as an autosomal dominant trait. It is characterized by palmar hyperlinearity, keratosis pilaris and a fine scale that is most prominent over the lower abdomen, arms, and legs. Ichthyosis vulgaris is characterized histologically by absent or reduced keratohyalin granules in the epidermis and mild hyperkeratosis. The disease can be associated with frequent asthma, eczema or hay fever. {ECO:0000269|PubMed:16444271}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dermatitis atopic 2 (ATOD2) [MIM:605803]: Atopic dermatitis is a complex, inflammatory disease with multiple alleles at several loci thought to be involved in the pathogenesis. It commonly begins in infancy or early childhood and is characterized by a chronic relapsing form of skin inflammation, a disturbance of epidermal barrier function that culminates in dry skin, and IgE-mediated sensitization to food and environmental allergens. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. {ECO:0000269|PubMed:16550169, ECO:0000269|PubMed:16815158, ECO:0000269|PubMed:17030239, ECO:0000269|PubMed:17291859}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.08975	.	24.30246465	99.98820477	16458.42079	27.35022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	445	1	152285358	chr1:152285358	A	G	130	PASS	DP=445;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	152285651	152285651	T	-	exonic	FLG	.	frameshift deletion	FLG:NM_002016:exon3:c.1711delA:p.T571Hfs*226	.	.	.	DISEASE: Ichthyosis vulgaris (VI) [MIM:146700]: The most common form of ichthyosis inherited as an autosomal dominant trait. It is characterized by palmar hyperlinearity, keratosis pilaris and a fine scale that is most prominent over the lower abdomen, arms, and legs. Ichthyosis vulgaris is characterized histologically by absent or reduced keratohyalin granules in the epidermis and mild hyperkeratosis. The disease can be associated with frequent asthma, eczema or hay fever. {ECO:0000269|PubMed:16444271}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dermatitis atopic 2 (ATOD2) [MIM:605803]: Atopic dermatitis is a complex, inflammatory disease with multiple alleles at several loci thought to be involved in the pathogenesis. It commonly begins in infancy or early childhood and is characterized by a chronic relapsing form of skin inflammation, a disturbance of epidermal barrier function that culminates in dry skin, and IgE-mediated sensitization to food and environmental allergens. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. {ECO:0000269|PubMed:16550169, ECO:0000269|PubMed:16815158, ECO:0000269|PubMed:17030239, ECO:0000269|PubMed:17291859}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.08975	.	24.30246465	99.98820477	16458.42079	27.35022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.25	40	1	152285650	chr1:152285650	GT	G	18.25	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	152883550	152883550	A	T	exonic	IVL	.	nonsynonymous SNV	IVL:NM_005547:exon2:c.A1277T:p.Q426L	3.43E-09	0.093504834	0.906495163	.	0.37637	.	0.53464283	81.00967209	386.0752	4.1378	0.002	0.721	D	0.267	0.299	B	0.113	0.301	B	.	.	.	1	0.090	N	1.195	0.303	L	3.0	0.092	T	-2.22	0.498	N	0.373	0.435	-0.924	0.450	T	0.005	0.018	T	0.020	0.433	T	0.972	0.187	10.50	0.895	0.183	0.043	0.098	N	c	-1.179	-1.262	0.997	0.354	0.615	0.372	0	-1.34	0.086	-0.410	0.072	0.765	0.311	0.000	0.063	0.004	0.083	3.557	0.074	.	.	.	0.5	124	401	1	152883550	chr1:152883550	A	T	124	PASS	DP=401;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	152944379	152944379	C	A	exonic	SPRR4	.	nonsynonymous SNV	SPRR4:NM_173080:exon2:c.C13A:p.Q5K	0.582181679	0.375036467	0.042781855	.	0.11466	0.05263	0.369407109	74.95281906	771.02285	5.49621	0.0	0.912	D	0.092	0.237	B	0.007	0.121	B	.	.	.	0.999	0.214	N	.	.	.	2.15	0.193	T	-2.22	0.498	N	0.263	0.320	-0.982	0.346	T	0.015	0.060	T	0.003	0.069	T	1.455	0.237	13.08	0.822	0.136	0.607	0.310	D	c	-0.473	-0.456	0.975	0.296	0.487	0.133	0	1.71	0.233	0.313	0.190	0.485	0.279	0.815	0.297	0.140	0.202	6.736	0.225	.	.	.	0.5	.	181	1	152944379	chr1:152944379	C	A	.	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	153516163	153516163	A	-	UTR3	S100A4	NM_019554:c.*72delT;NM_002961:c.*72delT	.	.	0.004651459	0.444541538	0.550807003	.	0.26207	0.5196	-0.185391282	39.67916962	6.99406	0.26106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	242	1	153516162	chr1:153516162	GA	G,GAA	80	PASS	DP=242;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	153516163	153516163	-	A	UTR3	S100A4	NM_019554:c.*71_*72insT;NM_002961:c.*71_*72insT	.	.	0.004651459	0.444541538	0.550807003	.	0.26207	0.5196	-0.185391282	39.67916962	6.99406	0.26106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	242	1	153516162	chr1:153516162	GA	G,GAA	80	PASS	DP=242;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	153658184	153658184	G	A	intronic	NPR1	.	.	.	0.000172509	0.999775772	5.17E-05	.	0.25987	0.31819	-0.238793231	36.3116301	1510.90255	7.21833	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	1	153658184	chr1:153658184	G	A	.	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	153742142	153742142	-	T	intronic	INTS3	.	.	.	0.999997023	2.98E-06	1.24E-17	.	0.51743	0.13588	-1.287751345	5.03066761	26.14611	0.84795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	121	1	153742142	chr1:153742142	A	AT	74	PASS	DP=121;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	153920564	153920564	A	G	UTR3	CRTC2	NM_181715:c.*21T>C	.	.	0.996361791	0.003638199	1.01E-08	.	0.25674	0.23695	-0.690637458	15.12149092	1834.62554	7.89581	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	58	1	153920564	chr1:153920564	A	G	108	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	154207835	154207835	T	-	intronic	UBAP2L	.	.	.	0.999999873	1.27E-07	3.41E-18	.	0.11769	0.11029	-1.109541557	6.782259967	61.03443	1.58905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	79	1	154207834	chr1:154207834	AT	A	89	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	154294499	154294499	G	A	exonic	AQP10	.	nonsynonymous SNV	AQP10:NM_080429:exon2:c.G196A:p.V66I	0.015278293	0.878522243	0.106199464	.	0.1078	0.10375	0.104848986	61.49445624	4035.92542	12.59512	0.036	0.433	D	0.448	0.342	B	0.079	0.292	B	0.001	0.410	N	0.610	0.326	D	1.785	0.466	L	-1.99	0.853	D	-0.81	0.223	N	0.437	0.527	-0.377	0.728	T	0.341	0.707	T	.	.	.	4.244	0.569	23.9	0.995	0.660	0.928	0.563	D	c	-0.135	-0.123	1.000	0.747	0.447	0.083	0	4.34	0.511	4.316	0.587	0.958	0.565	1.000	0.715	0.512	0.273	12.764	0.566	Aquaporin-like	.	.	0.5	114	231	1	154294499	chr1:154294499	G	A	114	PASS	DP=231;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	154562629	154562629	-	A	intronic	ADAR	.	.	.	0.907595373	0.092404575	5.12E-08	DISEASE: Dyschromatosis symmetrica hereditaria (DSH) [MIM:127400]: An autosomal dominant pigmentary genodermatosis characterized by a mixture of hyperpigmented and hypopigmented macules distributed on the face and the dorsal parts of the hands and feet, that appear in infancy or early childhood. {ECO:0000269|PubMed:12916015, ECO:0000269|PubMed:15146470, ECO:0000269|PubMed:15659327}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Aicardi-Goutieres syndrome 6 (AGS6) [MIM:615010]: A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood. {ECO:0000269|PubMed:23001123}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1228	0.23648	-0.639268965	16.70794999	78.80238	1.87521	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	138	1	154562629	chr1:154562629	C	CA	58	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	154963016	154963016	G	C	intronic	FLAD1	.	.	.	0.091793511	0.906439743	0.001766745	.	0.11392	0.23178	-1.043396569	7.71408351	87.62766	1.99904	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	157	1	154963016	chr1:154963016	G	C	99	PASS	DP=157;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	155059035	155059035	-	G	UTR3	EFNA3	NM_004952:c.*16_*17insG	.	.	0.180564105	0.765883297	0.053552599	.	0.43564	0.13588	0.193034296	66.82000472	606.48242	4.98163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	305	1	155059035	chr1:155059035	T	TG	74	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	155152397	155152397	-	C	exonic	TRIM46	.	frameshift insertion	TRIM46:NM_001282378:exon7:c.1198dupC:p.A402Gfs*9,TRIM46:NM_001256599:exon8:c.1507dupC:p.A505Gfs*9,TRIM46:NM_001256601:exon8:c.1537dupC:p.A515Gfs*9,TRIM46:NM_001282379:exon8:c.1576dupC:p.A528Gfs*37,TRIM46:NM_025058:exon8:c.1576dupC:p.A528Gfs*9,TRIM46:NM_001256600:exon9:c.1450dupC:p.A486Gfs*9	0.998652125	0.00134787	4.43E-09	.	0.59864	0.14106	-0.843147538	11.2762444	131.25378	2.49537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	184	1	155152397	chr1:155152397	G	GC	90	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	155188270	155188270	C	A	ncRNA_exonic	GBAP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	261	1	155188270	chr1:155188270	C	A	90	PASS	DP=261;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	155307999	155307999	-	T	exonic	ASH1L	.	frameshift insertion	ASH1L:NM_018489:exon27:c.8683dupA:p.T2895Nfs*3	1	1.66E-13	1.32E-34	.	0.35554	.	-1.798985783	2.223401746	588.79734	4.92053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	839	1	155307999	chr1:155307999	G	GT	80	PASS	DP=839;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
1	155720557	155720557	T	-	intronic	GON4L	.	.	.	0.999998892	1.11E-06	2.27E-19	.	0.14902	0.08718	-1.357871407	4.535267752	369.16949	4.0602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	152	1	155720556	chr1:155720556	CT	C,CTT	76	PASS	DP=152;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/2
1	155720557	155720557	-	T	intronic	GON4L	.	.	.	0.999998892	1.11E-06	2.27E-19	.	0.14902	0.08718	-1.357871407	4.535267752	369.16949	4.0602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	152	1	155720556	chr1:155720556	CT	C,CTT	76	PASS	DP=152;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/2
1	156012038	156012038	G	A	intronic	UBQLN4	.	.	.	0.99752242	0.002477484	9.67E-08	.	0.27058	0.13363	0.062575634	58.74026893	4087.61153	12.68896	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	279	1	156012038	chr1:156012038	G	A	.	PASS	DP=279;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	156106164	156106164	C	T	exonic	LMNA	.	synonymous SNV	LMNA:NM_001257374:exon7:c.C981T:p.R327R,LMNA:NM_001282626:exon7:c.C1317T:p.R439R,LMNA:NM_005572:exon7:c.C1317T:p.R439R,LMNA:NM_170707:exon7:c.C1317T:p.R439R,LMNA:NM_170708:exon7:c.C1317T:p.R439R,LMNA:NM_001282624:exon8:c.C1074T:p.R358R,LMNA:NM_001282625:exon10:c.C1317T:p.R439R	0.993449023	0.006550767	2.10E-07	DISEASE: Emery-Dreifuss muscular dystrophy 2, autosomal dominant (EDMD2) [MIM:181350]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10739764, ECO:0000269|PubMed:10908904, ECO:0000269|PubMed:10939567, ECO:0000269|PubMed:11503164, ECO:0000269|PubMed:12032588, ECO:0000269|PubMed:12467752, ECO:0000269|PubMed:12649505, ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:14985400, ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:20848652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Emery-Dreifuss muscular dystrophy 3, autosomal recessive (EDMD3) [MIM:616516]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:22431096}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1A (CMD1A) [MIM:115200]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:11561226, ECO:0000269|PubMed:11897440, ECO:0000269|PubMed:12486434, ECO:0000269|PubMed:12628721, ECO:0000269|PubMed:12920062, ECO:0000269|PubMed:14684700, ECO:0000269|PubMed:15140538, ECO:0000269|PubMed:15219508, ECO:0000269|PubMed:16061563, ECO:0000269|PubMed:20160190, ECO:0000269|PubMed:21846512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lipodystrophy, familial partial, 2 (FPLD2) [MIM:151660]: A disorder characterized by the loss of subcutaneous adipose tissue in the lower parts of the body (limbs, buttocks, trunk). It is accompanied by an accumulation of adipose tissue in the face and neck causing a double chin, fat neck, or cushingoid appearance. Adipose tissue may also accumulate in the axillae, back, labia majora, and intraabdominal region. Affected patients are insulin-resistant and may develop glucose intolerance and diabetes mellitus after age 20 years, hypertriglyceridemia, and low levels of high density lipoprotein cholesterol. {ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10655060, ECO:0000269|PubMed:10739751, ECO:0000269|PubMed:12015247, ECO:0000269|PubMed:12196663, ECO:0000269|PubMed:12629077, ECO:0000269|PubMed:17250669, ECO:0000269|PubMed:24485160}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Limb-girdle muscular dystrophy 1B (LGMD1B) [MIM:159001]: An autosomal dominant degenerative myopathy with age-related atrioventricular cardiac conduction disturbances, dilated cardiomyopathy, and the absence of early contractures. Characterized by slowly progressive skeletal muscle weakness of the hip and shoulder girdles. Muscle biopsy shows mild dystrophic changes. {ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:11525883, ECO:0000269|PubMed:12032588, ECO:0000269|PubMed:12673789, ECO:0000269|PubMed:15744034, ECO:0000269|PubMed:17136397}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease 2B1 (CMT2B1) [MIM:605588]: A recessive axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Nerve conduction velocities are normal or slightly reduced. {ECO:0000269|PubMed:11799477}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]: Rare genetic disorder characterized by features reminiscent of marked premature aging. {ECO:0000269|PubMed:12714972, ECO:0000269|PubMed:12768443, ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:15060110, ECO:0000269|PubMed:15286156, ECO:0000269|PubMed:15622532, ECO:0000269|PubMed:21791255, ECO:0000269|PubMed:22355414, ECO:0000269|PubMed:23666920}. Note=The disease is caused by mutations affecting the gene represented in this entry. HGPS is caused by the toxic accumulation of a truncated form of lamin-A/C. This mutant protein, called progerin (isoform 6), acts to deregulate mitosis and DNA damage signaling, leading to premature cell death and senescence. The mutant form is mainly generated by a silent or missense mutation at codon 608 of prelamin A that causes activation of a cryptic splice donor site, resulting in production of isoform 6 with a deletion of 50 amino acids near the C terminus. Progerin lacks the conserved ZMPSTE24/FACE1 cleavage site and therefore remains permanently farnesylated. Thus, although it can enter the nucleus and associate with the nuclear envelope, it cannot incorporate normally into the nuclear lamina (PubMed:12714972). {ECO:0000269|PubMed:12714972}.; DISEASE: Cardiomyopathy, dilated, with hypergonadotropic hypogonadism (CMDHH) [MIM:212112]: A disorder characterized by the association of genital anomalies, hypergonadotropic hypogonadism and dilated cardiomyopathy. Patients can present other variable clinical manifestations including mental retardation, skeletal anomalies, scleroderma-like skin, graying and thinning of hair, osteoporosis. Dilated cardiomyopathy is characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. {ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:17150192, ECO:0000269|PubMed:19283854}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370]: A disorder characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, progeroid appearance, partial alopecia, soft tissue calcinosis, joint contractures, and partial lipodystrophy with loss of subcutaneous fat from the extremities. Adipose tissue in the face, neck and trunk is normal or increased. {ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:15998779, ECO:0000269|PubMed:16278265}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lethal tight skin contracture syndrome (LTSCS) [MIM:275210]: Rare disorder mainly characterized by intrauterine growth retardation, tight and rigid skin with erosions, prominent superficial vasculature and epidermal hyperkeratosis, facial features (small mouth, small pinched nose and micrognathia), sparse/absent eyelashes and eyebrows, mineralization defects of the skull, thin dysplastic clavicles, pulmonary hypoplasia, multiple joint contractures and an early neonatal lethal course. Liveborn children usually die within the first week of life. The overall prevalence of consanguineous cases suggested an autosomal recessive inheritance. {ECO:0000269|PubMed:15317753}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Heart-hand syndrome Slovenian type (HHS-Slovenian) [MIM:610140]: Heart-hand syndrome (HHS) is a clinically and genetically heterogeneous disorder characterized by the co- occurrence of a congenital cardiac disease and limb malformations. {ECO:0000269|PubMed:18611980}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205]: A form of congenital muscular dystrophy. Patients present at birth, or within the first few months of life, with hypotonia, muscle weakness and often with joint contractures. {ECO:0000269|PubMed:18551513}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in LMNA may cause a late-onset cardiocutaneous progeria syndrome characterized by cutaneous manifestations of aging appearing in the third decade of life, cardiac valve calcification and dysfunction, prominent atherosclerosis, and cardiomyopathy, leading to death on average in the fourth decade. {ECO:0000269|PubMed:23666920}.; 	0.55819	0.98592	-0.911109353	9.961075725	32.23482	1.00909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	166	1	156106164	chr1:156106164	C	T	.	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	156294696	156294696	C	G	intronic	CCT3	.	.	.	0.998745413	0.001254583	3.72E-09	.	0.92111	0.69617	-0.380166007	27.88393489	753.2878	5.44224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	172	1	156294696	chr1:156294696	C	G	60	PASS	DP=172;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	156340956	156340956	T	-	intronic	RHBG	.	.	.	3.73E-10	0.093786647	0.906213352	.	0.04516	0.11744	.	.	6525.59053	16.96932	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.21	80	1	156340955	chr1:156340955	CT	C	11.21	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	156499898	156499898	T	A	exonic	IQGAP3	.	nonsynonymous SNV	IQGAP3:NM_178229:exon34:c.A4403T:p.K1468M	6.47E-16	0.999970782	2.92E-05	.	0.22954	0.22033	-0.376786957	28.01958009	7742.20989	18.98627	0.0	0.912	D	0.998	0.715	D	0.924	0.642	D	0.000	0.629	D	1	0.810	D	2.585	0.758	M	0.84	0.475	T	-4.83	0.809	D	0.456	0.508	-0.689	0.610	T	0.194	0.548	T	0.067	0.701	D	6.587	0.906	31	0.995	0.665	0.996	0.975	D	c	0.668	0.621	1.000	0.747	0.707	0.730	0	4.5	0.542	7.661	0.826	0.946	0.533	1.000	0.715	0.898	0.379	12.787	0.567	RasGAP protein, C-terminal	.	.	0.5	100	426	1	156499898	chr1:156499898	T	A	100	PASS	DP=426;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	156928857	156928857	C	A	exonic	ARHGEF11	.	stopgain	ARHGEF11:NM_014784:exon15:c.G1240T:p.E414X,ARHGEF11:NM_198236:exon16:c.G1360T:p.E454X	0.999945339	5.47E-05	5.06E-18	.	0.31017	0.15072	-1.714337031	2.500589762	1596.56628	7.39387	.	.	.	.	.	.	.	.	.	0.000	0.559	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.294	0.990	41	0.997	0.778	0.974	0.742	D	c	0.976	0.810	1.000	0.747	0.732	0.924	0	4.6	0.564	5.778	0.684	0.807	0.329	1.000	0.715	0.999	0.750	15.344	0.739	RGS domain|Regulator of G protein signalling-like domain	.	.	0.5	84	454	1	156928857	chr1:156928857	C	A	84	PASS	DP=454;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	157103941	157103942	CA	-	exonic	ETV3	.	frameshift deletion	ETV3:NM_001145312:exon4:c.362_363del:p.V121Dfs*41,ETV3:NM_005240:exon4:c.362_363del:p.V121Dfs*13	0.783799556	0.209446439	0.006754005	.	0.1465	0.24163	-0.339715008	30.06605331	22.17717	0.7442	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	22.4	19	1	157103940	chr1:157103940	TCA	T	22.4	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	159799641	159799641	G	C	intronic	SLAMF8	.	.	.	1.71E-06	0.422014191	0.577984104	.	0.14799	0.10599	-0.001743238	53.85114414	631.46276	5.06279	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	330	1	159799641	chr1:159799641	G	C	89	PASS	DP=330;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	161192208	161192208	G	T	exonic	APOA2	.	nonsynonymous SNV	APOA2:NM_001643:exon4:c.C290A:p.P97H	0.009437055	0.591169946	0.399392999	.	0.65547	0.43086	-0.031067188	51.03798066	1.71247	0.0561	0.005	0.632	D	0.996	0.670	D	0.923	0.641	D	0.484	0.121	N	1	0.090	N	1.625	0.417	L	.	.	.	-6.27	0.906	D	0.257	0.313	-0.892	0.488	T	0.150	0.478	T	0.008	0.221	T	3.540	0.483	23.1	0.991	0.510	0.204	0.208	N	c	0.006	-0.148	1.000	0.517	0.428	0.059	0	4.01	0.457	2.175	0.419	1.048	0.713	0.021	0.196	0.016	0.126	10.667	0.447	.	.	.	0.5	91	129	1	161192208	chr1:161192208	G	T	91	PASS	DP=129;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	161580116	161580116	G	T	intergenic	HSPA7;FCGR3B	dist=1775;dist=12872	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	381	1	161580116	chr1:161580116	G	T	74	PASS	DP=381;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
1	161645009	161645009	C	G	intronic	FCGR2B	.	.	.	0.047402608	0.855728325	0.096869067	DISEASE: Systemic lupus erythematosus (SLE) [MIM:152700]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. {ECO:0000269|PubMed:12115230, ECO:0000269|PubMed:20385827}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	.	0.12522	0.060756528	58.52795471	1693.68129	7.5857	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	509	1	161645009	chr1:161645009	C	G	132	PASS	DP=509;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	161829973	161829973	-	T	intronic	ATF6	.	.	.	3.11E-05	0.996993053	0.00297588	.	0.24087	0.27985	0.42259095	77.22929936	3604.57589	11.62279	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	16.66	70	1	161829973	chr1:161829973	C	CT,CTT	16.66	PASS	DP=70;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	0/1/.	././.	././.	././.	././.
1	161829973	161829973	-	TT	intronic	ATF6	.	.	.	3.11E-05	0.996993053	0.00297588	.	0.24087	0.27985	0.42259095	77.22929936	3604.57589	11.62279	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	16.66	70	1	161829973	chr1:161829973	C	CT,CTT	16.66	PASS	DP=70;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	0/1/.	././.	././.	././.	././.
1	162729685	162729685	G	T	exonic	DDR2	.	synonymous SNV	DDR2:NM_006182:exon8:c.G771T:p.V257V,DDR2:NM_001014796:exon9:c.G771T:p.V257V	0.990992372	0.009007624	3.79E-09	DISEASE: Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665]: A bone disease characterized by short- limbed dwarfism, a narrow chest with pectus excavatum, brachydactyly in the hands and feet, a characteristic craniofacial appearance and premature calcifications. The radiological findings are distinctive and comprise short long bones throughout the skeleton with striking epiphyses that are stippled, flattened and fragmented and flared, irregular metaphyses. Platyspondyly in the spine with wide intervertebral spaces is observed and some vertebral bodies are pear-shaped with central humps, anterior protrusions and posterior scalloping. {ECO:0000269|PubMed:19110212, ECO:0000269|PubMed:20223752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.85011	0.1349	-0.775187015	13.05142722	110.07197	2.27991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	74	1	162729685	chr1:162729685	G	T	.	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	162748361	162748361	C	T	intronic	DDR2	.	.	.	0.990992372	0.009007624	3.79E-09	DISEASE: Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665]: A bone disease characterized by short- limbed dwarfism, a narrow chest with pectus excavatum, brachydactyly in the hands and feet, a characteristic craniofacial appearance and premature calcifications. The radiological findings are distinctive and comprise short long bones throughout the skeleton with striking epiphyses that are stippled, flattened and fragmented and flared, irregular metaphyses. Platyspondyly in the spine with wide intervertebral spaces is observed and some vertebral bodies are pear-shaped with central humps, anterior protrusions and posterior scalloping. {ECO:0000269|PubMed:19110212, ECO:0000269|PubMed:20223752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.85011	0.1349	-0.775187015	13.05142722	110.07197	2.27991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	131	1	162748361	chr1:162748361	C	T	121	PASS	DP=131;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
1	162769510	162769510	-	T	intronic	HSD17B7	.	.	.	0.001754508	0.896172411	0.102073081	.	.	.	0.016664174	55.21939137	643.08042	5.09426	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	119	1	162769510	chr1:162769510	C	CT,CTT	70	PASS	DP=119;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	162769510	162769510	-	TT	intronic	HSD17B7	.	.	.	0.001754508	0.896172411	0.102073081	.	.	.	0.016664174	55.21939137	643.08042	5.09426	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	119	1	162769510	chr1:162769510	C	CT,CTT	70	PASS	DP=119;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	164326647	164326647	G	A	intergenic	LOC100422212;PBX1	dist=933666;dist=201950	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	150	1	164326647	chr1:164326647	G	A	100	PASS	DP=150;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	165664684	165664684	T	A	intronic	ALDH9A1	.	.	.	1.29E-05	0.953462413	0.046524673	.	0.04374	0.24685	-0.021969881	52.14673272	462.50185	4.4573	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	73	1	165664684	chr1:165664684	T	A	39	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	167190252	167190252	C	-	intronic	POU2F1	.	.	.	0.913950638	0.086048322	1.04E-06	.	0.97789	0.41629	-0.334253673	30.70299599	100.87731	2.1746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	579	1	167190251	chr1:167190251	GC	G	92	PASS	DP=579;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	167385279	167385279	T	-	UTR3	POU2F1	NM_001198786:c.*232delT;NM_002697:c.*232delT;NM_001198783:c.*232delT	.	.	0.913950638	0.086048322	1.04E-06	.	0.97789	0.41629	-0.334253673	30.70299599	100.87731	2.1746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	48	1	167385278	chr1:167385278	CT	C	42	PASS	DP=48;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	167893778	167893778	-	A	intronic	MPC2	.	.	.	0.449429467	0.522427122	0.028143411	.	0.22019	0.09609	0.501689326	79.7888653	143.21224	2.60927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	110	1	167893778	chr1:167893778	G	GA	67	PASS	DP=110;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	168205770	168205770	-	T	intronic	SFT2D2	.	.	.	0.003949651	0.855531759	0.140518591	.	0.10989	.	-0.229483771	36.86010852	10.43983	0.37986	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	126	1	168205770	chr1:168205770	G	GT	71	PASS	DP=126;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	168549282	168549282	-	T	intronic	XCL1	.	.	.	0.088160228	0.763202188	0.148637583	.	0.0931	0.20536	0.725794416	85.98136353	269.25512	3.52005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	332	1	168549282	chr1:168549282	G	GT	81	PASS	DP=332;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/1	./.
1	169757860	169757860	-	T	intergenic	SELE;METTL18	dist=54640;dist=3810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	176	1	169757859	chr1:169757859	CT	CTT,C	60	PASS	DP=176;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	169757860	169757860	T	-	intergenic	SELE;METTL18	dist=54640;dist=3810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	176	1	169757859	chr1:169757859	CT	CTT,C	60	PASS	DP=176;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	169764271	169764271	A	G	exonic	C1orf112	.	nonsynonymous SNV	C1orf112:NM_001320050:exon1:c.A28G:p.S10G	5.98E-08	0.992096257	0.007903683	.	0.45663	.	-0.196519234	39.20736023	683.3862	5.22243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	598	1	169764271	chr1:169764271	A	G	134	PASS	DP=598;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	171763621	171763621	G	T	exonic	METTL13	.	synonymous SNV	METTL13:NM_001007239:exon7:c.G1311T:p.V437V,METTL13:NM_014955:exon7:c.G1521T:p.V507V,METTL13:NM_015935:exon7:c.G1779T:p.V593V	0.00133198	0.99703939	0.00162863	.	0.24943	0.10191	-0.663133267	15.94715735	3322.76582	11.02115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	75	1	171763621	chr1:171763621	G	T	67	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	174926953	174926953	C	T	intronic	RABGAP1L	.	.	.	0.089172714	0.910824162	3.12E-06	.	0.37939	.	-1.087493118	7.106628922	552.4126	4.7801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	1	174926953	chr1:174926953	C	T	.	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	174926956	174926956	G	T	intronic	RABGAP1L	.	.	.	0.089172714	0.910824162	3.12E-06	.	0.37939	.	-1.087493118	7.106628922	552.4126	4.7801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	63	1	174926956	chr1:174926956	G	T	60	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	175087853	175087853	G	T	exonic	TNN	.	nonsynonymous SNV	TNN:NM_022093:exon11:c.G2543T:p.S848I	5.19E-15	0.506715096	0.493284904	.	0.17043	.	1.51017302	95.42934654	5625.2664	15.52544	0.039	0.424	D	0.006	0.126	B	0.082	0.276	B	0.050	0.231	N	0.983	0.249	N	2.22	0.631	M	0.37	0.577	T	-2.3	0.511	N	0.25	0.305	-0.836	0.529	T	0.151	0.479	T	0.022	0.452	T	1.409	0.232	12.83	0.985	0.420	0.179	0.198	N	c	-0.755	-0.794	0.997	0.351	0.595	0.332	0	-3.23	0.048	-0.007	0.126	0.908	0.420	0.004	0.165	0.750	0.322	16.174	0.816	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	.	207	1	175087853	chr1:175087853	G	T	.	PASS	DP=207;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	179089397	179089397	C	A	exonic	ABL2	.	stopgain	ABL2:NM_001136001:exon5:c.G910T:p.E304X,ABL2:NM_001168236:exon5:c.G910T:p.E304X,ABL2:NM_001168238:exon5:c.G910T:p.E304X,ABL2:NM_001168239:exon5:c.G865T:p.E289X,ABL2:NM_001136000:exon6:c.G928T:p.E310X,ABL2:NM_001168237:exon6:c.G973T:p.E325X,ABL2:NM_005158:exon6:c.G928T:p.E310X,ABL2:NM_007314:exon6:c.G973T:p.E325X	0.009702577	0.990293634	3.79E-06	.	0.8871	0.21266	-0.992035476	8.604623732	182.10584	2.93109	.	.	.	.	.	.	.	.	.	0.081	0.209	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.269	0.990	41	0.996	0.734	0.989	0.877	D	c	1.083	0.923	1.000	0.747	0.672	0.522	0	4.88	0.630	7.818	0.846	0.876	0.383	1.000	0.715	1.000	0.888	17.101	0.865	Protein kinase domain|Protein kinase, ATP binding site|Protein kinase-like domain|SH2 domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain;Protein kinase domain|Protein kinase, ATP binding site|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain;Protein kinase domain|Protein kinase-like domain|SH2 domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain;Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain	.	.	0.5	.	42	1	179089397	chr1:179089397	C	A	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	179271949	179271949	T	-	intronic	SOAT1	.	.	.	1.67E-05	0.96658748	0.03339587	.	0.09058	0.50106	-0.286522835	33.47487615	1212.8663	6.5907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	102	1	179271948	chr1:179271948	AT	A,ATT	56	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	179271949	179271949	-	T	intronic	SOAT1	.	.	.	1.67E-05	0.96658748	0.03339587	.	0.09058	0.50106	-0.286522835	33.47487615	1212.8663	6.5907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	102	1	179271948	chr1:179271948	AT	A,ATT	56	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	180945093	180945093	-	A	UTR3	STX6	NM_001286210:c.*612_*613insT;NM_005819:c.*612_*613insT	.	.	0.019849117	0.961753214	0.018397669	.	0.11325	0.17021	-0.538132194	20.26421326	21.51311	0.72474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	90	1	180945093	chr1:180945093	C	CA	53	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	181059534	181059534	-	AGAGCAC	UTR3	IER5	NM_016545:c.*512_*513insAGAGCAC	.	.	0.666267931	0.311334265	0.022397803	.	0.07907	0.10373	.	.	2285.7254	8.84614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	94	1	181059534	chr1:181059534	A	AAGAGCAC	83	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	181768572	181768572	G	A	UTR3	CACNA1E	NM_001205293:c.*602G>A;NM_001205294:c.*602G>A;NM_000721:c.*602G>A	.	.	1	6.60E-14	1.68E-33	.	0.53292	0.32174	-2.708891704	0.713611701	325.12803	3.83322	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	1	181768572	chr1:181768572	G	A	.	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	183498178	183498178	G	T	splicing	SMG7	NM_201568:exon7:c.707+1G>T;NM_001350219:exon9:c.794+1G>T;NM_001174061:exon6:c.581+1G>T;NM_001350220:exon9:c.794+1G>T;NM_001350222:exon7:UTR5;NM_001350221:exon9:c.794+1G>T;NM_173156:exon7:c.707+1G>T;NM_201569:exon7:c.707+1G>T;NM_001331007:exon8:c.794+1G>T	.	.	0.999981493	1.85E-05	5.27E-15	.	0.16156	0.11403	-0.306750577	32.23047889	2354.2528	8.99331	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.026	0.677	25.2	0.995	0.686	0.987	0.860	D	c	1.191	1.031	1.000	0.747	0.295	0.044	0	5.07	0.680	9.079	0.934	0.953	0.551	1.000	0.715	0.965	0.450	18.820	0.920	.	.	.	0.5	61	124	1	183498178	chr1:183498178	G	T	61	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	184006844	184006844	C	-	UTR5	COLGALT2	NM_001303420:c.-353delG;NM_001303421:c.-59287delG;NM_015101:c.-353delG	.	.	5.02E-07	0.958604921	0.041394577	.	0.12554	0.09957	-0.642904474	16.62538335	297.73119	3.68132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	16.92	54	1	184006843	chr1:184006843	TC	T	16.92	PASS	DP=54;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	186089252	186089252	G	T	exonic	HMCN1	.	nonsynonymous SNV	HMCN1:NM_031935:exon80:c.G12204T:p.L4068F	2.19E-18	1	6.42E-24	.	0.11657	0.21661	-3.689691478	0.247699929	8270.20936	19.62945	0.303	0.143	T	1.0	0.899	D	0.998	0.875	D	0.000	0.537	D	1.000	0.537	D	0.36	0.120	N	-0.23	0.667	T	-2.27	0.506	N	0.37	0.431	-0.669	0.619	T	0.238	0.606	T	0.032	0.542	D	4.125	0.553	23.8	0.998	0.882	0.937	0.586	D	c	0.287	0.289	0.001	0.082	0.638	0.428	0	2.97	0.333	2.643	0.460	0.089	0.194	1.000	0.715	0.993	0.574	5.862	0.179	Immunoglobulin I-set|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	52	259	1	186089252	chr1:186089252	G	T	52	PASS	DP=259;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	190066898	190066898	G	A	UTR3	BRINP3	NM_001317188:c.*250C>T;NM_199051:c.*250C>T	.	.	0.003759093	0.994437874	0.001803034	.	0.93585	0.11558	-1.155457828	6.168907761	50.74004	1.40353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	15	1	190066898	chr1:190066898	G	A	.	PASS	DP=15;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	198264408	198264408	-	A	intronic	NEK7	.	.	.	0.707657761	0.29219643	0.000145809	.	0.24935	0.11215	-0.029247611	51.40363293	55.39612	1.49342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	192	1	198264407	chr1:198264407	CA	CAA,C	58	PASS	DP=192;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	198264408	198264408	A	-	intronic	NEK7	.	.	.	0.707657761	0.29219643	0.000145809	.	0.24935	0.11215	-0.029247611	51.40363293	55.39612	1.49342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	192	1	198264407	chr1:198264407	CA	CAA,C	58	PASS	DP=192;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	198677416	198677416	-	T	intronic	PTPRC	.	.	.	0.999941156	5.88E-05	3.61E-15	DISEASE: Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-positive/NK-cell-positive (T(-)B()NK() SCID) [MIM:608971]: A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. {ECO:0000269|PubMed:11145714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiple sclerosis (MS) [MIM:126200]: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. {ECO:0000269|PubMed:11101853}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.; 	0.17677	0.67006	0.231457213	68.57159707	71.3304	1.75714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	176	1	198677416	chr1:198677416	A	AT	67	PASS	DP=176;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	200583451	200583451	G	A	exonic	KIF14	.	stopgain	KIF14:NM_014875:exon4:c.C1450T:p.Q484X	6.03E-05	0.999939646	7.94E-08	DISEASE: Meckel syndrome 12 (MKS12) [MIM:616258]: A form of Meckel syndrome, a disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly. {ECO:0000269|PubMed:24128419}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06815	0.11654	-0.027643533	51.41542817	315.29337	3.77299	.	.	.	.	.	.	.	.	.	0.003	0.360	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.256	0.973	37	0.997	0.831	0.879	0.473	D	c	0.739	0.571	0.977	0.297	0.651	0.465	0	3.8	0.427	1.096	0.304	0.154	0.240	0.848	0.302	0.997	0.653	10.435	0.434	Kinesin motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	27	1	200583451	chr1:200583451	G	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	201178768	201178768	A	G	exonic	IGFN1	.	nonsynonymous SNV	IGFN1:NM_001164586:exon12:c.A4747G:p.S1583G	2.50E-18	0.007485788	0.992514212	.	0.12425	0.10243	6.487063031	99.87615004	12297.47943	23.82839	0.621	0.053	T	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	-1.03	0.764	T	0.67	0.023	N	0.016	0.013	-1.014	0.258	T	0.146	0.471	T	0.069	0.706	D	-2.098	0.007	0.001	0.770	0.113	0.001	0.004	N	c	-1.686	-1.819	0.000	0.035	0.487	0.133	0	-1.87	0.073	-1.095	0.034	-3.069	0.001	0.000	0.063	0.000	0.016	0.803	0.010	.	.	.	0.5	112	210	1	201178768	chr1:201178768	A	G	112	PASS	DP=210;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	204119098	204119098	G	A	intronic	ETNK2	.	.	.	0.007118854	0.920754366	0.07212678	.	0.07996	0.08354	0.016664174	55.21939137	1450.59804	7.10742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	1	204119098	chr1:204119098	G	A	.	PASS	DP=45;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	204192723	204192723	G	A	intronic	PLEKHA6	.	.	.	0.98196907	0.018030926	4.22E-09	.	0.21929	0.11756	-1.207107349	5.726586459	192.56504	3.00941	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	1	204192723	chr1:204192723	G	A	.	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	204375080	204375080	A	-	UTR3	PPP1R15B	NM_032833:c.*140delT	.	.	0.161223928	0.835586348	0.003189724	.	0.2019	0.08179	0.734883636	86.29983487	244.79842	3.3742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	119	1	204375079	chr1:204375079	CA	C,CAA	57	PASS	DP=119;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	204375080	204375080	-	A	UTR3	PPP1R15B	NM_032833:c.*139_*140insT	.	.	0.161223928	0.835586348	0.003189724	.	0.2019	0.08179	0.734883636	86.29983487	244.79842	3.3742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	119	1	204375079	chr1:204375079	CA	C,CAA	57	PASS	DP=119;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	205028152	205028152	-	C	intronic	CNTN2	.	.	.	0.129621135	0.870378534	3.31E-07	DISEASE: Epilepsy, familial adult myoclonic, 5 (FAME5) [MIM:615400]: A form of cortical myoclonic tremor with epilepsy, a syndrome characterized by cortical myoclonus and variable occurrence of epileptic seizures. Usually, myoclonic tremor is the presenting symptom, characterized by tremulous finger movements and myoclonic jerks of the limbs increased by action and posture. In a minority of patients, seizures are the presenting symptom; both complex partial as well as generalized tonic clonic seizures are described. Some patients exhibit mild cognitive impairment. {ECO:0000269|PubMed:23518707}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.39019	0.18821	-0.189246284	39.30761972	2533.66697	9.38949	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	70	1	205028152	chr1:205028152	A	AC	130	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	205719177	205719177	C	-	UTR5	NUCKS1	NM_022731:c.-76delG	.	.	0.979237658	0.020744772	1.76E-05	.	0.90068	0.13281	-0.119252484	44.53880632	4.59039	0.16497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	982	1	205719176	chr1:205719176	AC	A	123	PASS	DP=982;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/1
1	205901802	205901802	C	T	intronic	SLC26A9	.	.	.	0.002985459	0.996911146	0.000103395	.	0.17926	0.11651	-0.143334748	42.35079028	424.02635	4.30029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	1	205901802	chr1:205901802	C	T	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	206566861	206566861	A	-	ncRNA_intronic	SRGAP2D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	107	1	206566860	chr1:206566860	TA	T	123	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	207828583	207828583	A	T	intronic	CR1L	.	.	.	3.56E-15	0.020225564	0.979774436	.	0.06963	.	3.872389272	99.64614296	2178.56335	8.59961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	17	1	207828583	chr1:207828583	A	T	.	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	207888641	207888641	-	T	intronic	CR1L	.	.	.	3.56E-15	0.020225564	0.979774436	.	0.06963	.	3.872389272	99.64614296	2178.56335	8.59961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	521	1	207888640	chr1:207888640	CT	CTT,C	94	PASS	DP=521;AN=6	GT	./.	0/1	./.	0/2	./.	./.	./.	./.	./.	./.	0/1	./.
1	207888641	207888641	T	-	intronic	CR1L	.	.	.	3.56E-15	0.020225564	0.979774436	.	0.06963	.	3.872389272	99.64614296	2178.56335	8.59961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	521	1	207888640	chr1:207888640	CT	CTT,C	94	PASS	DP=521;AN=6	GT	./.	0/1	./.	0/2	./.	./.	./.	./.	./.	./.	0/1	./.
1	207933082	207933082	T	-	intronic	CD46	.	.	.	0.000191603	0.974855327	0.02495307	DISEASE: Hemolytic uremic syndrome atypical 2 (AHUS2) [MIM:612922]: An atypical form of hemolytic uremic syndrome. It is a complex genetic disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, renal failure and absence of episodes of enterocolitis and diarrhea. In contrast to typical hemolytic uremic syndrome, atypical forms have a poorer prognosis, with higher death rates and frequent progression to end-stage renal disease. {ECO:0000269|PubMed:16386793, ECO:0000269|PubMed:16621965, ECO:0000269|PubMed:20513133}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Other genes may play a role in modifying the phenotype. Patients with CD46 mutations seem to have an overall better prognosis compared to patients carrying CFH mutations.; 	0.10479	0.17659	0.439181676	77.69521113	55.53796	1.49781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	215	1	207933081	chr1:207933081	CT	C	66	PASS	DP=215;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	209880509	209880509	A	-	ncRNA_intronic	LOC101930114	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	19	1	209880508	chr1:209880508	GA	G	80	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	209936964	209936964	-	CA	intronic	TRAF3IP3	.	.	.	1.38E-06	0.989497509	0.010501115	.	0.25181	0.12101	0.286674996	71.49681529	267.89298	3.51107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	34	1	209936964	chr1:209936964	T	TCA	113	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
1	213224717	213224719	GGT	-	UTR5	RPS6KC1	NM_012424:c.-30_-28del-;NM_001136138:c.-30_-28del-;NM_001287218:c.-78224_-78222del-;NM_001287219:c.-78224_-78222del-;NM_001287220:c.-189498_-189496del-;NM_001287221:c.-78224_-78222del-;NM_001349646:c.-30_-28del-;NM_001349647:c.-30_-28del-;NM_001349648:c.-78224_-78222del-;NM_001349649:c.-78224_-78222del-;NM_001349650:c.-78224_-78222del-;NM_001349651:c.-78224_-78222del-;NM_001349652:c.-78224_-78222del-;NM_001349653:c.-78224_-78222del-;NM_001349654:c.-78224_-78222del-;NM_001349657:c.-116540_-116538del-;NM_001349658:c.-116540_-116538del-;NM_001349659:c.-179135_-179133del-;NM_001349660:c.-179135_-179133del-;NM_001349661:c.-179135_-179133del-;NM_001349662:c.-179135_-179133del-;NM_001349663:c.-189498_-189496del-;NM_001349664:c.-189498_-189496del-;NM_001349665:c.-189498_-189496del-;NM_001349666:c.-189498_-189496del-;NM_001349667:c.-189498_-189496del-;NM_001349668:c.-189498_-189496del-;NM_001349669:c.-189498_-189496del-;NM_001349670:c.-189498_-189496del-;NM_001349671:c.-189498_-189496del-;NM_001349672:c.-189498_-189496del-	.	.	0.020440097	0.979528986	3.09E-05	.	0.12108	0.12186	0.450099045	78.01958009	426.82545	4.31586	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	36	1	213224716	chr1:213224716	GGGT	G	43	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	215256558	215256558	C	T	intronic	KCNK2	.	.	.	0.339842885	0.657147273	0.003009842	.	0.12841	.	-0.449946534	24.00330267	31.8264	1.00181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	1	215256558	chr1:215256558	C	T	.	PASS	DP=43;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	220101100	220101100	G	A	ncRNA_intronic	RNU5F-1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	1	220101100	chr1:220101100	G	A	.	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	220101115	220101115	C	A	ncRNA_intronic	RNU5F-1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	1	220101115	chr1:220101115	C	A	.	PASS	DP=48;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	220964980	220964980	C	A	exonic	MARC1	.	synonymous SNV	MARC1:NM_022746:exon2:c.C423A:p.P141P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	235	1	220964980	chr1:220964980	C	A	67	PASS	DP=235;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	223168205	223168205	-	T	intronic	DISP1	.	.	.	4.23E-06	0.997859918	0.002135849	.	0.16068	0.11183	0.369203982	74.77589054	4506.07665	13.48325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	151	1	223168205	chr1:223168205	C	CT	70	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	227068322	227068322	A	C	intronic	PSEN2	.	.	.	0.027014182	0.961183973	0.011801844	DISEASE: Alzheimer disease 4 (AD4) [MIM:606889]: A familial early- onset form of Alzheimer disease. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituent of these plaques is the neurotoxic amyloid-beta-APP 40-42 peptide (s), derived proteolytically from the transmembrane precursor protein APP by sequential secretase processing. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products such as C31 derived from APP, are also implicated in neuronal death. {ECO:0000269|PubMed:10631141, ECO:0000269|PubMed:10732806, ECO:0000269|PubMed:22503161, ECO:0000269|PubMed:7638622, ECO:0000269|PubMed:7651536, ECO:0000269|PubMed:9384602}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1V (CMD1V) [MIM:613697]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:17186461}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.64189	0.66407	-1.019530098	8.038452465	211.70746	3.13692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	109	1	227068322	chr1:227068322	A	C	102	PASS	DP=109;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	228335908	228335908	G	T	intronic	GUK1	.	.	.	0.00010002	0.573762218	0.426137762	.	0.61935	0.39826	-0.957024976	9.088228356	85.40721	1.97028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	575	1	228335908	chr1:228335908	G	T	85	PASS	DP=575;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	228399453	228399453	C	A	ncRNA_intronic	OBSCN-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	300	1	228399453	chr1:228399453	C	A	.	PASS	DP=300;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	228465346	228465346	A	G	exonic	OBSCN	.	nonsynonymous SNV	OBSCN:NM_001271223:exon29:c.A8020G:p.N2674D	5.36E-91	1.17E-06	0.999998832	DISEASE: Note=A chromosomal aberration involving OBSCN has been found in Wilms tumor. Translocation t(1;7)(q42;p15) with PTHB1. {ECO:0000269|PubMed:12618763}.; 	0.1804	0.12775	.	.	33482.92348	35.92354	.	.	.	.	.	.	.	.	.	.	.	.	1e-37	0.810	P	.	.	.	1.01	0.411	T	.	.	.	0.071	0.117	.	.	.	.	.	.	.	.	.	3.591	0.489	23.2	0.990	0.498	0.976	0.758	D	n	1.930	2.508	1.000	0.747	0.696	0.567	0	4.49	0.540	5.732	0.680	1.007	0.626	1.000	0.715	0.958	0.437	13.940	0.634	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	ENSG00000162913.9|ENSG00000162913.9|ENSG00000269890.1|ENSG00000154358.15|ENSG00000162913.9|ENSG00000270110.1|ENSG00000269934.1|ENSG00000154358.15|ENSG00000270110.1|ENSG00000162913.9|ENSG00000154358.15|ENSG00000154358.15|ENSG00000181218.4|ENSG00000270110.1|ENSG00000162913.9|ENSG00000162913.9|ENSG00000181873.8	Brain_Cerebellar_Hemisphere|Breast_Mammary_Tissue|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Esophagus_Mucosa|Lung|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Spleen|Thyroid|Whole_Blood	0.5	95	52	1	228465346	chr1:228465346	A	G	95	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
1	228494689	228494689	C	T	exonic	OBSCN	.	nonsynonymous SNV	OBSCN:NM_001098623:exon45:c.C12014T:p.A4005V,OBSCN:NM_052843:exon45:c.C12014T:p.A4005V,OBSCN:NM_001271223:exon56:c.C14885T:p.A4962V	5.36E-91	1.17E-06	0.999998832	DISEASE: Note=A chromosomal aberration involving OBSCN has been found in Wilms tumor. Translocation t(1;7)(q42;p15) with PTHB1. {ECO:0000269|PubMed:12618763}.; 	0.1804	0.12775	.	.	33482.92348	35.92354	0.058	0.377	T	0.996	0.670	D	0.792	0.560	P	0.676	0.103	N	1	0.090	N	1.16	0.298	L	3.54	0.048	T	-1.36	0.338	N	0.108	0.132	-0.971	0.371	T	0.034	0.148	T	0.013	0.327	T	1.115	0.201	11.30	0.792	0.122	0.173	0.196	N	c	-0.580	-0.718	0.001	0.077	0.635	0.413	0	0.51	0.161	0.228	0.175	-0.760	0.034	0.000	0.063	0.000	0.016	16.803	0.854	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	71	117	1	228494689	chr1:228494689	C	T	71	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
1	228646535	228646535	G	C	upstream;downstream	HIST3H2A;HIST3H2BB	dist=975;dist=276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	293	1	228646535	chr1:228646535	G	C	65	PASS	DP=293;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	233425136	233425136	C	A	intronic	PCNX2	.	.	.	.	.	.	.	0.09947	.	0.389303812	75.70181647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	299	1	233425136	chr1:233425136	C	A	.	PASS	DP=299;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	235491824	235491824	G	-	intronic	GGPS1	.	.	.	0.666629559	0.328220145	0.005150296	.	0.22133	0.17306	-0.317668748	31.45789101	27.92768	0.89682	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	714	1	235491823	chr1:235491823	CG	C	77	PASS	DP=714;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	236703818	236703818	T	-	intronic	LGALS8	.	.	.	0.000188797	0.896973744	0.102837458	.	0.48105	0.17047	1.063778722	91.58410002	6987.34024	17.79441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	177	1	236703817	chr1:236703817	GT	G,GTT	62	PASS	DP=177;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.
1	236703818	236703818	-	T	intronic	LGALS8	.	.	.	0.000188797	0.896973744	0.102837458	.	0.48105	0.17047	1.063778722	91.58410002	6987.34024	17.79441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	177	1	236703817	chr1:236703817	GT	G,GTT	62	PASS	DP=177;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.
1	236724605	236724605	G	T	intronic	HEATR1	.	.	.	0.999999993	6.78E-09	9.22E-25	.	0.09748	0.08985	2.322745612	98.36635999	19763.61088	30.12571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	141	81	1	236724605	chr1:236724605	G	T	141	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
1	236767238	236767239	TT	-	intronic	HEATR1	.	.	.	0.999999993	6.78E-09	9.22E-25	.	0.09748	0.08985	2.322745612	98.36635999	19763.61088	30.12571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.54	19	1	236767237	chr1:236767237	GTT	G	13.54	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	236899900	236899900	C	-	exonic	ACTN2	.	frameshift deletion	ACTN2:NM_001278344:exon10:c.91delC:p.P32Lfs*11	0.999811916	0.000188084	7.39E-12	DISEASE: Cardiomyopathy, familial hypertrophic 23, with or without left ventricular non-compaction (CMH23) [MIM:612158]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:20022194, ECO:0000269|PubMed:25173926}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1AA, with or without left ventricular non-compaction (CMD1AA) [MIM:612158]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:14567970, ECO:0000269|PubMed:25224718}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.77327	0.39885	-1.723336008	2.465204058	447.74179	4.40066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	45	1	236899899	chr1:236899899	TC	T	109	PASS	DP=45;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	237167423	237167423	-	A	UTR3	MT1HL1	NM_001276687:c.*63_*64insT	.	.	0.020062126	0.511088562	0.468849312	.	.	.	.	.	93.79969	2.08288	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	362	1	237167423	chr1:237167423	G	GA	80	PASS	DP=362;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	237850715	237850715	C	T	intronic	RYR2	.	.	.	0.999999934	6.56E-08	1.25E-37	DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:11157710, ECO:0000269|PubMed:12093772, ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073, ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27314	0.27889	-5.869562633	0.053078556	1401.64962	6.99815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	254	1	237850715	chr1:237850715	C	T	71	PASS	DP=254;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	240775299	240775299	C	A	ncRNA_intronic	MIR1273E	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	225	1	240775299	chr1:240775299	C	A	.	PASS	DP=225;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	241803116	241803116	G	A	intronic	OPN3	.	.	.	0.84628904	0.153140027	0.000570934	.	0.18445	0.20063	0.15257911	64.60839821	559.13945	4.80286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	1	241803116	chr1:241803116	G	A	.	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	242383170	242383170	-	AC	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	20	1	242383170	chr1:242383170	T	TAC	53	PASS	DP=20;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	242514199	242514199	-	T	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.67	31	1	242514199	chr1:242514199	C	CT	19.67	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	242540222	242540222	G	A	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	1	242540222	chr1:242540222	G	A	.	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	242540223	242540223	G	T	intronic	PLD5	.	.	.	0.124197737	0.874752709	0.001049554	.	0.21114	0.08983	-0.181750739	40.15687662	20.81668	0.70563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	1	242540223	chr1:242540223	G	T	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	243218249	243218249	A	T	intergenic	PLD5;LINC01347	dist=530251;dist=1367	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	189	1	243218249	chr1:243218249	A	T	.	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	243594955	243594955	T	-	intronic	SDCCAG8	.	.	.	1.33E-07	0.987717896	0.012281972	DISEASE: Bardet-Biedl syndrome 16 (BBS16) [MIM:615993]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:22626039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13767	0.11503	-0.154246007	42.22694032	1944.53595	8.11749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	424	1	243594954	chr1:243594954	AT	A,ATT	102	PASS	DP=424;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
1	243594955	243594955	-	T	intronic	SDCCAG8	.	.	.	1.33E-07	0.987717896	0.012281972	DISEASE: Bardet-Biedl syndrome 16 (BBS16) [MIM:615993]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:20835237, ECO:0000269|PubMed:22626039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13767	0.11503	-0.154246007	42.22694032	1944.53595	8.11749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	424	1	243594954	chr1:243594954	AT	A,ATT	102	PASS	DP=424;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
1	244595875	244595875	C	T	exonic	ADSS	.	synonymous SNV	ADSS:NM_001126:exon4:c.G378A:p.R126R	0.822870228	0.177095098	3.47E-05	.	0.71511	0.34803	0.014844891	54.94810097	99.3475	2.15777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	178	1	244595875	chr1:244595875	C	T	59	PASS	DP=178;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
1	244869242	244869242	A	-	UTR3	DESI2	NM_001297746:c.*151delA;NM_016076:c.*151delA	.	.	0.915084441	0.084325944	0.000589615	.	0.11628	0.07259	0.21326276	67.71644256	11.70962	0.42542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	21	1	244869241	chr1:244869241	CA	C	43	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
1	245005424	245005424	-	T	intronic	COX20	.	.	.	0.011885436	0.640070275	0.348044289	.	0.15623	.	0.080983847	59.76055674	22.69107	0.75925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	181	1	245005424	chr1:245005424	A	AT	69	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
1	245017649	245017649	C	A	UTR3	HNRNPU	NM_004501:c.*103G>T;NM_031844:c.*103G>T	.	.	0.999903323	9.67E-05	7.22E-12	.	0.51398	0.38821	-0.60427181	17.74593064	41.32875	1.20799	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	165	1	245017649	chr1:245017649	C	A	77	PASS	DP=165;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
1	245021338	245021338	C	T	exonic	HNRNPU	.	nonsynonymous SNV	HNRNPU:NM_004501:exon7:c.G1412A:p.G471E,HNRNPU:NM_031844:exon7:c.G1469A:p.G490E	0.999903323	9.67E-05	7.22E-12	.	0.51398	0.38821	-0.60427181	17.74593064	41.32875	1.20799	0.005	0.632	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	2.69	0.790	M	0.85	0.475	T	-5.12	0.835	D	0.945	0.940	-0.505	0.685	T	0.301	0.673	T	0.034	0.552	D	5.060	0.681	25.2	0.998	0.892	0.976	0.760	D	c	0.728	0.700	1.000	0.747	0.722	0.854	0	4.94	0.645	7.856	0.852	0.852	0.362	1.000	0.715	0.999	0.750	14.931	0.704	.	.	.	0.5	.	20	1	245021338	chr1:245021338	C	T	.	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
1	247267209	247267209	C	A	intronic	ZNF669	.	.	.	0.060499399	0.922901133	0.016599468	.	0.05547	.	0.97558591	90.37508846	1414.66175	7.02829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	279	1	247267209	chr1:247267209	C	A	.	PASS	DP=279;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	247597504	247597504	C	A	exonic	NLRP3	.	synonymous SNV	NLRP3:NM_001127462:exon4:c.C2256A:p.A752A,NLRP3:NM_183395:exon4:c.C2256A:p.A752A,NLRP3:NM_001243133:exon5:c.C2421A:p.A807A,NLRP3:NM_004895:exon5:c.C2427A:p.A809A,NLRP3:NM_001127461:exon6:c.C2427A:p.A809A,NLRP3:NM_001079821:exon7:c.C2427A:p.A809A	0.447262679	0.552726293	1.10E-05	DISEASE: Familial cold autoinflammatory syndrome 1 (FCAS1) [MIM:120100]: A rare autosomal dominant systemic inflammatory disease characterized by recurrent episodes of maculopapular rash associated with arthralgias, myalgias, fever and chills, swelling of the extremities, and conjunctivitis after generalized exposure to cold. Rarely, some patients may also develop late-onset renal amyloidosis. {ECO:0000269|PubMed:11687797, ECO:0000269|PubMed:11992256, ECO:0000269|PubMed:12355493, ECO:0000269|PubMed:12522564, ECO:0000269|PubMed:15593220, ECO:0000269|PubMed:17284928, ECO:0000269|PubMed:24952504}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muckle-Wells syndrome (MWS) [MIM:191900]: A hereditary periodic fever syndrome characterized by fever, chronic recurrent urticaria, arthralgias, progressive sensorineural deafness, and reactive renal amyloidosis. The disease may be severe if generalized reactive amyloidosis occurs. {ECO:0000269|PubMed:11687797, ECO:0000269|PubMed:11992256, ECO:0000269|PubMed:12355493, ECO:0000269|PubMed:15593220, ECO:0000269|PubMed:24952504}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115]: Rare congenital inflammatory disorder characterized by a triad of neonatal onset of cutaneous symptoms, chronic meningitis, and joint manifestations with recurrent fever and inflammation. {ECO:0000269|PubMed:12032915, ECO:0000269|PubMed:12483741, ECO:0000269|PubMed:14630794, ECO:0000269|PubMed:15231984, ECO:0000269|PubMed:15334500, ECO:0000269|PubMed:15593220, ECO:0000269|PubMed:24952504}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.41725	0.10512	-0.946125119	9.377211607	78.62534	1.87076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	137	1	247597504	chr1:247597504	C	A	.	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	248112554	248112554	T	C	exonic	OR2L8	.	nonsynonymous SNV	OR2L8:NM_001001963:exon1:c.T395C:p.L132P	0.17916862	0.766561924	0.054269456	.	0.05102	0.09448	2.396009417	98.49020996	223.42356	3.23122	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.405	0.131	N	1	0.090	N	-1.51	0.005	N	5.99	0.006	T	7.42	0.000	N	0.136	0.157	-0.991	0.324	T	0.001	0.002	T	0.000	0.001	T	-2.726	0.002	0.001	0.371	0.024	0.001	0.007	N	c	-2.527	-2.516	0.001	0.076	0.487	0.133	0	-3.28	0.047	-7.320	0.000	-5.127	0.000	0.000	0.063	0.000	0.016	2.974	0.055	GPCR, rhodopsin-like, 7TM	.	.	0.5	70	83	1	248112554	chr1:248112554	T	C	70	PASS	DP=83;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
1	248247188	248247188	G	C	intronic	OR2L13	.	.	.	0.014419191	0.679992608	0.305588201	.	0.12185	0.08854	0.595326758	82.66100495	760.16705	5.46484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	208	1	248247188	chr1:248247188	G	C	.	PASS	DP=208;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
1	248308521	248308521	C	A	exonic	OR2M5	.	nonsynonymous SNV	OR2M5:NM_001004690:exon1:c.C72A:p.H24Q	0.001566155	0.450104621	0.548329224	.	0.07654	.	2.33165376	98.38405284	958.84659	5.99448	0.1	0.305	T	0.312	0.311	B	0.089	0.282	B	0.005	0.332	U	1	0.090	N	0.165	0.090	N	8.12	0.003	T	-4.96	0.819	D	0.128	0.146	-1.067	0.100	T	0.000	0.001	T	0.002	0.034	T	1.149	0.205	11.48	0.946	0.245	0.001	0.008	N	c	-0.698	-0.627	0.000	0.012	0.487	0.133	0	2.2	0.268	-0.584	0.058	-0.452	0.056	0.000	0.063	0.001	0.043	5.358	0.153	.	.	.	0.5	90	307	1	248308521	chr1:248308521	C	A	90	PASS	DP=307;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	369955	369955	T	A	exonic	CHL1	.	synonymous SNV	CHL1:NM_001253388:exon3:c.T303A:p.S101S,CHL1:NM_001253387:exon5:c.T303A:p.S101S,CHL1:NM_006614:exon5:c.T303A:p.S101S	2.05E-06	0.999947701	5.02E-05	.	0.39224	0.09664	-0.158112528	41.92026421	1165.89885	6.49553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	3	369955	chr3:369955	T	A	.	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	4534940	4534940	G	-	upstream	ITPR1;ITPR1-AS1	dist=92	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	566	3	4534939	chr3:4534939	CG	C	62	PASS	DP=566;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	4872710	4872710	-	A	intronic	ITPR1	.	.	.	1	5.90E-12	3.24E-32	DISEASE: Spinocerebellar ataxia 15 (SCA15) [MIM:606658]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It is very slow progressing form with a wide range of onset, ranging from childhood to adult. Most patients remain ambulatory. {ECO:0000269|PubMed:17590087, ECO:0000269|PubMed:18579805}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spinocerebellar ataxia 29 (SCA29) [MIM:117360]: An autosomal dominant, congenital spinocerebellar ataxia characterized by early motor delay, hypotonia and mild cognitive delay. Affected individuals develop a very slowly progressive or non-progressive gait and limb ataxia associated with cerebellar atrophy on brain imaging. Additional variable features include nystagmus, dysarthria, and tremor. {ECO:0000269|PubMed:22986007}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.48957	0.4536	-3.352519381	0.401037981	228.28209	3.26405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	34.26	70	3	4872710	chr3:4872710	G	GA	34.26	PASS	DP=70;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	6903297	6903297	C	T	exonic	GRM7	.	synonymous SNV	GRM7:NM_000844:exon1:c.C222T:p.N74N,GRM7:NM_181874:exon1:c.C222T:p.N74N	0.999169069	0.00083093	1.36E-09	.	0.68439	0.09371	-1.616692429	2.937013447	1262.73334	6.70044	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	145	3	6903297	chr3:6903297	C	T	132	PASS	DP=145;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	7620433	7620433	C	G	exonic	GRM7	.	nonsynonymous SNV	GRM7:NM_000844:exon8:c.C1840G:p.R614G,GRM7:NM_181874:exon8:c.C1840G:p.R614G	0.999169069	0.00083093	1.36E-09	.	0.68439	0.09371	-1.616692429	2.937013447	1262.73334	6.70044	0.002	0.721	D	0.953	0.764	P	0.852	0.850	P	0.000	0.843	D	1	0.810	D	3.42	0.921	M	-2.51	0.893	D	-4.83	0.809	D	0.982	0.985	0.854	0.951	D	0.856	0.952	D	0.337	0.919	D	6.731	0.919	32	0.999	0.975	0.960	0.667	D	c	0.797	0.758	1.000	0.747	0.554	0.246	0	5.93	0.959	2.671	0.463	0.935	0.490	0.993	0.376	1.000	0.888	18.918	0.925	GPCR family 3, C-terminal	.	.	0.5	92	195	3	7620433	chr3:7620433	C	G	92	PASS	DP=195;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	9408575	9408575	-	T	intronic	THUMPD3	.	.	.	4.00E-11	0.093421697	0.906578303	.	0.13906	0.09925	0.266447942	70.5826846	866.34515	5.73321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	36	3	9408575	chr3:9408575	C	CT	43	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	9512194	9512194	A	T	exonic	SETD5	.	nonsynonymous SNV	SETD5:NM_001080517:exon19:c.A2776T:p.N926Y,SETD5:NM_001292043:exon21:c.A2482T:p.N828Y,SETD5:NM_001349451:exon22:c.A2482T:p.N828Y	0.999999564	4.36E-07	2.82E-18	DISEASE: Mental retardation, autosomal dominant 23 (MRD23) [MIM:615761]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD23 patients manifest moderate to severe intellectual disability with additional variable features of brachycephaly, a low hairline, depressed nasal bridge, prominent high nasal root, tubular nose, upslanting palpebral fissures, long and smooth philtrum, micrognathia, thin upper lip, and crowded teeth. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, are prominent features. {ECO:0000269|PubMed:24680889}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.46735	0.10674	-0.791786324	12.59731069	500.45582	4.59199	0.002	0.721	D	0.776	0.422	P	0.526	0.466	P	0.000	0.447	D	0.653	0.305	N	0.55	0.145	N	-2.67	0.922	D	-1.79	0.422	N	0.279	0.349	-0.916	0.461	T	0.113	0.403	T	0.030	0.529	D	3.788	0.512	23.4	0.991	0.528	0.964	0.686	D	c	0.154	0.269	1.000	0.747	0.719	0.830	0	5.31	0.750	4.384	0.591	1.028	0.649	1.000	0.715	1.000	0.888	15.254	0.732	.	.	.	0.5	.	35	3	9512194	chr3:9512194	A	T	.	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	9518173	9518173	G	A	UTR3	SETD5	NM_001292043:c.*398G>A;NM_001080517:c.*398G>A;NM_001349451:c.*398G>A	.	.	0.999999564	4.36E-07	2.82E-18	DISEASE: Mental retardation, autosomal dominant 23 (MRD23) [MIM:615761]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD23 patients manifest moderate to severe intellectual disability with additional variable features of brachycephaly, a low hairline, depressed nasal bridge, prominent high nasal root, tubular nose, upslanting palpebral fissures, long and smooth philtrum, micrognathia, thin upper lip, and crowded teeth. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, are prominent features. {ECO:0000269|PubMed:24680889}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.46735	0.10674	-0.791786324	12.59731069	500.45582	4.59199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	3	9518173	chr3:9518173	G	A	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	9518244	9518244	G	-	UTR3	SETD5	NM_001292043:c.*469delG;NM_001080517:c.*469delG;NM_001349451:c.*469delG	.	.	0.999999564	4.36E-07	2.82E-18	DISEASE: Mental retardation, autosomal dominant 23 (MRD23) [MIM:615761]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD23 patients manifest moderate to severe intellectual disability with additional variable features of brachycephaly, a low hairline, depressed nasal bridge, prominent high nasal root, tubular nose, upslanting palpebral fissures, long and smooth philtrum, micrognathia, thin upper lip, and crowded teeth. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, are prominent features. {ECO:0000269|PubMed:24680889}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.46735	0.10674	-0.791786324	12.59731069	500.45582	4.59199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	35.74	28	3	9518243	chr3:9518243	AG	A	35.74	PASS	DP=28;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	9730483	9730483	C	T	intronic	MTMR14	.	.	.	0.002939821	0.99695446	0.000105719	.	0.30998	0.11304	-0.911109353	9.961075725	98.92051	2.15158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	3	9730483	chr3:9730483	C	T	.	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	9730571	9730571	G	-	intronic	MTMR14	.	.	.	0.002939821	0.99695446	0.000105719	.	0.30998	0.11304	-0.911109353	9.961075725	98.92051	2.15158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	146	3	9730570	chr3:9730570	TG	T	127	PASS	DP=146;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	9912079	9912079	G	T	intronic	CIDEC	.	.	.	0.001416632	0.665901653	0.332681714	DISEASE: Note=In omental adipose tissue of obese patients matched for BMI, expression levels tend to correlate with insulin sensitivity. Expression is increased 2-3 fold in the group of patients with high insulin sensitivity, compared to the insulin- resistant group. This observation is consistent with the idea that triglyceride storage in adipocytes plays an important role in sequestering triglycerides and fatty acids away from the circulation and peripheral tissues, thus enhancing insulin sensitivity in liver and muscle. This effect is not significant in subcutaneous adipose tissue (PubMed:18509062). In subcutaneous adipose tissue of diabetic patients, tends to negatively correlate with body mass index and total fat mass, independently of insulin sensitivity (PubMed:18334488). {ECO:0000269|PubMed:18334488, ECO:0000269|PubMed:18509062}.; DISEASE: Lipodystrophy, familial partial, 5 (FPLD5) [MIM:615238]: A form of lipodystrophy characterized by loss of subcutaneous adipose tissue affecting limb, femorogluteal and subcutaneous abdominal fat, preservation of visceral, neck and axilliary fat, hepatomegaly, hepatic steatosis and insulin-resistant diabetes. {ECO:0000269|PubMed:20049731}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20849	.	0.262810045	70.43524416	157.22556	2.74041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	3	9912079	chr3:9912079	G	T	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	10103911	10103911	C	-	intronic	FANCD2	.	.	.	2.48E-14	0.999907163	9.28E-05	DISEASE: Fanconi anemia complementation group D2 (FANCD2) [MIM:227646]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:11239453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25008	.	-0.920453886	9.790044822	710.41171	5.29622	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	51	3	10103910	chr3:10103910	TC	T	41	PASS	DP=51;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	13613030	13613030	C	G	exonic	FBLN2	.	stopgain	FBLN2:NM_001004019:exon2:c.C1175G:p.S392X,FBLN2:NM_001165035:exon2:c.C1175G:p.S392X,FBLN2:NM_001998:exon2:c.C1175G:p.S392X	0.629825153	0.370172306	2.54E-06	.	0.76637	0.22472	-1.091439713	6.988676575	754.76604	5.44846	.	.	.	.	.	.	.	.	.	0.016	0.014	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.692	0.629	24.6	0.952	0.259	0.194	0.204	N	c	-0.196	-0.583	0.998	0.368	0.696	0.567	0	-1.13	0.092	0.510	0.223	-0.841	0.030	0.000	0.063	0.000	0.016	8.519	0.322	.	.	.	0.5	71	181	3	13613030	chr3:13613030	C	G	71	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	14208625	14208625	G	C	intronic	XPC	.	.	.	1.32E-10	0.769528282	0.230471718	DISEASE: Xeroderma pigmentosum complementation group C (XP-C) [MIM:278720]: An autosomal recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin, high predisposition for developing cancers on areas exposed to sunlight and, in some cases, neurological abnormalities. The skin develops marked freckling and other pigmentation abnormalities. {ECO:0000269|PubMed:10766188, ECO:0000269|PubMed:8298653}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.28185	0.48408	0.45192103	78.03727294	310.38459	3.74818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	13	3	14208625	chr3:14208625	G	C	44	PASS	DP=13;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	14520577	14520577	C	T	intronic	SLC6A6	.	.	.	0.98227565	0.017723862	4.88E-07	.	0.32797	.	-0.291981272	33.20358575	72.45796	1.77348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	3	14520577	chr3:14520577	C	T	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	23848923	23848923	-	T	intronic	UBE2E1	.	.	.	0.872957997	0.125383932	0.00165807	.	0.62873	0.11262	0.279402865	70.86577023	246.66235	3.38871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	200	3	23848923	chr3:23848923	C	CT	85	PASS	DP=200;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	24270412	24270412	-	A	intronic	THRB	.	.	.	0.994541861	0.005457474	6.65E-07	DISEASE: Generalized thyroid hormone resistance (GTHR) [MIM:188570]: A disease characterized by goiter, abnormal mental functions, increased susceptibility to infections, abnormal growth and bone maturation, tachycardia and deafness. Affected individuals may also have attention deficit-hyperactivity disorders (ADHD) and language difficulties. GTHR patients also have high levels of circulating thyroid hormones (T3-T4), with normal or slightly elevated thyroid stimulating hormone (TSH). {ECO:0000269|PubMed:10660344, ECO:0000269|PubMed:1314846, ECO:0000269|PubMed:1324420, ECO:0000269|PubMed:1563081, ECO:0000269|PubMed:1587388, ECO:0000269|PubMed:1619012, ECO:0000269|PubMed:1661299, ECO:0000269|PubMed:16804041, ECO:0000269|PubMed:1846005, ECO:0000269|PubMed:19268523, ECO:0000269|PubMed:2153155, ECO:0000269|PubMed:2510172, ECO:0000269|PubMed:7833659, ECO:0000269|PubMed:8175986, ECO:0000269|PubMed:8514853, ECO:0000269|PubMed:8664910, ECO:0000269|PubMed:8889584}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Generalized thyroid hormone resistance autosomal recessive (GTHRAR) [MIM:274300]: An autosomal recessive disorder characterized by goiter, clinical euthyroidism, end-organ unresponsiveness to thyroid hormone, abnormal growth and bone maturation, and deafness. Patients also have high levels of circulating thyroid hormones, with elevated thyroid stimulating hormone. {ECO:0000269|PubMed:1653889}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Selective pituitary thyroid hormone resistance (PRTH) [MIM:145650]: Variant form of thyroid hormone resistance and is characterized by clinical hyperthyroidism, with elevated free thyroid hormones, but inappropriately normal serum TSH. Unlike GRTH, where the syndrome usually segregates with a dominant allele, the mode of inheritance in PRTH has not been established. {ECO:0000269|PubMed:7528740, ECO:0000269|PubMed:8381821}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87928	0.51098	-0.471992905	23.03609342	18.48609	0.63978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	55	3	24270412	chr3:24270412	T	TA	76	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	25660094	25660094	-	T	intronic	TOP2B	.	.	.	0.997311093	0.002688907	1.64E-12	.	0.99834	0.37504	-0.150608082	42.28001887	748.55499	5.42826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	19	3	25660094	chr3:25660094	G	GT	75	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	32031962	32031962	A	G	exonic	ZNF860	.	nonsynonymous SNV	ZNF860:NM_001137674:exon2:c.A1391G:p.H464R	7.86E-11	0.020083806	0.979916194	.	.	.	1.77302331	96.80938901	2376.15674	9.04469	0.217	0.191	T	0.004	0.112	B	0.001	0.040	B	.	.	.	1	0.090	P	-1.345	0.007	N	2.28	0.173	T	0.38	0.036	N	0.039	0.019	-0.948	0.414	T	0.000	0.000	T	.	.	.	-2.240	0.005	0.001	0.229	0.009	0.005	0.022	N	c	-2.613	-2.632	0.780	0.238	0.554	0.283	0	-0.599	0.110	-1.314	0.028	-2.728	0.002	0.000	0.063	0.000	0.016	4.085	0.093	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	83	54	3	32031962	chr3:32031962	A	G	83	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	35726292	35726292	-	T	UTR3	ARPP21	NM_001267616:c.*771_*772insT;NM_001267618:c.*771_*772insT;NM_001025069:c.*771_*772insT;NM_001025068:c.*771_*772insT;NM_198399:c.*771_*772insT	.	.	0.003676931	0.996246529	7.65E-05	.	.	.	-0.176292081	40.56381222	963.20115	6.00774	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	151	3	35726292	chr3:35726292	G	GT	61	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	38105399	38105399	C	T	exonic	DLEC1	.	nonsynonymous SNV	DLEC1:NM_001321153:exon6:c.C1162T:p.P388S,DLEC1:NM_007335:exon6:c.C1162T:p.P388S,DLEC1:NM_007337:exon6:c.C1162T:p.P388S	6.45E-18	0.99562723	0.00437277	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The gene represented in this entry may be involved in disease pathogenesis. DLEC1 silencing due to promoter methylation and aberrant transcription are implicated in the development of lung cancer.; DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. {ECO:0000269|PubMed:10213508}. Note=The gene represented in this entry may be involved in disease pathogenesis. DLEC1 silencing due to promoter methylation and aberrant transcription may be implicated in the development of esophageal cancer.; 	0.98238	0.10873	0.161491526	64.92686954	3130.50362	10.64467	0.127	0.270	T	0.491	0.381	P	0.146	0.323	B	0.234	0.158	N	0.989	0.243	N	1.59	0.404	L	3.61	0.045	T	-1.1	0.285	N	0.06	0.048	-0.979	0.353	T	0.012	0.045	T	0.001	0.012	T	1.076	0.197	11.08	0.949	0.251	0.059	0.117	N	c	-0.641	-0.682	0.062	0.153	0.497	0.185	0	0.627	0.168	0.341	0.195	-0.042	0.124	0.016	0.191	0.976	0.476	3.142	0.060	.	.	.	0.5	.	33	3	38105399	chr3:38105399	C	T	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	38137959	38137959	-	T	intronic	DLEC1	.	.	.	6.45E-18	0.99562723	0.00437277	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The gene represented in this entry may be involved in disease pathogenesis. DLEC1 silencing due to promoter methylation and aberrant transcription are implicated in the development of lung cancer.; DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. {ECO:0000269|PubMed:10213508}. Note=The gene represented in this entry may be involved in disease pathogenesis. DLEC1 silencing due to promoter methylation and aberrant transcription may be implicated in the development of esophageal cancer.; 	0.98238	0.10873	0.161491526	64.92686954	3130.50362	10.64467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	168	3	38137959	chr3:38137959	G	GT	80	PASS	DP=168;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	39194899	39194899	C	A	intronic	CSRNP1	.	.	.	0.599530989	0.398521925	0.001947085	.	0.23152	0.09962	-0.222203495	37.54423213	58.28318	1.54604	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	3	39194899	chr3:39194899	C	A	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	39307372	39307372	-	A	exonic	CX3CR1	.	frameshift insertion	CX3CR1:NM_001171171:exon2:c.628dupT:p.C210Lfs*21,CX3CR1:NM_001171172:exon2:c.628dupT:p.C210Lfs*21,CX3CR1:NM_001171174:exon2:c.724dupT:p.C242Lfs*21,CX3CR1:NM_001337:exon2:c.628dupT:p.C210Lfs*21	0.107291641	0.775970084	0.116738275	DISEASE: Macular degeneration, age-related, 12 (ARMD12) [MIM:613784]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:15208270}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.33672	0.36637	0.92967242	89.79122435	996.80543	6.08548	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	20.63	36	3	39307372	chr3:39307372	C	CA	20.63	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	40550121	40550121	-	T	intronic	ZNF620	.	.	.	6.83E-06	0.715071728	0.284921445	.	0.10981	.	0.350995466	74.37485256	198.29097	3.04284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.36	118	3	40550121	chr3:40550121	C	CT	10.36	PASS	DP=118;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
3	41266113	41266113	C	T	exonic	CTNNB1	.	nonsynonymous SNV	CTNNB1:NM_001098209:exon3:c.C110T:p.S37F,CTNNB1:NM_001098210:exon3:c.C110T:p.S37F,CTNNB1:NM_001904:exon3:c.C110T:p.S37F,CTNNB1:NM_001330729:exon4:c.C89T:p.S30F	0.99981275	0.00018725	3.61E-11	DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:9065402}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Note=Activating mutations in CTNNB1 have oncogenic activity resulting in tumor development. Somatic mutations are found in various tumor types, including colon cancers, ovarian and prostate carcinomas, hepatoblastoma (HB), hepatocellular carcinoma (HCC). HBs are malignant embryonal tumors mainly affecting young children in the first three years of life.; DISEASE: Pilomatrixoma (PTR) [MIM:132600]: Common benign skin tumor. {ECO:0000269|PubMed:10192393, ECO:0000269|PubMed:11703283}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269|PubMed:10666372}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10391090}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CTNNB1 is found in salivary gland pleiomorphic adenomas, the most common benign epithelial tumors of the salivary gland. Translocation t(3;8)(p21;q12) with PLAG1.; DISEASE: Mesothelioma, malignant (MESOM) [MIM:156240]: An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle- shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. {ECO:0000269|PubMed:11464291}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Mental retardation, autosomal dominant 19 (MRD19) [MIM:615075]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD19 features include severe intellectual disability with absent or very limited speech, microcephaly, and spasticity which severely impaired the ability to walk. {ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:25326669}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99997	0.9963	-0.582225231	18.44184949	10.25364	0.37429	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.66	0.781	M	0.73	0.507	T	-5.85	0.885	D	0.305	0.852	-0.337	0.740	T	0.351	0.715	T	0.072	0.716	D	6.048	0.832	28.0	0.998	0.910	0.963	0.684	D	c	0.917	0.895	1.0	0.983	0.707	0.730	0	5.76	0.907	7.905	0.864	0.935	0.490	1.000	0.715	1.000	0.888	19.960	0.972	.	.	.	0.5	.	40	3	41266113	chr3:41266113	C	T	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	43607198	43607198	C	-	exonic	ANO10	.	frameshift deletion	ANO10:NM_001204833:exon6:c.907delG:p.A303Pfs*9,ANO10:NM_001204832:exon7:c.1042delG:p.A348Pfs*9,ANO10:NM_001204834:exon7:c.670delG:p.A224Pfs*9,ANO10:NM_001346466:exon7:c.1042delG:p.A348Pfs*9,ANO10:NM_001346469:exon7:c.1042delG:p.A348Pfs*9,ANO10:NM_001204831:exon8:c.1240delG:p.A414Pfs*9,ANO10:NM_001346463:exon8:c.1240delG:p.A414Pfs*9,ANO10:NM_001346464:exon8:c.1240delG:p.A414Pfs*9,ANO10:NM_001346465:exon8:c.1240delG:p.A414Pfs*9,ANO10:NM_001346467:exon8:c.1240delG:p.A414Pfs*9,ANO10:NM_001346468:exon8:c.1240delG:p.A414Pfs*9,ANO10:NM_018075:exon8:c.1240delG:p.A414Pfs*9	1.92E-06	0.880526516	0.119471561	.	0.13961	0.09565	0.957177419	90.14508139	912.19278	5.8726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	29	3	43607197	chr3:43607197	GC	G	75	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	47263926	47263926	T	-	ncRNA_intronic	KIF9-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	53	3	47263925	chr3:47263925	CT	C	97	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	48226193	48226193	-	A	intronic	CDC25A	.	.	.	0.979698045	0.020301273	6.82E-07	.	0.99898	0.37326	-0.291981272	33.20358575	96.05413	2.11781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.14	41	3	48226193	chr3:48226193	G	GA	11.14	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	48228116	48228116	C	A	intronic	CDC25A	.	.	.	0.979698045	0.020301273	6.82E-07	.	0.99898	0.37326	-0.291981272	33.20358575	96.05413	2.11781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	3	48228116	chr3:48228116	C	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	48636507	48636507	G	-	UTR3	UQCRC1	NM_003365:c.*54delC	.	.	0.132467103	0.866597704	0.000935193	.	0.19556	0.2411	-0.268115223	34.70747818	259.99619	3.46496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	314	3	48636506	chr3:48636506	TG	T	93	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	48682911	48682911	G	A	exonic	CELSR3	.	nonsynonymous SNV	CELSR3:NM_001407:exon24:c.C7762T:p.L2588F	0.999656221	0.000343779	1.51E-19	.	.	0.2449	-4.265082462	0.11205473	3038.6677	10.47295	0.036	0.433	D	0.002	0.546	B	0.012	0.582	B	.	.	.	0.926	0.368	D	1.585	0.400	L	1.15	0.382	T	-2.18	0.491	N	0.219	0.440	-0.894	0.486	T	0.147	0.472	T	0.032	0.540	D	3.539	0.483	23.1	0.987	0.443	0.899	0.504	D	c	0.067	0.133	0.805	0.242	0.696	0.567	0	4.23	0.492	1.426	0.343	0.939	0.529	1.000	0.715	0.999	0.750	14.076	0.643	GPCR, family 2-like	.	.	0.5	.	79	3	48682911	chr3:48682911	G	A	.	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	48684190	48684190	G	C	intronic	CELSR3	.	.	.	0.999656221	0.000343779	1.51E-19	.	.	0.2449	-4.265082462	0.11205473	3038.6677	10.47295	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	137	3	48684190	chr3:48684190	G	C	110	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	52858010	52858010	G	A	exonic;splicing	ITIH4;ITIH4-AS1	NR_046615:exon1:c.59+1G>A	synonymous SNV	ITIH4:NM_001166449:exon10:c.C1182T:p.N394N,ITIH4:NM_002218:exon10:c.C1182T:p.N394N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	3	52858010	chr3:52858010	G	A	.	PASS	DP=56;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	53919752	53919752	C	A	intronic	SELENOK	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	3	53919752	chr3:53919752	C	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	55052208	55052208	T	-	intronic	CACNA2D3	.	.	.	0.998032255	0.001967745	7.65E-13	.	0.66118	.	-0.837696902	11.45317292	106.33657	2.2377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	38	3	55052207	chr3:55052207	CT	C	45	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	55543261	55543261	-	T	UTR3	ERC2	NM_015576:c.*2082_*2083insA	.	.	0.996856462	0.003143537	5.86E-11	.	0.79983	0.1105	-0.328796968	30.86223166	667.89389	5.16807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	34	3	55543261	chr3:55543261	G	GT	67	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	56591278	56591278	-	GGGGTAAGCA	exonic	CCDC66	.	stopgain	CCDC66:NM_001141947:exon1:c.8_9insGGGGTAAGCA:p.D5fs*0	8.99E-28	5.33E-05	0.999946706	.	0.06976	.	0.808316435	87.73295589	3801.22948	12.11059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	203	3	56591278	chr3:56591278	T	TGGGGTAAGCA	131	PASS	DP=203;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	56787560	56787560	A	C	exonic	ARHGEF3	.	nonsynonymous SNV	ARHGEF3:NM_001128616:exon4:c.T428G:p.L143W,ARHGEF3:NM_019555:exon4:c.T410G:p.L137W,ARHGEF3:NM_001289698:exon5:c.T428G:p.L143W,ARHGEF3:NM_001128615:exon7:c.T506G:p.L169W	0.991271358	0.008728557	8.58E-08	.	0.32682	0.12378	-0.290161348	33.33923095	2959.45549	10.30538	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.24	0.636	M	-0.01	0.628	T	-4.92	0.837	D	0.898	0.890	0.108	0.843	D	0.492	0.807	T	0.169	0.847	D	5.910	0.811	27.5	0.960	0.278	0.983	0.809	D	c	0.919	0.880	1.0	0.983	0.707	0.730	0	5.63	0.861	8.945	0.925	1.119	0.881	1.000	0.715	1.000	0.888	15.810	0.782	Dbl homology (DH) domain	.	.	0.5	76	37	3	56787560	chr3:56787560	A	C	76	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	56835761	56835761	G	A	exonic	ARHGEF3	.	synonymous SNV	ARHGEF3:NM_019555:exon1:c.C66T:p.P22P	0.991271358	0.008728557	8.58E-08	.	0.32682	0.12378	-0.290161348	33.33923095	2959.45549	10.30538	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	172	207	3	56835761	chr3:56835761	G	A	172	PASS	DP=207;AN=2	GT	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	57140083	57140083	C	A	intronic	IL17RD	.	.	.	2.64E-05	0.98202302	0.017950625	.	0.6749	0.12392	-0.172654315	40.63458363	2297.79347	8.87861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	86	3	57140083	chr3:57140083	C	A	.	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	57843748	57843748	-	T	intronic	SLMAP	.	.	.	0.999325965	0.000674035	6.78E-12	.	0.43101	0.11509	-1.155457828	6.168907761	40.3211	1.1843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	30	3	57843748	chr3:57843748	C	CT	83	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	58368401	58368401	C	G	exonic	PXK	.	nonsynonymous SNV	PXK:NM_001289096:exon2:c.C263G:p.P88R,PXK:NM_001289100:exon2:c.C263G:p.P88R,PXK:NM_001349490:exon2:c.C263G:p.P88R,PXK:NM_001349500:exon2:c.C263G:p.P88R,PXK:NM_001349522:exon2:c.C263G:p.P88R,PXK:NM_001349524:exon2:c.C263G:p.P88R,PXK:NM_001289095:exon3:c.C311G:p.P104R,PXK:NM_001349494:exon3:c.C314G:p.P105R,PXK:NM_001349495:exon3:c.C314G:p.P105R,PXK:NM_001349496:exon3:c.C311G:p.P104R,PXK:NM_001349497:exon3:c.C311G:p.P104R,PXK:NM_001349501:exon3:c.C314G:p.P105R,PXK:NM_001349502:exon3:c.C311G:p.P104R,PXK:NM_001349510:exon3:c.C314G:p.P105R,PXK:NM_001349511:exon3:c.C314G:p.P105R,PXK:NM_001349512:exon3:c.C314G:p.P105R,PXK:NM_001349514:exon3:c.C311G:p.P104R,PXK:NM_001349515:exon3:c.C311G:p.P104R,PXK:NM_001349516:exon3:c.C314G:p.P105R,PXK:NM_001349517:exon3:c.C311G:p.P104R,PXK:NM_001349518:exon3:c.C311G:p.P104R,PXK:NM_001289098:exon4:c.C362G:p.P121R,PXK:NM_001289099:exon4:c.C113G:p.P38R,PXK:NM_001349488:exon4:c.C362G:p.P121R,PXK:NM_001349492:exon4:c.C362G:p.P121R,PXK:NM_001349493:exon4:c.C362G:p.P121R,PXK:NM_001349498:exon4:c.C302G:p.P101R,PXK:NM_001349499:exon4:c.C362G:p.P121R,PXK:NM_001349503:exon4:c.C362G:p.P121R,PXK:NM_001349504:exon4:c.C362G:p.P121R,PXK:NM_001349506:exon4:c.C362G:p.P121R,PXK:NM_001349507:exon4:c.C362G:p.P121R,PXK:NM_001349508:exon4:c.C362G:p.P121R,PXK:NM_001349509:exon4:c.C362G:p.P121R,PXK:NM_001349519:exon4:c.C362G:p.P121R,PXK:NM_001349520:exon4:c.C362G:p.P121R,PXK:NM_001349527:exon4:c.C362G:p.P121R,PXK:NM_017771:exon4:c.C362G:p.P121R,PXK:NM_001349489:exon5:c.C113G:p.P38R,PXK:NM_001349513:exon5:c.C113G:p.P38R,PXK:NM_001349521:exon5:c.C113G:p.P38R,PXK:NM_001349528:exon5:c.C113G:p.P38R,PXK:NM_001349529:exon5:c.C113G:p.P38R,PXK:NM_001349530:exon5:c.C113G:p.P38R,PXK:NM_001349531:exon5:c.C113G:p.P38R	0.932144256	0.06785563	1.15E-07	.	0.13995	0.09839	0.266447942	70.5826846	2672.1939	9.71802	0.045	0.784	D	0.751	0.487	P	0.327	0.479	B	0.000	0.843	D	1	0.810	D	3.1	0.878	M	1.06	0.398	T	-6.39	0.913	D	0.839	0.827	-0.699	0.605	T	0.203	0.561	T	0.028	0.508	D	5.715	0.780	26.8	0.996	0.710	0.986	0.847	D	c	0.610	0.657	1.000	0.747	0.732	0.924	0	5.57	0.840	7.347	0.784	0.935	0.490	1.000	0.715	1.000	0.888	19.545	0.953	Phox homologous domain;Phox homologous domain|Protein kinase domain	.	.	0.5	91	24	3	58368401	chr3:58368401	C	G	91	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	58631240	58631240	G	C	exonic	FAM3D	.	nonsynonymous SNV	FAM3D:NM_138805:exon5:c.C259G:p.R87G	0.004030909	0.959459476	0.036509615	.	0.0529	0.09521	0.262810045	70.43524416	38.8879	1.15175	0.054	0.390	T	0.055	0.213	B	0.039	0.223	B	0.010	0.012	N	1	0.090	N	1.525	0.387	L	1.87	0.241	T	-2.31	0.539	N	0.149	0.560	-1.035	0.188	T	0.049	0.207	T	0.007	0.187	T	0.507	0.143	7.482	0.930	0.220	0.038	0.090	N	c	-1.133	-1.183	0.004	0.105	0.487	0.133	0	-0.736	0.105	-0.543	0.061	-0.493	0.052	0.000	0.063	0.006	0.095	3.787	0.082	.	.	.	0.5	79	339	3	58631240	chr3:58631240	G	C	79	PASS	DP=339;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	59737880	59737880	C	A	UTR3	FHIT	NM_001320901:c.*72G>T;NM_001320900:c.*72G>T;NM_001320899:c.*72G>T	.	.	0.001391839	0.662104571	0.33650359	DISEASE: Note=A chromosomal aberration involving FHIT has been found in a lymphoblastoid cell line established from a family with renal cell carcinoma and thyroid carcinoma. Translocation t(3;8)(p14.2;q24.1) with RNF139. Although the 3p14.2 breakpoint has been shown to interrupt FHIT in its 5-prime non-coding region, it is unlikely that FHIT is causally related to renal or other malignancies. {ECO:0000269|PubMed:15007172}.; DISEASE: Note=Associated with digestive tract cancers. Numerous tumor types are found to have aberrant forms of FHIT protein due to deletions in a coding region of chromosome 3p14.2 including the fragile site locus FRA3B. {ECO:0000269|PubMed:15007172}.; 	0.25475	.	-0.560178693	19.30879925	49.36677	1.3751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	3	59737880	chr3:59737880	C	A	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	60522571	60522571	-	A	intronic	FHIT	.	.	.	0.001391839	0.662104571	0.33650359	DISEASE: Note=A chromosomal aberration involving FHIT has been found in a lymphoblastoid cell line established from a family with renal cell carcinoma and thyroid carcinoma. Translocation t(3;8)(p14.2;q24.1) with RNF139. Although the 3p14.2 breakpoint has been shown to interrupt FHIT in its 5-prime non-coding region, it is unlikely that FHIT is causally related to renal or other malignancies. {ECO:0000269|PubMed:15007172}.; DISEASE: Note=Associated with digestive tract cancers. Numerous tumor types are found to have aberrant forms of FHIT protein due to deletions in a coding region of chromosome 3p14.2 including the fragile site locus FRA3B. {ECO:0000269|PubMed:15007172}.; 	0.25475	.	-0.560178693	19.30879925	49.36677	1.3751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	28	3	60522571	chr3:60522571	C	CA	70	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	62114504	62114504	T	-	intronic	PTPRG	.	.	.	0.004176573	0.995823405	2.16E-08	.	0.72801	0.18321	-1.738187109	2.429818353	1119.45815	6.38788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	146	3	62114503	chr3:62114503	AT	A	44	PASS	DP=146;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	62535675	62535675	C	A	exonic	CADPS	.	synonymous SNV	CADPS:NM_003716:exon11:c.G1869T:p.T623T,CADPS:NM_183393:exon11:c.G1869T:p.T623T,CADPS:NM_183394:exon11:c.G1869T:p.T623T	0.052816468	0.94718353	2.47E-09	.	0.46523	.	-1.346642726	4.62962963	108.92082	2.26567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	96	3	62535675	chr3:62535675	C	A	.	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	63820995	63820995	A	C	ncRNA_intronic	C3orf49	.	.	.	.	.	.	.	0.11088	.	.	.	1468.35326	7.14177	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	64	3	63820995	chr3:63820995	A	C	98	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	63898180	63898180	G	T	intronic	ATXN7	.	.	.	0.928556028	0.071440779	3.19E-06	DISEASE: Spinocerebellar ataxia 7 (SCA7) [MIM:164500]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA7 belongs to the autosomal dominant cerebellar ataxias type II (ADCA II) which are characterized by cerebellar ataxia with retinal degeneration and pigmentary macular dystrophy. {ECO:0000269|PubMed:9288099}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40116	0.43982	0.205769367	67.49823071	3924.42931	12.38246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	113	3	63898180	chr3:63898180	G	T	.	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	66023660	66023660	C	A	intronic	MAGI1	.	.	.	0.999615675	0.000384325	2.89E-15	.	0.27232	0.12487	-1.383523256	4.358339231	581.76428	4.88893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	383	3	66023660	chr3:66023660	C	A	.	PASS	DP=383;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	66023661	66023661	C	A	intronic	MAGI1	.	.	.	0.999615675	0.000384325	2.89E-15	.	0.27232	0.12487	-1.383523256	4.358339231	581.76428	4.88893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	379	3	66023661	chr3:66023661	C	A	.	PASS	DP=379;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	71005788	71005788	A	T	UTR3	FOXP1	NM_001244813:c.*2610T>A;NM_001244814:c.*2610T>A;NM_001244815:c.*2610T>A;NM_001244810:c.*2610T>A;NM_001244816:c.*2610T>A;NM_001244812:c.*2610T>A;NM_001244808:c.*2610T>A;NM_032682:c.*2610T>A;NM_001349344:c.*2610T>A;NM_001349342:c.*2610T>A;NM_001349343:c.*2610T>A;NM_001349338:c.*2610T>A;NM_001349339:c.*2610T>A;NM_001349340:c.*2610T>A;NM_001349341:c.*2610T>A;NM_001349337:c.*2610T>A	.	.	0.999750735	0.000249265	1.47E-11	DISEASE: Note=A chromosomal aberration involving FOXP1 is found in acute lymphoblastic leukemia. Translocation t(9;3)(p13;p14.1) with PAX5.; DISEASE: Mental retardation with language impairment and autistic features (MRLIAF) [MIM:613670]: A developmental disorder characterized by mild to moderate mental retardation, language impairment, and autistic features. Patients show global delay, delayed walking, severely delayed speech development, and behavioral abnormalities, including irritability, hyperactivity, aggression, and stereotypical rigid behaviors. {ECO:0000269|PubMed:20950788}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.57291	0.32628	-0.378346116	28.01368247	60.34446	1.57849	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	3	71005788	chr3:71005788	A	T	.	PASS	DP=56;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	73432720	73432720	C	T	exonic	PDZRN3	.	synonymous SNV	PDZRN3:NM_001303139:exon8:c.G2091A:p.R697R,PDZRN3:NM_001303140:exon8:c.G1968A:p.R656R,PDZRN3:NM_001303141:exon8:c.G2163A:p.R721R,PDZRN3:NM_001303142:exon8:c.G2148A:p.R716R,PDZRN3:NM_015009:exon10:c.G2997A:p.R999R	0.908376144	0.091617814	6.04E-06	.	0.4722	0.13321	-0.990222991	8.634111819	1513.34426	7.23005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	81	3	73432720	chr3:73432720	C	T	.	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	74334562	74334562	T	G	exonic	CNTN3	.	synonymous SNV	CNTN3:NM_020872:exon19:c.A2598C:p.L866L	0.014141786	0.985856032	2.18E-06	.	0.27019	0.43019	0.316000233	72.80018872	1496.00916	7.19616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	325	3	74334562	chr3:74334562	T	G	106	PASS	DP=325;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	88101443	88101443	C	A	UTR3	CGGBP1	NM_003663:c.*3180G>T;NM_001195308:c.*3180G>T;NM_001008390:c.*3180G>T	.	.	0.777631518	0.215081104	0.007287378	.	0.22371	0.11109	0.013025609	54.62962963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	3	88101443	chr3:88101443	C	A	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	97185055	97185055	C	A	intronic	EPHA6	.	.	.	0.954513147	0.045486811	4.19E-08	.	0.34698	.	-0.771553417	13.15168672	252.47147	3.41934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	81	3	97185055	chr3:97185055	C	A	78	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	100348457	100348457	C	G	exonic	ADGRG7	.	stopgain	ADGRG7:NM_032787:exon2:c.C131G:p.S44X	.	.	.	.	0.04884	0.06553	0.806491657	87.72705827	.	.	.	.	.	.	.	.	.	.	.	0.092	0.025	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6.712	0.918	32	0.958	0.272	0.025	0.070	N	c	0.114	-0.286	0.998	0.358	0.487	0.133	0	0.351	0.152	0.267	0.182	0.077	0.185	0.000	0.063	0.000	0.016	3.166	0.061	.	.	.	0.5	81	98	3	100348457	chr3:100348457	C	G	81	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	101006886	101006886	C	A	intronic	IMPG2	.	.	.	1.47E-08	0.997551473	0.002448512	DISEASE: Retinitis pigmentosa 56 (RP56) [MIM:613581]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:20673862}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular dystrophy, vitelliform, 5 (VMD5) [MIM:616152]: A form of macular dystrophy, a retinal disease in which various forms of deposits, pigmentary changes, and atrophic lesions are observed in the macula lutea. Vitelliform macular dystrophies are characterized by yellow, lipofuscin-containing deposits, usually localized at the center of the macula. VMD5 features include late- onset moderate visual impairment and preservation of retinal pigment epithelium reflectivity. {ECO:0000269|PubMed:20673862, ECO:0000269|PubMed:25085631}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11371	0.11319	-0.837696902	11.45317292	209.43193	3.12459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	203	3	101006886	chr3:101006886	C	A	.	PASS	DP=203;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	108183701	108183701	C	A	intronic	MYH15	.	.	.	4.74E-39	0.000158734	0.999841266	.	0.10968	0.09113	0.464695413	78.59754659	3550.47942	11.51131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	3	108183701	chr3:108183701	C	A	.	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	113169205	113169205	C	T	exonic	SPICE1	.	synonymous SNV	SPICE1:NM_001331078:exon15:c.G2301A:p.Q767Q,SPICE1:NM_001331079:exon15:c.G2343A:p.Q781Q,SPICE1:NM_144718:exon15:c.G2301A:p.Q767Q	5.14E-08	0.990209074	0.009790874	.	0.13123	.	0.249861693	69.66265629	475.73296	4.50529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	58	3	113169205	chr3:113169205	C	T	85	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	113207968	113207968	-	T	intronic	SPICE1	.	.	.	5.14E-08	0.990209074	0.009790874	.	0.13123	.	0.249861693	69.66265629	475.73296	4.50529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	15	3	113207968	chr3:113207968	C	CT	67	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	113236435	113236435	T	C	intergenic	SPICE1;SIDT1	dist=2401;dist=14783	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	161	3	113236435	chr3:113236435	T	C	84	PASS	DP=161;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	113368347	113368347	T	-	UTR3	USF3	NM_001009899:c.*5444delA	.	.	.	.	.	.	0.42318	.	-0.711157248	14.50224109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	96	3	113368346	chr3:113368346	GT	G	55	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	116163752	116163752	C	T	exonic	LSAMP	.	nonsynonymous SNV	LSAMP:NM_001318915:exon1:c.G127A:p.V43M,LSAMP:NM_002338:exon1:c.G127A:p.V43M	0.946283747	0.053678415	3.78E-05	.	0.72117	0.19389	0.03689118	56.64071715	22.84835	0.76216	0.001	0.912	D	0.984	0.899	D	0.738	0.774	P	0.004	0.344	N	0.832	0.355	D	3.89	0.961	H	-0.63	0.720	T	-1.81	0.473	N	0.461	0.525	0.552	0.913	D	0.597	0.856	D	0.105	0.780	D	6.619	0.909	32	0.999	0.966	0.862	0.451	D	c	0.768	0.692	1.000	0.747	0.652	0.477	0	4.47	0.536	5.574	0.669	0.932	0.445	1.000	0.715	1.000	0.888	16.369	0.831	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	81	3	116163752	chr3:116163752	C	T	.	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	119469924	119469924	C	G	exonic	MAATS1	.	nonsynonymous SNV	MAATS1:NM_001320318:exon15:c.C1906G:p.Q636E,MAATS1:NM_001320317:exon16:c.C2098G:p.Q700E,MAATS1:NM_001320316:exon17:c.C2224G:p.Q742E,MAATS1:NM_033364:exon17:c.C2284G:p.Q762E	9.78E-10	0.904945227	0.095054772	.	0.06869	0.09515	0.872633161	88.87119604	840.25979	5.67623	0.316	0.137	T	0.0	0.026	B	0.002	0.063	B	0.540	0.115	N	1	0.090	N	.	.	.	1.71	0.267	T	-0.37	0.132	N	0.029	0.115	-0.964	0.384	T	0.024	0.104	T	0.004	0.111	T	-1.774	0.011	0.002	0.649	0.074	0.073	0.132	N	c	-1.165	-1.145	0.304	0.192	0.638	0.428	0	0.059	0.136	0.546	0.228	0.841	0.343	0.000	0.063	0.002	0.062	6.517	0.213	.	.	.	0.5	47	45	3	119469924	chr3:119469924	C	G	47	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	119533787	119533787	C	-	intronic	NR1I2	.	.	.	0.000129417	0.846347083	0.1535235	.	0.4518	0.65028	-0.552898813	19.86317528	99.56266	2.15923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	83	3	119533786	chr3:119533786	TC	T	82	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	121515941	121515941	T	-	intronic	IQCB1	.	.	.	1.20E-07	0.985796861	0.014203019	DISEASE: Senior-Loken syndrome 5 (SLSN5) [MIM:609254]: A renal- retinal disorder characterized by progressive wasting of the filtering unit of the kidney (nephronophthisis), with or without medullary cystic renal disease, and progressive eye disease. Typically this disorder becomes apparent during the first year of life. {ECO:0000269|PubMed:15723066}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16973	0.17555	0.598963042	82.7789573	3536.66111	11.47062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	25	3	121515940	chr3:121515940	AT	A	50	PASS	DP=25;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	121616268	121616268	A	G	exonic	SLC15A2	.	nonsynonymous SNV	SLC15A2:NM_001145998:exon3:c.A227G:p.H76R,SLC15A2:NM_021082:exon3:c.A227G:p.H76R	1.50E-10	0.937563918	0.062436082	.	0.61335	0.17076	-0.176292081	40.56381222	6543.27894	17.03613	0.666	0.069	T	0.021	0.172	B	0.015	0.162	B	0.075	0.213	N	0.998	0.449	D	1.995	0.543	M	0.23	0.597	T	-1.58	0.545	N	0.215	0.371	-0.953	0.405	T	0.150	0.477	T	0.005	0.140	T	0.781	0.168	9.349	0.919	0.206	0.911	0.525	D	c	-0.071	0.135	0.643	0.221	0.554	0.283	0	5.75	0.904	6.173	0.717	1.088	0.866	1.000	0.715	0.998	0.697	14.018	0.639	Major facilitator superfamily domain	.	.	0.5	112	72	3	121616268	chr3:121616268	A	G	112	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
3	122811188	122811188	-	T	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	246	3	122811187	chr3:122811187	GT	GTT,G,GTTTT	99	PASS	DP=246;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	122811188	122811188	T	-	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	246	3	122811187	chr3:122811187	GT	GTT,G,GTTTT	99	PASS	DP=246;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	122811188	122811188	-	TTT	intronic	PDIA5	.	.	.	1.00E-06	0.983714807	0.016284189	.	0.23723	0.1339	-0.953385901	9.206180703	310.15723	3.74607	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	246	3	122811187	chr3:122811187	GT	GTT,G,GTTTT	99	PASS	DP=246;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	123456300	123456300	C	T	exonic	MYLK	.	nonsynonymous SNV	MYLK:NM_001321309:exon7:c.G151A:p.D51N,MYLK:NM_053025:exon8:c.G679A:p.D227N,MYLK:NM_053026:exon8:c.G679A:p.D227N,MYLK:NM_053027:exon8:c.G679A:p.D227N,MYLK:NM_053028:exon8:c.G679A:p.D227N	9.38E-06	0.999990574	4.70E-08	DISEASE: Aortic aneurysm, familial thoracic 7 (AAT7) [MIM:613780]: A disease characterized by permanent dilation of the thoracic aorta usually due to degenerative changes in the aortic wall. It is primarily associated with a characteristic histologic appearance known as 'medial necrosis' or 'Erdheim cystic medial necrosis' in which there is degeneration and fragmentation of elastic fibers, loss of smooth muscle cells, and an accumulation of basophilic ground substance. {ECO:0000269|PubMed:21055718}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23578	.	-0.323627113	30.93300307	6562.91179	17.06993	0.005	0.632	D	1.0	0.899	D	0.999	0.971	D	.	.	.	0.999	0.467	D	3.265	0.902	M	-1.44	0.808	T	-2.92	0.611	D	0.247	0.318	0.672	0.928	D	0.750	0.915	D	0.166	0.846	D	3.591	0.489	23.2	0.998	0.899	0.959	0.664	D	c	0.600	0.425	1.000	0.747	0.706	0.609	0	5.2	0.716	5.960	0.699	0.935	0.490	1.000	0.715	0.004	0.083	17.660	0.880	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	64	3	123456300	chr3:123456300	C	T	.	PASS	DP=64;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	125648158	125648158	G	T	ncRNA_exonic	FAM86JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	253	3	125648158	chr3:125648158	G	T	.	PASS	DP=253;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	126229438	126229438	C	A	intronic	UROC1	.	.	.	3.36E-10	0.734541324	0.265458675	DISEASE: Urocanase deficiency (UROCD) [MIM:276880]: An inborn error of histidine metabolism resulting in urocanic aciduria and neurological manifestations including mental retardation, ataxia, episodic aggressive behavior or exaggerated affection-seeking. {ECO:0000269|PubMed:19304569}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10659	0.13811	0.319642692	72.82967681	647.41865	5.10863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	136	3	126229438	chr3:126229438	C	A	.	PASS	DP=136;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	128712187	128712187	G	A	intronic	KIAA1257	.	.	.	1.75E-08	0.12477453	0.875225452	.	0.05969	0.08096	0.951720429	90.06251474	89.37584	2.03224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	786	3	128712187	chr3:128712187	G	A	82	PASS	DP=786;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	129207068	129207070	TCT	-	intronic	IFT122	.	.	.	2.16E-11	0.999599617	0.000400383	.	0.37127	0.14087	-1.271459448	5.207596131	277.35114	3.56725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	52	3	129207067	chr3:129207067	GTCT	G	119	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	129811914	129811914	A	T	ncRNA_intronic	LINC02014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	250	3	129811914	chr3:129811914	A	T	66	PASS	DP=250;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	129811919	129811919	G	A	ncRNA_intronic	LINC02014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	64	3	129811919	chr3:129811919	G	A	.	PASS	DP=64;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	130158343	130158343	C	A	intronic	COL6A5	.	.	.	9.56E-12	0.041150214	0.958849786	DISEASE: Note=Patients affected by atopic dermatitis display an abnormal distribution of COL29A1 mRNA and protein in skin suggesting that COL29A1 may be involved in the pathogenesis of the disease.; 	.	0.06307	.	.	13360.06109	24.98933	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	147	3	130158343	chr3:130158343	C	A	82	PASS	DP=147;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	131081092	131081092	G	A	ncRNA_exonic	NUDT16P1	.	.	.	.	.	.	.	0.10767	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	152	3	131081092	chr3:131081092	G	A	.	PASS	DP=152;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
3	132071600	132071600	G	C	exonic	ACPP	.	nonsynonymous SNV	ACPP:NM_001292037:exon8:c.G802C:p.D268H,ACPP:NM_001099:exon9:c.G901C:p.D301H,ACPP:NM_001134194:exon9:c.G901C:p.D301H	1.76E-07	0.64651458	0.353485244	.	0.18544	0.1556	-0.602450568	17.91106393	66.58925	1.68257	0.076	0.373	T	0.262	0.341	B	0.063	0.322	B	0.008	0.308	N	0.893	0.406	D	2.87	0.836	M	2.22	0.182	T	-2.26	0.543	N	0.362	0.423	-1.068	0.098	T	0.041	0.177	T	0.007	0.190	T	2.531	0.365	19.67	0.981	0.374	0.577	0.302	D	c	-0.147	-0.100	1.000	0.747	0.520	0.210	0	4.04	0.461	1.717	0.374	1.044	0.665	1.000	0.715	0.803	0.337	6.341	0.204	.	.	.	0.5	53	57	3	132071600	chr3:132071600	G	C	53	PASS	DP=57;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	132363753	132363753	A	-	ncRNA_intronic	NPHP3-ACAD11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	135	3	132363752	chr3:132363752	TA	T	85	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	133614314	133614314	G	T	UTR5	RAB6B	NM_016577:c.-4C>A	.	.	0.893311149	0.106470904	0.000217948	.	0.70633	0.14229	0.014844891	54.94810097	3.08689	0.1111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	129	3	133614314	chr3:133614314	G	T	.	PASS	DP=129;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	138362810	138362810	T	-	intergenic	FAIM;PIK3CB	dist=10597;dist=8730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	160	3	138362809	chr3:138362809	CT	C	90	PASS	DP=160;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	140661001	140661001	G	A	intronic	SLC25A36	.	.	.	0.883013619	0.116709235	0.000277146	.	0.16774	0.10791	-0.405853867	26.23260203	27.59314	0.88809	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	111	3	140661001	chr3:140661001	G	A	.	PASS	DP=111;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	140661003	140661003	G	A	intronic	SLC25A36	.	.	.	0.883013619	0.116709235	0.000277146	.	0.16774	0.10791	-0.405853867	26.23260203	27.59314	0.88809	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	111	3	140661003	chr3:140661003	G	A	.	PASS	DP=111;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	140678384	140678384	-	A	splicing	SLC25A36	NM_018155:exon3:c.284+2->A;NM_001104647:exon3:c.284+2->A	.	.	0.883013619	0.116709235	0.000277146	.	0.16774	0.10791	-0.405853867	26.23260203	27.59314	0.88809	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.93	112	3	140678384	chr3:140678384	T	TA	11.93	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	141696554	141696554	-	T	intronic	TFDP2	.	.	.	0.975087598	0.024911272	1.13E-06	.	0.96272	0.18236	-0.139478553	43.29440906	42.91096	1.24214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	270	3	141696554	chr3:141696554	A	AT	77	PASS	DP=270;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	145841052	145841052	C	G	intronic	PLOD2	.	.	.	0.00117484	0.998744975	8.02E-05	DISEASE: Note=PLOD2 mutations give rise to a broad variety of phenotypes with variable degrees of severity of bone fragility and joint contractures. Disease-associated mutations have been found in patients with autosomal recessive osteogenesis imperfecta (AR- OI) (PubMed:22689593). {ECO:0000269|PubMed:22689593}.; 	0.65048	0.12778	0.112125503	62.09601321	137.52121	2.55175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	109	3	145841052	chr3:145841052	C	G	77	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	145879271	145879271	G	T	UTR5	PLOD2	NM_000935:c.-495C>A;NM_182943:c.-495C>A	.	.	0.00117484	0.998744975	8.02E-05	DISEASE: Note=PLOD2 mutations give rise to a broad variety of phenotypes with variable degrees of severity of bone fragility and joint contractures. Disease-associated mutations have been found in patients with autosomal recessive osteogenesis imperfecta (AR- OI) (PubMed:22689593). {ECO:0000269|PubMed:22689593}.; 	0.65048	0.12778	0.112125503	62.09601321	137.52121	2.55175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	807	3	145879271	chr3:145879271	G	T	109	PASS	DP=807;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	147124452	147124452	-	T	UTR5	ZIC4	NM_032153:c.-3869_-3868insA;NM_001243256:c.-3869_-3868insA	.	.	0.001816904	0.900072856	0.09811024	.	0.20879	0.10422	-0.047654689	50.22410946	125.09939	2.43427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	128	3	147124452	chr3:147124452	C	CT	69	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	148711906	148711906	-	T	intronic	GYG1	.	.	.	6.91E-07	0.4631179	0.536881409	DISEASE: Glycogen storage disease 15 (GSD15) [MIM:613507]: A metabolic disorder resulting in muscle weakness, associated with the glycogen depletion in skeletal muscle, and cardiac arrhythmia, associated with the accumulation of abnormal storage material in the heart. The skeletal muscle shows a marked predominance of slow-twitch, oxidative muscle fibers and mitochondrial proliferation. {ECO:0000269|PubMed:20357282}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polyglucosan body myopathy 2 (PGBM2) [MIM:616199]: A glycogen storage disease characterized by polyglucosan accumulation in muscle, and skeletal myopathy without cardiac involvement. Most patients manifest slowly progressive, hip girdle, shoulder girdle, and/or hand and leg muscle weakness. Polyglucosan contains abnormally long and poorly branched glucosyl chains and is variably resistant to digestion by alpha-amylase. {ECO:0000269|PubMed:25272951}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17298	0.16384	-0.069700724	48.54328851	98.90905	2.15121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	91	3	148711906	chr3:148711906	G	GT	58	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	149233665	149233665	-	TTG	intergenic	TM4SF4;WWTR1	dist=12484;dist=1351	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	53	3	149233665	chr3:149233665	T	TTTG	86	PASS	DP=53;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	153842088	153842088	G	T	intronic	ARHGEF26	.	.	.	5.99E-06	0.993649364	0.006344644	.	.	.	0.580556395	82.31304553	2005.54992	8.24753	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	3	153842088	chr3:153842088	G	T	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	154072393	154072393	G	A	intronic	GPR149	.	.	.	2.65E-05	0.763728348	0.236245188	.	0.15312	0.09679	-0.554717505	19.79830149	121.73084	2.40326	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	38	3	154072393	chr3:154072393	G	A	39	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	155197843	155197843	G	A	UTR3	PLCH1	NM_001130961:c.*3015C>T;NM_001130960:c.*914C>T;NM_001349250:c.*3012C>T;NM_014996:c.*914C>T;NM_001349251:c.*914C>T;NM_001349252:c.*3012C>T	.	.	0.425540925	0.574459075	8.93E-10	.	0.10745	0.09748	-1.074802575	7.336635999	322.80077	3.81661	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	44	3	155197843	chr3:155197843	G	A	39	PASS	DP=44;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	156411797	156411797	G	T	intronic	TIPARP	.	.	.	0.99775209	0.002247834	7.62E-08	.	0.43821	0.12448	-0.66859065	15.76433121	52.4418	1.43246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	38	3	156411797	chr3:156411797	G	T	66	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	159711453	159711453	C	T	ncRNA_intronic	IL12A-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	3	159711453	chr3:159711453	C	T	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	160119820	160119820	A	G	exonic	SMC4	.	nonsynonymous SNV	SMC4:NM_005496:exon2:c.A257G:p.H86R,SMC4:NM_001002800:exon3:c.A257G:p.H86R,SMC4:NM_001288753:exon3:c.A182G:p.H61R	0.105530996	0.894468908	9.61E-08	.	0.99449	0.27637	-0.992035476	8.604623732	434.06529	4.34898	0.252	0.193	T	0.984	0.588	D	0.86	0.594	P	0.000	0.843	D	1	0.810	D	1.17	0.299	L	3.47	0.085	T	-3.4	0.717	D	0.865	0.852	-1.109	0.031	T	0.033	0.143	T	0.016	0.368	T	1.876	0.286	15.44	0.997	0.774	0.980	0.786	D	c	0.335	0.416	1.000	0.747	0.660	0.490	0	5.19	0.713	9.083	0.934	1.028	0.649	1.000	0.715	1.000	0.888	15.042	0.713	P-loop containing nucleoside triphosphate hydrolase|RecF/RecN/SMC, N-terminal	.	.	0.5	105	93	3	160119820	chr3:160119820	A	G	105	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	160248732	160248732	-	A	intronic	KPNA4	.	.	.	0.998180756	0.001819234	9.21E-09	.	0.86481	0.44724	-0.139478553	43.29440906	13.68591	0.49653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	170	3	160248732	chr3:160248732	C	CA	69	PASS	DP=170;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	160970622	160970622	G	C	exonic	NMD3	.	nonsynonymous SNV	NMD3:NM_001320227:exon17:c.G1558C:p.D520H	4.42E-05	0.991223131	0.008732642	.	0.07893	0.10797	-0.512444034	21.55579146	81.92408	1.91851	0.322	0.135	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	.	.	.	0.86	0.468	T	0.07	0.061	N	0.075	0.065	-1.001	0.297	T	0.086	0.336	T	0.006	0.160	T	-0.346	0.065	0.520	0.188	0.006	0.000	0.003	N	c	-1.240	-1.379	0.003	0.100	0.498	0.195	0	0.597	0.166	-0.191	0.095	-0.578	0.045	0.001	0.137	0.005	0.090	.	.	.	.	.	0.5	63	161	3	160970622	chr3:160970622	G	C	63	PASS	DP=161;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	166784093	166784093	T	G	intergenic	LOC105374194;ZBBX	dist=134481;dist=173984	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	155	3	166784093	chr3:166784093	T	G	54	PASS	DP=155;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	167745600	167745600	T	A	exonic	GOLIM4	.	nonsynonymous SNV	GOLIM4:NM_001308155:exon11:c.A1455T:p.Q485H,GOLIM4:NM_014498:exon12:c.A1539T:p.Q513H	5.54E-11	0.945879645	0.054120355	.	0.10082	0.09393	-0.33061537	30.82094834	857.93003	5.71496	0.026	0.469	D	0.997	0.689	D	0.918	0.662	D	0.017	0.279	N	0.969	0.387	D	2.25	0.640	M	.	.	.	-2.47	0.539	N	0.345	0.424	-0.539	0.672	T	0.299	0.671	T	0.007	0.180	T	5.811	0.795	27.2	0.997	0.797	0.876	0.469	D	c	0.384	0.340	0.669	0.223	0.732	0.924	0	4.15	0.478	0.695	0.250	1.060	0.767	1.000	0.715	1.000	0.888	6.099	0.191	.	.	.	0.5	92	114	3	167745600	chr3:167745600	T	A	92	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	168849226	168849285	CCGGCGCCATAGTTTCATGGGGATAGTCTTCGCTCTTCATGAACAGCAGAAGCTCCTCTC	-	exonic	MECOM	.	frameshift deletion	MECOM:NM_005241:wholegene,MECOM:NM_001205194:wholegene,MECOM:NM_001105078:wholegene,MECOM:NM_001164000:wholegene,MECOM:NM_001163999:wholegene	0.999085313	0.000914686	3.49E-10	DISEASE: Note=A chromosomal aberration involving EVI1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with RUNX1/AML1. {ECO:0000269|PubMed:8313895}.; 	0.47994	0.30246	-0.993849454	8.56334041	1129.59722	6.41503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.85	20	3	168849225	chr3:168849225	TCCGGCGCCATAGTTTCATGGGGATAGTCTTCGCTCTTCATGAACAGCAGAAGCTCCTCTC	T	14.85	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	179082937	179082937	G	A	exonic	MFN1	.	nonsynonymous SNV	MFN1:NM_033540:exon7:c.G677A:p.R226Q	0.01903819	0.980927452	3.44E-05	.	0.82846	0.13128	-0.246069119	36.06982779	58.55807	1.55048	0.004	0.654	D	0.954	0.715	P	0.308	0.564	B	0.000	0.629	D	1.000	0.485	D	2.24	0.636	M	-4.12	0.967	D	-2.09	0.551	N	0.519	0.561	0.684	0.930	D	0.851	0.950	D	.	.	.	4.272	0.572	24.0	0.999	0.982	0.978	0.772	D	c	0.649	0.673	0.154	0.175	0.732	0.924	0	5.5	0.813	6.541	0.736	1.048	0.713	1.000	0.715	0.996	0.625	10.280	0.425	Dynamin-type guanine nucleotide-binding (G) domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	95	200	3	179082937	chr3:179082937	G	A	95	PASS	DP=200;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	179083024	179083024	-	T	intronic	MFN1	.	.	.	0.01903819	0.980927452	3.44E-05	.	0.82846	0.13128	-0.246069119	36.06982779	58.55807	1.55048	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	383	3	179083024	chr3:179083024	A	AT	101	PASS	DP=383;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	179119110	179119110	-	A	intronic	GNB4	.	.	.	0.629775083	0.369918722	0.000306195	.	0.45415	0.12971	-0.029247611	51.40363293	17.25958	0.60544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	529	3	179119110	chr3:179119110	G	GA	79	PASS	DP=529;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	179333753	179333753	-	T	intronic	NDUFB5	.	.	.	0.003441089	0.835086357	0.161472554	.	0.10317	0.14954	0.147123112	64.11299835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	378	3	179333753	chr3:179333753	C	CT	62	PASS	DP=378;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
3	180326488	180326488	G	C	splicing	TTC14	NM_001288582:exon11:c.1291-1G>C;NM_133462:exon11:c.1291-1G>C	.	.	4.42E-06	0.955823688	0.044171893	.	0.10216	0.1043	-0.020150552	52.25288983	125.31545	2.43621	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.409	0.590	24.1	0.995	0.675	0.998	0.995	D	c	1.224	1.087	1.000	0.747	0.295	0.044	0	5.64	0.864	8.519	0.903	1.048	0.713	1.000	0.715	1.000	0.888	19.701	0.960	.	.	.	0.5	75	40	3	180326488	chr3:180326488	G	C	75	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
3	180559378	180559378	T	C	ncRNA_intronic	LOC101928882	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	90	3	180559378	chr3:180559378	T	C	116	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	180680814	180680820	AGGTTCT	-	exonic	FXR1	.	frameshift deletion	FXR1:NM_001013438:exon13:c.1136_1140del:p.G379Efs*3,FXR1:NM_005087:exon13:c.1136_1140del:p.G379Efs*3,FXR1:NM_001013439:exon14:c.881_885del:p.G294Efs*3	0.999992198	7.80E-06	7.76E-14	.	0.83345	0.19444	-0.648365105	16.35999056	32.43007	1.01245	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.26	15	3	180680813	chr3:180680813	AAGGTTCT	A	21.26	PASS	DP=15;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	182897192	182897192	C	G	exonic	MCF2L2	.	synonymous SNV	MCF2L2:NM_015078:exon30:c.G3321C:p.P1107P	1.61E-12	0.999318945	0.000681055	.	0.57276	0.09212	0.854236942	88.51144138	3783.20077	12.04253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	67	3	182897192	chr3:182897192	C	G	50	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	183210014	183210014	C	A	exonic	KLHL6	.	nonsynonymous SNV	KLHL6:NM_130446:exon7:c.G1567T:p.G523W	3.43E-06	0.797610641	0.202385932	.	0.22527	0.11012	-0.907472583	10.07313046	190.44155	2.99478	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.04	0.971	H	-3.47	0.945	D	-6.35	0.910	D	0.98	0.982	1.074	0.987	D	0.935	0.979	D	0.441	0.942	D	6.806	0.925	32	0.995	0.671	0.997	0.986	D	c	0.873	0.780	1.000	0.747	0.707	0.730	0	5.53	0.825	7.376	0.788	0.892	0.403	1.000	0.715	0.234	0.225	19.448	0.948	Kelch-type beta propeller	.	.	0.5	.	109	3	183210014	chr3:183210014	C	A	.	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	183400568	183400568	-	T	UTR3	KLHL24	NM_001349417:c.*3494_*3495insT;NM_001349420:c.*3494_*3495insT;NM_001349419:c.*3494_*3495insT;NM_001349418:c.*3494_*3495insT;NM_001349414:c.*3494_*3495insT;NM_001349413:c.*3494_*3495insT;NM_001349416:c.*3494_*3495insT;NM_001349415:c.*3494_*3495insT;NM_001349421:c.*3494_*3495insT;NM_001349423:c.*3494_*3495insT;NM_001349422:c.*3494_*3495insT;NM_001349427:c.*3494_*3495insT;NM_001349429:c.*3494_*3495insT;NM_001349428:c.*3494_*3495insT;NM_001349426:c.*3494_*3495insT;NM_001349425:c.*3494_*3495insT;NM_001349424:c.*3494_*3495insT;NM_017644:c.*3494_*3495insT	.	.	0.25241443	0.746312969	0.001272601	.	0.21414	0.11262	-0.780646273	12.77423921	734.84508	5.37741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	314	3	183400567	chr3:183400567	AT	ATT,A	82	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	183400568	183400568	T	-	UTR3	KLHL24	NM_001349417:c.*3494delT;NM_001349420:c.*3494delT;NM_001349419:c.*3494delT;NM_001349418:c.*3494delT;NM_001349414:c.*3494delT;NM_001349413:c.*3494delT;NM_001349416:c.*3494delT;NM_001349415:c.*3494delT;NM_001349421:c.*3494delT;NM_001349423:c.*3494delT;NM_001349422:c.*3494delT;NM_001349427:c.*3494delT;NM_001349429:c.*3494delT;NM_001349428:c.*3494delT;NM_001349426:c.*3494delT;NM_001349425:c.*3494delT;NM_001349424:c.*3494delT;NM_017644:c.*3494delT	.	.	0.25241443	0.746312969	0.001272601	.	0.21414	0.11262	-0.780646273	12.77423921	734.84508	5.37741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	314	3	183400567	chr3:183400567	AT	ATT,A	82	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	183665257	183665257	A	-	exonic	ABCC5	.	frameshift deletion	ABCC5:NM_001320032:exon23:c.1853delT:p.L618Cfs*24,ABCC5:NM_005688:exon23:c.3269delT:p.L1090Cfs*24	0.896205135	0.103794865	2.35E-11	.	0.38723	0.35905	-1.967739992	1.816466148	80.81009	1.89955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	226	3	183665256	chr3:183665256	CA	C,CAA	74	PASS	DP=226;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/2
3	183665257	183665257	-	A	exonic	ABCC5	.	frameshift insertion	ABCC5:NM_001320032:exon23:c.1852dupT:p.L618Ffs*62,ABCC5:NM_005688:exon23:c.3268dupT:p.L1090Ffs*62	0.896205135	0.103794865	2.35E-11	.	0.38723	0.35905	-1.967739992	1.816466148	80.81009	1.89955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	226	3	183665256	chr3:183665256	CA	C,CAA	74	PASS	DP=226;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/2
3	183900836	183900836	G	A	intronic	AP2M1	.	.	.	0.993893174	0.006106649	1.77E-07	.	0.23681	0.247	-0.141298762	42.87567823	32.02466	1.00657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	11	3	183900836	chr3:183900836	G	A	50	PASS	DP=11;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	184062437	184062437	G	T	exonic	FAM131A	.	synonymous SNV	FAM131A:NM_001171093:exon6:c.G525T:p.L175L,FAM131A:NM_144635:exon6:c.G780T:p.L260L	0.031328424	0.925656059	0.043015517	.	0.38029	0.09699	-0.205617011	38.57631517	64.91238	1.65518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	281	3	184062437	chr3:184062437	G	T	.	PASS	DP=281;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	184552422	184552422	-	T	intronic	VPS8	.	.	.	3.62E-06	0.999996197	1.85E-07	.	0.13365	0.11078	-0.365622677	28.30856334	3238.91039	10.83959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	44	3	184552422	chr3:184552422	C	CT	80	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	186006618	186006618	G	C	exonic	DGKG	.	nonsynonymous SNV	DGKG:NM_001080744:exon6:c.C425G:p.T142S,DGKG:NM_001080745:exon6:c.C425G:p.T142S,DGKG:NM_001346:exon6:c.C425G:p.T142S	5.44E-06	0.99850148	0.001493082	.	0.45176	0.18992	-1.524862616	3.42061807	110.98235	2.29646	0.814	0.033	T	0.002	0.090	B	0.006	0.133	B	0.914	0.085	N	1	0.090	P	0.695	0.181	N	1.0	0.414	T	0.04	0.065	N	0.057	0.040	-0.922	0.453	T	0.000	0.000	T	.	.	.	-1.570	0.015	0.002	0.428	0.032	0.063	0.122	N	c	-1.255	-1.199	0.996	0.343	0.487	0.133	0	2.16	0.265	1.920	0.394	-0.752	0.034	0.802	0.295	0.000	0.016	5.379	0.154	Diacylglycerol kinase type I, N-terminal	.	.	0.5	138	71	3	186006618	chr3:186006618	G	C	138	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
3	186358318	186358318	G	T	exonic	FETUB	.	nonsynonymous SNV	FETUB:NM_001308077:exon1:c.G69T:p.Q23H,FETUB:NM_001308079:exon1:c.G69T:p.Q23H,FETUB:NM_014375:exon1:c.G69T:p.Q23H	6.88E-05	0.732564853	0.26736631	.	0.02716	.	0.621009802	83.41589998	583.45117	4.89852	0.226	0.245	T	0.641	0.385	P	0.275	0.383	B	0.000	0.003	N	1	0.090	N	0.805	0.203	L	0.93	0.441	T	-1.23	0.322	N	0.069	0.114	-1.064	0.109	T	0.071	0.289	T	0.010	0.262	T	-1.031	0.031	0.014	0.949	0.252	0.074	0.133	N	c	-1.190	-1.264	1.000	0.747	0.497	0.185	0	-0.705	0.106	-0.098	0.109	-0.443	0.057	0.000	0.063	0.000	0.016	2.956	0.055	Cystatin domain	.	.	0.5	.	73	3	186358318	chr3:186358318	G	T	.	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	186917751	186917751	C	G	exonic	RTP1	.	nonsynonymous SNV	RTP1:NM_153708:exon2:c.C685G:p.Q229E	0.563829726	0.423951854	0.01221842	.	0.79035	0.11684	0.064394823	58.84642604	2341.27335	8.96348	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.003	0.351	N	1	0.090	P	0.55	0.145	N	1.62	0.282	T	-0.48	0.154	N	0.056	0.039	-0.976	0.358	T	0.000	0.000	T	.	.	.	0.084	0.102	3.442	0.622	0.067	0.018	0.056	N	c	-0.780	-0.618	0.910	0.263	0.615	0.372	0	5.74	0.900	1.719	0.374	0.133	0.217	0.528	0.269	0.580	0.285	12.993	0.579	.	ENSG00000198491.3|ENSG00000175077.5	Artery_Aorta|Nerve_Tibial	0.5	88	62	3	186917751	chr3:186917751	C	G	88	PASS	DP=62;AN=4	GT	./.	0/1	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	188592084	188592084	C	A	intronic	LPP	.	.	.	0.582399908	0.417507007	9.31E-05	DISEASE: Note=A chromosomal aberration involving LPP is associated with pulmonary chondroid hamartomas. Translocation t(3;12)(q27- q28;q14-q15) with HMGA2 is detected in pulmonary chondroid hamartomas.; DISEASE: Note=A chromosomal aberration involving LPP is associated with parosteal lipomas. Translocation t(3;12)(q28;q14) with HMGA2 is also shown in one parosteal lipoma.; DISEASE: Note=A chromosomal aberration involving LPP is associated with acute monoblastic leukemia. Translocation t(3;11)(q28;q23) with KMT2A/MLL1 is associated with acute monoblastic leukemia.; 	0.24469	0.15914	1.050838371	91.36588818	2291.9413	8.8632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	3	188592084	chr3:188592084	C	A	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
3	189705447	189705447	C	A	exonic	P3H2	.	nonsynonymous SNV	P3H2:NM_001134418:exon5:c.G424T:p.V142L,P3H2:NM_018192:exon5:c.G967T:p.V323L	.	.	.	.	0.14234	0.13152	-0.554717505	19.79830149	.	.	0.254	0.178	T	0.0	0.026	B	0.0	0.013	B	0.025	0.262	N	0.821	0.348	D	1.5	0.380	L	1.76	0.260	T	-0.97	0.258	N	0.141	0.168	-1.032	0.198	T	0.032	0.137	T	0.006	0.159	T	2.954	0.415	22.1	0.985	0.421	0.626	0.316	D	c	-0.577	-0.445	0.806	0.242	0.732	0.924	0	3.2	0.357	0.486	0.219	0.935	0.490	0.001	0.137	1.000	0.888	5.443	0.157	Tetratricopeptide-like helical domain	.	.	0.5	115	58	3	189705447	chr3:189705447	C	A	115	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	193209178	193209178	T	C	exonic	ATP13A4	.	nonsynonymous SNV	ATP13A4:NM_032279:exon6:c.A543G:p.I181M	6.08E-10	0.999598041	0.000401958	DISEASE: Note=A chromosomal aberration involving ATP13A4 is found in 2 patients with specific language impairment (SLI) disorders. Paracentric inversion inv(3)(q25;q29). The inversion produces a disruption of the protein. {ECO:0000269|PubMed:15925480}.; 	0.08132	0.09862	-1.383523256	4.358339231	5510.00677	15.30149	0.153	0.282	T	0.998	0.764	D	0.981	0.769	D	0.000	0.629	D	0.109	0.359	P	2.085	0.579	M	-1.2	0.785	T	-1.6	0.387	N	0.226	0.389	-0.935	0.434	T	0.000	0.000	T	.	.	.	4.024	0.541	23.6	0.994	0.623	0.540	0.292	D	c	0.394	0.329	0.008	0.115	0.487	0.133	0	4.63	0.570	-0.414	0.071	1.011	0.635	0.712	0.285	1.000	0.888	9.318	0.369	Cation-transporting P-type ATPase, N-terminal	ENSG00000127249.10|ENSG00000127249.10	Lung|Testis	0.5	132	45	3	193209178	chr3:193209178	T	C	132	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0
3	195410627	195410627	A	G	ncRNA_exonic	SDHAP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	396	3	195410627	chr3:195410627	A	G	137	PASS	DP=396;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	195410687	195410687	T	A	ncRNA_exonic	SDHAP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	150	574	3	195410687	chr3:195410687	T	A	150	PASS	DP=574;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
3	195453249	195453249	T	C	exonic	MUC20	.	nonsynonymous SNV	MUC20:NM_001282506:exon2:c.T1775C:p.M592T,MUC20:NM_001291833:exon4:c.T1262C:p.M421T,MUC20:NM_020790:exon4:c.T1319C:p.M440T,MUC20:NM_152673:exon4:c.T1262C:p.M421T	.	.	.	.	.	0.05395	.	.	2482.91489	9.29408	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.830	0.091	N	1	0.206	N	-1.65	0.004	N	3.45	0.086	T	2.15	0.004	N	0.419	0.476	-0.954	0.403	T	0.007	0.026	T	.	.	.	-2.240	0.005	0.001	0.392	0.027	0.000	0.001	N	c	-1.579	-1.475	0.000	0.064	0.516	0.203	0	2.7	0.309	0.520	0.224	-2.118	0.004	0.000	0.063	0.000	0.016	7.490	0.265	.	.	.	0.5	.	140	3	195453249	chr3:195453249	T	C	.	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	195477936	195477936	A	G	exonic	MUC4	.	nonsynonymous SNV	MUC4:NM_138297:exon21:c.T2834C:p.V945A,MUC4:NM_004532:exon22:c.T2987C:p.V996A,MUC4:NM_018406:exon23:c.T15695C:p.V5232A	.	.	.	.	0.37408	.	6.320387277	99.8643548	14250.21522	26.01128	0.003	0.682	D	0.996	0.715	D	0.883	0.660	P	0.005	0.331	N	1	0.090	N	1.905	0.510	L	0.88	0.460	T	-3.36	0.666	D	0.382	0.527	-0.851	0.519	T	0.202	0.560	T	0.017	0.393	T	0.664	0.157	8.591	0.452	0.035	0.627	0.316	D	c	0.189	0.072	0.019	0.131	0.581	0.330	0	5.15	0.702	4.639	0.608	1.187	0.908	0.716	0.285	0.010	0.111	11.381	0.488	.	.	.	0.5	69	58	3	195477936	chr3:195477936	A	G	69	PASS	DP=58;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	195505960	195505960	G	C	exonic	MUC4	.	nonsynonymous SNV	MUC4:NM_018406:exon2:c.C12491G:p.T4164S	.	.	.	.	0.37408	.	6.320387277	99.8643548	14250.21522	26.01128	0.291	0.149	T	0.613	0.378	P	0.213	0.357	B	.	.	.	1.000	0.588	D	.	.	.	1.38	0.358	T	-0.6	0.206	N	0.047	0.028	-1.047	0.153	T	0.046	0.198	T	.	.	.	-0.520	0.054	0.196	0.420	0.030	0.014	0.046	N	c	-1.001	-1.186	0.000	0.029	0.554	0.283	0	.	.	0.464	0.215	0.174	0.246	0.000	0.063	0.005	0.090	5.853	0.178	.	.	.	0.5	126	117	3	195505960	chr3:195505960	G	C	126	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	195692311	195692311	T	C	ncRNA_exonic	SDHAP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	151	314	3	195692311	chr3:195692311	T	C	151	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
3	195717077	195717077	-	GCGCCAG	ncRNA_exonic	SDHAP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	159	3	195717077	chr3:195717077	A	AGCGCCAG	95	PASS	DP=159;AN=4	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	195978246	195978246	T	C	intronic	PCYT1A	.	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	57	3	195978246	chr3:195978246	T	C	90	PASS	DP=57;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
3	195984818	195984818	-	A	intronic	PCYT1A	.	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.05	23	3	195984818	chr3:195984818	T	TA	11.05	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
3	196159011	196159011	G	-	ncRNA_intronic	UBXN7-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	424	3	196159010	chr3:196159010	CG	C	76	PASS	DP=424;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.
3	197577609	197577609	C	T	intronic	LRCH3	.	.	.	1.20E-08	0.984194783	0.015805205	.	0.25359	0.09814	-0.530852121	20.82448691	509.6375	4.62536	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	666	3	197577609	chr3:197577609	C	T	72	PASS	DP=666;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
3	197610474	197610474	G	T	intergenic	LRCH3;IQCG	dist=12018;dist=5472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	3	197610474	chr3:197610474	G	T	.	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	59454	59454	G	T	splicing	ZNF718	NM_001039127:exon2:c.133+2G>T;NM_001289931:exon2:c.37+2G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	263	4	59454	chr4:59454	G	T	.	PASS	DP=263;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	184267	184268	GT	-	intergenic	ZNF718;ZNF876P	dist=26318;dist=22121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.23	31	4	184266	chr4:184266	AGT	A	13.23	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	343795	343795	-	TGCT	intronic	ZNF141	.	.	.	0.161888983	0.82300848	0.015102537	.	0.39436	0.16446	0.795569043	87.49115357	156.94519	2.73623	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	25	4	343795	chr4:343795	C	CTGCT	96	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	950124	950179	CTGGCTGTTGCTTCCTTCCAGCGTCTGCTCCTCCGCGGCCTCATCTGCCTCTTCGT	-	intronic	TMEM175	.	.	.	0.00043963	0.963215421	0.03634495	.	0.16848	.	0.810142476	87.7388535	748.44954	5.42749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	41	4	950123	chr4:950123	GCTGGCTGTTGCTTCCTTCCAGCGTCTGCTCCTCCGCGGCCTCATCTGCCTCTTCGT	G	60	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	997905	997905	G	A	intronic	IDUA	.	.	.	2.64E-08	0.478326206	0.521673767	DISEASE: Mucopolysaccharidosis 1H (MPS1H) [MIM:607014]: A severe form of mucopolysaccharidosis type 1, a rare lysosomal storage disease characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. Patients with MPS1H usually present, within the first year of life, a combination of hepatosplenomegaly, skeletal deformities, corneal clouding and severe mental retardation. Obstructive airways disease, respiratory infection and cardiac complications usually result in death before 10 years of age. {ECO:0000269|PubMed:10466419, ECO:0000269|PubMed:10735634, ECO:0000269|PubMed:12559846, ECO:0000269|PubMed:1301941, ECO:0000269|PubMed:15300847, ECO:0000269|PubMed:21394825, ECO:0000269|PubMed:7550232, ECO:0000269|PubMed:7550242, ECO:0000269|PubMed:7951228, ECO:0000269|PubMed:8019563, ECO:0000269|PubMed:8328452, ECO:0000269|PubMed:8401515, ECO:0000269|Ref.20}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucopolysaccharidosis 1H/S (MPS1H/S) [MIM:607015]: A form of mucopolysaccharidosis type 1, a rare lysosomal storage disease characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. MPS1H/S represents an intermediate phenotype of the MPS1 clinical spectrum. It is characterized by relatively little neurological involvement, but most of the somatic symptoms described for severe MPS1 develop in the early to mid-teens, causing considerable loss of mobility. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucopolysaccharidosis 1S (MPS1S) [MIM:607016]: A mild form of mucopolysaccharidosis type 1, a rare lysosomal storage disease characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. Patients with MPS1S may have little or no neurological involvement, normal stature and life span, but present development of joints stiffness, mild hepatosplenomegaly, aortic valve disease and corneal clouding. {ECO:0000269|PubMed:12559846, ECO:0000269|PubMed:15300847, ECO:0000269|PubMed:19396826, ECO:0000269|PubMed:21394825, ECO:0000269|PubMed:25256405, ECO:0000269|PubMed:7550232, ECO:0000269|PubMed:7550242, ECO:0000269|PubMed:8213840}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08409	0.09876	.	.	2688.19258	9.75774	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	97	4	997905	chr4:997905	G	A	.	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	1087328	1087329	AC	CTGCCCAGGCTGGAGCCAGCCTT	exonic	RNF212	.	nonframeshift substitution	RNF212:NM_001193318:exon4:c.720_721AAGGCTGGCTCCAGCCTGGGCAG:p.S241delinsRLAPAWAA	0.125225584	0.869720008	0.005054408	.	0.13995	.	.	.	166.87321	2.82299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	168	180	4	1087328	chr4:1087328	AC	CTGCCCAGGCTGGAGCCAGCCTT,A	168	PASS	DP=180;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	1087329	1087329	C	-	exonic	RNF212	.	frameshift deletion	RNF212:NM_001193318:exon4:c.720delG:p.R240Sfs*20	0.125225584	0.869720008	0.005054408	.	0.13995	.	.	.	166.87321	2.82299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	168	180	4	1087328	chr4:1087328	AC	CTGCCCAGGCTGGAGCCAGCCTT,A	168	PASS	DP=180;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	1741566	1741566	T	C	intronic	TACC3	.	.	.	0.091951814	0.907690378	0.000357807	.	0.60266	0.07352	0.099178678	60.75725407	2050.27567	8.34503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	126	4	1741566	chr4:1741566	T	C	93	PASS	DP=126;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	1929514	1929514	T	A	intronic	NSD2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	77	4	1929514	chr4:1929514	T	A	39	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	2159559	2159559	C	A	intronic	POLN	.	.	.	3.00E-32	1.69E-06	0.999998313	.	0.06562	.	0.653987697	84.18259023	4366.19692	13.18659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	4	2159559	chr4:2159559	C	A	.	PASS	DP=38;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	2460571	2460571	C	T	exonic	CFAP99	.	nonsynonymous SNV	CFAP99:NM_001193282:exon12:c.C1283T:p.A428V	.	.	.	.	.	.	.	.	.	.	0.561	0.063	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.05	0.078	N	0.034	0.014	-0.952	0.406	T	0.000	0.000	T	.	.	.	0.663	0.157	8.585	0.870	0.163	0.031	0.080	N	c	-0.964	-1.035	1.000	0.747	0.581	0.326	0	0.034	0.134	1.083	0.302	-0.858	0.029	0.764	0.290	0.005	0.090	0.910	0.012	.	ENSG00000206113.3|ENSG00000159733.9|ENSG00000159733.9	Colon_Transverse|Lung|Whole_Blood	0.5	165	181	4	2460571	chr4:2460571	C	T	165	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	2516306	2516306	-	CCA	UTR3	RNF4	NM_001185010:c.*831_*832insCCA;NM_002938:c.*760_*761insCCA;NM_001185009:c.*760_*761insCCA	.	.	0.628950995	0.363852204	0.007196801	.	0.15544	0.12342	0.547599505	81.2160887	26.29011	0.85255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	288	4	2516306	chr4:2516306	C	CCCA	107	PASS	DP=288;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	3498664	3498664	A	G	intronic	DOK7	.	.	.	0.004808382	0.881308685	0.113882933	DISEASE: Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. CMS10 is an autosomal recessive, post-synaptic form characterized by a typical 'limb girdle' pattern of muscle weakness with small, simplified neuromuscular junctions but normal acetylcholine receptor and acetylcholinesterase function. {ECO:0000269|PubMed:16917026, ECO:0000269|PubMed:17439981, ECO:0000269|PubMed:20012313, ECO:0000269|PubMed:22661499}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1712	.	.	.	2606.59203	9.55466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	4	3498664	chr4:3498664	A	G	.	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	3769789	3769789	-	GGGGAGCTTTCCCAGAGACCC	UTR3	ADRA2C	NM_000683:c.*67_*68insGGGGAGCTTTCCCAGAGACCC	.	.	0.645951821	0.347840902	0.006207277	.	0.03325	0.09956	.	.	2173.15437	8.58195	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	118	4	3769789	chr4:3769789	G	GGGGGAGCTTTCCCAGAGACCC	135	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	3937148	3937148	C	A	intergenic	ADRA2C;FAM86EP	dist=166895;dist=6339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	270	4	3937148	chr4:3937148	C	A	75	PASS	DP=270;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	4864404	4864404	-	T	intronic	MSX1	.	.	.	0.275361731	0.633641369	0.090996899	DISEASE: Tooth agenesis selective 1 (STHAG1) [MIM:106600]: A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). Tooth agenesis selective type 1 can be associated with orofacial cleft in some patients. {ECO:0000269|PubMed:12097313, ECO:0000269|PubMed:8696335}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=MSX1 is deleted in some patients with Wolf- Hirschhorn syndrome (WHS). WHS results from sub-telomeric deletions in the short arm of chromosome 4. {ECO:0000305|PubMed:1969845}.; DISEASE: Ectodermal dysplasia 3, Witkop type (ECTD3) [MIM:189500]: A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures such as hair, teeth, nails and sweat glands, with or without any additional clinical sign. Each combination of clinical features represents a different type of ectodermal dysplasia. ECTD3 is characterized by abnormalities largely limited largely to teeth (some of which are missing) and nails (which are poorly formed early in life, especially toenails). This condition is distinguished from anhidrotic ectodermal dysplasia by autosomal dominant inheritance and little involvement of hair and sweat glands. The teeth are not as severely affected. {ECO:0000269|PubMed:11369996}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Non-syndromic orofacial cleft 5 (OFC5) [MIM:608874]: A birth defect consisting of cleft lips with or without cleft palate. Cleft lips are associated with cleft palate in two-third of cases. A cleft lip can occur on one or both sides and range in severity from a simple notch in the upper lip to a complete opening in the lip extending into the floor of the nostril and involving the upper gum. {ECO:0000269|PubMed:12807959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83114	0.60631	.	.	590.93175	4.92812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	19	4	4864404	chr4:4864404	C	CT	40	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	6711493	6711493	-	T	UTR5	MRFAP1L1	NM_203462:c.-138_-137insA	.	.	0.008908008	0.578868963	0.412223029	.	0.16044	0.11262	0.125076652	62.7388535	42.65034	1.23741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	441	4	6711493	chr4:6711493	A	AT	64	PASS	DP=441;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
4	8305930	8305930	G	C	exonic	HTRA3	.	nonsynonymous SNV	HTRA3:NM_053044:exon8:c.G1120C:p.A374P	1.72E-05	0.675145167	0.324837634	.	0.16158	0.11489	-0.822919685	11.76574664	170.60666	2.84944	0.272	0.159	T	0.172	0.271	B	0.063	0.256	B	0.091	0.203	N	0.858	0.284	N	0.75	0.191	N	2.43	0.153	T	-0.61	0.181	N	0.291	0.350	-1.044	0.162	T	0.027	0.117	T	0.006	0.163	T	2.478	0.359	19.32	0.976	0.341	0.128	0.173	N	c	-0.352	-0.257	1.000	0.747	0.507	0.198	0	1.61	0.226	2.509	0.449	0.998	0.613	1.000	0.715	0.997	0.653	7.319	0.255	PDZ domain	.	.	0.5	123	195	4	8305930	chr4:8305930	G	C	123	PASS	DP=195;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	8472786	8472786	-	A	intronic	TRMT44	.	.	.	1.48E-13	0.006885759	0.993114241	.	0.11127	0.07994	.	.	301.17928	3.69794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	341	4	8472785	chr4:8472785	GA	GAA,G	66	PASS	DP=341;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
4	8472786	8472786	A	-	intronic	TRMT44	.	.	.	1.48E-13	0.006885759	0.993114241	.	0.11127	0.07994	.	.	301.17928	3.69794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	341	4	8472785	chr4:8472785	GA	GAA,G	66	PASS	DP=341;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
4	9699761	9699761	A	T	intergenic	MIR548I2;DRD5	dist=141824;dist=83497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	653	4	9699761	chr4:9699761	A	T	121	PASS	DP=653;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	9706544	9706544	G	C	intergenic	MIR548I2;DRD5	dist=148607;dist=76714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	271	4	9706544	chr4:9706544	G	C	64	PASS	DP=271;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	10443184	10443184	G	A	UTR3	ZNF518B	NM_053042:c.*1544C>T	.	.	0.591536151	0.408038434	0.000425414	.	0.13257	0.08374	0.657639543	84.20028309	1202.5769	6.5715	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	4	10443184	chr4:10443184	G	A	.	PASS	DP=32;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	13628028	13628028	C	G	intronic	BOD1L1	.	.	.	0.999528154	0.000471846	4.77E-15	.	0.44566	0.08925	-0.63057096	16.79051663	1099.59021	6.34651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	252	4	13628028	chr4:13628028	C	G	76	PASS	DP=252;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	15724487	15724487	T	G	intronic	BST1	.	.	.	2.81E-08	0.291985673	0.708014299	.	0.1269	0.19823	0.861712133	88.6883699	1705.28413	7.61637	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	25	4	15724487	chr4:15724487	T	G	58	PASS	DP=25;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	24833093	24833093	C	A	intronic	CCDC149	.	.	.	0.002049284	0.977529378	0.020421338	.	0.16007	0.098	-0.47017169	23.25430526	5120.65553	14.70466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	417	4	24833093	chr4:24833093	C	A	94	PASS	DP=417;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	37848746	37848746	G	T	intronic	PGM2	.	.	.	1.06E-12	0.14776252	0.85223748	.	0.13924	0.40444	0.090079492	60.64519934	383.06081	4.12803	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	122	4	37848746	chr4:37848746	G	T	.	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	38937317	38937317	T	-	intronic	FAM114A1	.	.	.	2.38E-08	0.457538177	0.542461799	.	0.11964	.	0.358272123	74.66383581	2541.88338	9.41853	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	41	4	38937316	chr4:38937316	CT	C	76	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	39459818	39459818	T	-	exonic	RPL9	.	frameshift deletion	RPL9:NM_000661:exon3:c.158delA:p.K53Rfs*27,RPL9:NM_001024921:exon3:c.158delA:p.K53Rfs*27	0.918456438	0.081011629	0.000531934	.	0.99267	0.1069	-0.163345027	41.24793583	8.97949	0.32975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	428	4	39459817	chr4:39459817	CT	C,CTT	73	PASS	DP=428;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	39459818	39459818	-	T	exonic	RPL9	.	frameshift insertion	RPL9:NM_000661:exon3:c.157dupA:p.R54Efs*4,RPL9:NM_001024921:exon3:c.157dupA:p.R54Efs*4	0.918456438	0.081011629	0.000531934	.	0.99267	0.1069	-0.163345027	41.24793583	8.97949	0.32975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	428	4	39459817	chr4:39459817	CT	C,CTT	73	PASS	DP=428;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	39924431	39924431	T	A	intronic	PDS5A	.	.	.	0.99985292	0.00014708	3.36E-14	.	0.68436	0.10157	-0.688817379	15.20405756	46.97579	1.3251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	17	4	39924431	chr4:39924431	T	A	.	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	39975008	39975008	C	G	intronic	PDS5A	.	.	.	0.99985292	0.00014708	3.36E-14	.	0.68436	0.10157	-0.688817379	15.20405756	46.97579	1.3251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	51	4	39975008	chr4:39975008	C	G	85	PASS	DP=51;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	42088174	42088174	C	T	UTR3	SLC30A9	NM_006345:c.*31C>T	.	.	0.001423485	0.998515682	6.08E-05	.	0.15803	0.1344	0.531004228	80.87992451	64.38665	1.64576	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	4	42088174	chr4:42088174	C	T	.	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	46314618	46314618	G	A	exonic	GABRA2	.	nonsynonymous SNV	GABRA2:NM_001114175:exon4:c.C371T:p.P124L,GABRA2:NM_001286827:exon4:c.C206T:p.P69L,GABRA2:NM_000807:exon5:c.C371T:p.P124L,GABRA2:NM_001330690:exon5:c.C371T:p.P124L	0.976963701	0.023031697	4.60E-06	.	0.31694	0.13475	-0.273576253	33.97027601	19.24152	0.66325	0.0	0.912	D	0.999	0.899	D	0.98	0.971	D	0.000	0.843	D	1	0.810	D	3.72	0.949	H	-5.0	0.985	D	-9.21	0.983	D	0.732	0.978	1.055	0.982	D	0.981	0.994	D	0.365	0.926	D	6.582	0.905	31	0.998	0.925	0.991	0.910	D	c	1.149	1.073	1.000	0.747	0.487	0.133	0	5.95	0.964	10.003	0.997	1.048	0.713	1.000	0.715	1.000	0.888	19.363	0.944	Neurotransmitter-gated ion-channel ligand-binding domain	.	.	0.5	123	52	4	46314618	chr4:46314618	G	A	123	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	47427792	47427792	G	T	exonic	GABRB1	.	nonsynonymous SNV	GABRB1:NM_000812:exon9:c.G1182T:p.M394I	0.977782833	0.022216315	8.52E-07	.	0.31766	0.11156	-0.359940251	28.93371078	31.23713	0.98534	0.416	0.099	T	0.008	0.195	B	0.038	0.252	B	0.011	0.296	N	1.000	0.490	D	1.71	0.444	L	-1.96	0.851	D	-0.97	0.258	N	0.388	0.477	-0.319	0.745	T	0.506	0.814	D	0.034	0.552	D	2.412	0.351	18.90	0.980	0.367	0.933	0.576	D	c	0.020	0.190	0.263	0.188	0.487	0.133	0	5.38	0.772	3.374	0.519	1.048	0.713	1.000	0.715	0.996	0.625	14.526	0.673	Neurotransmitter-gated ion-channel transmembrane domain	.	.	0.5	102	411	4	47427792	chr4:47427792	G	T	102	PASS	DP=411;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	47915946	47915946	G	A	intronic	NFXL1	.	.	.	0.00788898	0.992109984	1.04E-06	.	0.11984	0.07985	0.222355725	68.44184949	4983.51379	14.41291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	166	4	47915946	chr4:47915946	G	A	.	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	48485962	48485962	C	T	exonic	SLC10A4	.	synonymous SNV	SLC10A4:NM_152679:exon1:c.C384T:p.H128H	0.167299362	0.771814239	0.060886399	.	0.04161	.	.	.	57.29346	1.52517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	268	4	48485962	chr4:48485962	C	T	.	PASS	DP=268;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	52780909	52780909	C	T	UTR3	DCUN1D4	NM_015115:c.*1159C>T;NM_001040402:c.*1159C>T;NM_001287757:c.*1159C>T;NM_001287755:c.*1159C>T	.	.	0.160650286	0.836138462	0.003211253	.	0.29277	.	-0.251530012	35.42108988	17.88872	0.62462	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	16	4	52780909	chr4:52780909	C	T	.	PASS	DP=16;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	53525349	53525349	C	A	UTR5	USP46	NM_022832:c.-32G>T;NM_001286768:c.-32952G>T;NM_001286767:c.-32G>T	.	.	0.911054239	0.088809549	0.000136212	.	0.50572	0.11809	-0.229483771	36.86010852	7.68154	0.28352	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	470	4	53525349	chr4:53525349	C	A	84	PASS	DP=470;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	54439886	54439886	T	A	exonic	LNX1	.	nonsynonymous SNV	LNX1:NM_001126328:exon2:c.A284T:p.N95I	0.007243627	0.992057434	0.00069894	.	0.31424	0.15781	-1.194104514	5.850436424	109.44427	2.27278	0.008	0.586	D	0.612	0.378	P	0.259	0.377	B	0.003	0.358	N	1	0.810	D	1.79	0.469	L	4.49	0.131	T	-1.82	0.760	N	0.22	0.387	-1.057	0.126	T	0.037	0.162	T	0.024	0.473	T	3.757	0.508	23.3	0.983	0.394	0.943	0.604	D	c	-0.038	-0.027	0.994	0.334	0.638	0.428	0	3.34	0.372	3.485	0.527	0.112	0.206	1.000	0.715	0.998	0.697	10.239	0.423	Zinc finger, RING/FYVE/PHD-type	.	.	0.5	80	272	4	54439886	chr4:54439886	T	A	80	PASS	DP=272;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	56458190	56458190	C	T	intronic	PDCL2	.	.	.	0.041360287	0.844538805	0.114100908	.	0.24036	0.0992	0.014844891	54.94810097	75.77943	1.8232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	151	4	56458190	chr4:56458190	C	T	.	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	57220269	57220269	A	-	exonic	AASDH	.	frameshift deletion	AASDH:NM_001286668:exon7:c.1019delT:p.L340Wfs*42,AASDH:NM_001286669:exon7:c.860delT:p.L287Wfs*42,AASDH:NM_001323893:exon7:c.860delT:p.L287Wfs*42,AASDH:NM_001323899:exon7:c.188delT:p.L63Wfs*42,AASDH:NM_001286671:exon8:c.1319delT:p.L440Wfs*42,AASDH:NM_001286672:exon8:c.1319delT:p.L440Wfs*41,AASDH:NM_001323890:exon8:c.1319delT:p.L440Wfs*42,AASDH:NM_001323892:exon8:c.1319delT:p.L440Wfs*42,AASDH:NM_181806:exon8:c.1319delT:p.L440Wfs*42	2.01E-05	0.998849623	0.001130277	.	0.07506	0.13832	1.054492917	91.3717858	3473.29703	11.34473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	27	4	57220268	chr4:57220268	CA	C	42	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	66388644	66388644	G	T	intronic	EPHA5	.	.	.	0.00039007	0.999530763	7.92E-05	.	0.29288	0.13579	-1.238203625	5.490681765	548.86151	4.76544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	4	66388644	chr4:66388644	G	T	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	68443006	68443006	-	T	intronic	STAP1	.	.	.	0.00012955	0.846504647	0.153365802	.	0.66261	0.0976	-0.582225231	18.44184949	42.83661	1.24007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	14	4	68443006	chr4:68443006	C	CT	40	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	70152475	70152475	G	T	exonic	UGT2B28	.	nonsynonymous SNV	UGT2B28:NM_001207004:exon3:c.G876T:p.M292I,UGT2B28:NM_053039:exon3:c.G876T:p.M292I	6.44E-08	0.434127347	0.565872588	.	0.08008	.	1.534092314	95.56499174	6528.21825	16.98038	0.208	0.206	T	0.036	0.194	B	0.036	0.216	B	0.037	0.245	U	0.994	0.235	N	1.575	0.398	L	0.22	0.599	T	-2.26	0.505	N	0.168	0.203	-1.018	0.242	T	0.112	0.402	T	0.011	0.285	T	0.269	0.120	5.388	0.576	0.057	0.549	0.295	D	c	-0.680	-0.679	0.000	0.012	0.487	0.133	0	0.946	0.186	0.567	0.231	0.792	0.321	1.000	0.715	0.794	0.334	2.507	0.043	.	.	.	0.5	79	399	4	70152475	chr4:70152475	G	T	79	PASS	DP=399;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	71554691	71554693	GGA	-	exonic	UTP3	.	nonframeshift deletion	UTP3:NM_020368:exon1:c.297_299del:p.E105del	0.002776963	0.93819451	0.059028527	.	0.05932	0.09551	0.795569043	87.49115357	195.12242	3.0281	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	47	4	71554690	chr4:71554690	GGGA	G	45	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	71588258	71588258	C	G	UTR5	RUFY3	NM_014961:c.-33C>G;NM_001291994:c.-33C>G;NM_001037442:c.-33C>G	.	.	0.980976379	0.019023598	2.38E-08	.	0.86149	0.084	-0.844966979	11.1759849	66.52798	1.68028	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	39	4	71588258	chr4:71588258	C	G	52	PASS	DP=39;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
4	73434535	73434536	CA	-	upstream	ADAMTS3	dist=19	.	.	1.79E-06	0.999985819	1.24E-05	.	0.22292	0.11688	-0.654057602	16.14177872	316.52138	3.77881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	254	4	73434534	chr4:73434534	CCA	C	104	PASS	DP=254;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	73957836	73957836	T	C	exonic	ANKRD17	.	nonsynonymous SNV	ANKRD17:NM_198889:exon28:c.A4756G:p.M1586V,ANKRD17:NM_001286771:exon29:c.A5170G:p.M1724V,ANKRD17:NM_015574:exon29:c.A5506G:p.M1836V,ANKRD17:NM_032217:exon29:c.A5509G:p.M1837V	1	3.51E-10	8.18E-26	.	0.30304	.	-2.938435282	0.548478415	117.58974	2.35717	0.585	0.059	T	0.0	0.026	B	0.0	0.013	B	0.000	0.537	D	0.789	0.306	N	-0.255	0.038	N	-0.06	0.636	T	-0.44	0.146	N	0.075	0.178	-1.017	0.246	T	0.074	0.298	T	0.003	0.073	T	-1.162	0.026	0.008	0.521	0.046	0.677	0.332	D	c	-0.582	-0.345	0.999	0.372	0.707	0.730	0	3.85	0.434	2.018	0.404	0.112	0.206	1.000	0.715	1.000	0.888	5.386	0.154	K Homology domain	.	.	0.5	62	47	4	73957836	chr4:73957836	T	C	62	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	74847618	74847618	C	A	exonic	PF4	.	nonsynonymous SNV	PF4:NM_002619:exon1:c.G53T:p.G18V	0.033296817	0.613399998	0.353303185	.	0.05528	0.31251	-0.009020804	52.8544468	13.35188	0.48559	0.072	0.349	T	0.998	0.715	D	0.785	0.557	P	0.197	0.167	N	0.821	0.348	D	0.975	0.246	L	.	.	.	-1.29	0.324	N	0.426	0.482	-0.974	0.363	T	0.095	0.359	T	0.003	0.064	T	1.814	0.279	15.07	0.933	0.224	0.209	0.210	N	c	-0.411	-0.548	1.000	0.747	0.206	0.033	2	2.25	0.272	0.905	0.279	0.637	0.291	0.347	0.255	0.198	0.217	7.947	0.290	.	.	.	0.5	.	133	4	74847618	chr4:74847618	C	A	.	PASS	DP=133;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	76583936	76583936	-	A	intronic	G3BP2	.	.	.	0.983145417	0.016854151	4.31E-07	.	0.96341	0.18404	-0.317668748	31.45789101	27.08786	0.87395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	47	4	76583936	chr4:76583936	G	GA	50	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	76787418	76787418	A	T	exonic	PPEF2	.	nonsynonymous SNV	PPEF2:NM_006239:exon15:c.T1844A:p.V615E	7.34E-10	0.869787638	0.130212361	.	0.37944	0.08962	1.164733225	92.65746638	2139.83122	8.51045	0.005	0.632	D	0.963	0.537	D	0.642	0.503	P	0.000	0.537	D	0.924	0.368	D	2.95	0.852	M	0.84	0.475	T	-4.43	0.775	D	0.788	0.779	-0.589	0.653	T	0.195	0.549	T	0.054	0.659	D	5.948	0.817	27.6	0.984	0.409	0.927	0.561	D	c	0.451	0.424	0.988	0.314	0.554	0.246	0	4.67	0.579	3.858	0.554	1.140	0.893	1.000	0.715	0.987	0.523	12.130	0.531	EF-hand domain pair	.	.	0.5	.	65	4	76787418	chr4:76787418	A	T	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	76817383	76817383	T	C	intronic	PPEF2	.	.	.	7.34E-10	0.869787638	0.130212361	.	0.37944	0.08962	1.164733225	92.65746638	2139.83122	8.51045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	4	76817383	chr4:76817383	T	C	.	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	77116932	77116932	T	C	exonic	SCARB2	.	nonsynonymous SNV	SCARB2:NM_001204255:exon2:c.A203G:p.N68S,SCARB2:NM_005506:exon2:c.A203G:p.N68S	0.072442869	0.927026675	0.000530456	DISEASE: Epilepsy, progressive myoclonic 4, with or without renal failure (EPM4) [MIM:254900]: An autosomal recessive progressive myoclonic epilepsy associated with renal failure in some cases. Cognitive function is preserved. Myoclonus is a brief, involuntary twitching of a muscle or a group of muscles. {ECO:0000269|PubMed:18308289, ECO:0000269|PubMed:18424452, ECO:0000269|PubMed:19454373, ECO:0000269|PubMed:21670406}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Genetic variants in SCARB2 can act as modifier of the phenotypic expression and severity of Gaucher disease. {ECO:0000269|PubMed:21796727}.; 	0.2098	0.44672	0.485092724	79.37603208	107.27576	2.24626	0.008	0.586	D	0.999	0.899	D	0.996	0.916	D	0.000	0.843	D	1	0.810	D	3.23	0.897	M	-1.5	0.813	D	-3.98	0.737	D	0.438	0.515	0.631	0.923	D	0.724	0.905	D	0.178	0.854	D	5.247	0.709	25.6	0.999	0.959	0.963	0.683	D	c	0.871	0.812	1.000	0.747	0.706	0.609	0	5.55	0.832	7.674	0.830	0.113	0.207	1.000	0.715	0.996	0.625	14.673	0.684	.	.	.	0.5	51	61	4	77116932	chr4:77116932	T	C	51	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	77969239	77969239	-	T	UTR3	CCNI	NM_001348133:c.*132_*133insA;NM_001348132:c.*132_*133insA;NM_001348134:c.*132_*133insA;NM_001348135:c.*132_*133insA;NM_001348136:c.*132_*133insA;NM_001348137:c.*132_*133insA;NM_001348138:c.*132_*133insA;NM_001348139:c.*132_*133insA;NM_001348140:c.*557_*558insA;NM_006835:c.*132_*133insA	.	.	0.789094043	0.209550825	0.001355133	.	0.26347	0.16383	0.104848986	61.49445624	48.69159	1.3608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	69	4	77969239	chr4:77969239	A	AT	51	PASS	DP=69;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	./.
4	78806528	78806528	-	T	intronic	MRPL1	.	.	.	3.21E-05	0.799827061	0.200140813	.	0.4348	.	0.284856336	71.40835103	424.39081	4.30388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	42	4	78806528	chr4:78806528	A	AT	70	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	78815273	78815273	T	-	intronic	MRPL1	.	.	.	3.21E-05	0.799827061	0.200140813	.	0.4348	.	0.284856336	71.40835103	424.39081	4.30388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	298	4	78815272	chr4:78815272	CT	C,CTT	77	PASS	DP=298;AN=4	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/2	./.
4	78815273	78815273	-	T	intronic	MRPL1	.	.	.	3.21E-05	0.799827061	0.200140813	.	0.4348	.	0.284856336	71.40835103	424.39081	4.30388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	298	4	78815272	chr4:78815272	CT	C,CTT	77	PASS	DP=298;AN=4	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/2	./.
4	79102082	79102082	C	T	intronic	FRAS1	.	.	.	2.29E-23	0.999999999	7.91E-10	DISEASE: Fraser syndrome (FRASS) [MIM:219000]: Multisystem malformation usually comprising cryptophthalmos, cutaneous syndactyly, ear abnormalities, renal agenesis and congenital heart defects. {ECO:0000269|PubMed:23473829}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59318	0.10946	4.646228703	99.76999292	7813.79024	19.03935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	672	4	79102082	chr4:79102082	C	T	79	PASS	DP=672;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	79781098	79781098	C	T	intronic	BMP2K	.	.	.	0.001916525	0.99804383	3.96E-05	.	0.78082	.	0.273728691	70.74781788	1787.12697	7.80244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	4	79781098	chr4:79781098	C	T	.	PASS	DP=46;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	85165687	85165687	C	A	ncRNA_intronic	LOC101928978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	4	85165687	chr4:85165687	C	A	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	85166011	85166011	C	A	ncRNA_intronic	LOC101928978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	4	85166011	chr4:85166011	C	A	.	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	86396749	86396749	C	G	intronic	ARHGAP24	.	.	.	0.004696081	0.995038485	0.000265435	.	0.39284	0.12435	-0.617221851	17.44515216	242.67907	3.36262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	66	4	86396749	chr4:86396749	C	G	66	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	88813100	88813100	G	A	intergenic	MEPE;SPP1	dist=45132;dist=83702	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	137	81	4	88813100	chr4:88813100	G	A	137	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.
4	89443189	89443189	-	A	intronic	PIGY;PYURF	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	19	4	89443189	chr4:89443189	G	GA	39	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	90830450	90830450	C	A	exonic	MMRN1	.	nonsynonymous SNV	MMRN1:NM_007351:exon2:c.C647A:p.T216N	9.35E-17	0.008835231	0.991164769	DISEASE: Note=Deficiency in multimerin-1 due to proteolytic degradation within the platelet alpha granules is associated with an autosomal dominant bleeding disorder (factor V Quebec). {ECO:0000269|PubMed:8652809}.; 	0.13885	0.16819	0.347157132	73.79688606	483.52708	4.52727	0.236	0.179	T	0.992	0.715	D	0.856	0.728	P	0.000	0.537	D	0.979	0.810	D	1.94	0.524	M	0.78	0.494	T	-1.92	0.446	N	0.318	0.380	-0.817	0.542	T	0.202	0.559	T	0.019	0.416	T	4.018	0.540	23.6	0.990	0.498	0.919	0.543	D	c	0.279	0.256	0.978	0.299	0.672	0.522	0	4.45	0.532	2.965	0.486	0.935	0.490	1.000	0.715	0.945	0.419	14.979	0.708	EMI domain	.	.	0.5	.	48	4	90830450	chr4:90830450	C	A	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	95198159	95198159	A	C	intronic	SMARCAD1	.	.	.	0.999996803	3.20E-06	1.79E-15	.	0.31853	0.24651	0.266447942	70.5826846	3025.83606	10.4458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	78	4	95198159	chr4:95198159	A	C	74	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	95494467	95494467	-	T	intronic	PDLIM5	.	.	.	0.012278281	0.986126064	0.001595655	.	0.21242	0.85159	1.335644081	94.24982307	220.34888	3.20885	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	151	4	95494467	chr4:95494467	A	AT	42	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	100784134	100784134	C	G	intronic	DAPP1	.	.	.	0.18349368	0.804567476	0.011938844	.	0.18283	0.11376	-0.075159878	47.78839349	10.06314	0.36728	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	305	4	100784134	chr4:100784134	C	G	66	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	101337123	101337123	-	A	intronic	EMCN	.	.	.	1.65E-05	0.666582651	0.33340082	.	0.31171	.	0.060756528	58.52795471	2740.85611	9.87049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	114	4	101337123	chr4:101337123	G	GA	62	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	102076260	102076260	A	C	intronic	PPP3CA	.	.	.	0.998148789	0.001851202	9.61E-09	.	0.91458	0.30319	-0.427900189	25.14744043	6.37885	0.23918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	334	4	102076260	chr4:102076260	A	C	97	PASS	DP=334;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
4	106557482	106557482	A	G	intronic	ARHGEF38	.	.	.	0.005631717	0.720124339	0.274243944	.	.	.	.	.	2057.23092	8.3587	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	13	4	106557482	chr4:106557482	A	G	43	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	107237814	107237814	C	T	UTR5	TBCK	NM_001163436:c.-7697G>A	.	.	3.22E-06	0.999352989	0.000643795	.	.	.	-0.042196577	50.49539986	1635.40912	7.4738	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	410	4	107237814	chr4:107237814	C	T	85	PASS	DP=410;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	110737293	110737293	-	T	intronic	GAR1	.	.	.	0.81256498	0.187235181	0.000199839	.	0.15921	0.12543	0.347360312	73.97381458	48.13207	1.35139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	332	4	110737293	chr4:110737293	G	GT	79	PASS	DP=332;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	111482530	111482530	G	T	intronic	ENPEP	.	.	.	3.58E-19	0.016944416	0.983055584	.	0.21927	0.47886	0.385781814	75.678226	422.73046	4.29372	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	4	111482530	chr4:111482530	G	T	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	113178967	113178967	A	-	intronic	AP1AR	.	.	.	0.511166929	0.488021686	0.000811385	.	0.14777	0.14109	0.327131069	73.27199811	63.26348	1.62796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.85	166	4	113178966	chr4:113178966	TA	T,TAAA	12.85	PASS	DP=166;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	././.	././.	././.	././.	0/1/.
4	113178967	113178967	-	AA	intronic	AP1AR	.	.	.	0.511166929	0.488021686	0.000811385	.	0.14777	0.14109	0.327131069	73.27199811	63.26348	1.62796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.85	166	4	113178966	chr4:113178966	TA	T,TAAA	12.85	PASS	DP=166;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	././.	././.	././.	././.	0/1/.
4	120986916	120986916	G	A	exonic	MAD2L1	.	nonsynonymous SNV	MAD2L1:NM_002358:exon2:c.C131T:p.T44I	0.013167455	0.861483837	0.125348708	.	0.99211	0.15588	0.03689118	56.64071715	19.38659	0.66662	0.017	0.512	D	0.986	0.657	D	0.951	0.672	D	0.000	0.843	D	1	0.810	D	2.405	0.698	M	.	.	.	-3.54	0.686	D	0.789	0.784	-0.373	0.729	T	0.381	0.738	T	0.010	0.267	T	3.706	0.502	23.3	0.998	0.854	0.942	0.603	D	c	0.749	0.729	1.000	0.747	0.628	0.401	0	4.78	0.605	9.498	0.969	1.048	0.713	1.000	0.715	0.995	0.604	18.181	0.897	HORMA domain	.	.	0.5	.	56	4	120986916	chr4:120986916	G	A	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	129208729	129208729	C	T	exonic	PGRMC2	.	nonsynonymous SNV	PGRMC2:NM_006320:exon1:c.G289A:p.V97M	0.403432082	0.557987569	0.038580349	.	0.24502	0.15979	.	.	86.09241	1.98113	0.249	0.341	T	0.379	0.325	B	0.057	0.248	B	0.083	0.208	N	0.615	0.326	D	1.355	0.339	L	-1.12	0.780	T	-0.54	0.172	N	0.186	0.227	-0.714	0.598	T	0.231	0.597	T	0.935	0.995	D	2.226	0.329	17.68	0.984	0.409	0.190	0.203	N	c	-0.432	-0.370	1.000	0.747	0.442	0.072	0	2.05	0.257	0.563	0.231	-0.069	0.120	1.000	0.715	0.996	0.625	1.542	0.024	Cytochrome b5-like heme/steroid binding domain	.	.	0.5	.	36	4	129208729	chr4:129208729	C	T	.	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	141294814	141294814	G	C	exonic	SCOC	.	nonsynonymous SNV	SCOC:NM_001153484:exon1:c.G124C:p.V42L,SCOC:NM_001153552:exon1:c.G124C:p.V42L,SCOC:NM_001153663:exon1:c.G124C:p.V42L	0.280616506	0.631537689	0.087845805	.	0.3001	0.11229	0.701931997	85.34442085	698.26576	5.26029	0.036	0.433	D	0.001	0.067	B	0.001	0.040	B	0.167	0.031	N	1	0.197	P	1.04	0.263	L	.	.	.	-0.37	0.132	N	0.164	0.198	-1.089	0.057	T	0.000	0.001	T	.	.	.	1.962	0.297	15.98	0.586	0.059	0.236	0.219	N	c	-0.773	-0.755	1.000	0.747	0.442	0.072	0	3.31	0.369	1.416	0.341	1.048	0.713	0.007	0.175	0.003	0.074	6.448	0.209	.	ENSG00000153132.8|ENSG00000153132.8	Esophagus_Mucosa|Muscle_Skeletal	0.5	136	168	4	141294814	chr4:141294814	G	C	136	PASS	DP=168;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	141446575	141446575	A	-	UTR5	ELMOD2	NM_153702:c.-8del-	.	.	0.804445978	0.195329266	0.000224756	.	0.35237	0.11956	0.193034296	66.82000472	54.66599	1.47966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	104	4	141446574	chr4:141446574	GA	G	59	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	141481204	141481204	T	-	intronic	UCP1	.	.	.	4.52E-08	0.114065456	0.885934498	.	0.17669	0.5878	0.196671391	67.19155461	861.30815	5.72408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.49	94	4	141481203	chr4:141481203	AT	A	11.49	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	143000716	143000716	G	T	intronic	INPP4B	.	.	.	0.99861101	0.00138899	8.00E-12	.	0.04918	0.1047	-0.440847477	24.59896202	99.84144	2.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	4	143000716	chr4:143000716	G	T	.	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	143011461	143011461	T	-	intronic	INPP4B	.	.	.	0.99861101	0.00138899	8.00E-12	.	0.04918	0.1047	-0.440847477	24.59896202	99.84144	2.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.92	69	4	143011460	chr4:143011460	AT	A	21.92	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	146026683	146026683	A	G	intronic	ABCE1	.	.	.	0.999982597	1.74E-05	5.48E-13	.	0.54899	0.31462	-0.251530012	35.42108988	5.45332	0.20296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	68	4	146026683	chr4:146026683	A	G	99	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
4	151120063	151120063	C	-	intronic	DCLK2	.	.	.	0.966310095	0.033689808	9.78E-08	.	0.13998	0.10102	-0.378346116	28.01368247	110.56188	2.28968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	17	4	151120062	chr4:151120062	AC	A	42	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	151560826	151560826	G	A	intronic	LRBA	.	.	.	0.044229437	0.955770563	1.54E-17	DISEASE: Immunodeficiency, common variable, 8, with autoimmunity (CVID8) [MIM:614700]: An autosomal recessive immunologic disorder associated with defective B-cell differentiation and decreased or absent antibody production. Affected individuals have early- childhood onset of recurrent infections, particularly respiratory infections, and also develop variable autoimmune disorders, including idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and inflammatory bowel disease. {ECO:0000269|PubMed:22608502}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.31593	.	-2.513092117	0.925925926	4753.32179	13.94798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	4	151560826	chr4:151560826	G	A	.	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	151683004	151683004	A	-	intronic	LRBA	.	.	.	0.044229437	0.955770563	1.54E-17	DISEASE: Immunodeficiency, common variable, 8, with autoimmunity (CVID8) [MIM:614700]: An autosomal recessive immunologic disorder associated with defective B-cell differentiation and decreased or absent antibody production. Affected individuals have early- childhood onset of recurrent infections, particularly respiratory infections, and also develop variable autoimmune disorders, including idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and inflammatory bowel disease. {ECO:0000269|PubMed:22608502}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.31593	.	-2.513092117	0.925925926	4753.32179	13.94798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	139	4	151683003	chr4:151683003	TA	T	67	PASS	DP=139;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	153244050	153244050	C	A	exonic	FBXW7	.	nonsynonymous SNV	FBXW7:NM_001013415:exon11:c.G1753T:p.D585Y,FBXW7:NM_018315:exon11:c.G1867T:p.D623Y,FBXW7:NM_033632:exon12:c.G2107T:p.D703Y,FBXW7:NM_001349798:exon14:c.G2107T:p.D703Y	0.999977859	2.21E-05	9.84E-13	.	0.98577	0.62169	-0.111973265	45.35857514	117.50249	2.35679	0.001	0.784	D	1.0	0.899	D	0.973	0.832	D	0.000	0.843	D	1	0.810	D	2.535	0.741	M	0.3	0.599	T	-8.5	0.975	D	0.763	0.768	-0.126	0.795	T	0.406	0.756	T	0.051	0.645	D	4.761	0.639	24.7	0.991	0.510	0.986	0.840	D	c	0.788	0.742	1.000	0.747	0.706	0.609	0	4.82	0.615	7.874	0.855	0.935	0.490	1.000	0.715	1.000	0.888	15.003	0.710	WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain	.	.	0.5	.	33	4	153244050	chr4:153244050	C	A	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	153864407	153864407	T	C	exonic	FHDC1	.	synonymous SNV	FHDC1:NM_033393:exon1:c.T198C:p.L66L	0.024454127	0.975428958	0.000116915	.	0.39667	0.08948	0.969962249	90.20995518	6091.11428	16.31408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	170	4	153864407	chr4:153864407	T	C	120	PASS	DP=170;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	155470035	155470035	G	A	exonic	PLRG1	.	nonsynonymous SNV	PLRG1:NM_001201564:exon2:c.C62T:p.T21I,PLRG1:NM_002669:exon2:c.C62T:p.T21I	0.998224783	0.001775215	1.76E-09	.	0.55468	0.15289	-0.291981272	33.20358575	28.74018	0.91926	0.001	0.784	D	0.993	0.715	D	0.9	0.693	P	0.000	0.843	D	1	0.810	D	2.81	0.821	M	-0.64	0.721	T	-4.06	0.755	D	0.306	0.790	0.183	0.856	D	0.568	0.843	D	0.200	0.867	D	6.101	0.841	28.2	0.999	0.953	0.971	0.723	D	c	0.940	0.921	1.0	0.983	0.660	0.490	0	5.72	0.893	9.505	0.970	1.048	0.713	1.000	0.715	1.000	0.888	19.889	0.969	.	.	.	0.5	.	27	4	155470035	chr4:155470035	G	A	.	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
4	158281848	158281848	-	T	intronic	GRIA2	.	.	.	0.99550949	0.004490506	3.42E-09	.	0.3057	0.25829	-0.778825328	12.88039632	32.84712	1.01918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	104	4	158281848	chr4:158281848	G	GT	81	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	160253030	160253030	-	T	intronic	RAPGEF2	.	.	.	0.999996667	3.33E-06	1.64E-17	.	0.57738	0.133	-1.658985203	2.724699222	98.637	2.1472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	49	4	160253030	chr4:160253030	G	GT	71	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	161925015	161925015	G	C	intergenic	LINC02233;FSTL5	dist=1226079;dist=380029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	790	4	161925015	chr4:161925015	G	C	120	PASS	DP=790;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	166326887	166326887	C	A	intronic	CPE	.	.	.	0.997846906	0.002153025	6.86E-08	.	0.71178	0.25258	-0.047654689	50.22410946	45.06523	1.28909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	195	4	166326887	chr4:166326887	C	A	60	PASS	DP=195;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	167012390	167012390	C	A	exonic	TLL1	.	nonsynonymous SNV	TLL1:NM_012464:exon19:c.C2553A:p.N851K	0.327496391	0.672503562	4.66E-08	DISEASE: Atrial septal defect 6 (ASD6) [MIM:613087]: A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. {ECO:0000269|PubMed:18830233}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54651	0.13658	-0.927704399	9.719273414	309.19572	3.74397	0.108	0.294	T	0.234	0.290	B	0.119	0.306	B	0.001	0.432	U	0.895	0.360	D	0.8	0.197	N	2.37	0.160	T	-1.05	0.275	N	0.151	0.179	-1.058	0.122	T	0.027	0.114	T	0.004	0.110	T	3.017	0.423	22.3	0.994	0.604	0.845	0.432	D	c	-0.128	0.045	0.964	0.287	0.534	0.214	0	5.3	0.746	1.950	0.397	0.892	0.403	1.000	0.715	0.997	0.653	6.899	0.233	CUB domain	.	.	0.5	.	36	4	167012390	chr4:167012390	C	A	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	167656229	167656229	T	C	exonic	SPOCK3	.	nonsynonymous SNV	SPOCK3:NM_001251967:exon8:c.A860G:p.E287G,SPOCK3:NM_001204355:exon9:c.A866G:p.E289G,SPOCK3:NM_001204353:exon10:c.A794G:p.E265G,SPOCK3:NM_001204354:exon10:c.A878G:p.E293G,SPOCK3:NM_001204356:exon10:c.A1025G:p.E342G,SPOCK3:NM_001040159:exon11:c.A1145G:p.E382G,SPOCK3:NM_001204352:exon12:c.A1001G:p.E334G,SPOCK3:NM_016950:exon12:c.A1154G:p.E385G	0.495144484	0.504669024	0.000186492	.	0.12678	0.11885	0.042348793	57.31304553	237.48342	3.32713	0.435	0.224	T	0.981	0.629	D	0.704	0.612	P	0.000	0.629	D	1.000	0.530	D	2.67	0.784	M	0.98	0.421	T	-0.87	0.268	N	0.795	0.790	-0.924	0.451	T	0.176	0.521	T	0.020	0.426	T	4.070	0.546	23.7	0.998	0.874	0.952	0.637	D	c	0.460	0.485	0.051	0.149	0.554	0.246	0	5.11	0.691	5.956	0.698	0.954	0.563	1.000	0.715	0.998	0.697	14.913	0.703	EF-hand domain pair|SPARC/Testican, calcium-binding domain;Thyroglobulin type-1	.	.	0.5	89	93	4	167656229	chr4:167656229	T	C	89	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	169315628	169315628	T	-	exonic	DDX60L	.	frameshift deletion	DDX60L:NM_001012967:exon28:c.3798delA:p.I1269Lfs*2,DDX60L:NM_001291510:exon28:c.3801delA:p.I1270Lfs*2,DDX60L:NM_001345927:exon28:c.3801delA:p.I1270Lfs*2	8.17E-30	0.000634233	0.999365767	.	0.07164	0.0727	2.618410593	98.77919321	7052.9357	17.9578	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	140	4	169315627	chr4:169315627	CT	C	147	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
4	174253277	174253279	TCC	-	exonic	HMGB2	.	nonframeshift deletion	HMGB2:NM_001130689:exon4:c.582_584del:p.E197del,HMGB2:NM_001130688:exon5:c.582_584del:p.E197del,HMGB2:NM_002129:exon5:c.582_584del:p.E197del	0.907849743	0.091424126	0.00072613	.	0.93997	0.22063	-0.031067188	51.03798066	28.58852	0.91569	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	50	4	174253276	chr4:174253276	TTCC	T	54	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
4	174459375	174459375	C	G	ncRNA_exonic	HAND2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	146	772	4	174459375	chr4:174459375	C	G	146	PASS	DP=772;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	178243570	178243571	TG	-	intronic	NEIL3	.	.	.	3.55E-07	0.556963409	0.443036236	.	0.04798	0.07588	2.157029472	98.01250295	2050.68609	8.34807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	29	4	178243569	chr4:178243569	TTG	T	41	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	184174907	184174909	TAG	-	splicing	WWC2	.	.	.	2.48E-05	0.99913924	0.000835949	.	0.47147	0.09503	0.055085661	57.54895022	2659.69867	9.69726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.77	19	4	184174906	chr4:184174906	TTAG	T	14.77	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
4	186378975	186378975	-	A	intronic	CCDC110	.	.	.	1.35E-08	0.571522479	0.428477507	.	0.09113	0.08327	3.004392866	99.21561689	2433.27149	9.16393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	38	4	186378975	chr4:186378975	G	GA	42	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
4	187630808	187630808	C	A	exonic	FAT1	.	nonsynonymous SNV	FAT1:NM_005245:exon2:c.G174T:p.K58N	1.78E-10	1	5.46E-11	.	0.43649	0.17117	-0.392997457	27.05826846	12587.77428	24.10511	0.002	0.721	D	1.0	0.899	D	0.982	0.739	D	0.000	0.843	D	1.000	0.588	D	2.955	0.853	M	0.16	0.606	T	-3.56	0.750	D	0.2	0.245	-0.406	0.718	T	0.354	0.718	T	0.048	0.634	D	4.395	0.588	24.1	0.997	0.828	0.876	0.469	D	c	0.405	0.282	1.000	0.747	0.554	0.246	0	4.12	0.473	2.061	0.408	0.041	0.156	1.000	0.715	0.246	0.227	6.273	0.200	Cadherin|Cadherin-like	.	.	0.5	.	37	4	187630808	chr4:187630808	C	A	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
4	190874255	190874255	A	T	exonic	FRG1	.	nonsynonymous SNV	FRG1:NM_004477:exon4:c.A292T:p.T98S	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	0.046	0.405	D	0.043	0.202	B	0.083	0.277	B	0.000	0.843	D	1.000	0.588	D	-0.345	0.033	N	1.8	0.520	T	-2.93	0.612	D	0.628	0.654	-1.073	0.087	T	0.058	0.243	T	0.014	0.335	T	2.496	0.361	19.44	0.990	0.494	0.966	0.698	D	c	-0.253	-0.061	1.000	0.747	0.732	0.924	0	3.71	0.416	4.531	0.601	0.187	0.248	1.000	0.715	0.868	0.363	11.050	0.469	Actin cross-linking	.	.	0.5	140	369	4	190874255	chr4:190874255	A	T	140	PASS	DP=369;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
4	190878577	190878577	A	G	exonic	FRG1	.	nonsynonymous SNV	FRG1:NM_004477:exon6:c.A457G:p.N153D	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	0.004	0.654	D	0.481	0.349	P	0.6	0.489	P	0.000	0.843	D	1.000	0.588	D	2.56	0.750	M	1.75	0.505	T	-4.0	0.769	D	0.204	0.530	-0.731	0.589	T	0.247	0.616	T	.	.	.	4.427	0.593	24.2	0.993	0.572	0.982	0.800	D	c	0.095	0.054	1.000	0.427	0.707	0.730	0	2.99	0.335	7.501	0.803	0.136	0.221	1.000	0.715	0.992	0.562	8.215	0.305	Actin cross-linking	.	.	0.5	121	493	4	190878577	chr4:190878577	A	G	121	PASS	DP=493;AN=4	GT	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.
4	190878626	190878626	G	A	exonic	FRG1	.	nonsynonymous SNV	FRG1:NM_004477:exon6:c.G506A:p.S169N	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	0.346	0.200	T	0.531	0.358	P	0.479	0.452	P	0.000	0.629	N	0.999	0.453	D	0.72	0.188	N	1.77	0.485	T	-1.16	0.439	N	0.321	0.516	-1.077	0.080	T	0.097	0.365	T	0.012	0.295	T	1.752	0.272	14.70	0.986	0.430	0.857	0.446	D	c	-0.184	-0.131	0.995	0.337	0.707	0.730	0	2.41	0.285	2.028	0.405	-0.327	0.075	1.000	0.715	0.990	0.544	7.682	0.275	Actin cross-linking	.	.	0.5	88	379	4	190878626	chr4:190878626	G	A	88	PASS	DP=379;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	190878664	190878664	A	G	intronic	FRG1	.	.	.	3.67E-06	0.359220086	0.64077624	.	.	0.13913	-0.251530012	35.42108988	86.27493	1.98323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	620	4	190878664	chr4:190878664	A	G	133	PASS	DP=620;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	190894317	190894317	A	C	intergenic	FRG1;FRG2	dist=9958;dist=51206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	130	4	190894317	chr4:190894317	A	C	111	PASS	DP=130;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
4	190905501	190905501	G	A	intergenic	FRG1;FRG2	dist=21142;dist=40022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	165	4	190905501	chr4:190905501	G	A	.	PASS	DP=165;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	256379	256379	C	T	intronic	SDHA	.	.	.	9.39E-06	0.996636308	0.003354304	DISEASE: Mitochondrial complex II deficiency (MT-C2D) [MIM:252011]: A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations. Clinical features include psychomotor regression in infants, poor growth with lack of speech development, severe spastic quadriplegia, dystonia, progressive leukoencephalopathy, muscle weakness, exercise intolerance, cardiomyopathy. Some patients manifest Leigh syndrome or Kearns-Sayre syndrome. Note=The disease is caused by mutations affecting the gene represented in this entry. {ECO:0000269|PubMed:12794685}.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:10746566, ECO:0000269|PubMed:24781757, ECO:0000269|PubMed:7550341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1GG (CMD1GG) [MIM:613642]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:20551992}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Paragangliomas 5 (PGL5) [MIM:614165]: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion. Paragangliomas can develop at various body sites, including the head, neck, thorax and abdomen. Most commonly, they are located in the head and neck region, specifically at the carotid bifurcation, the jugular foramen, the vagal nerve, and in the middle ear. {ECO:0000269|PubMed:20484225}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2964	.	-0.857930839	10.95187544	1260.39498	6.69421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	138	5	256379	chr5:256379	C	T	84	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	256514	256514	G	C	exonic	SDHA	.	synonymous SNV	SDHA:NM_001330758:exon13:c.G1731C:p.P577P,SDHA:NM_001294332:exon14:c.G1830C:p.P610P,SDHA:NM_004168:exon15:c.G1974C:p.P658P	9.39E-06	0.996636308	0.003354304	DISEASE: Mitochondrial complex II deficiency (MT-C2D) [MIM:252011]: A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations. Clinical features include psychomotor regression in infants, poor growth with lack of speech development, severe spastic quadriplegia, dystonia, progressive leukoencephalopathy, muscle weakness, exercise intolerance, cardiomyopathy. Some patients manifest Leigh syndrome or Kearns-Sayre syndrome. Note=The disease is caused by mutations affecting the gene represented in this entry. {ECO:0000269|PubMed:12794685}.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:10746566, ECO:0000269|PubMed:24781757, ECO:0000269|PubMed:7550341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1GG (CMD1GG) [MIM:613642]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:20551992}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Paragangliomas 5 (PGL5) [MIM:614165]: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion. Paragangliomas can develop at various body sites, including the head, neck, thorax and abdomen. Most commonly, they are located in the head and neck region, specifically at the carotid bifurcation, the jugular foramen, the vagal nerve, and in the middle ear. {ECO:0000269|PubMed:20484225}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2964	.	-0.857930839	10.95187544	1260.39498	6.69421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	156	300	5	256514	chr5:256514	G	C	156	PASS	DP=300;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	434847	434847	G	T	exonic	AHRR	.	nonsynonymous SNV	AHRR:NM_001242412:exon11:c.G2004T:p.Q668H,AHRR:NM_020731:exon12:c.G2058T:p.Q686H	6.76E-05	0.977269885	0.022662496	.	.	0.16352	1.004917985	90.78792168	1613.48158	7.43304	0.028	0.469	D	0.5	0.353	P	0.264	0.379	B	0.073	0.213	N	1	0.090	N	0	0.065	N	2.26	0.229	T	-0.52	0.221	N	0.044	0.032	-0.997	0.309	T	0.024	0.103	T	0.004	0.091	T	1.382	0.229	12.69	0.796	0.124	0.147	0.183	N	c	-1.653	-1.816	1.000	0.747	0.672	0.522	0	-9.49	0.005	-2.148	0.014	-1.933	0.005	0.000	0.063	0.000	0.016	9.154	0.360	.	.	.	0.5	.	349	5	434847	chr5:434847	G	T	.	PASS	DP=349;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	666150	666151	CG	-	exonic	TPPP	.	frameshift deletion	TPPP:NM_007030:exon3:c.399_400del:p.S133Rfs*159	0.447860539	0.523687832	0.028451629	.	0.32775	0.16177	-0.315847836	31.68789809	36.35113	1.08938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	344	5	666149	chr5:666149	TCG	T	62	PASS	DP=344;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	796015	796015	A	C	UTR3	ZDHHC11	NM_024786:c.*688T>G	.	.	5.60E-11	0.031527346	0.968472654	.	0.07275	.	0.979225112	90.42816702	206.54905	3.10549	.	.	.	.	.	.	.	.	.	.	.	.	0.994	0.422	D	.	.	.	.	.	.	.	.	.	.	.	-0.904	0.475	T	0.173	0.516	T	.	.	.	-0.255	0.072	0.839	0.492	0.041	0.066	0.125	N	c	-0.611	-0.824	0.000	0.052	0.258	0.037	0	1.07	0.193	-1.126	0.033	-0.703	0.037	0.000	0.063	0.002	0.062	3.397	0.068	.	.	.	0.5	102	33	5	796015	chr5:796015	A	C	102	PASS	DP=33;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	840644	840644	G	C	exonic	ZDHHC11	.	nonsynonymous SNV	ZDHHC11:NM_024786:exon5:c.C750G:p.H250Q	5.60E-11	0.031527346	0.968472654	.	0.07275	.	0.979225112	90.42816702	206.54905	3.10549	0.343	0.138	T	0.001	0.067	B	0.014	0.158	B	0.003	0.009	U	1	0.090	N	-0.205	0.041	N	1.86	0.437	T	0.89	0.324	N	0.461	0.513	-1.007	0.279	T	0.062	0.258	T	0.002	0.034	T	-1.687	0.013	0.002	0.409	0.029	0.000	0.003	N	c	-1.735	-1.738	0.118	0.168	0.696	0.567	0	-0.394	0.118	0.260	0.181	-0.152	0.108	0.187	0.239	0.016	0.126	13.336	0.598	Zinc finger, DHHC-type, palmitoyltransferase	.	.	0.5	94	107	5	840644	chr5:840644	G	C	94	PASS	DP=107;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	840661	840661	A	G	exonic	ZDHHC11	.	nonsynonymous SNV	ZDHHC11:NM_024786:exon5:c.T733C:p.F245L	5.60E-11	0.031527346	0.968472654	.	0.07275	.	0.979225112	90.42816702	206.54905	3.10549	1.0	0.108	T	0.0	0.026	B	0.002	0.063	B	.	.	.	1	0.090	N	0.09	0.084	N	1.96	0.386	T	1.6	0.332	N	0.468	0.519	-1.058	0.123	T	0.035	0.151	T	0.001	0.012	T	-3.140	0.001	0.001	0.082	0.001	0.002	0.011	N	c	-2.141	-2.214	0.998	0.363	0.696	0.567	0	-5.47	0.024	-0.923	0.041	-1.725	0.007	0.000	0.063	0.000	0.016	3.145	0.060	Zinc finger, DHHC-type, palmitoyltransferase	.	.	0.5	88	105	5	840661	chr5:840661	A	G	88	PASS	DP=105;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	840712	840712	C	G	exonic	ZDHHC11	.	nonsynonymous SNV	ZDHHC11:NM_024786:exon5:c.G682C:p.V228L	5.60E-11	0.031527346	0.968472654	.	0.07275	.	0.979225112	90.42816702	206.54905	3.10549	0.045	0.408	D	0.804	0.432	P	0.688	0.519	P	.	.	.	1	0.090	N	.	.	.	1.63	0.551	T	-1.5	0.577	N	0.392	0.452	-0.978	0.355	T	0.133	0.446	T	.	.	.	-0.046	0.089	2.162	0.927	0.216	0.028	0.075	N	c	-0.845	-1.031	0.126	0.170	0.696	0.567	0	-0.481	0.114	-0.244	0.088	-0.926	0.025	0.000	0.063	0.001	0.043	8.106	0.299	Zinc finger, DHHC-type, palmitoyltransferase	.	.	0.5	113	327	5	840712	chr5:840712	C	G	113	PASS	DP=327;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
5	878461	878461	G	A	intronic	BRD9	.	.	.	0.249187874	0.749502264	0.001309862	.	0.12337	0.10817	-0.797234383	12.48525596	290.83161	3.64776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	157	342	5	878461	chr5:878461	G	A	157	PASS	DP=342;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	1004352	1004352	C	T	intergenic	LOC100506688;NKD2	dist=6897;dist=4725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	1015	5	1004352	chr5:1004352	C	T	90	PASS	DP=1015;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	1064002	1064002	A	-	exonic	SLC12A7	.	frameshift deletion	SLC12A7:NM_006598:exon20:c.2696delT:p.L899Cfs*28	8.45E-11	0.968735953	0.031264047	.	0.09754	.	-2.793650711	0.654635527	209.87901	3.12733	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	267	5	1064001	chr5:1064001	CA	C	69	PASS	DP=267;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	1065611	1065611	G	A	intronic	SLC12A7	.	.	.	8.45E-11	0.968735953	0.031264047	.	0.09754	.	-2.793650711	0.654635527	209.87901	3.12733	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	332	5	1065611	chr5:1065611	G	A	85	PASS	DP=332;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	1078922	1078922	G	A	intronic	SLC12A7	.	.	.	8.45E-11	0.968735953	0.031264047	.	0.09754	.	-2.793650711	0.654635527	209.87901	3.12733	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	5	1078922	chr5:1078922	G	A	.	PASS	DP=52;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	1213547	1213547	C	T	intronic	SLC6A19	.	.	.	8.52E-18	0.004157	0.995843	DISEASE: Hyperglycinuria (HG) [MIM:138500]: A condition characterized by excess of glycine in the urine. In some cases it is associated with renal colic and renal oxalate stones. {ECO:0000269|PubMed:19033659}. Note=The disease may be caused by mutations affecting the gene represented in this entry. SLC6A19 deficiency combined with haploinsufficiency of SLC6A20 or partially inactivating mutations in SLC36A2, can be responsible for hyperglycinuria.; DISEASE: Iminoglycinuria (IG) [MIM:242600]: A disorder of renal tubular reabsorption of glycine and imino acids (proline and hydroxyproline), marked by excessive levels of all three substances in the urine. {ECO:0000269|PubMed:19033659}. Note=The disease may be caused by mutations affecting the gene represented in this entry. SLC6A19 deficiency combined with haploinsufficiency of SLC6A20 or partially inactivating mutations in SLC36A2, can be responsible for iminoglycinuria. Additional polymorphisms and mutations in SLC6A18 can contribute to the IG phenotype in some families.; 	0.20028	0.16452	-1.92362963	1.916725643	1140.864	6.44137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	5	1213547	chr5:1213547	C	T	.	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	2746912	2746912	G	-	UTR3	IRX2	NM_033267:c.*766delC	.	.	0.648697597	0.345244394	0.006058009	.	0.53433	0.1523	.	.	877.19497	5.76492	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	38	5	2746911	chr5:2746911	AG	A	72	PASS	DP=38;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	5146432	5146432	G	A	exonic	ADAMTS16	.	nonsynonymous SNV	ADAMTS16:NM_139056:exon3:c.G365A:p.G122D	0.001086503	0.998912754	7.44E-07	.	0.15638	0.1321	0.679686641	84.77235197	6129.25449	16.35226	0.834	0.029	T	0.995	0.657	D	0.927	0.644	D	0.000	0.843	D	1	0.810	D	2.105	0.586	M	3.23	0.070	T	-3.44	0.674	D	0.877	0.871	-1.220	0.001	T	0.070	0.284	T	0.010	0.267	T	3.336	0.460	22.9	0.823	0.136	0.857	0.446	D	c	0.266	0.244	1.0	0.983	0.707	0.730	0	5.74	0.900	7.272	0.777	1.048	0.713	1.000	0.715	0.648	0.298	19.069	0.931	Peptidase M12B, propeptide	.	.	0.5	.	72	5	5146432	chr5:5146432	G	A	.	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	6651976	6651976	G	C	exonic	SRD5A1	.	synonymous SNV	SRD5A1:NM_001047:exon2:c.G315C:p.L105L,SRD5A1:NM_001324323:exon3:c.G96C:p.L32L	1.82E-06	0.252700789	0.747297393	.	0.05869	.	-0.073340031	48.11866006	31.3139	0.98785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	32	5	6651976	chr5:6651976	G	C	72	PASS	DP=32;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
5	7300363	7300383	GCTTCCGCATCTGCTCTTTCT	-	intergenic	MIR4454;LOC442132	dist=30896;dist=1060	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	360	5	7300362	chr5:7300362	CGCTTCCGCATCTGCTCTTTCT	C	67	PASS	DP=360;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	9119250	9119250	G	T	exonic	SEMA5A	.	nonsynonymous SNV	SEMA5A:NM_003966:exon15:c.C1785A:p.N595K	0.000979594	0.999016141	4.26E-06	.	0.23092	0.10687	-2.892521092	0.583864119	185.92785	2.96172	0.007	0.599	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	0.999	0.451	D	2.23	0.633	M	2.18	0.189	T	-4.08	0.747	D	0.321	0.382	-0.431	0.710	T	0.082	0.322	T	0.016	0.372	T	1.065	0.196	11.03	0.960	0.280	0.360	0.252	N	c	-1.060	-1.367	1.000	0.747	0.539	0.216	0	-10.7	0.002	-0.272	0.085	-2.161	0.004	0.200	0.241	0.680	0.305	10.557	0.441	.	.	.	0.5	98	620	5	9119250	chr5:9119250	G	T	98	PASS	DP=620;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	10618641	10618641	C	A	intronic	ANKRD33B	.	.	.	.	.	.	.	.	.	.	.	245.21895	3.37855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	697	5	10618641	chr5:10618641	C	A	99	PASS	DP=697;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	14601134	14601134	G	A	exonic	FAM105A	.	nonsynonymous SNV	FAM105A:NM_019018:exon2:c.G125A:p.R42K	2.33E-07	0.275709326	0.724290442	.	0.1028	0.09828	0.106667882	61.73036093	389.06175	4.15395	0.055	0.384	T	0.167	0.270	B	0.085	0.279	B	0.019	0.273	N	1.000	0.090	N	2.34	0.674	M	2.26	0.176	T	-0.73	0.206	N	0.156	0.186	-1.030	0.203	T	0.030	0.131	T	0.008	0.209	T	0.917	0.182	10.18	0.942	0.238	0.335	0.246	N	c	-0.535	-0.504	1.000	0.436	0.706	0.609	0	2.64	0.304	1.228	0.320	0.143	0.228	0.854	0.303	0.135	0.201	7.490	0.265	.	.	.	0.5	.	35	5	14601134	chr5:14601134	G	A	.	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	17273722	17273722	A	C	intronic	BASP1	.	.	.	0.539222353	0.403650733	0.057126915	.	0.20195	0.13818	.	.	157.19188	2.73957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	218	5	17273722	chr5:17273722	A	C	90	PASS	DP=218;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	17486848	17486848	G	T	intergenic	LINC02218;LINC02223	dist=2793;dist=320535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	517	5	17486848	chr5:17486848	G	T	97	PASS	DP=517;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	17632247	17632247	C	G	intergenic	LINC02218;LINC02223	dist=148192;dist=175136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	396	5	17632247	chr5:17632247	C	G	.	PASS	DP=396;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	24511520	24511520	G	T	exonic	CDH10	.	stopgain	CDH10:NM_001317224:exon5:c.C918A:p.Y306X,CDH10:NM_006727:exon6:c.C918A:p.Y306X	0.309152977	0.690814761	3.23E-05	.	0.42021	0.11113	-0.800872469	12.33191791	34.27199	1.04877	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.073	0.972	37	0.996	0.746	0.858	0.447	D	c	0.454	0.253	0.003	0.102	0.554	0.246	0	-0.294	0.121	1.501	0.351	0.067	0.174	1.000	0.715	0.999	0.750	10.529	0.440	Cadherin|Cadherin-like	.	.	0.5	.	52	5	24511520	chr5:24511520	G	T	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	31435975	31435975	-	A	intronic	DROSHA	.	.	.	0.996399648	0.003600352	2.77E-14	.	0.60911	0.25509	-0.461076406	23.66124086	2101.94263	8.44322	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.54	29	5	31435975	chr5:31435975	C	CA	19.54	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	33546166	33546166	G	A	exonic	ADAMTS12	.	synonymous SNV	ADAMTS12:NM_001324512:exon20:c.C4189T:p.L1397L,ADAMTS12:NM_030955:exon22:c.C4444T:p.L1482L	1.54E-11	0.999347073	0.000652927	.	0.10893	0.12072	0.865222355	88.74734607	1284.68357	6.74639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	73	5	33546166	chr5:33546166	G	A	67	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	34830879	34830879	C	G	UTR3	RAI14	NM_015577:c.*9C>G;NM_001145522:c.*9C>G;NM_001145520:c.*9C>G;NM_001145525:c.*9C>G;NM_001145521:c.*9C>G;NM_001145523:c.*9C>G	.	.	0.487656416	0.512341946	1.64E-06	.	0.2442	0.11401	-0.216746887	37.69757018	3767.60269	12.00361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	39	5	34830879	chr5:34830879	C	G	54	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	36876937	36876937	C	-	UTR5	NIPBL	NM_015384:c.-76862del-;NM_133433:c.-76862del-	.	.	1	9.20E-18	1.38E-43	DISEASE: Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186, ECO:0000269|PubMed:15318302, ECO:0000269|PubMed:20124326, ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:21934712, ECO:0000269|PubMed:23254390, ECO:0000269|PubMed:25447906}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94334	0.10487	-2.44943873	1.014390186	759.33568	5.46172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	613	5	36876936	chr5:36876936	TC	T	100	PASS	DP=613;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	41904406	41904406	G	T	upstream	C5orf51	dist=40	.	.	0.0038889	0.957830834	0.038280267	.	.	.	0.104848986	61.49445624	180.03222	2.91542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	794	5	41904406	chr5:41904406	G	T	120	PASS	DP=794;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	52781430	52781430	C	T	intronic	FST	.	.	.	0.963797332	0.036133213	6.95E-05	.	0.88912	0.4861	0.591694063	82.45458835	44.28611	1.27001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	5	52781430	chr5:52781430	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	53606347	53606347	-	A	UTR5	ARL15	NM_019087:c.-39_-38insT	.	.	0.008866422	0.804130998	0.18700258	.	0.61156	0.1051	-0.163345027	41.24793583	6.04468	0.22863	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	659	5	53606347	chr5:53606347	G	GA	92	PASS	DP=659;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	55042105	55042105	G	T	intronic	DDX4	.	.	.	0.998516038	0.001483962	4.64E-11	.	0.68619	0.10786	-0.310388054	32.14791224	861.19729	5.72325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	5	55042105	chr5:55042105	G	T	.	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	63507969	63507969	A	C	exonic	RNF180	.	synonymous SNV	RNF180:NM_001113561:exon3:c.A213C:p.I71I,RNF180:NM_001323291:exon3:c.A213C:p.I71I,RNF180:NM_001323292:exon3:c.A213C:p.I71I,RNF180:NM_178532:exon3:c.A213C:p.I71I	5.17E-05	0.672649596	0.32729867	.	0.41298	0.07689	0.108486928	61.90728946	571.53785	4.85009	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	145	5	63507969	chr5:63507969	A	C	135	PASS	DP=145;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	64756006	64756006	C	T	exonic	ADAMTS6	.	nonsynonymous SNV	ADAMTS6:NM_197941:exon4:c.G622A:p.G208R	0.998800473	0.001199527	1.13E-12	.	0.4309	0.11953	-0.574945567	18.90186365	218.20018	3.19214	0.021	0.491	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	2.455	0.715	M	0.14	0.609	T	-3.74	0.710	D	0.864	0.858	-0.396	0.722	T	0.368	0.728	T	0.067	0.701	D	6.838	0.927	33	0.999	0.997	0.988	0.872	D	c	0.759	0.797	1.000	0.747	0.707	0.730	0	6.06	0.983	7.435	0.794	0.935	0.490	1.000	0.715	1.000	0.888	20.640	0.995	.	.	.	0.5	.	50	5	64756006	chr5:64756006	C	T	.	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	65029420	65029420	G	T	intronic	NLN	.	.	.	3.60E-07	0.985541392	0.014458248	.	0.39163	0.14364	-0.354480518	29.42911064	1132.42209	6.4199	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	140	5	65029420	chr5:65029420	G	T	.	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	67595055	67595055	A	-	UTR3	PIK3R1	NM_181523:c.*1626delA;NM_181524:c.*1626delA;NM_181504:c.*1626delA;NM_001242466:c.*1626delA	.	.	0.998240488	0.001759512	7.03E-11	DISEASE: Agammaglobulinemia 7, autosomal recessive (AGM7) [MIM:615214]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:22351933}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: SHORT syndrome (SHORTS) [MIM:269880]: A rare, multisystem disease characterized by short stature, anomalies of the anterior chamber of the eye, characteristic facial features such as triangular facies, lack of facial fat, and hypoplastic nasal alae with overhanging columella, partial lipodystrophy, hernias, hyperextensibility, and delayed dentition. The clinical phenotype can include insulin resistance, nephrocalcinosis, and hearing deficits. Developmental milestones and cognition are normal. {ECO:0000269|PubMed:23810378, ECO:0000269|PubMed:23810379, ECO:0000269|PubMed:23810382}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Immunodeficiency 36 (IMD36) [MIM:616005]: A primary immunodeficiency characterized by impaired B-cell function, hypogammaglobulinemia and recurrent infections. {ECO:0000269|PubMed:25133428}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.88821	0.86719	-0.756778259	13.44656759	2135.01489	8.50101	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	26	5	67595054	chr5:67595054	GA	G	42	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	68875556	68875556	-	T	intronic	GTF2H2C;GTF2H2C_2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	123	5	68875556	chr5:68875556	G	GT	65	PASS	DP=123;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	69730714	69730714	-	T	ncRNA_intronic	GTF2H2B;GUSBP3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	165	5	69730714	chr5:69730714	G	GT	76	PASS	DP=165;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	74011539	74011539	T	-	intronic	HEXB	.	.	.	1.49E-05	0.991564206	0.008420879	DISEASE: GM2-gangliosidosis 2 (GM2G2) [MIM:268800]: An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. Clinically indistinguishable from GM2-gangliosidosis type 1, presenting startle reactions, early blindness, progressive motor and mental deterioration, macrocephaly and cherry-red spots on the macula. {ECO:0000269|PubMed:1531140, ECO:0000269|PubMed:1720305, ECO:0000269|PubMed:7557963, ECO:0000269|PubMed:7626071, ECO:0000269|PubMed:7633435, ECO:0000269|PubMed:8357844, ECO:0000269|PubMed:8950198, ECO:0000269|PubMed:9401004, ECO:0000269|PubMed:9694901, ECO:0000269|PubMed:9856491}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20473	0.08046	0.951720429	90.06251474	1282.40292	6.74324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	135	5	74011538	chr5:74011538	CT	C	74	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	74011540	74011540	-	A	intronic	HEXB	.	.	.	1.49E-05	0.991564206	0.008420879	DISEASE: GM2-gangliosidosis 2 (GM2G2) [MIM:268800]: An autosomal recessive lysosomal storage disease marked by the accumulation of GM2 gangliosides in the neuronal cells. Clinically indistinguishable from GM2-gangliosidosis type 1, presenting startle reactions, early blindness, progressive motor and mental deterioration, macrocephaly and cherry-red spots on the macula. {ECO:0000269|PubMed:1531140, ECO:0000269|PubMed:1720305, ECO:0000269|PubMed:7557963, ECO:0000269|PubMed:7626071, ECO:0000269|PubMed:7633435, ECO:0000269|PubMed:8357844, ECO:0000269|PubMed:8950198, ECO:0000269|PubMed:9401004, ECO:0000269|PubMed:9694901, ECO:0000269|PubMed:9856491}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20473	0.08046	0.951720429	90.06251474	1282.40292	6.74324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.76	71	5	74011540	chr5:74011540	T	TA	14.76	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	76640691	76640691	G	T	exonic	PDE8B	.	nonsynonymous SNV	PDE8B:NM_001029853:exon6:c.G751T:p.V251L,PDE8B:NM_001029851:exon7:c.G811T:p.V271L,PDE8B:NM_001029852:exon7:c.G811T:p.V271L,PDE8B:NM_001029854:exon7:c.G811T:p.V271L,PDE8B:NM_001349748:exon7:c.G808T:p.V270L,PDE8B:NM_001349751:exon7:c.G808T:p.V270L,PDE8B:NM_001349752:exon7:c.G505T:p.V169L,PDE8B:NM_003719:exon7:c.G811T:p.V271L,PDE8B:NM_001349749:exon8:c.G874T:p.V292L,PDE8B:NM_001349750:exon8:c.G571T:p.V191L,PDE8B:NM_001349753:exon8:c.G439T:p.V147L	0.986862336	0.013137655	9.57E-09	DISEASE: Striatal degeneration autosomal dominant (ADSD) [MIM:609161]: A movement disorder affecting the striatal part of the basal ganglia and characterized by bradykinesia, dysarthria and muscle rigidity. These symptoms resemble idiopathic Parkinson disease, but tremor is not present. {ECO:0000269|PubMed:20085714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Primary pigmented nodular adrenocortical disease 3 (PPNAD3) [MIM:614190]: A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Adrenal glands show overall normal size and weight, and multiple small yellow-to-dark brown nodules surrounded by a cortex with a uniform appearance. Microscopically, there are moderate diffuse cortical hyperplasia with mostly nonpigmented nodules, multiple capsular deficits and massive circumscribed and infiltrating extra-adrenal cortical excrescences with micronodules. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:18431404}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.47483	.	-0.688817379	15.20405756	135.71543	2.53301	0.856	0.031	T	0.018	0.165	B	0.074	0.267	B	0.005	0.330	N	1.000	0.516	D	-1.065	0.010	N	-0.24	0.749	T	0.18	0.138	N	0.519	0.591	-0.887	0.492	T	0.117	0.414	T	0.019	0.420	T	1.689	0.264	14.34	0.840	0.145	0.906	0.517	D	c	-0.378	-0.069	0.172	0.178	0.554	0.246	0	5.01	0.663	2.235	0.424	1.048	0.713	1.000	0.715	1.000	0.888	11.329	0.485	PAS domain	.	.	0.5	.	29	5	76640691	chr5:76640691	G	T	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	77772515	77772515	C	T	UTR3	SCAMP1	NM_001290229:c.*1024C>T;NM_004866:c.*1024C>T	.	.	0.84227628	0.157111882	0.000611838	.	0.92895	0.10741	.	.	145.44918	2.62753	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	5	77772515	chr5:77772515	C	T	.	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	79945913	79945913	A	G	UTR5	MTRNR2L2	NM_001190470:c.-8T>C	.	.	.	.	.	.	.	.	.	.	22.30248	0.74815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	5	79945913	chr5:79945913	A	G	.	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	80088493	80088493	-	T	intronic	MSH3	.	.	.	4.57E-23	0.002294752	0.997705248	DISEASE: Endometrial cancer (ENDMC) [MIM:608089]: A malignancy of endometrium, the mucous lining of the uterus. Most endometrial cancers are adenocarcinomas, cancers that begin in cells that make and release mucus and other fluids. {ECO:0000305|PubMed:8782829}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.47698	0.19216	-0.079012906	47.25760793	3510.45198	11.4303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	31	5	80088493	chr5:80088493	G	GT	67	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	80504281	80504281	C	T	ncRNA_intronic	RNU5D-1;RNU5E-1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	5	80504281	chr5:80504281	C	T	.	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	85582748	85582748	A	G	ncRNA_exonic	NBPF22P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	137	5	85582748	chr5:85582748	A	G	82	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	86564459	86564459	G	T	exonic	RASA1	.	nonsynonymous SNV	RASA1:NM_002890:exon1:c.G191T:p.G64V	0.999998286	1.71E-06	7.92E-17	DISEASE: Note=Mutations in the SH2 domain of RASA seem to be oncogenic and cause basal cell carcinomas.; DISEASE: Capillary malformation-arteriovenous malformation (CMAVM) [MIM:608354]: A disorder characterized by atypical capillary malformations that are multiple, small, round to oval in shape and pinkish red in color. These capillary malformations are associated with either arteriovenous malformation, arteriovenous fistula, or Parkes Weber syndrome. {ECO:0000269|PubMed:14639529, ECO:0000269|PubMed:24038909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Parkes Weber syndrome (PKWS) [MIM:608355]: Disorder characterized by a cutaneous flush with underlying multiple micro- arteriovenous fistulas, in association with soft tissue and skeletal hypertrophy of the affected limb. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.71615	0.1353	-0.821100135	11.88369899	144.431	2.61738	0.01	0.564	D	0.889	0.469	P	0.238	0.368	B	0.239	0.036	N	0.995	0.426	D	0.695	0.181	N	-0.67	0.725	T	-0.43	0.144	N	0.453	0.511	-0.828	0.534	T	0.184	0.533	T	0.144	0.827	D	4.731	0.634	24.6	0.983	0.397	0.127	0.172	N	c	-0.132	-0.054	1.000	0.747	0.442	0.072	0	3.7	0.414	0.568	0.232	0.877	0.384	0.902	0.312	0.983	0.502	12.682	0.561	.	.	.	0.5	.	48	5	86564459	chr5:86564459	G	T	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	86629061	86629061	-	T	intronic	RASA1	.	.	.	0.999998286	1.71E-06	7.92E-17	DISEASE: Note=Mutations in the SH2 domain of RASA seem to be oncogenic and cause basal cell carcinomas.; DISEASE: Capillary malformation-arteriovenous malformation (CMAVM) [MIM:608354]: A disorder characterized by atypical capillary malformations that are multiple, small, round to oval in shape and pinkish red in color. These capillary malformations are associated with either arteriovenous malformation, arteriovenous fistula, or Parkes Weber syndrome. {ECO:0000269|PubMed:14639529, ECO:0000269|PubMed:24038909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Parkes Weber syndrome (PKWS) [MIM:608355]: Disorder characterized by a cutaneous flush with underlying multiple micro- arteriovenous fistulas, in association with soft tissue and skeletal hypertrophy of the affected limb. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.71615	0.1353	-0.821100135	11.88369899	144.431	2.61738	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	16	5	86629061	chr5:86629061	C	CT	51	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	89999592	89999592	G	T	exonic	ADGRV1	.	stopgain	ADGRV1:NM_032119:exon35:c.G8266T:p.G2756X	.	.	.	DISEASE: Usher syndrome 2C (USH2C) [MIM:605472]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:14740321, ECO:0000269|PubMed:22147658}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Febrile seizures, familial, 4 (FEB4) [MIM:604352]: Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.07741	0.17025	8.124040712	99.95281906	.	.	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.580	0.999	51	0.990	0.505	0.994	0.960	D	c	1.211	1.057	1.000	0.747	0.554	0.246	0	5.15	0.702	9.222	0.943	1.048	0.713	1.000	0.715	0.877	0.367	18.825	0.920	Na-Ca exchanger/integrin-beta4	.	.	0.5	.	40	5	89999592	chr5:89999592	G	T	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	90671341	90671341	C	T	exonic	ARRDC3	.	synonymous SNV	ARRDC3:NM_020801:exon4:c.G600A:p.K200K	0.978746962	0.021249266	3.77E-06	.	0.7962	0.13881	-0.095386216	46.48502005	15.79241	0.56251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	5	90671341	chr5:90671341	C	T	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	92920263	92920263	G	A	UTR5	NR2F1	NM_005654:c.-467G>A	.	.	.	.	.	DISEASE: Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722]: An autosomal dominant disorder characterized by optic atrophy associated with developmental delay and intellectual disability. Most patients also have evidence of cerebral visual impairment. {ECO:0000269|PubMed:24462372}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.7496	0.11262	-0.339715008	30.06605331	3.34161	0.12228	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	13	5	92920263	chr5:92920263	G	A	.	PASS	DP=13;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	92923754	92923754	C	A	exonic	NR2F1	.	nonsynonymous SNV	NR2F1:NM_005654:exon2:c.C595A:p.P199T	.	.	.	DISEASE: Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) [MIM:615722]: An autosomal dominant disorder characterized by optic atrophy associated with developmental delay and intellectual disability. Most patients also have evidence of cerebral visual impairment. {ECO:0000269|PubMed:24462372}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.7496	0.11262	-0.339715008	30.06605331	3.34161	0.12228	0.03	0.453	D	0.997	0.689	D	0.975	0.717	D	0.000	0.843	D	1	0.810	D	1.57	0.397	L	0.72	0.510	T	-5.94	0.891	D	0.644	0.660	-0.669	0.619	T	0.274	0.646	T	0.045	0.621	D	2.325	0.341	18.33	0.997	0.823	0.996	0.981	D	c	0.524	0.446	1.000	0.747	0.707	0.730	0	4.5	0.542	7.879	0.856	0.932	0.445	1.000	0.715	0.971	0.463	17.383	0.872	Nuclear hormone receptor, ligand-binding domain	.	.	0.5	.	228	5	92923754	chr5:92923754	C	A	.	PASS	DP=228;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	96314793	96314793	-	T	intronic	LNPEP	.	.	.	0.998308426	0.001691574	6.39E-11	.	0.07652	0.30451	0.181903047	66.2361406	2452.71206	9.21552	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	125	5	96314793	chr5:96314793	C	CT	43	PASS	DP=125;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	108516618	108516618	-	T	intronic	FER	.	.	.	0.968420467	0.031579516	1.69E-08	.	0.10446	0.1442	-0.440847477	24.59896202	528.33339	4.69026	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	14	5	108516618	chr5:108516618	A	AT	50	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	108680378	108680378	C	T	intronic	PJA2	.	.	.	0.466603862	0.533163979	0.000232159	.	0.32444	0.09509	-0.132199953	43.97853267	2997.44585	10.38957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	5	108680378	chr5:108680378	C	T	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	110842001	110842002	TG	-	intronic	STARD4	.	.	.	2.96E-07	0.173957488	0.826042216	.	0.12935	0.12152	-0.295622497	32.61972163	25.69887	0.83663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	29	5	110842000	chr5:110842000	CTG	C	69	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	112111396	112111396	C	T	exonic	APC	.	nonsynonymous SNV	APC:NM_001127511:exon4:c.C523T:p.L175F,APC:NM_000038:exon5:c.C493T:p.L165F,APC:NM_001127510:exon6:c.C493T:p.L165F	0.999999928	7.23E-08	1.20E-23	DISEASE: Familial adenomatous polyposis (FAP) [MIM:175100]: A cancer predisposition syndrome characterized by adenomatous polyps of the colon and rectum, but also of upper gastrointestinal tract (ampullary, duodenal and gastric adenomas). This is a viciously premalignant disease with one or more polyps progressing through dysplasia to malignancy in untreated gene carriers with a median age at diagnosis of 40 years. {ECO:0000269|PubMed:10470088, ECO:0000269|PubMed:1338691, ECO:0000269|PubMed:1338764, ECO:0000269|PubMed:1338904, ECO:0000269|PubMed:1651563, ECO:0000269|PubMed:7833149, ECO:0000269|PubMed:7833931, ECO:0000269|PubMed:8990002}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hereditary desmoid disease (HDD) [MIM:135290]: Autosomal dominant trait with 100% penetrance and possible variable expression among affected relatives. HDD patients show multifocal fibromatosis of the paraspinal muscles, breast, occiput, arms, lower ribs, abdominal wall, and mesentery. Desmoid tumors appears also as a complication of familial adenomatous polyposis. {ECO:0000269|PubMed:10782927, ECO:0000269|PubMed:8940264}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269|PubMed:10666372}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Mismatch repair cancer syndrome (MMRCS) [MIM:276300]: An autosomal recessive, rare, childhood cancer predisposition syndrome encompassing a broad tumor spectrum. This includes hematological malignancies, central nervous system tumors, Lynch syndrome-associated malignancies such as colorectal tumors as well as multiple intestinal polyps, embryonic tumors and rhabdomyosarcoma. Multiple cafe-au-lait macules, a feature reminiscent of neurofibromatosis type 1, are often found as first manifestation of the underlying cancer. Areas of skin hypopigmentation have also been reported in MMRCS patients. {ECO:0000269|PubMed:7661930}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Hepatocellular carcinoma (HCC) [MIM:114550]: A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.53216	0.57092	-2.523543479	0.902335456	395.17068	4.17713	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1.000	0.588	D	1.585	0.400	L	-1.58	0.820	D	-3.03	0.651	D	0.31	0.775	0.429	0.895	D	0.669	0.885	D	0.123	0.805	D	6.456	0.891	29.9	0.999	0.977	0.981	0.797	D	c	0.716	0.708	1.000	0.747	0.732	0.924	0	5.3	0.746	5.553	0.668	0.935	0.490	1.000	0.715	1.000	0.888	18.959	0.926	Adenomatous polyposis coli protein|Armadillo-like helical	.	.	0.5	.	32	5	112111396	chr5:112111396	C	T	.	PASS	DP=32;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	118309599	118309599	G	A	intronic	DTWD2	.	.	.	2.16E-05	0.484452633	0.515525762	.	0.17158	0.1149	-0.448125345	24.19202642	92.81718	2.06998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	117	5	118309599	chr5:118309599	G	A	.	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	121187815	121187815	G	A	exonic	FTMT	.	nonsynonymous SNV	FTMT:NM_177478:exon1:c.G157A:p.A53T	0.081623987	0.756095225	0.162280788	.	0.06302	0.20458	0.371224249	75.12384996	105.36958	2.22323	0.193	0.209	T	0.014	0.156	B	0.002	0.063	B	.	.	.	1	0.090	N	1.05	0.269	L	-0.05	0.634	T	-0.73	0.206	N	0.061	0.045	-1.040	0.173	T	0.106	0.387	T	0.034	0.552	D	0.490	0.141	7.352	0.982	0.389	0.037	0.089	N	c	-1.141	-1.219	0.000	0.029	0.487	0.133	0	-1.73	0.076	-0.049	0.118	-0.235	0.093	0.000	0.063	0.000	0.016	2.593	0.045	.	.	.	0.5	.	110	5	121187815	chr5:121187815	G	A	.	PASS	DP=110;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	122139264	122139264	A	G	exonic	SNX2	.	nonsynonymous SNV	SNX2:NM_001278199:exon6:c.A248G:p.H83R,SNX2:NM_003100:exon6:c.A599G:p.H200R	0.997941242	0.002058746	1.25E-08	.	0.339	0.13169	-0.692458599	14.96815287	25.76147	0.83932	1.0	0.085	T	0.001	0.067	B	0.01	0.139	B	0.000	0.629	D	1.000	0.588	D	1.005	0.253	L	1.29	0.358	T	-1.11	0.383	N	0.464	0.519	-1.076	0.082	T	0.050	0.213	T	0.012	0.306	T	0.454	0.138	7.070	0.927	0.217	0.983	0.817	D	c	-0.333	-0.115	0.988	0.315	0.732	0.924	0	4.38	0.519	7.334	0.783	1.028	0.649	1.000	0.715	0.999	0.750	11.303	0.484	Phox homologous domain;Sorting nexin, N-terminal	.	.	0.5	.	56	5	122139264	chr5:122139264	A	G	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	126253834	126253834	G	C	exonic	MARCH3	.	synonymous SNV	MARCH3:NM_178450:exon2:c.C30G:p.P10P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	122	5	126253834	chr5:126253834	G	C	.	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	127593605	127593605	C	A	UTR3	FBN2	NM_001999:c.*1542G>T	.	.	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	98	5	127593605	chr5:127593605	C	A	59	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	127872118	127872118	G	T	exonic	FBN2	.	nonsynonymous SNV	FBN2:NM_001999:exon2:c.C314A:p.P105H	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	0.001	0.784	D	0.999	0.764	D	0.935	0.653	D	0.000	0.629	D	1.000	0.810	D	1.78	0.463	L	-1.96	0.869	D	-4.83	0.925	D	0.729	0.731	0.262	0.869	D	0.632	0.871	D	0.066	0.699	D	5.064	0.682	25.2	0.997	0.831	0.959	0.665	D	c	0.540	0.639	1.0	0.983	0.726	0.872	0	5.32	0.753	9.898	0.986	1.048	0.713	1.000	0.715	0.999	0.750	19.186	0.936	.	.	.	0.5	.	102	5	127872118	chr5:127872118	G	T	.	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	127872119	127872119	G	T	exonic	FBN2	.	nonsynonymous SNV	FBN2:NM_001999:exon2:c.C313A:p.P105T	0.999999992	8.21E-09	4.12E-30	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.2165	0.066	0.365	T	0.208	0.282	B	0.068	0.262	B	0.000	0.629	D	1.000	0.588	D	1.32	0.331	L	-1.91	0.865	D	-4.1	0.860	D	0.708	0.716	-0.381	0.726	T	0.382	0.739	T	0.040	0.595	D	3.058	0.427	22.4	0.998	0.861	0.821	0.411	D	c	-0.104	0.122	1.000	0.747	0.726	0.872	0	5.32	0.753	2.895	0.481	1.048	0.713	1.000	0.715	0.998	0.697	13.803	0.625	.	.	.	0.5	.	103	5	127872119	chr5:127872119	G	T	.	PASS	DP=103;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	131325197	131325197	G	A	exonic	ACSL6	.	nonsynonymous SNV	ACSL6:NM_001009185:exon5:c.C455T:p.A152V,ACSL6:NM_001205247:exon5:c.C350T:p.A117V,ACSL6:NM_001205248:exon5:c.C380T:p.A127V,ACSL6:NM_001205250:exon5:c.C413T:p.A138V,ACSL6:NM_001205251:exon5:c.C275T:p.A92V,ACSL6:NM_015256:exon5:c.C455T:p.A152V	0.088562272	0.911422111	1.56E-05	DISEASE: Note=A chromosomal aberration involving ACSL6 may be a cause of myelodysplastic syndrome with basophilia. Translocation t(5;12)(q31;p13) with ETV6. {ECO:0000269|PubMed:10502316}.; DISEASE: Note=A chromosomal aberration involving ACSL6 may be a cause of acute myelogenous leukemia with eosinophilia. Translocation t(5;12)(q31;p13) with ETV6. {ECO:0000269|PubMed:10502316}.; DISEASE: Note=A chromosomal aberration involving ACSL6 may be a cause of acute eosinophilic leukemia (AEL). Translocation t(5;12)(q31;p13) with ETV6. {ECO:0000269|PubMed:10502316}.; 	0.05423	0.12209	-0.642904474	16.62538335	97.99912	2.13957	0.498	0.316	T	0.002	0.090	B	0.007	0.149	B	0.003	0.354	N	0.986	0.415	D	1.055	0.270	L	0.95	0.433	T	-0.77	0.463	N	0.064	0.472	-1.049	0.147	T	0.095	0.360	T	0.010	0.258	T	1.030	0.193	10.83	0.977	0.348	0.973	0.734	D	c	-0.320	-0.202	1.000	0.443	0.554	0.283	0	4.51	0.544	4.888	0.626	0.953	0.551	0.992	0.373	0.985	0.512	14.367	0.662	AMP-dependent synthetase/ligase	.	.	0.5	.	40	5	131325197	chr5:131325197	G	A	.	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	133861381	133861381	G	A	UTR5	JADE2	NM_001289984:c.-10167G>A;NM_001289985:c.-4G>A	.	.	.	.	.	.	0.54969	0.1093	-0.484940685	22.75300778	183.73703	2.94069	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	5	133861381	chr5:133861381	G	A	.	PASS	DP=50;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	133916215	133916215	C	T	UTR3	JADE2	NM_001308143:c.*1208C>T;NM_001289984:c.*1208C>T;NM_001289985:c.*1208C>T;NM_015288:c.*1208C>T	.	.	.	.	.	.	0.54969	0.1093	-0.484940685	22.75300778	183.73703	2.94069	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	5	133916215	chr5:133916215	C	T	.	PASS	DP=53;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	133948395	133948396	CC	-	exonic	SAR1B	.	frameshift deletion	SAR1B:NM_016103:exon4:c.229_230del:p.G77Wfs*38,SAR1B:NM_001033503:exon5:c.229_230del:p.G77Wfs*38	0.006300416	0.910141255	0.083558329	.	0.4566	0.14201	-0.229483771	36.86010852	11.40907	0.41222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	411	5	133948394	chr5:133948394	ACC	A	73	PASS	DP=411;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	134015276	134015276	-	T	intronic	SEC24A	.	.	.	1.31E-05	0.999969557	1.73E-05	.	0.19793	0.09969	-1.058182374	7.554847841	248.85929	3.3989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	92	5	134015276	chr5:134015276	G	GT	85	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	134194789	134194789	-	A	UTR3	C5orf24	NM_152409:c.*3632_*3633insA;NM_001300894:c.*1702_*1703insA;NM_001135586:c.*3632_*3633insA	.	.	0.640813736	0.331572836	0.027613428	.	0.34193	.	0.058937498	58.26256192	19.20533	0.66119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.36	41	5	134194789	chr5:134194789	G	GA	10.36	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	137527605	137527605	C	T	exonic	CDC23	.	synonymous SNV	CDC23:NM_004661:exon12:c.G1308A:p.L436L	0.999307693	0.000692306	8.74E-10	.	0.80825	0.14086	-0.005381972	53.50908233	136.88847	2.54297	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	5	137527605	chr5:137527605	C	T	.	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
5	139227249	139227249	-	T	UTR3	NRG2	NM_001184935:c.*252_*253insA;NM_004883:c.*252_*253insA;NM_013981:c.*252_*253insA;NM_013982:c.*252_*253insA;NM_013983:c.*252_*253insA	.	.	0.995154288	0.004845611	1.01E-07	.	0.87096	0.14813	.	.	357.16396	4.00512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	44	5	139227249	chr5:139227249	C	CT	58	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	140080299	140080299	G	T	intronic	ZMAT2	.	.	.	0.97143376	0.028527624	3.86E-05	.	0.64216	0.11262	-0.031067188	51.03798066	2.53643	0.09383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	54	5	140080299	chr5:140080299	G	T	.	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	140165915	140165915	C	T	exonic	PCDHA1	.	synonymous SNV	PCDHA1:NM_018900:exon1:c.C40T:p.L14L,PCDHA1:NM_031410:exon1:c.C40T:p.L14L,PCDHA1:NM_031411:exon1:c.C40T:p.L14L	0.000559475	0.973083018	0.026357507	.	0.08763	.	0.213053688	67.54541165	435.99793	4.35381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	280	5	140165915	chr5:140165915	C	T	89	PASS	DP=280;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	140201593	140201593	T	A	exonic	PCDHA5	.	nonsynonymous SNV	PCDHA5:NM_018908:exon1:c.T233A:p.L78Q,PCDHA5:NM_031501:exon1:c.T233A:p.L78Q	0.003538248	0.986919756	0.009541996	.	0.09837	.	0.100999032	60.76315169	773.98299	5.50488	0.037	0.430	D	0.899	0.475	P	0.59	0.486	P	.	.	.	1	0.810	D	1.725	0.447	L	1.17	0.379	T	-4.49	0.780	D	0.207	0.479	-0.972	0.369	T	0.107	0.389	T	0.053	0.654	D	4.407	0.590	24.1	0.992	0.538	0.397	0.260	N	c	-0.293	-0.357	0.374	0.199	0.517	0.208	0	2.83	0.320	-0.729	0.050	0.908	0.420	0.000	0.063	1.000	0.888	3.128	0.060	Cadherin|Cadherin, N-terminal|Cadherin-like	.	.	0.5	.	340	5	140201593	chr5:140201593	T	A	.	PASS	DP=340;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	140209257	140209257	G	T	exonic	PCDHA6	.	nonsynonymous SNV	PCDHA6:NM_018909:exon1:c.G1581T:p.E527D,PCDHA6:NM_031848:exon1:c.G1581T:p.E527D,PCDHA6:NM_031849:exon1:c.G1581T:p.E527D	6.16E-08	0.425463275	0.574536663	.	0.0666	0.452	-0.764300099	13.18117481	231.91909	3.2905	0.006	0.614	D	0.105	0.326	B	0.386	0.422	B	0.049	0.232	U	1	0.810	D	1.275	0.323	L	0.6	0.537	T	-2.81	0.597	D	0.116	0.127	-0.918	0.459	T	0.147	0.473	T	0.017	0.391	T	2.554	0.368	19.81	0.982	0.388	0.397	0.260	N	c	-0.401	-0.405	0.000	0.065	0.554	0.246	0	2.86	0.323	0.022	0.133	0.728	0.305	0.003	0.159	0.975	0.474	6.943	0.235	Cadherin|Cadherin-like	.	.	0.5	136	1584	5	140209257	chr5:140209257	G	T	136	PASS	DP=1584;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
5	140257373	140257373	C	T	exonic	PCDHA12	.	synonymous SNV	PCDHA12:NM_018903:exon1:c.C2316T:p.F772F,PCDHA12:NM_031864:exon1:c.C2316T:p.F772F	3.52E-10	0.090786698	0.909213301	.	0.1303	.	1.234540528	93.27671621	295.25165	3.66735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	186	5	140257373	chr5:140257373	C	T	.	PASS	DP=186;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	140604454	140604454	C	T	exonic	PCDHB14	.	synonymous SNV	PCDHB14:NM_018934:exon1:c.C1377T:p.F459F	9.06E-09	0.086280185	0.913719806	.	0.03309	.	1.030617021	91.10639302	666.24151	5.16589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	1148	5	140604454	chr5:140604454	C	T	81	PASS	DP=1148;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
5	140616226	140616226	C	A	ncRNA_exonic	PCDHB18P	.	.	.	.	.	.	.	0.0684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	424	5	140616226	chr5:140616226	C	A	.	PASS	DP=424;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	140755476	140755476	T	A	exonic	PCDHGA6	.	nonsynonymous SNV	PCDHGA6:NM_018919:exon1:c.T1826A:p.L609H,PCDHGA6:NM_032086:exon1:c.T1826A:p.L609H	8.20E-07	0.736871867	0.263127313	.	0.20048	.	-0.079012906	47.25760793	336.38673	3.89594	0.035	0.437	D	0.999	0.764	D	0.978	0.725	D	0.223	0.161	U	1	0.810	D	3.395	0.918	M	0.35	0.580	T	-5.61	0.867	D	0.312	0.373	-0.685	0.612	T	0.299	0.671	T	0.026	0.494	D	4.802	0.644	24.8	0.985	0.418	0.265	0.228	N	c	0.344	0.230	0.156	0.175	0.646	0.450	0	4.85	0.622	0.010	0.130	1.061	0.807	0.000	0.063	1.000	0.888	4.751	0.123	Cadherin|Cadherin-like	.	.	0.5	125	906	5	140755476	chr5:140755476	T	A	125	PASS	DP=906;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	140764446	140764446	C	A	exonic	PCDHGA7	.	synonymous SNV	PCDHGA7:NM_018920:exon1:c.C1980A:p.L660L,PCDHGA7:NM_032087:exon1:c.C1980A:p.L660L	5.28E-06	0.660312893	0.33968183	.	.	.	0.143271594	63.67067705	862.76559	5.72657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	179	5	140764446	chr5:140764446	C	A	.	PASS	DP=179;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	141691634	141691634	G	A	UTR3	SPRY4	NM_030964:c.*2140C>T;NM_001293289:c.*2140C>T;NM_001293290:c.*2140C>T;NM_001127496:c.*2140C>T	.	.	0.109919686	0.776973195	0.11310712	DISEASE: Hypogonadotropic hypogonadism 17 with or without anosmia (HH17) [MIM:615266]: A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic- pituitary axis. In some cases, it is associated with non- reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). {ECO:0000269|PubMed:23643382}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Some patients carrying mutations in SPRY4 also have a heterozygous mutation in another HH-associated gene including DUSP6 and FGFR1 (PubMed:23643382). {ECO:0000269|PubMed:23643382}.; 	0.93024	0.1419	-0.045835247	50.34206181	112.70425	2.30891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	99	5	141691634	chr5:141691634	G	A	53	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	142662264	142662264	C	T	exonic	NR3C1	.	nonsynonymous SNV	NR3C1:NM_000176:exon8:c.G2050A:p.E684K,NR3C1:NM_001018074:exon8:c.G2050A:p.E684K,NR3C1:NM_001018075:exon8:c.G2050A:p.E684K,NR3C1:NM_001018076:exon8:c.G2050A:p.E684K,NR3C1:NM_001018077:exon8:c.G2050A:p.E684K,NR3C1:NM_001020825:exon8:c.G2050A:p.E684K,NR3C1:NM_001024094:exon8:c.G2053A:p.E685K,NR3C1:NM_001204258:exon8:c.G1972A:p.E658K,NR3C1:NM_001204259:exon8:c.G1795A:p.E599K,NR3C1:NM_001204260:exon8:c.G1783A:p.E595K,NR3C1:NM_001204261:exon8:c.G1759A:p.E587K,NR3C1:NM_001204262:exon8:c.G1105A:p.E369K,NR3C1:NM_001204263:exon8:c.G1060A:p.E354K,NR3C1:NM_001204264:exon8:c.G1045A:p.E349K	0.311618466	0.688225337	0.000156198	DISEASE: Glucocorticoid resistance, generalized (GCCR) [MIM:615962]: An autosomal dominant disease characterized by increased plasma cortisol concentration and high urinary free cortisol, resistance to adrenal suppression by dexamethasone, and the absence of Cushing syndrome typical signs. Clinical features include hypoglycemia, hypertension, metabolic alkalosis, chronic fatigue and profound anxiety. {ECO:0000269|PubMed:11589680, ECO:0000269|PubMed:11701741, ECO:0000269|PubMed:12050230, ECO:0000269|PubMed:15769988, ECO:0000269|PubMed:1704018, ECO:0000269|PubMed:17635946, ECO:0000269|PubMed:7683692}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99538	0.92999	-0.156065314	42.16206653	135.29579	2.53062	0.332	0.137	T	0.012	0.161	B	0.043	0.229	B	0.005	0.330	N	0.523	0.319	D	-1.15	0.009	N	-4.31	0.972	D	-0.72	0.204	N	0.214	0.281	-0.128	0.795	T	0.723	0.905	D	0.026	0.489	D	3.897	0.525	23.5	0.993	0.589	0.864	0.454	D	c	-0.221	0.006	1.000	0.432	0.707	0.730	0	4.66	0.577	0.540	0.227	0.928	0.438	0.991	0.370	0.999	0.750	10.239	0.423	Nuclear hormone receptor, ligand-binding domain	.	.	0.5	.	13	5	142662264	chr5:142662264	C	T	.	PASS	DP=13;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	145435519	145435519	-	A	intronic	SH3RF2	.	.	.	1.79E-11	0.111247308	0.888752692	.	0.17894	0.09775	-0.146971018	42.31540458	238.18509	3.33526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.53	32	5	145435519	chr5:145435519	T	TA	13.53	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	145719086	145719086	G	A	intronic	POU4F3	.	.	.	0.721115139	0.275871589	0.003013271	.	0.89518	0.15588	-0.53631094	20.53550366	20.59903	0.70015	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	90	5	145719086	chr5:145719086	G	A	.	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	145843174	145843174	G	T	exonic	TCERG1	.	nonsynonymous SNV	TCERG1:NM_001040006:exon5:c.G953T:p.S318I,TCERG1:NM_006706:exon5:c.G953T:p.S318I	0.999962712	3.73E-05	1.19E-15	.	0.94723	0.23802	-0.865195027	10.79853739	89.92295	2.04005	0.037	0.453	D	0.968	0.546	D	0.558	0.477	P	0.000	0.843	D	1.000	0.484	D	1.32	0.331	L	-1.81	0.840	D	-1.57	0.439	N	0.561	0.595	-0.029	0.817	T	0.542	0.831	D	0.087	0.750	D	4.366	0.585	24.1	0.991	0.534	0.992	0.925	D	c	0.438	0.503	1.000	0.747	0.707	0.730	0	5.16	0.704	6.851	0.750	1.048	0.713	1.000	0.715	1.000	0.888	18.652	0.914	.	.	.	0.5	117	271	5	145843174	chr5:145843174	G	T	117	PASS	DP=271;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
5	145890197	145890197	A	C	exonic	TCERG1	.	nonsynonymous SNV	TCERG1:NM_001040006:exon21:c.A3226C:p.T1076P,TCERG1:NM_006706:exon22:c.A3289C:p.T1097P	0.999962712	3.73E-05	1.19E-15	.	0.94723	0.23802	-0.865195027	10.79853739	89.92295	2.04005	0.008	0.614	D	0.998	0.715	D	0.934	0.652	D	0.000	0.843	D	1	0.810	D	1.355	0.339	L	1.75	0.262	T	-1.44	0.354	N	0.619	0.640	-1.026	0.218	T	0.120	0.420	T	0.023	0.466	T	3.375	0.464	22.9	0.992	0.549	0.993	0.941	D	c	0.747	0.798	1.000	0.747	0.707	0.730	0	6.16	0.993	9.230	0.944	1.199	0.960	1.000	0.715	1.000	0.888	16.806	0.855	FF domain	.	.	0.5	58	183	5	145890197	chr5:145890197	A	C	58	PASS	DP=183;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	147162132	147162132	-	T	UTR5	JAKMIP2	NM_014790:c.-110764_-110763insA;NM_001270934:c.-110764_-110763insA;NM_001282282:c.-112_-111insA;NM_001270941:c.-110764_-110763insA	.	.	0.999936528	6.35E-05	1.06E-13	.	0.66287	0.12537	-1.199555187	5.761972163	105.04961	2.21693	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	79	5	147162132	chr5:147162132	G	GT	51	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
5	147504305	147504305	-	T	intronic	SPINK5	.	.	.	2.12E-17	0.920781311	0.079218689	DISEASE: Netherton syndrome (NETH) [MIM:256500]: An autosomal recessive congenital ichthyosis associated with hair shaft abnormalities and anomalies of the immune system. Typical features are ichthyosis linearis circumflexa, ichthyosiform erythroderma, trichorrhexis invaginata (bamboo hair), atopic dermatitis, and hayfever. High postnatal mortality is due to failure to thrive, infections and hypernatremic dehydration. {ECO:0000269|PubMed:10835624}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2529	0.29285	2.831581484	99.08586931	18873.47781	29.29597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	264	5	147504305	chr5:147504305	C	CT	77	PASS	DP=264;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	148579955	148579955	G	A	exonic	ABLIM3	.	nonsynonymous SNV	ABLIM3:NM_001301015:exon4:c.G412A:p.A138T,ABLIM3:NM_001301028:exon4:c.G412A:p.A138T,ABLIM3:NM_001345861:exon4:c.G412A:p.A138T,ABLIM3:NM_001301018:exon5:c.G412A:p.A138T,ABLIM3:NM_001301027:exon5:c.G436A:p.A146T,ABLIM3:NM_001345858:exon5:c.G412A:p.A138T,ABLIM3:NM_001345859:exon5:c.G412A:p.A138T,ABLIM3:NM_001345860:exon5:c.G412A:p.A138T,ABLIM3:NM_014945:exon5:c.G412A:p.A138T	0.016025349	0.983972836	1.82E-06	.	0.44749	0.10843	-1.150005948	6.286860109	169.47144	2.84089	0.42	0.098	T	0.0	0.026	B	0.0	0.063	B	0.002	0.382	N	0.997	0.228	N	-0.41	0.029	N	1.01	0.411	T	-0.03	0.095	N	0.019	0.080	-1.024	0.224	T	0.032	0.139	T	0.005	0.112	T	1.796	0.277	14.96	0.946	0.246	0.611	0.311	D	c	-0.602	-0.377	1.000	0.458	0.646	0.442	0	2.54	0.295	2.231	0.424	-0.513	0.050	1.000	0.715	0.995	0.604	4.614	0.117	Zinc finger, LIM-type	.	.	0.5	.	77	5	148579955	chr5:148579955	G	A	.	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	149678006	149678006	G	T	exonic	ARSI	.	nonsynonymous SNV	ARSI:NM_001012301:exon2:c.C481A:p.R161S	1.05E-09	0.089882668	0.910117331	.	0.1223	0.15805	-1.03976177	7.802547771	156.19896	2.73165	0.162	0.248	T	0.26	0.298	B	0.233	0.367	B	0.000	0.843	D	1	0.810	D	0.73	0.189	N	-3.93	0.961	D	-2.07	0.563	N	0.903	0.909	0.380	0.888	D	0.743	0.912	D	0.099	0.772	D	3.232	0.448	22.8	0.992	0.537	0.953	0.641	D	c	-0.022	0.130	1.000	0.747	0.615	0.372	0	4.58	0.559	4.886	0.626	0.953	0.551	1.000	0.715	0.998	0.697	17.591	0.878	Alkaline phosphatase-like, alpha/beta/alpha|Alkaline-phosphatase-like, core domain|Sulfatase, N-terminal	.	.	0.5	.	152	5	149678006	chr5:149678006	G	T	.	PASS	DP=152;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	150138378	150138378	-	C	intronic	DCTN4	.	.	.	0.953389998	0.046608916	1.09E-06	.	0.38025	0.11977	-0.512444034	21.55579146	2570.86813	9.47719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	632	5	150138378	chr5:150138378	G	GC	96	PASS	DP=632;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	154169883	154169883	A	G	splicing	LARP1	NM_015315:exon2:c.206-2A>G	.	.	0.999952189	4.78E-05	5.32E-14	.	0.27569	0.0905	-1.350267166	4.600141543	57.4938	1.52959	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.357	0.583	24.1	0.995	0.685	0.998	0.994	D	c	1.065	0.893	1.000	0.747	0.257	0.036	0	5.39	0.775	7.727	0.837	1.199	0.960	1.000	0.715	0.907	0.385	15.442	0.748	.	.	.	0.5	80	69	5	154169883	chr5:154169883	A	G	80	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	156087404	156087404	A	C	intronic	SGCD	.	.	.	0.0023391	0.92474999	0.07291091	DISEASE: Limb-girdle muscular dystrophy 2F (LGMD2F) [MIM:601287]: An autosomal recessive degenerative myopathy initially affecting the proximal limb girdle musculature. Muscle from patients shows a complete loss of delta-sarcoglycan as well as of the others components of the sarcoglycan complex. {ECO:0000269|PubMed:9832045}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1L (CMD1L) [MIM:606685]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:10974018}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14985	0.36776	-0.271755481	34.31823543	233.51927	3.30188	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.021	0.092	2.387	0.406	0.029	0.001	0.008	N	n	-0.322	-0.218	0.000	0.050	0.162	0.029	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	222	5	156087404	chr5:156087404	A	C	135	PASS	DP=222;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
5	156934070	156934070	G	A	exonic	ADAM19	.	synonymous SNV	ADAM19:NM_033274:exon10:c.C984T:p.V328V	4.20E-06	0.999906953	8.88E-05	.	0.71514	0.13137	0.918552705	89.5730125	5188.76456	14.82439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	120	5	156934070	chr5:156934070	G	A	.	PASS	DP=120;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	156945760	156945760	G	A	intronic	ADAM19	.	.	.	4.20E-06	0.999906953	8.88E-05	.	0.71514	0.13137	0.918552705	89.5730125	5188.76456	14.82439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	129	5	156945760	chr5:156945760	G	A	.	PASS	DP=129;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	157053271	157053271	-	T	UTR3	SOX30	NM_178424:c.*76_*77insA;NM_007017:c.*339_*340insA;NM_001308165:c.*76_*77insA	.	.	0.998986334	0.001013655	1.09E-08	.	0.27011	0.09592	1.289723716	93.85468271	1024.43935	6.15363	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	216	5	157053271	chr5:157053271	C	CT	78	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	158126222	158126222	-	A	intronic	EBF1	.	.	.	0.996264497	0.00373545	5.33E-08	.	0.9897	0.28911	-0.47017169	23.25430526	46.86767	1.32389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	17.88	31	5	158126222	chr5:158126222	T	TA	17.88	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	158630629	158630629	-	T	exonic	RNF145	.	frameshift insertion	RNF145:NM_001199380:exon2:c.86dupA:p.N29Kfs*43,RNF145:NM_001199381:exon2:c.47dupA:p.N16Kfs*43,RNF145:NM_001199382:exon2:c.38dupA:p.N13Kfs*43,RNF145:NM_144726:exon2:c.80dupA:p.N27Kfs*43	0.663621979	0.336332443	4.56E-05	.	0.33859	.	-0.736552314	13.93606983	26.28405	0.85227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	378	5	158630629	chr5:158630629	G	GT	110	PASS	DP=378;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	168044008	168044008	C	T	intergenic	PANK3;SLIT3	dist=37394;dist=44730	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	166	5	168044008	chr5:168044008	C	T	.	PASS	DP=166;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	168044028	168044029	TA	-	intergenic	PANK3;SLIT3	dist=37414;dist=44709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	544	5	168044027	chr5:168044027	TTA	T	58	PASS	DP=544;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	168137995	168137995	C	A	exonic	SLIT3	.	nonsynonymous SNV	SLIT3:NM_001271946:exon25:c.G2624T:p.G875V,SLIT3:NM_003062:exon25:c.G2624T:p.G875V	0.991788384	0.008211616	4.20E-14	.	0.82846	0.13042	-2.196075097	1.374144845	779.81909	5.52544	0.015	0.546	D	0.981	0.577	D	0.938	0.656	D	0.000	0.843	D	1	0.810	D	2.075	0.572	M	-0.99	0.759	T	-5.58	0.867	D	0.854	0.888	0.185	0.857	D	0.561	0.841	D	0.097	0.767	D	6.759	0.922	32	0.998	0.882	0.975	0.747	D	c	0.699	0.649	0.999	0.399	0.554	0.283	0	4.8	0.610	4.939	0.630	0.935	0.490	1.000	0.715	0.986	0.517	18.416	0.905	Cysteine-rich flanking region, C-terminal|Leucine-rich repeat domain, L domain-like	.	.	0.5	.	126	5	168137995	chr5:168137995	C	A	.	PASS	DP=126;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	171424015	171424015	C	A	intronic	FBXW11	.	.	.	0.997161484	0.002838511	5.51E-09	.	0.6328	0.16023	-0.471992905	23.03609342	11.11765	0.40246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	81	5	171424015	chr5:171424015	C	A	83	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	171849555	171849555	T	C	intronic	SH3PXD2B	.	.	.	0.018536793	0.981286619	0.000176588	DISEASE: Frank-Ter Haar syndrome (FTHS) [MIM:249420]: A syndrome characterized by brachycephaly, wide fontanels, prominent forehead, hypertelorism, prominent eyes, macrocornea with or without glaucoma, full cheeks, small chin, bowing of the long bones and flexion deformity of the fingers. {ECO:0000269|PubMed:20137777}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26216	0.10532	-0.279250919	33.56923803	389.35486	4.15627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	158	5	171849555	chr5:171849555	T	C	107	PASS	DP=158;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	172744196	172744196	C	-	UTR3	STC2	NM_003714:c.*654delG	.	.	0.453518118	0.540378643	0.006103239	.	0.14459	0.16191	-0.53631094	20.53550366	76.39753	1.83301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	263	5	172744195	chr5:172744195	TC	T	62	PASS	DP=263;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	175717357	175717357	G	T	exonic	SIMC1	.	nonsynonymous SNV	SIMC1:NM_001308195:exon2:c.G830T:p.G277V,SIMC1:NM_001308196:exon4:c.G773T:p.G258V	0.000207487	0.907420866	0.092371647	.	0.11144	0.08199	-0.580403979	18.58928993	498.88864	4.58624	0.015	0.524	D	0.016	0.261	B	0.015	0.190	B	0.000	0.006	N	1.000	0.189	N	1.445	0.365	L	2.28	0.307	T	-1.02	0.301	N	0.073	0.062	-1.046	0.155	T	0.051	0.219	T	0.003	0.054	T	-0.518	0.054	0.199	0.461	0.036	0.143	0.181	N	c	-1.079	-1.151	0.002	0.087	0.706	0.609	0	0.422	0.156	-0.094	0.110	-0.470	0.054	0.182	0.239	0.000	0.016	6.185	0.196	.	.	.	0.5	.	151	5	175717357	chr5:175717357	G	T	.	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	175819527	175819527	A	-	UTR3	CLTB	NM_001834:c.*248delT;NM_007097:c.*248delT	.	.	0.11549246	0.85740865	0.02709889	.	0.42524	0.24613	-0.229483771	36.86010852	6.86616	0.25469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	108	5	175819526	chr5:175819526	GA	G	55	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
5	175957072	175957072	C	T	intronic	RNF44	.	.	.	0.567929658	0.431553355	0.000516987	.	0.35919	.	-0.179930907	40.35739561	104.3157	2.20769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	143	5	175957072	chr5:175957072	C	T	.	PASS	DP=143;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	176930231	176930231	C	G	exonic	DOK3	.	nonsynonymous SNV	DOK3:NM_001144876:exon5:c.G502C:p.E168Q,DOK3:NM_001144875:exon6:c.G808C:p.E270Q	7.28E-05	0.743816689	0.256110523	.	0.16443	0.09799	-0.08265057	47.20452937	503.42172	4.60415	0.0	0.912	D	0.914	0.518	P	0.483	0.517	P	.	.	.	1	0.090	N	.	.	.	0.63	0.542	T	-0.4	0.138	N	0.022	0.005	-1.059	0.120	T	0.099	0.369	T	0.010	0.268	T	0.367	0.129	6.323	0.993	0.574	0.067	0.126	N	c	-0.725	-0.837	1.000	0.747	0.722	0.854	0	2.4	0.284	-0.378	0.074	0.461	0.278	0.000	0.063	0.005	0.090	8.393	0.315	IRS-type PTB domain|PH domain-like;PH domain-like|Pleckstrin homology domain	.	.	0.5	68	180	5	176930231	chr5:176930231	C	G	68	PASS	DP=180;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
5	177099140	177099140	T	A	ncRNA_exonic	LOC202181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	103	5	177099140	chr5:177099140	T	A	104	PASS	DP=103;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
5	177987759	177987759	A	-	intronic	COL23A1	.	.	.	9.57E-10	0.90264393	0.097356069	.	0.07258	0.08141	0.75875178	86.82472281	1444.11081	7.08807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	46	5	177987758	chr5:177987758	GA	G	68	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
5	178293175	178293175	-	T	intronic	ZNF354B	.	.	.	1.96E-05	0.892509081	0.107471311	.	0.16272	0.10945	0.244401822	69.50931824	62.26671	1.60991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	171	5	178293175	chr5:178293175	C	CT	125	PASS	DP=171;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	179049991	179049991	C	T	intronic	HNRNPH1	.	.	.	0.999148294	0.000851699	7.16E-09	.	0.83563	.	-0.273576253	33.97027601	18.26126	0.63463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	271	5	179049991	chr5:179049991	C	T	.	PASS	DP=271;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	179050084	179050084	G	A	exonic	HNRNPH1	.	synonymous SNV	HNRNPH1:NM_001257293:exon2:c.C51T:p.G17G,HNRNPH1:NM_005520:exon2:c.C51T:p.G17G	0.999148294	0.000851699	7.16E-09	.	0.83563	.	-0.273576253	33.97027601	18.26126	0.63463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	180	5	179050084	chr5:179050084	G	A	.	PASS	DP=180;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	179150788	179150788	-	T	intronic	CANX	.	.	.	0.86247386	0.137522598	3.54E-06	.	0.78419	0.89499	-0.159704656	41.90846898	163.62404	2.79331	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	118	5	179150788	chr5:179150788	G	GT	93	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
5	180004133	180004133	C	T	UTR3	CNOT6	NM_001303241:c.*2933C>T	.	.	0.478458001	0.521329968	0.00021203	.	0.46135	0.12733	-0.291981272	33.20358575	52.51247	1.43432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	5	180004133	chr5:180004133	C	T	.	PASS	DP=26;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	180055849	180055849	T	G	intronic	FLT4	.	.	.	0.999936679	6.33E-05	4.32E-15	DISEASE: Lymphedema, hereditary, 1A (LMPH1A) [MIM:153100]: A chronic disabling condition which results in swelling of the extremities due to altered lymphatic flow. Patients with lymphedema suffer from recurrent local infections and physical impairment. {ECO:0000269|PubMed:10835628, ECO:0000269|PubMed:10856194, ECO:0000269|PubMed:16924388, ECO:0000269|PubMed:16965327, ECO:0000269|PubMed:17458866, ECO:0000269|PubMed:19289394, ECO:0000269|PubMed:26091405, ECO:0000269|PubMed:9817924}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hemangioma, capillary infantile (HCI) [MIM:602089]: A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring. {ECO:0000269|PubMed:11807987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=Plays an important role in tumor lymphangiogenesis, in cancer cell survival, migration, and formation of metastases.; 	0.19958	0.23555	0.707220641	85.53314461	835.41804	5.65903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	93	5	180055849	chr5:180055849	T	G	127	PASS	DP=93;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
5	180058748	180058748	G	-	exonic	FLT4	.	frameshift deletion	FLT4:NM_002020:exon2:c.89delC:p.P30Rfs*2,FLT4:NM_182925:exon2:c.89delC:p.P30Rfs*2	0.999936679	6.33E-05	4.32E-15	DISEASE: Lymphedema, hereditary, 1A (LMPH1A) [MIM:153100]: A chronic disabling condition which results in swelling of the extremities due to altered lymphatic flow. Patients with lymphedema suffer from recurrent local infections and physical impairment. {ECO:0000269|PubMed:10835628, ECO:0000269|PubMed:10856194, ECO:0000269|PubMed:16924388, ECO:0000269|PubMed:16965327, ECO:0000269|PubMed:17458866, ECO:0000269|PubMed:19289394, ECO:0000269|PubMed:26091405, ECO:0000269|PubMed:9817924}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hemangioma, capillary infantile (HCI) [MIM:602089]: A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring. {ECO:0000269|PubMed:11807987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=Plays an important role in tumor lymphangiogenesis, in cancer cell survival, migration, and formation of metastases.; 	0.19958	0.23555	0.707220641	85.53314461	835.41804	5.65903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	500	5	180058747	chr5:180058747	CG	C	77	PASS	DP=500;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	7402814	7402814	T	-	intronic	RIOK1	.	.	.	8.14E-07	0.909984901	0.090014285	.	0.07427	0.09451	0.778977686	87.21396556	153.59995	2.71046	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	195	6	7402813	chr6:7402813	CT	C	83	PASS	DP=195;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	10756688	10756688	T	C	intronic	TMEM14B	.	.	.	6.48E-07	0.077805418	0.922193935	.	.	0.07094	-0.073340031	48.11866006	72.00791	1.76647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	6	10756688	chr6:10756688	T	C	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	12037946	12037946	-	T	intronic	HIVEP1	.	.	.	0.999986917	1.31E-05	9.27E-17	.	0.18367	.	1.216289636	93.09389007	3060.83267	10.52275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	138	6	12037945	chr6:12037945	CT	CTT,C	43	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	12037946	12037946	T	-	intronic	HIVEP1	.	.	.	0.999986917	1.31E-05	9.27E-17	.	0.18367	.	1.216289636	93.09389007	3060.83267	10.52275	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	138	6	12037945	chr6:12037945	CT	CTT,C	43	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	13652921	13652921	-	A	intronic	RANBP9	.	.	.	0.999958496	4.15E-05	4.55E-12	.	0.77088	0.20645	-0.756778259	13.44656759	118.2155	2.36558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	88	6	13652921	chr6:13652921	G	GA	61	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	15468723	15468729	GGGTGAG	-	intronic	JARID2	.	.	.	0.999862193	0.000137807	7.01E-13	.	0.98339	0.18221	-1.741783094	2.418023119	264.05908	3.48721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	8	6	15468722	chr6:15468722	AGGGTGAG	A	58	PASS	DP=8;AN=2	GT	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	16761565	16761565	G	-	ncRNA_intronic	LOC101928433	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	387	6	16761564	chr6:16761564	AG	A	68	PASS	DP=387;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	17779922	17779922	-	A	intronic	KIF13A	.	.	.	0.999958506	4.15E-05	5.23E-19	.	0.14914	0.13297	-0.093786226	46.49681529	493.50968	4.56777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	17.87	93	6	17779922	chr6:17779922	G	GA	17.87	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	18256118	18256118	A	T	intronic	DEK	.	.	.	0.102359187	0.890489819	0.007150994	DISEASE: Note=A chromosomal aberration involving DEK is found in a subset of acute myeloid leukemia (AML); also known as acute non- lymphocytic leukemia (PubMed:1549122). Translocation t(6;9)(p23;q34) with NUP214/CAN (PubMed:1549122). It results in the formation of a DEK-NUP214 fusion gene (PubMed:1549122). {ECO:0000269|PubMed:1549122}.; 	0.89842	.	-0.381986487	27.68931352	22.40799	0.75211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	94	6	18256118	chr6:18256118	A	T	58	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	18256134	18256134	A	T	intronic	DEK	.	.	.	0.102359187	0.890489819	0.007150994	DISEASE: Note=A chromosomal aberration involving DEK is found in a subset of acute myeloid leukemia (AML); also known as acute non- lymphocytic leukemia (PubMed:1549122). Translocation t(6;9)(p23;q34) with NUP214/CAN (PubMed:1549122). It results in the formation of a DEK-NUP214 fusion gene (PubMed:1549122). {ECO:0000269|PubMed:1549122}.; 	0.89842	.	-0.381986487	27.68931352	22.40799	0.75211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	97	6	18256134	chr6:18256134	A	T	58	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	18256509	18256509	T	C	intronic	DEK	.	.	.	0.102359187	0.890489819	0.007150994	DISEASE: Note=A chromosomal aberration involving DEK is found in a subset of acute myeloid leukemia (AML); also known as acute non- lymphocytic leukemia (PubMed:1549122). Translocation t(6;9)(p23;q34) with NUP214/CAN (PubMed:1549122). It results in the formation of a DEK-NUP214 fusion gene (PubMed:1549122). {ECO:0000269|PubMed:1549122}.; 	0.89842	.	-0.381986487	27.68931352	22.40799	0.75211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	302	6	18256509	chr6:18256509	T	C	68	PASS	DP=302;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
6	24666321	24666321	A	-	intronic	TDP2	.	.	.	0.000137008	0.960870954	0.038992038	.	0.82591	0.12207	1.039913547	91.25973107	2341.47191	8.96523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	188	6	24666320	chr6:24666320	TA	T	60	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	26406255	26406255	G	A	exonic	BTN3A1	.	synonymous SNV	BTN3A1:NM_001145008:exon3:c.G204A:p.V68V,BTN3A1:NM_001145009:exon3:c.G204A:p.V68V,BTN3A1:NM_007048:exon3:c.G204A:p.V68V,BTN3A1:NM_194441:exon3:c.G204A:p.V68V	8.65E-07	0.747593221	0.252405913	.	0.06787	0.07707	0.531004228	80.87992451	647.15095	5.10575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	183	6	26406255	chr6:26406255	G	A	.	PASS	DP=183;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	26422353	26422353	C	T	ncRNA_exonic	BTN2A3P	.	.	.	.	.	.	.	0.08337	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	160	6	26422353	chr6:26422353	C	T	.	PASS	DP=160;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	27277082	27277082	C	A	exonic	POM121L2	.	synonymous SNV	POM121L2:NM_033482:exon1:c.G2868T:p.G956G	.	.	.	.	0.03374	.	.	.	4148.61055	12.78909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	78	6	27277082	chr6:27277082	C	A	.	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
6	27834598	27834598	C	A	UTR3	HIST1H1B	NM_005322:c.*29G>T	.	.	0.509138756	0.421807909	0.069053335	.	0.27585	0.20571	0.575097644	82.1656051	458.1171	4.44431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	6	27834598	chr6:27834598	C	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	27839699	27839699	C	G	exonic	HIST1H3I	.	nonsynonymous SNV	HIST1H3I:NM_003533:exon1:c.G395C:p.R132P	0.360879945	0.587736996	0.051383059	.	0.31574	.	-0.09720619	46.20193442	6.59255	0.24364	.	.	.	.	.	.	.	.	.	.	.	.	0.999	0.456	D	.	.	.	.	.	.	.	.	.	0.909	0.899	-0.099	0.801	T	0.425	0.769	T	0.200	0.867	D	7.189	0.945	34	0.993	0.568	0.760	0.369	D	c	0.431	0.468	1.0	0.983	0.243	0.034	2	4.12	0.473	7.701	0.834	0.848	0.348	1.000	0.715	0.971	0.463	16.634	0.848	Histone H2A/H2B/H3|Histone-fold	.	.	0.5	107	168	6	27839699	chr6:27839699	C	G	107	PASS	DP=168;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	28352670	28352670	C	G	intergenic	ZKSCAN3;ZSCAN12	dist=15716;dist=4057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	143	6	28352670	chr6:28352670	C	G	52	PASS	DP=143;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	28352758	28352758	C	G	intergenic	ZKSCAN3;ZSCAN12	dist=15804;dist=3969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	113	6	28352758	chr6:28352758	C	G	81	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	34495048	34495048	G	A	intronic	PACSIN1	.	.	.	0.991339222	0.008658723	2.06E-06	.	0.29818	0.20704	-0.137658575	43.57159707	108.56082	2.26081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	387	6	34495048	chr6:34495048	G	A	105	PASS	DP=387;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	35263513	35263513	C	G	UTR3	ZNF76	NM_003427:c.*488C>G;NM_001292032:c.*488C>G	.	.	5.07E-16	0.006453546	0.993546454	.	0.26454	0.10496	0.404185162	76.48619958	1199.49311	6.56948	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	130	6	35263513	chr6:35263513	C	G	.	PASS	DP=130;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	35436822	35436822	C	A	intronic	RPL10A	.	.	.	0.302378831	0.678598653	0.019022516	.	0.89137	.	-0.185391282	39.67916962	2.4123	0.08544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	198	6	35436822	chr6:35436822	C	A	.	PASS	DP=198;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	36169432	36169433	CC	-	exonic	BRPF3	.	frameshift deletion	BRPF3:NM_015695:exon2:c.1333_1334del:p.P445Qfs*42	0.993940981	0.006059011	7.11E-09	.	0.23528	0.10053	-1.059995566	7.537154989	446.92674	4.39883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	31.94	17	6	36169431	chr6:36169431	GCC	G	31.94	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	36322471	36322471	-	A	intronic	ETV7	.	.	.	2.01E-08	0.245599352	0.754400627	.	0.70881	.	1.243805243	93.41825902	433.45398	4.34535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	215	6	36322471	chr6:36322471	T	TA	76	PASS	DP=215;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/1
6	37427378	37427378	G	A	exonic	CMTR1	.	nonsynonymous SNV	CMTR1:NM_015050:exon10:c.G1013A:p.R338H	0.999294924	0.000705076	7.57E-12	.	0.3161	0.11198	-1.087493118	7.106628922	28.34808	0.90802	0.161	0.272	T	1.0	0.899	D	0.945	0.664	D	0.000	0.843	D	1	0.810	D	-0.115	0.046	N	0.97	0.425	T	-1.12	0.289	N	0.762	0.766	-1.009	0.271	T	0.103	0.379	T	0.012	0.313	T	6.359	0.878	29.4	0.999	0.999	0.988	0.868	D	c	0.597	0.689	1.0	0.983	0.722	0.854	0	6.17	0.997	6.324	0.727	1.048	0.713	1.000	0.715	1.000	0.888	19.868	0.968	Ribosomal RNA methyltransferase FtsJ domain|RrmJ-type ribose 2-O-methyltransferase domain|S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	98	110	6	37427378	chr6:37427378	G	A	98	PASS	DP=110;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	41126404	41126404	G	C	exonic	TREM2	.	synonymous SNV	TREM2:NM_001271821:exon4:c.C597G:p.L199L	2.35E-08	0.041595266	0.958404711	.	0.04385	0.1552	0.483275131	79.25218212	446.17961	4.3976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	102	6	41126404	chr6:41126404	G	C	87	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
6	42176568	42176568	C	A	intronic	MRPS10	.	.	.	0.028212146	0.922237701	0.049550153	.	0.19668	0.10229	-0.0274281	51.65723048	31.89637	1.00349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	6	42176568	chr6:42176568	C	A	.	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	43098306	43098306	A	T	exonic	PTK7	.	nonsynonymous SNV	PTK7:NM_001270398:exon5:c.A743T:p.E248V,PTK7:NM_002821:exon5:c.A719T:p.E240V,PTK7:NM_152880:exon5:c.A719T:p.E240V,PTK7:NM_152881:exon5:c.A719T:p.E240V,PTK7:NM_152882:exon5:c.A719T:p.E240V	0.975879481	0.02412051	8.65E-09	.	0.64562	0.13964	-0.766111714	13.17527719	636.95125	5.07778	0.005	0.654	D	0.599	0.764	P	0.633	0.774	P	0.000	0.843	D	1.000	0.810	D	3.16	0.888	M	4.57	0.767	T	-3.59	0.755	D	0.66	0.696	0.256	0.868	D	0.571	0.845	D	0.241	0.887	D	5.908	0.810	27.5	0.993	0.580	0.942	0.601	D	c	0.576	0.514	1.000	0.747	0.737	0.974	0	4.62	0.568	4.835	0.622	1.194	0.916	1.000	0.715	0.953	0.430	11.583	0.500	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	74	264	6	43098306	chr6:43098306	A	T	74	PASS	DP=264;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	43222886	43222886	G	A	intronic	TTBK1	.	.	.	0.997306963	0.002693036	9.81E-10	.	0.26651	0.11543	-0.459259448	23.69072895	6694.9523	17.33817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	6	43222886	chr6:43222886	G	A	.	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	43237695	43237695	-	C	intronic	TTBK1	.	.	.	0.997306963	0.002693036	9.81E-10	.	0.26651	0.11543	-0.459259448	23.69072895	6694.9523	17.33817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	322	6	43237695	chr6:43237695	G	GC	88	PASS	DP=322;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	44200534	44200534	G	T	intronic	SLC29A1	.	.	.	0.964281535	0.035704824	1.36E-05	.	0.51344	0.22208	0.573279816	82.08303845	81.44022	1.91023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	192	6	44200534	chr6:44200534	G	T	.	PASS	DP=192;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	44437514	44437514	G	A	intergenic	CDC5L;LOC105375075	dist=19353;dist=76384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	141	6	44437514	chr6:44437514	G	A	.	PASS	DP=141;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	47576839	47576839	T	-	intronic	CD2AP	.	.	.	0.813221347	0.186777009	1.64E-06	DISEASE: Focal segmental glomerulosclerosis 3 (FSGS3) [MIM:607832]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:12764198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.69543	0.37908	-0.354480518	29.42911064	262.95445	3.47978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	62	6	47576838	chr6:47576838	AT	A	39	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	48036386	48036386	G	T	exonic	PTCHD4	.	stopgain	PTCHD4:NM_001013732:exon1:c.C6A:p.C2X,PTCHD4:NM_207499:exon1:c.C6A:p.C2X	0.002760598	0.98371978	0.013519622	.	0.76784	.	-0.707227564	14.71455532	97.49459	2.13448	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.214	0.966	36	0.991	0.512	0.969	0.713	D	c	1.008	0.822	1.000	0.747	0.549	0.223	0	4.19	0.485	6.906	0.754	0.945	0.533	1.000	0.715	1.000	0.888	16.577	0.845	.	.	.	0.5	59	203	6	48036386	chr6:48036386	G	T	59	PASS	DP=203;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	49815815	49815815	G	A	intronic	CRISP1	.	.	.	0.000219402	0.741846921	0.257933677	.	0.02698	0.07066	-0.426079032	25.36565228	232.57631	3.29761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	6	49815815	chr6:49815815	G	A	.	PASS	DP=39;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	50681703	50681703	-	T	UTR5	TFAP2D	NM_172238:c.-66_-65insT	.	.	0.981586998	0.018399928	1.31E-05	.	0.75149	0.14024	0.016664174	55.21939137	509.04894	4.62407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	479	6	50681703	chr6:50681703	A	AT	86	PASS	DP=479;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	50681714	50681714	C	T	UTR5	TFAP2D	NM_172238:c.-55C>T	.	.	0.981586998	0.018399928	1.31E-05	.	0.75149	0.14024	0.016664174	55.21939137	509.04894	4.62407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	6	50681714	chr6:50681714	C	T	.	PASS	DP=48;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	51523718	51523718	C	G	intronic	PKHD1	.	.	.	2.89E-23	1	2.32E-11	.	0.08201	0.25544	0.37824847	75.51309271	3737.47294	11.94762	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	6	51523718	chr6:51523718	C	G	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	53517053	53517053	C	A	exonic	KLHL31	.	synonymous SNV	KLHL31:NM_001003760:exon3:c.G1248T:p.V416V	0.019083264	0.961463994	0.019452742	.	0.27723	0.10718	0.022122107	55.69120075	214.20925	3.15893	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	438	6	53517053	chr6:53517053	C	A	89	PASS	DP=438;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
6	57255016	57255016	-	C	intronic	PRIM2	.	.	.	5.15E-08	0.39171957	0.608280379	.	0.89222	0.08308	.	.	55.84911	1.50063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	46	6	57255016	chr6:57255016	A	AC	100	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	57393144	57393144	A	T	exonic	PRIM2	.	unknown	UNKNOWN	5.15E-08	0.39171957	0.608280379	.	0.89222	0.08308	.	.	55.84911	1.50063	.	.	.	0.134	0.257	B	0.091	0.284	B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.391	0.451	.	.	.	.	.	.	.	.	.	2.510	0.363	19.53	0.889	0.178	0.926	0.558	D	n	1.419	0.069	1.000	0.747	0.258	0.037	0	4.7	0.586	5.569	0.669	1.093	0.878	1.000	0.715	0.948	0.423	10.683	0.448	.	.	.	0.5	.	69	6	57393144	chr6:57393144	A	T	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	70048747	70048747	-	T	intronic	ADGRB3	.	.	.	.	.	.	.	0.46112	.	-1.74358502	2.394432649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	32	6	70048747	chr6:70048747	A	AT	39	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	72186673	72186673	G	C	intergenic	LINC01626;RIMS1	dist=18098;dist=409733	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	233	6	72186673	chr6:72186673	G	C	107	PASS	DP=233;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	73951959	73951959	C	T	exonic	KHDC1	.	synonymous SNV	KHDC1:NM_030568:exon3:c.G114A:p.G38G,KHDC1:NM_001251874:exon4:c.G333A:p.G111G	6.80E-05	0.49146714	0.508464847	.	0.09427	.	0.038710339	56.92380278	694.65301	5.25432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	128	6	73951959	chr6:73951959	C	T	72	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	74230807	74230807	A	-	upstream	EEF1A1	dist=52	.	.	0.984461027	0.015530359	8.61E-06	.	0.98787	0.6963	-0.273576253	33.97027601	10.98489	0.39784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	1016	6	74230806	chr6:74230806	GA	G	98	PASS	DP=1016;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	75966506	75966506	T	C	intronic	TMEM30A	.	.	.	0.040683085	0.952897895	0.00641902	.	0.2106	0.13393	-0.271755481	34.31823543	18.76838	0.64828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	24	6	75966506	chr6:75966506	T	C	85	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	76618183	76618183	T	-	intronic	MYO6	.	.	.	0.017788399	0.9822116	5.28E-10	DISEASE: Deafness, autosomal dominant, 22 (DFNA22) [MIM:606346]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA22 is progressive and postlingual, with onset during childhood. By the age of approximately 50 years, affected individuals invariably have profound sensorineural deafness. {ECO:0000269|PubMed:11468689}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 37 (DFNB37) [MIM:607821]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12687499}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, sensorineural, with hypertrophic cardiomyopathy (DFNHCM) [MIM:606346]: An autosomal dominant sensorineural deafness associated with hypertrophic cardiomyopathy. {ECO:0000269|PubMed:15060111}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26137	0.31948	-0.369255208	28.25548478	419.15519	4.27823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	25	6	76618182	chr6:76618182	AT	A	58	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	80194766	80194766	-	A	UTR3	LCA5	NM_181714:c.*1954_*1955insT;NM_001122769:c.*1954_*1955insT	.	.	0.004282174	0.994223193	0.001494632	DISEASE: Leber congenital amaurosis 5 (LCA5) [MIM:604537]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:17546029, ECO:0000269|PubMed:18000884, ECO:0000269|PubMed:18334959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1667	0.11088	-0.130380821	44.03161123	3626.18224	11.68454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	19	6	80194766	chr6:80194766	G	GA	42	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	80775100	80775100	A	T	intergenic	TTK;BCKDHB	dist=22856;dist=41227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	388	6	80775100	chr6:80775100	A	T	.	PASS	DP=388;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	83877682	83877682	G	A	exonic	DOPEY1	.	synonymous SNV	DOPEY1:NM_015018:exon39:c.G7194A:p.P2398P,DOPEY1:NM_001199942:exon40:c.G7227A:p.P2409P	0.999995778	4.22E-06	4.05E-22	.	0.3292	0.09427	-1.052752328	7.619721632	1415.32398	7.03165	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	205	6	83877682	chr6:83877682	G	A	51	PASS	DP=205;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	89601638	89601638	T	A	intronic	RNGTT	.	.	.	0.763456431	0.236540369	3.20E-06	.	0.84113	0.19698	-0.558357437	19.54470394	54.7413	1.48185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	128	6	89601638	chr6:89601638	T	A	52	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	99374464	99374464	T	C	exonic	FBXL4	.	nonsynonymous SNV	FBXL4:NM_012160:exon3:c.A401G:p.Q134R,FBXL4:NM_001278716:exon4:c.A401G:p.Q134R	0.007908799	0.989068654	0.003022548	.	0.42917	0.09922	-0.933156985	9.54824251	139.80195	2.5782	0.513	0.074	T	0.167	0.270	B	0.062	0.255	B	0.000	0.843	D	0.912	0.364	D	0.345	0.112	N	2.57	0.136	T	-0.45	0.148	N	0.104	0.130	-0.946	0.417	T	0.006	0.021	T	0.008	0.208	T	1.392	0.231	12.75	0.931	0.221	0.940	0.595	D	c	-0.263	-0.027	0.800	0.241	0.707	0.730	0	4.33	0.509	3.785	0.549	1.061	0.807	1.000	0.715	1.000	0.888	12.079	0.528	.	.	.	0.5	.	47	6	99374464	chr6:99374464	T	C	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	102247559	102247559	G	A	exonic	GRIK2	.	nonsynonymous SNV	GRIK2:NM_001166247:exon7:c.G988A:p.V330M,GRIK2:NM_021956:exon7:c.G988A:p.V330M,GRIK2:NM_175768:exon7:c.G988A:p.V330M	0.994567954	0.005432045	1.10E-09	DISEASE: Mental retardation, autosomal recessive 6 (MRT6) [MIM:611092]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. In contrast to syndromic or specific mental retardation which also present with associated physical, neurological and/or psychiatric manifestations, intellectual deficiency is the only primary symptom of non-syndromic mental retardation. MRT6 patients display mild to severe mental retardation and psychomotor development delay in early childhood. Patients do not have neurologic problems, congenital malformations, or facial dysmorphism. Body height, weight, and head circumference are normal. {ECO:0000269|PubMed:17847003}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.53627	.	-1.131590109	6.481481481	129.48869	2.48041	0.043	0.473	D	0.998	0.715	D	0.936	0.654	D	0.000	0.843	D	1.000	0.588	D	2.27	0.647	M	-1.63	0.825	D	-0.74	0.383	N	0.671	0.710	0.230	0.864	D	0.594	0.855	D	0.101	0.774	D	6.493	0.895	31	0.999	0.982	0.991	0.912	D	c	0.794	0.811	1.000	0.747	0.554	0.283	0	5.44	0.793	9.602	0.976	1.048	0.713	1.000	0.715	1.000	0.888	19.253	0.939	Periplasmic binding protein-like I|Receptor, ligand binding region	.	.	0.5	.	50	6	102247559	chr6:102247559	G	A	.	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	107474777	107474777	-	A	UTR3	PDSS2	NM_020381:c.*1045_*1046insT	.	.	1.90E-05	0.695884938	0.304096105	DISEASE: Coenzyme Q10 deficiency, primary, 3 (COQ10D3) [MIM:614652]: A fatal encephalomyopathic form of coenzyme Q10 deficiency with nephrotic syndrome. Coenzyme Q10 deficiency is an autosomal recessive disorder with variable manifestations consistent with 5 major phenotypes. The phenotypes include an encephalomyopathic form with seizures and ataxia; a multisystem infantile form with encephalopathy, cardiomyopathy and renal failure; a predominantly cerebellar form with ataxia and cerebellar atrophy; Leigh syndrome with growth retardation; and an isolated myopathic form. {ECO:0000269|PubMed:17186472}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07675	0.11464	-0.069700724	48.54328851	310.44253	3.74923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	48	6	107474777	chr6:107474777	G	GA	55	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	111527961	111527961	C	T	intronic	SLC16A10	.	.	.	0.067607006	0.918407882	0.013985112	.	0.08076	0.10491	-0.049474214	50.01179523	216.00513	3.17412	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	19	6	111527961	chr6:111527961	C	T	.	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	114292040	114292040	T	-	exonic	HDAC2	.	frameshift deletion	HDAC2:NM_001527:exon1:c.33delA:p.V12Sfs*18	0.999390588	0.000609409	3.17E-09	.	0.95245	0.84052	-0.119252484	44.53880632	722.29744	5.33473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	1334	6	114292039	chr6:114292039	CT	C,CTT	84	PASS	DP=1334;AN=6	GT	0/1	./.	./.	./.	0/2	./.	./.	./.	./.	./.	./.	0/1
6	114292040	114292040	-	T	exonic	HDAC2	.	frameshift insertion	HDAC2:NM_001527:exon1:c.32dupA:p.V12Sfs*7	0.999390588	0.000609409	3.17E-09	.	0.95245	0.84052	-0.119252484	44.53880632	722.29744	5.33473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	1334	6	114292039	chr6:114292039	CT	C,CTT	84	PASS	DP=1334;AN=6	GT	0/1	./.	./.	./.	0/2	./.	./.	./.	./.	./.	./.	0/1
6	118320548	118320548	T	C	intronic	SLC35F1	.	.	.	0.38850627	0.611072726	0.000421004	.	0.29195	0.10809	0.060756528	58.52795471	23.09728	0.77064	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	120	6	118320548	chr6:118320548	T	C	91	PASS	DP=120;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	123696766	123696766	G	C	exonic	TRDN	.	nonsynonymous SNV	TRDN:NM_001251987:exon19:c.C1260G:p.D420E,TRDN:NM_006073:exon19:c.C1257G:p.D419E	1.82E-10	0.82694144	0.17305856	DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness (CPVT5) [MIM:615441]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, or sudden death after physical activity or emotional stress. Some patients have muscle weakness. {ECO:0000269|PubMed:22422768}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18235	0.15914	1.976952171	97.61146497	4408.1144	13.27537	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.327	0.142	N	1.000	0.090	P	-0.805	0.016	N	2.57	0.136	T	0.22	0.047	N	0.027	0.009	-0.910	0.469	T	0.004	0.012	T	0.018	0.402	T	0.655	0.156	8.529	0.298	0.016	0.425	0.267	N	c	-1.057	-0.785	0.000	0.052	0.487	0.133	0	4.14	0.477	0.616	0.239	-0.339	0.072	1.000	0.715	0.987	0.523	9.685	0.391	.	.	.	0.5	83	49	6	123696766	chr6:123696766	G	C	83	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	129511373	129511373	T	C	exonic	LAMA2	.	synonymous SNV	LAMA2:NM_000426:exon11:c.T1491C:p.C497C,LAMA2:NM_001079823:exon11:c.T1491C:p.C497C	1.18E-24	0.999999998	2.28E-09	DISEASE: Merosin-deficient congenital muscular dystrophy 1A (MDC1A) [MIM:607855]: Characterized by difficulty walking, hypotonia, proximal weakness, hyporeflexia, and white matter hypodensity on MRI. {ECO:0000269|PubMed:11591858, ECO:0000269|PubMed:12552556}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30049	0.63589	0.497724973	79.64142486	3368.62227	11.11486	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	19	6	129511373	chr6:129511373	T	C	54	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
6	133119524	133119524	G	A	intronic	SLC18B1	.	.	.	3.95E-10	0.179498685	0.820501314	.	0.13733	.	-0.110153916	45.48832272	589.95485	4.92467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	236	6	133119524	chr6:133119524	G	A	125	PASS	DP=236;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	133135715	133135715	C	A	UTR5	RPS12	NM_001016:c.-193C>A	.	.	0.827435142	0.168866928	0.00369793	.	0.26171	0.19444	0.035072054	56.2514744	9.87588	0.36197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	206	6	133135715	chr6:133135715	C	A	.	PASS	DP=206;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	134490613	134490613	-	A	UTR3	SGK1	NM_001143678:c.*792_*793insT;NM_005627:c.*792_*793insT;NM_001291995:c.*792_*793insT;NM_001143677:c.*792_*793insT;NM_001143676:c.*792_*793insT	.	.	0.986448163	0.013551585	2.52E-07	.	0.67964	0.57708	-0.288341872	33.41589998	105.09569	2.21804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	24.58	60	6	134490613	chr6:134490613	C	CA	24.58	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	134758928	134758932	TCCTT	-	ncRNA_exonic	LINC01010	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	137	6	134758927	chr6:134758927	GTCCTT	G	118	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	136582417	136582417	G	A	exonic	BCLAF1	.	nonsynonymous SNV	BCLAF1:NM_001077440:exon11:c.C2590T:p.R864C,BCLAF1:NM_001077441:exon12:c.C2224T:p.R742C,BCLAF1:NM_001301038:exon12:c.C2737T:p.R913C,BCLAF1:NM_014739:exon12:c.C2743T:p.R915C	.	.	.	.	0.85841	0.18154	1.987926294	97.63505544	3652.78199	11.74717	0.032	0.469	D	1.0	0.899	D	0.988	0.850	D	0.000	0.629	D	1.000	0.588	D	0	0.065	N	4.26	0.161	T	-1.2	0.320	N	0.874	0.863	-0.997	0.309	T	0.084	0.329	T	.	.	.	4.562	0.611	24.4	0.992	0.542	0.972	0.729	D	c	0.262	0.417	1.000	0.747	0.707	0.730	0	5.71	0.890	5.465	0.662	1.048	0.713	1.000	0.715	1.000	0.888	18.034	0.892	.	.	.	0.5	99	83	6	136582417	chr6:136582417	G	A	99	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
6	137325757	137325757	C	G	splicing	IL20RA	NM_014432:exon6:c.864+1G>C;NM_001278723:exon5:c.531+1G>C;NM_001278722:exon6:c.717+1G>C;NM_001278724:exon5:c.465+1G>C	.	.	0.007575317	0.977001984	0.015422699	.	0.13796	0.11768	0.376678994	75.50719509	564.20193	4.82236	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.099	0.687	25.3	0.994	0.638	0.965	0.693	D	c	1.062	0.903	0.999	0.399	0.054	0.004	0	5.29	0.743	4.088	0.572	0.790	0.321	1.000	0.715	0.991	0.552	14.451	0.668	.	.	.	0.5	70	42	6	137325757	chr6:137325757	C	G	70	PASS	DP=42;AN=2	GT	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	148835564	148835564	G	A	exonic	SASH1	.	synonymous SNV	SASH1:NM_001346507:exon2:c.G117A:p.V39V,SASH1:NM_001346508:exon2:c.G117A:p.V39V,SASH1:NM_001346505:exon9:c.G699A:p.V233V,SASH1:NM_015278:exon9:c.G834A:p.V278V,SASH1:NM_001346506:exon10:c.G462A:p.V154V	0.003254445	0.996741817	3.74E-06	.	0.3689	0.11167	-0.562239385	19.06699693	3939.62918	12.40945	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	6	148835564	chr6:148835564	G	A	.	PASS	DP=68;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	150052786	150052786	G	A	exonic	NUP43	.	synonymous SNV	NUP43:NM_198887:exon7:c.C876T:p.S292S	3.54E-06	0.803512486	0.196483972	.	0.48504	.	-0.381986487	27.68931352	249.75864	3.40424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	60	6	150052786	chr6:150052786	G	A	60	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	157150537	157150537	G	C	exonic	ARID1B	.	nonsynonymous SNV	ARID1B:NM_001346813:exon2:c.G1719C:p.M573I,ARID1B:NM_017519:exon2:c.G1719C:p.M573I,ARID1B:NM_020732:exon2:c.G1719C:p.M573I	0.99994993	5.01E-05	4.93E-16	DISEASE: Mental retardation, autosomal dominant 12 (MRD12) [MIM:614562]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD12 patients present with moderate to severe psychomotor retardation, and most show evidence of muscular hypotonia. In many patients, expressive speech is more severely affected than receptive function. Additional common findings include short stature, abnormal head shape and low-set, posteriorly rotated, and abnormally shaped ears, downslanting palpebral fissures, a bulbous nasal tip, a thin upper lip, minor teeth anomalies, and brachydactyly or single palmar creases. Autistic features are uncommon. {ECO:0000269|PubMed:22405089, ECO:0000269|PubMed:22426308, ECO:0000269|PubMed:22426309}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15152	0.12645	-2.622392448	0.802075961	623.55868	5.03581	0.116	0.371	T	0.0	0.026	B	0.001	0.063	B	0.001	0.426	D	0.627	0.327	D	1.385	0.346	L	4.69	0.022	T	-1.83	0.441	N	0.294	0.354	-0.890	0.489	T	0.003	0.010	T	0.007	0.194	T	2.186	0.324	17.42	0.970	0.312	0.982	0.804	D	c	-0.350	-0.161	1.000	0.747	0.707	0.730	0	4.22	0.490	4.549	0.602	0.124	0.212	1.000	0.715	0.993	0.574	15.343	0.739	.	.	.	0.5	124	310	6	157150537	chr6:157150537	G	C	124	PASS	DP=310;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	158049415	158049415	C	G	exonic	ZDHHC14	.	nonsynonymous SNV	ZDHHC14:NM_024630:exon4:c.C600G:p.N200K,ZDHHC14:NM_153746:exon4:c.C600G:p.N200K	0.982366558	0.01763106	2.38E-06	.	.	0.10652	0.350995466	74.37485256	67.03988	1.69272	0.001	0.912	D	1.0	0.899	D	0.995	0.971	D	0.000	0.843	D	1	0.810	D	3.71	0.948	H	1.72	0.266	T	-5.84	0.884	D	0.488	0.535	-0.374	0.729	T	0.221	0.584	T	0.072	0.714	D	6.510	0.897	31	0.998	0.908	0.972	0.734	D	c	0.872	0.798	1.000	0.747	0.706	0.609	0	5.56	0.836	5.746	0.681	0.935	0.490	1.000	0.715	1.000	0.888	19.535	0.952	Zinc finger, DHHC-type, palmitoyltransferase	.	.	0.5	108	152	6	158049415	chr6:158049415	C	G	108	PASS	DP=152;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	158923222	158923222	G	A	exonic	TULP4	.	nonsynonymous SNV	TULP4:NM_020245:exon13:c.G2527A:p.A843T	0.999936803	6.32E-05	5.19E-13	.	0.23566	.	-2.528819961	0.896437839	581.49333	4.88756	0.074	0.346	T	1.0	0.899	D	0.99	0.774	D	0.000	0.629	D	1.000	0.810	D	1.655	0.426	L	-0.28	0.676	T	-0.52	0.162	N	0.592	0.619	-0.263	0.760	T	0.394	0.748	T	0.210	0.873	D	1.613	0.255	13.92	0.997	0.839	0.984	0.822	D	c	0.417	0.308	1.000	0.747	0.646	0.450	0	5.07	0.680	4.960	0.631	1.045	0.669	1.000	0.715	0.685	0.306	18.087	0.893	.	.	.	0.5	.	34	6	158923222	chr6:158923222	G	A	.	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	159655276	159655276	C	T	exonic	FNDC1	.	synonymous SNV	FNDC1:NM_032532:exon11:c.C3732T:p.L1244L	3.07E-07	0.999968249	3.14E-05	.	0.1324	0.09503	2.671889479	98.84996461	6512.79761	16.93629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	431	6	159655276	chr6:159655276	C	T	94	PASS	DP=431;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	159670100	159670100	A	G	exonic	FNDC1	.	nonsynonymous SNV	FNDC1:NM_032532:exon16:c.A4720G:p.T1574A	3.07E-07	0.999968249	3.14E-05	.	0.1324	0.09503	2.671889479	98.84996461	6512.79761	16.93629	0.042	0.416	D	0.15	0.264	B	0.066	0.260	B	0.264	0.153	N	0.227	0.342	P	0.17	0.090	N	3.04	0.088	T	0.15	0.053	N	0.022	0.214	-0.917	0.460	T	0.005	0.015	T	.	.	.	0.592	0.151	8.100	0.783	0.118	0.015	0.050	N	c	-1.004	-1.009	1.000	0.454	0.487	0.133	0	-3.14	0.049	-0.991	0.038	-1.017	0.021	0.000	0.063	0.012	0.117	4.383	0.107	.	.	.	0.5	104	29	6	159670100	chr6:159670100	A	G	104	PASS	DP=29;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
6	160524764	160524764	-	T	intronic	IGF2R	.	.	.	0.999999196	8.04E-07	3.52E-23	.	0.14522	0.70508	-1.928748556	1.904930408	3396.75143	11.16393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	426	6	160524764	chr6:160524764	C	CT	82	PASS	DP=426;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
6	161121626	161121626	C	T	intergenic	LPA;PLG	dist=34219;dist=1599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	343	6	161121626	chr6:161121626	C	T	90	PASS	DP=343;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
6	167622276	167622276	C	A	intergenic	TCP10L2;UNC93A	dist=25880;dist=82527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	233	6	167622276	chr6:167622276	C	A	.	PASS	DP=233;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
6	168323593	168323593	A	-	exonic	AFDN	.	frameshift deletion	AFDN:NM_001207008:exon20:c.2897delA:p.G967Vfs*18,AFDN:NM_001040000:exon21:c.2945delA:p.G983Vfs*17,AFDN:NM_001291964:exon21:c.2822delA:p.G942Vfs*18	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.41	28	6	168323592	chr6:168323592	GA	G	12.41	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
6	168355108	168355108	T	-	intronic	AFDN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	139	6	168355107	chr6:168355107	CT	C,CTT	54	PASS	DP=139;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	0/2	./.	./.	./.	./.
6	168355108	168355108	-	T	intronic	AFDN	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	139	6	168355107	chr6:168355107	CT	C,CTT	54	PASS	DP=139;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	0/2	./.	./.	./.	./.
6	168439334	168439334	C	G	exonic	KIF25	.	nonsynonymous SNV	KIF25:NM_005355:exon5:c.C419G:p.A140G,KIF25:NM_030615:exon5:c.C419G:p.A140G	3.75E-09	0.098368373	0.901631624	.	0.04864	0.08777	1.936492053	97.50530786	587.48576	4.91639	0.586	0.059	T	0.002	0.090	B	0.004	0.139	B	0.715	0.063	N	1	0.090	N	-0.515	0.026	N	-0.68	0.726	T	0.13	0.055	N	0.063	0.097	-1.043	0.163	T	0.049	0.209	T	0.014	0.346	T	-0.926	0.035	0.023	0.088	0.001	0.012	0.043	N	c	-1.111	-1.079	0.119	0.168	0.646	0.450	0	0.843	0.180	1.421	0.342	-0.166	0.106	0.005	0.169	0.000	0.016	6.239	0.199	Kinesin motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	130	329	6	168439334	chr6:168439334	C	G	130	PASS	DP=329;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
6	169625360	169625392	CCTGGTTGGCGTTGGAGATGTAGGGGCAGTTGT	-	exonic	THBS2	.	nonframeshift deletion	THBS2:NM_003247:exon18:c.2621_2653del:p.D874_Q884del	0.245000803	0.754998734	4.63E-07	.	0.74508	0.52113	-0.470420436	23.04788865	378.07788	4.09997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	16	6	169625359	chr6:169625359	GCCTGGTTGGCGTTGGAGATGTAGGGGCAGTTGT	G	42	PASS	DP=16;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	959589	959589	A	C	intronic	ADAP1	.	.	.	0.657926854	0.341835895	0.000237251	.	0.17754	0.12827	-0.933156985	9.54824251	48.02044	1.34684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	303	7	959589	chr7:959589	A	C	109	PASS	DP=303;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	1538589	1538589	C	-	intronic	INTS1	.	.	.	0.224121375	0.775878625	1.91E-10	.	0.15585	.	-5.050633482	0.070771408	422.05224	4.29253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	41	7	1538588	chr7:1538588	AC	A	62	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	1579980	1579980	C	-	exonic	MAFK	.	frameshift deletion	MAFK:NM_002360:exon3:c.440delC:p.T148Pfs*168	0.557286406	0.391983491	0.050730103	.	0.18771	0.13279	0.125076652	62.7388535	24.39748	0.80257	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	73	7	1579979	chr7:1579979	TC	T	58	PASS	DP=73;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	2284095	2284095	G	A	intronic	NUDT1	.	.	.	1.29E-09	0.01462753	0.985372469	.	0.4263	0.18011	-0.025608647	51.91672564	148.84611	2.6606	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	7	2284095	chr7:2284095	G	A	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	2284171	2284171	G	A	intronic	NUDT1	.	.	.	1.29E-09	0.01462753	0.985372469	.	0.4263	0.18011	-0.025608647	51.91672564	148.84611	2.6606	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	7	2284171	chr7:2284171	G	A	.	PASS	DP=68;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	2296436	2296436	C	A	intronic	SNX8	.	.	.	0.165170969	0.831782233	0.003046798	.	0.16684	0.11365	0.376678994	75.50719509	357.15648	4.00401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	416	7	2296436	chr7:2296436	C	A	95	PASS	DP=416;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	4722356	4722356	C	A	exonic	FOXK1	.	synonymous SNV	FOXK1:NM_001037165:exon1:c.C417A:p.G139G	0.962670921	0.037313855	1.52E-05	.	0.15597	0.12005	-1.107723888	6.829440906	888.10645	5.80361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	595	7	4722356	chr7:4722356	C	A	112	PASS	DP=595;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	4843227	4843227	C	A	exonic	RADIL	.	nonsynonymous SNV	RADIL:NM_018059:exon11:c.G2449T:p.G817C	1.31E-12	0.089137837	0.910862163	.	.	.	0.236922632	68.73083274	3259.52862	10.87748	0.016	0.518	D	0.989	0.637	D	0.584	0.559	P	0.736	0.064	N	1	0.090	N	0.69	0.170	N	3.33	0.062	T	-1.68	0.401	N	0.25	0.305	-1.030	0.203	T	0.019	0.080	T	0.045	0.621	D	4.241	0.568	23.9	0.988	0.468	0.022	0.064	N	c	-0.880	-1.102	0.005	0.108	0.646	0.450	0	-1.01	0.096	-1.559	0.022	-0.823	0.031	0.000	0.063	0.016	0.126	2.796	0.050	.	.	.	0.5	.	206	7	4843227	chr7:4843227	C	A	.	PASS	DP=206;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	5959485	5959485	G	A	exonic	CCZ1	.	nonsynonymous SNV	CCZ1:NM_015622:exon12:c.G994A:p.V332I	0.994694688	0.005304692	6.20E-07	.	0.2029	.	-0.159704656	41.90846898	84.72538	1.9605	0.44	0.092	T	0.001	0.067	B	0.004	0.093	B	0.045	0.236	N	1	0.090	P	.	.	.	.	.	.	-0.17	0.096	N	0.043	0.023	-1.016	0.249	T	0.000	0.000	T	.	.	.	-1.013	0.031	0.015	0.631	0.069	0.021	0.061	N	c	-1.612	-1.668	0.000	0.057	0.706	0.609	0	-5.07	0.027	0.961	0.287	-0.569	0.046	0.134	0.232	0.001	0.043	9.832	0.399	.	ENSG00000122674.8	Colon_Transverse	0.5	147	576	7	5959485	chr7:5959485	G	A	147	PASS	DP=576;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	6068175	6068175	A	G	intronic	EIF2AK1	.	.	.	0.000121058	0.997788588	0.002090354	.	0.13551	0.29413	0.356452144	74.62845011	1369.09001	6.94068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	98	7	6068175	chr7:6068175	A	G	43	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	6470059	6470059	-	T	intronic	DAGLB	.	.	.	1.65E-06	0.962595118	0.037403231	.	0.12004	0.10395	0.033039107	55.85633404	760.30438	5.46562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	214	7	6470058	chr7:6470058	CT	CTT,C	80	PASS	DP=214;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
7	6470059	6470059	T	-	intronic	DAGLB	.	.	.	1.65E-06	0.962595118	0.037403231	.	0.12004	0.10395	0.033039107	55.85633404	760.30438	5.46562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	214	7	6470058	chr7:6470058	CT	CTT,C	80	PASS	DP=214;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
7	6470111	6470111	C	A	exonic	DAGLB	.	nonsynonymous SNV	DAGLB:NM_139179:exon6:c.G929T:p.C310F	1.65E-06	0.962595118	0.037403231	.	0.12004	0.10395	0.033039107	55.85633404	760.30438	5.46562	0.032	0.477	D	0.038	0.202	B	0.034	0.212	B	0.000	0.843	N	1	0.810	D	2.855	0.832	M	0.31	0.588	T	-6.27	0.906	D	0.915	0.916	-0.585	0.655	T	0.275	0.647	T	0.076	0.725	D	5.215	0.704	25.6	0.970	0.315	0.960	0.667	D	c	0.311	0.405	1.000	0.747	0.632	0.408	0	4.85	0.622	7.186	0.771	0.932	0.445	1.000	0.715	0.995	0.604	18.316	0.901	Alpha/Beta hydrolase fold	.	.	0.5	.	106	7	6470111	chr7:6470111	C	A	.	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	6899511	6899511	C	A	intergenic	CCZ1B;MIR3683	dist=33585;dist=207084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	475	7	6899511	chr7:6899511	C	A	98	PASS	DP=475;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	6977554	6977554	C	A	intergenic	CCZ1B;MIR3683	dist=111628;dist=129041	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	551	7	6977554	chr7:6977554	C	A	.	PASS	DP=551;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	11091407	11091407	G	A	exonic	PHF14	.	synonymous SNV	PHF14:NM_014660:exon14:c.G2481A:p.T827T	0.20653924	0.793444436	1.63E-05	.	0.53698	0.10653	-0.532670911	20.78320359	132.45351	2.50445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	7	11091407	chr7:11091407	G	A	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	11521436	11521436	G	C	exonic	THSD7A	.	nonsynonymous SNV	THSD7A:NM_015204:exon7:c.C1996G:p.L666V	0.999280749	0.000719251	1.10E-16	.	0.27361	0.08944	-1.308377521	4.865534324	3259.76198	10.88292	0.082	0.332	T	0.995	0.657	D	0.951	0.672	D	0.000	0.843	D	1.000	0.537	D	1.54	0.390	L	0.73	0.507	T	-2.31	0.513	N	0.412	0.643	-0.889	0.491	T	0.200	0.557	T	0.026	0.495	D	4.447	0.595	24.2	0.998	0.877	0.960	0.667	D	c	0.140	0.132	0.023	0.135	0.707	0.730	0	3.16	0.353	2.020	0.404	-0.213	0.100	1.000	0.715	0.991	0.552	10.944	0.463	.	.	.	0.5	90	168	7	11521436	chr7:11521436	G	C	90	PASS	DP=168;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	18631214	18631214	C	A	exonic	HDAC9	.	nonsynonymous SNV	HDAC9:NM_001204147:exon4:c.C389A:p.P130Q,HDAC9:NM_001204148:exon4:c.C398A:p.P133Q,HDAC9:NM_058176:exon4:c.C482A:p.P161Q,HDAC9:NM_178425:exon4:c.C491A:p.P164Q,HDAC9:NM_001204145:exon5:c.C482A:p.P161Q,HDAC9:NM_001204146:exon5:c.C491A:p.P164Q,HDAC9:NM_001321874:exon5:c.C491A:p.P164Q,HDAC9:NM_001321875:exon5:c.C497A:p.P166Q,HDAC9:NM_001321876:exon5:c.C491A:p.P164Q,HDAC9:NM_001321877:exon5:c.C491A:p.P164Q,HDAC9:NM_001321878:exon5:c.C482A:p.P161Q,HDAC9:NM_001321879:exon5:c.C491A:p.P164Q,HDAC9:NM_001321884:exon5:c.C491A:p.P164Q,HDAC9:NM_001321885:exon5:c.C506A:p.P169Q,HDAC9:NM_001321888:exon5:c.C482A:p.P161Q,HDAC9:NM_001321890:exon5:c.C482A:p.P161Q,HDAC9:NM_001321891:exon5:c.C482A:p.P161Q,HDAC9:NM_001321895:exon5:c.C491A:p.P164Q,HDAC9:NM_001321898:exon5:c.C506A:p.P169Q,HDAC9:NM_001321900:exon5:c.C482A:p.P161Q,HDAC9:NM_001321901:exon5:c.C491A:p.P164Q,HDAC9:NM_001321902:exon5:c.C491A:p.P164Q,HDAC9:NM_014707:exon5:c.C482A:p.P161Q,HDAC9:NM_178423:exon5:c.C482A:p.P161Q,HDAC9:NM_001321868:exon6:c.C548A:p.P183Q,HDAC9:NM_001321869:exon6:c.C557A:p.P186Q,HDAC9:NM_001321870:exon6:c.C548A:p.P183Q,HDAC9:NM_001321871:exon6:c.C563A:p.P188Q,HDAC9:NM_001321872:exon6:c.C557A:p.P186Q,HDAC9:NM_001321873:exon6:c.C557A:p.P186Q,HDAC9:NM_001321886:exon6:c.C389A:p.P130Q,HDAC9:NM_001321887:exon6:c.C398A:p.P133Q,HDAC9:NM_001321889:exon6:c.C398A:p.P133Q,HDAC9:NM_001321893:exon6:c.C482A:p.P161Q,HDAC9:NM_001321894:exon6:c.C491A:p.P164Q,HDAC9:NM_001321896:exon6:c.C398A:p.P133Q,HDAC9:NM_001321897:exon6:c.C491A:p.P164Q,HDAC9:NM_001321899:exon6:c.C491A:p.P164Q,HDAC9:NM_001204144:exon7:c.C608A:p.P203Q	0.998375125	0.001624875	1.17E-11	DISEASE: Note=A chromosomal aberration involving HDAC9 is found in a family with Peters anomaly. Translocation t(1;7)(q41;p21) with TGFB2 resulting in lack of HDAC9 protein. {ECO:0000269|PubMed:12706107}.; 	0.93284	0.71489	-1.061810361	7.519462137	78.75617	1.8735	0.015	0.524	D	0.553	0.500	P	0.146	0.460	B	0.000	0.629	D	0.634	0.345	D	1.7	0.440	L	0.97	0.570	T	-1.32	0.350	N	0.36	0.437	-0.586	0.654	T	0.165	0.502	T	0.011	0.284	T	3.935	0.530	23.5	0.990	0.494	0.980	0.783	D	c	0.357	0.452	1.000	0.747	0.732	0.924	0	5.74	0.900	1.680	0.370	0.935	0.490	1.000	0.715	1.000	0.888	13.172	0.589	.	.	.	0.5	.	29	7	18631214	chr7:18631214	C	A	.	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	19748658	19748658	C	A	UTR5	TWISTNB	NM_001002926:c.-19G>T	.	.	0.309424388	0.672567774	0.018007838	.	0.14338	0.12628	-0.404032746	26.53338051	60.1892	1.57562	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	173	7	19748658	chr7:19748658	C	A	.	PASS	DP=173;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	20784999	20784999	G	A	exonic	ABCB5	.	nonsynonymous SNV	ABCB5:NM_178559:exon17:c.G2032A:p.D678N,ABCB5:NM_001163941:exon26:c.G3367A:p.D1123N	1.17E-23	0.02699293	0.97300707	.	0.14704	0.09307	4.176155702	99.69922151	9731.34505	21.45196	0.049	0.398	D	0.014	0.156	B	0.021	0.205	B	0.238	0.158	N	1.000	0.213	N	1.33	0.334	L	-2.71	0.906	D	-2.7	0.643	D	0.042	0.051	-0.249	0.764	T	0.576	0.847	D	0.015	0.352	T	2.891	0.408	21.8	0.997	0.792	0.780	0.381	D	c	-0.348	-0.280	0.971	0.292	0.666	0.498	0	2.85	0.322	3.426	0.523	0.974	0.594	1.000	0.715	0.949	0.424	8.517	0.322	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	60	7	20784999	chr7:20784999	G	A	.	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	21747481	21747481	-	T	intronic	DNAH11	.	.	.	.	.	.	DISEASE: Kartagener syndrome (KTGS) [MIM:244400]: An autosomal recessive disorder characterized by the association of primary ciliary dyskinesia with situs inversus. Clinical features include recurrent respiratory infections, bronchiectasis, infertility, and lateral transposition of the viscera of the thorax and abdomen. The situs inversus is most often total, although it can be partial in some cases (isolated dextrocardia or isolated transposition of abdominal viscera). {ECO:0000269|PubMed:12142464, ECO:0000269|PubMed:18022865, ECO:0000269|PubMed:25186273}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ciliary dyskinesia, primary, 7 (CILD7) [MIM:611884]: A disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia; reduced fertility is often observed in male patients due to abnormalities of sperm tails. Half of the patients exhibit randomization of left-right body asymmetry and situs inversus, due to dysfunction of monocilia at the embryonic node. Primary ciliary dyskinesia associated with situs inversus is referred to as Kartagener syndrome. {ECO:0000269|PubMed:12142464, ECO:0000269|PubMed:18022865}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12513	0.12171	.	.	20704.35568	30.36052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	122	7	21747481	chr7:21747481	A	AT	66	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	21856068	21856068	C	G	intronic	DNAH11	.	.	.	.	.	.	DISEASE: Kartagener syndrome (KTGS) [MIM:244400]: An autosomal recessive disorder characterized by the association of primary ciliary dyskinesia with situs inversus. Clinical features include recurrent respiratory infections, bronchiectasis, infertility, and lateral transposition of the viscera of the thorax and abdomen. The situs inversus is most often total, although it can be partial in some cases (isolated dextrocardia or isolated transposition of abdominal viscera). {ECO:0000269|PubMed:12142464, ECO:0000269|PubMed:18022865, ECO:0000269|PubMed:25186273}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ciliary dyskinesia, primary, 7 (CILD7) [MIM:611884]: A disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia; reduced fertility is often observed in male patients due to abnormalities of sperm tails. Half of the patients exhibit randomization of left-right body asymmetry and situs inversus, due to dysfunction of monocilia at the embryonic node. Primary ciliary dyskinesia associated with situs inversus is referred to as Kartagener syndrome. {ECO:0000269|PubMed:12142464, ECO:0000269|PubMed:18022865}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12513	0.12171	.	.	20704.35568	30.36052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	37	7	21856068	chr7:21856068	C	G	89	PASS	DP=37;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	23625204	23625204	C	T	ncRNA_exonic	CLK2P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	278	7	23625204	chr7:23625204	C	T	92	PASS	DP=278;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	26247985	26247985	T	-	intronic	CBX3	.	.	.	0.633200403	0.359860988	0.006938609	.	0.65881	0.2066	0.057118534	57.99716914	6.1306	0.23144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	67	7	26247984	chr7:26247984	CT	C	106	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	26576535	26576535	T	C	ncRNA_exonic	KIAA0087	.	.	.	.	.	.	.	.	.	.	.	17.91578	0.62616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	39	7	26576535	chr7:26576535	T	C	108	PASS	DP=39;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	27150104	27150104	G	C	exonic	HOXA3	.	synonymous SNV	HOXA3:NM_030661:exon2:c.C156G:p.L52L,HOXA3:NM_153631:exon3:c.C156G:p.L52L	0.931754221	0.067906759	0.00033902	.	0.56281	0.12883	-0.005381972	53.50908233	83.09844	1.93755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	1160	7	27150104	chr7:27150104	G	C	142	PASS	DP=1160;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	27209045	27209045	C	G	ncRNA_exonic	HOXA10-AS	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	80	7	27209045	chr7:27209045	C	G	128	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	27236537	27236537	C	T	UTR3	HOXA13	NM_000522:c.*1280G>A	.	.	.	.	.	DISEASE: Hand-foot-genital syndrome (HFG) [MIM:140000]: A disorder characterized by limb and genitourinary anomalies. Clinical features include small feet with unusually short great toes and abnormal thumbs. Females with the disorder have duplication of the genital tract. {ECO:0000269|PubMed:10839976, ECO:0000269|PubMed:12073020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Guttmacher syndrome (GUTTS) [MIM:176305]: Dominantly inherited combination of distal limb and genital tract abnormalities. It has several features in common with hand-foot- genital syndrome, including hypoplastic first digits and hypospadias. Typical features not seen in hand-foot-genital syndrome include postaxial polydactyly of the hands and uniphalangeal second toes with absent nails. {ECO:0000269|PubMed:11968094}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.68929	.	.	.	122.9053	2.41409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	7	27236537	chr7:27236537	C	T	.	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	27236557	27236557	-	T	UTR3	HOXA13	NM_000522:c.*1259_*1260insA	.	.	.	.	.	DISEASE: Hand-foot-genital syndrome (HFG) [MIM:140000]: A disorder characterized by limb and genitourinary anomalies. Clinical features include small feet with unusually short great toes and abnormal thumbs. Females with the disorder have duplication of the genital tract. {ECO:0000269|PubMed:10839976, ECO:0000269|PubMed:12073020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Guttmacher syndrome (GUTTS) [MIM:176305]: Dominantly inherited combination of distal limb and genital tract abnormalities. It has several features in common with hand-foot- genital syndrome, including hypoplastic first digits and hypospadias. Typical features not seen in hand-foot-genital syndrome include postaxial polydactyly of the hands and uniphalangeal second toes with absent nails. {ECO:0000269|PubMed:11968094}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.68929	.	.	.	122.9053	2.41409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	164	7	27236557	chr7:27236557	G	GT	62	PASS	DP=164;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	./.
7	28547355	28547355	G	T	exonic	CREB5	.	synonymous SNV	CREB5:NM_182899:exon3:c.G192T:p.R64R,CREB5:NM_004904:exon4:c.G270T:p.R90R,CREB5:NM_182898:exon4:c.G291T:p.R97R	0.989844565	0.010154821	6.14E-07	.	0.7763	.	-0.670411825	15.61689078	30.64753	0.97477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	256	7	28547355	chr7:28547355	G	T	77	PASS	DP=256;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	29771637	29771637	C	A	intergenic	DPY19L2P3;WIPF3	dist=43778;dist=74533	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	7	29771637	chr7:29771637	C	A	.	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	30795291	30795291	G	T	exonic	INMT	.	nonsynonymous SNV	INMT:NM_001199219:exon3:c.G613T:p.V205L,INMT:NM_006774:exon3:c.G616T:p.V206L	0.000120278	0.385695	0.614184722	.	0.10895	0.11082	1.976952171	97.61146497	4681.43934	13.79634	0.009	0.574	D	0.986	0.596	D	0.874	0.603	P	0.003	0.355	N	0.909	0.364	D	1.91	0.513	L	3.92	0.035	T	-2.07	0.473	N	0.284	0.420	-1.073	0.088	T	0.023	0.100	T	0.002	0.050	T	4.535	0.607	24.3	0.994	0.604	0.773	0.377	D	c	0.333	0.248	1.000	0.747	0.625	0.395	0	2.78	0.316	2.354	0.435	0.857	0.375	1.000	0.715	0.905	0.384	8.857	0.342	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	.	74	7	30795291	chr7:30795291	G	T	.	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	32861170	32861171	AT	-	intergenic	LINC00997;DPY19L1P2	dist=58634;dist=4743	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	51	7	32861169	chr7:32861169	CAT	C	92	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	36465572	36465572	A	G	intronic	ANLN	.	.	.	0.923521452	0.076478547	1.29E-09	DISEASE: Focal segmental glomerulosclerosis 8 (FSGS8) [MIM:616032]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:24676636}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.52557	0.15234	-1.146380093	6.334041047	5386.34454	15.13898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	46	33	7	36465572	chr7:36465572	A	G	46	PASS	DP=33;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	42000586	42000586	-	T	UTR3	GLI3	NM_000168:c.*3341_*3342insA	.	.	0.999994739	5.26E-06	6.01E-15	DISEASE: Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]: Autosomal dominant disorder affecting limb and craniofacial development. It is characterized by pre- and postaxial polydactyly, syndactyly of fingers and toes, macrocephaly and hypertelorism. {ECO:0000269|PubMed:10441342, ECO:0000269|PubMed:12414818, ECO:0000269|PubMed:12794692, ECO:0000269|PubMed:9302279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pallister-Hall syndrome (PHS) [MIM:146510]: An autosomal dominant disorder characterized by a wide range of clinical manifestations. Clinical features include hypothalamic hamartoma, pituitary dysfunction, central or postaxial polydactyly, and syndactyly. Malformations are frequent in the viscera, e.g. anal atresia, bifid uvula, congenital heart malformations, pulmonary or renal dysplasia. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial A1 (PAPA1) [MIM:174200]: A condition characterized by the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type A, the extra digit is well-formed and articulates with the fifth or a sixth metacarpal/metatarsal. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial B (PAPB) [MIM:174200]: A condition characterized by an extra digit in the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type B the extra digit is not well formed and is frequently in the form of a skin. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly preaxial 4 (POP4) [MIM:174700]: Preaxial polydactyly (i.e., polydactyly on the radial/tibial side of the hand/foot) covers a heterogeneous group of entities. In preaxial polydactyly type IV, the thumb shows only the mildest degree of duplication, and syndactyly of various degrees affects fingers 3 and 4. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.9964	0.10708	-1.310171316	4.83014862	2831.41391	10.04419	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	568	7	42000586	chr7:42000586	A	AT	61	PASS	DP=568;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	44054022	44054022	A	G	ncRNA_intronic	POLR2J4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	161	7	44054022	chr7:44054022	A	G	.	PASS	DP=161;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	44080619	44080619	-	CTT	ncRNA_exonic	LINC00957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	314	7	44080619	chr7:44080619	A	ACTT	140	PASS	DP=314;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	44097842	44097842	C	G	exonic	DBNL	.	nonsynonymous SNV	DBNL:NM_001284313:exon5:c.C358G:p.R120G,DBNL:NM_001284315:exon5:c.C382G:p.R128G,DBNL:NM_001014436:exon7:c.C667G:p.R223G,DBNL:NM_001122956:exon7:c.C667G:p.R223G,DBNL:NM_014063:exon7:c.C667G:p.R223G	0.070981914	0.926323701	0.002694385	.	0.20108	0.72014	-0.023789244	52.09365416	77.70496	1.85644	0.015	0.574	D	0.799	0.577	P	0.401	0.585	B	0.001	0.393	N	0.999	0.506	D	3.4	0.918	M	1.8	0.338	T	-3.83	0.790	D	0.238	0.523	-1.076	0.082	T	0.092	0.352	T	0.079	0.733	D	6.393	0.883	29.6	0.996	0.729	0.519	0.288	D	c	-0.122	-0.110	1.000	0.747	0.722	0.854	0	4.05	0.462	-0.098	0.109	0.935	0.490	0.008	0.178	0.996	0.625	7.320	0.255	ADF-H/Gelsolin-like domain|Actin-depolymerising factor homology domain	.	.	0.5	117	118	7	44097842	chr7:44097842	C	G	117	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	44282825	44282825	G	T	intronic	CAMK2B	.	.	.	0.468620194	0.531370436	9.37E-06	.	0.30429	0.29938	-0.624497208	17.16206653	1301.92267	6.78858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	7	44282825	chr7:44282825	G	T	.	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	44553195	44553195	C	A	exonic	NPC1L1	.	nonsynonymous SNV	NPC1L1:NM_001101648:exon19:c.G3850T:p.V1284L,NPC1L1:NM_013389:exon20:c.G3931T:p.V1311L	1.37E-10	0.983840205	0.016159795	.	0.12878	0.1868	1.377872212	94.53880632	380.20775	4.11083	0.116	0.294	T	0.0	0.026	B	0.0	0.013	B	0.000	0.002	N	1	0.090	N	0	0.065	N	-0.01	0.628	T	-0.15	0.093	N	0.033	0.031	-1.012	0.264	T	0.121	0.423	T	0.004	0.088	T	0.564	0.148	7.901	0.895	0.183	0.023	0.066	N	c	-1.137	-1.156	0.000	0.052	0.554	0.246	0	0.684	0.171	0.212	0.172	-0.345	0.071	0.000	0.063	0.000	0.016	7.574	0.269	.	.	.	0.5	.	80	7	44553195	chr7:44553195	C	A	.	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	44805177	44805177	G	A	exonic	ZMIZ2	.	synonymous SNV	ZMIZ2:NM_174929:exon14:c.G2163A:p.Q721Q,ZMIZ2:NM_001300959:exon15:c.G2067A:p.Q689Q,ZMIZ2:NM_031449:exon16:c.G2241A:p.Q747Q	0.999620382	0.000379618	4.09E-11	.	0.21655	0.09565	-0.08446956	47.15145081	1705.86311	7.61894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	7	44805177	chr7:44805177	G	A	.	PASS	DP=46;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	45108047	45108047	G	T	exonic	CCM2	.	nonsynonymous SNV	CCM2:NM_001167934:exon4:c.G304T:p.D102Y,CCM2:NM_001029835:exon5:c.G541T:p.D181Y,CCM2:NM_031443:exon5:c.G478T:p.D160Y	0.483088351	0.515904177	0.001007472	DISEASE: Cerebral cavernous malformations 2 (CCM2) [MIM:603284]: A congenital vascular anomaly of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters. {ECO:0000269|PubMed:14624391, ECO:0000269|PubMed:14740320, ECO:0000269|PubMed:22415356}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17979	0.11593	-0.376526807	28.10804435	1216.01154	6.59576	0.005	0.654	D	0.983	0.637	D	0.736	0.614	P	0.000	0.466	D	1.000	0.810	D	1.79	0.469	L	1.05	0.400	T	-2.96	0.617	D	0.612	0.690	-0.672	0.617	T	0.205	0.564	T	0.052	0.652	D	6.036	0.831	28.0	0.995	0.697	0.996	0.982	D	c	0.653	0.624	1.000	0.747	0.706	0.609	0	4.2	0.486	9.077	0.934	1.048	0.713	1.000	0.715	1.000	0.888	15.476	0.751	PH domain-like|PTB/PI domain	.	.	0.5	80	410	7	45108047	chr7:45108047	G	T	80	PASS	DP=410;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	45956171	45956171	C	T	exonic	IGFBP3	.	synonymous SNV	IGFBP3:NM_000598:exon3:c.G726A:p.K242K,IGFBP3:NM_001013398:exon3:c.G744A:p.K248K	0.362251902	0.586835044	0.050913054	.	0.28872	0.82225	.	.	2102.84042	8.44477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	7	45956171	chr7:45956171	C	T	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	47979921	47979921	A	-	intronic	PKD1L1	.	.	.	1.72E-23	0.999996492	3.51E-06	.	0.07124	.	2.171086137	98.04788865	3392.60955	11.14655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	100	7	47979920	chr7:47979920	GA	G	81	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	48965281	48965281	G	T	ncRNA_exonic	CDC14C	.	.	.	.	.	.	.	.	0.09972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	392	7	48965281	chr7:48965281	G	T	105	PASS	DP=392;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	51287470	51287470	A	G	exonic	COBL	.	synonymous SNV	COBL:NM_001287436:exon2:c.T213C:p.S71S,COBL:NM_001287438:exon2:c.T213C:p.S71S,COBL:NM_001346441:exon2:c.T213C:p.S71S,COBL:NM_001346442:exon2:c.T213C:p.S71S,COBL:NM_001346443:exon2:c.T213C:p.S71S,COBL:NM_001346444:exon2:c.T213C:p.S71S,COBL:NM_015198:exon2:c.T213C:p.S71S	0.982698637	0.017301344	1.88E-08	.	0.36124	0.11214	0.554715755	81.55225289	758.96902	5.45703	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	200	7	51287470	chr7:51287470	A	G	155	PASS	DP=200;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	55242391	55242391	G	C	intronic	EGFR	.	.	.	0.99866453	0.00133547	2.97E-13	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:16672372}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]: A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99968	0.98895	-2.160861741	1.439018636	119.9504	2.38669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	88	7	55242391	chr7:55242391	G	C	122	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
7	55242466	55242480	GAATTAAGAGAAGCA	-	exonic	EGFR	.	nonframeshift deletion	EGFR:NM_001346941:exon13:c.1435_1449del:p.E479_A483del,EGFR:NM_001346897:exon18:c.2101_2115del:p.E701_A705del,EGFR:NM_001346899:exon18:c.2101_2115del:p.E701_A705del,EGFR:NM_001346898:exon19:c.2236_2250del:p.E746_A750del,EGFR:NM_001346900:exon19:c.2077_2091del:p.E693_A697del,EGFR:NM_005228:exon19:c.2236_2250del:p.E746_A750del	0.99866453	0.00133547	2.97E-13	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:16672372}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]: A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99968	0.98895	-2.160861741	1.439018636	119.9504	2.38669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	77	7	55242465	chr7:55242465	GGAATTAAGAGAAGCA	G	81	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	55259515	55259515	T	G	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_001346941:exon15:c.T1772G:p.L591R,EGFR:NM_001346897:exon20:c.T2438G:p.L813R,EGFR:NM_001346899:exon20:c.T2438G:p.L813R,EGFR:NM_001346898:exon21:c.T2573G:p.L858R,EGFR:NM_001346900:exon21:c.T2414G:p.L805R,EGFR:NM_005228:exon21:c.T2573G:p.L858R	0.99866453	0.00133547	2.97E-13	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:16672372}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]: A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99968	0.98895	-2.160861741	1.439018636	119.9504	2.38669	0.0	0.912	D	0.999	0.899	D	0.956	0.916	D	0.000	0.504	D	1.000	0.810	D	3.65	0.943	H	-2.83	0.913	D	-5.23	0.839	D	0.989	0.993	0.987	0.970	D	0.881	0.960	D	0.698	0.975	D	6.930	0.933	33	0.998	0.896	0.981	0.798	D	c	0.927	0.868	1.000	0.747	0.741	0.978	0	5.71	0.890	7.960	0.873	1.061	0.807	1.000	0.715	1.000	0.888	14.811	0.695	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain	.	.	0.5	113	124	7	55259515	chr7:55259515	T	G	113	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	55268916	55268916	C	T	exonic	EGFR	.	synonymous SNV	EGFR:NM_001346941:exon19:c.C2181T:p.D727D,EGFR:NM_001346897:exon24:c.C2847T:p.D949D,EGFR:NM_001346899:exon24:c.C2847T:p.D949D,EGFR:NM_001346898:exon25:c.C2982T:p.D994D,EGFR:NM_001346900:exon25:c.C2823T:p.D941D,EGFR:NM_005228:exon25:c.C2982T:p.D994D	0.99866453	0.00133547	2.97E-13	DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:15118125, ECO:0000269|PubMed:16533793, ECO:0000269|PubMed:16672372}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Inflammatory skin and bowel disease, neonatal, 2 (NISBD2) [MIM:616069]: A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized. {ECO:0000269|PubMed:24691054}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99968	0.98895	-2.160861741	1.439018636	119.9504	2.38669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	541	7	55268916	chr7:55268916	C	T	.	PASS	DP=541;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	56149274	56149274	G	C	intronic	PHKG1	.	.	.	3.58E-10	0.170265638	0.829734362	.	0.17418	0.1871	-1.418232832	4.110639302	78.27585	1.86564	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	141	7	56149274	chr7:56149274	G	C	119	PASS	DP=141;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	56879527	56879527	A	G	ncRNA_exonic	LOC401357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	84	7	56879527	chr7:56879527	A	G	90	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
7	57069658	57069658	G	T	intergenic	MIR4283-1;ZNF479	dist=46087;dist=117668	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	7	57069658	chr7:57069658	G	T	.	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	57245934	57245934	C	A	ncRNA_exonic	GUSBP10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	386	7	57245934	chr7:57245934	C	A	64	PASS	DP=386;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	57247689	57247689	C	A	ncRNA_exonic	GUSBP10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	761	7	57247689	chr7:57247689	C	A	132	PASS	DP=761;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	63020525	63020525	C	A	intergenic	LOC100287834;MIR4283-1	dist=161106;dist=60943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	959	7	63020525	chr7:63020525	C	A	121	PASS	DP=959;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	63020733	63020733	C	G	intergenic	LOC100287834;MIR4283-1	dist=161314;dist=60735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	501	7	63020733	chr7:63020733	C	G	134	PASS	DP=501;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	63033363	63033363	G	T	intergenic	LOC100287834;MIR4283-1	dist=173944;dist=48105	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	511	7	63033363	chr7:63033363	G	T	121	PASS	DP=511;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	63033371	63033371	C	T	intergenic	LOC100287834;MIR4283-1	dist=173952;dist=48097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	503	7	63033371	chr7:63033371	C	T	122	PASS	DP=503;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	63225779	63225779	C	T	intergenic	MIR4283-1;ZNF722P	dist=144232;dist=233405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	171	7	63225779	chr7:63225779	C	T	122	PASS	DP=171;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	63232336	63232336	G	T	intergenic	MIR4283-1;ZNF722P	dist=150789;dist=226848	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	471	7	63232336	chr7:63232336	G	T	103	PASS	DP=471;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	63537783	63537783	G	A	exonic	ZNF727	.	nonsynonymous SNV	ZNF727:NM_001159522:exon4:c.G356A:p.R119H	1.56E-07	0.065227374	0.93477247	.	.	.	2.34827224	98.40764331	260.10396	3.46546	.	.	.	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	1.51	0.383	L	.	.	.	.	.	.	0.041	0.021	-0.923	0.452	T	0.000	0.000	T	.	.	.	0.297	0.123	5.666	0.811	0.131	0.000	0.004	N	c	-1.681	-1.761	0.000	0.064	0.487	0.133	0	-1.15	0.092	-0.122	0.105	-0.609	0.043	0.000	0.063	0.079	0.180	.	.	.	.	.	0.5	129	278	7	63537783	chr7:63537783	G	A	129	PASS	DP=278;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	63538100	63538100	A	G	exonic	ZNF727	.	nonsynonymous SNV	ZNF727:NM_001159522:exon4:c.A673G:p.K225E	1.56E-07	0.065227374	0.93477247	.	.	.	2.34827224	98.40764331	260.10396	3.46546	.	.	.	0.001	0.067	B	0.002	0.063	B	.	.	.	0.999	0.212	N	-1.56	0.005	N	.	.	.	.	.	.	0.073	0.062	-0.943	0.422	T	0.014	0.058	T	0.006	0.155	T	-0.057	0.088	2.070	0.755	0.107	0.000	0.002	N	c	-1.104	-1.127	0.001	0.078	0.487	0.133	0	-1.49	0.082	3.387	0.520	-0.892	0.027	1.000	0.715	0.082	0.182	3.985	0.089	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	86	57	7	63538100	chr7:63538100	A	G	86	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	63673455	63673455	-	T	intronic	ZNF735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	163	7	63673455	chr7:63673455	C	CT	83	PASS	DP=163;AN=4	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	64168649	64168649	T	G	exonic	ZNF107	.	nonsynonymous SNV	ZNF107:NM_001282360:exon3:c.T2078G:p.I693R,ZNF107:NM_001282359:exon4:c.T2174G:p.I725R,ZNF107:NM_001013746:exon5:c.T1967G:p.I656R,ZNF107:NM_016220:exon7:c.T1967G:p.I656R	7.59E-17	0.000568738	0.999431262	.	.	.	0.158037129	64.85020052	284.42435	3.61089	1.0	0.010	T	0.01	0.144	B	0.03	0.205	B	.	.	.	0.713	0.335	D	-1.22	0.008	N	2.68	0.124	T	-0.01	0.072	N	0.34	0.401	-0.943	0.421	T	0.006	0.021	T	0.005	0.119	T	0.149	0.108	4.131	0.765	0.111	0.000	0.001	N	c	-1.321	-1.277	0.001	0.073	0.706	0.609	0	-2.54	0.059	-0.920	0.041	-1.237	0.015	0.000	0.063	0.031	0.148	2.106	0.034	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	59	24	7	64168649	chr7:64168649	T	G	59	PASS	DP=24;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	64498715	64498715	-	GGAGGCGGAG	upstream	CCT6P3	dist=17	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	26	7	64498715	chr7:64498715	T	TGGAGGCGGAG	42	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	64838858	64838873	CAAGAACTTGGAGGTT	-	UTR5	ZNF92	NM_001287534:c.-24398_-24383del-;NM_001287532:c.-53_-38del-;NM_152626:c.-53_-38del-;NM_001287533:c.-24398_-24383del-;NM_007139:c.-14938_-14923del-	.	.	9.99E-08	0.176620877	0.823379023	.	0.1653	0.0977	0.174625237	65.9648502	1743.34182	7.7071	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	734	7	64838857	chr7:64838857	GCAAGAACTTGGAGGTT	G	105	PASS	DP=734;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	65257835	65257835	C	G	intergenic	LOC441242;VKORC1L1	dist=22038;dist=80251	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	156	177	7	65257835	chr7:65257835	C	G	156	PASS	DP=177;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	65445227	65445227	T	A	exonic	GUSB	.	nonsynonymous SNV	GUSB:NM_000181:exon2:c.A380T:p.H127L,GUSB:NM_001284290:exon2:c.A380T:p.H127L	4.07E-05	0.997935444	0.002023856	DISEASE: Mucopolysaccharidosis 7 (MPS7) [MIM:253220]: An autosomal recessive lysosomal storage disease characterized by inability to degrade glucuronic acid-containing glycosaminoglycans. The phenotype is highly variable, ranging from severe lethal hydrops fetalis to mild forms with survival into adulthood. Most patients with the intermediate phenotype show hepatomegaly, skeletal anomalies, coarse facies, and variable degrees of mental impairment. {ECO:0000269|PubMed:12522561, ECO:0000269|PubMed:12859417, ECO:0000269|PubMed:1702266, ECO:0000269|PubMed:7573038, ECO:0000269|PubMed:7633414, ECO:0000269|PubMed:7680524, ECO:0000269|PubMed:8089138, ECO:0000269|PubMed:8111412, ECO:0000269|PubMed:8111413, ECO:0000269|PubMed:8644704, ECO:0000269|PubMed:8707294, ECO:0000269|PubMed:9099834, ECO:0000269|PubMed:9490302}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1733	.	-0.821100135	11.88369899	22.67372	0.75898	0.052	0.390	T	1.0	0.899	D	0.977	0.722	D	0.000	0.843	D	1	0.810	D	2.975	0.857	M	-2.44	0.888	D	-7.29	0.944	D	0.901	0.894	0.834	0.948	D	0.829	0.943	D	0.475	0.948	D	5.659	0.771	26.7	0.964	0.293	0.958	0.661	D	c	0.688	0.592	1.000	0.747	0.722	0.854	0	5.22	0.722	7.419	0.792	1.024	0.645	1.000	0.715	0.853	0.356	14.303	0.658	Galactose-binding domain-like|Glycosyl hydrolases family 2, sugar binding domain	.	.	0.5	.	135	7	65445227	chr7:65445227	T	A	.	PASS	DP=135;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	65445258	65445258	T	A	exonic	GUSB	.	nonsynonymous SNV	GUSB:NM_000181:exon2:c.A349T:p.T117S,GUSB:NM_001284290:exon2:c.A349T:p.T117S,GUSB:NM_001293105:exon2:c.A20T:p.H7L	4.07E-05	0.997935444	0.002023856	DISEASE: Mucopolysaccharidosis 7 (MPS7) [MIM:253220]: An autosomal recessive lysosomal storage disease characterized by inability to degrade glucuronic acid-containing glycosaminoglycans. The phenotype is highly variable, ranging from severe lethal hydrops fetalis to mild forms with survival into adulthood. Most patients with the intermediate phenotype show hepatomegaly, skeletal anomalies, coarse facies, and variable degrees of mental impairment. {ECO:0000269|PubMed:12522561, ECO:0000269|PubMed:12859417, ECO:0000269|PubMed:1702266, ECO:0000269|PubMed:7573038, ECO:0000269|PubMed:7633414, ECO:0000269|PubMed:7680524, ECO:0000269|PubMed:8089138, ECO:0000269|PubMed:8111412, ECO:0000269|PubMed:8111413, ECO:0000269|PubMed:8644704, ECO:0000269|PubMed:8707294, ECO:0000269|PubMed:9099834, ECO:0000269|PubMed:9490302}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1733	.	-0.821100135	11.88369899	22.67372	0.75898	0.617	0.060	T	0.192	0.278	B	0.111	0.300	B	0.000	0.452	D	1	0.090	N	1.92	0.515	L	-3.46	0.945	D	-1.2	0.346	N	0.161	0.193	0.020	0.827	D	0.724	0.906	D	0.245	0.889	D	-0.461	0.058	0.275	0.913	0.200	0.495	0.282	N	c	-0.440	-0.430	1.000	0.747	0.707	0.730	0	5.22	0.722	2.719	0.467	1.024	0.645	0.189	0.240	0.057	0.169	10.354	0.429	Galactose-binding domain-like|Glycosyl hydrolases family 2, sugar binding domain	.	.	0.5	.	123	7	65445258	chr7:65445258	T	A	.	PASS	DP=123;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	66463196	66463196	T	-	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	200	7	66463195	chr7:66463195	AT	A	70	PASS	DP=200;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	66703239	66703239	T	-	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	417	7	66703238	chr7:66703238	AT	A,ATT	72	PASS	DP=417;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
7	66703239	66703239	-	T	intronic	TYW1	.	.	.	0.000457249	0.999231545	0.000311206	.	0.12951	0.08688	-1.173870472	5.99197924	2883.67083	10.17398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	417	7	66703238	chr7:66703238	AT	A,ATT	72	PASS	DP=417;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
7	66764425	66764426	AC	-	ncRNA_intronic	PMS2P4	.	.	.	.	.	.	.	0.0654	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	64	7	66764424	chr7:66764424	TAC	T	50	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	72338211	72338211	G	A	ncRNA_intronic	SPDYE7P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	114	7	72338211	chr7:72338211	G	A	.	PASS	DP=114;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	72341068	72341068	C	A	intergenic	SPDYE7P;POM121	dist=1412;dist=8838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	168	7	72341068	chr7:72341068	C	A	.	PASS	DP=168;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	72341070	72341070	T	C	intergenic	SPDYE7P;POM121	dist=1414;dist=8836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	162	7	72341070	chr7:72341070	T	C	.	PASS	DP=162;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	72361246	72361246	A	T	UTR5	POM121	NM_001257190:c.-35705A>T;NM_172020:c.-35705A>T	.	.	.	.	.	.	0.2255	0.08649	-0.33061537	30.82094834	663.23352	5.16151	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	484	7	72361246	chr7:72361246	A	T	116	PASS	DP=484;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	72640078	72640078	G	A	ncRNA_intronic	NCF1B	.	.	.	.	.	.	.	.	0.11535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	151	182	7	72640078	chr7:72640078	G	A	151	PASS	DP=182;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	73530070	73530070	G	T	intronic	LIMK1	.	.	.	0.990896287	0.009103618	9.51E-08	DISEASE: Note=LIMK1 is located in the Williams-Beuren syndrome (WBS) critical region. WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region.; 	0.30864	0.32739	-0.821100135	11.88369899	175.30019	2.8795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	102	7	73530070	chr7:73530070	G	T	.	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	73814774	73814774	G	A	exonic	CLIP2	.	synonymous SNV	CLIP2:NM_032421:exon14:c.G2850A:p.R950R,CLIP2:NM_003388:exon15:c.G2955A:p.R985R	0.999881647	0.000118353	1.18E-11	DISEASE: Note=CLIP2 is located in the Williams-Beuren syndrome (WBS) critical region (PubMed:9799601). WBS results from a hemizygous deletion of several genes on chromosome 7q11.23, thought to arise as a consequence of unequal crossing over between highly homologous low-copy repeat sequences flanking the deleted region. Haploinsufficiency of CLIP2 may be the cause of certain cardiovascular and musculo-skeletal abnormalities observed in the disease. However, it has been demonstrated that haploinsufficiency of this gene alone is not sufficient to cause any of the cognitive or facial features of WBS (PubMed:22608712). {ECO:0000305|PubMed:22608712, ECO:0000305|PubMed:9799601}.; 	0.13125	.	-1.186862251	5.90351498	632.85889	5.0685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	703	7	73814774	chr7:73814774	G	A	122	PASS	DP=703;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	74573036	74573036	C	G	ncRNA_intronic	NCF1C	.	.	.	.	.	.	.	0.17774	0.11639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	442	7	74573036	chr7:74573036	C	G	118	PASS	DP=442;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	74573061	74573061	G	-	ncRNA_exonic	NCF1C	.	.	.	.	.	.	.	0.17774	0.11639	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	570	7	74573060	chr7:74573060	CG	C	120	PASS	DP=570;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	75141604	75141604	C	G	ncRNA_intronic	PMS2P3	.	.	.	.	.	.	.	0.17911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	258	7	75141604	chr7:75141604	C	G	120	PASS	DP=258;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	75684340	75684340	G	T	intronic	MDH2	.	.	.	0.177605136	0.809688717	0.012706147	.	0.32327	0.90548	-0.334253673	30.70299599	208.93323	3.11958	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	65	7	75684340	chr7:75684340	G	T	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	76069902	76069902	G	C	exonic	ZP3	.	nonsynonymous SNV	ZP3:NM_001110354:exon7:c.G1034C:p.R345T,ZP3:NM_007155:exon8:c.G881C:p.R294T	0.001596815	0.88505152	0.113351664	.	0.2396	0.20208	0.775339069	87.13729653	870.97448	5.74737	0.263	0.164	T	0.002	0.197	B	0.004	0.176	B	0.499	0.120	U	1	0.090	N	1.175	0.300	L	2.41	0.252	T	-2.4	0.527	N	0.034	0.346	-0.987	0.332	T	0.030	0.131	T	.	.	.	-1.381	0.020	0.003	0.447	0.034	0.042	0.097	N	c	-1.589	-1.705	0.999	0.386	0.644	0.439	0	-8.56	0.008	-0.279	0.084	-0.405	0.062	0.000	0.063	0.000	0.016	12.211	0.535	Zona pellucida domain	.	.	0.5	64	37	7	76069902	chr7:76069902	G	C	64	PASS	DP=37;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	76610356	76610356	C	-	ncRNA_exonic	DTX2P1-UPK3BP1-PMS2P11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	770	7	76610355	chr7:76610355	AC	A	107	PASS	DP=770;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	76681186	76681186	G	T	ncRNA_exonic	PMS2P9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	325	7	76681186	chr7:76681186	G	T	.	PASS	DP=325;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	76991911	76991911	T	-	exonic	GSAP	.	frameshift deletion	GSAP:NM_001350900:exon11:c.293delA:p.Y98Sfs*20,GSAP:NM_001350901:exon11:c.293delA:p.Y98Sfs*20,GSAP:NM_001350898:exon12:c.881delA:p.Y294Sfs*20,GSAP:NM_001350896:exon13:c.938delA:p.Y313Sfs*20,GSAP:NM_001350897:exon13:c.938delA:p.Y313Sfs*20,GSAP:NM_001350899:exon13:c.938delA:p.Y313Sfs*20,GSAP:NM_017439:exon13:c.938delA:p.Y313Sfs*20	3.60E-16	0.241435267	0.758564733	.	.	.	0.268267497	70.64166077	2346.20682	8.97223	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	34	7	76991910	chr7:76991910	GT	G	87	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	84594250	84594253	AAGG	-	intergenic	LOC101927378;SEMA3D	dist=380616;dist=30619	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	189	7	84594249	chr7:84594249	AAAGG	A	80	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	87138689	87138689	T	A	exonic	ABCB1	.	nonsynonymous SNV	ABCB1:NM_001348946:exon26:c.A3391T:p.I1131F,ABCB1:NM_000927:exon27:c.A3391T:p.I1131F,ABCB1:NM_001348944:exon28:c.A3391T:p.I1131F,ABCB1:NM_001348945:exon30:c.A3601T:p.I1201F	0.734473812	0.265526186	1.52E-09	DISEASE: Inflammatory bowel disease 13 (IBD13) [MIM:612244]: A chronic, relapsing inflammation of the gastrointestinal tract with a complex etiology. It is subdivided into Crohn disease and ulcerative colitis phenotypes. Crohn disease may affect any part of the gastrointestinal tract from the mouth to the anus, but most frequently it involves the terminal ileum and colon. Bowel inflammation is transmural and discontinuous; it may contain granulomas or be associated with intestinal or perianal fistulas. In contrast, in ulcerative colitis, the inflammation is continuous and limited to rectal and colonic mucosal layers; fistulas and granulomas are not observed. Both diseases include extraintestinal inflammation of the skin, eyes, or joints. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.58236	0.67981	0.099178678	60.75725407	402.73587	4.20979	0.0	0.912	D	1.0	0.899	D	0.974	0.971	D	0.000	0.843	D	1	0.810	D	2.53	0.740	M	-3.17	0.931	D	-3.81	0.718	D	0.975	0.976	1.016	0.975	D	0.904	0.968	D	0.381	0.930	D	7.172	0.944	34	0.989	0.473	0.986	0.850	D	c	0.920	0.887	1.000	0.747	0.638	0.428	0	6.06	0.983	8.009	0.880	1.061	0.807	1.000	0.715	0.999	0.750	15.797	0.781	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	50	67	7	87138689	chr7:87138689	T	A	50	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	87323210	87323210	T	-	intronic	ABCB1;RUNDC3B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	29	7	87323209	chr7:87323209	AT	A	50	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	87323220	87323220	A	T	intronic	ABCB1;RUNDC3B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	112	7	87323220	chr7:87323220	A	T	59	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	90226055	90226055	C	-	intronic	CDK14	.	.	.	0.476260128	0.52352424	0.000215631	.	0.45755	0.11073	-0.514264485	21.41424864	102.95947	2.19295	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	1125	7	90226054	chr7:90226054	GC	G	94	PASS	DP=1125;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	92765209	92765209	C	T	exonic	SAMD9L	.	nonsynonymous SNV	SAMD9L:NM_001303500:exon4:c.G76A:p.D26N,SAMD9L:NM_001350083:exon4:c.G76A:p.D26N,SAMD9L:NM_001303496:exon5:c.G76A:p.D26N,SAMD9L:NM_001303498:exon5:c.G76A:p.D26N,SAMD9L:NM_001350085:exon5:c.G76A:p.D26N,SAMD9L:NM_152703:exon5:c.G76A:p.D26N,SAMD9L:NM_001303497:exon6:c.G76A:p.D26N,SAMD9L:NM_001350082:exon6:c.G76A:p.D26N,SAMD9L:NM_001350084:exon6:c.G76A:p.D26N	3.80E-10	0.921807367	0.078192632	.	0.12163	0.0905	-0.033100763	50.56027365	662.11912	5.15496	0.142	0.267	T	0.919	0.489	P	0.59	0.486	P	0.011	0.297	N	1	0.090	N	2.015	0.552	M	1.96	0.838	T	-1.06	0.456	N	0.037	0.017	-0.535	0.674	T	0.449	0.784	T	0.055	0.661	D	0.893	0.179	10.04	0.993	0.566	0.026	0.071	N	c	-0.522	-0.646	0.006	0.112	0.707	0.730	0	1.86	0.244	0.045	0.138	-0.041	0.124	0.000	0.063	0.657	0.300	5.984	0.185	Sterile alpha motif domain|Sterile alpha motif/pointed domain	.	.	0.5	.	64	7	92765209	chr7:92765209	C	T	.	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	94027043	94027043	-	T	intronic	COL1A2	.	.	.	0.999754944	0.000245056	9.66E-16	DISEASE: Ehlers-Danlos syndrome 7B (EDS7B) [MIM:130060]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations. {ECO:0000269|PubMed:1577745, ECO:0000269|PubMed:2394758, ECO:0000269|PubMed:3680255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. {ECO:0000269|PubMed:16705691, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. {ECO:0000269|PubMed:10627137, ECO:0000269|PubMed:1284475, ECO:0000269|PubMed:1339453, ECO:0000269|PubMed:1385413, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1874719, ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:2777764, ECO:0000269|PubMed:2914942, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:7891382, ECO:0000269|PubMed:7906591, ECO:0000269|PubMed:7959683, ECO:0000269|PubMed:8182080, ECO:0000269|Ref.33}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form (EDSCV) [MIM:225320]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. In addition to joint laxity, skin hyperextensibility and friability, and abnormal scar formation, patients have mitral valve prolapse and insufficiency, mitral regurgitation, and aortic insufficiency. {ECO:0000269|PubMed:16816023}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:10408781, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:7520724, ECO:0000269|PubMed:7720740, ECO:0000269|PubMed:7749416, ECO:0000269|PubMed:7860070, ECO:0000269|PubMed:7881420, ECO:0000269|PubMed:8081394, ECO:0000269|PubMed:8444468, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:8800927, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:1642148, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:2052622, ECO:0000269|PubMed:2064612, ECO:0000269|PubMed:2897363, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8401517, ECO:0000269|PubMed:8800927}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving COL1A2 may be a cause of lipoblastomas, which are benign tumors resulting from transformation of adipocytes, usually diagnosed in children. Translocation t(7;8)(p22;q13) with PLAG1.; 	0.99859	.	-1.144569759	6.363529134	161.91131	2.78024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	53	7	94027043	chr7:94027043	C	CT	51	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	94042504	94042504	-	T	intronic	COL1A2	.	.	.	0.999754944	0.000245056	9.66E-16	DISEASE: Ehlers-Danlos syndrome 7B (EDS7B) [MIM:130060]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations. {ECO:0000269|PubMed:1577745, ECO:0000269|PubMed:2394758, ECO:0000269|PubMed:3680255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. {ECO:0000269|PubMed:16705691, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. {ECO:0000269|PubMed:10627137, ECO:0000269|PubMed:1284475, ECO:0000269|PubMed:1339453, ECO:0000269|PubMed:1385413, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1874719, ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:2777764, ECO:0000269|PubMed:2914942, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:7891382, ECO:0000269|PubMed:7906591, ECO:0000269|PubMed:7959683, ECO:0000269|PubMed:8182080, ECO:0000269|Ref.33}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form (EDSCV) [MIM:225320]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. In addition to joint laxity, skin hyperextensibility and friability, and abnormal scar formation, patients have mitral valve prolapse and insufficiency, mitral regurgitation, and aortic insufficiency. {ECO:0000269|PubMed:16816023}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:10408781, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:7520724, ECO:0000269|PubMed:7720740, ECO:0000269|PubMed:7749416, ECO:0000269|PubMed:7860070, ECO:0000269|PubMed:7881420, ECO:0000269|PubMed:8081394, ECO:0000269|PubMed:8444468, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:8800927, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:1642148, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:2052622, ECO:0000269|PubMed:2064612, ECO:0000269|PubMed:2897363, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8401517, ECO:0000269|PubMed:8800927}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving COL1A2 may be a cause of lipoblastomas, which are benign tumors resulting from transformation of adipocytes, usually diagnosed in children. Translocation t(7;8)(p22;q13) with PLAG1.; 	0.99859	.	-1.144569759	6.363529134	161.91131	2.78024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	172	7	94042504	chr7:94042504	C	CT	76	PASS	DP=172;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	94054477	94054477	C	A	exonic	COL1A2	.	nonsynonymous SNV	COL1A2:NM_000089:exon42:c.C2722A:p.P908T	0.999754944	0.000245056	9.66E-16	DISEASE: Ehlers-Danlos syndrome 7B (EDS7B) [MIM:130060]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations. {ECO:0000269|PubMed:1577745, ECO:0000269|PubMed:2394758, ECO:0000269|PubMed:3680255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. {ECO:0000269|PubMed:16705691, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. {ECO:0000269|PubMed:10627137, ECO:0000269|PubMed:1284475, ECO:0000269|PubMed:1339453, ECO:0000269|PubMed:1385413, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1874719, ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:2777764, ECO:0000269|PubMed:2914942, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:7891382, ECO:0000269|PubMed:7906591, ECO:0000269|PubMed:7959683, ECO:0000269|PubMed:8182080, ECO:0000269|Ref.33}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form (EDSCV) [MIM:225320]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. In addition to joint laxity, skin hyperextensibility and friability, and abnormal scar formation, patients have mitral valve prolapse and insufficiency, mitral regurgitation, and aortic insufficiency. {ECO:0000269|PubMed:16816023}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:10408781, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:7520724, ECO:0000269|PubMed:7720740, ECO:0000269|PubMed:7749416, ECO:0000269|PubMed:7860070, ECO:0000269|PubMed:7881420, ECO:0000269|PubMed:8081394, ECO:0000269|PubMed:8444468, ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:8800927, ECO:0000269|PubMed:8829649}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:1642148, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:2052622, ECO:0000269|PubMed:2064612, ECO:0000269|PubMed:2897363, ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8401517, ECO:0000269|PubMed:8800927}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving COL1A2 may be a cause of lipoblastomas, which are benign tumors resulting from transformation of adipocytes, usually diagnosed in children. Translocation t(7;8)(p22;q13) with PLAG1.; 	0.99859	.	-1.144569759	6.363529134	161.91131	2.78024	0.001	0.784	D	0.997	0.689	D	0.939	0.657	D	0.000	0.559	D	1.000	0.588	D	2.51	0.734	M	-4.22	0.970	D	-5.39	0.850	D	0.645	0.660	1.085	0.991	D	0.945	0.982	D	0.293	0.906	D	4.592	0.615	24.4	0.992	0.562	0.931	0.570	D	c	0.699	0.657	1.000	0.747	0.707	0.730	0	5.25	0.731	3.245	0.509	0.892	0.403	1.000	0.715	0.980	0.490	19.231	0.938	.	.	.	0.5	113	567	7	94054477	chr7:94054477	C	A	113	PASS	DP=567;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	94285912	94285912	-	T	intronic	PEG10	.	.	.	0.894178858	0.10478651	0.001034632	.	0.70725	0.10969	-0.273576253	33.97027601	11.52995	0.4171	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	629	7	94285912	chr7:94285912	G	GT	115	PASS	DP=629;AN=4	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	0/1
7	98507900	98507900	G	A	exonic	TRRAP	.	synonymous SNV	TRRAP:NM_001244580:exon15:c.G1572A:p.V524V,TRRAP:NM_003496:exon15:c.G1572A:p.V524V	1	1.50E-21	1.65E-53	DISEASE: Note=TRRAP mutation Phe-722 has been frequently found in cutaneous malignant melanoma, suggesting that TRRAP may play a role in the pathogenesis of melanoma. {ECO:0000269|PubMed:21499247}.; 	0.90101	0.52705	-6.141724508	0.035385704	221.99559	3.22188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	7	98507900	chr7:98507900	G	A	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	99905688	99905688	C	A	intronic	SPDYE3	.	.	.	0.825434138	0.173760887	0.000804975	.	.	.	.	.	7.34499	0.27357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	353	7	99905688	chr7:99905688	C	A	65	PASS	DP=353;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	99971918	99971918	A	G	exonic	PILRA	.	nonsynonymous SNV	PILRA:NM_013439:exon2:c.A316G:p.K106E,PILRA:NM_178272:exon2:c.A316G:p.K106E,PILRA:NM_178273:exon2:c.A316G:p.K106E	2.14E-08	0.139762091	0.860237888	.	0.05578	.	0.685332364	85.09672092	24.52952	0.80605	0.688	0.065	T	0.3	0.308	B	0.065	0.259	B	0.028	0.017	N	1	0.090	N	0.805	0.203	L	2.0	0.215	T	-1.04	0.277	N	0.061	0.047	-1.056	0.128	T	0.024	0.102	T	0.005	0.122	T	-2.340	0.004	0.001	0.583	0.058	0.004	0.022	N	c	-1.585	-1.700	1.000	0.747	0.657	0.484	0	-6.76	0.016	-0.190	0.095	-0.632	0.042	0.000	0.063	0.043	0.159	5.144	0.142	Immunoglobulin V-set domain|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	91	231	7	99971918	chr7:99971918	A	G	91	PASS	DP=231;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	100460331	100460331	G	A	exonic	SLC12A9	.	synonymous SNV	SLC12A9:NM_001267814:exon11:c.G1473A:p.P491P,SLC12A9:NM_001267812:exon13:c.G1740A:p.P580P,SLC12A9:NM_020246:exon13:c.G1740A:p.P580P	2.37E-06	0.976967908	0.02302972	.	0.23194	0.15806	-1.168429872	6.062750649	76.20765	1.82962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	89	7	100460331	chr7:100460331	G	A	.	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	100552044	100552044	T	G	exonic	MUC3A	.	synonymous SNV	MUC3A:NM_005960:exon4:c.T2625G:p.S875S	.	.	.	.	.	.	.	.	4720.00036	13.87692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	67	7	100552044	chr7:100552044	T	G	121	PASS	DP=67;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	100608268	100608268	-	CTTAACCCCTTGAT	intronic	MUC3A	.	.	.	.	.	.	.	.	.	.	.	4720.00036	13.87692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	90	7	100608268	chr7:100608268	C	CCTTAACCCCTTGAT	97	PASS	DP=90;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	100636196	100636196	C	A	exonic	MUC12	.	synonymous SNV	MUC12:NM_001164462:exon2:c.C2352A:p.A784A	.	.	.	.	0.09711	.	.	.	8273.45926	19.64989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	1143	7	100636196	chr7:100636196	C	A	107	PASS	DP=1143;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	100645661	100645661	C	A	exonic	MUC12	.	synonymous SNV	MUC12:NM_001164462:exon2:c.C11817A:p.T3939T	.	.	.	.	0.09711	.	.	.	8273.45926	19.64989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	474	7	100645661	chr7:100645661	C	A	.	PASS	DP=474;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	100677225	100677225	T	C	exonic	MUC17	.	nonsynonymous SNV	MUC17:NM_001040105:exon3:c.T2528C:p.V843A	.	.	.	.	0.01571	.	16.94869906	99.98230715	4366.26914	13.19122	0.836	0.028	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	-1.215	0.008	N	4.22	0.027	T	0.03	0.066	N	0.053	0.035	-0.943	0.421	T	0.003	0.010	T	0.000	0.002	T	-1.983	0.008	0.001	0.140	0.003	0.000	0.003	N	c	-1.979	-2.031	0.000	0.055	0.497	0.185	0	-2.5	0.060	-2.061	0.015	-2.736	0.002	0.000	0.063	0.000	0.016	3.548	0.073	.	.	.	0.5	74	175	7	100677225	chr7:100677225	T	C	74	PASS	DP=175;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	100677228	100677228	G	C	exonic	MUC17	.	nonsynonymous SNV	MUC17:NM_001040105:exon3:c.G2531C:p.S844T	.	.	.	.	0.01571	.	16.94869906	99.98230715	4366.26914	13.19122	0.467	0.085	T	0.008	0.135	B	0.003	0.080	B	.	.	.	1	0.090	N	1.665	0.427	L	4.27	0.025	T	0.14	0.054	N	0.056	0.039	-0.896	0.484	T	0.005	0.015	T	0.001	0.005	T	-1.126	0.027	0.009	0.139	0.003	0.001	0.005	N	c	-1.553	-1.649	0.000	0.035	0.497	0.185	0	-1.8	0.074	-3.019	0.007	-2.014	0.005	0.000	0.063	0.000	0.016	6.411	0.208	.	.	.	0.5	42	174	7	100677228	chr7:100677228	G	C	42	PASS	DP=174;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
7	100677415	100677415	T	C	exonic	MUC17	.	synonymous SNV	MUC17:NM_001040105:exon3:c.T2718C:p.P906P	.	.	.	.	0.01571	.	16.94869906	99.98230715	4366.26914	13.19122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	96	7	100677415	chr7:100677415	T	C	119	PASS	DP=96;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	100677557	100677557	C	G	exonic	MUC17	.	nonsynonymous SNV	MUC17:NM_001040105:exon3:c.C2860G:p.P954A	.	.	.	.	0.01571	.	16.94869906	99.98230715	4366.26914	13.19122	0.012	0.546	D	0.718	0.403	P	0.126	0.311	B	.	.	.	1	0.090	N	1.265	0.321	L	4.04	0.032	T	-0.69	0.197	N	0.068	0.055	-0.935	0.434	T	0.005	0.018	T	0.002	0.037	T	-1.287	0.022	0.005	0.155	0.004	0.002	0.010	N	c	-1.305	-1.480	0.000	0.058	0.516	0.203	0	-2.38	0.062	-3.328	0.006	-0.692	0.038	0.000	0.063	0.000	0.016	7.728	0.278	.	.	.	0.5	100	498	7	100677557	chr7:100677557	C	G	100	PASS	DP=498;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	100678405	100678405	T	C	exonic	MUC17	.	synonymous SNV	MUC17:NM_001040105:exon3:c.T3708C:p.A1236A	.	.	.	.	0.01571	.	16.94869906	99.98230715	4366.26914	13.19122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	157	7	100678405	chr7:100678405	T	C	95	PASS	DP=157;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	100681883	100681883	A	G	exonic	MUC17	.	nonsynonymous SNV	MUC17:NM_001040105:exon3:c.A7186G:p.S2396G	.	.	.	.	0.01571	.	16.94869906	99.98230715	4366.26914	13.19122	0.131	0.266	T	0.805	0.432	P	0.483	0.453	P	.	.	.	1	0.090	N	2.33	0.670	M	4.25	0.026	T	-1.48	0.362	N	0.058	0.041	-0.930	0.442	T	0.009	0.031	T	0.001	0.021	T	-0.383	0.063	0.425	0.789	0.121	0.003	0.017	N	c	-0.863	-1.082	0.002	0.090	0.487	0.133	0	0.762	0.175	0.153	0.160	0.540	0.282	0.000	0.063	0.001	0.043	3.695	0.078	.	.	.	0.5	58	112	7	100681883	chr7:100681883	A	G	58	PASS	DP=112;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	100773732	100773732	T	A	exonic	SERPINE1	.	nonsynonymous SNV	SERPINE1:NM_000602:exon3:c.T302A:p.L101Q	0.219519977	0.772130789	0.008349234	DISEASE: Plasminogen activator inhibitor-1 deficiency (PAI-1D) [MIM:613329]: A hematologic disorder characterized by increased bleeding after trauma, injury, or surgery. Affected females have menorrhagia. The bleeding defect is due to increased fibrinolysis of fibrin blood clots due to deficiency of plasminogen activator inhibitor-1, which inhibits tissue and urinary activators of plasminogen. {ECO:0000269|PubMed:9207454}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=High concentrations of SERPINE1 seem to contribute to the development of venous but not arterial occlusions.; 	0.42306	0.86891	-0.268115223	34.70747818	478.10918	4.51469	0.051	0.393	T	0.999	0.899	D	0.922	0.697	D	0.000	0.523	D	0.999	0.456	D	3.355	0.913	M	-2.44	0.888	D	-3.76	0.712	D	0.921	0.913	0.864	0.952	D	0.832	0.944	D	0.173	0.850	D	4.402	0.589	24.1	0.992	0.550	0.943	0.604	D	c	0.466	0.301	1.000	0.747	0.696	0.573	0	5.44	0.793	4.762	0.617	1.061	0.807	0.981	0.351	0.007	0.100	13.445	0.604	Serpin domain	.	.	0.5	95	296	7	100773732	chr7:100773732	T	A	95	PASS	DP=296;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	101194452	101194452	G	-	intronic	COL26A1	.	.	.	0.000191086	0.974764546	0.025044368	.	0.19198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	632	7	101194451	chr7:101194451	TG	T	125	PASS	DP=632;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	101921209	101921209	-	C	intronic	CUX1	.	.	.	0.999988878	1.11E-05	3.08E-16	.	0.78386	0.44868	-1.868734056	2.011087521	217.29988	3.18613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	469	7	101921209	chr7:101921209	T	TC	81	PASS	DP=469;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	101936424	101936424	G	A	ncRNA_exonic	MIR4285	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	64	7	101936424	chr7:101936424	G	A	.	PASS	DP=64;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	102213302	102213302	G	A	upstream	POLR2J3	dist=234	.	.	.	.	.	.	.	0.09141	.	.	170.88018	2.85115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	417	7	102213302	chr7:102213302	G	A	.	PASS	DP=417;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	103003182	103003182	G	C	exonic	PSMC2	.	nonsynonymous SNV	PSMC2:NM_002803:exon6:c.G472C:p.D158H	0.999210833	0.000789161	5.94E-09	.	0.86027	.	-0.273576253	33.97027601	6.07663	0.23004	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	4.065	0.972	H	-3.7	0.954	D	-6.16	0.902	D	0.841	0.850	1.082	0.989	D	0.946	0.982	D	0.351	0.923	D	6.638	0.911	32	0.997	0.771	0.998	0.993	D	c	1.055	0.992	1.000	0.747	0.732	0.924	0	5.49	0.809	9.844	0.983	1.048	0.713	1.000	0.715	1.000	0.888	19.729	0.962	.	.	.	0.5	108	111	7	103003182	chr7:103003182	G	C	108	PASS	DP=111;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	103202348	103202348	C	A	exonic	RELN	.	nonsynonymous SNV	RELN:NM_005045:exon35:c.G5263T:p.D1755Y,RELN:NM_173054:exon35:c.G5263T:p.D1755Y	1	2.44E-15	3.10E-43	DISEASE: Lissencephaly 2 (LIS2) [MIM:257320]: A classic type lissencephaly associated with ataxia, mental retardation, seizures and abnormalities of the cerebellum, hippocampus and brainstem. {ECO:0000269|PubMed:10973257}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, familial temporal lobe, 7 (ETL7) [MIM:616436]: A focal form of epilepsy characterized by recurrent seizures that arise from foci within the temporal lobe. Seizures are usually accompanied by sensory symptoms, most often auditory in nature. {ECO:0000269|PubMed:26046367}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25073	.	-2.151227095	1.462609106	2605.03558	9.54865	0.006	0.632	D	0.997	0.899	D	0.956	0.850	D	0.000	0.843	D	1.000	0.588	D	2.125	0.592	M	1.59	0.288	T	-2.88	0.605	D	0.844	0.831	-0.849	0.521	T	0.186	0.537	T	0.039	0.587	D	5.137	0.693	25.4	0.995	0.650	0.976	0.754	D	c	0.662	0.639	1.000	0.747	0.624	0.395	0	5.78	0.914	5.628	0.672	0.935	0.490	1.000	0.715	0.500	0.271	20.012	0.974	Sialidases	.	.	0.5	.	59	7	103202348	chr7:103202348	C	A	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	104753296	104753296	C	T	exonic	KMT2E	.	nonsynonymous SNV	KMT2E:NM_018682:exon26:c.C5093T:p.T1698I,KMT2E:NM_182931:exon27:c.C5093T:p.T1698I	0.999999995	5.30E-09	1.49E-21	.	0.43067	0.11436	-1.449682288	3.904222694	397.35924	4.18819	0.002	0.721	D	0.527	0.358	P	0.123	0.309	B	0.119	0.191	U	0.991	0.240	N	0.345	0.112	N	-3.01	0.922	D	-0.77	0.214	N	0.121	0.135	-0.069	0.808	T	0.490	0.806	T	0.193	0.863	D	2.375	0.347	18.66	0.896	0.184	0.960	0.668	D	c	-0.279	-0.155	1.000	0.747	0.672	0.522	0	2.99	0.335	3.171	0.503	0.881	0.386	0.110	0.228	1.000	0.888	14.818	0.695	.	.	.	0.5	.	64	7	104753296	chr7:104753296	C	T	.	PASS	DP=64;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	105752696	105752696	G	A	UTR5	SYPL1	NM_182715:c.-42C>T	.	.	0.28913231	0.689759149	0.021108542	.	0.11594	0.12639	-0.205617011	38.57631517	23.88737	0.78764	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	507	7	105752696	chr7:105752696	G	A	66	PASS	DP=507;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	107221265	107221265	A	T	exonic	BCAP29	.	synonymous SNV	BCAP29:NM_001008405:exon1:c.A48T:p.I16I,BCAP29:NM_018844:exon2:c.A48T:p.I16I	0.220058296	0.771634792	0.008306911	.	0.08739	0.08176	0.17280645	65.75843359	329.90016	3.8596	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	56	7	107221265	chr7:107221265	A	T	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	107392911	107392911	C	G	intronic	CBLL1	.	.	.	0.997784848	0.002215079	7.36E-08	.	0.29297	0.11049	-0.516085732	21.20193442	14.90934	0.5368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	61	7	107392911	chr7:107392911	C	G	58	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	107688549	107688549	C	T	exonic	LAMB4	.	nonsynonymous SNV	LAMB4:NM_001318046:exon28:c.G4130A:p.G1377E,LAMB4:NM_007356:exon28:c.G4130A:p.G1377E	3.21E-30	0.002614573	0.997385427	.	0.09686	0.26112	-1.552781294	3.237791932	3441.9669	11.26972	0.002	0.721	D	1.0	0.899	D	0.998	0.916	D	0.009	0.303	N	1.000	0.492	D	1.955	0.530	M	0.98	0.421	T	-7.04	0.950	D	0.564	0.597	-0.763	0.573	T	0.192	0.545	T	0.021	0.442	T	5.092	0.686	25.3	0.994	0.621	0.909	0.521	D	c	0.193	0.074	1.000	0.747	0.487	0.133	0	4.48	0.538	3.525	0.530	0.664	0.294	0.976	0.346	0.011	0.114	16.956	0.861	Laminin EGF domain	.	.	0.5	.	62	7	107688549	chr7:107688549	C	T	.	PASS	DP=62;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	107688557	107688557	C	T	splicing	LAMB4	NM_001318046:exon28:c.4123-1G>A;NM_007356:exon28:c.4123-1G>A	.	.	3.21E-30	0.002614573	0.997385427	.	0.09686	0.26112	-1.552781294	3.237791932	3441.9669	11.26972	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2.467	0.358	19.26	0.917	0.204	0.784	0.384	D	c	0.510	0.212	0.609	0.218	0.074	0.012	0	2.68	0.307	2.596	0.456	0.664	0.294	1.000	0.715	0.249	0.227	10.102	0.415	.	.	.	0.5	.	59	7	107688557	chr7:107688557	C	T	.	PASS	DP=59;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	117188750	117188750	C	T	exonic	CFTR	.	nonsynonymous SNV	CFTR:NM_000492:exon10:c.C1265T:p.S422F	2.96E-36	5.19E-06	0.999994809	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.76593	0.87681	-0.50727808	21.73271998	637.50803	5.08064	0.09	0.329	T	0.675	0.393	P	0.246	0.371	B	0.024	0.264	N	0.909	0.317	N	2.3	0.659	M	-3.12	0.931	D	-1.39	0.344	N	0.255	0.524	0.455	0.899	D	0.707	0.899	D	0.117	0.798	D	1.454	0.237	13.07	0.886	0.176	0.731	0.355	D	c	-0.081	-0.132	0.009	0.119	0.554	0.246	0	3.01	0.337	3.118	0.499	0.852	0.362	0.992	0.373	0.155	0.206	10.332	0.428	.	.	.	0.5	128	342	7	117188750	chr7:117188750	C	T	128	PASS	DP=342;AN=4	GT	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.
7	121699790	121699790	T	-	intronic	PTPRZ1	.	.	.	0.994707963	0.005292037	7.09E-14	.	0.41776	0.27352	-2.216367922	1.350554376	7148.28548	18.18568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	69	7	121699789	chr7:121699789	CT	C,CTT	82	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	121699790	121699790	-	T	intronic	PTPRZ1	.	.	.	0.994707963	0.005292037	7.09E-14	.	0.41776	0.27352	-2.216367922	1.350554376	7148.28548	18.18568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	69	7	121699789	chr7:121699789	CT	C,CTT	82	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	122194609	122194609	A	G	exonic	CADPS2	.	synonymous SNV	CADPS2:NM_001009571:exon8:c.T1470C:p.H490H,CADPS2:NM_001167940:exon8:c.T1470C:p.H490H,CADPS2:NM_017954:exon8:c.T1470C:p.H490H	0.997778954	0.002221046	5.08E-12	.	0.45062	0.12261	-0.661316159	16.02382637	194.52292	3.0232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	135	7	122194609	chr7:122194609	A	G	128	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	123334697	123334697	T	-	intronic	WASL	.	.	.	0.961960487	0.038036282	3.23E-06	.	0.89386	0.35187	-0.692458599	14.96815287	24.64068	0.80952	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	75	7	123334696	chr7:123334696	GT	G	148	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	127326714	127326714	G	A	exonic	SND1	.	synonymous SNV	SND1:NM_014390:exon2:c.G126A:p.G42G	0.999917089	8.29E-05	4.11E-14	.	0.73895	0.12655	-1.063626766	7.484076433	188.34653	2.98065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	130	7	127326714	chr7:127326714	G	A	.	PASS	DP=130;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	128255933	128255933	G	A	intergenic	METTL2B;LINC01000	dist=112955;dist=25362	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	41	7	128255933	chr7:128255933	G	A	58	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	129690336	129690336	A	-	intronic	ZC3HC1	.	.	.	0.000510516	0.998179913	0.00130957	.	0.1856	.	0.242582624	69.45623968	3942.67551	12.41332	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	57	7	129690335	chr7:129690335	CA	C	57	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	130080669	130080669	C	T	intronic	CEP41	.	.	.	0.000125629	0.956230668	0.043643703	DISEASE: Joubert syndrome 15 (JBTS15) [MIM:614464]: An autosomal recessive disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis and polydactyly. {ECO:0000269|PubMed:22246503}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Genetic variations in CEP41 may be associated with susceptibility to autism (PubMed:21438139). {ECO:0000269|PubMed:21438139}.; 	0.35352	0.12266	0.551232944	81.48148148	110.55518	2.28931	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	73	7	130080669	chr7:130080669	C	T	.	PASS	DP=73;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	131113757	131113757	T	-	intronic	MKLN1	.	.	.	0.999577505	0.000422495	5.31E-11	.	0.35761	0.14611	-0.427900189	25.14744043	19.26303	0.66403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	198	7	131113756	chr7:131113756	CT	C,CTT	83	PASS	DP=198;AN=8	GT	./.	./.	0/1	./.	./.	./.	./.	0/2	0/2	./.	./.	0/2
7	131113757	131113757	-	T	intronic	MKLN1	.	.	.	0.999577505	0.000422495	5.31E-11	.	0.35761	0.14611	-0.427900189	25.14744043	19.26303	0.66403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	198	7	131113756	chr7:131113756	CT	C,CTT	83	PASS	DP=198;AN=8	GT	./.	./.	0/1	./.	./.	./.	./.	0/2	0/2	./.	./.	0/2
7	132174174	132174174	G	T	exonic	PLXNA4	.	synonymous SNV	PLXNA4:NM_001105543:exon3:c.C1248A:p.S416S,PLXNA4:NM_020911:exon3:c.C1248A:p.S416S,PLXNA4:NM_181775:exon4:c.C1248A:p.S416S	0.999999702	2.98E-07	4.57E-20	.	0.16772	0.11298	-0.194946553	39.21325784	462.81286	4.45854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	7	132174174	chr7:132174174	G	T	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	135614509	135614509	-	T	UTR5;UTR3	LUZP6;MTPN	NM_001128619:c.-2312_-2311insA;NM_145808:c.*164_*165insA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	92	7	135614509	chr7:135614509	A	AT	50	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	140508052	140508052	C	T	intronic	BRAF	.	.	.	0.999978196	2.18E-05	3.88E-14	DISEASE: Note=Defects in BRAF are found in a wide range of cancers. {ECO:0000269|PubMed:18974108}.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:12198537, ECO:0000269|PubMed:23263490, ECO:0000269|PubMed:24455489}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:12460919}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Familial non-Hodgkin lymphoma (NHL) [MIM:605027]: Cancer that starts in cells of the lymph system, which is part of the body's immune system. NHLs can occur at any age and are often marked by enlarged lymph nodes, fever and weight loss. {ECO:0000269|PubMed:14612909}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Cardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]: A multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. {ECO:0000269|PubMed:16439621, ECO:0000269|PubMed:16474404, ECO:0000269|PubMed:18042262, ECO:0000269|PubMed:19206169}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Noonan syndrome 7 (NS7) [MIM:613706]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. {ECO:0000269|PubMed:19206169}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: LEOPARD syndrome 3 (LPRD3) [MIM:613707]: A disorder characterized by lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and sensorineural deafness. {ECO:0000269|PubMed:19206169}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving BRAF is found in pilocytic astrocytomas. A tandem duplication of 2 Mb at 7q34 leads to the expression of a KIAA1549-BRAF fusion protein with a constitutive kinase activity and inducing cell transformation. {ECO:0000269|PubMed:18974108}.; 	0.95401	.	-0.60427181	17.74593064	63.2093	1.62731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	7	140508052	chr7:140508052	C	T	.	PASS	DP=53;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	141671685	141671685	A	G	downstream	TAS2R38	dist=746	.	.	0.065390402	0.729870734	0.204738864	.	0.1324	0.10729	1.196071381	92.92285916	1623.12511	7.45029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	81	7	141671685	chr7:141671685	A	G	105	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	141987184	141987184	C	T	intergenic	TRY2P;MTRNR2L6	dist=15116;dist=386947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	7	141987184	chr7:141987184	C	T	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	142032275	142032275	C	A	intergenic	TRY2P;MTRNR2L6	dist=60207;dist=341856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	7	142032275	chr7:142032275	C	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	142120111	142120111	G	T	intergenic	TRY2P;MTRNR2L6	dist=148043;dist=254020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	7	142120111	chr7:142120111	G	T	.	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	142448556	142448556	C	G	intergenic	MTRNR2L6;PRSS1	dist=73031;dist=8763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	212	7	142448556	chr7:142448556	C	G	96	PASS	DP=212;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	142459679	142459679	G	A	exonic	PRSS1	.	synonymous SNV	PRSS1:NM_002769:exon3:c.G255A:p.E85E	0.001220295	0.848354593	0.150425112	DISEASE: Pancreatitis, hereditary (PCTT) [MIM:167800]: A disease characterized by pancreas inflammation, permanent destruction of the pancreatic parenchyma, maldigestion, and severe abdominal pain attacks. {ECO:0000269|PubMed:10204851, ECO:0000269|PubMed:10381903, ECO:0000269|PubMed:10930381, ECO:0000269|PubMed:11073545, ECO:0000269|PubMed:11788572, ECO:0000269|PubMed:11866271, ECO:0000269|PubMed:14695529, ECO:0000269|PubMed:15776435, ECO:0000269|PubMed:8841182, ECO:0000269|PubMed:9322498, ECO:0000269|PubMed:9633818}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.47806	0.78094	-0.117432389	44.89266336	35.65715	1.07286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	237	7	142459679	chr7:142459679	G	A	100	PASS	DP=237;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	142983878	142983878	G	T	exonic	TMEM139	.	nonsynonymous SNV	TMEM139:NM_001282876:exon3:c.G607T:p.D203Y,TMEM139:NM_153345:exon3:c.G607T:p.D203Y,TMEM139:NM_001242773:exon4:c.G607T:p.D203Y,TMEM139:NM_001242775:exon4:c.G607T:p.D203Y,TMEM139:NM_001282877:exon4:c.G607T:p.D203Y,TMEM139:NM_001242774:exon5:c.G607T:p.D203Y	0.018754136	0.731195381	0.250050483	.	0.00814	0.04021	0.703746784	85.42108988	71.67324	1.7618	0.002	0.721	D	0.952	0.522	P	0.785	0.557	P	0.009	0.305	N	1	0.090	N	1.545	0.392	L	.	.	.	-5.56	0.863	D	0.472	0.522	-0.966	0.380	T	0.158	0.491	T	0.003	0.053	T	4.025	0.541	23.6	0.990	0.497	0.206	0.209	N	c	-0.127	-0.328	1.000	0.454	0.625	0.396	0	2.62	0.302	1.672	0.369	0.065	0.171	0.011	0.184	0.020	0.134	6.974	0.237	.	.	.	0.5	.	70	7	142983878	chr7:142983878	G	T	.	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	143453661	143453661	T	G	exonic	CTAGE6	.	nonsynonymous SNV	CTAGE6:NM_178561:exon1:c.A1091C:p.E364A	0.366836245	0.621526849	0.011636907	.	.	.	.	.	126.17664	2.44439	.	.	.	0.0	0.026	B	0.0	0.013	B	.	.	.	.	.	.	-3	0.000	N	3.5	0.050	T	.	.	.	0.041	0.021	.	.	.	.	.	.	.	.	.	-1.880	0.010	0.002	0.508	0.044	0.000	0.003	N	n	-0.640	-0.258	0.000	0.012	0.075	0.013	0	0.109	0.138	-0.293	0.083	-0.934	0.025	0.493	0.267	0.028	0.145	.	.	.	.	.	0.5	98	367	7	143453661	chr7:143453661	T	G	98	PASS	DP=367;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	148106465	148106465	-	TCTT	intronic	CNTNAP2	.	.	.	3.83E-05	0.99995799	3.72E-06	DISEASE: Autism 15 (AUTS15) [MIM:612100]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving CNTNAP2 is found in a patient with autism spectrum disorder. Paracentric inversion 46,XY,inv(7)(q11.22;q35). The inversion breakpoints disrupt the genes AUTS2 and CNTNAP2.; 	0.59066	0.10874	-2.24910054	1.29747582	193.23796	3.0143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	185	7	148106465	chr7:148106465	C	CTCTT	119	PASS	DP=185;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	148311249	148311249	A	G	exonic	C7orf33	.	nonsynonymous SNV	C7orf33:NM_145304:exon2:c.A320G:p.Q107R	0.000634926	0.49300977	0.506355304	.	0.18666	.	0.681699246	84.93158764	125.57575	2.43933	0.0	0.912	D	0.002	0.090	B	0.001	0.040	B	.	.	.	1	0.090	N	0	0.065	N	.	.	.	-4.0	0.740	D	0.177	0.215	-1.047	0.151	T	0.055	0.232	T	0.002	0.036	T	-1.541	0.016	0.002	0.255	0.012	0.001	0.007	N	c	-1.466	-1.593	0.003	0.100	0.666	0.498	0	-2.16	0.066	-1.070	0.035	-0.163	0.107	0.014	0.188	0.025	0.141	2.832	0.051	.	.	.	0.5	105	58	7	148311249	chr7:148311249	A	G	105	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	149191319	149191319	C	T	exonic	ZNF746	.	synonymous SNV	ZNF746:NM_001163474:exon2:c.G300A:p.P100P,ZNF746:NM_152557:exon2:c.G300A:p.P100P	0.051738567	0.943820828	0.004440606	.	0.64319	.	-0.332434268	30.74427931	75.84437	1.82523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	667	7	149191319	chr7:149191319	C	T	108	PASS	DP=667;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
7	149430875	149430875	G	C	exonic	KRBA1	.	unknown	UNKNOWN	1.47E-12	0.095501601	0.904498399	.	0.07786	.	.	.	814.97375	5.61027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	209	7	149430875	chr7:149430875	G	C	101	PASS	DP=209;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	149485964	149486017	CTTTGTGACAACCAGGACGACTGTGGCGATGGCTCTGATGAGGAGGGTGAGTGT	-	exonic	SSPO	.	frameshift deletion	SSPO:NM_198455:exon29:c.4183_4228del:p.L1395Vfs*10	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.79	15	7	149485963	chr7:149485963	GCTTTGTGACAACCAGGACGACTGTGGCGATGGCTCTGATGAGGAGGGTGAGTGT	G	11.79	PASS	DP=15;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	149489467	149489467	G	A	exonic	SSPO	.	nonsynonymous SNV	SSPO:NM_198455:exon37:c.G5620A:p.G1874S	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	1.0	0.899	D	0.999	0.916	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.42	0.477	.	.	.	.	.	.	.	.	.	0.316	0.124	5.852	0.672	0.080	0.958	0.661	D	n	1.283	2.151	0.999	0.392	0.078	0.016	0	4.13	0.475	2.601	0.457	1.048	0.713	0.973	0.343	0.005	0.090	12.914	0.574	VWC out|VWFC domain	.	.	0.5	70	412	7	149489467	chr7:149489467	G	A	70	PASS	DP=412;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
7	149495134	149495134	G	C	intronic	SSPO	.	.	.	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	505	7	149495134	chr7:149495134	G	C	126	PASS	DP=505;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	149497462	149497462	C	A	exonic	SSPO	.	nonsynonymous SNV	SSPO:NM_198455:exon49:c.C7220A:p.A2407E	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	0.0	0.026	B	0.002	0.063	B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.115	0.126	.	.	.	.	.	.	.	.	.	1.592	0.253	13.81	0.879	0.170	0.023	0.066	N	n	0.827	2.765	0.857	0.251	0.070	0.012	0	-4.21	0.035	-1.105	0.034	-1.465	0.011	0.000	0.063	0.933	0.406	1.166	0.017	Low-density lipoprotein (LDL) receptor class A, conserved site	.	.	0.5	130	492	7	149497462	chr7:149497462	C	A	130	PASS	DP=492;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	149518641	149518641	G	T	intronic	SSPO	.	.	.	.	.	.	.	0.20432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	108	7	149518641	chr7:149518641	G	T	.	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	149990333	149990333	A	T	intronic	ACTR3C	.	.	.	0.001231511	0.635607514	0.363160974	.	.	.	0.479642105	78.95140363	1248.01469	6.67146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	27	7	149990333	chr7:149990333	A	T	71	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
7	151479545	151479545	C	T	intronic	PRKAG2	.	.	.	0.977557429	0.022442395	1.77E-07	DISEASE: Wolff-Parkinson-White syndrome (WPWS) [MIM:194200]: A supernormal conduction disorder characterized by the presence of one or several accessory atrioventricular connections, which can lead to episodes of sporadic tachycardia. {ECO:0000269|PubMed:11407343, ECO:0000269|PubMed:11748095}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 6 (CMH6) [MIM:600858]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. CMH6 patients present Wolff-Parkinson-White ventricular preexcitation, enlarged myocytes without myofiber disarray, and glycogen- containing cytosolic vacuoles within cardiomyocytes. {ECO:0000269|PubMed:11371514, ECO:0000269|PubMed:11827995}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glycogen storage disease of heart lethal congenital (GSDH) [MIM:261740]: Rare disease which leads to death within a few weeks to a few months after birth, through heart failure and respiratory compromise. {ECO:0000269|PubMed:15877279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75824	0.19412	-0.867014353	10.72776598	322.64102	3.81555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	122	7	151479545	chr7:151479545	C	T	72	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
7	151505788	151505788	A	-	intronic	PRKAG2	.	.	.	0.977557429	0.022442395	1.77E-07	DISEASE: Wolff-Parkinson-White syndrome (WPWS) [MIM:194200]: A supernormal conduction disorder characterized by the presence of one or several accessory atrioventricular connections, which can lead to episodes of sporadic tachycardia. {ECO:0000269|PubMed:11407343, ECO:0000269|PubMed:11748095}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 6 (CMH6) [MIM:600858]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. CMH6 patients present Wolff-Parkinson-White ventricular preexcitation, enlarged myocytes without myofiber disarray, and glycogen- containing cytosolic vacuoles within cardiomyocytes. {ECO:0000269|PubMed:11371514, ECO:0000269|PubMed:11827995}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glycogen storage disease of heart lethal congenital (GSDH) [MIM:261740]: Rare disease which leads to death within a few weeks to a few months after birth, through heart failure and respiratory compromise. {ECO:0000269|PubMed:15877279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75824	0.19412	-0.867014353	10.72776598	322.64102	3.81555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	51	7	151505787	chr7:151505787	GA	G,GAA	76	PASS	DP=51;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	151505788	151505788	-	A	intronic	PRKAG2	.	.	.	0.977557429	0.022442395	1.77E-07	DISEASE: Wolff-Parkinson-White syndrome (WPWS) [MIM:194200]: A supernormal conduction disorder characterized by the presence of one or several accessory atrioventricular connections, which can lead to episodes of sporadic tachycardia. {ECO:0000269|PubMed:11407343, ECO:0000269|PubMed:11748095}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 6 (CMH6) [MIM:600858]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. CMH6 patients present Wolff-Parkinson-White ventricular preexcitation, enlarged myocytes without myofiber disarray, and glycogen- containing cytosolic vacuoles within cardiomyocytes. {ECO:0000269|PubMed:11371514, ECO:0000269|PubMed:11827995}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glycogen storage disease of heart lethal congenital (GSDH) [MIM:261740]: Rare disease which leads to death within a few weeks to a few months after birth, through heart failure and respiratory compromise. {ECO:0000269|PubMed:15877279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75824	0.19412	-0.867014353	10.72776598	322.64102	3.81555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	51	7	151505787	chr7:151505787	GA	G,GAA	76	PASS	DP=51;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	151878157	151878157	C	A	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon36:c.G6788T:p.G2263V	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.092	0.329	T	0.014	0.156	B	0.011	0.145	B	0.002	0.385	N	0.999	0.459	D	2.32	0.666	M	-1.81	0.840	D	-4.03	0.749	D	0.408	0.466	-0.401	0.720	T	0.405	0.755	T	0.072	0.715	D	1.809	0.278	15.04	0.985	0.420	0.913	0.531	D	c	-0.373	-0.280	0.542	0.212	0.707	0.730	0	2.91	0.328	1.520	0.353	0.870	0.379	1.000	0.715	0.958	0.437	10.289	0.426	.	.	.	0.5	.	63	7	151878157	chr7:151878157	C	A	.	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	151932916	151932916	C	G	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon16:c.G2755C:p.V919L	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.465	0.086	T	0.005	0.119	B	0.006	0.112	B	0.001	0.407	D	0.910	0.275	N	1.04	0.263	L	-1.76	0.836	D	-0.87	0.236	N	0.106	0.208	-0.782	0.562	T	0.290	0.662	T	.	.	.	1.682	0.263	14.31	0.935	0.226	0.885	0.481	D	c	-0.471	-0.289	0.000	0.060	0.737	0.974	0	3.05	0.341	0.914	0.280	0.892	0.403	0.989	0.365	1.000	0.888	9.075	0.355	.	.	.	0.5	151	493	7	151932916	chr7:151932916	C	G	151	PASS	DP=493;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	151935853	151935853	T	C	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon15:c.A2591G:p.E864G	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.077	0.346	T	0.986	0.596	D	0.655	0.508	P	0.010	0.301	N	1.000	0.488	D	1.95	0.526	M	-2.06	0.860	D	-1.73	0.410	N	0.593	0.620	-0.013	0.820	T	0.585	0.851	D	.	.	.	4.196	0.562	23.9	0.998	0.907	0.978	0.770	D	c	0.478	0.540	1.000	0.747	0.651	0.465	0	5.53	0.825	7.411	0.791	1.061	0.807	1.000	0.715	1.000	0.888	15.955	0.796	.	.	.	0.5	.	172	7	151935853	chr7:151935853	T	C	.	PASS	DP=172;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	151936975	151936975	A	G	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	73	7	151936975	chr7:151936975	A	G	97	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	151944961	151944961	T	A	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	114	7	151944961	chr7:151944961	T	A	70	PASS	DP=114;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
7	151962265	151962265	C	T	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon8:c.G1042A:p.D348N	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.027	0.465	D	1.0	0.899	D	0.99	0.774	D	0.001	0.437	U	1.000	0.495	D	2.62	0.769	M	-5.15	0.988	D	-3.29	0.677	D	0.144	0.169	1.060	0.984	D	0.951	0.984	D	.	.	.	4.868	0.654	24.9	0.993	0.581	0.995	0.972	D	c	0.470	0.415	1.000	0.747	0.707	0.730	0	4.65	0.575	7.902	0.860	0.847	0.346	1.000	0.715	0.995	0.604	17.916	0.888	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING-type|Zinc finger, RING/FYVE/PHD-type	.	.	0.5	129	302	7	151962265	chr7:151962265	C	T	129	PASS	DP=302;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
7	151962290	151962290	C	G	exonic	KMT2C	.	nonsynonymous SNV	KMT2C:NM_170606:exon8:c.G1017C:p.K339N	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	0.246	0.173	T	0.999	0.764	D	0.991	0.782	D	0.001	0.432	U	0.938	0.372	D	1.445	0.365	L	-5.16	0.988	D	-2.17	0.490	N	0.153	0.189	0.881	0.954	D	0.928	0.976	D	.	.	.	2.356	0.344	18.53	0.986	0.425	0.867	0.457	D	c	-0.067	-0.115	0.503	0.209	0.707	0.730	0	3.77	0.423	1.960	0.398	0.802	0.324	1.000	0.715	0.997	0.653	11.249	0.481	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Zinc finger, FYVE/PHD-type|Zinc finger, RING/FYVE/PHD-type	.	.	0.5	94	120	7	151962290	chr7:151962290	C	G	94	PASS	DP=120;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	151970710	151970710	C	A	intronic	KMT2C	.	.	.	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	212	7	151970710	chr7:151970710	C	A	120	PASS	DP=212;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	151970797	151970797	A	T	exonic	KMT2C	.	synonymous SNV	KMT2C:NM_170606:exon7:c.T1005A:p.P335P	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	426	7	151970797	chr7:151970797	A	T	109	PASS	DP=426;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	152841603	152841603	C	A	intergenic	ACTR3B;LINC01287	dist=289139;dist=255401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	7	152841603	chr7:152841603	C	A	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
7	155567837	155567837	G	T	UTR3	RBM33	NM_053043:c.*102G>T	.	.	0.999967325	3.27E-05	5.14E-13	.	0.15099	.	-1.144569759	6.363529134	1720.69538	7.64985	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	167	7	155567837	chr7:155567837	G	T	.	PASS	DP=167;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
7	157931119	157931119	A	G	exonic	PTPRN2	.	synonymous SNV	PTPRN2:NM_001308267:exon6:c.T885C:p.A295A,PTPRN2:NM_130842:exon6:c.T948C:p.A316A,PTPRN2:NM_001308268:exon7:c.T1068C:p.A356A,PTPRN2:NM_002847:exon7:c.T999C:p.A333A,PTPRN2:NM_130843:exon7:c.T999C:p.A333A	0.016557153	0.983434299	8.55E-06	DISEASE: Note=Autoantigen in insulin-dependent diabetes mellitus (IDDM). {ECO:0000269|PubMed:8637868, ECO:0000269|PubMed:8798755, ECO:0000269|PubMed:8878534}.; 	0.18753	0.09983	0.889106693	89.19556499	4454.24566	13.37565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	183	211	7	157931119	chr7:157931119	A	G	183	PASS	DP=211;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	169317	169317	C	-	ncRNA_exonic	RPL23AP53	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	40	8	169316	chr8:169316	TC	T	53	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	608055	608055	C	A	intronic	ERICH1	.	.	.	1.39E-10	0.027971373	0.972028627	.	0.06769	0.07517	0.07167258	59.15899976	140.672	2.58786	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	406	8	608055	chr8:608055	C	A	.	PASS	DP=406;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	1616806	1616806	G	A	exonic	DLGAP2	.	nonsynonymous SNV	DLGAP2:NM_001346810:exon9:c.G2122A:p.E708K	0.950397326	0.049601404	1.27E-06	.	0.18261	0.10991	-1.609459583	3.001887238	.	.	0.217	0.191	T	0.604	0.389	P	0.392	0.424	B	0.000	0.477	D	0.849	0.352	D	2.2	0.622	M	2.24	0.179	T	-1.1	0.285	N	0.404	0.463	-1.066	0.103	T	0.047	0.200	T	0.004	0.096	T	1.438	0.236	12.99	0.984	0.402	0.971	0.725	D	c	-0.068	-0.057	1.000	0.747	0.487	0.133	0	4.7	0.586	6.254	0.722	1.048	0.713	1.000	0.715	0.030	0.147	14.818	0.695	.	.	.	0.5	98	158	8	1616806	chr8:1616806	G	A	98	PASS	DP=158;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	1626429	1626429	G	C	exonic	DLGAP2	.	nonsynonymous SNV	DLGAP2:NM_001346810:exon12:c.G2338C:p.D780H	0.950397326	0.049601404	1.27E-06	.	0.18261	0.10991	-1.609459583	3.001887238	.	.	0.0	0.912	D	1.0	0.899	D	0.996	0.971	D	0.000	0.843	D	1.000	0.588	D	3.325	0.910	M	1.99	0.217	T	-6.03	0.897	D	0.939	0.933	-0.692	0.608	T	0.177	0.522	T	0.068	0.705	D	6.198	0.855	28.7	0.996	0.734	0.982	0.799	D	c	0.821	0.756	1.000	0.747	0.554	0.283	0	4.95	0.648	7.421	0.792	1.048	0.713	1.000	0.715	0.990	0.544	18.187	0.897	.	.	.	0.5	106	468	8	1626429	chr8:1626429	G	C	106	PASS	DP=468;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	7189853	7189853	C	A	ncRNA_intronic	FAM66B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	628	8	7189853	chr8:7189853	C	A	108	PASS	DP=628;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	10480541	10480541	G	T	exonic	RP1L1	.	synonymous SNV	RP1L1:NM_178857:exon2:c.C171A:p.A57A	.	.	.	DISEASE: Occult macular dystrophy (OCMD) [MIM:613587]: An inherited macular dystrophy characterized by progressive loss of macular function but normal ophthalmoscopic appearance. It is typically characterized by a central cone dysfunction leading to a loss of vision despite normal ophthalmoscopic appearance, normal fluorescein angiography, and normal full-field electroretinogram (ERGs), but the amplitudes of the focal macular ERGs and multifocal ERGs are significantly reduced at the central retina. {ECO:0000269|PubMed:20826268, ECO:0000269|PubMed:22605915}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09178	.	7.246646544	99.8997405	19576.13196	29.90294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	274	8	10480541	chr8:10480541	G	T	.	PASS	DP=274;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	10753654	10753654	T	-	downstream	XKR6	dist=3	.	.	0.956776701	0.043218854	4.45E-06	.	0.31948	0.1039	-0.824740496	11.67728238	40.49271	1.18751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	198	8	10753653	chr8:10753653	CT	C,CTT	67	PASS	DP=198;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	0/2	./.	./.	./.	./.
8	10753654	10753654	-	T	downstream	XKR6	dist=3	.	.	0.956776701	0.043218854	4.45E-06	.	0.31948	0.1039	-0.824740496	11.67728238	40.49271	1.18751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	198	8	10753653	chr8:10753653	CT	C,CTT	67	PASS	DP=198;AN=4	GT	./.	./.	0/1	./.	./.	./.	./.	0/2	./.	./.	./.	./.
8	12384196	12384196	-	T	ncRNA_intronic	LOC100506990	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	732	8	12384196	chr8:12384196	G	GT	96	PASS	DP=732;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	12522853	12522861	GTCCTCGCA	-	ncRNA_exonic	LOC729732	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	153	8	12522852	chr8:12522852	CGTCCTCGCA	C	120	PASS	DP=153;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	12881517	12881517	A	G	UTR3	KIAA1456	NM_020844:c.*1964A>G;NM_001099677:c.*1964A>G	.	.	.	.	.	.	0.08688	0.08809	0.428052693	77.31186601	330.03285	3.86068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	36	8	12881517	chr8:12881517	A	G	41	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	17088039	17088039	-	T	UTR3	CNOT7	NM_013354:c.*189_*190insA;NM_001322091:c.*189_*190insA;NM_001322092:c.*189_*190insA;NM_001322093:c.*189_*190insA;NM_001322095:c.*189_*190insA;NM_001322096:c.*189_*190insA;NM_001322097:c.*189_*190insA;NM_001322090:c.*189_*190insA	.	.	0.986495484	0.013498412	6.10E-06	.	0.82396	0.11262	-0.141298762	42.87567823	5.94172	0.22349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	36	8	17088039	chr8:17088039	G	GT	51	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	21550683	21550683	-	T	UTR3	GFRA2	NM_001495:c.*106_*107insA;NM_001165038:c.*106_*107insA;NM_001165039:c.*106_*107insA	.	.	0.337127995	0.648312857	0.014559149	.	0.31812	0.14483	.	.	4026.41733	12.57097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	216	8	21550683	chr8:21550683	A	AT	62	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	21903695	21903695	G	T	exonic	FGF17	.	nonsynonymous SNV	FGF17:NM_001304478:exon3:c.G110T:p.S37I,FGF17:NM_003867:exon3:c.G143T:p.S48I	0.86533156	0.132739231	0.00192921	DISEASE: Hypogonadotropic hypogonadism 20 with or without anosmia (HH20) [MIM:615270]: A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic- pituitary axis. In some cases, it is associated with non- reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). {ECO:0000269|PubMed:23643382}. Note=The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Some patients carrying mutations in FGF17 also have a mutation in another HH-associated gene including FGFR1, HS6ST1 and FLRT3 (PubMed:23643382). {ECO:0000269|PubMed:23643382}.; 	0.9799	0.11262	-0.229483771	36.86010852	5.5877	0.20855	0.001	0.912	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1.000	0.588	D	2.645	0.776	M	-2.3	0.877	D	-4.36	0.769	D	0.88	0.891	0.686	0.930	D	0.765	0.920	D	0.211	0.873	D	6.401	0.884	29.6	0.997	0.787	0.971	0.724	D	c	0.816	0.776	1.000	0.747	0.598	0.340	0	4.75	0.598	9.541	0.972	0.953	0.551	1.000	0.715	1.000	0.888	15.252	0.731	.	.	.	0.5	110	506	8	21903695	chr8:21903695	G	T	110	PASS	DP=506;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	21981270	21981270	A	-	exonic	HR	.	frameshift deletion	HR:NM_005144:exon6:c.1807delT:p.C603Afs*56,HR:NM_018411:exon6:c.1807delT:p.C603Afs*56	2.13E-05	0.999767444	0.000211283	DISEASE: Alopecia universalis congenita (ALUNC) [MIM:203655]: A rare disorder characterized by loss of hair from the entire body. No hair are present in hair follicles on skin biopsy. {ECO:0000269|PubMed:12406339, ECO:0000269|PubMed:9445480, ECO:0000269|PubMed:9736769}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrichia with papular lesions (APL) [MIM:209500]: An autosomal recessive disease characterized by papillary lesions over most of the body and almost complete absence of hair. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hypotrichosis 4 (HYPT4) [MIM:146550]: An autosomal dominant condition characterized by reduced amount of hair, alopecia, little or no eyebrows, eyelashes or body hair, and coarse, wiry, twisted hair in early childhood. {ECO:0000269|PubMed:19122663, ECO:0000269|PubMed:24961381}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20146	0.12424	1.238210393	93.30620429	2359.44163	9.0145	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	359	8	21981269	chr8:21981269	CA	C	65	PASS	DP=359;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	22459801	22459801	C	T	exonic	C8orf58	.	synonymous SNV	C8orf58:NM_001013842:exon5:c.C855T:p.H285H,C8orf58:NM_001198827:exon5:c.C855T:p.H285H,C8orf58:NM_173686:exon5:c.C855T:p.H285H	7.26E-07	0.279282222	0.720717052	.	0.11805	.	0.775339069	87.13729653	146.34089	2.63608	0.0	0.912	D	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	-0.5	0.158	N	.	.	-0.984	0.341	T	0.106	0.388	T	.	.	.	-0.071	0.087	1.957	0.374	0.025	0.042	0.095	N	c	-0.485	-0.624	1.000	0.422	0.707	0.730	0	1.96	0.251	0.002	0.129	0.783	0.315	0.000	0.063	0.005	0.090	5.274	0.148	.	.	.	0.5	.	66	8	22459801	chr8:22459801	C	T	.	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	25287397	25287397	T	C	exonic	KCTD9	.	synonymous SNV	KCTD9:NM_017634:exon12:c.A1146G:p.L382L	0.073396831	0.926083873	0.000519296	.	0.10831	0.11262	-0.117432389	44.89266336	12.22101	0.44285	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	54	8	25287397	chr8:25287397	T	C	130	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
8	25766097	25766097	-	T	intronic	EBF2	.	.	.	0.97196579	0.028033904	3.06E-07	.	.	.	-0.624497208	17.16206653	336.08683	3.8943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	40	8	25766097	chr8:25766097	A	AT	110	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	29996158	29996158	A	G	exonic	MBOAT4	.	synonymous SNV	MBOAT4:NM_001100916:exon2:c.T234C:p.A78A	.	.	.	.	0.23427	0.10875	1.23654218	93.29440906	215.80004	3.17043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	8	8	29996158	chr8:29996158	A	G	52	PASS	DP=8;AN=2	GT	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	30210458	30210458	C	A	intergenic	DCTN6;RBPMS-AS1	dist=169303;dist=29177	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	189	8	30210458	chr8:30210458	C	A	.	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	37968324	37968324	T	G	exonic	ASH2L	.	nonsynonymous SNV	ASH2L:NM_001282272:exon4:c.T141G:p.H47Q,ASH2L:NM_001105214:exon5:c.T276G:p.H92Q,ASH2L:NM_001261832:exon5:c.T276G:p.H92Q,ASH2L:NM_004674:exon5:c.T558G:p.H186Q	0.995792116	0.00420787	1.44E-08	.	0.14146	0.11705	-0.26993514	34.59542345	107.32611	2.24775	0.68	0.682	T	0.012	0.561	B	0.006	0.572	B	0.000	0.843	D	1	0.810	D	1.59	0.404	L	1.87	0.241	T	-0.4	0.247	N	0.736	0.790	-1.071	0.091	T	0.081	0.320	T	0.019	0.414	T	1.274	0.218	12.14	0.847	0.150	0.915	0.533	D	c	-0.183	-0.140	0.992	0.325	0.719	0.830	0	2.34	0.279	0.209	0.171	0.890	0.394	0.991	0.370	0.994	0.587	8.795	0.338	.	.	.	0.5	74	80	8	37968324	chr8:37968324	T	G	74	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	38239293	38239293	T	C	intronic	NSD3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	1387	8	38239293	chr8:38239293	T	C	144	PASS	DP=1387;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	38645040	38645040	A	-	UTR5	TACC1	NM_006283:c.-61del-;NM_001122824:c.-61del-	.	.	0.015120874	0.984640575	0.00023855	.	0.18153	0.10845	-0.639268965	16.70794999	84.23672	1.95388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	2453	8	38645039	chr8:38645039	GA	G	120	PASS	DP=2453;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	39634686	39634686	A	-	intronic	ADAM2	.	.	.	7.21E-14	0.114372503	0.885627497	.	0.24145	0.11638	0.870809653	88.86529842	460.37141	4.45049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	29	8	39634685	chr8:39634685	GA	G	44	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	42176208	42176208	T	-	intronic	IKBKB	.	.	.	0.998786699	0.001213301	5.75E-12	DISEASE: Immunodeficiency 15 (IMD15) [MIM:615592]: An autosomal recessive primary immunodeficiency disorder characterized by onset in infancy of life-threatening bacterial, fungal, and viral infections and failure to thrive. Laboratory studies show hypo- or agammaglobulinemia with relatively normal numbers of B and T- cells, and impaired differentiation and activation of immune cells. {ECO:0000269|PubMed:24369075}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43187	0.81149	-0.754958418	13.57631517	247.23048	3.39162	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	76	8	42176207	chr8:42176207	CT	C	55	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	52321066	52321066	C	T	exonic	PXDNL	.	nonsynonymous SNV	PXDNL:NM_144651:exon17:c.G3118A:p.V1040M	1.94E-27	0.000599486	0.999400514	.	.	.	2.732433216	98.95022411	6585.72871	17.14983	0.004	0.654	D	0.998	0.715	D	0.95	0.671	D	0.000	0.469	D	0.541	0.320	D	2.84	0.828	M	-0.74	0.732	T	-2.12	0.481	N	0.208	0.398	0.565	0.914	D	0.615	0.864	D	0.006	0.165	T	4.884	0.656	24.9	0.997	0.809	0.111	0.162	N	c	0.087	-0.190	0.475	0.207	0.646	0.450	0	3.82	0.430	0.328	0.193	0.700	0.299	0.001	0.137	0.001	0.043	13.168	0.588	.	.	.	0.5	.	39	8	52321066	chr8:52321066	C	T	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	52733023	52733023	T	C	exonic	PCMTD1	.	nonsynonymous SNV	PCMTD1:NM_001286782:exon4:c.A734G:p.N245S,PCMTD1:NM_001286783:exon6:c.A434G:p.N145S,PCMTD1:NM_052937:exon6:c.A962G:p.N321S	2.56E-06	0.503470629	0.496526814	.	.	0.10723	0.169169615	65.33380514	3481.72932	11.35685	0.739	0.059	T	0.0	0.026	B	0.0	0.013	B	0.758	0.065	N	0.999	0.217	N	1.04	0.263	L	1.6	0.421	T	0.05	0.064	N	0.041	0.021	-1.001	0.297	T	0.036	0.153	T	.	.	.	-2.130	0.006	0.001	0.580	0.058	0.445	0.271	N	c	-1.086	-0.938	0.982	0.303	0.707	0.730	0	2.0	0.254	0.127	0.155	-0.448	0.056	0.924	0.318	0.161	0.208	2.389	0.041	.	.	.	0.5	116	151	8	52733023	chr8:52733023	T	C	116	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	52733079	52733079	A	C	exonic	PCMTD1	.	nonsynonymous SNV	PCMTD1:NM_001286782:exon4:c.T678G:p.S226R,PCMTD1:NM_001286783:exon6:c.T378G:p.S126R,PCMTD1:NM_052937:exon6:c.T906G:p.S302R	2.56E-06	0.503470629	0.496526814	.	.	0.10723	0.169169615	65.33380514	3481.72932	11.35685	0.069	0.496	T	0.999	0.764	D	0.994	0.807	D	0.000	0.629	N	1.000	0.588	D	1.955	0.530	M	0.98	0.421	T	-0.9	0.468	N	0.411	0.776	-0.920	0.455	T	0.174	0.518	T	.	.	.	1.490	0.241	13.26	0.998	0.850	0.846	0.434	D	c	0.047	0.054	0.982	0.303	0.707	0.730	0	0.773	0.176	1.452	0.345	0.237	0.263	1.000	0.715	0.999	0.750	6.433	0.209	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	80	71	8	52733079	chr8:52733079	A	C	80	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	53024435	53024435	A	-	UTR3	ST18	NM_014682:c.*1323delT	.	.	0.999009548	0.000990452	1.73E-11	.	0.47084	0.11285	-0.613589782	17.49823071	543.59199	4.74421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.89	48	8	53024434	chr8:53024434	TA	T	12.89	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	53535765	53535765	T	-	UTR3	RB1CC1	NM_014781:c.*577delA;NM_001083617:c.*577delA	.	.	0.999999799	2.01E-07	4.29E-19	.	0.82038	0.21518	-1.587406381	3.113941967	234.10831	3.30711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	21	8	53535764	chr8:53535764	CT	C	72	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	62555482	62555482	-	A	intronic	ASPH	.	.	.	1.02E-08	0.995846118	0.004153872	.	0.0978	0.18131	-1.236390924	5.520169851	189.544	2.98859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	111	8	62555482	chr8:62555482	G	GA	55	PASS	DP=111;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	65494784	65494784	G	C	UTR3	BHLHE22	NM_152414:c.*291G>C	.	.	0.677980337	0.301773469	0.020246194	.	0.83732	0.19325	.	.	465.53138	4.46972	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	81	8	65494784	chr8:65494784	G	C	62	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	68112596	68112596	G	A	intronic	ARFGEF1	.	.	.	0.999999909	9.06E-08	1.03E-22	.	0.89864	0.2827	-1.745389579	2.37084218	294.25109	3.66374	0.13	0.267	T	.	.	.	.	.	.	.	.	.	1	0.182	N	.	.	.	0.88	0.460	T	-0.58	0.174	N	0.108	0.115	-1.010	0.268	T	0.040	0.171	T	0.003	0.078	T	0.251	0.118	5.206	0.720	0.095	0.113	0.163	N	c	-0.687	-0.836	0.006	0.112	0.707	0.730	0	1.75	0.236	0.014	0.131	-0.415	0.060	0.000	0.063	0.001	0.043	5.222	0.146	.	.	.	0.5	107	156	8	68112596	chr8:68112596	G	A	107	PASS	DP=156;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	68140383	68140383	-	T	intronic	ARFGEF1	.	.	.	0.999999909	9.06E-08	1.03E-22	.	0.89864	0.2827	-1.745389579	2.37084218	294.25109	3.66374	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	175	8	68140383	chr8:68140383	A	AT	64	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	70667786	70667786	C	G	exonic	SLCO5A1	.	nonsynonymous SNV	SLCO5A1:NM_001146008:exon3:c.G1131C:p.K377N,SLCO5A1:NM_001146009:exon3:c.G1131C:p.K377N,SLCO5A1:NM_030958:exon4:c.G1131C:p.K377N	1.52E-05	0.962450752	0.03753401	.	0.44543	0.10196	0.516238257	80.33734371	3042.61323	10.48038	0.024	0.555	D	0.995	0.715	D	0.945	0.682	D	0.066	0.022	N	0.999	0.451	D	1.945	0.524	M	1.05	0.400	T	-1.96	0.454	N	0.236	0.289	-0.980	0.351	T	0.256	0.627	T	0.008	0.217	T	4.603	0.617	24.4	0.999	0.942	0.958	0.660	D	c	0.404	0.417	1.000	0.409	0.563	0.310	0	4.49	0.540	3.851	0.554	0.935	0.490	1.000	0.715	1.000	0.888	10.16	0.418	Major facilitator superfamily domain	.	.	0.5	76	105	8	70667786	chr8:70667786	C	G	76	PASS	DP=105;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	73849078	73849078	G	A	exonic	KCNB2	.	synonymous SNV	KCNB2:NM_004770:exon3:c.G1488A:p.R496R	0.954615847	0.045379131	5.02E-06	.	0.26567	0.11554	-1.107723888	6.829440906	126.18709	2.44478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	254	8	73849078	chr8:73849078	G	A	81	PASS	DP=254;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
8	75148840	75148841	CC	-	UTR3	JPH1	NM_001317830:c.*166_*165delGG;NM_020647:c.*446_*445delGG	.	.	0.706129633	0.293141818	0.00072855	.	0.62199	0.14032	0.090079492	60.64519934	307.58841	3.73294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	34	8	75148839	chr8:75148839	TCC	T	61	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	77765437	77765437	C	A	exonic	ZFHX4	.	nonsynonymous SNV	ZFHX4:NM_024721:exon10:c.C6280A:p.Q2094K	0.999999642	3.58E-07	1.44E-20	.	0.92237	0.08897	-1.737130259	2.435715971	2869.66786	10.14403	0.017	0.512	D	0.924	0.524	P	0.857	0.650	P	0.001	0.421	U	1	0.810	D	1.2	0.304	L	0.63	0.531	T	-2.51	0.545	D	0.382	0.442	-0.781	0.562	T	0.191	0.543	T	0.025	0.481	T	4.580	0.613	24.4	0.951	0.256	0.961	0.674	D	c	0.386	0.361	1.0	0.983	0.554	0.246	0	3.76	0.422	4.724	0.614	0.932	0.445	1.000	0.715	0.130	0.199	14.640	0.682	Homeobox domain|Homeodomain-like	.	.	0.5	.	125	8	77765437	chr8:77765437	C	A	.	PASS	DP=125;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	79672953	79672953	A	G	intronic	IL7	.	.	.	0.879873742	0.118691896	0.001434362	.	0.10724	0.49624	0.21326276	67.71644256	134.94454	2.52665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	270	8	79672953	chr8:79672953	A	G	127	PASS	DP=270;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	92365183	92365183	C	A	exonic	SLC26A7	.	synonymous SNV	SLC26A7:NM_001282357:exon11:c.C370A:p.R124R,SLC26A7:NM_052832:exon11:c.C1273A:p.R425R,SLC26A7:NM_134266:exon11:c.C1273A:p.R425R,SLC26A7:NM_001282356:exon12:c.C1273A:p.R425R	3.32E-08	0.923716211	0.076283756	.	0.50174	0.12722	0.112125503	62.09601321	242.55786	3.36166	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	8	92365183	chr8:92365183	C	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	97506454	97506454	G	C	UTR5	SDC2	NM_002998:c.-46G>C	.	.	0.579949601	0.409281236	0.010769163	.	0.55337	0.55515	0.104848986	61.49445624	3205.08824	10.79403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	86	8	97506454	chr8:97506454	G	C	119	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
8	98787959	98787959	C	A	UTR5	LAPTM4B	NM_018407:c.-6C>A	.	.	3.43E-05	0.583037321	0.416928384	.	0.48759	0.10563	-0.381986487	27.68931352	162.96113	2.78656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	174	8	98787959	chr8:98787959	C	A	124	PASS	DP=174;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	101730036	101730036	-	C	exonic	PABPC1	.	frameshift insertion	PABPC1:NM_002568:exon3:c.467_468insG:p.M158Nfs*7	0.999692443	0.000307557	1.21E-10	.	0.49883	0.4528	-0.383807564	27.41802312	3992.89486	12.49537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	48	8	101730036	chr8:101730036	T	TC	63	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	101908345	101908345	G	A	intergenic	PABPC1;YWHAZ	dist=174030;dist=22459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	164	8	101908345	chr8:101908345	G	A	100	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	101960934	101960934	C	A	exonic	YWHAZ	.	nonsynonymous SNV	YWHAZ:NM_001135699:exon2:c.G184T:p.V62F,YWHAZ:NM_001135700:exon2:c.G184T:p.V62F,YWHAZ:NM_001135701:exon2:c.G184T:p.V62F,YWHAZ:NM_001135702:exon2:c.G184T:p.V62F,YWHAZ:NM_003406:exon2:c.G184T:p.V62F,YWHAZ:NM_145690:exon2:c.G184T:p.V62F	0.817170005	0.181916765	0.00091323	.	0.99976	0.58572	0.079165051	59.43029016	1.06384	0.02718	0.0	0.912	D	0.987	0.600	D	0.748	0.541	P	0.000	0.629	D	1.000	0.810	D	2.105	0.586	M	0.83	0.478	T	-2.39	0.623	N	0.82	0.821	-0.773	0.567	T	0.189	0.541	T	0.050	0.642	D	6.470	0.892	29.9	0.997	0.785	0.960	0.667	D	c	0.461	0.497	1.000	0.747	0.672	0.522	0	5.51	0.817	0.788	0.263	0.935	0.490	0.858	0.303	1.000	0.888	19.492	0.950	14-3-3 domain	.	.	0.5	76	444	8	101960934	chr8:101960934	C	A	76	PASS	DP=444;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	102564947	102564947	C	T	exonic	GRHL2	.	nonsynonymous SNV	GRHL2:NM_001330593:exon3:c.C173T:p.P58L,GRHL2:NM_024915:exon3:c.C221T:p.P74L	0.999880613	0.000119387	1.21E-11	DISEASE: Deafness, autosomal dominant, 28 (DFNA28) [MIM:608641]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA28 is characterized by mild to moderate hearing loss across most frequencies that progresses to severe loss in the higher frequencies by the fifth decade. {ECO:0000269|PubMed:12393799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectodermal dysplasia/short stature syndrome (ECTDS) [MIM:616029]: An autosomal recessive ectodermal dysplasia syndrome characterized by nail dystrophy and/or loss, oral mucosa and/or tongue pigmentation, abnormal dentition, keratoderma affecting the margins of the palms and soles, focal hyperkeratosis of the dorsal aspects of the hands and feet, and short stature. {ECO:0000269|PubMed:25152456}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94042	0.15234	-0.402212257	26.7338995	378.61795	4.10168	0.0	0.912	D	1.0	0.899	D	0.997	0.916	D	0.000	0.843	D	1	0.810	D	2.88	0.837	M	-0.03	0.631	T	-7.49	0.950	D	0.783	0.774	0.045	0.832	D	0.489	0.806	T	0.177	0.853	D	7.208	0.945	34	0.999	0.945	0.983	0.808	D	c	0.853	0.814	1.000	0.747	0.732	0.924	0	5.47	0.803	6.626	0.739	0.935	0.490	1.000	0.715	1.000	0.888	18.918	0.925	.	.	.	0.5	41	43	8	102564947	chr8:102564947	C	T	41	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	103317396	103317396	C	G	exonic	UBR5	.	nonsynonymous SNV	UBR5:NM_001282873:exon21:c.G2744C:p.R915T,UBR5:NM_015902:exon21:c.G2744C:p.R915T	1	4.65E-20	3.53E-49	.	0.81886	0.14055	-2.918150067	0.572068884	77.52713	1.85304	0.003	0.682	D	0.967	0.544	D	0.879	0.606	P	0.000	0.843	D	1	0.810	D	2.455	0.715	M	0.82	0.481	T	-4.51	0.782	D	0.867	0.917	-0.585	0.654	T	0.248	0.618	T	0.110	0.788	D	6.052	0.833	28.0	0.985	0.412	0.993	0.945	D	c	0.647	0.648	1.000	0.747	0.707	0.730	0	5.03	0.669	7.905	0.864	0.892	0.403	1.000	0.715	1.000	0.888	18.373	0.903	.	.	.	0.5	84	83	8	103317396	chr8:103317396	C	G	84	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	103665676	103665676	A	-	intronic	KLF10	.	.	.	0.003421767	0.834210438	0.162367795	.	0.62417	0.17296	0.374860183	75.43052607	239.0998	3.341	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.38	49	8	103665675	chr8:103665675	TA	T,TAA	10.38	PASS	DP=49;AN=2	GT	././.	0/1/.	././.	././.	././.	././.	././.	././.	././.	././.	././.	././.
8	103665676	103665676	-	A	intronic	KLF10	.	.	.	0.003421767	0.834210438	0.162367795	.	0.62417	0.17296	0.374860183	75.43052607	239.0998	3.341	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.38	49	8	103665675	chr8:103665675	TA	T,TAA	10.38	PASS	DP=49;AN=2	GT	././.	0/1/.	././.	././.	././.	././.	././.	././.	././.	././.	././.	././.
8	104439486	104439486	-	T	intronic	DCAF13	.	.	.	6.93E-05	0.998985212	0.000945515	.	0.87388	0.08975	0.846940207	88.47605567	3332.2896	11.04368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	7	8	104439486	chr8:104439486	G	GT	40	PASS	DP=7;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
8	104863776	104863776	C	T	intronic	RIMS2	.	.	.	0.999998399	1.60E-06	1.12E-19	.	0.85345	0.13067	-0.5879134	18.28261382	2152.14667	8.53415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	15	8	104863776	chr8:104863776	C	T	.	PASS	DP=15;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	106573525	106573525	A	-	intronic	ZFPM2	.	.	.	0.999955694	4.43E-05	5.33E-12	DISEASE: Tetralogy of Fallot (TOF) [MIM:187500]: A congenital heart anomaly which consists of pulmonary stenosis, ventricular septal defect, dextroposition of the aorta (aorta is on the right side instead of the left) and hypertrophy of the right ventricle. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing cyanosis. {ECO:0000269|PubMed:14517948, ECO:0000269|PubMed:20807224}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Diaphragmatic hernia 3 (DIH3) [MIM:610187]: Form of congenital diaphragmatic hernia (CDH). CDH refers to a group of congenital defects in the structural integrity of the diaphragm associated with often lethal pulmonary hypoplasia and pulmonary hypertension. {ECO:0000269|PubMed:16103912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XY sex reversal 9 (SRXY9) [MIM:616067]: A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females or have ambiguous external genitalia. {ECO:0000269|PubMed:24549039}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Conotruncal heart malformations (CTHM) [MIM:217095]: A group of congenital heart defects involving the outflow tracts. Examples include truncus arteriosus communis, double-outlet right ventricle and transposition of great arteries. Truncus arteriosus communis is characterized by a single outflow tract instead of a separate aorta and pulmonary artery. In transposition of the great arteries, the aorta arises from the right ventricle and the pulmonary artery from the left ventricle. In double outlet of the right ventricle, both the pulmonary artery and aorta arise from the right ventricle. {ECO:0000269|PubMed:20807224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.5623	0.26433	0.519883383	80.37272942	1899.90602	8.01507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	27	8	106573524	chr8:106573524	CA	C	84	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	110499005	110499005	C	A	exonic	PKHD1L1	.	nonsynonymous SNV	PKHD1L1:NM_177531:exon59:c.C9835A:p.R3279S	9.13E-65	1.02E-07	0.999999898	.	0.38442	0.10513	5.453048233	99.84666195	12241.38174	23.72246	0.004	0.682	D	0.942	0.510	P	0.809	0.568	P	0.000	0.537	D	0.989	0.244	N	2.9	0.842	M	-1.29	0.795	T	-4.98	0.867	D	0.523	0.763	-0.013	0.820	T	0.642	0.875	D	0.043	0.608	D	4.720	0.633	24.6	0.996	0.753	0.761	0.370	D	c	0.477	0.409	0.849	0.250	0.554	0.246	0	5.42	0.786	1.543	0.355	0.935	0.490	0.999	0.424	0.676	0.304	17.071	0.864	Pectin lyase fold/virulence factor	.	.	0.5	63	78	8	110499005	chr8:110499005	C	A	63	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	110657322	110657322	-	T	intronic	LOC100132813;SYBU	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	276	8	110657322	chr8:110657322	C	CT	90	PASS	DP=276;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
8	113871300	113871300	G	A	intronic	CSMD3	.	.	.	0.999999996	4.08E-09	1.04E-35	.	0.39932	0.10693	-3.486527925	0.347959424	4750.0149	13.94247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	8	113871300	chr8:113871300	G	A	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	116422130	116422130	C	T	UTR3	TRPS1	NM_001282902:c.*4121G>A;NM_014112:c.*4121G>A;NM_001330599:c.*4121G>A;NM_001282903:c.*4121G>A	.	.	0.990109018	0.009890959	2.36E-08	DISEASE: Tricho-rhino-phalangeal syndrome 1 (TRPS1) [MIM:190350]: Autosomal dominant disorder characterized by craniofacial and skeletal abnormalities. It is allelic with tricho-rhino-phalangeal type 3. Typical features include sparse scalp hair, a bulbous tip of the nose, protruding ears, a long flat philtrum and a thin upper vermilion border. Skeletal defects include cone-shaped epiphyses at the phalanges, hip malformations and short stature. {ECO:0000269|PubMed:14560312}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tricho-rhino-phalangeal syndrome 2 (TRPS2) [MIM:150230]: A syndrome that combines the clinical features of tricho-rhino- phalangeal syndrome type 1 and multiple exostoses type 1. Affected individuals manifest multiple dysmorphic facial features including large, laterally protruding ears, a bulbous nose, an elongated upper lip, as well as sparse scalp hair, winged scapulae, multiple cartilaginous exostoses, redundant skin, and mental retardation. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration resulting in the loss of functional copies of TRPS1 and EXT1 has been found in TRPS2 patients.; DISEASE: Tricho-rhino-phalangeal syndrome 3 (TRPS3) [MIM:190351]: Autosomal dominant disorder characterized by craniofacial and skeletal abnormalities. It is allelic with tricho-rhino-phalangeal type 1. In TRPS3 a more severe brachydactyly and growth retardation are observed. {ECO:0000269|PubMed:11112658, ECO:0000269|PubMed:11807863}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66817	0.13373	-1.747196778	2.359046945	118.19802	2.36482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	8	116422130	chr8:116422130	C	T	.	PASS	DP=45;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	120800692	120800692	-	A	intronic	TAF2	.	.	.	0.56608706	0.433912904	3.61E-08	.	0.41383	0.119	-0.042196577	50.49539986	1043.41092	6.19966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	74	8	120800692	chr8:120800692	T	TA	61	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	120818427	120818427	G	C	intronic	TAF2	.	.	.	0.56608706	0.433912904	3.61E-08	.	0.41383	0.119	-0.042196577	50.49539986	1043.41092	6.19966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	46	54	8	120818427	chr8:120818427	G	C	46	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	124822508	124822508	T	-	intronic	FAM91A1	.	.	.	0.515693527	0.484306207	2.67E-07	.	0.30469	.	-0.622676946	17.30950696	54.36063	1.47405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	93	8	124822507	chr8:124822507	CT	C,CTT	74	PASS	DP=93;AN=4	GT	./.	0/1	./.	./.	./.	./.	./.	./.	0/2	./.	./.	./.
8	124822508	124822508	-	T	intronic	FAM91A1	.	.	.	0.515693527	0.484306207	2.67E-07	.	0.30469	.	-0.622676946	17.30950696	54.36063	1.47405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	93	8	124822507	chr8:124822507	CT	C,CTT	74	PASS	DP=93;AN=4	GT	./.	0/1	./.	./.	./.	./.	./.	./.	0/2	./.	./.	./.
8	128428591	128428591	G	A	exonic	POU5F1B	.	synonymous SNV	POU5F1B:NM_001159542:exon1:c.G480A:p.L160L	7.27E-07	0.154902824	0.845096449	.	0.06534	.	.	.	6077.10056	16.28567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	84	8	128428591	chr8:128428591	G	A	.	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	128428862	128428862	C	T	exonic	POU5F1B	.	stopgain	POU5F1B:NM_001159542:exon1:c.C751T:p.Q251X	7.27E-07	0.154902824	0.845096449	.	0.06534	.	.	.	6077.10056	16.28567	.	.	.	.	.	.	.	.	.	0.000	0.537	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8.918	0.960	35	0.986	0.430	0.241	0.221	N	c	0.201	-0.139	0.002	0.089	0.706	0.609	0	0.197	0.144	2.119	0.413	0.439	0.276	0.960	0.334	0.082	0.182	1.798	0.029	Homeobox domain|Homeodomain-like	.	.	0.5	79	396	8	128428862	chr8:128428862	C	T	79	PASS	DP=396;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	128429315	128429315	T	A	ncRNA_intronic	CASC8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	125	8	128429315	chr8:128429315	T	A	100	PASS	DP=125;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
8	128750605	128750607	CAG	-	exonic	MYC	.	nonframeshift deletion	MYC:NM_002467:exon2:c.142_144del:p.Q52del	.	.	.	DISEASE: Note=A chromosomal aberration involving MYC may be a cause of a form of B-cell chronic lymphocytic leukemia. Translocation t(8;12)(q24;q22) with BTG1. {ECO:0000269|PubMed:2069907}.; DISEASE: Burkitt lymphoma (BL) [MIM:113970]: A form of undifferentiated malignant lymphoma commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. {ECO:0000269|PubMed:2166998, ECO:0000269|PubMed:8220424}. Note=The gene represented in this entry is involved in disease pathogenesis. Chromosomal aberrations involving MYC are usually found in Burkitt lymphoma. Translocations t(8;14), t(8;22) or t(2;8) which juxtapose MYC to one of the heavy or light chain immunoglobulin gene loci.; 	0.70121	0.98749	-0.003562597	53.72729417	227.85179	3.25935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	56	8	128750604	chr8:128750604	CCAG	C	42	PASS	DP=56;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	128806836	128806836	G	T	ncRNA_exonic	PVT1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	705	8	128806836	chr8:128806836	G	T	89	PASS	DP=705;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	134488107	134488107	A	G	exonic	ST3GAL1	.	nonsynonymous SNV	ST3GAL1:NM_003033:exon4:c.T161C:p.I54T,ST3GAL1:NM_173344:exon5:c.T161C:p.I54T	0.593559246	0.404393836	0.002046918	.	0.12911	0.14444	0.286674996	71.49681529	215.8106	3.17089	0.301	0.564	T	0.02	0.170	B	0.021	0.181	B	0.333	0.141	N	1.000	0.186	N	1.525	0.387	L	2.28	0.173	T	-0.22	0.679	N	0.111	0.126	-1.048	0.150	T	0.039	0.167	T	0.008	0.213	T	0.349	0.128	6.153	0.957	0.270	0.763	0.371	D	c	-0.316	-0.222	1.000	0.500	0.707	0.730	0	5.55	0.832	4.746	0.616	1.112	0.879	1.000	0.715	0.012	0.117	14.887	0.701	.	.	.	0.5	109	191	8	134488107	chr8:134488107	A	G	109	PASS	DP=191;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	135725032	135725032	C	T	intronic	ZFAT	.	.	.	0.002928673	0.996965027	0.0001063	.	0.06704	0.1068	-0.385854854	27.08185893	876.35347	5.76073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	8	135725032	chr8:135725032	C	T	.	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	139145002	139145002	G	T	exonic	FAM135B	.	nonsynonymous SNV	FAM135B:NM_015912:exon20:c.C4055A:p.P1352H	0.999998682	1.32E-06	2.06E-16	.	0.08052	0.09691	-1.425829947	4.051663128	148.31692	2.65323	0.0	0.912	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	2.85	0.831	M	2.3	0.170	T	-8.44	0.972	D	0.811	0.800	-0.912	0.466	T	0.145	0.469	T	0.051	0.647	D	6.407	0.884	29.6	0.997	0.789	0.993	0.943	D	c	0.971	0.946	1.000	0.747	0.487	0.133	0	5.74	0.900	9.754	0.981	1.048	0.713	1.000	0.715	0.996	0.625	18.906	0.924	.	.	.	0.5	.	46	8	139145002	chr8:139145002	G	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	141754827	141754827	G	C	exonic	PTK2	.	nonsynonymous SNV	PTK2:NM_001199649:exon19:c.C1558G:p.L520V,PTK2:NM_001316342:exon19:c.C1258G:p.L420V,PTK2:NM_005607:exon19:c.C1624G:p.L542V,PTK2:NM_153831:exon19:c.C1558G:p.L520V	0.999992958	7.04E-06	1.01E-16	DISEASE: Note=Aberrant PTK2/FAK1 expression may play a role in cancer cell proliferation, migration and invasion, in tumor formation and metastasis. PTK2/FAK1 overexpression is seen in many types of cancer.; 	0.86876	.	-1.506435464	3.544468035	55.1779	1.48998	0.406	0.377	T	0.977	0.566	D	0.843	0.585	P	0.000	0.843	D	1.000	0.513	D	0.11	0.085	N	-0.0	0.626	T	-2.06	0.539	N	0.692	0.697	-1.056	0.128	T	0.103	0.379	T	0.017	0.391	T	1.949	0.295	15.89	0.987	0.450	0.961	0.674	D	c	-0.024	0.056	0.072	0.156	0.707	0.730	0	2.58	0.299	1.545	0.355	0.998	0.613	0.988	0.363	0.997	0.653	10.713	0.450	Protein kinase domain|Protein kinase-like domain|Serine-threonine/tyrosine-protein kinase catalytic domain|Tyrosine-protein kinase, catalytic domain	.	.	0.5	67	47	8	141754827	chr8:141754827	G	C	67	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
8	142160876	142160876	C	T	intronic	DENND3	.	.	.	0.017173033	0.982825328	1.64E-06	.	0.09826	0.08644	-0.564052047	19.0552017	1817.59938	7.86039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	117	8	142160876	chr8:142160876	C	T	103	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
8	142437186	142437186	G	T	intronic	PTP4A3	.	.	.	0.127669884	0.780179392	0.092150724	.	0.21928	0.22085	-0.317668748	31.45789101	12.49227	0.45442	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	622	8	142437186	chr8:142437186	G	T	123	PASS	DP=622;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	142517131	142517131	G	-	intronic	MROH5	.	.	.	.	.	.	.	.	.	4.384391577	99.74050484	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	53	8	142517130	chr8:142517130	TG	T	125	PASS	DP=53;AN=2	GT	./.	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.
8	143603494	143603494	C	T	intronic	ADGRB1	.	.	.	.	.	.	.	0.12027	0.1959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	144	8	143603494	chr8:143603494	C	T	.	PASS	DP=144;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	144400065	144400065	C	T	intronic	TOP1MT	.	.	.	1.63E-19	0.001500191	0.998499809	.	0.18543	0.14812	-0.435396074	24.70511913	3501.83574	11.39955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	396	8	144400065	chr8:144400065	C	T	135	PASS	DP=396;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
8	144406691	144406691	G	C	exonic	TOP1MT	.	nonsynonymous SNV	TOP1MT:NM_001258447:exon6:c.C486G:p.I162M,TOP1MT:NM_052963:exon6:c.C780G:p.I260M,TOP1MT:NM_001258446:exon7:c.C486G:p.I162M	1.63E-19	0.001500191	0.998499809	.	0.18543	0.14812	-0.435396074	24.70511913	3501.83574	11.39955	0.052	0.395	T	0.95	0.519	P	0.864	0.597	P	0.125	0.189	U	0.739	0.338	D	2.215	0.627	M	0.91	0.449	T	-1.66	0.416	N	0.263	0.435	-0.797	0.553	T	0.150	0.478	T	0.005	0.141	T	2.172	0.322	17.33	0.991	0.510	0.737	0.358	D	c	-0.035	-0.191	0.993	0.331	0.707	0.730	0	1.66	0.230	0.250	0.179	0.797	0.323	0.998	0.411	0.184	0.214	0.936	0.012	DNA topoisomerase I, DNA binding, eukaryotic-type|DNA topoisomerase I, DNA binding, mixed alpha/beta motif, eukaryotic-type;DNA topoisomerase I, DNA binding, eukaryotic-type|DNA topoisomerase I, DNA binding, mixed alpha/beta motif, eukaryotic-type|DNA topoisomerase I, eukaryotic-type	.	.	0.5	140	351	8	144406691	chr8:144406691	G	C	140	PASS	DP=351;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
8	144464706	144464706	C	G	exonic	RHPN1	.	nonsynonymous SNV	RHPN1:NM_052924:exon15:c.C1898G:p.P633R	1.30E-06	0.822567716	0.177430984	.	0.10052	0.10074	-0.529034136	20.85987261	149.9984	2.67044	0.003	0.682	D	0.998	0.715	D	0.962	0.690	D	0.004	0.348	N	0.827	0.348	D	1.83	0.482	L	0.45	0.565	T	-2.55	0.551	D	0.669	0.679	-0.489	0.691	T	0.246	0.615	T	0.053	0.653	D	4.491	0.601	24.3	0.997	0.825	0.164	0.192	N	c	0.097	-0.050	0.998	0.368	0.696	0.567	0	3.89	0.439	-0.180	0.097	0.852	0.362	0.000	0.063	0.438	0.260	9.219	0.363	.	.	.	0.5	79	209	8	144464706	chr8:144464706	C	G	79	PASS	DP=209;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	144681894	144681894	C	G	exonic	TIGD5	.	synonymous SNV	TIGD5:NM_032862:exon1:c.C1821G:p.P607P	0.000172429	0.454277628	0.545549943	.	0.12455	0.0998	.	.	82.12906	1.92231	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	294	8	144681894	chr8:144681894	C	G	.	PASS	DP=294;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
8	144774499	144774499	A	G	exonic	ZNF707	.	synonymous SNV	ZNF707:NM_001288807:exon5:c.A36G:p.L12L	0.012770085	0.857656122	0.129573793	.	0.17147	0.10299	0.264628794	70.5178108	77.30133	1.84692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	139	475	8	144774499	chr8:144774499	A	G	139	PASS	DP=475;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
8	144801452	144801452	G	A	intronic	MAPK15	.	.	.	1.29E-16	0.002878183	0.997121817	.	0.15685	0.17839	0.565800595	81.72918141	972.94541	6.02994	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	240	8	144801452	chr8:144801452	G	A	.	PASS	DP=240;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	144808652	144808652	G	A	exonic	FAM83H	.	synonymous SNV	FAM83H:NM_198488:exon5:c.C2979T:p.N993N	0.88482471	0.115121211	5.41E-05	.	0.27378	0.10604	.	.	1586.01963	7.36593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	63	8	144808652	chr8:144808652	G	A	.	PASS	DP=63;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	144887012	144887012	G	A	intronic	SCRIB	.	.	.	0.913273181	0.086726818	1.78E-09	DISEASE: Neural tube defects (NTD) [MIM:182940]: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components. {ECO:0000269|PubMed:22095531}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42375	0.13468	-2.440554124	1.026185421	1336.78509	6.86559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	168	8	144887012	chr8:144887012	G	A	.	PASS	DP=168;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	144887074	144887074	T	A	intronic	SCRIB	.	.	.	0.913273181	0.086726818	1.78E-09	DISEASE: Neural tube defects (NTD) [MIM:182940]: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components. {ECO:0000269|PubMed:22095531}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42375	0.13468	-2.440554124	1.026185421	1336.78509	6.86559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	8	144887074	chr8:144887074	T	A	.	PASS	DP=59;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	144919516	144919516	G	A	intronic	NRBP2	.	.	.	0.002412945	0.92737531	0.070211744	.	0.14009	.	.	.	302.68543	3.70523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	8	144919516	chr8:144919516	G	A	.	PASS	DP=59;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	144992643	144992643	G	C	exonic	PLEC	.	synonymous SNV	PLEC:NM_201378:exon32:c.C11304G:p.L3768L,PLEC:NM_201379:exon32:c.C11280G:p.L3760L,PLEC:NM_201380:exon32:c.C11757G:p.L3919L,PLEC:NM_201381:exon32:c.C11250G:p.L3750L,PLEC:NM_201382:exon32:c.C11346G:p.L3782L,PLEC:NM_201383:exon32:c.C11358G:p.L3786L,PLEC:NM_201384:exon32:c.C11346G:p.L3782L,PLEC:NM_000445:exon33:c.C11427G:p.L3809L	0.024936271	0.975063729	8.97E-16	DISEASE: Epidermolysis bullosa simplex with pyloric atresia (EBS- PA) [MIM:612138]: Autosomal recessive genodermatosis characterized by severe skin blistering at birth and congenital pyloric atresia. Death usually occurs in infancy. This disorder is allelic to MD- EBS. {ECO:0000269|PubMed:14675180, ECO:0000269|PubMed:20665883}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, with muscular dystrophy (MD-EBS) [MIM:226670]: A form of epidermolysis bullosa characterized by the association of blister formation at the level of the hemidesmosome with late-onset muscular dystrophy. {ECO:0000269|PubMed:11159198, ECO:0000269|PubMed:21263134, ECO:0000269|PubMed:8894687}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, Ogna type (O-EBS) [MIM:131950]: A form of intraepidermal epidermolysis bullosa characterized by generalized skin bruising, skin fragility with non-scarring blistering and small hemorrhagic blisters on hands. At the ultrastructural level, it is differentiated from classical cases of K-EBS, WC-EBS and DM-EBS, by the occurrence of blisters originating in basal cells above hemidesmosomes, and abnormal hemidesmosome intracellular attachment plates. {ECO:0000269|PubMed:11851880}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Limb-girdle muscular dystrophy 2Q (LGMD2Q) [MIM:613723]: A form of limb-girdle muscular dystrophy characterized by early childhood onset of proximal muscle weakness. Limb-girdle muscular dystrophies are characterized by proximal weakness, weakness of the hip and shoulder girdles and prominent asymmetrical quadriceps femoris and biceps brachii atrophy. {ECO:0000269|PubMed:21109228}. Note=The disease is caused by mutations affecting the gene represented in this entry. A 9 bp deletion containing the initiation codon in exon 1f of PLEC have been found in limb-girdle muscular dystrophy patients. The mutation results in deficient expression of isoform 9 and disorganization of the myofibers, without any effect on the skin.; DISEASE: Epidermolysis bullosa simplex with nail dystrophy (EBSND) [MIM:616487]: A form of epidermolysis bullosa, a dermatologic disorder characterized by skin blistering. EBSND patients also manifest nail dystrophy. {ECO:0000269|PubMed:25712130}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27288	0.29936	-6.570947902	0.029488087	16481.80337	27.47256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	960	8	144992643	chr8:144992643	G	C	130	PASS	DP=960;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
8	145234350	145234350	C	T	intronic	MROH1	.	.	.	0.587142255	0.412416428	0.000441317	.	.	.	.	.	77.45123	1.85066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	433	8	145234350	chr8:145234350	C	T	125	PASS	DP=433;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
8	145537492	145537492	C	G	intronic	HSF1	.	.	.	0.586374295	0.413181557	0.000444148	.	0.11458	0.16496	-0.865195027	10.79853739	350.11867	3.96676	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	92	8	145537492	chr8:145537492	C	G	64	PASS	DP=92;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	145542674	145542674	C	T	intronic	DGAT1	.	.	.	2.90E-10	0.274285644	0.725714356	DISEASE: Diarrhea 7 (DIAR7) [MIM:615863]: A life-threatening disease characterized by severe, intractable, watery diarrhea. {ECO:0000269|PubMed:23114594}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21291	0.34238	-0.841329384	11.36470866	296.55679	3.67459	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	8	145542674	chr8:145542674	C	T	.	PASS	DP=68;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	145579950	145579950	-	CCGCTGACCCTGGCACGGCACAAGGGCCCCCACACCTCACGTGCCTGGCCACAACCCAGA	intronic	FBXL6	.	.	.	3.70E-06	0.810919383	0.189076922	.	0.09239	0.10079	-0.442665927	24.53408823	363.5906	4.03651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	512	8	145579950	chr8:145579950	G	GCCGCTGACCCTGGCACGGCACAAGGGCCCCCACACCTCACGTGCCTGGCCACAACCCAGA	159	PASS	DP=512;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	145638078	145638078	C	A	intronic	SLC39A4	.	.	.	0.005737361	0.971586525	0.022676115	.	0.09914	0.12725	1.208829905	93.05260675	6782.66145	17.50995	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	570	8	145638078	chr8:145638078	C	A	127	PASS	DP=570;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	145652340	145652340	-	G	UTR5	VPS28	NM_016208:c.-13_-12insC;NM_183057:c.-13_-12insC	.	.	0.115974874	0.857110731	0.026914395	.	0.20134	0.1297	-0.404032746	26.53338051	18.89106	0.65215	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	447	8	145652340	chr8:145652340	T	TG	94	PASS	DP=447;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
8	145725599	145725599	G	A	intronic	PPP1R16A	.	.	.	0.047670337	0.947290127	0.005039535	.	0.16096	0.11053	-0.778825328	12.88039632	88.81106	2.02338	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	692	8	145725599	chr8:145725599	G	A	124	PASS	DP=692;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	145755800	145755800	C	-	UTR3	ARHGAP39	NM_025251:c.*6delG;NM_001308207:c.*6delG;NM_001308208:c.*6delG	.	.	0.001681796	0.997152661	0.001165542	.	.	.	-1.390744555	4.305260675	202.55456	3.07112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	44	8	145755799	chr8:145755799	GC	G	43	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	145756062	145756062	G	A	intronic	ARHGAP39	.	.	.	0.001681796	0.997152661	0.001165542	.	.	.	-1.390744555	4.305260675	202.55456	3.07112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	124	8	145756062	chr8:145756062	G	A	.	PASS	DP=124;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
8	145948629	145948629	C	A	exonic	ZNF251	.	nonsynonymous SNV	ZNF251:NM_138367:exon5:c.G416T:p.R139L	3.06E-06	0.77679478	0.22320216	.	0.06873	.	-0.510624372	21.65015334	82.4269	1.92785	0.648	0.049	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	0.55	0.145	N	3.31	0.063	T	0.73	0.021	N	0.186	0.227	-0.919	0.457	T	0.007	0.022	T	0.001	0.006	T	-0.712	0.044	0.067	0.207	0.008	0.033	0.082	N	c	-2.046	-2.108	0.005	0.109	0.651	0.465	0	-3.14	0.049	-4.047	0.003	-2.334	0.003	0.000	0.063	0.000	0.016	0.460	0.005	.	.	.	0.5	76	165	8	145948629	chr8:145948629	C	A	76	PASS	DP=165;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
8	145979746	145979746	G	A	intronic	ZNF251	.	.	.	3.06E-06	0.77679478	0.22320216	.	0.06873	.	-0.510624372	21.65015334	82.4269	1.92785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	230	8	145979746	chr8:145979746	G	A	112	PASS	DP=230;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	52577	52577	G	A	intergenic	FAM138C;PGM5P3-AS1	dist=16713;dist=20113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	193	9	52577	chr9:52577	G	A	.	PASS	DP=193;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	73247	73247	C	T	ncRNA_intronic	PGM5P3-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	244	9	73247	chr9:73247	C	T	87	PASS	DP=244;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	146032	146032	C	A	intronic	CBWD1	.	.	.	0.642141452	0.356513512	0.001345035	.	0.1465	0.09079	.	.	228.50043	3.26546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	28	9	146032	chr9:146032	C	A	51	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	146221	146221	G	A	intronic	CBWD1	.	.	.	0.642141452	0.356513512	0.001345035	.	0.1465	0.09079	.	.	228.50043	3.26546	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	314	9	146221	chr9:146221	G	A	61	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	5811338	5811338	A	-	intronic	ERMP1	.	.	.	4.55E-05	0.998228722	0.001725778	.	0.17248	0.09494	-1.03976177	7.802547771	243.10681	3.36551	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	34	9	5811337	chr9:5811337	CA	C	78	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	6413120	6413120	C	A	upstream	UHRF2	dist=31	.	.	0.999646144	0.000353856	3.45E-11	DISEASE: Note=Associated with various cancers. DNA copy number loss is found in multiple kinds of malignancies originating from the brain, breast, stomach, kidney, hematopoietic tissue and lung.; 	0.26264	0.13812	-0.380166007	27.88393489	43.75397	1.25932	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	548	9	6413120	chr9:6413120	C	A	.	PASS	DP=548;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	8449660	8449660	T	C	intronic	PTPRD	.	.	.	0.999999982	1.80E-08	4.88E-23	.	0.89661	0.17382	-3.078871465	0.483604624	1565.5627	7.32256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	59	9	8449660	chr9:8449660	T	C	131	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	8449690	8449690	G	C	intronic	PTPRD	.	.	.	0.999999982	1.80E-08	4.88E-23	.	0.89661	0.17382	-3.078871465	0.483604624	1565.5627	7.32256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	269	9	8449690	chr9:8449690	G	C	103	PASS	DP=269;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	15433520	15433520	-	T	intronic	SNAPC3	.	.	.	5.54E-05	0.883341296	0.116603314	.	0.17643	0.10767	-0.069700724	48.54328851	386.09549	4.13838	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	27	9	15433520	chr9:15433520	A	AT	50	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	18706829	18706829	G	T	exonic	ADAMTSL1	.	synonymous SNV	ADAMTSL1:NM_001040272:exon14:c.G1659T:p.L553L	8.83E-05	0.999911689	4.59E-08	.	.	.	-0.860112269	10.89879689	3092.36494	10.5706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	9	18706829	chr9:18706829	G	T	.	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	19350926	19350926	-	T	intronic	DENND4C	.	.	.	0.406967594	0.593032405	1.03E-09	.	0.38649	.	-0.957327604	9.017456947	1816.18274	7.85903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	28	9	19350926	chr9:19350926	C	CT	50	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	21202073	21202073	C	G	exonic	IFNA7	.	nonsynonymous SNV	IFNA7:NM_021057:exon1:c.G92C:p.S31T	9.02E-05	0.189291662	0.810618153	.	0.03655	.	1.038098315	91.20665251	30.6513	0.97504	0.086	0.326	T	0.032	0.189	B	0.047	0.234	B	0.838	0.090	N	1	0.090	N	2.33	0.670	M	3.94	0.034	T	-1.4	0.346	N	0.107	0.114	-0.915	0.463	T	0.013	0.052	T	0.002	0.036	T	-1.314	0.022	0.004	0.855	0.154	0.038	0.090	N	c	-1.105	-1.220	0.000	0.041	0.447	0.083	0	-0.052	0.131	-0.605	0.057	-0.088	0.118	0.000	0.063	0.002	0.062	3.153	0.061	Four-helical cytokine, core|Four-helical cytokine-like, core	.	.	0.5	61	106	9	21202073	chr9:21202073	C	G	61	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	21974695	21974695	G	T	exonic	CDKN2A	.	stopgain	CDKN2A:NM_000077:exon1:c.C132A:p.Y44X,CDKN2A:NM_001195132:exon1:c.C132A:p.Y44X,CDKN2A:NM_058197:exon1:c.C132A:p.Y44X	0.357648776	0.58984451	0.052506714	DISEASE: Note=The association between cutaneous and uveal melanomas in some families suggests that mutations in CDKN2A may account for a proportion of uveal melanomas. However, CDKN2A mutations are rarely found in uveal melanoma patients.; DISEASE: Melanoma, cutaneous malignant 2 (CMM2) [MIM:155601]: A malignant neoplasm of melanocytes, arising de novo or from a pre- existing benign nevus, which occurs most often in the skin but also may involve other sites. {ECO:0000269|PubMed:10651484, ECO:0000269|PubMed:10874641, ECO:0000269|PubMed:11506491, ECO:0000269|PubMed:12019208, ECO:0000269|PubMed:14646619, ECO:0000269|PubMed:19260062, ECO:0000269|PubMed:7987387, ECO:0000269|PubMed:8595405, ECO:0000269|PubMed:8653684, ECO:0000269|PubMed:8710906, ECO:0000269|PubMed:9328469, ECO:0000269|PubMed:9425228}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome (FAMMMPC) [MIM:606719]: An inherited cancer predisposition syndrome characterized by an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Li-Fraumeni syndrome (LFS) [MIM:151623]: Autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:10484981}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Melanoma-astrocytoma syndrome (MASTS) [MIM:155755]: Characterized by a dual predisposition to melanoma and neural system tumors, commonly astrocytoma. {ECO:0000269|PubMed:11136714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.03037	0.06846	0.725794416	85.98136353	20.60127	0.70067	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7.848	0.956	35	0.984	0.403	0.199	0.206	N	c	-0.369	-0.750	1.000	0.747	0.658	0.486	0	-2.57	0.059	-1.027	0.037	0.108	0.203	0.000	0.063	0.004	0.083	3.596	0.075	Ankyrin repeat-containing domain	.	.	0.5	97	405	9	21974695	chr9:21974695	G	T	97	PASS	DP=405;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	27011885	27011885	-	T	intronic	IFT74	.	.	.	9.27E-06	0.999295023	0.000695708	.	0.28662	0.08508	1.199707453	92.98183534	3982.59417	12.48355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	85	9	27011885	chr9:27011885	C	CT	75	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	30690073	30690073	G	C	intergenic	LINC01242;LINC01243	dist=281621;dist=681536	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	418	9	30690073	chr9:30690073	G	C	100	PASS	DP=418;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	33071757	33071757	G	A	exonic	SMU1	.	nonsynonymous SNV	SMU1:NM_018225:exon3:c.C371T:p.S124F	0.998978044	0.001021944	1.12E-08	.	0.19476	0.14163	-0.141298762	42.87567823	5.43983	0.20203	0.008	0.586	D	0.859	0.453	P	0.62	0.495	P	0.000	0.843	D	1	0.810	D	2.84	0.828	M	0.57	0.544	T	-3.96	0.735	D	0.668	0.679	-0.338	0.739	T	0.309	0.680	T	0.051	0.646	D	6.539	0.900	31	0.999	0.929	0.998	0.994	D	c	0.821	0.826	1.000	0.747	0.732	0.924	0	5.47	0.803	9.810	0.983	0.998	0.613	1.000	0.715	1.000	0.888	17.187	0.867	.	.	.	0.5	.	19	9	33071757	chr9:33071757	G	A	.	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	33387111	33387111	G	A	intronic	AQP7	.	.	.	1.86E-09	0.034706833	0.965293165	.	0.0624	0.1324	0.108486928	61.90728946	500.92929	4.59263	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	362	9	33387111	chr9:33387111	G	A	.	PASS	DP=362;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	33469406	33469406	C	T	intronic	NOL6	.	.	.	0.999078032	0.000921968	2.94E-12	.	0.21138	0.11067	-0.231522913	36.36470866	535.96118	4.71978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	53	9	33469406	chr9:33469406	C	T	84	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	34665603	34665603	C	A	intronic	LOC730098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	725	9	34665603	chr9:34665603	C	A	79	PASS	DP=725;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	36052363	36052363	T	C	intronic	RECK	.	.	.	0.000196798	0.999760397	4.28E-05	.	0.37337	0.19959	-0.951568548	9.271054494	1398.34528	6.99259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	22	9	36052363	chr9:36052363	T	C	42	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	36058803	36058803	T	-	intronic	RECK	.	.	.	0.000196798	0.999760397	4.28E-05	.	0.37337	0.19959	-0.951568548	9.271054494	1398.34528	6.99259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	61	9	36058802	chr9:36058802	CT	C	54	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	36344900	36344900	C	T	exonic	RNF38	.	synonymous SNV	RNF38:NM_194329:exon9:c.G1164A:p.L388L,RNF38:NM_194332:exon9:c.G1065A:p.L355L,RNF38:NM_022781:exon10:c.G1314A:p.L438L,RNF38:NM_194328:exon10:c.G1065A:p.L355L,RNF38:NM_194330:exon10:c.G1065A:p.L355L	0.999390257	0.000609742	6.41E-10	.	0.5568	0.11262	-0.471992905	23.03609342	10.65785	0.3869	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	92	9	36344900	chr9:36344900	C	T	52	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	37708421	37708421	C	-	exonic	FRMPD1	.	frameshift deletion	FRMPD1:NM_014907:exon4:c.285delC:p.P96Lfs*7	3.53E-10	0.995711787	0.004288213	.	0.15661	0.09359	1.70862952	96.44373673	4200.93656	12.88726	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	15	9	37708420	chr9:37708420	TC	T	95	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
9	40332652	40332652	G	T	intergenic	FAM74A1;LOC105379450	dist=426433;dist=351167	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	416	9	40332652	chr9:40332652	G	T	114	PASS	DP=416;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	44093256	44093256	A	G	intergenic	CNTNAP3P2;XLOC_007697	dist=169199;dist=88255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	175	9	44093256	chr9:44093256	A	G	87	PASS	DP=175;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	66457161	66457161	A	G	upstream	LINC01410	dist=128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	96	9	66457161	chr9:66457161	A	G	92	PASS	DP=96;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	66457523	66457526	TTTG	-	ncRNA_intronic	LINC01410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	379	9	66457522	chr9:66457522	CTTTG	C	123	PASS	DP=379;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	66457628	66457628	G	A	ncRNA_intronic	LINC01410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	169	9	66457628	chr9:66457628	G	A	106	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	66499664	66499664	C	T	ncRNA_exonic	PTGER4P2-CDK2AP2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	139	9	66499664	chr9:66499664	C	T	.	PASS	DP=139;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	66513785	66513785	C	T	ncRNA_exonic	LOC403323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	414	9	66513785	chr9:66513785	C	T	133	PASS	DP=414;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
9	66513792	66513792	C	G	ncRNA_exonic	LOC403323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	98	9	66513792	chr9:66513792	C	G	76	PASS	DP=98;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	66553447	66553447	G	C	ncRNA_exonic	LOC403323;LOC728673	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	146	9	66553447	chr9:66553447	G	C	96	PASS	DP=146;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	67273446	67273446	G	A	ncRNA_intronic	AQP7P1	.	.	.	.	.	.	.	0.02901	0.081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	215	9	67273446	chr9:67273446	G	A	107	PASS	DP=215;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	67284054	67284054	G	T	ncRNA_intronic	AQP7P1	.	.	.	.	.	.	.	0.02901	0.081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	301	9	67284054	chr9:67284054	G	T	130	PASS	DP=301;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	67293607	67293607	T	C	ncRNA_exonic	LOC102724580	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	164	457	9	67293607	chr9:67293607	T	C	164	PASS	DP=457;AN=4	GT	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.
9	68426480	68426480	G	A	intergenic	MIR4477B;FRG1JP	dist=11092;dist=1304	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	318	9	68426480	chr9:68426480	G	A	100	PASS	DP=318;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
9	68426500	68426500	C	T	intergenic	MIR4477B;FRG1JP	dist=11112;dist=1284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	339	9	68426500	chr9:68426500	C	T	85	PASS	DP=339;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
9	68429152	68429152	T	C	ncRNA_exonic	FRG1JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	65	9	68429152	chr9:68429152	T	C	89	PASS	DP=65;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	68433481	68433481	-	CTC	ncRNA_exonic	FRG1JP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	79	9	68433481	chr9:68433481	T	TCTC	93	PASS	DP=79;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	69067893	69067897	AAAAG	-	ncRNA_exonic	FRG1HP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	53	9	69067892	chr9:69067892	AAAAAG	A	79	PASS	DP=53;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	69082095	69082095	A	-	ncRNA_intronic	FRG1HP;PGM5P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	46	9	69082094	chr9:69082094	CA	C	65	PASS	DP=46;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
9	69830318	69830318	G	A	intergenic	LOC101928381;FOXD4L5	dist=72534;dist=345389	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	745	9	69830318	chr9:69830318	G	A	128	PASS	DP=745;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	69847082	69847082	C	T	intergenic	LOC101928381;FOXD4L5	dist=89298;dist=328625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	431	9	69847082	chr9:69847082	C	T	71	PASS	DP=431;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	70177139	70177139	G	C	exonic	FOXD4L5	.	nonsynonymous SNV	FOXD4L5:NM_001126334:exon1:c.C845G:p.P282R	.	.	.	.	.	.	.	.	79.92726	1.89028	0.004	0.654	D	0.998	0.715	D	0.965	0.695	D	0.055	0.227	U	0.999	0.215	N	0.945	0.238	L	-3.23	0.934	D	-1.92	0.446	N	0.178	0.217	-0.033	0.816	T	0.729	0.907	D	0.075	0.722	D	3.024	0.424	22.3	0.995	0.665	0.006	0.026	N	c	-0.490	-0.739	0.000	0.012	0.487	0.133	0	1.07	0.193	-0.797	0.046	0.576	0.285	0.000	0.063	0.008	0.104	5.494	0.160	.	.	.	0.5	.	437	9	70177139	chr9:70177139	G	C	.	PASS	DP=437;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	70871836	70871836	C	G	splicing	CBWD3	NM_201453:exon5:c.431-1C>G	.	.	0.358916975	0.589020154	0.052062871	.	.	0.09807	.	.	7163.3464	18.21502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	446	9	70871836	chr9:70871836	C	G	115	PASS	DP=446;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
9	71849367	71849367	G	A	exonic	TJP2	.	nonsynonymous SNV	TJP2:NM_001170415:exon12:c.G1696A:p.D566N,TJP2:NM_001170416:exon12:c.G1777A:p.D593N,TJP2:NM_004817:exon12:c.G1684A:p.D562N,TJP2:NM_201629:exon12:c.G1684A:p.D562N,TJP2:NM_001170414:exon13:c.G1615A:p.D539N	6.24E-07	0.999943176	5.62E-05	DISEASE: Cholestasis, progressive familial intrahepatic, 4 (PFIC4) [MIM:615878]: A disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. {ECO:0000269|PubMed:24614073}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30256	0.24991	1.458702267	95.175749	1977.00591	8.193	0.053	0.430	T	0.687	0.899	P	0.301	0.875	B	0.000	0.843	D	1	0.810	D	0.94	0.237	L	0.7	0.515	T	-3.45	0.685	D	0.134	0.293	-0.713	0.598	T	0.267	0.638	T	0.012	0.294	T	4.658	0.624	24.5	0.999	0.984	0.996	0.982	D	c	0.660	0.717	1.000	0.747	0.732	0.924	0	5.45	0.796	9.803	0.982	0.953	0.551	1.000	0.715	1.000	0.888	19.655	0.958	PDZ domain	.	.	0.5	.	19	9	71849367	chr9:71849367	G	A	.	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	71852904	71852904	-	T	intronic	TJP2	.	.	.	6.24E-07	0.999943176	5.62E-05	DISEASE: Cholestasis, progressive familial intrahepatic, 4 (PFIC4) [MIM:615878]: A disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. {ECO:0000269|PubMed:24614073}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30256	0.24991	1.458702267	95.175749	1977.00591	8.193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	145	9	71852904	chr9:71852904	G	GT	71	PASS	DP=145;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	79119830	79119830	T	-	UTR3	GCNT1	NM_001097634:c.*1246delT;NM_001490:c.*1246delT;NM_001097633:c.*1246delT;NM_001097635:c.*1246delT;NM_001097636:c.*1246delT	.	.	0.066576637	0.871276331	0.062147032	.	0.09236	0.15899	0.374860183	75.43052607	1448.65204	7.10058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	32	9	79119829	chr9:79119829	AT	A	78	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	79318365	79318365	C	A	exonic	PRUNE2	.	stopgain	PRUNE2:NM_001308047:exon9:c.G8164T:p.E2722X,PRUNE2:NM_001308048:exon9:c.G8164T:p.E2722X,PRUNE2:NM_015225:exon9:c.G8164T:p.E2722X	3.68E-12	0.999991467	8.53E-06	.	0.07279	0.07799	2.779178029	99.02689314	10480.06134	22.38246	.	.	.	.	.	.	.	.	.	0.001	0.407	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.257	0.996	45	0.997	0.791	0.926	0.558	D	c	0.998	0.846	1.000	0.747	0.615	0.372	0	5.71	0.890	1.226	0.320	0.892	0.403	1.000	0.715	1.000	0.888	13.305	0.596	.	.	.	0.5	66	202	9	79318365	chr9:79318365	C	A	66	PASS	DP=202;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	79634988	79634988	C	T	exonic	FOXB2	.	nonsynonymous SNV	FOXB2:NM_001013735:exon1:c.C418T:p.H140Y	2.39E-06	0.086886107	0.913111501	.	0.57849	0.10915	.	.	70.49669	1.74683	0.348	0.124	T	0.678	0.394	P	0.157	0.329	B	.	.	.	0.894	0.278	N	0.695	0.181	N	0.82	0.481	T	-0.15	0.093	N	0.282	0.341	-1.063	0.111	T	0.079	0.314	T	0.265	0.897	D	-0.920	0.035	0.023	0.603	0.063	0.626	0.316	D	c	-0.437	-0.470	1.000	0.500	0.598	0.340	0	3.69	0.413	2.506	0.448	0.752	0.309	0.624	0.277	0.250	0.228	12.329	0.542	.	.	.	0.5	.	21	9	79634988	chr9:79634988	C	T	.	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	80646047	80646047	G	A	exonic	GNAQ	.	synonymous SNV	GNAQ:NM_002072:exon1:c.C105T:p.D35D	0.984390021	0.015608215	1.76E-06	DISEASE: Capillary malformations, congenital (CMC) [MIM:163000]: A form of vascular malformations that are present from birth, tend to grow with the individual, do not regress spontaneously, and show normal rates of endothelial cell turnover. Capillary malformations are distinct from capillary hemangiomas, which are highly proliferative lesions that appear shortly after birth and show rapid growth, slow involution, and endothelial hypercellularity. {ECO:0000269|PubMed:23656586}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Sturge-Weber syndrome (SWS) [MIM:185300]: A syndrome characterized by an intracranial vascular anomaly, leptomeningeal angiomatosis, most often involving the occipital and posterior parietal lobes. The most common features are facial cutaneous vascular malformations (port-wine stains), seizures, and glaucoma. Stasis results in ischemia underlying the leptomeningeal angiomatosis, leading to calcification and laminar cortical necrosis. The clinical course is highly variable and some children experience intractable seizures, mental retardation, and recurrent stroke-like episodes. {ECO:0000269|PubMed:23656586}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.49774	0.43956	-0.251530012	35.42108988	4.88397	0.18068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	494	9	80646047	chr9:80646047	G	A	130	PASS	DP=494;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	82242418	82242418	G	T	intronic	TLE4	.	.	.	0.99992164	7.84E-05	4.33E-12	.	0.94973	0.14686	-0.556537043	19.72753008	90.91723	2.05178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	368	9	82242418	chr9:82242418	G	T	67	PASS	DP=368;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	84530614	84530614	C	G	ncRNA_exonic	SPATA31D5P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	306	9	84530614	chr9:84530614	C	G	95	PASS	DP=306;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	86894167	86894167	A	-	intronic	SLC28A3	.	.	.	1.96E-17	0.006793446	0.993206554	.	0.17401	0.11684	0.846940207	88.47605567	2204.23741	8.64325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	55	9	86894166	chr9:86894166	CA	C	69	PASS	DP=55;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	90473388	90473388	A	T	ncRNA_exonic	LOC392364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	318	9	90473388	chr9:90473388	A	T	.	PASS	DP=318;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	90535825	90535825	C	T	exonic	SPATA31C1	.	synonymous SNV	SPATA31C1:NM_001145124:exon4:c.C1003T:p.L335L	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	361	9	90535825	chr9:90535825	C	T	.	PASS	DP=361;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	95646774	95646774	G	A	ncRNA_intronic	LOC642943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	209	9	95646774	chr9:95646774	G	A	87	PASS	DP=209;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
9	100618882	100618900	GGTTCAGTCCAAATGGGGA	-	UTR3	FOXE1	NM_004473:c.*1564_*1582delGGTTCAGTCCAAATGGGGA	.	.	.	.	.	DISEASE: Bamforth-Lazarus syndrome (BLS) [MIM:241850]: A disease characterized by thyroid agenesis, cleft palate and choanal atresia. {ECO:0000269|PubMed:12165566, ECO:0000269|PubMed:9697705}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.10592	.	.	82.34677	1.92681	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	69	9	100618881	chr9:100618881	TGGTTCAGTCCAAATGGGGA	T	94	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	101052938	101052938	G	A	exonic	GABBR2	.	synonymous SNV	GABBR2:NM_005458:exon19:c.C2754T:p.C918C	0.999790263	0.000209737	9.64E-12	.	0.72097	0.15588	-1.285933373	5.083746167	1340.48679	6.87315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	100	9	101052938	chr9:101052938	G	A	.	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	101068579	101068579	C	T	exonic	GABBR2	.	nonsynonymous SNV	GABBR2:NM_005458:exon15:c.G2053A:p.A685T	0.999790263	0.000209737	9.64E-12	.	0.72097	0.15588	-1.285933373	5.083746167	1340.48679	6.87315	0.012	0.546	D	0.999	0.764	D	0.996	0.832	D	0.000	0.843	D	1	0.810	D	1.01	0.254	L	-2.26	0.874	D	-3.06	0.630	D	0.739	0.736	0.767	0.940	D	0.799	0.932	D	0.171	0.849	D	4.022	0.540	23.6	0.999	0.995	0.994	0.954	D	c	0.706	0.605	1.000	0.747	0.706	0.609	0	5.15	0.702	7.676	0.832	0.935	0.490	1.000	0.715	0.969	0.458	16.142	0.813	GPCR family 3, C-terminal	.	.	0.5	79	354	9	101068579	chr9:101068579	C	T	79	PASS	DP=354;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	102588038	102588038	G	T	UTR5	NR4A3	NM_006981:c.-2287G>T;NM_173200:c.-1015G>T;NM_173199:c.-2287G>T	.	.	.	.	.	DISEASE: Ewing sarcoma (ES) [MIM:612219]: A highly malignant, metastatic, primitive small round cell tumor of bone and soft tissue that affects children and adolescents. It belongs to the Ewing sarcoma family of tumors, a group of morphologically heterogeneous neoplasms that share the same cytogenetic features. They are considered neural tumors derived from cells of the neural crest. Ewing sarcoma represents the less differentiated form of the tumors. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving NR4A3 is found in patients with Erwing sarcoma. Translocation t(9;22)(q22- 31;q11-12) with EWSR1.; DISEASE: Note=A chromosomal aberration involving NR4A3 is a cause of a form of extraskeletal myxoid chondrosarcomas (EMC). Translocation t(9;17)(q22;q11) with TAF2N.; 	0.71461	0.18411	-0.339715008	30.06605331	1958.05838	8.14638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	309	9	102588038	chr9:102588038	G	T	95	PASS	DP=309;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	105751516	105751516	A	G	intergenic	LINC00587;CYLC2	dist=331725;dist=6077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	9	105751516	chr9:105751516	A	G	.	PASS	DP=30;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	112225553	112225553	-	A	intronic	PTPN3	.	.	.	0.000188228	0.999811394	3.78E-07	.	0.33179	0.60913	-1.16661987	6.074545883	3579.8361	11.56829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	92	9	112225552	chr9:112225552	TA	TAA,T	53	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	112225553	112225553	A	-	intronic	PTPN3	.	.	.	0.000188228	0.999811394	3.78E-07	.	0.33179	0.60913	-1.16661987	6.074545883	3579.8361	11.56829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	92	9	112225552	chr9:112225552	TA	TAA,T	53	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	115818958	115818958	G	A	exonic	ZFP37	.	nonsynonymous SNV	ZFP37:NM_001282515:exon1:c.C11T:p.S4F,ZFP37:NM_001282518:exon1:c.C11T:p.S4F,ZFP37:NM_003408:exon1:c.C11T:p.S4F	4.11E-09	0.103496806	0.89650319	.	0.07258	0.06248	0.264628794	70.5178108	1185.08476	6.53135	0.001	0.784	D	0.005	0.119	B	0.005	0.104	B	.	.	.	1	0.090	N	0	0.065	N	3.37	0.062	T	0.19	0.119	N	0.163	0.284	-0.950	0.411	T	0.010	0.035	T	0.010	0.271	T	4.237	0.568	23.9	0.995	0.652	0.006	0.026	N	c	-0.866	-0.849	1.000	0.747	0.524	0.211	1	1.26	0.204	0.678	0.248	0.951	0.538	0.295	0.251	0.415	0.257	4.528	0.113	.	.	.	0.5	130	618	9	115818958	chr9:115818958	G	A	130	PASS	DP=618;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	116155669	116155669	-	CCCCAA	intronic	ALAD	.	.	.	0.06295026	0.933785175	0.003264564	DISEASE: Acute hepatic porphyria (AHEPP) [MIM:612740]: A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. AHP is characterized by attacks of gastrointestinal disturbances, abdominal colic, paralyses and peripheral neuropathy. Most attacks are precipitated by drugs, alcohol, caloric deprivation, infections, or endocrine factors. {ECO:0000269|PubMed:10706561, ECO:0000269|PubMed:1309003, ECO:0000269|PubMed:1569184, ECO:0000269|PubMed:2063868}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11936	0.55928	-0.558357437	19.54470394	471.54569	4.49402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	77	9	116155669	chr9:116155669	T	TCCCCAA	126	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	116172489	116172489	C	-	intronic	POLE3	.	.	.	0.077745399	0.751043147	0.171211454	.	0.34686	0.24974	-0.119252484	44.53880632	8.01565	0.29467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	2980	9	116172488	chr9:116172488	GC	G,GCC	108	PASS	DP=2980;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
9	116172489	116172489	-	C	intronic	POLE3	.	.	.	0.077745399	0.751043147	0.171211454	.	0.34686	0.24974	-0.119252484	44.53880632	8.01565	0.29467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	2980	9	116172488	chr9:116172488	GC	G,GCC	108	PASS	DP=2980;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/2
9	117053128	117053128	C	A	exonic	COL27A1	.	synonymous SNV	COL27A1:NM_032888:exon48:c.C4407A:p.G1469G	0.999999361	6.39E-07	9.95E-23	DISEASE: Steel syndrome (STLS) [MIM:615155]: A syndrome characterized by dislocated hips and radial heads, fusion of carpal bones, short stature, scoliosis, and cervical spine anomalies. Facial features include prominent forehead, long oval- shaped face, hypertelorism and broad nasal bridge. {ECO:0000269|PubMed:24986830}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.70075	.	0.170613481	65.33970276	8956.48219	20.50775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	9	117053128	chr9:117053128	C	A	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	118228115	118228115	-	G	intergenic	DEC1;LOC101928775	dist=63192;dist=273834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	82	9	118228115	chr9:118228115	A	AG	136	PASS	DP=82;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	123715023	123715023	T	C	exonic	C5	.	synonymous SNV	C5:NM_001317163:exon41:c.A5043G:p.G1681G,C5:NM_001735:exon41:c.A5025G:p.G1675G	5.61E-11	0.999999829	1.71E-07	DISEASE: Complement component 5 deficiency (C5D) [MIM:609536]: A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=An association study of C5 haplotypes and genotypes in individuals with chronic hepatitis C virus infection shows that individuals homozygous for the C5_1 haplotype have a significantly higher stage of liver fibrosis than individuals carrying at least 1 other allele. {ECO:0000269|PubMed:15995705}.; 	0.25448	0.15814	-0.051509809	49.39254541	5639.16587	15.54132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	9	123715023	chr9:123715023	T	C	.	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	124116829	124116829	T	A	intronic	STOM	.	.	.	0.000669923	0.742296515	0.257033562	.	0.39969	0.14827	0.281220278	71.07808445	192.29982	3.0063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	79	9	124116829	chr9:124116829	T	A	77	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
9	124534970	124534970	C	T	exonic	DAB2IP	.	synonymous SNV	DAB2IP:NM_138709:exon10:c.C1791T:p.P597P,DAB2IP:NM_032552:exon12:c.C2079T:p.P693P	0.999652088	0.000347912	1.63E-10	DISEASE: Note=A chromosomal aberration involving DAB2IP is found in a patient with acute myeloid leukemia (AML). Translocation t(9;11)(q34;q23) with KMT2A/MLL1. May give rise to a KMT2A/MLL1- DAB2IP fusion protein lacking the PH domain (PubMed:14978793). {ECO:0000269|PubMed:14978793}.; 	0.49661	0.13993	-1.517642441	3.467799009	1179.95825	6.52137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	348	9	124534970	chr9:124534970	C	T	101	PASS	DP=348;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	125866165	125866165	C	T	UTR3	RABGAP1	NM_012197:c.*673C>T	.	.	0.9999998	2.00E-07	1.04E-17	.	0.29209	0.11542	-1.50825116	3.503184713	121.41418	2.40018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	9	125866165	chr9:125866165	C	T	.	PASS	DP=45;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	127620830	127620830	C	G	intronic	RPL35	.	.	.	0.527875069	0.456078589	0.016046342	.	0.92515	.	0.125076652	62.7388535	10.99298	0.39832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	306	9	127620830	chr9:127620830	C	G	103	PASS	DP=306;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	127623857	127623857	C	G	intronic	RPL35	.	.	.	0.527875069	0.456078589	0.016046342	.	0.92515	.	0.125076652	62.7388535	10.99298	0.39832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	521	9	127623857	chr9:127623857	C	G	78	PASS	DP=521;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	130279245	130279245	C	A	exonic	FAM129B	.	nonsynonymous SNV	FAM129B:NM_001035534:exon8:c.G825T:p.E275D,FAM129B:NM_022833:exon8:c.G864T:p.E288D	0.096703214	0.903283319	1.35E-05	.	0.24632	0.10776	-1.346642726	4.62962963	224.45345	3.23964	0.223	0.188	T	0.122	0.252	B	0.056	0.247	B	0.000	0.504	D	0.933	0.370	D	0.61	0.157	N	1.87	0.241	T	-0.87	0.236	N	0.08	0.072	-1.069	0.096	T	0.042	0.182	T	0.010	0.257	T	1.657	0.260	14.17	0.986	0.433	0.078	0.136	N	c	-0.549	-0.502	1.000	0.517	0.672	0.522	0	3.9	0.441	-0.708	0.051	0.016	0.142	0.063	0.217	0.021	0.135	7.542	0.268	.	.	.	0.5	.	207	9	130279245	chr9:130279245	C	A	.	PASS	DP=207;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	130869493	130869493	G	-	intronic	SLC25A25	.	.	.	0.973302049	0.026691324	6.63E-06	.	0.11945	0.09594	-0.44448505	24.46331682	56.75648	1.51571	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	506	9	130869492	chr9:130869492	CG	C	65	PASS	DP=506;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
9	131388269	131388269	G	T	ncRNA_intronic	MIR1268A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	223	9	131388269	chr9:131388269	G	T	96	PASS	DP=223;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
9	131457105	131457106	GG	-	UTR3	SET	NM_001122821:c.*162_*163delGG;NM_001248000:c.*162_*163delGG;NM_003011:c.*162_*163delGG;NM_001248001:c.*162_*163delGG	.	.	0.96336428	0.036564183	7.15E-05	DISEASE: Note=A chromosomal aberration involving SET is found in some cases of acute undifferentiated leukemia (AUL). Translocation t(6;9)(q21;q34.1) with NUP214/CAN.; 	0.60962	0.29577	0.3032669	72.009908	21.10998	0.71452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	214	9	131457104	chr9:131457104	TGG	T	78	PASS	DP=214;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
9	132595850	132595850	T	-	intronic	C9orf78	.	.	.	0.117679602	0.876685775	0.005634624	.	0.16424	0.11262	-0.141298762	42.87567823	13.49973	0.49056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	118	9	132595849	chr9:132595849	AT	A	55	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
9	132982937	132982937	C	T	intronic	NCS1	.	.	.	0.947220876	0.052601383	0.000177741	.	0.18713	0.18619	-0.141298762	42.87567823	2.47706	0.0911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	9	132982937	chr9:132982937	C	T	.	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	133269139	133269139	C	A	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	238	9	133269139	chr9:133269139	C	A	.	PASS	DP=238;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	133271585	133271585	G	C	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	0.627	0.382	P	0.399	0.427	B	.	.	.	.	.	.	0.15	0.089	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.781	0.041	0.047	0.411	0.029	0.102	0.156	N	n	-0.008	1.149	0.998	0.358	0.253	0.035	0	-9.45	0.005	-1.542	0.023	-1.392	0.012	0.000	0.063	0.000	0.016	6.662	0.221	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	62	189	9	133271585	chr9:133271585	G	C	62	PASS	DP=189;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	133280335	133280335	G	T	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	0.005	0.119	B	0.002	0.063	B	.	.	.	.	.	.	-1.075	0.010	N	.	.	.	.	.	.	0.168	0.203	-0.993	0.317	T	0.075	0.301	T	0.003	0.073	T	1.953	0.296	15.92	0.981	0.374	0.185	0.201	N	c	-0.892	-0.739	0.040	0.144	0.646	0.450	0	1.18	0.200	-0.101	0.109	0.095	0.197	0.028	0.201	0.974	0.471	6.172	0.195	Immunoglobulin I-set|Immunoglobulin V-set domain|Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	121	475	9	133280335	chr9:133280335	G	T	121	PASS	DP=475;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	134184484	134184484	C	A	UTR3	PLPP7	NM_032728:c.*810C>A	.	.	.	.	.	.	0.13175	.	-0.291981272	33.20358575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	435	9	134184484	chr9:134184484	C	A	92	PASS	DP=435;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	136083528	136083528	T	A	exonic	OBP2B	.	nonsynonymous SNV	OBP2B:NM_001288987:exon3:c.A269T:p.Y90F,OBP2B:NM_014581:exon3:c.A269T:p.Y90F	0.182972936	0.764684023	0.052343041	.	0.07451	.	0.593509966	82.51356452	9.30105	0.3415	0.297	0.146	T	0.393	0.329	B	0.257	0.376	B	0.027	0.259	N	1	0.192	N	1.055	0.270	L	3.25	0.068	T	-2.4	0.527	N	0.059	0.303	-0.959	0.394	T	0.012	0.048	T	.	.	.	-0.834	0.039	0.036	0.146	0.003	0.002	0.012	N	c	-1.564	-1.642	0.002	0.092	0.487	0.133	0	0.679	0.171	-0.405	0.072	-0.573	0.046	0.001	0.137	0.016	0.126	5.651	0.168	Calycin|Calycin-like|Lipocalin/cytosolic fatty-acid binding domain	.	.	0.5	.	286	9	136083528	chr9:136083528	T	A	.	PASS	DP=286;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	136083634	136083634	A	C	intronic	OBP2B	.	.	.	0.182972936	0.764684023	0.052343041	.	0.07451	.	0.593509966	82.51356452	9.30105	0.3415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	471	9	136083634	chr9:136083634	A	C	85	PASS	DP=471;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
9	136103948	136103948	T	C	intergenic	OBP2B;ABO	dist=19311;dist=26615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	137	9	136103948	chr9:136103948	T	C	.	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	136403431	136403431	C	G	intronic	ADAMTSL2	.	.	.	0.071058667	0.916004048	0.012937285	DISEASE: Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]: An autosomal recessive disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone- shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues. {ECO:0000269|PubMed:18677313, ECO:0000269|PubMed:21415077}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26032	0.11516	.	.	74.41925	1.80297	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	510	9	136403431	chr9:136403431	C	G	123	PASS	DP=510;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	136412300	136412300	G	T	exonic	ADAMTSL2	.	nonsynonymous SNV	ADAMTSL2:NM_001145320:exon9:c.G904T:p.A302S,ADAMTSL2:NM_014694:exon9:c.G904T:p.A302S	0.071058667	0.916004048	0.012937285	DISEASE: Geleophysic dysplasia 1 (GPHYSD1) [MIM:231050]: An autosomal recessive disorder characterized by severe short stature, short hands and feet, joint limitations, and skin thickening. Radiologic features include delayed bone age, cone- shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues. {ECO:0000269|PubMed:18677313, ECO:0000269|PubMed:21415077}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26032	0.11516	.	.	74.41925	1.80297	0.0	0.912	D	1.0	0.899	D	0.984	0.745	D	0.002	0.372	N	1	0.810	D	1.455	0.369	L	0.56	0.546	T	-2.4	0.527	N	0.606	0.764	-0.625	0.638	T	0.310	0.681	T	0.024	0.468	T	4.603	0.617	24.4	0.998	0.850	0.989	0.883	D	c	0.695	0.670	1.000	0.747	0.646	0.450	0	5.16	0.704	9.847	0.984	1.048	0.713	1.000	0.715	0.997	0.653	18.645	0.913	ADAM-TS Spacer 1	.	.	0.5	76	496	9	136412300	chr9:136412300	G	T	76	PASS	DP=496;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	137600270	137600270	T	-	intronic	COL5A1	.	.	.	1	2.48E-13	8.59E-33	DISEASE: Ehlers-Danlos syndrome, classic type (EDS) [MIM:130000]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. {ECO:0000269|PubMed:10602121, ECO:0000269|PubMed:11992482, ECO:0000269|PubMed:15580559, ECO:0000269|PubMed:18972565, ECO:0000269|PubMed:9042913}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.69297	.	-3.009169053	0.524887945	863.84203	5.72906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	215	9	137600269	chr9:137600269	GT	G	98	PASS	DP=215;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
9	138648974	138648974	C	T	intronic	KCNT1	.	.	.	0.005348738	0.994649439	1.82E-06	DISEASE: Epileptic encephalopathy, early infantile, 14 (EIEE14) [MIM:614959]: A rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay. This severe neurologic disorder is characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another. {ECO:0000269|PubMed:23086397}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, nocturnal frontal lobe, 5 (ENFL5) [MIM:615005]: An autosomal dominant focal epilepsy syndrome characterized by childhood onset of clusters of motor seizures during sleep. Some patients may develop behavioral or psychiatric manifestations and/or intellectual disability. The phenotype is more severe than observed in other genetic forms of nocturnal frontal lobe epilepsy. {ECO:0000269|PubMed:23086396}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10242	0.10521	-2.070835943	1.615947157	121.99362	2.40558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	505	9	138648974	chr9:138648974	C	T	74	PASS	DP=505;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	139298595	139298595	C	A	exonic	SDCCAG3	.	nonsynonymous SNV	SDCCAG3:NM_001039708:exon7:c.G901T:p.G301C,SDCCAG3:NM_006643:exon8:c.G1051T:p.G351C,SDCCAG3:NM_001039707:exon9:c.G1120T:p.G374C	1.38E-07	0.368767768	0.631232094	.	0.13869	0.10313	0.468503535	78.79806558	1803.84196	7.83738	0.067	0.359	T	0.13	0.278	B	0.077	0.311	B	0.148	0.180	N	0.599	0.309	N	1.59	0.404	L	1.49	0.315	T	-2.55	0.558	D	0.275	0.483	-1.049	0.148	T	0.053	0.226	T	0.014	0.345	T	2.394	0.349	18.78	0.971	0.319	0.467	0.276	N	c	-0.057	-0.035	1.000	0.747	0.672	0.522	0	2.67	0.306	1.072	0.301	0.852	0.362	0.982	0.353	0.290	0.235	2.448	0.042	.	.	.	0.5	88	441	9	139298595	chr9:139298595	C	A	88	PASS	DP=441;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	139840877	139840877	G	C	intronic	C8G	.	.	.	1.63E-09	0.032163822	0.967836176	.	0.04668	.	0.196671391	67.19155461	801.2629	5.57646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	600	9	139840877	chr9:139840877	G	C	132	PASS	DP=600;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	140177108	140177108	G	A	downstream	TOR4A	dist=15	.	.	0.215534136	0.647904223	0.136561641	.	0.09004	0.12134	.	.	186.39911	2.9648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	9	140177108	chr9:140177108	G	A	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
9	140356813	140356813	T	A	intronic	PNPLA7	.	.	.	6.23E-27	0.002298147	0.997701853	.	0.10273	0.0978	0.163315215	64.96815287	2633.02271	9.62537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	649	9	140356813	chr9:140356813	T	A	124	PASS	DP=649;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	140357105	140357105	G	A	intronic	PNPLA7	.	.	.	6.23E-27	0.002298147	0.997701853	.	0.10273	0.0978	0.163315215	64.96815287	2633.02271	9.62537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	423	9	140357105	chr9:140357105	G	A	104	PASS	DP=423;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
9	140396079	140396079	C	-	intronic	PNPLA7	.	.	.	6.23E-27	0.002298147	0.997701853	.	0.10273	0.0978	0.163315215	64.96815287	2633.02271	9.62537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	433	9	140396078	chr9:140396078	GC	G	101	PASS	DP=433;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	1779236	1779236	G	A	intronic	ADARB2	.	.	.	0.738168861	0.261726193	0.000104945	.	0.18882	0.14637	-0.505170032	21.79759377	584.19726	4.90127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	608	10	1779236	chr10:1779236	G	A	126	PASS	DP=608;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	3208567	3208567	-	GCACGCTAGGGAAGAGAGAGGAATG	exonic	PITRM1	.	stopgain	PITRM1:NM_001242309:exon3:c.175_176insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q59Pfs*6,PITRM1:NM_001242307:exon4:c.271_272insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q91Pfs*6,PITRM1:NM_001347725:exon4:c.271_272insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q91Pfs*6,PITRM1:NM_001347729:exon4:c.247_248insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q83Pfs*6,PITRM1:NM_001347730:exon4:c.247_248insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q83Pfs*6,PITRM1:NM_014889:exon4:c.271_272insCATTCCTCTCTCTTCCCTAGCGTGC:p.Q91Pfs*6	7.16E-16	0.192931146	0.807068854	.	0.09989	0.1727	3.215903205	99.35715971	3783.48611	12.04965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	28	10	3208567	chr10:3208567	T	TGCACGCTAGGGAAGAGAGAGGAATG	93	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	11367781	11367781	T	-	ncRNA_intronic	CELF2-AS1	.	.	.	.	.	.	.	0.03536	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	20	10	11367780	chr10:11367780	CT	C	97	PASS	DP=20;AN=2	GT	./.	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.
10	11797352	11797352	G	A	intronic	ECHDC3	.	.	.	0.000536786	0.458749649	0.540713565	.	0.12334	0.16358	0.420771676	77.15852795	961.97162	6.0042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	106	10	11797352	chr10:11797352	G	A	.	PASS	DP=106;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	12068570	12068570	C	T	intronic	UPF2	.	.	.	0.999998269	1.73E-06	8.11E-17	.	0.89697	.	-0.885424753	10.4623732	286.42271	3.62468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	80	10	12068570	chr10:12068570	C	T	.	PASS	DP=80;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	12126729	12126729	G	A	exonic	DHTKD1	.	synonymous SNV	DHTKD1:NM_018706:exon3:c.G501A:p.S167S	1.98E-16	0.094735079	0.905264921	DISEASE: Charcot-Marie-Tooth disease 2Q (CMT2Q) [MIM:615025]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. Nerve conduction velocities are normal or slightly reduced. {ECO:0000269|PubMed:23141294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 2-aminoadipic 2-oxoadipic aciduria (AMOXAD) [MIM:204750]: A metabolic disorder characterized by increased levels of 2- oxoadipate and 2-hydroxyadipate in the urine, and elevated 2- aminoadipate in the plasma. Patients can have mild to severe intellectual disability, muscular hypotonia, developmental delay, ataxia, and epilepsy. Most cases are asymptomatic. {ECO:0000269|PubMed:23141293}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13449	.	0.986521626	90.48124558	3727.11408	11.93027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	102	10	12126729	chr10:12126729	G	A	80	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
10	12871236	12871236	A	-	UTR3	CAMK1D	NM_153498:c.*350delA	.	.	0.993807052	0.006192043	9.05E-07	.	0.18445	0.13388	-0.271755481	34.31823543	16.76649	0.58938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	12	10	12871235	chr10:12871235	CA	C	43	PASS	DP=12;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	15761714	15761714	G	T	exonic	ITGA8	.	synonymous SNV	ITGA8:NM_001291494:exon1:c.C57A:p.P19P,ITGA8:NM_003638:exon1:c.C57A:p.P19P	5.02E-08	0.999982572	1.74E-05	.	0.19255	0.19038	-0.786348947	12.63269639	602.10061	4.96627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	213	10	15761714	chr10:15761714	G	T	90	PASS	DP=213;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	18430127	18430127	C	A	exonic	CACNB2	.	nonsynonymous SNV	CACNB2:NM_001167945:exon1:c.C19A:p.L7M,CACNB2:NM_201571:exon1:c.C19A:p.L7M,CACNB2:NM_201572:exon1:c.C19A:p.L7M	0.001820338	0.997139378	0.001040285	DISEASE: Brugada syndrome 4 (BRGDA4) [MIM:611876]: A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18213	0.15589	-0.705410796	14.77942911	766.55161	5.48442	0.141	0.330	T	0.742	0.442	P	0.047	0.293	B	.	.	.	1.000	0.516	D	.	.	.	-1.74	0.836	D	0.49	0.031	N	0.096	0.100	-0.844	0.524	T	0.163	0.500	T	0.098	0.770	D	2.148	0.319	17.17	0.967	0.301	0.340	0.247	N	c	-0.354	-0.239	1.000	0.405	0.598	0.340	0	2.63	0.303	1.396	0.339	0.739	0.307	1.000	0.715	1.000	0.888	6.157	0.194	.	.	.	0.5	.	59	10	18430127	chr10:18430127	C	A	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	21803522	21803522	A	G	UTR3	SKIDA1	NM_207371:c.*503T>C	.	.	.	.	.	.	0.891	.	.	.	438.2434	4.36472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	277	10	21803522	chr10:21803522	A	G	134	PASS	DP=277;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	21807709	21807709	G	T	UTR5	SKIDA1	NM_207371:c.-958C>A	.	.	.	.	.	.	0.891	.	.	.	438.2434	4.36472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	10	21807709	chr10:21807709	G	T	.	PASS	DP=30;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	24834880	24834880	G	T	exonic	KIAA1217	.	nonsynonymous SNV	KIAA1217:NM_001321681:exon14:c.G2813T:p.G938V,KIAA1217:NM_001282768:exon18:c.G3677T:p.G1226V,KIAA1217:NM_001098500:exon19:c.G3422T:p.G1141V,KIAA1217:NM_001282767:exon19:c.G3752T:p.G1251V,KIAA1217:NM_019590:exon21:c.G5459T:p.G1820V	0.014167894	0.985832017	8.91E-08	.	0.22162	0.09445	-3.009169053	0.524887945	2127.12642	8.49315	0.009	0.912	D	0.879	0.588	P	0.426	0.500	B	0.014	0.286	N	0.998	0.810	D	1.795	0.474	L	1.42	0.344	T	-2.69	0.574	D	0.358	0.551	-1.018	0.245	T	0.124	0.428	T	0.016	0.368	T	5.390	0.730	26.0	0.996	0.732	0.815	0.406	D	c	0.437	0.470	0.987	0.311	0.706	0.609	0	4.62	0.568	2.364	0.436	1.048	0.713	1.000	0.715	0.999	0.750	13.765	0.623	.	.	.	0.5	102	127	10	24834880	chr10:24834880	G	T	102	PASS	DP=127;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	27054256	27054256	A	-	intronic	ABI1	.	.	.	0.632775183	0.367164391	6.04E-05	DISEASE: Note=A chromosomal aberration involving ABI1 is a cause of acute leukemias. Translocation t(10;11)(p11.2;q23) with KMT2A/MLL1. ABI1 isoform 2 was found to be present in acute leukemia KMT2A/MLL1-ABI1 fusion transcript. {ECO:0000269|PubMed:9694699}.; 	0.52357	0.29688	-0.315847836	31.68789809	53.85297	1.46346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	128	10	27054255	chr10:27054255	GA	G	73	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	27793246	27793246	G	A	UTR5	RAB18	NM_021252:c.-53G>A;NM_001256412:c.-53G>A;NM_001256411:c.-53G>A;NM_001256410:c.-53G>A;NM_001256415:c.-53G>A	.	.	0.955008595	0.044872127	0.000119278	.	0.19227	0.1096	0.103030231	61.2762444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	454	10	27793246	chr10:27793246	G	A	108	PASS	DP=454;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	28908452	28908452	-	T	intronic	WAC	.	.	.	0.999891943	0.000108057	4.68E-11	.	0.23812	0.12474	-0.867014353	10.72776598	545.45625	4.75017	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	68	10	28908452	chr10:28908452	C	CT	51	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	30316534	30316534	C	A	exonic	JCAD	.	nonsynonymous SNV	JCAD:NM_020848:exon3:c.G2543T:p.S848I,JCAD:NM_001350001:exon4:c.G2129T:p.S710I,JCAD:NM_001350021:exon4:c.G2129T:p.S710I,JCAD:NM_001350022:exon4:c.G2543T:p.S848I	.	.	.	.	.	.	.	.	.	.	0.01	0.564	D	1.0	0.899	D	0.971	0.708	D	.	.	.	0.951	0.265	N	1.87	0.498	L	2.25	0.178	T	-1.91	0.444	N	0.392	0.452	-1.077	0.080	T	0.083	0.325	T	0.019	0.409	T	5.862	0.803	27.3	0.996	0.729	0.938	0.590	D	c	0.239	0.136	1.000	0.747	0.714	0.819	0	4.61	0.566	2.624	0.459	0.935	0.490	0.995	0.385	0.017	0.128	11.758	0.510	.	.	.	0.5	102	334	10	30316534	chr10:30316534	C	A	102	PASS	DP=334;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	30638190	30638190	G	T	exonic	MTPAP	.	synonymous SNV	MTPAP:NM_018109:exon1:c.C15A:p.G5G	0.910575497	0.089418828	5.67E-06	.	0.0821	0.07339	-0.179930907	40.35739561	83.82931	1.94936	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	417	10	30638190	chr10:30638190	G	T	.	PASS	DP=417;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	32096466	32096466	A	-	UTR3	ARHGAP12	NM_001270696:c.*120delT;NM_001270699:c.*120delT;NM_018287:c.*120delT;NM_001270695:c.*120delT;NM_001270697:c.*120delT;NM_001270698:c.*120delT	.	.	0.002317772	0.997652082	3.01E-05	.	0.59182	0.1351	-0.819281839	11.93677754	2139.4248	8.5073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	130	10	32096465	chr10:32096465	CA	C	66	PASS	DP=130;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	35360310	35360310	G	A	intronic	CUL2	.	.	.	0.99999841	1.59E-06	1.61E-15	.	0.72401	0.19444	-0.580403979	18.58928993	30.29769	0.96644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	36	10	35360310	chr10:35360310	G	A	55	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	37442560	37442560	G	A	exonic	ANKRD30A	.	nonsynonymous SNV	ANKRD30A:NM_052997:exon13:c.G1600A:p.E534K	1.26E-23	0.003987679	0.996012321	.	0.05405	.	2.702925512	98.90304317	3097.8543	10.58328	0.0	0.912	D	0.963	0.537	D	0.424	0.434	B	.	.	.	1	0.090	N	0.695	0.181	N	3.4	0.057	T	-0.76	0.295	N	0.111	0.120	-0.965	0.381	T	0.014	0.058	T	0.001	0.014	T	2.209	0.327	17.57	0.989	0.471	0.017	0.054	N	c	-0.569	-0.769	0.060	0.152	0.487	0.133	0	1.47	0.217	1.040	0.297	0.636	0.291	0.041	0.208	0.006	0.095	6.435	0.209	.	.	.	0.5	.	77	10	37442560	chr10:37442560	G	A	.	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	42833142	42833142	A	T	ncRNA_exonic	LOC441666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	123	10	42833142	chr10:42833142	A	T	131	PASS	DP=123;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	42833154	42833154	T	C	ncRNA_exonic	LOC441666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	131	10	42833154	chr10:42833154	T	C	152	PASS	DP=131;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	42922650	42922651	TA	-	ncRNA_intronic	CCNYL2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	28	10	42922649	chr10:42922649	GTA	G	60	PASS	DP=28;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	42924593	42924593	G	-	ncRNA_exonic	CCNYL2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	287	10	42924592	chr10:42924592	AG	A	80	PASS	DP=287;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	43694491	43694491	G	-	intronic	RASGEF1A	.	.	.	0.910096302	0.089875281	2.84E-05	.	0.28193	0.10809	0.084621747	60.31493277	52.5675	1.43524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	412	10	43694490	chr10:43694490	CG	C	73	PASS	DP=412;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
10	45938895	45938895	G	C	exonic	ALOX5	.	nonsynonymous SNV	ALOX5:NM_000698:exon11:c.G1483C:p.E495Q,ALOX5:NM_001256153:exon11:c.G1387C:p.E463Q,ALOX5:NM_001256154:exon11:c.G1483C:p.E495Q,ALOX5:NM_001320861:exon11:c.G1396C:p.E466Q,ALOX5:NM_001320862:exon11:c.G1048C:p.E350Q	0.001644393	0.998111454	0.000244152	.	0.58302	0.38768	-0.953385901	9.206180703	89.21156	2.03011	0.068	0.357	T	0.01	0.271	B	0.014	0.347	B	0.012	0.292	N	1	0.090	N	.	.	.	-2.55	0.896	D	-0.28	0.116	N	0.108	0.132	-0.484	0.692	T	0.481	0.802	T	0.026	0.487	D	1.601	0.254	13.86	0.959	0.276	0.668	0.329	D	c	-0.323	-0.180	0.903	0.261	0.635	0.413	0	3.54	0.395	1.459	0.346	0.135	0.219	0.813	0.296	0.964	0.448	9.299	0.368	Lipoxygenase, C-terminal	.	.	0.5	130	592	10	45938895	chr10:45938895	G	C	130	PASS	DP=592;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	46217869	46217869	C	G	intergenic	ZFAND4;WASHC2C	dist=49608;dist=4779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	74	10	46217869	chr10:46217869	C	G	.	PASS	DP=74;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
10	46968680	46968680	G	A	exonic	SYT15	.	stopgain	SYT15:NM_031912:exon3:c.C256T:p.R86X,SYT15:NM_181519:exon3:c.C256T:p.R86X	3.40E-18	0.000175723	0.999824277	.	0.03366	0.12113	0.780798785	87.24345364	417.36536	4.27585	.	.	.	.	.	.	.	.	.	0.565	0.113	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.567	0.963	35	0.998	0.901	0.625	0.315	D	c	0.334	0.083	1.000	0.747	0.765	0.991	0	1.43	0.215	1.336	0.332	0.722	0.304	0.918	0.317	0.459	0.264	8.235	0.306	.	.	.	0.5	.	98	10	46968680	chr10:46968680	G	A	.	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	49791107	49791107	C	G	exonic	ARHGAP22	.	nonsynonymous SNV	ARHGAP22:NM_001256024:exon2:c.G125C:p.G42A,ARHGAP22:NM_001256025:exon2:c.G143C:p.G48A,ARHGAP22:NM_001347735:exon2:c.G125C:p.G42A,ARHGAP22:NM_001347737:exon2:c.G125C:p.G42A,ARHGAP22:NM_021226:exon2:c.G125C:p.G42A,ARHGAP22:NM_001347736:exon3:c.G143C:p.G48A,ARHGAP22:NM_001347738:exon3:c.G143C:p.G48A	0.000724652	0.980744858	0.01853049	.	0.12203	0.13515	-0.396754488	26.97570182	185.07105	2.95338	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1.000	0.588	D	3.81	0.956	H	-1.36	0.801	T	-4.73	0.800	D	0.464	0.732	0.820	0.947	D	0.781	0.926	D	0.206	0.871	D	5.863	0.803	27.3	0.998	0.928	0.993	0.936	D	c	0.987	0.894	1.000	0.747	0.707	0.730	0	5.28	0.740	7.531	0.807	0.935	0.490	1.000	0.715	0.916	0.392	17.462	0.875	PH domain-like|Pleckstrin homology domain	.	.	0.5	67	290	10	49791107	chr10:49791107	C	G	67	PASS	DP=290;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	50339798	50339798	C	A	exonic	FAM170B	.	stopgain	FAM170B:NM_001164484:exon2:c.G712T:p.E238X	.	.	.	.	0.14419	.	1.436808095	95.04600142	2513.30848	9.33771	.	.	.	.	.	.	.	.	.	0.002	0.383	N	1.000	0.520	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.868	0.964	36	0.994	0.614	0.403	0.262	N	c	0.451	0.247	1.000	0.517	0.497	0.185	0	2.64	0.304	2.607	0.457	0.935	0.490	0.942	0.325	0.990	0.544	7.549	0.268	.	.	.	0.5	61	232	10	50339798	chr10:50339798	C	A	61	PASS	DP=232;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	61549576	61549576	C	A	UTR3	CCDC6	NM_005436:c.*3099G>T	.	.	0.967799856	0.03219801	2.13E-06	DISEASE: Note=A chromosomal aberration involving CCDC6 is found in papillary thyroid carcinomas (PTCs). Inversion inv(10)(q11.2;q21) generates the RET/CCDC6 (PTC1) oncogene. {ECO:0000269|PubMed:2406025}.; 	0.4367	0.16675	-0.137658575	43.57159707	4670.49647	13.75925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	10	61549576	chr10:61549576	C	A	.	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	63423610	63423610	C	T	intronic	C10orf107	.	.	.	0.00079093	0.774574838	0.224634231	.	0.07541	.	-0.404032746	26.53338051	18.06284	0.63027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	32	10	63423610	chr10:63423610	C	T	50	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	63661555	63661555	C	T	intronic	ARID5B	.	.	.	0.999889943	0.000110057	4.89E-11	DISEASE: Note=Defects in ARID5B may be a cause of susceptibility to coronary atherosclerosis in the Japanese population.; DISEASE: Leukemia, acute lymphoblastic (ALL) [MIM:613065]: A subtype of acute leukemia, a cancer of the white blood cells. ALL is a malignant disease of bone marrow and the most common malignancy diagnosed in children. The malignant cells are lymphoid precursor cells (lymphoblasts) that are arrested in an early stage of development. The lymphoblasts replace the normal marrow elements, resulting in a marked decrease in the production of normal blood cells. Consequently, anemia, thrombocytopenia, and neutropenia occur to varying degrees. The lymphoblasts also proliferate in organs other than the marrow, particularly the liver, spleen, and lymphonodes. {ECO:0000269|PubMed:19684603, ECO:0000269|PubMed:19684604, ECO:0000269|PubMed:20042726, ECO:0000269|PubMed:20054350, ECO:0000269|PubMed:20189245, ECO:0000269|PubMed:20460642, ECO:0000269|PubMed:21098271}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.79023	0.1136	-1.03794674	7.832035858	133.85694	2.51593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	124	10	63661555	chr10:63661555	C	T	.	PASS	DP=124;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	63853315	63853315	G	T	UTR3	ARID5B	NM_032199:c.*526G>T;NM_001244638:c.*526G>T	.	.	0.999889943	0.000110057	4.89E-11	DISEASE: Note=Defects in ARID5B may be a cause of susceptibility to coronary atherosclerosis in the Japanese population.; DISEASE: Leukemia, acute lymphoblastic (ALL) [MIM:613065]: A subtype of acute leukemia, a cancer of the white blood cells. ALL is a malignant disease of bone marrow and the most common malignancy diagnosed in children. The malignant cells are lymphoid precursor cells (lymphoblasts) that are arrested in an early stage of development. The lymphoblasts replace the normal marrow elements, resulting in a marked decrease in the production of normal blood cells. Consequently, anemia, thrombocytopenia, and neutropenia occur to varying degrees. The lymphoblasts also proliferate in organs other than the marrow, particularly the liver, spleen, and lymphonodes. {ECO:0000269|PubMed:19684603, ECO:0000269|PubMed:19684604, ECO:0000269|PubMed:20042726, ECO:0000269|PubMed:20054350, ECO:0000269|PubMed:20189245, ECO:0000269|PubMed:20460642, ECO:0000269|PubMed:21098271}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.79023	0.1136	-1.03794674	7.832035858	133.85694	2.51593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	54	10	63853315	chr10:63853315	G	T	.	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	70182521	70182521	A	-	exonic	DNA2	.	frameshift deletion	DNA2:NM_001080449:exon15:c.2335delT:p.S779Hfs*5	1.95E-08	0.991999565	0.008000415	DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6 (PEOA6) [MIM:615156]: A disorder characterized by muscle weakness, mainly affecting the lower limbs, external ophthalmoplegia, exercise intolerance, and mitochondrial DNA deletions on muscle biopsy. Symptoms may appear in childhood or adulthood and show slow progression. {ECO:0000269|PubMed:23352259}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Seckel syndrome 8 (SCKL8) [MIM:615807]: A rare autosomal recessive disorder characterized by proportionate dwarfism of prenatal onset associated with low birth weight, growth retardation, severe microcephaly with a bird-headed like appearance, and mental retardation. {ECO:0000269|PubMed:24389050}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.62197	.	.	.	1134.53366	6.42769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	159	10	70182520	chr10:70182520	GA	G	67	PASS	DP=159;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	70450718	70450718	A	T	exonic	TET1	.	nonsynonymous SNV	TET1:NM_030625:exon12:c.A5558T:p.K1853M	0.999563278	0.000436722	9.65E-14	DISEASE: Note=A chromosomal aberration involving TET1 may be a cause of acute leukemias (PubMed:12646957). Translocation t(10;11)(q22;q23) with KMT2A/MLL1. This is a rare chromosomal translocation 5' KMT2A/MLL1-TET1 3' (PubMed:12124344, PubMed:12646957). {ECO:0000269|PubMed:12124344, ECO:0000269|PubMed:12646957}.; 	0.67616	0.10932	0.398551838	76.31516867	4993.56015	14.43135	0.002	0.721	D	0.997	0.689	D	0.911	0.630	D	0.000	0.005	N	1	0.090	N	2.175	0.612	M	3.11	0.082	T	-0.66	0.191	N	0.371	0.432	-1.094	0.049	T	0.060	0.252	T	0.008	0.217	T	3.872	0.522	23.5	0.990	0.497	0.225	0.216	N	c	-0.085	-0.272	0.033	0.141	0.672	0.522	0	2.78	0.316	1.406	0.340	1.199	0.960	0.014	0.188	0.016	0.126	7.701	0.276	2OGFeDO domain, nucleic acid-modifying type	.	.	0.5	.	52	10	70450718	chr10:70450718	A	T	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	71658520	71658520	T	C	splicing	COL13A1	NM_080798:exon10:c.609+2T>C;NM_080800:exon13:c.723+2T>C;NM_001320951:exon14:c.750+2T>C;NM_001130103:exon14:c.780+2T>C	.	.	0.003928968	0.996068184	2.85E-06	.	0.28276	0.14899	-0.440847477	24.59896202	250.76638	3.41203	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.763	0.639	24.7	0.993	0.589	0.918	0.541	D	c	1.056	0.900	1.000	0.747	0.060	0.007	0	5.38	0.772	5.327	0.654	1.061	0.807	1.000	0.715	0.996	0.625	13.899	0.631	.	.	.	0.5	122	309	10	71658520	chr10:71658520	T	C	122	PASS	DP=309;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	72520775	72520775	G	T	UTR3	ADAMTS14	NM_139155:c.*166G>T;NM_080722:c.*166G>T	.	.	2.33E-06	0.999989194	8.47E-06	.	0.21639	0.12333	-0.5513802	19.86907289	5123.0958	14.71781	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	194	10	72520775	chr10:72520775	G	T	69	PASS	DP=194;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	75053203	75053203	T	-	intronic	CFAP70	.	.	.	.	.	.	.	0.108	.	0.293954043	71.62066525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	25	10	75053202	chr10:75053202	GT	G	92	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	75835805	75835805	C	T	intronic	VCL	.	.	.	0.994870402	0.005129598	3.92E-11	DISEASE: Cardiomyopathy, dilated 1W (CMD1W) [MIM:611407]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11815424, ECO:0000269|PubMed:16236538}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 15 (CMH15) [MIM:613255]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:16712796}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.84455	.	-1.793112871	2.229299363	332.65362	3.87638	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	91	10	75835805	chr10:75835805	C	T	98	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	79163748	79163780	CCTGGCTTGAGCCATTGTTAATCTTCTGGGCCT	-	exonic	KCNMA1	.	nonframeshift deletion	KCNMA1:NM_001014797:exon2:c.380_412del:p.E127_Q137del,KCNMA1:NM_001161352:exon2:c.380_412del:p.E127_Q137del,KCNMA1:NM_001161353:exon2:c.380_412del:p.E127_Q137del,KCNMA1:NM_001271519:exon2:c.380_412del:p.E127_Q137del,KCNMA1:NM_001322829:exon2:c.380_412del:p.E127_Q137del,KCNMA1:NM_001322830:exon2:c.380_412del:p.E127_Q137del,KCNMA1:NM_001322832:exon2:c.380_412del:p.E127_Q137del,KCNMA1:NM_001322835:exon2:c.380_412del:p.E127_Q137del,KCNMA1:NM_001322836:exon2:c.380_412del:p.E127_Q137del,KCNMA1:NM_001322837:exon2:c.380_412del:p.E127_Q137del,KCNMA1:NM_002247:exon2:c.380_412del:p.E127_Q137del	0.999216603	0.000783397	1.98E-12	DISEASE: Generalized epilepsy and paroxysmal dyskinesia (GEPD) [MIM:609446]: Epilepsy is one of the most common and debilitating neurological disorders. Paroxysmal dyskinesias are neurological disorders characterized by sudden, unpredictable, disabling attacks of involuntary movement often requiring life-long treatment. The coexistence of epilepsy and paroxysmal dyskinesia in the same individual or family is an increasingly recognized phenomenon. Patients manifest absence seizures, generalized tonic- clonic seizures, paroxysmal nonkinesigenic dyskinesia, involuntary dystonic or choreiform movements. Onset is usually in childhood and patients may have seizures only, dyskinesia only, or both. {ECO:0000269|PubMed:15937479}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.76173	0.14035	-1.682848699	2.653927813	154.36657	2.71502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.8	19	10	79163747	chr10:79163747	GCCTGGCTTGAGCCATTGTTAATCTTCTGGGCCT	G	12.8	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	79628875	79628875	A	G	intronic	DLG5	.	.	.	0.999998542	1.46E-06	2.19E-18	.	0.27889	0.16537	-2.369063868	1.126444916	774.17189	5.50725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	149	10	79628875	chr10:79628875	A	G	99	PASS	DP=149;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	81273578	81273578	C	-	UTR3	EIF5AL1	NM_001099692:c.*708delC	.	.	.	.	.	.	.	0.29774	.	.	18.72537	0.64596	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	23.07	77	10	81273577	chr10:81273577	TC	T	23.07	PASS	DP=77;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	81465992	81465992	T	A	exonic	NUTM2B	.	nonsynonymous SNV	NUTM2B:NM_001278495:exon2:c.T577A:p.C193S	0.841786847	0.155272462	0.002940691	.	.	.	.	.	421.0619	4.28418	0.471	0.084	T	.	.	.	.	.	.	.	.	.	1	0.090	N	0.345	0.112	N	2.01	0.213	T	0.45	0.043	N	0.093	0.092	-0.965	0.382	T	0.017	0.070	T	0.001	0.018	T	-1.849	0.010	0.002	0.285	0.015	0.003	0.016	N	c	-1.202	-1.417	0.000	0.012	0.554	0.246	0	-1.44	0.083	-1.628	0.021	-2.511	0.003	0.000	0.063	0.000	0.016	5.635	0.167	Nuclear Testis  protein, N-terminal	.	.	0.5	107	1375	10	81465992	chr10:81465992	T	A	107	PASS	DP=1375;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	81667395	81667398	TTTG	-	ncRNA_intronic	BMS1P21	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	41	10	81667394	chr10:81667394	TTTTG	T	50	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	83635665	83635665	C	T	exonic	NRG3	.	nonsynonymous SNV	NRG3:NM_001010848:exon1:c.C569T:p.P190L,NRG3:NM_001165972:exon1:c.C569T:p.P190L	0.21033799	0.789584348	7.77E-05	.	0.1568	0.1028	-0.464712395	23.5727766	868.61501	5.74237	0.001	0.784	D	0.99	0.615	D	0.792	0.560	P	0.001	0.395	U	0.993	0.418	D	0.345	0.112	N	1.33	0.350	T	-1.42	0.350	N	0.118	0.130	-0.978	0.355	T	0.090	0.346	T	0.164	0.844	D	5.556	0.756	26.4	0.999	0.946	0.625	0.315	D	c	0.109	0.059	1.000	0.747	0.658	0.486	0	3.41	0.380	6.372	0.729	0.802	0.324	0.954	0.330	0.567	0.282	12.737	0.564	.	.	.	0.5	145	829	10	83635665	chr10:83635665	C	T	145	PASS	DP=829;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	87966306	87966306	G	A	exonic	GRID1	.	nonsynonymous SNV	GRID1:NM_017551:exon3:c.C335T:p.P112L	0.950796126	0.049203622	2.52E-07	.	0.40271	0.11711	-2.100076584	1.545175749	701.32829	5.26849	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	1.04	0.263	L	-2.92	0.918	D	-8.09	0.967	D	0.968	0.968	0.862	0.952	D	0.864	0.955	D	0.548	0.958	D	6.467	0.892	29.9	0.999	0.984	0.994	0.960	D	c	0.959	0.963	1.000	0.747	0.554	0.283	0	6.06	0.983	9.988	0.992	1.048	0.713	1.000	0.715	0.999	0.750	19.609	0.956	Periplasmic binding protein-like I|Receptor, ligand binding region	.	.	0.5	92	59	10	87966306	chr10:87966306	G	A	92	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	88760253	88760253	C	T	intronic	AGAP11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	183	10	88760253	chr10:88760253	C	T	83	PASS	DP=183;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	89127071	89127071	A	T	intronic	NUTM2D	.	.	.	0.227557524	0.646694336	0.12574814	.	0.01294	.	.	.	4268.05044	12.98771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	560	10	89127071	chr10:89127071	A	T	117	PASS	DP=560;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	92656136	92656136	G	T	exonic	RPP30	.	synonymous SNV	RPP30:NM_001104546:exon10:c.G684T:p.A228A,RPP30:NM_006413:exon10:c.G684T:p.A228A	2.35E-05	0.912665745	0.08731072	.	0.25392	0.24934	0.106667882	61.73036093	95.28898	2.10698	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	70	10	92656136	chr10:92656136	G	T	.	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	93809881	93809881	T	C	UTR3	CPEB3	NM_001178137:c.*2088A>G;NM_014912:c.*2088A>G	.	.	0.994664052	0.005335821	1.27E-07	.	0.78253	0.1114	-0.426079032	25.36565228	524.24587	4.67134	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	10	93809881	chr10:93809881	T	C	.	PASS	DP=25;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	94429247	94429247	-	T	intergenic	KIF11;HHEX	dist=14095;dist=20434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	132	10	94429247	chr10:94429247	G	GT	60	PASS	DP=132;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	95123715	95123715	C	A	intronic	MYOF	.	.	.	2.08E-36	0.259659118	0.740340882	.	0.19502	0.13376	-0.435697896	24.68152866	2094.22471	8.43082	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	505	10	95123715	chr10:95123715	C	A	116	PASS	DP=505;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	96073026	96073026	G	C	exonic	PLCE1	.	nonsynonymous SNV	PLCE1:NM_001165979:exon27:c.G5095C:p.E1699Q,PLCE1:NM_001288989:exon28:c.G5971C:p.E1991Q,PLCE1:NM_016341:exon28:c.G6019C:p.E2007Q	0.204555596	0.795444404	7.85E-14	DISEASE: Nephrotic syndrome 3 (NPHS3) [MIM:610725]: A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. Most patients with NPHS3 show diffuse mesangial sclerosis on renal biopsy, which is a pathologic entity characterized by mesangial matrix expansion with no mesangial hypercellularity, hypertrophy of the podocytes, vacuolized podocytes, thickened basement membranes, and diminished patency of the capillary lumen. {ECO:0000269|PubMed:17086182}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08183	0.11603	0.356282176	74.58716678	11765.49279	23.41934	0.102	0.308	T	0.998	0.764	D	0.991	0.832	D	0.000	0.843	D	1.000	0.588	D	2.515	0.735	M	1.73	0.264	T	-0.85	0.258	N	0.61	0.640	-0.993	0.320	T	0.153	0.482	T	0.010	0.263	T	5.366	0.727	25.9	0.998	0.922	0.997	0.991	D	c	0.820	0.828	1.000	0.747	0.554	0.246	0	5.6	0.849	9.659	0.979	1.048	0.713	1.000	0.715	0.999	0.750	19.238	0.938	Ubiquitin-related domain	.	.	0.5	71	79	10	96073026	chr10:96073026	G	C	71	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	96448040	96448040	-	T	intronic	CYP2C18	.	.	.	5.27E-08	0.227331799	0.772668149	.	0.03976	0.24838	1.177658736	92.77541873	2268.87678	8.81391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	44	10	96448040	chr10:96448040	C	CT	40	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	99126522	99126524	CTC	-	exonic	RRP12	.	nonframeshift deletion	RRP12:NM_001284337:exon24:c.2890_2892del:p.E964del,RRP12:NM_001145114:exon25:c.3007_3009del:p.E1003del,RRP12:NM_015179:exon27:c.3190_3192del:p.E1064del	4.36E-06	0.999994938	6.97E-07	.	0.36713	0.09995	-0.981182694	8.657702288	7215.81402	18.30427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	276	10	99126521	chr10:99126521	GCTC	G	115	PASS	DP=276;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	101542578	101542578	C	T	UTR5	ABCC2	NM_000392:c.-24C>T	.	.	3.36E-29	0.002811963	0.997188037	.	0.10813	0.23913	0.955252644	90.09200283	1270.67962	6.71605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	26	10	101542578	chr10:101542578	C	T	83	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	101959818	101959818	T	C	intronic	CHUK	.	.	.	0.998703705	0.001296295	1.65E-10	DISEASE: Cocoon syndrome (COCOS) [MIM:613630]: A lethal syndrome characterized by multiple fetal malformations including defective face and seemingly absent limbs, which are bound to the trunk and encased under the skin. {ECO:0000269|PubMed:20961246}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.84106	0.63405	-0.201976964	38.98325077	135.45191	2.53221	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	50	10	101959818	chr10:101959818	T	C	97	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
10	102265084	102265084	A	C	intronic	SEC31B	.	.	.	1.30E-24	0.001046577	0.998953423	.	0.06552	0.07762	2.081666378	97.82377919	8025.98175	19.31489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	49	10	102265084	chr10:102265084	A	C	96	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	104161672	104161672	G	T	exonic	NFKB2	.	stopgain	NFKB2:NM_001261403:exon20:c.G2464T:p.E822X,NFKB2:NM_001322935:exon20:c.G2338T:p.E780X,NFKB2:NM_001077494:exon21:c.G2464T:p.E822X,NFKB2:NM_001288724:exon21:c.G2464T:p.E822X,NFKB2:NM_001322934:exon21:c.G2464T:p.E822X,NFKB2:NM_002502:exon21:c.G2464T:p.E822X	0.999696458	0.000303542	4.80E-12	DISEASE: Note=A chromosomal aberration involving NFKB2 is found in a case of B-cell non Hodgkin lymphoma (B-NHL). Translocation t(10;14)(q24;q32) with IGHA1. The resulting oncogene is also called Lyt-10C alpha variant.; DISEASE: Note=A chromosomal aberration involving NFKB2 is found in a cutaneous T-cell leukemia (C-TCL) cell line. This rearrangement produces the p80HT gene which codes for a truncated 80 kDa protein (p80HT).; DISEASE: Note=In B-cell leukemia (B-CLL) cell line, LB40 and EB308, can be found after heterogeneous chromosomal aberrations, such as internal deletions.; DISEASE: Immunodeficiency, common variable, 10 (CVID10) [MIM:615577]: A primary immunodeficiency characterized by childhood-onset of recurrent infections, hypogammaglobulinemia, and decreased numbers of memory and marginal zone B-cells. Some patients may develop autoimmune features and have circulating autoantibodies. An unusual feature is central adrenal insufficiency. {ECO:0000269|PubMed:24140114, ECO:0000269|PubMed:25524009}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.82248	0.47581	-0.778825328	12.88039632	68.14775	1.70783	.	.	.	.	.	.	.	.	.	0.036	0.246	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.738	0.970	36	0.981	0.378	0.484	0.279	N	c	0.076	-0.286	1.000	0.747	0.632	0.406	0	-1.9	0.072	0.312	0.190	-0.104	0.116	0.073	0.219	0.191	0.215	5.762	0.174	Death domain|Death-like domain	.	.	0.5	111	224	10	104161672	chr10:104161672	G	T	111	PASS	DP=224;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	104162673	104162673	A	-	UTR3	PSD	NM_001270966:c.*284delT;NM_001270965:c.*284delT;NM_002779:c.*284delT	.	.	0.987334022	0.012665969	8.75E-09	.	0.11541	0.10253	-1.322782544	4.759377212	234.01091	3.30663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	383	10	104162672	chr10:104162672	CA	C,CAA	70	PASS	DP=383;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	104162673	104162673	-	A	UTR3	PSD	NM_001270966:c.*283_*284insT;NM_001270965:c.*283_*284insT;NM_002779:c.*283_*284insT	.	.	0.987334022	0.012665969	8.75E-09	.	0.11541	0.10253	-1.322782544	4.759377212	234.01091	3.30663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	383	10	104162672	chr10:104162672	CA	C,CAA	70	PASS	DP=383;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	112840278	112840278	G	C	UTR3	ADRA2A	NM_000681:c.*1126G>C	.	.	.	.	.	.	0.18963	0.11371	.	.	204.06999	3.08511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	134	10	112840278	chr10:112840278	G	C	109	PASS	DP=134;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	118615126	118615126	T	C	intronic	ENO4	.	.	.	.	.	.	.	.	.	.	.	139.77329	2.5778	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	10	118615126	chr10:118615126	T	C	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	118927199	118927276	GGTCCCGGCGCCCGGCCTGTGTGGTGCTCAGATCAGACTTATCCACCCGAGCACCACGCAGACCAGCGCCTGGACCAA	-	ncRNA_exonic	MIR3663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	965	10	118927198	chr10:118927198	TGGTCCCGGCGCCCGGCCTGTGTGGTGCTCAGATCAGACTTATCCACCCGAGCACCACGCAGACCAGCGCCTGGACCAA	T	91	PASS	DP=965;AN=4	GT	./.	./.	./.	0/1	./.	0/1	./.	./.	./.	./.	./.	./.
10	118936242	118936242	T	C	intergenic	MIR3663HG;KCNK18	dist=7676;dist=20758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	175	10	118936242	chr10:118936242	T	C	43	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	119764587	119764587	C	A	UTR3	RAB11FIP2	NM_014904:c.*3922G>T;NM_001330167:c.*3922G>T	.	.	0.910707841	0.089154579	0.000137579	.	0.32279	0.13177	0.086440867	60.47416844	470.93745	4.49152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	36	10	119764587	chr10:119764587	C	A	70	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.
10	120354653	120354653	C	T	exonic	PRLHR	.	nonsynonymous SNV	PRLHR:NM_004248:exon2:c.G104A:p.G35D	0.000426454	0.413912411	0.585661135	.	0.1946	0.14591	0.461228372	78.46190139	251.29074	3.41495	0.094	0.313	T	0.0	0.026	B	0.0	0.013	B	0.144	0.029	N	1	0.090	N	0.55	0.145	N	0.01	0.625	T	0.22	0.047	N	0.055	0.107	-1.034	0.193	T	0.108	0.393	T	0.023	0.460	T	-0.449	0.059	0.294	0.890	0.179	0.004	0.021	N	c	-1.472	-1.481	0.867	0.253	0.598	0.340	0	-2.39	0.062	-0.035	0.121	-1.144	0.017	0.112	0.228	0.005	0.090	5.811	0.176	.	.	.	0.5	58	253	10	120354653	chr10:120354653	C	T	58	PASS	DP=253;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	120631623	120631623	C	T	intergenic	CACUL1;NANOS1	dist=116865;dist=157605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	10	120631623	chr10:120631623	C	T	.	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
10	120923662	120923662	G	A	exonic	SFXN4	.	nonsynonymous SNV	SFXN4:NM_213649:exon2:c.C158T:p.T53I	0.00014832	0.992238286	0.007613393	DISEASE: Combined oxidative phosphorylation deficiency 18 (COXPD18) [MIM:615578]: An autosomal recessive disorder of mitochondrial dysfunction characterized by intrauterine growth retardation, hypotonia, visual impairment, speech delay, and lactic acidosis associated with decreased mitochondrial respiratory chain activity. Affected patients may also show hematologic abnormalities, mainly macrocytic anemia. {ECO:0000269|PubMed:24119684}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.04555	0.06327	-0.714505427	14.4019816	9.01689	0.33046	0.083	0.330	T	0.953	0.523	P	0.444	0.441	B	0.627	0.107	N	0.991	0.241	N	2.32	0.666	M	1.57	0.293	T	-2.25	0.503	N	0.141	0.166	-1.044	0.161	T	0.070	0.285	T	0.026	0.492	D	1.767	0.273	14.80	0.990	0.508	0.347	0.249	N	c	-0.443	-0.563	1.000	0.415	0.706	0.609	0	1.34	0.209	1.096	0.304	-0.314	0.078	0.861	0.304	0.063	0.172	6.114	0.192	.	.	.	0.5	.	53	10	120923662	chr10:120923662	G	A	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	123241642	123241642	C	T	UTR3	FGFR2	NM_001144913:c.*44G>A;NM_001144919:c.*44G>A	.	.	0.999752493	0.000247507	1.44E-11	DISEASE: Crouzon syndrome (CS) [MIM:123500]: An autosomal dominant syndrome characterized by craniosynostosis, hypertelorism, exophthalmos and external strabismus, parrot-beaked nose, short upper lip, hypoplastic maxilla, and a relative mandibular prognathism. {ECO:0000269|PubMed:10574673, ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11380921, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7581378, ECO:0000269|PubMed:7655462, ECO:0000269|PubMed:7874170, ECO:0000269|PubMed:7987400, ECO:0000269|PubMed:8528214, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:8946174, ECO:0000269|PubMed:8956050, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9152842, ECO:0000269|PubMed:9521581, ECO:0000269|PubMed:9677057, ECO:0000269|Ref.10}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Jackson-Weiss syndrome (JWS) [MIM:123150]: An autosomal dominant craniosynostosis syndrome characterized by craniofacial abnormalities and abnormality of the feet: broad great toes with medial deviation and tarsal-metatarsal coalescence. {ECO:0000269|PubMed:7874170, ECO:0000269|PubMed:8528214, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9385368, ECO:0000269|PubMed:9677057}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Apert syndrome (APRS) [MIM:101200]: A syndrome characterized by facio-cranio-synostosis, osseous and membranous syndactyly of the four extremities, and midface hypoplasia. The craniosynostosis is bicoronal and results in acrocephaly of brachysphenocephalic type. Syndactyly of the fingers and toes may be total (mitten hands and sock feet) or partial affecting the second, third, and fourth digits. Intellectual deficit is frequent and often severe, usually being associated with cerebral malformations. {ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7668257, ECO:0000269|PubMed:7719344, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9452027, ECO:0000269|PubMed:9677057}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pfeiffer syndrome (PS) [MIM:101600]: A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3). {ECO:0000269|PubMed:10394936, ECO:0000269|PubMed:10945669, ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7719333, ECO:0000269|PubMed:7719345, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9150725, ECO:0000269|PubMed:9693549, ECO:0000269|PubMed:9719378}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Beare-Stevenson cutis gyrata syndrome (BSTVS) [MIM:123790]: An autosomal dominant disease characterized by craniofacial anomalies, particularly craniosynostosis, and ear defects, cutis gyrata, acanthosis nigricans, anogenital anomalies, skin tags, and prominent umbilical stump. The skin furrows have a corrugated appearance and are widespread. Cutis gyrata variably affects the scalp, forehead, face, preauricular area, neck, trunk, hands, and feet. {ECO:0000269|PubMed:12000365, ECO:0000269|PubMed:8696350}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial scaphocephaly syndrome (FSPC) [MIM:609579]: An autosomal dominant craniosynostosis syndrome characterized by scaphocephaly, macrocephaly, hypertelorism, maxillary retrusion, and mild intellectual disability. Scaphocephaly is the most common of the craniosynostosis conditions and is characterized by a long, narrow head. It is due to premature fusion of the sagittal suture or from external deformation. {ECO:0000269|PubMed:16061565}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730]: An autosomal dominant ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Lacrimo-auriculo-dento-digital syndrome is characterized by aplastic/hypoplastic lacrimal and salivary glands and ducts, cup-shaped ears, hearing loss, hypodontia and enamel hypoplasia, and distal limb segments anomalies. In addition to these cardinal features, facial dysmorphism, malformations of the kidney and respiratory system and abnormal genitalia have been reported. Craniosynostosis and severe syndactyly are not observed. {ECO:0000269|PubMed:16501574}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410]: A rare syndrome characterized by craniosynostosis, radiohumeral synostosis present from the perinatal period, midface hypoplasia, choanal stenosis or atresia, femoral bowing and multiple joint contractures. Arachnodactyly and/or camptodactyly have also been reported. {ECO:0000269|PubMed:10633130}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bent bone dysplasia syndrome (BBDS) [MIM:614592]: A perinatal lethal skeletal dysplasia characterized by poor mineralization of the calvarium, craniosynostosis, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones. Dysmorphic facial features included low-set ears, hypertelorism, midface hypoplasia, prematurely erupted fetal teeth, and micrognathia. {ECO:0000269|PubMed:22387015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.96396	0.7628	-1.50462206	3.568058504	593.43974	4.93642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	91	10	123241642	chr10:123241642	C	T	41	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	123260325	123260325	C	A	intronic	FGFR2	.	.	.	0.999752493	0.000247507	1.44E-11	DISEASE: Crouzon syndrome (CS) [MIM:123500]: An autosomal dominant syndrome characterized by craniosynostosis, hypertelorism, exophthalmos and external strabismus, parrot-beaked nose, short upper lip, hypoplastic maxilla, and a relative mandibular prognathism. {ECO:0000269|PubMed:10574673, ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11380921, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7581378, ECO:0000269|PubMed:7655462, ECO:0000269|PubMed:7874170, ECO:0000269|PubMed:7987400, ECO:0000269|PubMed:8528214, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:8946174, ECO:0000269|PubMed:8956050, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9152842, ECO:0000269|PubMed:9521581, ECO:0000269|PubMed:9677057, ECO:0000269|Ref.10}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Jackson-Weiss syndrome (JWS) [MIM:123150]: An autosomal dominant craniosynostosis syndrome characterized by craniofacial abnormalities and abnormality of the feet: broad great toes with medial deviation and tarsal-metatarsal coalescence. {ECO:0000269|PubMed:7874170, ECO:0000269|PubMed:8528214, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9385368, ECO:0000269|PubMed:9677057}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Apert syndrome (APRS) [MIM:101200]: A syndrome characterized by facio-cranio-synostosis, osseous and membranous syndactyly of the four extremities, and midface hypoplasia. The craniosynostosis is bicoronal and results in acrocephaly of brachysphenocephalic type. Syndactyly of the fingers and toes may be total (mitten hands and sock feet) or partial affecting the second, third, and fourth digits. Intellectual deficit is frequent and often severe, usually being associated with cerebral malformations. {ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7668257, ECO:0000269|PubMed:7719344, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9452027, ECO:0000269|PubMed:9677057}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pfeiffer syndrome (PS) [MIM:101600]: A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3). {ECO:0000269|PubMed:10394936, ECO:0000269|PubMed:10945669, ECO:0000269|PubMed:11173845, ECO:0000269|PubMed:11781872, ECO:0000269|PubMed:7719333, ECO:0000269|PubMed:7719345, ECO:0000269|PubMed:8644708, ECO:0000269|PubMed:9002682, ECO:0000269|PubMed:9150725, ECO:0000269|PubMed:9693549, ECO:0000269|PubMed:9719378}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Beare-Stevenson cutis gyrata syndrome (BSTVS) [MIM:123790]: An autosomal dominant disease characterized by craniofacial anomalies, particularly craniosynostosis, and ear defects, cutis gyrata, acanthosis nigricans, anogenital anomalies, skin tags, and prominent umbilical stump. The skin furrows have a corrugated appearance and are widespread. Cutis gyrata variably affects the scalp, forehead, face, preauricular area, neck, trunk, hands, and feet. {ECO:0000269|PubMed:12000365, ECO:0000269|PubMed:8696350}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial scaphocephaly syndrome (FSPC) [MIM:609579]: An autosomal dominant craniosynostosis syndrome characterized by scaphocephaly, macrocephaly, hypertelorism, maxillary retrusion, and mild intellectual disability. Scaphocephaly is the most common of the craniosynostosis conditions and is characterized by a long, narrow head. It is due to premature fusion of the sagittal suture or from external deformation. {ECO:0000269|PubMed:16061565}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730]: An autosomal dominant ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Lacrimo-auriculo-dento-digital syndrome is characterized by aplastic/hypoplastic lacrimal and salivary glands and ducts, cup-shaped ears, hearing loss, hypodontia and enamel hypoplasia, and distal limb segments anomalies. In addition to these cardinal features, facial dysmorphism, malformations of the kidney and respiratory system and abnormal genitalia have been reported. Craniosynostosis and severe syndactyly are not observed. {ECO:0000269|PubMed:16501574}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Antley-Bixler syndrome, without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410]: A rare syndrome characterized by craniosynostosis, radiohumeral synostosis present from the perinatal period, midface hypoplasia, choanal stenosis or atresia, femoral bowing and multiple joint contractures. Arachnodactyly and/or camptodactyly have also been reported. {ECO:0000269|PubMed:10633130}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bent bone dysplasia syndrome (BBDS) [MIM:614592]: A perinatal lethal skeletal dysplasia characterized by poor mineralization of the calvarium, craniosynostosis, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones. Dysmorphic facial features included low-set ears, hypertelorism, midface hypoplasia, prematurely erupted fetal teeth, and micrognathia. {ECO:0000269|PubMed:22387015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.96396	0.7628	-1.50462206	3.568058504	593.43974	4.93642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	359	10	123260325	chr10:123260325	C	A	77	PASS	DP=359;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	124359956	124359956	C	T	intronic	DMBT1	.	.	.	7.36E-32	0.326788431	0.673211569	DISEASE: Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note=The gene represented in this entry is involved in disease pathogenesis. Homozygous deletions may be the predominant mechanism of DMBT1 inactivation playing a role in carcinogenesis. DMBT1 is deleted in medulloblastoma and glioblastoma cell lines; point mutations have also been reported in patients with glioma. A loss or reduction of DMBT1 expression has been seen in esophageal, gastric, lung and colorectal carcinomas as well.; 	0.25445	.	4.221416241	99.71691437	3210.34948	10.79937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	361	10	124359956	chr10:124359956	C	T	83	PASS	DP=361;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	124640270	124640270	G	T	ncRNA_exonic	LOC399815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	71	10	124640270	chr10:124640270	G	T	.	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	124802598	124802598	G	A	exonic	ACADSB	.	nonsynonymous SNV	ACADSB:NM_001330174:exon5:c.G412A:p.D138N,ACADSB:NM_001609:exon6:c.G718A:p.D240N	2.99E-08	0.301001539	0.698998431	.	0.50662	0.27521	-0.402212257	26.7338995	1017.15986	6.13626	0.194	0.258	T	0.001	0.067	B	0.003	0.080	B	0.000	0.481	N	1.000	0.588	D	2	0.545	M	-5.35	0.990	D	-2.59	0.574	D	0.061	0.045	0.805	0.945	D	0.897	0.966	D	0.075	0.722	D	3.099	0.432	22.5	0.997	0.835	0.876	0.468	D	c	-0.213	-0.070	1.000	0.517	0.706	0.609	0	4.72	0.591	3.285	0.512	1.030	0.653	0.976	0.346	0.436	0.260	10.917	0.462	Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain|Acyl-CoA oxidase/dehydrogenase, central domain;Acyl-CoA dehydrogenase/oxidase, N-terminal|Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain	.	.	0.5	.	49	10	124802598	chr10:124802598	G	A	.	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
10	127585212	127585212	A	T	exonic	FANK1	.	nonsynonymous SNV	FANK1:NM_001350939:exon1:c.A1T:p.M1L,FANK1:NM_145235:exon1:c.A1T:p.M1L	0.000115654	0.951345271	0.048539075	.	0.24852	0.09413	1.642526957	96.14885586	280.30409	3.588	0.109	0.292	T	0.0	0.067	B	0.0	0.063	B	.	.	.	1	0.810	D	.	.	.	1.25	0.365	T	-0.25	0.110	N	0.827	0.815	-1.086	0.063	T	0.052	0.223	T	.	.	.	1.357	0.227	12.56	0.817	0.134	0.027	0.073	N	c	-0.487	-0.442	1.000	0.747	0.005	0.000	3	2.62	0.302	0.546	0.228	0.884	0.388	0.576	0.273	0.640	0.296	7.116	0.244	.	.	.	0.5	95	344	10	127585212	chr10:127585212	A	T	95	PASS	DP=344;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
10	127789606	127789606	T	-	intronic	ADAM12	.	.	.	0.341608447	0.658390535	1.02E-06	.	0.65368	0.23183	0.009173042	54.15782024	245.04565	3.37758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	145	10	127789605	chr10:127789605	CT	C	71	PASS	DP=145;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
10	128780161	128780161	-	T	intronic	DOCK1	.	.	.	0.36842317	0.63157683	9.50E-14	.	0.11584	0.19704	.	.	350.01956	3.96565	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	24	10	128780161	chr10:128780161	G	GT	58	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
10	131909019	131909019	G	A	ncRNA_exonic	LINC00959	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	10	131909019	chr10:131909019	G	A	.	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
10	134143942	134143942	C	T	exonic	STK32C	.	synonymous SNV	STK32C:NM_001318883:exon2:c.G303A:p.Q101Q	0.309709769	0.689507911	0.000782319	.	0.08231	0.1102	-0.356299879	29.31115829	1893.96573	8.00243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	148	10	134143942	chr10:134143942	C	T	127	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
10	135142432	135142432	C	A	exonic	CALY	.	nonsynonymous SNV	CALY:NM_015722:exon2:c.G62T:p.G21V	0.706613402	0.277792655	0.015593942	.	0.1537	0.13077	.	.	177.87988	2.8985	0.0	0.912	D	1.0	0.899	D	0.985	0.749	D	0.000	0.629	D	1.000	0.810	D	2.915	0.845	M	.	.	.	-5.47	0.904	D	0.651	0.771	-0.458	0.702	T	0.326	0.695	T	0.192	0.863	D	5.028	0.677	25.2	0.995	0.678	0.227	0.216	N	c	0.132	-0.057	0.997	0.354	0.598	0.340	0	2.62	0.302	0.230	0.175	0.047	0.160	0.010	0.182	0.020	0.134	6.860	0.231	.	.	.	0.5	67	393	10	135142432	chr10:135142432	C	A	67	PASS	DP=393;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	135372870	135372870	C	G	intronic	SYCE1	.	.	.	0.000763635	0.981995413	0.017240952	.	.	0.08486	1.374284246	94.51521585	1749.70499	7.72284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	173	436	10	135372870	chr10:135372870	C	G	173	PASS	DP=436;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
10	135379064	135379064	G	T	UTR5	SYCE1	NM_001143763:c.-31C>A	.	.	0.000763635	0.981995413	0.017240952	.	.	0.08486	1.374284246	94.51521585	1749.70499	7.72284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	1015	10	135379064	chr10:135379064	G	T	129	PASS	DP=1015;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	193112	193112	C	T	exonic	SCGB1C1;SCGB1C2	.	nonsynonymous SNV	SCGB1C2:NM_001097610:exon1:c.C13T:p.R5C,SCGB1C1:NM_145651:exon1:c.C13T:p.R5C	.	.	.	.	.	.	.	.	.	.	0.155	0.241	T	0.0	0.026	B	0.0	0.013	B	0.867	0.071	N	1	0.090	N	.	.	.	1.9	0.235	T	-0.11	0.087	N	0.028	0.009	-0.945	0.419	T	0.000	0.000	T	.	.	.	0.671	0.158	8.638	0.897	0.184	0.005	0.022	N	c	-1.488	-1.643	1.000	0.747	0.598	0.340	0	-7.44	0.012	-1.428	0.025	-1.024	0.021	0.000	0.063	0.097	0.188	1.826	0.029	.	ENSG00000142082.10|ENSG00000142082.10|ENSG00000177963.8|ENSG00000232495.2|ENSG00000177951.13	Adipose_Subcutaneous|Cells_Transformed_fibroblasts|Esophagus_Muscularis|Whole_Blood|Whole_Blood	0.5	77	50	11	193112	chr11:193112	C	T	77	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	199467	199467	C	A	exonic	ODF3	.	nonsynonymous SNV	ODF3:NM_053280:exon6:c.C633A:p.D211E	0.586974862	0.402841641	0.010183496	.	0.18037	0.1095	0.174625237	65.9648502	456.66332	4.43875	0.06	0.373	T	0.634	0.384	P	0.281	0.386	B	0.000	0.486	D	1	0.810	D	2.005	0.547	M	1.41	0.334	T	-2.98	0.620	D	0.301	0.361	-1.099	0.041	T	0.058	0.244	T	0.009	0.227	T	2.785	0.396	21.3	0.991	0.519	0.230	0.217	N	c	-0.179	-0.167	0.962	0.285	0.403	0.052	0	2.23	0.271	-0.189	0.095	0.077	0.185	0.742	0.288	0.999	0.750	4.226	0.100	.	.	.	0.5	100	421	11	199467	chr11:199467	C	A	100	PASS	DP=421;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	281553	281555	GAG	-	exonic	NLRP6	.	nonframeshift deletion	NLRP6:NM_001276700:exon4:c.1819_1821del:p.E611del,NLRP6:NM_138329:exon4:c.1819_1821del:p.E611del	.	.	.	.	0.13321	0.11045	1.271321208	93.65416372	1076.87015	6.29039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	60	11	281552	chr11:281552	AGAG	A	43	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	372810	372810	G	A	intronic	B4GALNT4	.	.	.	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	11	372810	chr11:372810	G	A	.	PASS	DP=57;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	373427	373427	C	T	intronic	B4GALNT4	.	.	.	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	85	11	373427	chr11:373427	C	T	91	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	403122	403122	G	A	exonic	PKP3	.	synonymous SNV	PKP3:NM_007183:exon9:c.G1782A:p.K594K,PKP3:NM_001303029:exon10:c.G1827A:p.K609K	0.194350415	0.805198634	0.000450952	.	0.50658	0.11351	.	.	238.13226	3.33382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	68	11	403122	chr11:403122	G	A	72	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	792780	792780	A	G	intronic	SLC25A22	.	.	.	0.568405565	0.42907803	0.002516405	.	0.4027	0.12155	0.128714042	63.19886766	219.59154	3.20559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	128	11	792780	chr11:792780	A	G	84	PASS	DP=128;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	1016630	1016630	G	A	exonic	MUC6	.	synonymous SNV	MUC6:NM_005961:exon31:c.C6171T:p.S2057S	1.09E-32	4.75E-05	0.999952489	.	0.16113	0.17704	1.26225728	93.56569946	5602.29835	15.48599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	849	11	1016630	chr11:1016630	G	A	145	PASS	DP=849;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	1031096	1031096	C	T	intronic	MUC6	.	.	.	1.09E-32	4.75E-05	0.999952489	.	0.16113	0.17704	1.26225728	93.56569946	5602.29835	15.48599	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	11	1031096	chr11:1031096	C	T	.	PASS	DP=59;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	1221758	1221758	G	A	exonic	MUC5AC	.	unknown	UNKNOWN	.	.	.	.	0.15646	.	.	.	993.41134	6.07467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.23	0.897	M	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.865	0.177	9.861	0.799	0.125	0.913	0.531	D	n	1.251	1.181	1.000	0.747	0.078	0.016	0	4.48	0.538	3.067	0.495	0.951	0.538	1.000	0.715	0.049	0.163	14.439	0.667	Cystine knot, C-terminal	.	.	0.5	115	285	11	1221758	chr11:1221758	G	A	115	PASS	DP=285;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	1271009	1271009	C	A	exonic	MUC5B	.	nonsynonymous SNV	MUC5B:NM_002458:exon31:c.C12899A:p.S4300Y	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	0.008	0.586	D	0.464	0.346	P	0.086	0.280	B	.	.	.	1	0.090	N	2.005	0.547	M	2.05	0.207	T	-1.0	0.264	N	0.157	0.189	-1.034	0.190	T	0.043	0.186	T	0.003	0.070	T	-0.383	0.063	0.424	0.608	0.064	0.016	0.051	N	c	-0.834	-1.010	0.000	0.038	0.554	0.246	0	0.016	0.134	1.089	0.303	-0.152	0.108	0.003	0.159	0.005	0.090	5.720	0.171	.	.	.	0.5	.	305	11	1271009	chr11:1271009	C	A	.	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	1271010	1271010	C	A	exonic	MUC5B	.	synonymous SNV	MUC5B:NM_002458:exon31:c.C12900A:p.S4300S	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	297	11	1271010	chr11:1271010	C	A	.	PASS	DP=297;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	1457375	1457375	C	T	intronic	BRSK2	.	.	.	0.779570081	0.220416998	1.29E-05	.	0.16676	0.10676	-1.506435464	3.544468035	64.45039	1.64641	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	11	1457375	chr11:1457375	C	T	.	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	1464604	1464604	T	A	exonic	BRSK2	.	nonsynonymous SNV	BRSK2:NM_001256627:exon7:c.T604A:p.C202S,BRSK2:NM_001256629:exon7:c.T604A:p.C202S,BRSK2:NM_001256630:exon7:c.T742A:p.C248S,BRSK2:NM_001282218:exon7:c.T424A:p.C142S,BRSK2:NM_003957:exon7:c.T604A:p.C202S	0.779570081	0.220416998	1.29E-05	.	0.16676	0.10676	-1.506435464	3.544468035	64.45039	1.64641	0.003	0.784	D	0.58	0.615	P	0.557	0.670	P	0.000	0.843	U	1.000	0.810	D	0.67	0.164	N	1.86	0.243	T	-8.64	0.975	D	0.69	0.813	-0.978	0.354	T	0.117	0.413	T	0.253	0.892	D	4.816	0.646	24.8	0.993	0.589	0.851	0.439	D	c	0.187	0.142	0.999	0.398	0.696	0.567	0	3.55	0.396	4.389	0.592	0.831	0.339	1.000	0.715	0.964	0.448	12.312	0.541	Protein kinase domain|Protein kinase-like domain|Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	0.5	114	578	11	1464604	chr11:1464604	T	A	114	PASS	DP=578;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	1576396	1576396	G	A	UTR3	DUSP8	NM_004420:c.*1352C>T	.	.	0.684472965	0.311172545	0.00435449	.	0.12453	0.12894	.	.	35.08836	1.06434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	38	11	1576396	chr11:1576396	G	A	51	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	1629400	1629400	G	T	exonic	KRTAP5-3	.	synonymous SNV	KRTAP5-3:NM_001012708:exon1:c.C216A:p.G72G	0.262910457	0.638148141	0.098941402	.	0.11645	.	0.637604436	83.77565464	285.15099	3.61497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	204	11	1629400	chr11:1629400	G	T	.	PASS	DP=204;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	2018440	2018440	G	A	ncRNA_exonic	H19	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	437	11	2018440	chr11:2018440	G	A	89	PASS	DP=437;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	2321896	2321896	C	A	intronic	C11orf21	.	.	.	.	.	.	.	0.12372	.	0.880130671	88.9596603	484.52242	4.53231	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	219	11	2321896	chr11:2321896	C	A	.	PASS	DP=219;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
11	2336456	2336456	A	G	intronic	TSPAN32	.	.	.	0.000537261	0.88875402	0.110708719	.	0.07365	.	0.376678994	75.50719509	156.95947	2.73665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	382	11	2336456	chr11:2336456	A	G	76	PASS	DP=382;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	2356603	2356603	T	C	ncRNA_intronic	CD81-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	145	148	11	2356603	chr11:2356603	T	C	145	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	2591883	2591883	G	T	exonic	KCNQ1	.	nonsynonymous SNV	KCNQ1:NM_000218:exon3:c.G503T:p.G168V,KCNQ1:NM_181798:exon3:c.G122T:p.G41V	2.45E-05	0.980167927	0.019807543	DISEASE: Long QT syndrome 1 (LQT1) [MIM:192500]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:10024302, ECO:0000269|PubMed:10220144, ECO:0000269|PubMed:10220146, ECO:0000269|PubMed:10367071, ECO:0000269|PubMed:10409658, ECO:0000269|PubMed:10482963, ECO:0000269|PubMed:10728423, ECO:0000269|PubMed:10973849, ECO:0000269|PubMed:11799244, ECO:0000269|PubMed:12442276, ECO:0000269|PubMed:15840476, ECO:0000269|PubMed:16414944, ECO:0000269|PubMed:16922724, ECO:0000269|PubMed:18165683, ECO:0000269|PubMed:18400097, ECO:0000269|PubMed:19540844, ECO:0000269|PubMed:19716085, ECO:0000269|PubMed:21241800, ECO:0000269|PubMed:24184248, ECO:0000269|PubMed:24269949, ECO:0000269|PubMed:24713462, ECO:0000269|PubMed:25037568, ECO:0000269|PubMed:25139741, ECO:0000269|PubMed:25705178, ECO:0000269|PubMed:8528244, ECO:0000269|PubMed:8818942, ECO:0000269|PubMed:8872472, ECO:0000269|PubMed:9024139, ECO:0000269|PubMed:9272155, ECO:0000269|PubMed:9302275, ECO:0000269|PubMed:9312006, ECO:0000269|PubMed:9323054, ECO:0000269|PubMed:9386136, ECO:0000269|PubMed:9482580, ECO:0000269|PubMed:9570196, ECO:0000269|PubMed:9641694, ECO:0000269|PubMed:9693036, ECO:0000269|PubMed:9702906, ECO:0000269|PubMed:9799083, ECO:0000269|PubMed:9927399, ECO:0000269|Ref.31}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Jervell and Lange-Nielsen syndrome 1 (JLNS1) [MIM:220400]: An autosomal recessive disorder characterized by congenital deafness, prolongation of the QT interval, syncopal attacks due to ventricular arrhythmias, and a high risk of sudden death. {ECO:0000269|PubMed:10090886, ECO:0000269|PubMed:10728423, ECO:0000269|PubMed:18400097, ECO:0000269|PubMed:18441444, ECO:0000269|PubMed:25705178, ECO:0000269|PubMed:9781056}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Atrial fibrillation, familial, 3 (ATFB3) [MIM:607554]: An autosomal dominant form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure. {ECO:0000269|PubMed:12522251}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short QT syndrome 2 (SQT2) [MIM:609621]: A heart disorder characterized by idiopathic persistently and uniformly short QT interval on ECG in the absence of structural heart disease in affected individuals. It causes syncope and sudden death. {ECO:0000269|PubMed:15159330}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:18711366, ECO:0000269|PubMed:18711367, ECO:0000269|PubMed:24390345}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.32219	0.33671	-0.685180376	15.32200991	131.10283	2.49419	0.004	0.784	D	0.999	0.764	D	0.993	0.797	D	0.000	0.843	D	1	0.810	D	0.96	0.240	L	-4.84	0.982	D	-6.79	0.928	D	0.937	0.931	1.084	0.990	D	0.930	0.977	D	0.823	0.986	D	6.022	0.828	27.9	0.998	0.882	0.997	0.987	D	c	0.616	0.615	1.000	0.747	0.701	0.575	0	4.41	0.524	7.615	0.821	0.998	0.613	1.000	0.715	0.992	0.562	16.105	0.809	Ion transport domain	.	.	0.5	116	289	11	2591883	chr11:2591883	G	T	116	PASS	DP=289;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	2877402	2877402	T	-	ncRNA_intronic	KCNQ1-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.11	61	11	2877401	chr11:2877401	CT	C	10.11	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	2938242	2938242	-	AGACAGGGAAGGTGCTAGGAGGGGAGGCCT	intronic	SLC22A18	.	.	.	0.001923068	0.90615362	0.091923312	DISEASE: Rhabdomyosarcoma, embryonal, 1 (RMSE1) [MIM:268210]: A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.11404	.	1.245625743	93.42415664	1793.90512	7.81719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	105	11	2938242	chr11:2938242	C	CAGACAGGGAAGGTGCTAGGAGGGGAGGCCT,CAGACAGGGAAGGCGTTAGGAGGGGAGGCCT	110	PASS	DP=105;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	2938242	2938242	-	AGACAGGGAAGGCGTTAGGAGGGGAGGCCT	intronic	SLC22A18	.	.	.	0.001923068	0.90615362	0.091923312	DISEASE: Rhabdomyosarcoma, embryonal, 1 (RMSE1) [MIM:268210]: A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.11404	.	1.245625743	93.42415664	1793.90512	7.81719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	105	11	2938242	chr11:2938242	C	CAGACAGGGAAGGTGCTAGGAGGGGAGGCCT,CAGACAGGGAAGGCGTTAGGAGGGGAGGCCT	110	PASS	DP=105;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	3047792	3047792	T	C	intronic	CARS	.	.	.	2.96E-06	0.999273135	0.000723902	DISEASE: Note=A chromosomal aberration involving CARS is associated with inflammatory myofibroblastic tumors (IMTs). Translocation t(2;11)(p23;p15) with ALK.; 	0.17352	0.23298	-0.394936437	27.02878037	1461.59792	7.13029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	11	3047792	chr11:3047792	T	C	.	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	3657347	3657347	G	T	ncRNA_exonic	TRPC2	.	.	.	.	.	.	.	0.54481	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	335	11	3657347	chr11:3657347	G	T	79	PASS	DP=335;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	4116260	4116291	AGGTGAGGGGGGGACGAGGTGGGCGAGAAGGA	-	exonic	RRM1	.	frameshift deletion	RRM1:NM_001033:exon1:c.18_19del:p.D7Wfs*8	0.999994804	5.20E-06	2.88E-14	.	0.9905	0.35194	-0.644723694	16.52512385	49.59769	1.37845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	22.24	21	11	4116259	chr11:4116259	GAGGTGAGGGGGGGACGAGGTGGGCGAGAAGGA	G	22.24	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	4159457	4159457	A	G	exonic	RRM1	.	synonymous SNV	RRM1:NM_001318065:exon13:c.A1209G:p.T403T,RRM1:NM_001330193:exon13:c.A1557G:p.T519T,RRM1:NM_001318064:exon18:c.A1932G:p.T644T,RRM1:NM_001033:exon19:c.A2223G:p.T741T	0.999994804	5.20E-06	2.88E-14	.	0.9905	0.35194	-0.644723694	16.52512385	49.59769	1.37845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	43	11	4159457	chr11:4159457	A	G	105	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	4263954	4263954	C	A	intergenic	LOC100506082;OR52B4	dist=40071;dist=124539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	221	11	4263954	chr11:4263954	C	A	78	PASS	DP=221;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	4827273	4827273	A	-	intergenic	OR52R1;OR51F2	dist=1663;dist=15343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	35	11	4827272	chr11:4827272	GA	G	75	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	5443988	5444063	GATCCGCCTGGTCTGTGCTGACATCAGGCTCAACAGCTGGTATGGATTTGCTCTTGCCTTGCTCATTATTATCGTG	-	exonic	OR51Q1	.	frameshift deletion	OR51Q1:NM_001004757:exon1:c.558_633del:p.R188Lfs*4	0.003685054	0.630936593	0.365378353	.	0.12799	.	2.754408354	98.99150743	12173.23218	23.67045	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	42	11	5443987	chr11:5443987	TGATCCGCCTGGTCTGTGCTGACATCAGGCTCAACAGCTGGTATGGATTTGCTCTTGCCTTGCTCATTATTATCGTG	T	40	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	5878874	5878874	A	T	exonic	OR52E8	.	nonsynonymous SNV	OR52E8:NM_001005168:exon1:c.T59A:p.L20Q	0.016692038	0.709059944	0.274248018	.	0.14356	.	1.0858272	91.82000472	1046.46948	6.208	0.0	0.912	D	1.0	0.899	D	0.997	0.850	D	0.001	0.436	D	1	0.810	D	4.4	0.987	H	6.57	0.006	T	-5.25	0.840	D	0.79	0.780	-0.971	0.370	T	0.015	0.060	T	0.019	0.414	T	3.432	0.471	23.0	0.992	0.556	0.150	0.185	N	c	0.363	0.070	0.364	0.198	0.487	0.133	0	4.87	0.627	4.105	0.573	1.059	0.766	0.284	0.250	0.014	0.122	13.577	0.612	.	.	.	0.5	.	25	11	5878874	chr11:5878874	A	T	.	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	5922816	5922816	C	A	intergenic	OR52E4;OR56A3	dist=16355;dist=45761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.618	0.256	13.95	0.693	0.086	0.085	0.143	N	n	0.674	-0.081	0.000	0.012	0.061	0.009	0	-2.6	0.058	-2.263	0.012	0.059	0.165	0.000	0.063	0.970	0.461	11.902	0.518	GPCR, rhodopsin-like, 7TM	.	.	0.5	.	35	11	5922816	chr11:5922816	C	A	.	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	6470696	6470696	G	C	intronic	TRIM3	.	.	.	0.952560875	0.047437989	1.14E-06	.	0.41195	0.15175	-1.199555187	5.761972163	44.30437	1.27061	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	133	11	6470696	chr11:6470696	G	C	.	PASS	DP=133;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	10529781	10529781	A	G	UTR5	MTRNR2L8	NM_001190702:c.-8T>C	.	.	.	.	.	.	.	.	.	.	1.89325	0.05902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	197	11	10529781	chr11:10529781	A	G	80	PASS	DP=197;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	12400051	12400051	C	T	intronic	PARVA	.	.	.	0.34376402	0.655640245	0.000595734	.	0.24069	0.17061	-0.405853867	26.23260203	31.71128	0.99845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	11	12400051	chr11:12400051	C	T	.	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	15134112	15134112	G	T	splicing	INSC	NM_001031853:exon1:c.96+1G>T	.	.	1.34E-09	0.338205484	0.661794515	.	0.24334	0.13495	0.892856963	89.28992687	1315.35282	6.81837	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.322	0.579	24.0	0.988	0.454	0.898	0.502	D	c	0.899	0.678	0.343	0.196	0.054	0.004	0	3.54	0.395	3.841	0.553	1.048	0.713	0.994	0.380	0.730	0.316	10.919	0.462	.	.	.	0.5	116	728	11	15134112	chr11:15134112	G	T	116	PASS	DP=728;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	16760009	16760009	C	T	upstream	C11orf58	dist=139	.	.	0.709037216	0.287547536	0.003415248	.	0.46512	0.13942	0.035072054	56.2514744	5.6395	0.21112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	383	11	16760009	chr11:16760009	C	T	109	PASS	DP=383;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
11	17426154	17426154	G	T	exonic	ABCC8	.	synonymous SNV	ABCC8:NM_000352:exon28:c.C3462A:p.A1154A,ABCC8:NM_001287174:exon28:c.C3465A:p.A1155A,ABCC8:NM_001351295:exon28:c.C3528A:p.A1176A,ABCC8:NM_001351296:exon28:c.C3462A:p.A1154A,ABCC8:NM_001351297:exon28:c.C3459A:p.A1153A	3.94E-15	0.998700876	0.001299124	DISEASE: Leucine-induced hypoglycemia (LIH) [MIM:240800]: Rare cause of hypoglycemia and is described as a condition in which symptomatic hypoglycemia is provoked by high protein feedings. Hypoglycemia is also elicited by administration of oral or intravenous infusions of a single amino acid, leucine. {ECO:0000269|PubMed:15356046}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial hyperinsulinemic hypoglycemia 1 (HHF1) [MIM:256450]: Most common cause of persistent hypoglycemia in infancy. Unless early and aggressive intervention is undertaken, brain damage from recurrent episodes of hypoglycemia may occur. {ECO:0000269|PubMed:10202168, ECO:0000269|PubMed:10334322, ECO:0000269|PubMed:12364426, ECO:0000269|PubMed:12941782, ECO:0000269|PubMed:15562009, ECO:0000269|PubMed:15579781, ECO:0000269|PubMed:15807877, ECO:0000269|PubMed:16357843, ECO:0000269|PubMed:16429405, ECO:0000269|PubMed:24814349, ECO:0000269|PubMed:25720052, ECO:0000269|PubMed:8751851, ECO:0000269|PubMed:8923011, ECO:0000269|PubMed:9618169, ECO:0000269|PubMed:9769320}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, permanent neonatal (PNDM) [MIM:606176]: A rare form of diabetes distinct from childhood- onset autoimmune diabetes mellitus type 1. It is characterized by insulin-requiring hyperglycemia that is diagnosed within the first months of life. Permanent neonatal diabetes requires lifelong therapy. {ECO:0000269|PubMed:16613899, ECO:0000269|PubMed:16885549, ECO:0000269|PubMed:17213273, ECO:0000269|PubMed:17668386}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Transient neonatal diabetes mellitus 2 (TNDM2) [MIM:610374]: Neonatal diabetes is a form of diabetes mellitus defined by the onset of mild-to-severe hyperglycemia within the first months of life. Transient neonatal diabetes remits early, with a possible relapse during adolescence. {ECO:0000269|PubMed:16885549}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15041	0.43468	-2.091107194	1.568766218	407.27264	4.2315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	323	11	17426154	chr11:17426154	G	T	84	PASS	DP=323;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	17526255	17526255	A	-	intronic	USH1C	.	.	.	2.72E-12	0.964484478	0.035515522	DISEASE: Usher syndrome 1C (USH1C) [MIM:276904]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:10973247}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 18A (DFNB18A) [MIM:602092]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12107438}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07835	0.169	-0.40608828	25.86694975	3991.78955	12.49143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	164	11	17526254	chr11:17526254	GA	G,GAA	106	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	17526255	17526255	-	A	intronic	USH1C	.	.	.	2.72E-12	0.964484478	0.035515522	DISEASE: Usher syndrome 1C (USH1C) [MIM:276904]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:10973247}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 18A (DFNB18A) [MIM:602092]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:12107438}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07835	0.169	-0.40608828	25.86694975	3991.78955	12.49143	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	164	11	17526254	chr11:17526254	GA	G,GAA	106	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	17664953	17664953	C	T	intronic	OTOG	.	.	.	.	.	.	DISEASE: Deafness, autosomal recessive, 18B (DFNB18B) [MIM:614945]: A form of non-syndromic deafness characterized by a moderate hearing impairment, which can be associated with vestibular dysfunction, and a flat to shallow "U" or slightly downsloping shaped audiograms. {ECO:0000269|PubMed:23122587}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08265	.	.	.	14123.45118	25.75321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	71	11	17664953	chr11:17664953	C	T	.	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	18291388	18291388	C	T	exonic	SAA1	.	nonsynonymous SNV	SAA1:NM_000331:exon4:c.C355T:p.P119S,SAA1:NM_199161:exon4:c.C355T:p.P119S,SAA1:NM_001178006:exon5:c.C355T:p.P119S	0.181814611	0.765265056	0.052920333	DISEASE: Note=Reactive, secondary amyloidosis is characterized by the extracellular accumulation in various tissues of the SAA1 protein. These deposits are highly insoluble and resistant to proteolysis; they disrupt tissue structure and compromise function. {ECO:0000269|PubMed:1463770}.; DISEASE: Note=Elevated serum SAA1 protein levels may be associated with lung cancer. {ECO:0000269|PubMed:1463770}.; 	0.07473	0.51812	0.103030231	61.2762444	286.88113	3.62775	0.05	0.395	D	0.999	0.764	D	0.996	0.832	D	0.000	0.477	D	0.997	0.437	D	2.925	0.847	M	2.78	0.113	T	-5.76	0.878	D	0.536	0.591	-0.884	0.495	T	0.107	0.390	T	0.004	0.093	T	5.605	0.763	26.5	0.998	0.926	0.843	0.431	D	c	0.630	0.481	1.000	0.517	0.581	0.326	0	3.55	0.396	3.416	0.522	0.932	0.445	1.000	0.715	0.989	0.536	12.917	0.574	.	.	.	0.5	.	97	11	18291388	chr11:18291388	C	T	.	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	18427177	18427177	G	C	intronic	LDHA	.	.	.	0.05865759	0.923941779	0.01740063	DISEASE: Glycogen storage disease 11 (GSD11) [MIM:612933]: A metabolic disorder that results in exertional myoglobinuria, pain, cramps and easy fatigue. {ECO:0000269|PubMed:2334430}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43011	0.85387	-0.404032746	26.53338051	41.17522	1.20476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	119	11	18427177	chr11:18427177	G	C	102	PASS	DP=119;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	18600278	18600278	G	A	exonic	UEVLD	.	synonymous SNV	UEVLD:NM_001040697:exon2:c.C120T:p.D40D,UEVLD:NM_001261382:exon2:c.C120T:p.D40D,UEVLD:NM_001261383:exon2:c.C120T:p.D40D,UEVLD:NM_001261385:exon2:c.C6T:p.D2D,UEVLD:NM_001261386:exon2:c.C120T:p.D40D,UEVLD:NM_001297771:exon2:c.C120T:p.D40D,UEVLD:NM_018314:exon2:c.C120T:p.D40D	1.09E-07	0.542920198	0.457079693	.	0.13244	0.14875	-0.402212257	26.7338995	286.11158	3.6211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	51	11	18600278	chr11:18600278	G	A	82	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	19263442	19263442	C	T	upstream	E2F8	dist=240	.	.	0.995041279	0.004958717	4.36E-09	.	0.39192	0.09135	-0.773369631	13.10450578	260.40561	3.46644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	668	11	19263442	chr11:19263442	C	T	88	PASS	DP=668;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	19853946	19853946	A	T	intronic	NAV2	.	.	.	0.997517125	0.002482875	4.58E-16	.	0.41631	0.11088	-1.555318186	3.22009908	8281.16376	19.67042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	196	11	19853946	chr11:19853946	A	T	103	PASS	DP=196;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	21305564	21305564	G	C	intronic	NELL1	.	.	.	2.17E-09	0.99233506	0.007664938	.	0.16311	0.14813	0.207589927	67.52182118	890.70295	5.81461	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	13	11	21305564	chr11:21305564	G	C	56	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	32976854	32976854	A	T	exonic	QSER1	.	nonsynonymous SNV	QSER1:NM_001076786:exon6:c.A4126T:p.T1376S	0.999935659	6.43E-05	1.10E-13	.	0.56585	0.09696	-0.231522913	36.36470866	711.28789	5.29998	0.117	0.303	T	0.041	0.200	B	0.016	0.166	B	0.122	0.190	N	0.982	0.250	N	1.95	0.526	M	2.11	0.255	T	-2.24	0.506	N	0.048	0.181	-1.041	0.171	T	0.046	0.196	T	0.005	0.114	T	1.775	0.274	14.84	0.970	0.314	0.942	0.601	D	c	-0.302	-0.185	0.000	0.070	0.732	0.924	0	1.53	0.221	3.408	0.522	1.140	0.893	1.000	0.715	1.000	0.888	5.019	0.136	.	.	.	0.5	.	40	11	32976854	chr11:32976854	A	T	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	33891508	33891508	C	T	UTR5	LMO2	NM_005574:c.-246G>A;NM_001142315:c.-576G>A	.	.	0.753952193	0.236452305	0.009595502	DISEASE: Note=A chromosomal aberration involving LMO2 may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(11,14)(p13;q11) with TCRD.; 	0.91591	0.38765	.	.	26.24832	0.85065	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	11	33891508	chr11:33891508	C	T	.	PASS	DP=55;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	35747672	35747672	A	G	exonic	TRIM44	.	synonymous SNV	TRIM44:NM_017583:exon3:c.A948G:p.Q316Q	0.163653747	0.82154148	0.014804773	.	0.5824	0.14627	-0.293801652	32.93819297	23.99448	0.78977	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	78	11	35747672	chr11:35747672	A	G	81	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	40162349	40162349	A	G	splicing	LRRC4C	NM_020929:exon4:UTR5;NM_001258419:exon6:UTR5	.	.	0.953730869	0.046141223	0.000127908	.	0.85527	0.14229	-0.799052816	12.45576787	78.16654	1.86462	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	11	40162349	chr11:40162349	A	G	.	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	43348195	43348195	G	C	intronic	API5	.	.	.	0.999555019	0.000444981	2.98E-10	.	0.73412	0.11262	-0.339715008	30.06605331	24.0593	0.7911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	45	11	43348195	chr11:43348195	G	C	69	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	43702296	43702296	C	T	UTR5	HSD17B12	NM_016142:c.-82C>T	.	.	0.005554478	0.970740124	0.023705398	.	0.11055	0.19829	0.060756528	58.52795471	416.42358	4.2711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	519	11	43702296	chr11:43702296	C	T	.	PASS	DP=519;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	45275989	45275989	A	T	intronic	SYT13	.	.	.	0.220165779	0.771535728	0.008298494	.	0.15386	0.125	-0.534490515	20.70063694	43.04749	1.24539	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	11	45275989	chr11:45275989	A	T	.	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	46539113	46539113	A	G	intronic	AMBRA1	.	.	.	0.999971641	2.84E-05	7.36E-14	.	0.36907	0.10363	-0.971800989	8.946685539	137.80881	2.55655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	155	11	46539113	chr11:46539113	A	G	62	PASS	DP=155;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	47204533	47204533	C	-	intronic	PACSIN3	.	.	.	0.016793048	0.978273746	0.004933206	.	0.49122	0.20173	-0.532670911	20.78320359	1052.93556	6.23032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	368	11	47204532	chr11:47204532	TC	T	91	PASS	DP=368;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	47270359	47270359	A	G	exonic	NR1H3	.	nonsynonymous SNV	NR1H3:NM_001251934:exon2:c.A5G:p.Q2R,NR1H3:NM_001251935:exon2:c.A5G:p.Q2R	0.856185983	0.143716688	9.73E-05	.	0.95723	0.54243	-0.646543901	16.44255721	37.64316	1.1206	.	.	.	0.0	0.026	B	0.0	0.013	B	.	.	.	0.855	0.284	N	.	.	.	.	.	.	.	.	.	0.058	0.041	.	.	.	.	.	.	.	.	.	0.826	0.173	9.625	0.648	0.074	0.004	0.019	N	n	0.972	3.363	1.0	0.983	0.047	0.003	1	-5.76	0.022	-0.697	0.052	-0.259	0.088	0.000	0.063	0.007	0.100	0.579	0.007	.	.	.	0.5	.	255	11	47270359	chr11:47270359	A	G	.	PASS	DP=255;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	47371399	47371399	C	A	exonic	MYBPC3	.	nonsynonymous SNV	MYBPC3:NM_000256:exon5:c.G580T:p.G194C	1.35E-06	0.999906933	9.17E-05	DISEASE: Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:11499718, ECO:0000269|PubMed:11499719, ECO:0000269|PubMed:11815426, ECO:0000269|PubMed:12379228, ECO:0000269|PubMed:12628722, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:12818575, ECO:0000269|PubMed:12951062, ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:14563344, ECO:0000269|PubMed:15114369, ECO:0000269|PubMed:15519027, ECO:0000269|PubMed:15563892, ECO:0000269|PubMed:16004897, ECO:0000269|PubMed:16199542, ECO:0000269|PubMed:18403758, ECO:0000269|PubMed:18929575, ECO:0000269|PubMed:18957093, ECO:0000269|PubMed:23840593, ECO:0000269|PubMed:7744002, ECO:0000269|PubMed:9048664, ECO:0000269|PubMed:9541104, ECO:0000269|PubMed:9541115, ECO:0000269|PubMed:9562578}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1MM (CMD1MM) [MIM:615396]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:20215591}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=MYBPC3 mutations may be involved in restrictive cardiomyopathy (RCM), a rare non-ischemic myocardial disease. RCM is characterized by restrictive ventricular-filling physiology in the presence of normal or reduced diastolic and/or systolic volumes (of 1 or both ventricles), biatrial enlargement, and normal ventricular wall thickness. {ECO:0000269|PubMed:26163040}.; DISEASE: Left ventricular non-compaction 10 (LVNC10) [MIM:615396]: A disease due to an arrest of myocardial morphogenesis. It is characterized by a hypertrophic left ventricle with deep trabeculations and with poor systolic function, with or without associated left ventricular dilation. In some cases, it is associated with other congenital heart anomalies. {ECO:0000269|PubMed:21551322}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.49203	0.21433	-0.534756622	20.54140127	1069.38163	6.26965	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	.	.	.	1	0.810	D	2.635	0.774	M	-0.6	0.717	T	-8.13	0.967	D	0.897	0.886	0.392	0.890	D	0.604	0.859	D	0.294	0.907	D	7.019	0.938	33	0.998	0.885	0.987	0.851	D	c	0.854	0.785	1.000	0.747	0.403	0.052	0	4.8	0.610	7.899	0.859	0.935	0.490	1.000	0.715	1.000	0.888	18.212	0.898	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	188	11	47371399	chr11:47371399	C	A	.	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	47371400	47371400	C	T	exonic	MYBPC3	.	synonymous SNV	MYBPC3:NM_000256:exon5:c.G579A:p.K193K	1.35E-06	0.999906933	9.17E-05	DISEASE: Cardiomyopathy, familial hypertrophic 4 (CMH4) [MIM:115197]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:11499718, ECO:0000269|PubMed:11499719, ECO:0000269|PubMed:11815426, ECO:0000269|PubMed:12379228, ECO:0000269|PubMed:12628722, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:12818575, ECO:0000269|PubMed:12951062, ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:14563344, ECO:0000269|PubMed:15114369, ECO:0000269|PubMed:15519027, ECO:0000269|PubMed:15563892, ECO:0000269|PubMed:16004897, ECO:0000269|PubMed:16199542, ECO:0000269|PubMed:18403758, ECO:0000269|PubMed:18929575, ECO:0000269|PubMed:18957093, ECO:0000269|PubMed:23840593, ECO:0000269|PubMed:7744002, ECO:0000269|PubMed:9048664, ECO:0000269|PubMed:9541104, ECO:0000269|PubMed:9541115, ECO:0000269|PubMed:9562578}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1MM (CMD1MM) [MIM:615396]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:20215591}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=MYBPC3 mutations may be involved in restrictive cardiomyopathy (RCM), a rare non-ischemic myocardial disease. RCM is characterized by restrictive ventricular-filling physiology in the presence of normal or reduced diastolic and/or systolic volumes (of 1 or both ventricles), biatrial enlargement, and normal ventricular wall thickness. {ECO:0000269|PubMed:26163040}.; DISEASE: Left ventricular non-compaction 10 (LVNC10) [MIM:615396]: A disease due to an arrest of myocardial morphogenesis. It is characterized by a hypertrophic left ventricle with deep trabeculations and with poor systolic function, with or without associated left ventricular dilation. In some cases, it is associated with other congenital heart anomalies. {ECO:0000269|PubMed:21551322}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.49203	0.21433	-0.534756622	20.54140127	1069.38163	6.26965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	188	11	47371400	chr11:47371400	C	T	.	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	49010731	49010731	T	A	intergenic	OR4A47;TRIM49B	dist=499457;dist=42421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	130	11	49010731	chr11:49010731	T	A	.	PASS	DP=130;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	49071098	49071098	C	A	intergenic	TRIM49B;TRIM64C	dist=11569;dist=4168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	118	11	49071098	chr11:49071098	C	A	.	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	49214450	49214450	G	A	intronic	FOLH1	.	.	.	0.253396885	0.746592621	1.05E-05	.	0.15752	0.43198	1.332002318	94.20853975	2268.34509	8.81053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	11	49214450	chr11:49214450	G	A	.	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	49859690	49859690	C	A	intergenic	LOC440040;OR4C13	dist=27721;dist=114253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	124	11	49859690	chr11:49859690	C	A	.	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	49860159	49860159	-	T	intergenic	LOC440040;OR4C13	dist=28190;dist=113784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	397	11	49860158	chr11:49860158	AT	ATT,A	74	PASS	DP=397;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	49860159	49860159	T	-	intergenic	LOC440040;OR4C13	dist=28190;dist=113784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	397	11	49860158	chr11:49860158	AT	ATT,A	74	PASS	DP=397;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	50276137	50276166	AATACAACTGAAGTTACTCAGCCAAGAACA	-	intergenic	LOC441601;LOC646813	dist=18504;dist=92152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.07	24	11	50276136	chr11:50276136	CAATACAACTGAAGTTACTCAGCCAAGAACA	C	10.07	PASS	DP=24;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	55032505	55032505	C	A	exonic	TRIM48	.	nonsynonymous SNV	TRIM48:NM_024114:exon2:c.C174A:p.N58K	1.77E-14	0.000532837	0.999467163	.	0.05186	.	1.840996754	97.08657702	499.24357	4.58752	0.277	0.156	T	0.17	0.270	B	0.297	0.392	B	.	.	.	0.993	0.237	N	0.1	0.085	N	3.18	0.075	T	-1.66	0.397	N	0.163	0.196	-0.884	0.494	T	0.013	0.052	T	0.002	0.026	T	1.003	0.190	10.68	0.593	0.060	0.564	0.299	D	c	-0.813	-0.864	0.000	0.035	0.487	0.133	0	0.596	0.166	4.273	0.585	0.142	0.226	0.366	0.257	0.655	0.299	7.138	0.246	Zinc finger, RING/FYVE/PHD-type	.	.	0.5	111	140	11	55032505	chr11:55032505	C	A	111	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	55059888	55059888	G	T	intergenic	TRIM48;TRIM51HP	dist=21293;dist=1291	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	336	11	55059888	chr11:55059888	G	T	91	PASS	DP=336;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	55579182	55579182	A	G	exonic	OR5L1	.	synonymous SNV	OR5L1:NM_001004738:exon1:c.A240G:p.K80K	5.94E-07	0.039026869	0.960972537	.	0.06073	0.09152	0.795569043	87.49115357	1193.77829	6.55439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	267	11	55579182	chr11:55579182	A	G	102	PASS	DP=267;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	58331615	58331615	-	A	intronic	LPXN	.	.	.	0.017200443	0.960285294	0.022514263	.	0.39737	0.134	0.018483465	55.44939844	220.53951	3.21071	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	160	11	58331615	chr11:58331615	G	GA	54	PASS	DP=160;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	58381664	58381664	T	-	ncRNA_intronic	ZFP91-CNTF	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	109	11	58381663	chr11:58381663	AT	A	65	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	60531157	60531157	A	C	intronic	MS4A15	.	.	.	0.038468197	0.837478034	0.124053769	.	0.11624	.	0.705562627	85.52724699	3456.33473	11.29059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	35	11	60531157	chr11:60531157	A	C	87	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	60785733	60785733	G	C	intronic	CD6	.	.	.	0.004304658	0.98846706	0.007228281	.	0.24185	.	0.821252311	88.01604152	3740.49434	11.95458	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	465	11	60785733	chr11:60785733	G	C	109	PASS	DP=465;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	61187363	61187363	C	-	intronic	CPSF7	.	.	.	0.991330175	0.008669408	4.17E-07	.	.	.	-0.626318434	17.03231894	16.33135	0.57846	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	1072	11	61187362	chr11:61187362	AC	A	105	PASS	DP=1072;AN=4	GT	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.
11	61507049	61507049	C	T	exonic	DAGLA	.	nonsynonymous SNV	DAGLA:NM_006133:exon17:c.C1769T:p.T590I	0.953148342	0.046851612	4.51E-08	.	0.39271	0.11988	-0.573127851	18.96083982	278.59856	3.57787	0.062	0.369	T	0.838	0.444	P	0.446	0.442	B	0.000	0.843	D	1.000	0.530	D	1.245	0.315	L	1.78	0.257	T	-2.31	0.513	N	0.21	0.258	-1.064	0.108	T	0.072	0.294	T	0.017	0.380	T	3.874	0.522	23.5	0.994	0.608	0.923	0.550	D	c	0.254	0.257	1.000	0.517	0.651	0.465	0	4.23	0.492	6.038	0.704	0.852	0.362	1.000	0.715	0.822	0.344	17.000	0.862	.	.	.	0.5	131	547	11	61507049	chr11:61507049	C	T	131	PASS	DP=547;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
11	61537709	61537709	C	T	intronic	MYRF	.	.	.	0.999847803	0.000152197	4.41E-12	.	0.22352	0.1057	-1.082044518	7.242274121	229.21291	3.27206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	374	11	61537709	chr11:61537709	C	T	112	PASS	DP=374;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	61734929	61734929	C	T	UTR5	FTH1	NM_002032:c.-32G>A	.	.	0.918437495	0.081030258	0.000532248	.	.	0.48545	0.103030231	61.2762444	8.70049	0.31993	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	672	11	61734929	chr11:61734929	C	T	74	PASS	DP=672;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	61908118	61908118	G	T	intronic	INCENP	.	.	.	0.996086665	0.003913333	2.44E-09	.	0.16577	0.12728	0.832189686	88.12809625	6919.01907	17.71496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	246	11	61908118	chr11:61908118	G	T	.	PASS	DP=246;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	62139512	62139512	G	A	intronic	ASRGL1	.	.	.	0.000386788	0.626060265	0.373552947	.	0.09435	0.27804	-0.314027422	31.9297004	41.01491	1.20213	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	11	62139512	chr11:62139512	G	A	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	62293635	62293635	C	A	exonic	AHNAK	.	nonsynonymous SNV	AHNAK:NM_001346445:exon5:c.G8254T:p.A2752S,AHNAK:NM_001346446:exon5:c.G8254T:p.A2752S,AHNAK:NM_001620:exon5:c.G8254T:p.A2752S	0.344567387	0.655432572	4.07E-08	.	0.19089	.	-2.834287974	0.613352206	5147.67106	14.73759	0.044	0.410	D	0.712	0.402	P	0.196	0.350	B	.	.	.	1	0.810	D	1.665	0.427	L	3.45	0.053	T	-1.26	0.318	N	0.099	0.101	-1.032	0.197	T	0.019	0.081	T	0.005	0.113	T	1.614	0.255	13.93	0.985	0.414	0.610	0.311	D	c	-0.402	-0.475	1.000	0.500	0.732	0.924	0	3.37	0.375	1.178	0.314	-0.086	0.118	0.000	0.063	0.001	0.043	12.170	0.533	.	.	.	0.5	98	350	11	62293635	chr11:62293635	C	A	98	PASS	DP=350;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	62378331	62378331	T	A	intronic	EML3	.	.	.	0.394340909	0.605658415	6.76E-07	.	0.25723	0.09936	-0.843147538	11.2762444	758.07118	5.45547	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	320	11	62378331	chr11:62378331	T	A	.	PASS	DP=320;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	62416325	62416325	G	C	exonic	INTS5	.	nonsynonymous SNV	INTS5:NM_030628:exon2:c.C1227G:p.F409L	0.999284368	0.000715627	4.68E-09	.	0.31626	0.12936	-0.971800989	8.946685539	92.50703	2.06784	0.369	0.116	T	0.106	0.245	B	0.25	0.373	B	0.000	0.843	D	0.907	0.276	N	1.1	0.281	L	.	.	.	-1.23	0.312	N	0.505	0.549	-1.009	0.273	T	0.081	0.320	T	0.007	0.184	T	2.926	0.412	22.0	0.803	0.127	0.968	0.708	D	c	-0.371	-0.239	0.996	0.341	0.737	0.974	0	2.92	0.329	1.921	0.394	0.135	0.219	1.000	0.715	0.997	0.653	6.528	0.214	Integrator complex subunit 5, C-terminal	.	.	0.5	68	146	11	62416325	chr11:62416325	G	C	68	PASS	DP=146;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	62476390	62476390	C	A	ncRNA_intronic	HNRNPUL2-BSCL2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	482	11	62476390	chr11:62476390	C	A	97	PASS	DP=482;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	62565992	62565992	G	A	intronic	NXF1	.	.	.	0.998990475	0.001009525	1.82E-11	.	0.58705	0.1604	-0.66859065	15.76433121	35.98594	1.08112	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	11	62565992	chr11:62565992	G	A	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	63683050	63683050	G	T	exonic	RCOR2	.	nonsynonymous SNV	RCOR2:NM_173587:exon2:c.C161A:p.A54D	0.115753697	0.883058055	0.001188248	.	0.15407	0.11192	-0.514264485	21.41424864	38.78816	1.14828	0.001	0.784	D	1.0	0.899	D	0.979	0.728	D	0.000	0.629	D	1	0.810	D	3.075	0.874	M	-1.43	0.807	T	-5.04	0.826	D	0.894	0.883	0.460	0.900	D	0.683	0.890	D	0.497	0.951	D	6.028	0.829	27.9	0.996	0.758	0.996	0.976	D	c	0.740	0.644	1.000	0.747	0.652	0.477	0	3.6	0.402	6.290	0.725	0.873	0.381	1.000	0.715	0.996	0.625	11.397	0.489	ELM2 domain	.	.	0.5	.	98	11	63683050	chr11:63683050	G	T	.	PASS	DP=98;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	63683077	63683077	A	T	exonic	RCOR2	.	nonsynonymous SNV	RCOR2:NM_173587:exon2:c.T134A:p.M45K	0.115753697	0.883058055	0.001188248	.	0.15407	0.11192	-0.514264485	21.41424864	38.78816	1.14828	0.922	0.023	T	0.963	0.537	D	0.53	0.467	P	0.000	0.843	D	1.000	0.548	D	1.105	0.287	L	1.67	0.273	T	0.06	0.063	N	0.85	0.837	-1.089	0.057	T	0.042	0.179	T	0.023	0.458	T	1.302	0.221	12.28	0.940	0.235	0.967	0.701	D	c	-0.013	0.075	1.000	0.747	0.726	0.872	0	4.1	0.470	3.656	0.540	0.995	0.605	1.000	0.715	1.000	0.888	12.499	0.551	ELM2 domain	.	.	0.5	.	126	11	63683077	chr11:63683077	A	T	.	PASS	DP=126;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	63886067	63886067	T	-	UTR3	FLRT1	NM_013280:c.*303delT	.	.	0.546319767	0.439707278	0.013972956	.	0.06239	0.11168	-0.705410796	14.77942911	67.31626	1.6983	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	76	11	63886066	chr11:63886066	GT	G	79	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	64367140	64367140	T	C	intronic	SLC22A12	.	.	.	4.90E-06	0.856135783	0.143859316	.	0.126	0.14076	-1.153638777	6.233781552	97.64363	2.13702	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	11	64367140	chr11:64367140	T	C	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	64457918	64457918	-	C	exonic	NRXN2	.	frameshift insertion	NRXN2:NM_015080:exon5:c.808dupG:p.A270Gfs*26	0.999895574	0.000104426	7.22E-14	.	0.24191	0.10189	-2.164449385	1.427223402	1296.88776	6.77694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	1738	11	64457918	chr11:64457918	G	GC	99	PASS	DP=1738;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	0/1	./.
11	64715289	64715289	T	C	exonic	MAJIN	.	nonsynonymous SNV	MAJIN:NM_001037225:exon7:c.A352G:p.K118E,MAJIN:NM_001318808:exon7:c.A34G:p.K12E	.	.	.	.	.	.	.	.	.	.	0.04	0.421	D	0.827	0.440	P	0.442	0.440	B	0.003	0.355	N	0.570	0.810	D	1.055	0.270	L	.	.	.	-2.2	0.495	N	0.345	0.406	-0.885	0.494	T	0.116	0.411	T	0.005	0.142	T	2.011	0.303	16.28	0.991	0.522	0.311	0.240	N	c	-0.132	-0.149	0.923	0.267	0.497	0.185	0	4.77	0.603	0.355	0.198	1.007	0.626	0.009	0.180	0.610	0.290	10.864	0.459	.	.	.	0.5	60	136	11	64715289	chr11:64715289	T	C	60	PASS	DP=136;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	64985172	64985172	G	A	intronic	SLC22A20	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	11	64985172	chr11:64985172	G	A	.	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	65266480	65266480	T	C	ncRNA_exonic	MALAT1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	200	11	65266480	chr11:65266480	T	C	111	PASS	DP=200;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	66045990	66045990	C	T	exonic	CNIH2	.	synonymous SNV	CNIH2:NM_182553:exon1:c.C63T:p.I21I	0.894540207	0.104434209	0.001025584	.	0.16073	0.11262	-0.119252484	44.53880632	2.28818	0.07752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	216	11	66045990	chr11:66045990	C	T	.	PASS	DP=216;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	66046015	66046015	C	T	intronic	CNIH2	.	.	.	0.894540207	0.104434209	0.001025584	.	0.16073	0.11262	-0.119252484	44.53880632	2.28818	0.07752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	175	11	66046015	chr11:66046015	C	T	.	PASS	DP=175;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	66249674	66249674	G	T	exonic	DPP3	.	nonsynonymous SNV	DPP3:NM_001256670:exon2:c.G3T:p.M1I,DPP3:NM_005700:exon2:c.G3T:p.M1I,DPP3:NM_130443:exon2:c.G3T:p.M1I	4.36E-09	0.939852021	0.060147975	.	.	0.29988	0.874458024	88.88888889	4443.48457	13.35156	0.034	0.538	D	0.225	0.342	B	0.047	0.264	B	0.000	0.843	D	1	0.810	D	.	.	.	1.98	0.433	T	-1.86	0.452	N	0.944	0.939	-1.010	0.269	T	0.093	0.355	T	0.050	0.642	D	4.266	0.571	23.9	0.996	0.722	0.995	0.970	D	c	0.323	0.476	1.000	0.747	0.742	0.980	0	5.71	0.890	7.961	0.874	0.948	0.535	1.000	0.715	1.000	0.888	15.355	0.740	.	.	.	0.5	.	98	11	66249674	chr11:66249674	G	T	.	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	66512290	66512290	-	GGCGGC	exonic	C11orf80	.	nonframeshift insertion	C11orf80:NM_024650:exon1:c.77_78insGGCGGC:p.A34_G35insAA	0.008462596	0.978338462	0.013198942	.	0.03682	.	0.106667882	61.73036093	116.69248	2.34991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	64	11	66512290	chr11:66512290	G	GGGCGGC	112	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	66623971	66623971	-	C	intronic	PC	.	.	.	0.71643567	0.283564107	2.23E-07	DISEASE: Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150]: Leads to lactic acidosis, mental retardation and death. It occurs in three forms: mild or type A, severe neonatal or type B, and a very mild lacticacidemia. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.19381	0.81784	-1.74358502	2.394432649	138.12153	2.55935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	480	11	66623971	chr11:66623971	G	GC	97	PASS	DP=480;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	67250632	67250632	G	T	exonic	AIP	.	nonsynonymous SNV	AIP:NM_001302960:exon1:c.G3T:p.M1I,AIP:NM_003977:exon1:c.G3T:p.M1I	0.673915914	0.325081824	0.001002262	DISEASE: ACTH-secreting pituitary adenoma (ASPA) [MIM:219090]: A pituitary adenoma resulting in excessive production of adrenocorticotropic hormone. This leads to hypersecretion of cortisol by the adrenal glands and ACTH-dependent Cushing syndrome. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:17360484}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Prolactin-secreting pituitary adenoma (PSPA) [MIM:600634]: Most common type of hormonally active pituitary adenoma. {ECO:0000269|PubMed:16728643, ECO:0000305|PubMed:17244780}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.51148	0.13318	-0.135838822	43.77211607	39.115	1.15958	0.0	0.912	D	0.963	0.537	D	0.447	0.442	P	0.000	0.843	D	1	0.810	D	.	.	.	-2.84	0.913	D	-1.35	0.375	N	0.876	0.864	0.550	0.912	D	0.713	0.901	D	0.851	0.989	D	6.836	0.927	33	0.996	0.765	0.958	0.660	D	c	0.424	0.468	1.0	0.983	0.442	0.072	0	5.16	0.704	3.410	0.522	1.048	0.713	1.000	0.715	1.000	0.888	14.006	0.638	.	.	.	0.5	105	694	11	67250632	chr11:67250632	G	T	105	PASS	DP=694;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	67564157	67564157	A	T	ncRNA_exonic	FAM86C2P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	1240	11	67564157	chr11:67564157	A	T	109	PASS	DP=1240;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
11	68133035	68133035	T	C	intronic	LRP5	.	.	.	0.99835557	0.00164443	2.44E-12	DISEASE: Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]: A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. {ECO:0000269|PubMed:15024691, ECO:0000269|PubMed:15346351, ECO:0000269|PubMed:15981244, ECO:0000269|PubMed:16929062, ECO:0000269|PubMed:19324841, ECO:0000269|PubMed:20340138, ECO:0000269|PubMed:24715757}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteoporosis (OSTEOP) [MIM:166710]: A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs. {ECO:0000269|PubMed:14727154, ECO:0000269|PubMed:15824851, ECO:0000269|PubMed:16234968}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]: A disease characterized by congenital or infancy-onset blindness and severe juvenile-onset osteoporosis and spontaneous fractures. Additional clinical manifestations may include microphthalmos, abnormalities of the iris, lens or vitreous, cataracts, short stature, microcephaly, ligamental laxity, mental retardation and hypotonia. {ECO:0000269|PubMed:11719191, ECO:0000269|PubMed:16252235, ECO:0000269|PubMed:16679074, ECO:0000269|PubMed:17437160, ECO:0000269|PubMed:18602879}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: High bone mass trait (HBM) [MIM:601884]: Rare phenotype characterized by exceptionally dense bones. HBM individuals show otherwise a completely normal skeletal structure and no other unusual clinical findings. {ECO:0000269|PubMed:11741193, ECO:0000269|PubMed:12015390, ECO:0000269|PubMed:15824861, ECO:0000269|PubMed:17295608}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Endosteal hyperostosis, Worth type (WENHY) [MIM:144750]: An autosomal dominant sclerosing bone dysplasia clinically characterized by elongation of the mandible, increased gonial angle, flattened forehead, and the presence of a slowly enlarging osseous prominence of the hard palate (torus palatinus). Serum calcium, phosphorus and alkaline phosphatase levels are normal. Radiologically, it is characterized by early thickening of the endosteum of long bones, the skull and of the mandible. With advancing age, the trabeculae of the metaphysis become thickened. WENHY becomes clinically and radiologically evident by adolescence, does not cause deformity except in the skull and mandible, and is not associated with bone pain or fracture. Affected patients have normal height, proportion, intelligence and longevity. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteopetrosis, autosomal dominant 1 (OPTA1) [MIM:607634]: A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. OPTA1 is an autosomal dominant form characterized by generalized osteosclerosis most pronounced in the cranial vault. Patients are often asymptomatic, but some suffer from pain and hearing loss. It appears to be the only type of osteopetrosis not associated with an increased fracture rate. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Van Buchem disease 2 (VBCH2) [MIM:607636]: VBCH2 is an autosomal dominant sclerosing bone dysplasia characterized by cranial osteosclerosis, thickened calvaria and cortices of long bones, enlarged mandible and normal serum alkaline phosphatase levels. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07666	0.10394	-3.724445291	0.241802312	2445.60749	9.20072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	162	134	11	68133035	chr11:68133035	T	C	162	PASS	DP=134;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	68133156	68133156	G	T	exonic	LRP5	.	nonsynonymous SNV	LRP5:NM_002335:exon5:c.G1001T:p.R334M	0.99835557	0.00164443	2.44E-12	DISEASE: Vitreoretinopathy, exudative 4 (EVR4) [MIM:601813]: A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. {ECO:0000269|PubMed:15024691, ECO:0000269|PubMed:15346351, ECO:0000269|PubMed:15981244, ECO:0000269|PubMed:16929062, ECO:0000269|PubMed:19324841, ECO:0000269|PubMed:20340138, ECO:0000269|PubMed:24715757}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteoporosis (OSTEOP) [MIM:166710]: A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs. {ECO:0000269|PubMed:14727154, ECO:0000269|PubMed:15824851, ECO:0000269|PubMed:16234968}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770]: A disease characterized by congenital or infancy-onset blindness and severe juvenile-onset osteoporosis and spontaneous fractures. Additional clinical manifestations may include microphthalmos, abnormalities of the iris, lens or vitreous, cataracts, short stature, microcephaly, ligamental laxity, mental retardation and hypotonia. {ECO:0000269|PubMed:11719191, ECO:0000269|PubMed:16252235, ECO:0000269|PubMed:16679074, ECO:0000269|PubMed:17437160, ECO:0000269|PubMed:18602879}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: High bone mass trait (HBM) [MIM:601884]: Rare phenotype characterized by exceptionally dense bones. HBM individuals show otherwise a completely normal skeletal structure and no other unusual clinical findings. {ECO:0000269|PubMed:11741193, ECO:0000269|PubMed:12015390, ECO:0000269|PubMed:15824861, ECO:0000269|PubMed:17295608}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Endosteal hyperostosis, Worth type (WENHY) [MIM:144750]: An autosomal dominant sclerosing bone dysplasia clinically characterized by elongation of the mandible, increased gonial angle, flattened forehead, and the presence of a slowly enlarging osseous prominence of the hard palate (torus palatinus). Serum calcium, phosphorus and alkaline phosphatase levels are normal. Radiologically, it is characterized by early thickening of the endosteum of long bones, the skull and of the mandible. With advancing age, the trabeculae of the metaphysis become thickened. WENHY becomes clinically and radiologically evident by adolescence, does not cause deformity except in the skull and mandible, and is not associated with bone pain or fracture. Affected patients have normal height, proportion, intelligence and longevity. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteopetrosis, autosomal dominant 1 (OPTA1) [MIM:607634]: A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. OPTA1 is an autosomal dominant form characterized by generalized osteosclerosis most pronounced in the cranial vault. Patients are often asymptomatic, but some suffer from pain and hearing loss. It appears to be the only type of osteopetrosis not associated with an increased fracture rate. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Van Buchem disease 2 (VBCH2) [MIM:607636]: VBCH2 is an autosomal dominant sclerosing bone dysplasia characterized by cranial osteosclerosis, thickened calvaria and cortices of long bones, enlarged mandible and normal serum alkaline phosphatase levels. {ECO:0000269|PubMed:12579474}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.07666	0.10394	-3.724445291	0.241802312	2445.60749	9.20072	0.057	0.379	T	0.646	0.386	P	0.492	0.456	P	0.420	0.129	U	0.821	0.289	N	2.155	0.604	M	-4.24	0.970	D	-1.25	0.316	N	0.266	0.323	0.643	0.925	D	0.873	0.958	D	0.195	0.865	D	2.065	0.309	16.62	0.948	0.250	0.842	0.430	D	c	-0.207	-0.266	0.997	0.356	0.672	0.522	0	-0.917	0.099	1.950	0.397	-0.165	0.106	1.000	0.715	0.995	0.604	9.825	0.399	EGF-like domain	.	.	0.5	.	48	11	68133156	chr11:68133156	G	T	.	PASS	DP=48;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	70317174	70317174	-	T	UTR3	SHANK2	NM_133266:c.*1799_*1800insA;NM_012309:c.*1799_*1800insA	.	.	0.99992017	7.98E-05	2.24E-11	DISEASE: Autism 17 (AUTS17) [MIM:613436]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:20473310}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.35021	.	.	.	1233.68596	6.63651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	66	11	70317174	chr11:70317174	G	GT	53	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	70348840	70348840	-	C	intronic	SHANK2	.	.	.	0.99992017	7.98E-05	2.24E-11	DISEASE: Autism 17 (AUTS17) [MIM:613436]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:20473310}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.35021	.	.	.	1233.68596	6.63651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	44	11	70348840	chr11:70348840	G	GC	78	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	70348982	70348982	G	A	exonic	SHANK2	.	nonsynonymous SNV	SHANK2:NM_133266:exon3:c.C352T:p.R118W	0.99992017	7.98E-05	2.24E-11	DISEASE: Autism 17 (AUTS17) [MIM:613436]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:20473310}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.35021	.	.	.	1233.68596	6.63651	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	2.62	0.769	M	1.48	0.317	T	-7.03	0.956	D	0.829	0.916	-0.366	0.731	T	0.256	0.626	T	0.126	0.808	D	7.972	0.956	35	0.999	0.991	0.984	0.823	D	c	0.864	0.781	1.000	0.747	0.696	0.567	0	4.46	0.534	9.253	0.947	1.045	0.669	1.000	0.715	1.000	0.888	17.503	0.876	PDZ domain	.	.	0.5	88	430	11	70348982	chr11:70348982	G	A	88	PASS	DP=430;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	71290790	71290790	-	CAGCAGCTGGACTGGGAGCAGCAGGACCTG	intergenic	KRTAP5-10;KRTAP5-11	dist=13124;dist=2111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	115	11	71290790	chr11:71290790	A	ACAGCAGCTGGACTGGGAGCAGCAGGACCTG	43	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	71507232	71507232	C	G	ncRNA_intronic	ALG1L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	200	11	71507232	chr11:71507232	C	G	148	PASS	DP=200;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	71507261	71507261	A	G	ncRNA_intronic	ALG1L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	178	205	11	71507261	chr11:71507261	A	G	178	PASS	DP=205;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	71822165	71822165	-	TGCTGGGGTCTCTGTCTA	intronic	ANAPC15	.	.	.	0.564413605	0.423423147	0.012163248	.	0.39459	0.11262	0.079165051	59.43029016	5.13875	0.19088	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	164	127	11	71822165	chr11:71822165	G	GTGCTGGGGTCTCTGTCTA	164	PASS	DP=127;AN=2	GT	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.	./.
11	72549649	72549649	-	A	UTR3	FCHSD2	NM_014824:c.*186_*187insT	.	.	0.994752587	0.005247408	5.00E-09	.	0.39961	0.11323	-0.88906181	10.36801132	103.87407	2.20142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	151	11	72549649	chr11:72549649	C	CA	58	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	73058016	73058016	G	T	intronic	ARHGEF17	.	.	.	0.995257099	0.004742901	5.43E-14	.	0.30241	0.104	-0.748045379	13.74734607	3511.2966	11.43648	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	96	11	73058016	chr11:73058016	G	T	.	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	73765608	73765608	T	-	intronic	C2CD3	.	.	.	8.08E-10	0.999999551	4.48E-07	DISEASE: Orofaciodigital syndrome 14 (OFD14) [MIM:615948]: A form of orofaciodigital syndrome, a group of heterogeneous disorders characterized by malformations of the oral cavity, face and digits, and associated phenotypic abnormalities that lead to the delineation of various subtypes. OFD14 patients show severe microcephaly, cerebral malformations the molar tooth sign, and intellectual disability in addition to canonical OFDS features. {ECO:0000269|PubMed:24997988}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.37109	.	2.177297739	98.07737674	7679.56022	18.83084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	17.42	17	11	73765607	chr11:73765607	CT	C	17.42	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	74875100	74875100	C	A	exonic	SLCO2B1	.	nonsynonymous SNV	SLCO2B1:NM_001145211:exon3:c.C174A:p.F58L,SLCO2B1:NM_007256:exon3:c.C240A:p.F80L	0.003353563	0.996214752	0.000431685	.	0.12048	0.17779	-0.483123186	22.78249587	2109.9785	8.45565	0.001	0.784	D	0.945	0.513	P	0.667	0.512	P	0.000	0.460	D	0.989	0.810	D	4.135	0.976	H	-0.09	0.641	T	-5.13	0.832	D	0.543	0.580	-0.231	0.769	T	0.356	0.719	T	0.158	0.839	D	5.636	0.768	26.6	0.993	0.579	0.179	0.198	N	c	-0.187	-0.389	1.000	0.500	0.549	0.223	0	-3.11	0.049	-2.095	0.014	-1.093	0.019	0.000	0.063	0.935	0.408	10.527	0.440	Major facilitator superfamily domain	.	.	0.5	.	296	11	74875100	chr11:74875100	C	A	.	PASS	DP=296;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	74998428	74998428	G	C	intronic	ARRB1	.	.	.	0.986801821	0.013197011	1.17E-06	.	0.26736	0.17451	-0.844966979	11.1759849	138.55265	2.56415	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	342	11	74998428	chr11:74998428	G	C	68	PASS	DP=342;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	75134961	75134961	-	C	intronic	KLHL35	.	.	.	1.35E-12	0.001844037	0.998155963	.	.	0.11511	.	.	89.19671	2.02976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	335	11	75134960	chr11:75134960	GC	GCC,G	78	PASS	DP=335;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	75134961	75134961	C	-	intronic	KLHL35	.	.	.	1.35E-12	0.001844037	0.998155963	.	.	0.11511	.	.	89.19671	2.02976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	335	11	75134960	chr11:75134960	GC	GCC,G	78	PASS	DP=335;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	75511966	75511966	C	T	UTR3	DGAT2	NM_001253891:c.*413C>T;NM_032564:c.*413C>T	.	.	7.51E-08	0.464501216	0.535498709	.	0.13912	0.1376	0.350995466	74.37485256	327.81893	3.84936	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	124	11	75511966	chr11:75511966	C	T	80	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	76807293	76807293	C	G	intronic	CAPN5	.	.	.	3.54E-07	0.935601786	0.06439786	.	0.23811	0.11589	-0.903841325	10.14390186	410.70074	4.24742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	523	11	76807293	chr11:76807293	C	G	88	PASS	DP=523;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	77639466	77639466	A	G	exonic	INTS4	.	synonymous SNV	INTS4:NM_033547:exon11:c.T1293C:p.S431S	0.653071264	0.346928651	8.43E-08	.	0.16947	0.15282	-0.576764155	18.7839113	270.96358	3.52905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	73	11	77639466	chr11:77639466	A	G	.	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	78423572	78423572	C	T	exonic	TENM4	.	nonsynonymous SNV	TENM4:NM_001098816:exon26:c.G4009A:p.G1337R	0.999718776	0.000281224	3.30E-14	.	0.59536	.	-1.696530647	2.589054022	1180.19147	6.52237	0.0	0.912	D	0.84	0.445	P	0.171	0.337	B	0.000	0.843	D	1	0.810	D	3.61	0.940	H	-4.07	0.966	D	-6.86	0.931	D	0.9	0.891	1.017	0.975	D	0.892	0.964	D	0.418	0.938	D	7.590	0.953	34	0.999	0.984	0.981	0.795	D	c	0.648	0.662	1.000	0.747	0.554	0.283	0	5.19	0.713	7.905	0.864	0.935	0.490	1.000	0.715	0.999	0.750	18.895	0.924	Six-bladed beta-propeller, TolB-like	.	.	0.5	.	105	11	78423572	chr11:78423572	C	T	.	PASS	DP=105;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	78614515	78614517	GCG	-	exonic	TENM4	.	nonframeshift deletion	TENM4:NM_001098816:exon7:c.545_547del:p.P182del	0.999718776	0.000281224	3.30E-14	.	0.59536	.	-1.696530647	2.589054022	1180.19147	6.52237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	37	11	78614514	chr11:78614514	AGCG	A	55	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	85375173	85375173	C	T	exonic	CREBZF	.	synonymous SNV	CREBZF:NM_001039618:exon1:c.G747A:p.E249E	0.036661649	0.832377449	0.130960902	.	0.37422	0.47084	-0.139478553	43.29440906	117.84489	2.35984	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	1450	11	85375173	chr11:85375173	C	T	94	PASS	DP=1450;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	85692737	85692737	G	-	intronic	PICALM	.	.	.	0.97208309	0.027916606	3.03E-07	.	0.97843	0.13037	-0.490397599	22.50530786	39.60281	1.16712	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.62	38	11	85692736	chr11:85692736	AG	A	13.62	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	86198530	86198530	T	-	intronic	ME3	.	.	.	1.14E-05	0.98774607	0.012242511	.	0.21938	0.18427	-0.821100135	11.88369899	2619.18186	9.5929	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	52	11	86198529	chr11:86198529	GT	G	51	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	89592603	89592603	T	-	ncRNA_intronic	TRIM51EP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	397	11	89592602	chr11:89592602	AT	A	54	PASS	DP=397;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	90017138	90017138	A	T	ncRNA_intronic	DISC1FP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	83	11	90017138	chr11:90017138	A	T	.	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	100211936	100211936	A	G	exonic	CNTN5	.	nonsynonymous SNV	CNTN5:NM_175566:exon20:c.A2807G:p.K936R,CNTN5:NM_001243270:exon22:c.A3029G:p.K1010R,CNTN5:NM_014361:exon23:c.A3029G:p.K1010R	0.001354061	0.998643262	2.68E-06	.	0.29361	0.20972	-0.080831688	47.22222222	849.40801	5.69596	0.038	0.427	D	0.986	0.609	D	0.689	0.600	P	0.000	0.843	D	1.000	0.548	D	2.16	0.606	M	0.73	0.507	T	-1.83	0.429	N	0.602	0.670	-0.617	0.641	T	0.255	0.626	T	0.026	0.488	D	4.222	0.566	23.9	0.999	0.941	0.920	0.544	D	c	0.629	0.611	0.998	0.360	0.487	0.133	0	5.46	0.799	6.232	0.721	1.199	0.960	1.000	0.715	0.985	0.512	14.709	0.687	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	.	51	11	100211936	chr11:100211936	A	G	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	100864088	100864088	T	A	UTR3	TMEM133	NM_032021:c.*659T>A	.	.	0.025317131	0.558322413	0.416360457	.	0.06337	.	0.080983847	59.76055674	196.60872	3.03256	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	11	100864088	chr11:100864088	T	A	.	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	101765595	101765595	-	A	intronic	ANGPTL5	.	.	.	1.75E-11	0.015997561	0.984002439	.	0.14304	0.10715	0.374860183	75.43052607	415.57896	4.26813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	425	11	101765595	chr11:101765595	T	TA	75	PASS	DP=425;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	104869776	104869776	T	-	intronic	CASP5	.	.	.	8.11E-09	0.273167235	0.726832757	.	0.1193	0.11456	1.199707453	92.98183534	431.34997	4.33449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	101	11	104869775	chr11:104869775	CT	C	59	PASS	DP=101;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	107326435	107326435	C	G	exonic	CWF19L2	.	nonsynonymous SNV	CWF19L2:NM_152434:exon2:c.G173C:p.W58S	9.65E-09	0.500135179	0.499864811	.	0.17764	0.09681	0.626470967	83.55154518	3527.13215	11.45817	0.007	0.599	D	0.995	0.657	D	0.904	0.624	P	.	.	.	1.000	0.588	D	3.15	0.886	M	2.01	0.213	T	-7.78	0.959	D	0.6	0.651	-0.890	0.489	T	0.135	0.450	T	0.022	0.449	T	6.408	0.885	29.6	0.989	0.476	0.815	0.406	D	c	0.703	0.658	1.000	0.434	0.732	0.924	0	4.43	0.528	3.965	0.562	0.876	0.383	1.000	0.715	0.998	0.697	13.303	0.596	.	.	.	0.5	84	69	11	107326435	chr11:107326435	C	G	84	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	108535865	108535867	CGC	-	UTR5	DDX10	NM_004398:c.-16_-14del-	.	.	5.42E-11	0.810476189	0.189523811	.	0.40748	0.09833	-0.483123186	22.78249587	110.0097	2.27841	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	62	11	108535864	chr11:108535864	TCGC	T	67	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
11	113668841	113668841	G	A	UTR3	USP28	NM_001301029:c.*1121C>T;NM_001346263:c.*1121C>T;NM_001346265:c.*1121C>T;NM_001346259:c.*1121C>T;NM_001346252:c.*1121C>T;NM_001346269:c.*1121C>T;NM_001346267:c.*1121C>T;NM_001346262:c.*1121C>T;NM_001346258:c.*1121C>T;NM_001346264:c.*1121C>T;NM_001346255:c.*1121C>T;NM_001346270:c.*1121C>T;NM_001346253:c.*1121C>T;NM_001346257:c.*1121C>T;NM_001346271:c.*1121C>T;NM_020886:c.*1121C>T;NM_001346272:c.*1121C>T;NM_001346261:c.*1121C>T;NM_001346268:c.*1121C>T;NM_001346254:c.*1121C>T;NM_001346260:c.*1121C>T	.	.	0.031657505	0.968342468	2.69E-08	.	0.60849	0.11751	-0.791786324	12.59731069	79.98741	1.89131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	252	11	113668841	chr11:113668841	G	A	126	PASS	DP=252;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	117900392	117900392	G	T	ncRNA_intronic	TMPRSS4-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.837	0.529	T	0.132	0.443	T	.	.	.	0.345	0.127	6.122	0.820	0.135	0.012	0.042	N	c	-0.635	-0.855	0.805	0.242	0.056	0.006	0	-0.625	0.109	-0.071	0.114	0.635	0.291	0.132	0.232	0.392	0.253	5.668	0.169	.	.	.	0.5	.	115	11	117900392	chr11:117900392	G	T	.	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
11	118350956	118350956	A	T	intronic	KMT2A	.	.	.	1	1.88E-16	1.78E-42	DISEASE: Wiedemann-Steiner syndrome (WDSTS) [MIM:605130]: A syndrome characterized by hairy elbows (hypertrichosis cubiti), intellectual disability, a distinctive facial appearance, and short stature. Facial characteristics include long eyelashes, thick or arched eyebrows with a lateral flare, and downslanting and vertically narrow palpebral fissures. {ECO:0000269|PubMed:22795537}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Chromosomal aberrations involving KMT2A are a cause of acute leukemias. Translocation t(1;11)(q21;q23) with MLLT11/AF1Q; translocation t(3;11)(p21;q23) with NCKIPSD/AF3p21; translocation t(3,11)(q25,q23) with GMPS; translocation t(4;11)(q21;q23) with AFF1/MLLT2/AF4; insertion ins(5;11)(q31;q13q23) with AFF4/AF5Q31; translocation t(5;11)(q12;q23) with AF5-alpha/CENPK; translocation t(6;11)(q27;q23) with MLLT4/AF6; translocation t(9;11)(p22;q23) with MLLT3/AF9; translocation t(10;11)(p11.2;q23) with ABI1; translocation t(10;11)(p12;q23) with MLLT10/AF10; t(11;15)(q23;q14) with CASC5 and ZFYVE19; translocation t(11;17)(q23;q21) with MLLT6/AF17; translocation t(11;19)(q23;p13.3) with ELL; translocation t(11;19)(q23;p13.3) with MLLT1/ENL; translocation t(11;19)(q23;p23) with GAS7; translocation t(X;11)(q13;q23) with FOXO4/AFX1. Translocation t(3;11)(q28;q23) with LPP. Translocation t(10;11)(q22;q23) with TET1. Translocation t(9;11)(q34;q23) with DAB2IP. Translocation t(4;11)(p12;q23) with FRYL. Fusion proteins KMT2A-MLLT1, KMT2A- MLLT3 and KMT2A-ELL interact with PPP1R15A and, on the contrary to unfused KMT2A, inhibit PPP1R15A-induced apoptosis. {ECO:0000269|PubMed:10490642}.; DISEASE: Note=A chromosomal aberration involving KMT2A may be a cause of chronic neutrophilic leukemia. Translocation t(4;11)(q21;q23) with SEPT11. {ECO:0000269|PubMed:10490642}.; 	0.58012	0.48908	-3.347291482	0.406935598	416.01763	4.26932	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	11	118350956	chr11:118350956	A	T	.	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	118443064	118443064	C	-	upstream	ARCN1	dist=38	.	.	0.999850871	0.000149129	1.03E-10	.	0.31441	0.17611	-0.626318434	17.03231894	55.4936	1.49655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	33	11	118443063	chr11:118443063	GC	G	79	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
11	118888210	118888210	A	G	exonic	RPS25	.	synonymous SNV	RPS25:NM_001028:exon3:c.T145C:p.L49L	0.809686936	0.185516254	0.00479681	.	0.94325	0.1705	0.013025609	54.62962963	2.43389	0.08748	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	213	11	118888210	chr11:118888210	A	G	.	PASS	DP=213;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	119210088	119210088	C	A	exonic	C1QTNF5	.	stopgain	C1QTNF5:NM_001278431:exon3:c.G685T:p.G229X,C1QTNF5:NM_015645:exon15:c.G685T:p.G229X	0.830646789	0.165834575	0.003518635	DISEASE: Late-onset retinal degeneration (LORD) [MIM:605670]: Autosomal dominant disorder characterized by onset in the fifth to sixth decade with night blindness and punctate yellow-white deposits in the retinal fundus, progressing to severe central and peripheral degeneration, with choroidal neovascularization and chorioretinal atrophy. {ECO:0000269|PubMed:12944416, ECO:0000269|PubMed:22892318}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10641	.	.	.	17.68431	0.61873	.	.	.	.	.	.	.	.	.	0.000	0.843	U	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.748	0.998	47	0.992	0.559	0.990	0.894	D	c	1.116	0.938	1.0	0.983	0.628	0.401	0	4.48	0.538	6.054	0.705	0.852	0.362	1.000	0.715	0.998	0.697	17.366	0.872	C1q domain|Tumour necrosis factor-like domain	.	.	0.5	.	187	11	119210088	chr11:119210088	C	A	.	PASS	DP=187;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	123893791	123893791	A	C	exonic	OR10G9	.	synonymous SNV	OR10G9:NM_001001953:exon1:c.A72C:p.P24P	0.007138452	0.531885237	0.460976311	.	0.05817	0.09497	3.688480395	99.5576787	1919.79326	8.06598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	154	11	123893791	chr11:123893791	A	C	135	PASS	DP=154;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	123909490	123909490	A	T	exonic	OR10G7	.	synonymous SNV	OR10G7:NM_001004463:exon1:c.T219A:p.T73T	0.007122109	0.531402926	0.461474965	.	0.06744	0.08917	1.774838537	96.82118424	459.74042	4.44864	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	317	11	123909490	chr11:123909490	A	T	88	PASS	DP=317;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
11	124015941	124015941	C	T	intronic	VWA5A	.	.	.	1.89E-15	0.026741774	0.973258226	.	0.04851	.	0.648517637	84.14720453	1165.38867	6.49454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	166	11	124015941	chr11:124015941	C	T	123	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	124086220	124086220	A	G	intergenic	VWA5A;OR8G2P	dist=68602;dist=9124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	69	11	124086220	chr11:124086220	A	G	69	PASS	DP=69;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	124096173	124096173	T	C	exonic	OR8G2P	.	nonsynonymous SNV	OR8G2P:NM_001291438:exon1:c.T776C:p.L259S	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	237	11	124096173	chr11:124096173	T	C	99	PASS	DP=237;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	124951303	124951303	-	T	intronic	SLC37A2	.	.	.	5.01E-10	0.581719585	0.418280414	.	0.10703	0.11611	0.04598748	57.47817882	1459.43023	7.12342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	282	11	124951303	chr11:124951303	A	AT	76	PASS	DP=282;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
11	125505377	125505377	-	A	exonic	CHEK1	.	frameshift insertion	CHEK1:NM_001330427:exon6:c.716dupA:p.T242Nfs*18,CHEK1:NM_001330428:exon6:c.386dupA:p.T132Nfs*18,CHEK1:NM_001114121:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001114122:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001244846:exon7:c.668dupA:p.T226Nfs*18,CHEK1:NM_001274:exon7:c.668dupA:p.T226Nfs*18	0.00024911	0.982312119	0.017438771	.	0.99413	0.5268	-0.315847836	31.68789809	581.70191	4.88824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	216	11	125505377	chr11:125505377	G	GA	60	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
11	128993822	128993822	G	T	intronic	ARHGAP32	.	.	.	0.98708852	0.01291148	3.11E-12	.	.	.	-2.151949495	1.450813871	693.40551	5.2506	0.308	0.141	T	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	1.26	0.363	T	-0.64	0.187	N	0.104	0.109	-0.892	0.488	T	0.168	0.508	T	.	.	.	2.643	0.379	20.5	0.913	0.200	0.878	0.472	D	c	0.447	0.541	0.992	0.326	0.638	0.428	0	5.93	0.959	3.281	0.511	1.048	0.713	1.000	0.715	0.997	0.653	12.787	0.567	.	.	.	0.5	.	40	11	128993822	chr11:128993822	G	T	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
11	129763186	129763186	A	G	intronic	NFRKB	.	.	.	0.752744578	0.247255416	6.10E-09	.	0.21273	0.12979	-2.651579643	0.76079264	181.58645	2.92847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	33	11	129763186	chr11:129763186	A	G	42	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	129763191	129763191	C	T	intronic	NFRKB	.	.	.	0.752744578	0.247255416	6.10E-09	.	0.21273	0.12979	-2.651579643	0.76079264	181.58645	2.92847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	11	129763191	chr11:129763191	C	T	.	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
11	130059634	130059634	C	T	exonic	ST14	.	synonymous SNV	ST14:NM_021978:exon5:c.C441T:p.S147S	0.852676553	0.147322586	8.62E-07	DISEASE: Ichthyosis, congenital, autosomal recessive 11 (ARCI11) [MIM:602400]: A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. {ECO:0000269|PubMed:17273967, ECO:0000269|PubMed:18843291}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43903	0.33644	-0.347208386	29.59424393	1268.8342	6.71293	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	155	11	130059634	chr11:130059634	C	T	.	PASS	DP=155;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
11	134078848	134078848	A	-	intronic	NCAPD3	.	.	.	0.073152087	0.926847913	2.97E-10	.	0.21247	0.0997	-0.374974929	28.11983958	451.0484	4.41414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	29	11	134078847	chr11:134078847	TA	T	54	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	208258	208258	G	T	intronic	IQSEC3	.	.	.	0.925104239	0.074895032	7.29E-07	.	0.52569	.	-0.839512508	11.40009436	1171.33568	6.50545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	389	12	208258	chr12:208258	G	T	85	PASS	DP=389;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	2602441	2602441	C	A	exonic	CACNA1C	.	synonymous SNV	CACNA1C:NM_000719:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129827:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129829:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129830:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129831:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129832:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129833:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129834:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129835:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129836:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129837:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129838:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129839:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129840:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129841:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129842:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129843:exon7:c.C1002A:p.P334P,CACNA1C:NM_001129844:exon7:c.C993A:p.P331P,CACNA1C:NM_001129846:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167623:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167624:exon7:c.C1002A:p.P334P,CACNA1C:NM_001167625:exon7:c.C1002A:p.P334P,CACNA1C:NM_199460:exon7:c.C1002A:p.P334P	0.999998433	1.57E-06	4.37E-21	DISEASE: Timothy syndrome (TS) [MIM:601005]: Disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities and autism. {ECO:0000269|PubMed:15454078, ECO:0000269|PubMed:15863612, ECO:0000269|PubMed:25260352}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brugada syndrome 3 (BRGDA3) [MIM:611875]: A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66288	0.13071	-2.087541484	1.574663836	257.23512	3.4497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	263	12	2602441	chr12:2602441	C	A	.	PASS	DP=263;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	2997016	2997016	C	T	intronic	RHNO1	.	.	.	0.000558185	0.704918917	0.294522899	.	0.10242	.	.	.	34.24976	1.04792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	12	2997016	chr12:2997016	C	T	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	3728437	3728437	C	T	exonic	CRACR2A	.	synonymous SNV	CRACR2A:NM_001144958:exon18:c.G2034A:p.T678T	.	.	.	.	0.10919	0.10015	1.846456612	97.11606511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	208	12	3728437	chr12:3728437	C	T	.	PASS	DP=208;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	6438271	6438271	C	T	UTR3	TNFRSF1A	NM_001065:c.*207G>A;NM_001346092:c.*207G>A;NM_001346091:c.*207G>A	.	.	0.985476047	0.014516656	7.30E-06	DISEASE: Familial hibernian fever (FHF) [MIM:142680]: A hereditary periodic fever syndrome characterized by recurrent fever, abdominal pain, localized tender skin lesions and myalgia. Reactive amyloidosis is the main complication and occurs in 25% of cases. {ECO:0000269|PubMed:10199409, ECO:0000269|PubMed:10902757, ECO:0000269|PubMed:11443543, ECO:0000269|PubMed:13130484, ECO:0000269|PubMed:14610673}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiple sclerosis 5 (MS5) [MIM:614810]: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. {ECO:0000269|PubMed:22801493}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. An intronic mutation affecting alternative splicing and skipping of exon 6 directs increased expression of isoform 4 a transcript encoding a C-terminally truncated protein which is secreted and may function as a TNF antagonist.; 	0.51029	0.91592	0.084621747	60.31493277	154.52417	2.71793	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	12	6438271	chr12:6438271	C	T	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	6709316	6709316	C	T	intronic	CHD4	.	.	.	0.999999998	1.61E-09	5.65E-27	.	0.80213	0.31816	-1.636932785	2.824958717	204.99058	3.09325	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	175	12	6709316	chr12:6709316	C	T	.	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	6840995	6840995	G	A	UTR3	COPS7A	NM_016319:c.*790G>A;NM_001164094:c.*790G>A;NM_001164095:c.*790G>A;NM_001164093:c.*790G>A	.	.	0.922072581	0.077830341	9.71E-05	.	0.53766	0.12327	-0.317668748	31.45789101	18.82591	0.6506	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	16	12	6840995	chr12:6840995	G	A	.	PASS	DP=16;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	7170167	7170167	-	T	intronic	C1S	.	.	.	0.863410048	0.136586473	3.48E-06	DISEASE: Complement component C1s deficiency (C1SD) [MIM:613783]: A rare defect resulting in C1 deficiency and impaired activation of the complement classical pathway. C1 deficiency generally leads to severe immune complex disease with features of systemic lupus erythematosus and glomerulonephritis. {ECO:0000269|PubMed:11390518}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18965	0.44275	-0.044015879	50.44821892	1211.71237	6.58867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	34	12	7170167	chr12:7170167	A	AT	52	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	7639333	7639333	C	T	exonic	CD163	.	stopgain	CD163:NM_004244:exon10:c.G2220A:p.W740X,CD163:NM_203416:exon10:c.G2220A:p.W740X	0.015136904	0.984853339	9.76E-06	.	0.22744	0.23364	-0.106515707	45.60627506	949.73058	5.96719	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.683	0.997	47	0.997	0.835	0.978	0.768	D	c	0.944	0.834	1.000	0.747	0.487	0.133	0	5.54	0.828	4.951	0.631	0.935	0.490	1.000	0.715	1.000	0.888	17.343	0.871	SRCR domain|SRCR-like domain	.	.	0.5	63	100	12	7639333	chr12:7639333	C	T	63	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	8082367	8082367	T	C	exonic	SLC2A3	.	synonymous SNV	SLC2A3:NM_006931:exon6:c.A774G:p.L258L	0.519822946	0.47941858	0.000758474	.	0.35764	0.14971	0.619191319	83.36282142	55.14143	1.4881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	88	12	8082367	chr12:8082367	T	C	97	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	9458891	9458891	A	G	ncRNA_exonic	LOC642846	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	107	12	9458891	chr12:9458891	A	G	93	PASS	DP=107;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
12	11083284	11083284	A	C	exonic	PRH2	.	nonsynonymous SNV	PRH2:NM_001110213:exon3:c.A124C:p.I42L	0.595625943	0.394875767	0.00949829	.	.	.	0.747842143	86.47676339	51.88257	1.4229	0.532	0.070	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	-1.1	0.010	N	2.36	0.161	T	0.05	0.064	N	0.2	0.245	-0.945	0.418	T	0.018	0.076	T	0.002	0.026	T	-3.060	0.001	0.001	0.216	0.008	0.000	0.003	N	c	-2.122	-2.199	0.848	0.250	0.554	0.246	0	-1.81	0.074	-1.135	0.033	-2.478	0.003	0.000	0.063	0.000	0.016	3.420	0.069	.	.	.	0.5	76	300	12	11083284	chr12:11083284	A	C	76	PASS	DP=300;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	11183752	11183752	T	C	exonic	TAS2R31	.	synonymous SNV	TAS2R31:NM_176885:exon1:c.A183G:p.V61V	2.54E-05	0.174294483	0.82568008	.	.	.	2.195683333	98.11276244	1586.0821	7.36714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	180	12	11183752	chr12:11183752	T	C	92	PASS	DP=180;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	11461742	11461742	C	T	exonic	PRB4	.	nonsynonymous SNV	PRB4:NM_001261399:exon3:c.G175A:p.G59R,PRB4:NM_002723:exon3:c.G175A:p.G59R	8.85E-08	0.165369218	0.834630694	.	.	.	1.352234299	94.36777542	885.28057	5.79602	0.049	0.398	D	0.006	0.126	B	0.002	0.063	B	.	.	.	1	0.090	N	.	.	.	3.54	0.048	T	-0.06	0.799	N	0.142	0.320	-0.958	0.395	T	0.017	0.069	T	.	.	.	-0.012	0.092	2.468	0.344	0.021	0.001	0.006	N	c	-1.276	-1.462	0.000	0.012	0.554	0.246	0	-1.91	0.072	-0.312	0.081	0.304	0.270	0.014	0.188	0.002	0.062	2.567	0.045	.	.	.	0.5	91	405	12	11461742	chr12:11461742	C	T	91	PASS	DP=405;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	11546749	11546749	T	C	exonic	PRB2	.	nonsynonymous SNV	PRB2:NM_006248:exon3:c.A263G:p.K88R	2.88E-14	0.009733594	0.990266406	.	.	.	1.932845308	97.48171739	718.49848	5.3211	.	.	.	0.833	0.442	P	0.136	0.317	B	.	.	.	0.950	0.265	N	1.79	0.469	L	3.87	0.036	T	-1.06	0.277	N	0.115	0.126	-0.923	0.452	T	0.005	0.018	T	0.001	0.006	T	-0.853	0.038	0.033	0.435	0.032	0.005	0.025	N	c	-0.985	-1.128	0.000	0.012	0.554	0.246	0	1.06	0.193	-0.770	0.048	0.338	0.272	0.001	0.137	0.000	0.016	6.283	0.201	.	.	.	0.5	87	115	12	11546749	chr12:11546749	T	C	87	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	14650683	14650683	G	T	exonic	ATF7IP	.	nonsynonymous SNV	ATF7IP:NM_001286514:exon15:c.G3486T:p.K1162N,ATF7IP:NM_018179:exon15:c.G3489T:p.K1163N,ATF7IP:NM_181352:exon15:c.G3513T:p.K1171N	0.999741038	0.000258962	3.26E-12	.	0.67749	0.10619	0.473967469	78.86293937	7630.06967	18.76351	0.001	0.784	D	0.996	0.670	D	0.985	0.749	D	0.003	0.358	N	1.000	0.537	D	1.73	0.448	L	1.54	0.301	T	-3.3	0.658	D	0.451	0.504	-1.006	0.283	T	0.117	0.414	T	0.028	0.505	D	3.711	0.503	23.3	0.998	0.896	0.989	0.886	D	c	0.305	0.313	0.894	0.259	0.707	0.730	0	4.04	0.461	3.383	0.520	-0.197	0.102	1.000	0.715	0.998	0.697	9.328	0.370	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	.	155	12	14650683	chr12:14650683	G	T	.	PASS	DP=155;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	15702158	15702158	T	A	exonic	PTPRO	.	nonsynonymous SNV	PTPRO:NM_030668:exon2:c.T2A:p.M1K,PTPRO:NM_030669:exon2:c.T2A:p.M1K,PTPRO:NM_030670:exon2:c.T2A:p.M1K,PTPRO:NM_030671:exon2:c.T2A:p.M1K,PTPRO:NM_002848:exon14:c.T2435A:p.M812K,PTPRO:NM_030667:exon14:c.T2435A:p.M812K	0.30462609	0.695373854	5.61E-08	DISEASE: Nephrotic syndrome 6 (NPHS6) [MIM:614196]: A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. {ECO:0000269|PubMed:21722858}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.57353	.	-1.965936983	1.828261382	172.96294	2.86316	0.008	0.912	D	0.118	0.392	B	0.01	0.331	B	0.000	0.629	D	0.759	0.367	D	1.5	0.380	L	3.86	0.041	T	-1.22	0.543	N	0.809	0.798	-0.940	0.427	T	0.009	0.031	T	0.009	0.240	T	4.555	0.610	24.4	0.963	0.287	0.982	0.801	D	c	-0.019	0.148	0.999	0.372	0.706	0.609	0	4.63	0.570	3.957	0.562	1.061	0.807	1.000	0.715	1.000	0.888	14.514	0.673	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	.	47	12	15702158	chr12:15702158	T	A	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	19410474	19410474	-	T	intronic	PLEKHA5	.	.	.	0.999999408	5.92E-07	1.20E-18	.	0.15553	0.09677	-0.418800956	25.79028073	470.79608	4.49027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.44	67	12	19410474	chr12:19410474	A	AT	10.44	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	20602478	20602478	G	T	intronic	PDE3A	.	.	.	0.106612096	0.893376508	1.14E-05	DISEASE: Hypertension and brachydactyly syndrome (HTNB) [MIM:112410]: A syndrome characterized by brachydactyly type E, severe salt-independent but age-dependent hypertension, an increased fibroblast growth rate, neurovascular contact at the rostral-ventrolateral medulla, and altered baroreflex blood pressure regulation. It results in death from stroke before age 50 years when untreated. Brachydactyly type E is characterized by shortening of the fingers mainly in the metacarpals and metatarsals. {ECO:0000269|PubMed:25961942}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09476	0.14669	-1.104093597	6.894314697	1899.16799	8.01225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	297	12	20602478	chr12:20602478	G	T	71	PASS	DP=297;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	23818504	23818504	G	A	intronic	SOX5	.	.	.	0.999398884	0.000601115	1.25E-10	.	0.63083	0.17821	-0.957024976	9.088228356	16.39611	0.58125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	16	12	23818504	chr12:23818504	G	A	.	PASS	DP=16;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	26834804	26834804	-	ACTC	intronic	ITPR2	.	.	.	5.74E-11	1	2.30E-12	DISEASE: Anhidrosis, isolated, with normal sweat glands (ANHD) [MIM:106190]: An autosomal recessive disorder characterized by generalized, isolated anhidrosis, severe heat intolerance, and morphologically normal eccrine sweat glands. Body growth, teeth, hair, nails, and skin are normal. {ECO:0000269|PubMed:25329695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90112	0.20622	-1.641009998	2.777777778	698.25496	5.25954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	39	12	26834804	chr12:26834804	T	TACTC	98	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	27109510	27109510	C	A	exonic	FGFR1OP2	.	nonsynonymous SNV	FGFR1OP2:NM_001171887:exon3:c.C170A:p.A57E,FGFR1OP2:NM_001171888:exon3:c.C170A:p.A57E,FGFR1OP2:NM_015633:exon3:c.C170A:p.A57E	0.429728003	0.568760515	0.001511482	.	0.16605	0.12716	-0.361761279	28.6329323	26.47953	0.85687	0.005	0.682	D	0.992	0.629	D	0.686	0.565	P	0.000	0.843	D	1	0.810	D	1.89	0.503	L	.	.	.	-3.14	0.650	D	0.972	0.974	-0.383	0.726	T	0.358	0.720	T	0.015	0.350	T	6.291	0.869	29.1	0.995	0.682	0.992	0.922	D	c	0.496	0.529	1.000	0.747	0.706	0.609	0	4.65	0.575	7.280	0.778	0.875	0.382	1.000	0.715	0.996	0.625	18.420	0.905	.	.	.	0.5	.	21	12	27109510	chr12:27109510	C	A	.	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	27648786	27648786	A	G	exonic	SMCO2	.	synonymous SNV	SMCO2:NM_001145010:exon8:c.A831G:p.A277A	.	.	.	.	.	.	0.881944684	89.02453409	398.02888	4.19168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	29	12	27648786	chr12:27648786	A	G	107	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0
12	29521181	29521181	C	A	exonic	ERGIC2	.	nonsynonymous SNV	ERGIC2:NM_016570:exon4:c.G255T:p.K85N	0.320357206	0.678925092	0.000717702	.	0.84052	0.08503	-0.339715008	30.06605331	9.56131	0.35232	0.098	0.318	T	0.563	0.365	P	0.487	0.454	P	0.000	0.559	D	0.915	0.365	D	2.38	0.688	M	.	.	.	-2.07	0.537	N	0.192	0.282	-0.273	0.758	T	0.327	0.696	T	0.010	0.257	T	5.379	0.729	25.9	0.998	0.917	0.953	0.640	D	c	0.319	0.368	0.059	0.152	0.732	0.924	0	5.37	0.769	0.998	0.291	0.875	0.382	1.000	0.715	1.000	0.888	16.644	0.850	.	.	.	0.5	.	69	12	29521181	chr12:29521181	C	A	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	29648275	29648275	G	A	exonic	OVCH1	.	nonsynonymous SNV	OVCH1:NM_183378:exon4:c.C397T:p.R133C	1.53E-28	1.88E-05	0.999981223	.	0.058	.	.	.	4524.95189	13.51306	0.052	0.390	T	0.855	0.451	P	0.285	0.388	B	.	.	.	1	0.090	P	1.665	0.427	L	-2.49	0.892	D	-2.21	0.496	N	0.148	0.175	-0.972	0.368	T	0.000	0.000	T	.	.	.	1.303	0.221	12.28	0.865	0.161	0.010	0.039	N	c	-0.770	-0.946	0.003	0.097	0.554	0.246	0	0.63	0.168	-0.542	0.061	-1.030	0.021	0.000	0.063	0.002	0.062	5.503	0.160	Peptidase S1, PA clan|Serine proteases, trypsin domain	.	.	0.5	64	19	12	29648275	chr12:29648275	G	A	64	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	29812859	29812859	A	T	intronic	TMTC1	.	.	.	3.06E-07	0.996221773	0.003777921	.	0.33022	0.13818	-0.418800956	25.79028073	1433.09079	7.06654	0.998	0.019	T	0.998	0.715	D	0.991	0.782	D	.	.	.	0.992	0.810	D	.	.	.	0.91	0.449	T	-0.81	0.223	N	0.309	0.465	-0.613	0.643	T	0.242	0.611	T	0.132	0.815	D	3.177	0.441	22.7	0.992	0.536	0.957	0.657	D	c	0.642	0.647	1.000	0.480	0.706	0.609	0	5.4	0.779	7.390	0.789	1.088	0.866	1.000	0.715	0.998	0.697	11.814	0.513	Domain of unknown function DUF1736	.	.	0.5	86	122	12	29812859	chr12:29812859	A	T	86	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	31595764	31595764	C	A	exonic	DENND5B	.	nonsynonymous SNV	DENND5B:NM_144973:exon7:c.G1957T:p.G653W,DENND5B:NM_001308339:exon9:c.G2062T:p.G688W	0.999945504	5.45E-05	3.62E-13	.	.	.	-0.440847477	24.59896202	5379.04327	15.1245	0.001	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.695	0.791	M	3.38	0.098	T	-4.2	0.778	D	0.897	0.897	-1.050	0.143	T	0.092	0.352	T	0.024	0.470	T	7.733	0.955	35	0.996	0.754	0.981	0.796	D	c	0.796	0.752	1.000	0.747	0.706	0.609	0	4.77	0.603	7.705	0.835	0.892	0.403	1.000	0.715	1.000	0.888	18.000	0.891	.	.	.	0.5	.	47	12	31595764	chr12:31595764	C	A	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	38363524	38363524	G	T	intergenic	NONE;ALG10B	dist=NONE;dist=347033	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	289	12	38363524	chr12:38363524	G	T	73	PASS	DP=289;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	46758223	46758223	G	A	exonic	SLC38A2	.	synonymous SNV	SLC38A2:NM_001307936:exon9:c.C522T:p.N174N,SLC38A2:NM_018976:exon10:c.C822T:p.N274N	0.969357	0.030641113	1.89E-06	.	0.5231	0.12079	0.130533008	63.35810333	54.54237	1.47748	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	248	12	46758223	chr12:46758223	G	A	.	PASS	DP=248;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	48184753	48184753	C	G	intronic	HDAC7	.	.	.	0.998019873	0.001980126	4.64E-10	.	0.1103	.	-0.038558137	50.51899033	940.4494	5.94619	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	18	12	48184753	chr12:48184753	C	G	.	PASS	DP=18;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	48191136	48191136	C	T	intronic	HDAC7	.	.	.	0.998019873	0.001980126	4.64E-10	.	0.1103	.	-0.038558137	50.51899033	940.4494	5.94619	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	12	48191136	chr12:48191136	C	T	.	PASS	DP=58;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	48501161	48501161	A	T	exonic	PFKM	.	nonsynonymous SNV	PFKM:NM_001166686:exon2:c.A5T:p.H2L	6.03E-07	0.999707802	0.000291594	DISEASE: Glycogen storage disease 7 (GSD7) [MIM:232800]: A metabolic disorder characterized by exercise intolerance with associated nausea and vomiting, muscle cramping, exertional myopathy and compensated hemolysis. Short bursts of intense activity are particularly difficult. Severe muscle cramps and myoglobinuria develop after vigorous exercise. {ECO:0000269|PubMed:22133655, ECO:0000269|PubMed:24427140, ECO:0000269|PubMed:7513946, ECO:0000269|PubMed:7825568, ECO:0000269|PubMed:8889589}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25899	0.78377	-0.464712395	23.5727766	3843.53437	12.20917	0.056	0.381	T	.	.	.	.	.	.	0.209	0.164	N	0.996	0.231	P	.	.	.	-1.33	0.872	T	-0.17	0.129	N	0.049	0.150	-0.924	0.450	T	0.000	0.000	T	.	.	.	2.873	0.406	21.7	0.850	0.151	0.097	0.152	N	c	-0.630	-0.693	1.000	0.747	0.421	0.056	0	-2.34	0.063	-1.241	0.030	-0.506	0.051	0.233	0.245	0.790	0.333	8.661	0.331	.	ENSG00000152556.11|ENSG00000240399.1|ENSG00000152556.11|ENSG00000139219.13|ENSG00000167528.8	Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Testis|Whole_Blood	0.5	72	11	12	48501161	chr12:48501161	A	T	72	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.
12	49334757	49334757	T	C	exonic	ARF3	.	nonsynonymous SNV	ARF3:NM_001659:exon2:c.A122G:p.E41G	0.622731324	0.36968033	0.007588347	.	0.8735	.	-0.031067188	51.03798066	.	.	0.0	0.912	D	0.974	0.559	D	0.887	0.612	P	0.000	0.843	D	1	0.810	D	3.63	0.941	H	-0.21	0.830	T	-6.36	0.922	D	0.85	0.837	0.654	0.926	D	0.729	0.907	D	0.346	0.922	D	6.299	0.870	29.1	0.998	0.908	0.997	0.987	D	c	0.795	0.739	1.000	0.747	0.719	0.830	0	4.96	0.650	8.014	0.882	1.056	0.757	1.000	0.715	1.000	0.888	13.912	0.632	P-loop containing nucleoside triphosphate hydrolase;P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	61	213	12	49334757	chr12:49334757	T	C	61	PASS	DP=213;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	49691409	49691409	C	A	ncRNA_exonic	LOC101927267	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	12	49691409	chr12:49691409	C	A	.	PASS	DP=39;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	50042048	50042048	G	A	exonic	FMNL3	.	synonymous SNV	FMNL3:NM_198900:exon21:c.C2451T:p.S817S,FMNL3:NM_175736:exon22:c.C2604T:p.S868S	0.356499504	0.643500313	1.83E-07	.	0.12501	0.10847	-1.017713296	8.103326256	188.83904	2.98373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	329	12	50042048	chr12:50042048	G	A	66	PASS	DP=329;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	51796890	51796941	TTAGGTAATAGGTATAAACTGCTCAGAACAGTGCTCAGAACATAATAAATGC	-	intronic	SLC4A8	.	.	.	0.999867374	0.000132626	6.38E-13	.	0.07064	0.11699	-0.799052816	12.45576787	53.47821	1.45321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	51	12	51796889	chr12:51796889	ATTAGGTAATAGGTATAAACTGCTCAGAACAGTGCTCAGAACATAATAAATGC	A	114	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	51874000	51874000	A	G	exonic	SLC4A8	.	synonymous SNV	SLC4A8:NM_001258403:exon17:c.A2238G:p.Q746Q	0.999867374	0.000132626	6.38E-13	.	0.07064	0.11699	-0.799052816	12.45576787	53.47821	1.45321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	72	12	51874000	chr12:51874000	A	G	62	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	52174448	52174448	C	T	exonic	SCN8A	.	nonsynonymous SNV	SCN8A:NM_001330260:exon21:c.C3835T:p.L1279F,SCN8A:NM_014191:exon21:c.C3835T:p.L1279F	0.99999829	1.71E-06	3.22E-18	DISEASE: Cognitive impairment with or without cerebellar ataxia (CIAT) [MIM:614306]: A disorder characterized by markedly delayed cognitive and motor development, attention deficit disorder, and cerebellar ataxia. Features include bilateral esophoria, strabismatic amblyopia, unsustained gaze evoked nystagmus on horizontal gaze, ataxic gait, dysmetria in the upper limbs and dysarthria, with normal strength, tone, and reflexes. {ECO:0000269|PubMed:16236810}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epileptic encephalopathy, early infantile, 13 (EIEE13) [MIM:614558]: A form of epilepsy characterized by frequent tonic seizures or spasms beginning in infancy with a specific EEG finding of suppression-burst patterns, characterized by high- voltage bursts alternating with almost flat suppression phases. Patients may progress to West syndrome, which is characterized by tonic spasms with clustering, arrest of psychomotor development, and hypsarrhythmia on EEG. EIEE13 is a severe form consisting of early-onset seizures, features of autism, intellectual disability, ataxia, and sudden unexplained death in epilepsy. {ECO:0000269|PubMed:22365152, ECO:0000269|PubMed:24352161, ECO:0000269|PubMed:24874546, ECO:0000269|PubMed:24888894, ECO:0000269|PubMed:25239001}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.6031	0.25451	-1.749006627	2.341354093	100.07778	2.16874	0.004	0.654	D	0.995	0.657	D	0.944	0.663	D	0.000	0.843	D	1	0.810	D	2.06	0.569	M	-5.09	0.987	D	-3.56	0.688	D	0.835	0.822	1.071	0.986	D	0.965	0.989	D	0.629	0.968	D	5.019	0.676	25.2	0.999	0.946	0.939	0.592	D	c	0.708	0.682	1.000	0.747	0.497	0.185	0	5.28	0.740	2.784	0.472	0.931	0.441	1.000	0.715	1.000	0.888	19.559	0.953	Ion transport domain|Voltage-dependent channel, four helix bundle domain	.	.	0.5	.	41	12	52174448	chr12:52174448	C	T	.	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	52841168	52841168	T	A	exonic	KRT6B	.	nonsynonymous SNV	KRT6B:NM_005555:exon9:c.A1501T:p.S501C	0.004792655	0.966239227	0.028968117	.	0.12487	.	-0.304932527	32.24817174	532.75963	4.70795	0.229	0.183	T	0.002	0.090	B	0.001	0.040	B	0.330	0.141	N	1	0.090	N	2.25	0.640	M	-2.32	0.878	D	-1.9	0.443	N	0.277	0.335	-0.703	0.603	T	0.445	0.782	T	0.044	0.616	D	0.385	0.131	6.483	0.783	0.118	0.073	0.131	N	c	-1.088	-1.182	0.994	0.335	0.497	0.185	0	-2.21	0.065	0.009	0.130	-0.028	0.127	0.017	0.192	0.002	0.062	7.916	0.288	.	.	.	0.5	108	388	12	52841168	chr12:52841168	T	A	108	PASS	DP=388;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	53084970	53084970	G	T	exonic	KRT77	.	synonymous SNV	KRT77:NM_175078:exon9:c.C1716A:p.S572S	1.05E-06	0.785358392	0.214640555	.	0.11671	.	2.289361599	98.30738382	4908.5509	14.28597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	809	12	53084970	chr12:53084970	G	T	125	PASS	DP=809;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	53170958	53170958	C	T	exonic	KRT76	.	nonsynonymous SNV	KRT76:NM_015848:exon1:c.G118A:p.G40S	6.27E-07	0.443932489	0.556066884	.	0.15911	.	1.249272484	93.46543996	5036.73118	14.50591	0.639	0.050	T	0.001	0.067	B	0.004	0.093	B	0.130	0.187	N	1	0.090	N	1.26	0.320	L	-3.29	0.937	D	-2.02	0.465	N	0.089	0.086	-0.494	0.689	T	0.591	0.854	D	0.034	0.553	D	-0.545	0.053	0.170	0.411	0.029	0.047	0.102	N	c	-1.448	-1.516	0.000	0.046	0.497	0.185	0	-3.94	0.038	0.006	0.129	-0.008	0.133	0.000	0.063	0.320	0.241	13.368	0.600	Keratin type II head	.	.	0.5	.	252	12	53170958	chr12:53170958	C	T	.	PASS	DP=252;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	53207548	53207548	G	T	exonic	KRT4	.	nonsynonymous SNV	KRT4:NM_002272:exon1:c.C295A:p.P99T	0.000566043	0.993911632	0.005522325	DISEASE: White sponge nevus 1 (WSN1) [MIM:193900]: A rare disorder characterized by the presence of soft, white, and spongy plaques in the oral mucosa. The characteristic histopathologic features are epithelial thickening, parakeratosis, and vacuolization of the suprabasal layer of oral epithelial keratinocytes. Less frequently the mucous membranes of the nose, esophagus, genitalia and rectum are involved. {ECO:0000269|PubMed:10652003, ECO:0000269|PubMed:12828738}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3298	0.21875	0.336225928	73.67893371	3276.78109	10.92393	0.086	0.326	T	0.179	0.273	B	0.039	0.223	B	0.370	0.135	N	1.000	0.090	N	2.465	0.718	M	-1.98	0.853	D	-2.32	0.514	N	0.19	0.250	-0.595	0.651	T	0.490	0.806	T	0.156	0.837	D	-0.948	0.034	0.020	0.985	0.411	0.384	0.258	N	c	-0.854	-0.950	1.000	0.480	0.497	0.185	0	-5.76	0.022	-0.112	0.107	0.098	0.198	0.000	0.063	0.516	0.274	8.993	0.350	Keratin type II head	.	.	0.5	115	379	12	53207548	chr12:53207548	G	T	115	PASS	DP=379;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	53774021	53774021	C	-	UTR5	SP1	NM_138473:c.-55del-;NM_001251825:c.-55del-	.	.	0.997637149	0.002362764	8.61E-08	.	0.99998	0.76734	-0.933156985	9.54824251	50.01247	1.38791	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	984	12	53774020	chr12:53774020	GC	G	100	PASS	DP=984;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	53873421	53873421	G	T	UTR3	PCBP2	NM_001128914:c.*195G>T;NM_001098620:c.*195G>T;NM_001128913:c.*195G>T;NM_001128912:c.*195G>T;NM_031989:c.*195G>T;NM_005016:c.*195G>T;NM_001128911:c.*195G>T	.	.	0.98703033	0.01296855	1.12E-06	.	0.33122	.	-0.185391282	39.67916962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	12	53873421	chr12:53873421	G	T	.	PASS	DP=28;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	54676165	54676165	-	T	ncRNA_intronic	HNRNPA1P10	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	77	12	54676165	chr12:54676165	G	GT	84	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	54763673	54763673	C	-	ncRNA_intronic	LOC102724050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	805	12	54763672	chr12:54763672	TC	T	93	PASS	DP=805;AN=4	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	0/1
12	55159834	55159834	T	-	intergenic	DCD;MUCL1	dist=117557;dist=88465	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	69	12	55159833	chr12:55159833	AT	A	51	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	56294484	56294484	A	-	downstream	PYM1	dist=713	.	.	.	.	.	.	0.15471	0.12127	-0.163345027	41.24793583	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	118	12	56294483	chr12:56294483	GA	G	80	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	56559113	56559113	G	-	exonic	SMARCC2	.	frameshift deletion	SMARCC2:NM_003075:exon26:c.3128delC:p.P1043Lfs*15,SMARCC2:NM_001130420:exon27:c.3221delC:p.P1074Lfs*15,SMARCC2:NM_001330288:exon27:c.3221delC:p.P1074Lfs*15,SMARCC2:NM_139067:exon27:c.3221delC:p.P1074Lfs*15	0.999999989	1.09E-08	8.71E-21	.	0.99223	0.13798	-1.660796428	2.707006369	91.03551	2.05285	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	1039	12	56559112	chr12:56559112	AG	A	84	PASS	DP=1039;AN=4	GT	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.
12	56622981	56622981	G	A	exonic	NABP2	.	nonsynonymous SNV	NABP2:NM_024068:exon7:c.G620A:p.R207K	0.956804648	0.043087592	0.00010776	.	0.29478	.	-0.141298762	42.87567823	1.67296	0.05407	0.0	0.912	D	0.841	0.445	P	0.745	0.540	P	0.000	0.629	D	0.684	0.332	D	0.975	0.246	L	0.1	0.614	T	-1.36	0.338	N	0.524	0.582	-0.350	0.736	T	0.299	0.670	T	0.031	0.537	D	6.159	0.850	28.5	0.993	0.598	0.961	0.673	D	c	0.558	0.586	1.000	0.747	0.732	0.924	0	5.39	0.775	4.212	0.581	1.048	0.713	1.000	0.715	1.000	0.888	16.442	0.837	.	.	.	0.5	.	47	12	56622981	chr12:56622981	G	A	.	PASS	DP=47;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	56629082	56629082	G	T	exonic	SLC39A5	.	nonsynonymous SNV	SLC39A5:NM_001135195:exon5:c.G776T:p.G259V,SLC39A5:NM_173596:exon7:c.G776T:p.G259V	1.21E-07	0.564508656	0.435491223	DISEASE: Myopia 24, autosomal dominant (MYP24) [MIM:615946]: A refractive error of the eye, in which parallel rays from a distant object come to focus in front of the retina, vision being better for near objects than for far. {ECO:0000269|PubMed:24891338, ECO:0000269|PubMed:25525168}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13096	.	-0.372889896	28.20240623	281.62781	3.5946	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	3.83	0.957	H	0.48	0.802	T	-8.81	0.980	D	0.952	0.949	0.802	0.944	D	0.766	0.921	D	0.345	0.921	D	5.971	0.820	27.7	0.998	0.898	0.908	0.521	D	c	0.912	0.801	1.000	0.747	0.421	0.056	0	4.44	0.530	8.895	0.921	1.048	0.713	1.000	0.715	1.000	0.888	16.703	0.852	.	.	.	0.5	.	225	12	56629082	chr12:56629082	G	T	.	PASS	DP=225;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	57522680	57522680	G	-	UTR5	LRP1	NM_002332:c.-68del-	.	.	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	527	12	57522679	chr12:57522679	TG	T	75	PASS	DP=527;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	57590798	57590798	G	C	exonic	LRP1	.	nonsynonymous SNV	LRP1:NM_002332:exon56:c.G8926C:p.D2976H	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	0.003	0.682	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1.000	0.588	D	2.96	0.854	M	-4.14	0.968	D	-4.8	0.806	D	0.867	0.854	1.079	0.989	D	0.946	0.982	D	0.296	0.908	D	6.956	0.935	33	0.991	0.528	0.991	0.911	D	c	0.905	0.854	1.000	0.747	0.672	0.522	0	5.34	0.759	8.018	0.890	1.048	0.713	1.000	0.715	0.975	0.474	17.970	0.890	Complement Clr-like EGF domain|EGF-like calcium-binding domain|EGF-like, conserved site|Growth factor receptor cysteine-rich domain	.	.	0.5	141	644	12	57590798	chr12:57590798	G	C	141	PASS	DP=644;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	57604120	57604120	G	A	exonic	LRP1	.	nonsynonymous SNV	LRP1:NM_002332:exon82:c.G12611A:p.C4204Y	1	1.45E-26	2.05E-66	.	0.65439	0.76644	-7.278555259	0.017692852	526.27186	4.68307	0.0	0.912	D	0.998	0.715	D	0.991	0.782	D	0.000	0.843	D	1.000	0.588	D	4.215	0.979	H	1.6	0.286	T	-7.07	0.939	D	0.941	0.936	-0.201	0.777	T	0.288	0.660	T	0.036	0.571	D	6.395	0.883	29.6	0.991	0.528	0.923	0.551	D	c	0.905	0.797	1.000	0.747	0.672	0.522	0	4.44	0.530	7.637	0.823	1.048	0.713	1.000	0.715	1.000	0.888	16.366	0.831	EGF-like domain	.	.	0.5	81	210	12	57604120	chr12:57604120	G	A	81	PASS	DP=210;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	57638386	57638386	T	A	exonic	STAC3	.	nonsynonymous SNV	STAC3:NM_001286257:exon6:c.A182T:p.Q61L,STAC3:NM_001286256:exon8:c.A623T:p.Q208L,STAC3:NM_145064:exon9:c.A740T:p.Q247L	0.004878302	0.989072823	0.006048875	DISEASE: Native American myopathy (NAM) [MIM:255995]: A disease characterized by congenital weakness and arthrogryposis, cleft palate, ptosis, short stature, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia provoked by anesthesia. {ECO:0000269|PubMed:23736855}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16182	0.10482	-0.137658575	43.57159707	50.70761	1.40292	0.26	0.165	T	0.01	0.144	B	0.004	0.093	B	0.104	0.197	N	0.750	0.306	N	1.15	0.294	L	1.62	0.282	T	-0.09	0.090	N	0.42	0.477	-1.018	0.244	T	0.021	0.087	T	0.008	0.226	T	2.404	0.350	18.85	0.973	0.329	0.810	0.402	D	c	-0.565	-0.295	1.000	0.500	0.706	0.609	0	3.87	0.437	0.181	0.166	0.964	0.580	0.991	0.370	1.000	0.888	6.628	0.219	SH3 domain	.	.	0.5	94	146	12	57638386	chr12:57638386	T	A	94	PASS	DP=146;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	58125636	58125636	C	A	exonic	AGAP2	.	nonsynonymous SNV	AGAP2:NM_001122772:exon8:c.G1909T:p.G637W,AGAP2:NM_014770:exon8:c.G901T:p.G301W	0.999218902	0.000781098	9.71E-12	.	0.8169	0.23301	-0.176292081	40.56381222	265.49784	3.49614	0.011	0.614	D	0.998	0.715	D	0.908	0.759	P	0.865	0.089	N	0.998	0.445	D	0.895	0.225	L	1.51	0.352	T	-1.68	0.402	N	0.556	0.591	-1.042	0.168	T	0.108	0.393	T	0.024	0.474	T	6.460	0.891	29.9	0.996	0.748	0.854	0.442	D	c	0.101	0.187	1.000	0.408	0.707	0.730	0	4.63	0.570	2.299	0.430	0.852	0.362	0.153	0.235	0.998	0.697	7.136	0.245	.	.	.	0.5	95	733	12	58125636	chr12:58125636	C	A	95	PASS	DP=733;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	58127972	58127972	G	A	intronic	AGAP2	.	.	.	0.999218902	0.000781098	9.71E-12	.	0.8169	0.23301	-0.176292081	40.56381222	265.49784	3.49614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	86	12	58127972	chr12:58127972	G	A	64	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	58157466	58157466	G	T	exonic	CYP27B1	.	synonymous SNV	CYP27B1:NM_000785:exon8:c.C1341A:p.P447P	3.60E-06	0.806445692	0.193550707	.	0.09767	0.39937	-0.404032746	26.53338051	111.70148	2.30098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	12	58157466	chr12:58157466	G	T	.	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	58339452	58339452	G	A	exonic	ATP23	.	nonsynonymous SNV	ATP23:NM_001320408:exon2:c.G73A:p.G25S,ATP23:NM_033276:exon2:c.G229A:p.G77S	.	.	.	.	0.12751	0.11458	0.305084559	72.22811984	.	.	0.032	0.446	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.565	0.752	M	0.31	0.586	T	-5.63	0.868	D	0.62	0.649	-0.132	0.794	T	0.403	0.754	T	0.103	0.778	D	5.924	0.813	27.6	0.998	0.856	0.977	0.761	D	c	0.724	0.641	0.960	0.284	0.615	0.372	0	4.14	0.477	8.322	0.898	1.045	0.669	1.000	0.715	0.997	0.653	13.607	0.614	.	.	.	0.5	95	314	12	58339452	chr12:58339452	G	A	95	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	62148744	62148744	G	T	exonic	FAM19A2	.	nonsynonymous SNV	FAM19A2:NM_178539:exon3:c.C168A:p.N56K	0.54745717	0.438689922	0.013852908	.	0.48543	0.09934	0.21326276	67.71644256	15.92723	0.56478	0.017	0.555	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	0.984	0.810	D	2.52	0.738	M	.	.	.	-5.93	0.895	D	0.352	0.415	-0.189	0.780	T	0.421	0.767	T	0.070	0.709	D	5.694	0.777	26.8	0.998	0.909	0.962	0.676	D	c	0.739	0.709	0.000	0.071	0.554	0.246	0	5.42	0.786	4.717	0.614	1.048	0.713	1.000	0.715	1.000	0.888	10.800	0.455	.	.	.	0.5	.	51	12	62148744	chr12:62148744	G	T	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	63964641	63964641	A	-	intronic	DPY19L2	.	.	.	7.03E-05	0.999003807	0.000925899	.	0.1085	.	1.354051915	94.39726351	4007.99241	12.53898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	47	12	63964640	chr12:63964640	GA	G	66	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	64891457	64891457	T	A	exonic	TBK1	.	nonsynonymous SNV	TBK1:NM_013254:exon19:c.T1989A:p.F663L	0.995096971	0.004903028	8.57E-10	DISEASE: Glaucoma 1, open angle, P (GLC1P) [MIM:177700]: A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. GLC1P is characterized by early onset, thin central corneas and low intraocular pressure. {ECO:0000269|PubMed:21447600, ECO:0000269|PubMed:22306015}. Note=The disease may be caused by mutations affecting the gene represented in this entry. A copy number variation on chromosome 12q14 consisting of a 300 kb duplication that includes TBK1, XPOT, RASSF3 and GNS has been found in individuals affected by glaucoma. TBK1 is the most likely candidate for the disorder (PubMed:21447600). {ECO:0000269|PubMed:21447600}.; DISEASE: Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 (FTDALS4) [MIM:616439]: A neurodegenerative disorder characterized by frontotemporal dementia and/or amyotrophic lateral sclerosis in affected individuals. There is high intrafamilial variation. Frontotemporal dementia is characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Amyotrophic lateral sclerosis is characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis. {ECO:0000269|PubMed:25803835, ECO:0000269|PubMed:25943890}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17165	0.35025	-0.291981272	33.20358575	93.23558	2.0775	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.000	0.491	N	0.753	0.339	D	-0.855	0.015	N	0.02	0.623	T	0.59	0.026	N	0.081	0.084	-1.024	0.225	T	0.100	0.371	T	0.013	0.324	T	1.540	0.247	13.53	0.600	0.062	0.818	0.409	D	c	-0.536	-0.374	0.003	0.099	0.719	0.830	0	1.49	0.219	0.277	0.184	0.045	0.158	0.995	0.385	0.584	0.286	6.979	0.237	.	.	.	0.5	.	30	12	64891457	chr12:64891457	T	A	.	PASS	DP=30;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	66716618	66716618	-	T	intronic	HELB	.	.	.	2.02E-13	0.201004528	0.798995472	.	0.03646	0.09863	1.076540831	91.72564284	4335.69084	13.10867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	41	12	66716618	chr12:66716618	G	GT	78	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	68690766	68690766	A	-	intronic	MDM1	.	.	.	5.78E-08	0.961965994	0.038033948	.	0.42256	0.109	0.383960053	75.66053314	1434.83695	7.07219	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	51	12	68690765	chr12:68690765	TA	T	78	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	70049190	70049190	C	T	exonic	BEST3	.	nonsynonymous SNV	BEST3:NM_152439:exon6:c.G865A:p.E289K,BEST3:NM_001282613:exon8:c.G1186A:p.E396K,BEST3:NM_032735:exon10:c.G1504A:p.E502K	3.69E-17	0.001380606	0.998619394	.	0.14764	0.10434	0.134171522	63.57041755	1059.3782	6.24526	0.001	0.784	D	0.999	0.764	D	0.994	0.807	D	0.075	0.212	N	0.647	0.810	D	1.935	0.520	L	-5.28	0.990	D	-1.1	0.326	N	0.471	0.686	1.082	0.989	D	0.967	0.990	D	0.354	0.924	D	4.793	0.643	24.7	0.999	0.935	0.937	0.586	D	c	0.206	0.110	1.000	0.747	0.487	0.133	0	4.6	0.564	4.645	0.609	-0.004	0.134	0.997	0.399	0.002	0.062	14.301	0.658	.	.	.	0.5	.	135	12	70049190	chr12:70049190	C	T	.	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	70329745	70329745	C	T	intronic	MYRFL	.	.	.	.	.	.	.	0.11494	.	.	.	3336.78291	11.06066	.	.	.	.	.	.	.	.	.	.	.	.	1.000	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.944	0.184	10.34	0.755	0.107	0.038	0.090	N	n	0.452	0.261	1.000	0.747	0.119	0.024	0	1.7	0.232	-0.248	0.088	0.855	0.374	0.000	0.063	0.574	0.284	4.496	0.112	.	.	.	0.5	.	73	12	70329745	chr12:70329745	C	T	.	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	70729217	70729217	G	A	splicing	CNOT2	NM_014515:exon8:c.650-1G>A;NM_001199302:exon9:c.650-1G>A;NM_001199303:exon8:c.650-1G>A	.	.	0.999868597	0.000131403	7.53E-11	.	0.28744	0.14229	-0.117432389	44.89266336	17.74579	0.62027	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.134	0.692	25.4	0.993	0.599	0.991	0.916	D	c	1.203	1.041	1.000	0.747	0.322	0.047	0	5.37	0.769	9.882	0.985	0.953	0.551	1.000	0.715	0.982	0.498	19.484	0.950	.	.	.	0.5	75	132	12	70729217	chr12:70729217	G	A	75	PASS	DP=132;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	72094581	72094581	T	C	intronic	TMEM19	.	.	.	0.001380694	0.866114693	0.132504613	.	0.0797	0.1104	0.350995466	74.37485256	257.67543	3.45315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	165	12	72094581	chr12:72094581	T	C	76	PASS	DP=165;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	75720278	75720278	T	C	exonic	CAPS2	.	nonsynonymous SNV	CAPS2:NM_001286547:exon2:c.A22G:p.M8V,CAPS2:NM_032606:exon2:c.A58G:p.M20V	2.65E-09	0.272459498	0.727540499	.	0.079	0.09221	0.198490371	67.30360934	2043.71225	8.33443	0.0	0.912	D	0.993	0.637	D	0.956	0.680	D	0.233	0.159	N	0.897	0.810	D	1.87	0.498	L	1.51	0.309	T	-0.7	0.247	N	0.603	0.628	-0.974	0.363	T	0.100	0.371	T	0.006	0.146	T	3.724	0.505	23.3	0.973	0.326	0.881	0.476	D	c	0.272	0.256	0.104	0.165	0.554	0.246	0	4.41	0.524	4.606	0.606	1.061	0.807	1.000	0.715	0.707	0.311	13.046	0.582	.	.	.	0.5	70	32	12	75720278	chr12:75720278	T	C	70	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	77216331	77216333	TTT	-	intronic	ZDHHC17	.	.	.	0.998394624	0.001605369	6.79E-09	.	0.57991	0.2033	-0.159704656	41.90846898	464.21173	4.46413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	23.41	53	12	77216330	chr12:77216330	ATTT	A,AT	23.41	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	77216332	77216333	TT	-	intronic	ZDHHC17	.	.	.	0.998394624	0.001605369	6.79E-09	.	0.57991	0.2033	-0.159704656	41.90846898	464.21173	4.46413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	23.41	53	12	77216330	chr12:77216330	ATTT	A,AT	23.41	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	78362403	78362403	G	T	exonic	NAV3	.	stopgain	NAV3:NM_001024383:exon5:c.G592T:p.E198X,NAV3:NM_014903:exon5:c.G592T:p.E198X	0.999999399	6.01E-07	4.23E-22	DISEASE: Note=A chromosomal aberration disrupting NAV3 has been found in patients with Sezary syndrome (PubMed:16166283). Translocation t(12;18)(q21;q21.2) (PubMed:16166283). {ECO:0000269|PubMed:16166283}.; 	0.8009	0.11717	-2.045202892	1.645435244	577.63321	4.87321	.	.	.	.	.	.	.	.	.	0.002	0.383	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.938	0.987	40	0.998	0.894	0.995	0.965	D	c	1.164	1.017	1.000	0.747	0.563	0.310	0	5.53	0.825	7.051	0.762	0.943	0.531	1.000	0.715	0.987	0.523	19.453	0.948	Calponin homology domain	.	.	0.5	70	79	12	78362403	chr12:78362403	G	T	70	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	85285725	85285725	C	G	exonic	SLC6A15	.	nonsynonymous SNV	SLC6A15:NM_018057:exon2:c.G175C:p.D59H,SLC6A15:NM_182767:exon2:c.G175C:p.D59H	0.002262596	0.994003974	0.003733431	.	0.12557	0.1124	0.068033485	59.0351498	70.72739	1.74982	0.035	0.682	D	0.902	0.478	P	0.687	0.518	P	0.002	0.373	N	1.000	0.810	D	1.79	0.469	L	-0.78	0.736	T	-3.36	0.759	D	0.306	0.455	-0.414	0.716	T	0.341	0.707	T	0.024	0.468	T	5.522	0.750	26.3	0.996	0.718	0.975	0.749	D	c	0.355	0.434	1.000	0.747	0.706	0.609	0	4.59	0.561	4.955	0.631	0.935	0.490	1.000	0.715	0.990	0.544	17.013	0.862	.	.	.	0.5	87	18	12	85285725	chr12:85285725	C	G	87	PASS	DP=18;AN=2	GT	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	88512304	88512304	-	T	exonic	CEP290	.	frameshift insertion	CEP290:NM_025114:exon17:c.1666dupA:p.I556Nfs*19	1.04E-34	0.00416173	0.99583827	DISEASE: Joubert syndrome 5 (JBTS5) [MIM:610188]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 5 shares the neurologic and neuroradiologic features of Joubert syndrome together with severe retinal dystrophy and/or progressive renal failure characterized by nephronophthisis. {ECO:0000269|PubMed:16682970, ECO:0000269|PubMed:16682973, ECO:0000269|PubMed:22425360}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Senior-Loken syndrome 6 (SLSN6) [MIM:610189]: A renal- retinal disorder characterized by progressive wasting of the filtering unit of the kidney (nephronophthisis), with or without medullary cystic renal disease, and progressive eye disease. Typically this disorder becomes apparent during the first year of life. {ECO:0000269|PubMed:20683928}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leber congenital amaurosis 10 (LCA10) [MIM:611755]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:16909394}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Meckel syndrome 4 (MKS4) [MIM:611134]: A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly. {ECO:0000269|PubMed:17564974}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Antibodies against CEP290 are present in sera from patients with cutaneous T-cell lymphomas, but not in the healthy control population. {ECO:0000269|PubMed:11149944}.; DISEASE: Bardet-Biedl syndrome 14 (BBS14) [MIM:615991]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:18327255}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.48442	0.31068	0.374677996	75.3066761	2616.79176	9.5828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	18	12	88512304	chr12:88512304	A	AT	41	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	91340253	91340253	T	-	ncRNA_exonic	LINC00615	.	.	.	.	.	.	.	0.06168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	106	12	91340252	chr12:91340252	CT	C,CTT	65	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	91340253	91340253	-	T	ncRNA_exonic	LINC00615	.	.	.	.	.	.	.	0.06168	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	106	12	91340252	chr12:91340252	CT	C,CTT	65	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	93130307	93130307	C	T	UTR5	PLEKHG7	NM_001004330:c.-988C>T	.	.	3.68E-11	0.089094005	0.910905995	.	0.1916	.	0.463046108	78.58575136	319.25993	3.79421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	12	93130307	chr12:93130307	C	T	.	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	94975543	94975543	G	T	exonic	TMCC3	.	nonsynonymous SNV	TMCC3:NM_001301036:exon2:c.C757A:p.Q253K,TMCC3:NM_020698:exon2:c.C850A:p.Q284K	0.000392184	0.845537036	0.15407078	.	0.0962	0.10967	0.178263593	66.12998349	211.70761	3.13738	0.175	0.235	T	0.285	0.304	B	0.131	0.313	B	0.004	0.340	N	0.983	0.422	D	1.355	0.339	L	1.03	0.405	T	-1.45	0.356	N	0.368	0.429	-1.061	0.114	T	0.101	0.375	T	0.009	0.227	T	2.161	0.321	17.25	0.982	0.386	0.988	0.865	D	c	0.215	0.400	0.936	0.272	0.707	0.730	0	5.93	0.959	7.384	0.789	0.974	0.594	1.000	0.715	0.989	0.536	20.344	0.988	.	.	.	0.5	123	215	12	94975543	chr12:94975543	G	T	123	PASS	DP=215;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	95479478	95479478	G	C	intronic	FGD6	.	.	.	0.995227689	0.004772311	3.29E-11	.	0.18424	0.0913	-1.076610636	7.324840764	1000.15705	6.09179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	10	12	95479478	chr12:95479478	G	C	43	PASS	DP=10;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	96679809	96679809	A	-	intronic	CDK17	.	.	.	0.988843485	0.011156483	3.17E-08	.	0.20942	0.14229	-0.514264485	21.41424864	26.55309	0.85822	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	523	12	96679808	chr12:96679808	GA	G,GAA	67	PASS	DP=523;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	96679809	96679809	-	A	intronic	CDK17	.	.	.	0.988843485	0.011156483	3.17E-08	.	0.20942	0.14229	-0.514264485	21.41424864	26.55309	0.85822	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	523	12	96679808	chr12:96679808	GA	G,GAA	67	PASS	DP=523;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
12	98909624	98909624	G	T	ncRNA_exonic	TMPO-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	762	12	98909624	chr12:98909624	G	T	125	PASS	DP=762;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	102140524	102140524	-	A	UTR3	GNPTAB	NM_024312:c.*417_*418insT	.	.	4.23E-06	0.999977941	1.78E-05	DISEASE: Mucolipidosis type II (MLII) [MIM:252500]: Fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features, peculiar fibroblast inclusions, and no excessive mucopolysacchariduria. Congenital dislocation of the hip, thoracic deformities, hernia, and hyperplastic gums are evident soon after birth. {ECO:0000269|PubMed:16200072, ECO:0000269|PubMed:16835905, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:22495880, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:23733939, ECO:0000269|PubMed:23773965, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24798265, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]: Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation. {ECO:0000269|PubMed:16094673, ECO:0000269|PubMed:16465621, ECO:0000269|PubMed:16630736, ECO:0000269|PubMed:17034777, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:24045841, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24550498, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTAB have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.70519	0.14868	-1.366884746	4.505779665	437.11196	4.35866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	134	12	102140522	chr12:102140522	GAA	GAAA,G,GA	69	PASS	DP=134;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	102140523	102140524	AA	-	UTR3	GNPTAB	NM_024312:c.*419_*418delTT	.	.	4.23E-06	0.999977941	1.78E-05	DISEASE: Mucolipidosis type II (MLII) [MIM:252500]: Fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features, peculiar fibroblast inclusions, and no excessive mucopolysacchariduria. Congenital dislocation of the hip, thoracic deformities, hernia, and hyperplastic gums are evident soon after birth. {ECO:0000269|PubMed:16200072, ECO:0000269|PubMed:16835905, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:22495880, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:23733939, ECO:0000269|PubMed:23773965, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24798265, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]: Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation. {ECO:0000269|PubMed:16094673, ECO:0000269|PubMed:16465621, ECO:0000269|PubMed:16630736, ECO:0000269|PubMed:17034777, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:24045841, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24550498, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTAB have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.70519	0.14868	-1.366884746	4.505779665	437.11196	4.35866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	134	12	102140522	chr12:102140522	GAA	GAAA,G,GA	69	PASS	DP=134;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	102140524	102140524	A	-	UTR3	GNPTAB	NM_024312:c.*418delT	.	.	4.23E-06	0.999977941	1.78E-05	DISEASE: Mucolipidosis type II (MLII) [MIM:252500]: Fatal, autosomal recessive, lysosomal storage disorder characterized by severe clinical and radiologic features, peculiar fibroblast inclusions, and no excessive mucopolysacchariduria. Congenital dislocation of the hip, thoracic deformities, hernia, and hyperplastic gums are evident soon after birth. {ECO:0000269|PubMed:16200072, ECO:0000269|PubMed:16835905, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:22495880, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:23733939, ECO:0000269|PubMed:23773965, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24798265, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600]: Autosomal recessive disease of lysosomal enzyme targeting. Clinically MLIII is characterized by restricted joint mobility, skeletal dysplasia, and short stature. Mildly coarsened facial features and thickening of the skin have been described. Cardiac valvular disease and corneal clouding may also occur. Half of the reported patients show learning disabilities or mental retardation. {ECO:0000269|PubMed:16094673, ECO:0000269|PubMed:16465621, ECO:0000269|PubMed:16630736, ECO:0000269|PubMed:17034777, ECO:0000269|PubMed:19197337, ECO:0000269|PubMed:19617216, ECO:0000269|PubMed:19634183, ECO:0000269|PubMed:19938078, ECO:0000269|PubMed:23566849, ECO:0000269|PubMed:24045841, ECO:0000269|PubMed:24375680, ECO:0000269|PubMed:24550498, ECO:0000269|PubMed:25505245, ECO:0000269|PubMed:25788519}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTAB have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.70519	0.14868	-1.366884746	4.505779665	437.11196	4.35866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	134	12	102140522	chr12:102140522	GAA	GAAA,G,GA	69	PASS	DP=134;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	102301162	102301162	-	T	intronic	DRAM1	.	.	.	0.080700077	0.872050796	0.047249127	.	.	.	-0.229483771	36.86010852	8.7844	0.32424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	276	12	102301162	chr12:102301162	G	GT	80	PASS	DP=276;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
12	104461712	104461712	T	-	intronic	HCFC2	.	.	.	0.994468276	0.005531718	5.69E-09	.	0.54137	0.20015	0.084621747	60.31493277	202.17732	3.06842	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	75	12	104461711	chr12:104461711	CT	C	92	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	107237615	107237615	-	T	intronic	RIC8B	.	.	.	0.997486827	0.002513073	1.00E-07	.	0.53798	0.10163	-0.26993514	34.59542345	85.92104	1.97938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	135	12	107237614	chr12:107237614	GT	GTT,G	95	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	107237615	107237615	T	-	intronic	RIC8B	.	.	.	0.997486827	0.002513073	1.00E-07	.	0.53798	0.10163	-0.26993514	34.59542345	85.92104	1.97938	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	135	12	107237614	chr12:107237614	GT	GTT,G	95	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	108012065	108012065	A	C	exonic	BTBD11	.	nonsynonymous SNV	BTBD11:NM_001017523:exon8:c.A973C:p.S325R,BTBD11:NM_001018072:exon10:c.A2362C:p.S788R	0.993432981	0.00656701	8.66E-09	.	0.42445	0.12301	-0.462894052	23.62585515	7389.82344	18.4572	0.047	0.403	D	0.838	0.715	P	0.367	0.649	B	0.000	0.843	D	1.000	0.810	D	1.355	0.339	L	1.28	0.396	T	-1.65	0.395	N	0.562	0.647	-0.867	0.508	T	0.172	0.515	T	0.019	0.417	T	3.696	0.501	23.3	0.998	0.917	0.959	0.666	D	c	0.473	0.512	1.000	0.489	0.638	0.428	0	5.07	0.680	5.381	0.657	1.199	0.960	1.000	0.715	1.000	0.888	15.123	0.720	.	.	.	0.5	.	87	12	108012065	chr12:108012065	A	C	.	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	108913293	108913293	A	-	UTR3	FICD	NM_007076:c.*41delA	.	.	0.006385822	0.74494476	0.248669418	.	0.16362	0.11879	-0.841329384	11.36470866	77.87832	1.86121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	316	12	108913292	chr12:108913292	GA	G,GAA	55	PASS	DP=316;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	0/2	./.	./.	./.	./.
12	108913293	108913293	-	A	UTR3	FICD	NM_007076:c.*41_*42insA	.	.	0.006385822	0.74494476	0.248669418	.	0.16362	0.11879	-0.841329384	11.36470866	77.87832	1.86121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	316	12	108913292	chr12:108913292	GA	G,GAA	55	PASS	DP=316;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	0/2	./.	./.	./.	./.
12	109921356	109921356	C	A	UTR5	UBE3B	NM_130466:c.-1C>A;NM_001270449:c.-1C>A;NM_001270450:c.-1C>A;NM_001270451:c.-1C>A;NM_183415:c.-1C>A	.	.	0.009387706	0.990612131	1.63E-07	.	0.19362	0.09343	-2.232421897	1.315168672	170.30974	2.84773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	73	12	109921356	chr12:109921356	C	A	.	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	110910825	110910826	CA	-	intronic	FAM216A	.	.	.	0.001116299	0.834605539	0.164278162	.	0.04692	.	0.170987912	65.5579146	62.01365	1.60508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	58	12	110910824	chr12:110910824	TCA	T	64	PASS	DP=58;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	111180637	111180637	C	-	UTR5	PPP1CC	NM_002710:c.-125delG;NM_001244974:c.-125delG	.	.	0.944905081	0.055054589	4.03E-05	.	0.99939	0.29199	-0.031067188	51.03798066	4.80302	0.1749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	51	12	111180636	chr12:111180636	TC	T	55	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
12	111375005	111375005	T	C	ncRNA_exonic	LINC01405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	169	12	111375005	chr12:111375005	T	C	.	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	112580121	112580121	T	C	intronic	TRAFD1	.	.	.	1.83E-05	0.970465578	0.029516153	.	0.07103	0.09821	-0.201976964	38.98325077	125.66239	2.4405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	100	12	112580121	chr12:112580121	T	C	108	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	116397416	116397416	C	T	UTR3	MED13L	NM_015335:c.*1655G>A	.	.	0.999999999	1.32E-09	2.08E-24	DISEASE: Note=A chromosomal aberration involving MED13L is found in a patient with transposition of the great arteries, dextro- looped and mental retardation. Translocation t(12;17)(q24.1;q21). {ECO:0000269|PubMed:14638541}.; 	0.80264	0.11567	-2.736273894	0.690021231	206.98599	3.10912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	75	12	116397416	chr12:116397416	C	T	76	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	117461949	117461949	C	A	intronic	FBXW8	.	.	.	8.69E-13	0.037230433	0.962769567	.	0.19894	0.27411	-0.28470423	33.48667138	330.90072	3.86825	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	341	12	117461949	chr12:117461949	C	A	90	PASS	DP=341;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
12	120806124	120806124	C	-	intronic	MSI1	.	.	.	0.997146451	0.002853413	1.36E-07	.	0.66447	0.10166	-0.161524709	41.6430762	9.92984	0.36366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	198	12	120806123	chr12:120806123	TC	T	93	PASS	DP=198;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	121471308	121471389	GCAGTCCCCCTGGTCTGGATGGTGAAGACGAGAGCATCGGGGACTCTCTGCTCCATCCTCAGGTCCTCGAGCCCGAGGTCCA	-	exonic	OASL	.	frameshift deletion	OASL:NM_001261825:exon2:c.356_437del:p.L119Rfs*29,OASL:NM_003733:exon2:c.356_437del:p.L119Rfs*29,OASL:NM_198213:exon2:c.356_437del:p.L119Rfs*29	5.07E-12	0.014859491	0.985140509	.	0.10031	0.10724	-0.398573136	26.92852088	65.07146	1.66071	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.21	23	12	121471307	chr12:121471307	CGCAGTCCCCCTGGTCTGGATGGTGAAGACGAGAGCATCGGGGACTCTCTGCTCCATCCTCAGGTCCTCGAGCCCGAGGTCCA	C	11.21	PASS	DP=23;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	121676365	121676365	-	A	UTR3	CAMKK2	NM_153500:c.*2234_*2235insT;NM_006549:c.*2136_*2137insT;NM_172226:c.*2234_*2235insT;NM_001270485:c.*2136_*2137insT;NM_172216:c.*2136_*2137insT;NM_001270486:c.*1905_*1906insT;NM_153499:c.*2234_*2235insT	.	.	0.503475917	0.496488678	3.54E-05	.	0.5179	0.23396	-0.26629572	34.81953291	2630.25871	9.61927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	115	12	121676365	chr12:121676365	G	GA	71	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
12	121783849	121783849	G	A	intronic	ANAPC5	.	.	.	4.18E-05	0.99800999	0.00194821	.	0.36079	.	-0.554717505	19.79830149	76.22212	1.8303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	23	12	121783849	chr12:121783849	G	A	.	PASS	DP=23;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	122405912	122405912	G	T	exonic	WDR66	.	nonsynonymous SNV	WDR66:NM_001178003:exon17:c.G2608T:p.V870L,WDR66:NM_144668:exon17:c.G2608T:p.V870L	1.25E-10	0.981629339	0.018370661	.	0.16334	.	1.409099734	94.8041991	10305.45886	22.15777	0.197	0.223	T	0.518	0.356	P	0.241	0.369	B	0.000	0.473	D	0.000	0.501	P	2.215	0.627	M	0.57	0.544	T	-1.88	0.439	N	0.292	0.352	-0.911	0.467	T	0.000	0.000	T	.	.	.	2.470	0.358	19.27	0.996	0.767	0.859	0.448	D	c	0.226	0.286	1.000	0.451	0.554	0.283	0	5.19	0.713	6.424	0.731	1.048	0.713	1.000	0.715	0.964	0.448	18.708	0.916	WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain	ENSG00000158023.5|ENSG00000158023.5|ENSG00000158023.5|ENSG00000256811.1|ENSG00000158104.7|ENSG00000110801.9	Artery_Tibial|Brain_Cerebellum|Cells_Transformed_fibroblasts|Muscle_Skeletal|Muscle_Skeletal|Thyroid	0.5	91	40	12	122405912	chr12:122405912	G	T	91	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	123200158	123200158	G	C	exonic	HCAR3	.	nonsynonymous SNV	HCAR3:NM_006018:exon1:c.C1127G:p.A376G	6.93E-06	0.157373991	0.842619078	.	.	.	0.643056625	84.05284265	4388.50195	13.21909	0.523	0.072	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	0	0.065	N	-0.06	0.636	T	0.0	0.070	N	0.076	0.067	-1.043	0.165	T	0.089	0.343	T	0.011	0.275	T	0.947	0.185	10.36	0.491	0.041	0.000	0.003	N	c	-1.515	-1.539	0.070	0.155	0.447	0.083	0	0.929	0.185	-0.246	0.088	-0.171	0.105	0.000	0.063	0.002	0.062	3.352	0.067	.	.	.	0.5	74	56	12	123200158	chr12:123200158	G	C	74	PASS	DP=56;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	123214555	123214555	G	A	exonic	HCAR1	.	nonsynonymous SNV	HCAR1:NM_032554:exon1:c.C332T:p.A111V	0.14099939	0.779311972	0.079688637	.	0.13233	0.08739	-0.356299879	29.31115829	238.79328	3.33717	1.0	0.010	T	0.0	0.026	B	0.001	0.040	B	0.060	0.223	N	0.999	0.216	N	-2.69	0.000	N	1.49	0.315	T	2.42	0.003	N	0.109	0.156	-0.973	0.366	T	0.013	0.049	T	0.002	0.034	T	0.884	0.178	9.973	0.668	0.079	0.027	0.073	N	c	-1.116	-0.832	1.000	0.441	0.497	0.185	0	4.04	0.461	4.498	0.599	0.239	0.266	0.262	0.247	0.995	0.604	6.982	0.237	GPCR, rhodopsin-like, 7TM	.	.	0.5	58	216	12	123214555	chr12:123214555	G	A	58	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	123892323	123892323	-	T	UTR3	KMT5A	NM_001324504:c.*73_*74insT;NM_001324505:c.*73_*74insT;NM_020382:c.*73_*74insT;NM_001324506:c.*73_*74insT	.	.	.	.	.	.	0.13779	0.14003	0.104848986	61.49445624	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	184	12	123892323	chr12:123892323	A	AT	77	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
12	124074896	124074896	G	A	exonic	TMED2	.	synonymous SNV	TMED2:NM_006815:exon3:c.G381A:p.Q127Q,TMED2:NM_001321445:exon4:c.G402A:p.Q134Q	0.797679588	0.19667058	0.005649831	.	0.70097	0.11835	-0.119252484	44.53880632	7.09498	0.26483	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	18	12	124074896	chr12:124074896	G	A	.	PASS	DP=18;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	125397648	125397648	G	A	exonic	UBC	.	nonsynonymous SNV	UBC:NM_021009:exon2:c.C670T:p.R224C	0.704156667	0.292254881	0.003588452	.	.	.	-0.80269335	12.23755603	8.43713	0.30824	0.138	0.258	T	0.987	0.600	D	0.834	0.580	P	0.000	0.629	U	1.000	0.810	D	3.265	0.902	M	-1.08	0.771	T	-0.96	0.912	N	0.541	0.704	0.381	0.888	D	0.619	0.865	D	0.039	0.588	D	4.891	0.657	24.9	0.996	0.764	0.714	0.347	D	c	0.336	0.195	1.000	0.747	0.628	0.401	0	2.21	0.269	3.834	0.553	0.765	0.311	0.995	0.385	0.344	0.245	10.667	0.447	Ubiquitin domain|Ubiquitin-related domain	.	.	0.5	74	164	12	125397648	chr12:125397648	G	A	74	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
12	132398253	132398256	AAAC	-	intronic	ULK1	.	.	.	0.964459663	0.035540332	4.57E-09	.	0.39547	0.14281	-1.223753865	5.561453173	1096.67628	6.33982	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	86	12	132398252	chr12:132398252	AAAAC	A	88	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
12	132445261	132445261	A	G	exonic	EP400	.	nonsynonymous SNV	EP400:NM_015409:exon2:c.A97G:p.N33D	1	1.17E-10	1.58E-32	.	0.18578	0.27854	-3.863869047	0.218211842	4549.61959	13.54811	0.004	0.654	D	0.634	0.577	P	0.124	0.473	B	0.021	0.270	N	1.000	0.090	N	1.955	0.530	M	-2.76	0.910	D	-2.59	0.558	D	0.092	0.129	0.063	0.835	D	0.703	0.898	D	0.140	0.823	D	1.401	0.231	12.79	0.599	0.062	0.853	0.442	D	c	-0.163	-0.229	0.999	0.379	0.732	0.924	0	4.54	0.551	3.487	0.527	1.199	0.960	0.388	0.258	0.144	0.203	11.455	0.492	E1A-binding protein p400, N-terminal	.	.	0.5	58	143	12	132445261	chr12:132445261	A	G	58	PASS	DP=143;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
12	132635999	132635999	G	T	intronic	NOC4L	.	.	.	.	.	.	.	0.5431	0.11298	-1.280491183	5.16631281	149.35551	2.66469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	54	12	132635999	chr12:132635999	G	T	.	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
12	133398711	133398711	C	A	exonic	GOLGA3	.	nonsynonymous SNV	GOLGA3:NM_001172557:exon2:c.G4T:p.D2Y,GOLGA3:NM_005895:exon2:c.G4T:p.D2Y	0.991564256	0.008435744	5.42E-12	.	0.42503	0.13258	-0.571624906	18.96673744	4390.25176	13.22841	0.003	0.721	D	0.997	0.764	D	0.912	0.657	D	0.010	0.303	N	0.959	0.810	D	2.14	0.601	M	1.53	0.394	T	-2.43	0.532	N	0.517	0.582	-0.745	0.583	T	0.213	0.574	T	0.047	0.629	D	5.305	0.718	25.8	0.991	0.531	0.985	0.837	D	c	0.523	0.484	1.000	0.489	0.707	0.730	0	5.6	0.849	4.449	0.595	0.852	0.362	1.000	0.715	0.521	0.274	16.776	0.853	.	.	.	0.5	.	69	12	133398711	chr12:133398711	C	A	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	19118367	19118367	G	A	intergenic	NONE;OR11H12	dist=NONE;dist=259227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	14	19118367	chr14:19118367	G	A	.	PASS	DP=58;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	19378020	19378020	C	A	exonic	OR11H12	.	nonsynonymous SNV	OR11H12:NM_001013354:exon1:c.C427A:p.R143S	0.79839868	0.196005182	0.005596138	.	.	.	.	.	4405.8371	13.26123	0.075	0.344	T	0.162	0.268	B	0.039	0.223	B	0.819	0.092	N	.	.	.	1.19	0.302	L	5.03	0.013	T	-3.74	0.710	D	0.161	0.193	-0.951	0.408	T	0.004	0.014	T	.	.	.	0.707	0.161	8.876	0.755	0.107	0.005	0.022	N	c	-1.241	-1.393	0.000	0.012	0.487	0.133	0	-1.17	0.091	-5.359	0.002	0.200	0.252	0.000	0.063	0.008	0.104	6.168	0.195	GPCR, rhodopsin-like, 7TM	.	.	0.5	.	74	14	19378020	chr14:19378020	C	A	.	PASS	DP=74;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
14	19806550	19806550	A	T	intergenic	DUXAP10;LINC01296	dist=113634;dist=73659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	146	14	19806550	chr14:19806550	A	T	.	PASS	DP=146;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	19807147	19807147	A	C	intergenic	DUXAP10;LINC01296	dist=114231;dist=73062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	127	14	19807147	chr14:19807147	A	C	104	PASS	DP=127;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	19807304	19807304	T	A	intergenic	DUXAP10;LINC01296	dist=114388;dist=72905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	194	14	19807304	chr14:19807304	T	A	.	PASS	DP=194;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	19891116	19891116	C	A	ncRNA_exonic	LINC01296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	421	14	19891116	chr14:19891116	C	A	.	PASS	DP=421;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
14	21542838	21542838	G	A	exonic	ARHGEF40	.	nonsynonymous SNV	ARHGEF40:NM_018071:exon3:c.G949A:p.E317K	7.19E-05	0.999928131	1.25E-08	.	.	.	-0.226073511	37.1255013	1688.98262	7.57807	0.169	0.230	T	0.004	0.165	B	0.004	0.127	B	0.042	0.239	N	1	0.090	N	0	0.065	N	4.45	0.022	T	-0.36	0.221	N	0.126	0.290	-0.898	0.482	T	0.005	0.016	T	0.009	0.234	T	-0.348	0.065	0.516	0.816	0.133	0.137	0.178	N	c	-0.826	-0.745	0.997	0.355	0.632	0.406	0	4.23	0.492	2.765	0.471	1.048	0.713	0.115	0.229	0.034	0.151	11.400	0.489	.	.	.	0.5	84	447	14	21542838	chr14:21542838	G	A	84	PASS	DP=447;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	21702046	21702046	-	A	intronic	HNRNPC	.	.	.	0.985848437	0.014144716	6.85E-06	.	0.16171	0.28104	-0.075159878	47.78839349	6.88559	0.25634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	71	14	21702046	chr14:21702046	C	CA	52	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	22038042	22038042	C	A	exonic	OR10G3	.	synonymous SNV	OR10G3:NM_001005465:exon1:c.G834T:p.T278T	0.234560474	0.645560257	0.119879269	.	0.12713	0.09782	1.174022298	92.72823779	733.81635	5.37359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	108	14	22038042	chr14:22038042	C	A	.	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	22771929	22771929	-	A	intergenic	OR4E1;LINC02332	dist=632697;dist=253276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	170	14	22771929	chr14:22771929	G	GA	69	PASS	DP=170;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	23299066	23299066	C	T	upstream	MRPL52	dist=26	.	.	0.000108205	0.590927605	0.40896419	.	0.02834	0.04392	0.569646743	81.88841708	17.44704	0.61182	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	855	14	23299066	chr14:23299066	C	T	80	PASS	DP=855;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
14	23315908	23315908	G	-	UTR3	MMP14	NM_004995:c.*660delG	.	.	0.987123657	0.01287612	2.23E-07	DISEASE: Winchester syndrome (WNCHRS) [MIM:277950]: A disease characterized by severe osteolysis in the hands and feet, generalized osteoporosis, bone thinning, and absence of subcutaneous nodules. Various additional features include coarse face, corneal opacities, gum hypertrophy, and EKG changes. {ECO:0000269|PubMed:22922033}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54891	0.55746	0.04598748	57.47817882	1317.7477	6.82691	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	90	14	23315907	chr14:23315907	AG	A	155	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	23528502	23528503	TC	-	exonic	ACIN1	.	frameshift deletion	ACIN1:NM_001164816:exon12:c.1699_1700del:p.E567Kfs*11,ACIN1:NM_001164817:exon13:c.1606_1607del:p.E536Kfs*11,ACIN1:NM_001164815:exon18:c.3760_3761del:p.E1254Kfs*11,ACIN1:NM_001164814:exon19:c.3841_3842del:p.E1281Kfs*11,ACIN1:NM_014977:exon19:c.3880_3881del:p.E1294Kfs*11	0.999998437	1.56E-06	2.59E-18	.	0.75733	0.42314	-0.435396074	24.70511913	7850.70685	19.11113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	136	14	23528501	chr14:23528501	TTC	T	91	PASS	DP=136;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	23533397	23533397	G	A	exonic	ACIN1	.	nonsynonymous SNV	ACIN1:NM_001164816:exon5:c.C505T:p.R169C,ACIN1:NM_001164817:exon6:c.C412T:p.R138C,ACIN1:NM_001164815:exon11:c.C2566T:p.R856C,ACIN1:NM_001164814:exon12:c.C2647T:p.R883C,ACIN1:NM_014977:exon12:c.C2686T:p.R896C	0.999998437	1.56E-06	2.59E-18	.	0.75733	0.42314	-0.435396074	24.70511913	7850.70685	19.11113	0.005	0.912	D	1.0	0.899	D	0.984	0.745	D	0.002	0.375	N	1.000	0.524	D	1.245	0.315	L	3.3	0.181	T	-3.22	0.789	D	0.423	0.728	-1.140	0.014	T	0.083	0.324	T	0.014	0.343	T	6.993	0.937	33	0.999	0.995	0.899	0.504	D	c	0.557	0.568	1.000	0.747	0.722	0.854	0	4.45	0.532	2.876	0.479	1.048	0.713	1.000	0.715	0.998	0.697	15.448	0.749	.	.	.	0.5	.	68	14	23533397	chr14:23533397	G	A	.	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	23777193	23777193	G	T	exonic	BCL2L2;BCL2L2-PABPN1	.	nonsynonymous SNV	BCL2L2:NM_001199839:exon3:c.G217T:p.G73C,BCL2L2-PABPN1:NM_001199864:exon3:c.G217T:p.G73C,BCL2L2:NM_004050:exon3:c.G217T:p.G73C	.	.	.	.	.	.	.	.	.	.	0.052	0.682	T	0.592	0.556	P	0.281	0.677	B	0.000	0.473	D	0.562	0.461	N	2.095	0.583	M	2.66	0.126	T	-3.18	0.656	D	0.308	0.454	-0.824	0.537	T	0.136	0.452	T	0.031	0.535	D	4.130	0.554	23.8	0.996	0.724	0.971	0.723	D	c	0.021	0.101	1.000	0.747	0.660	0.490	0	4.94	0.645	4.022	0.567	1.048	0.713	1.000	0.715	1.000	0.888	12.745	0.565	.	.	.	0.5	126	652	14	23777193	chr14:23777193	G	T	126	PASS	DP=652;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	23829836	23829836	G	T	exonic	EFS	.	nonsynonymous SNV	EFS:NM_005864:exon2:c.C225A:p.S75R	2.45E-06	0.494202308	0.505795246	.	0.41116	0.14682	1.734373503	96.61476763	5246.98871	14.94057	0.358	0.120	T	0.004	0.112	B	0.002	0.063	B	0.117	0.192	N	1	0.810	D	2.005	0.547	M	1.95	0.225	T	-1.16	0.297	N	0.14	0.163	-1.066	0.103	T	0.032	0.138	T	0.003	0.077	T	0.906	0.180	10.11	0.950	0.253	0.321	0.243	N	c	-0.687	-0.628	1.000	0.747	0.632	0.408	0	3.16	0.353	0.726	0.255	1.048	0.713	0.002	0.151	0.950	0.426	5.295	0.150	SH3 domain	.	.	0.5	106	181	14	23829836	chr14:23829836	G	T	106	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	23889445	23889445	-	G	splicing	MYH7	NM_000257:exon27:c.3337-2->C	.	.	0.000145766	0.999854234	1.85E-10	DISEASE: Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:10065021, ECO:0000269|PubMed:10329202, ECO:0000269|PubMed:10521296, ECO:0000269|PubMed:10563488, ECO:0000269|PubMed:10679957, ECO:0000269|PubMed:10862102, ECO:0000269|PubMed:11113006, ECO:0000269|PubMed:11133230, ECO:0000269|PubMed:11214007, ECO:0000269|PubMed:11424919, ECO:0000269|PubMed:11733062, ECO:0000269|PubMed:11861413, ECO:0000269|PubMed:11968089, ECO:0000269|PubMed:12081993, ECO:0000269|PubMed:12566107, ECO:0000269|PubMed:12590187, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:12818575, ECO:0000269|PubMed:12820698, ECO:0000269|PubMed:12951062, ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:12975413, ECO:0000269|PubMed:1417858, ECO:0000269|PubMed:15358028, ECO:0000269|PubMed:15483641, ECO:0000269|PubMed:1552912, ECO:0000269|PubMed:15563892, ECO:0000269|PubMed:15856146, ECO:0000269|PubMed:15858117, ECO:0000269|PubMed:16199542, ECO:0000269|PubMed:16267253, ECO:0000269|PubMed:1638703, ECO:0000269|PubMed:16650083, ECO:0000269|PubMed:16938236, ECO:0000269|PubMed:17372140, ECO:0000269|PubMed:18175163, ECO:0000269|PubMed:18403758, ECO:0000269|PubMed:1975517, ECO:0000269|PubMed:25182012, ECO:0000269|PubMed:7581410, ECO:0000269|PubMed:7731997, ECO:0000269|PubMed:7848441, ECO:0000269|PubMed:7874131, ECO:0000269|PubMed:8250038, ECO:0000269|PubMed:8254035, ECO:0000269|PubMed:8268932, ECO:0000269|PubMed:8282798, ECO:0000269|PubMed:8343162, ECO:0000269|PubMed:8435239, ECO:0000269|PubMed:8483915, ECO:0000269|PubMed:8655135, ECO:0000269|PubMed:8899546, ECO:0000269|PubMed:9544842, ECO:0000269|PubMed:9822100, ECO:0000269|PubMed:9829907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358]: A rare congenital myopathy characterized by subsarcolemmal hyalinized bodies in type 1 muscle fibers. {ECO:0000269|PubMed:14520662, ECO:0000269|PubMed:15136674, ECO:0000269|PubMed:16684601, ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Scapuloperoneal myopathy MYH7-related (SPMM) [MIM:181430]: Progressive muscular atrophia beginning in the lower legs and affecting the shoulder region earlier and more severely than distal arm. {ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11106718, ECO:0000269|PubMed:12379228, ECO:0000269|PubMed:15769782, ECO:0000269|PubMed:18506004, ECO:0000269|PubMed:21127202, ECO:0000269|PubMed:21846512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, distal, 1 (MPD1) [MIM:160500]: A muscular disorder characterized by early-onset selective weakness of the great toe and ankle dorsiflexors, followed by weakness of the finger extensors. Mild proximal weakness occasionally develops years later after the onset of the disease. {ECO:0000269|PubMed:15322983, ECO:0000269|PubMed:17548557}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal recessive (MSMB) [MIM:255160]: An autosomal recessive form of myosin storage myopathy, a muscle disease characterized by subsarcolemmal accumulation of hyalinized bodies in type 1 muscle fibers. MSMB clinical features include muscle weakness, type II respiratory failure and cardiac failure, due to hypertrophic cardiomyopathy. {ECO:0000269|PubMed:25666907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43904	0.16764	-3.644803418	0.283085633	108.56923	2.26118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	198	14	23889445	chr14:23889445	T	TG	120	PASS	DP=198;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	23898326	23898326	G	A	intronic	MYH7	.	.	.	0.000145766	0.999854234	1.85E-10	DISEASE: Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:10065021, ECO:0000269|PubMed:10329202, ECO:0000269|PubMed:10521296, ECO:0000269|PubMed:10563488, ECO:0000269|PubMed:10679957, ECO:0000269|PubMed:10862102, ECO:0000269|PubMed:11113006, ECO:0000269|PubMed:11133230, ECO:0000269|PubMed:11214007, ECO:0000269|PubMed:11424919, ECO:0000269|PubMed:11733062, ECO:0000269|PubMed:11861413, ECO:0000269|PubMed:11968089, ECO:0000269|PubMed:12081993, ECO:0000269|PubMed:12566107, ECO:0000269|PubMed:12590187, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:12818575, ECO:0000269|PubMed:12820698, ECO:0000269|PubMed:12951062, ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:12975413, ECO:0000269|PubMed:1417858, ECO:0000269|PubMed:15358028, ECO:0000269|PubMed:15483641, ECO:0000269|PubMed:1552912, ECO:0000269|PubMed:15563892, ECO:0000269|PubMed:15856146, ECO:0000269|PubMed:15858117, ECO:0000269|PubMed:16199542, ECO:0000269|PubMed:16267253, ECO:0000269|PubMed:1638703, ECO:0000269|PubMed:16650083, ECO:0000269|PubMed:16938236, ECO:0000269|PubMed:17372140, ECO:0000269|PubMed:18175163, ECO:0000269|PubMed:18403758, ECO:0000269|PubMed:1975517, ECO:0000269|PubMed:25182012, ECO:0000269|PubMed:7581410, ECO:0000269|PubMed:7731997, ECO:0000269|PubMed:7848441, ECO:0000269|PubMed:7874131, ECO:0000269|PubMed:8250038, ECO:0000269|PubMed:8254035, ECO:0000269|PubMed:8268932, ECO:0000269|PubMed:8282798, ECO:0000269|PubMed:8343162, ECO:0000269|PubMed:8435239, ECO:0000269|PubMed:8483915, ECO:0000269|PubMed:8655135, ECO:0000269|PubMed:8899546, ECO:0000269|PubMed:9544842, ECO:0000269|PubMed:9822100, ECO:0000269|PubMed:9829907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358]: A rare congenital myopathy characterized by subsarcolemmal hyalinized bodies in type 1 muscle fibers. {ECO:0000269|PubMed:14520662, ECO:0000269|PubMed:15136674, ECO:0000269|PubMed:16684601, ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Scapuloperoneal myopathy MYH7-related (SPMM) [MIM:181430]: Progressive muscular atrophia beginning in the lower legs and affecting the shoulder region earlier and more severely than distal arm. {ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11106718, ECO:0000269|PubMed:12379228, ECO:0000269|PubMed:15769782, ECO:0000269|PubMed:18506004, ECO:0000269|PubMed:21127202, ECO:0000269|PubMed:21846512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, distal, 1 (MPD1) [MIM:160500]: A muscular disorder characterized by early-onset selective weakness of the great toe and ankle dorsiflexors, followed by weakness of the finger extensors. Mild proximal weakness occasionally develops years later after the onset of the disease. {ECO:0000269|PubMed:15322983, ECO:0000269|PubMed:17548557}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal recessive (MSMB) [MIM:255160]: An autosomal recessive form of myosin storage myopathy, a muscle disease characterized by subsarcolemmal accumulation of hyalinized bodies in type 1 muscle fibers. MSMB clinical features include muscle weakness, type II respiratory failure and cardiac failure, due to hypertrophic cardiomyopathy. {ECO:0000269|PubMed:25666907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43904	0.16764	-3.644803418	0.283085633	108.56923	2.26118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	14	23898326	chr14:23898326	G	A	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	23898530	23898530	C	T	exonic	MYH7	.	nonsynonymous SNV	MYH7:NM_000257:exon13:c.G1165A:p.G389R	0.000145766	0.999854234	1.85E-10	DISEASE: Cardiomyopathy, familial hypertrophic 1 (CMH1) [MIM:192600]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:10065021, ECO:0000269|PubMed:10329202, ECO:0000269|PubMed:10521296, ECO:0000269|PubMed:10563488, ECO:0000269|PubMed:10679957, ECO:0000269|PubMed:10862102, ECO:0000269|PubMed:11113006, ECO:0000269|PubMed:11133230, ECO:0000269|PubMed:11214007, ECO:0000269|PubMed:11424919, ECO:0000269|PubMed:11733062, ECO:0000269|PubMed:11861413, ECO:0000269|PubMed:11968089, ECO:0000269|PubMed:12081993, ECO:0000269|PubMed:12566107, ECO:0000269|PubMed:12590187, ECO:0000269|PubMed:12707239, ECO:0000269|PubMed:12818575, ECO:0000269|PubMed:12820698, ECO:0000269|PubMed:12951062, ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:12975413, ECO:0000269|PubMed:1417858, ECO:0000269|PubMed:15358028, ECO:0000269|PubMed:15483641, ECO:0000269|PubMed:1552912, ECO:0000269|PubMed:15563892, ECO:0000269|PubMed:15856146, ECO:0000269|PubMed:15858117, ECO:0000269|PubMed:16199542, ECO:0000269|PubMed:16267253, ECO:0000269|PubMed:1638703, ECO:0000269|PubMed:16650083, ECO:0000269|PubMed:16938236, ECO:0000269|PubMed:17372140, ECO:0000269|PubMed:18175163, ECO:0000269|PubMed:18403758, ECO:0000269|PubMed:1975517, ECO:0000269|PubMed:25182012, ECO:0000269|PubMed:7581410, ECO:0000269|PubMed:7731997, ECO:0000269|PubMed:7848441, ECO:0000269|PubMed:7874131, ECO:0000269|PubMed:8250038, ECO:0000269|PubMed:8254035, ECO:0000269|PubMed:8268932, ECO:0000269|PubMed:8282798, ECO:0000269|PubMed:8343162, ECO:0000269|PubMed:8435239, ECO:0000269|PubMed:8483915, ECO:0000269|PubMed:8655135, ECO:0000269|PubMed:8899546, ECO:0000269|PubMed:9544842, ECO:0000269|PubMed:9822100, ECO:0000269|PubMed:9829907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal dominant (MSMA) [MIM:608358]: A rare congenital myopathy characterized by subsarcolemmal hyalinized bodies in type 1 muscle fibers. {ECO:0000269|PubMed:14520662, ECO:0000269|PubMed:15136674, ECO:0000269|PubMed:16684601, ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Scapuloperoneal myopathy MYH7-related (SPMM) [MIM:181430]: Progressive muscular atrophia beginning in the lower legs and affecting the shoulder region earlier and more severely than distal arm. {ECO:0000269|PubMed:17336526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1S (CMD1S) [MIM:613426]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:11106718, ECO:0000269|PubMed:12379228, ECO:0000269|PubMed:15769782, ECO:0000269|PubMed:18506004, ECO:0000269|PubMed:21127202, ECO:0000269|PubMed:21846512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, distal, 1 (MPD1) [MIM:160500]: A muscular disorder characterized by early-onset selective weakness of the great toe and ankle dorsiflexors, followed by weakness of the finger extensors. Mild proximal weakness occasionally develops years later after the onset of the disease. {ECO:0000269|PubMed:15322983, ECO:0000269|PubMed:17548557}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, myosin storage, autosomal recessive (MSMB) [MIM:255160]: An autosomal recessive form of myosin storage myopathy, a muscle disease characterized by subsarcolemmal accumulation of hyalinized bodies in type 1 muscle fibers. MSMB clinical features include muscle weakness, type II respiratory failure and cardiac failure, due to hypertrophic cardiomyopathy. {ECO:0000269|PubMed:25666907}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43904	0.16764	-3.644803418	0.283085633	108.56923	2.26118	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	.	.	.	1	0.810	D	3.195	0.893	M	-2.49	0.892	D	-6.18	0.903	D	0.821	0.809	1.040	0.979	D	0.882	0.961	D	0.963	0.998	D	6.768	0.922	32	0.999	0.997	0.975	0.749	D	c	0.750	0.608	1.000	0.747	0.487	0.133	0	4.04	0.461	3.965	0.562	0.847	0.346	1.000	0.715	1.000	0.888	16.373	0.831	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	55	14	23898530	chr14:23898530	C	T	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	24475265	24475265	T	C	UTR3	DHRS4L2	NM_001193637:c.*193T>C;NM_001193636:c.*193T>C;NM_001193635:c.*193T>C;NM_198083:c.*193T>C	.	.	0.357376762	0.630130113	0.012493125	.	0.03505	0.0907	2.465816951	98.61405992	3973.73722	12.46785	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	402	14	24475265	chr14:24475265	T	C	118	PASS	DP=402;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	24507037	24507037	G	C	UTR5	DHRS4L1	NM_001277864:c.-33G>C	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	161	14	24507037	chr14:24507037	G	C	.	PASS	DP=161;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	24606081	24606081	G	A	intronic	PSME1	.	.	.	0.050880833	0.927571331	0.021547835	.	0.39132	0.11179	0.283038099	71.26680821	19.18514	0.66093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	14	24606081	chr14:24606081	G	A	.	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	24906515	24906515	C	T	UTR3	KHNYN	NM_001290256:c.*24C>T;NM_001290257:c.*24C>T;NM_015299:c.*24C>T	.	.	1.39E-05	0.957699167	0.042286927	.	0.13632	0.0949	-0.821100135	11.88369899	1285.96189	6.75059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	190	14	24906515	chr14:24906515	C	T	114	PASS	DP=190;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
14	31174980	31174980	G	T	intronic	SCFD1	.	.	.	0.991579194	0.008420806	6.51E-10	.	0.22735	0.11778	-0.179930907	40.35739561	171.75077	2.85758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	14	31174980	chr14:31174980	G	T	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	31290994	31290994	A	C	intergenic	SCFD1;COCH	dist=85961;dist=52747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	86	14	31290994	chr14:31290994	A	C	97	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	31575374	31575374	A	-	intronic	HECTD1	.	.	.	1	2.36E-13	1.27E-35	.	0.71166	0.10385	-2.227040428	1.332861524	686.62409	5.23205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	133	14	31575373	chr14:31575373	TA	T	53	PASS	DP=133;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	31762500	31762500	-	A	UTR3	HEATR5A	NM_015473:c.*10_*11insT	.	.	.	.	.	.	0.2293	.	.	.	4462.98132	13.39987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	35	14	31762500	chr14:31762500	C	CA	69	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	31926571	31926571	G	C	exonic	DTD2	.	nonsynonymous SNV	DTD2:NM_080664:exon1:c.C29G:p.A10G	0.001708149	0.467463368	0.530828483	.	0.25961	0.07098	-0.053113545	49.38664779	6.20561	0.23402	0.079	0.344	T	0.476	0.348	P	0.132	0.314	B	0.008	0.310	N	1.000	0.548	D	2.24	0.636	M	0.27	0.592	T	-2.5	0.543	D	0.416	0.607	-0.768	0.570	T	0.181	0.528	T	0.045	0.617	D	3.890	0.524	23.5	0.996	0.726	0.947	0.619	D	c	-0.046	-0.001	1.0	0.983	0.442	0.072	0	4.09	0.469	6.242	0.721	0.079	0.188	1.000	0.715	0.362	0.248	12.504	0.551	D-Tyr tRNAtyr deacylase-like domain	.	.	0.5	152	1356	14	31926571	chr14:31926571	G	C	152	PASS	DP=1356;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	33836421	33836421	A	T	exonic	NPAS3	.	nonsynonymous SNV	NPAS3:NM_001165893:exon3:c.A325T:p.S109C,NPAS3:NM_022123:exon3:c.A319T:p.S107C,NPAS3:NM_001164749:exon4:c.A415T:p.S139C,NPAS3:NM_173159:exon4:c.A376T:p.S126C	0.98054867	0.019451206	1.24E-07	.	0.30103	0.1462	-1.350267166	4.600141543	902.6267	5.84777	0.005	0.784	D	0.982	0.647	D	0.789	0.654	P	0.000	0.843	D	0.999	0.504	D	1.15	0.294	L	3.35	0.080	T	-2.44	0.548	N	0.703	0.771	-0.755	0.577	T	0.179	0.526	T	0.021	0.442	T	5.178	0.699	25.5	0.993	0.574	0.975	0.748	D	c	0.571	0.625	0.998	0.359	0.487	0.133	0	5.53	0.825	6.911	0.754	1.088	0.866	1.000	0.715	0.999	0.750	15.662	0.769	Myc-type, basic helix-loop-helix (bHLH) domain	.	.	0.5	99	166	14	33836421	chr14:33836421	A	T	99	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	36988512	36988512	C	A	exonic	NKX2-1	.	nonsynonymous SNV	NKX2-1:NM_003317:exon1:c.G51T:p.L17F,NKX2-1:NM_001079668:exon2:c.G141T:p.L47F	0.081926486	0.871861122	0.046212392	DISEASE: Chorea, hereditary benign (BHC) [MIM:118700]: A rare autosomal dominant movement disorder, defined by early onset in childhood, a stable or non-progressive course of chorea, and no mental deterioration. Chorea is characterized by involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. {ECO:0000269|PubMed:11971878, ECO:0000269|PubMed:15955952}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction (CAHTP) [MIM:610978]: An autosomal dominant disorder that manifests in infancy with neurological disturbances, hypothyroidism, and respiratory problems. It is characterized by movement abnormalities beginning with muscular hypotonia followed by the development of chorea, athetosis, dystonia, ataxia, and dysarthria. {ECO:0000269|PubMed:11854318, ECO:0000269|PubMed:11854319, ECO:0000269|PubMed:15289765, ECO:0000269|PubMed:24714694}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.81487	0.52282	1.273147413	93.66595895	44.04874	1.26407	0.0	0.912	D	0.999	0.764	D	0.998	0.875	D	0.000	0.523	D	1	0.810	D	2.155	0.604	M	-0.95	0.754	T	-3.04	0.640	D	0.954	0.952	0.226	0.864	D	0.563	0.841	D	0.321	0.915	D	5.424	0.736	26.0	0.989	0.485	0.978	0.773	D	c	0.682	0.636	1.000	0.747	0.437	0.062	0	4.16	0.480	4.559	0.603	0.855	0.374	1.000	0.715	1.000	0.888	15.002	0.710	.	.	.	0.5	107	535	14	36988512	chr14:36988512	C	A	107	PASS	DP=535;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	38014894	38014894	C	G	intronic	MIPOL1	.	.	.	6.82E-06	0.899072397	0.100920787	.	0.05246	0.09163	-0.712684326	14.49634348	75.79942	1.82421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	32	14	38014894	chr14:38014894	C	G	54	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	38261457	38261457	-	T	intronic	TTC6	.	.	.	8.74E-09	0.283902582	0.716097409	.	0.06305	0.08734	.	.	3948.4689	12.42494	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	117	14	38261457	chr14:38261457	A	AT	64	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	39597470	39597470	-	T	intronic	GEMIN2	.	.	.	0.006609197	0.97473644	0.018654363	.	0.1302	0.1438	0.016664174	55.21939137	6043.31497	16.22939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	13	14	39597470	chr14:39597470	C	CT	64	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	39788502	39788502	T	-	intronic	MIA2	.	.	.	0.00020882	0.908098694	0.091692485	.	0.18559	0.10293	1.133561642	92.28591649	1216.13549	6.59678	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	45	14	39788501	chr14:39788501	CT	C	57	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	45431332	45431332	T	C	upstream	KLHL28;TOGARAM1	dist=61	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	890	14	45431332	chr14:45431332	T	C	126	PASS	DP=890;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	45716018	45716018	-	T	exonic	MIS18BP1	.	frameshift insertion	MIS18BP1:NM_018353:exon2:c.471dupA:p.L158Ifs*7	2.30E-05	0.999045195	0.000931804	.	0.25957	0.06969	1.743518989	96.6383581	1469.92348	7.14407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	115	14	45716018	chr14:45716018	A	AT	91	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	50361216	50361216	C	T	UTR3	ARF6	NM_001663:c.*234C>T	.	.	0.600609559	0.361887013	0.037503427	.	0.43767	0.41336	-0.141298762	42.87567823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	14	50361216	chr14:50361216	C	T	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	50361284	50361284	G	A	UTR3	ARF6	NM_001663:c.*302G>A	.	.	0.600609559	0.361887013	0.037503427	.	0.43767	0.41336	-0.141298762	42.87567823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	14	50361284	chr14:50361284	G	A	.	PASS	DP=24;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	50647379	50647379	C	G	exonic	SOS2	.	nonsynonymous SNV	SOS2:NM_006939:exon7:c.G880C:p.E294Q	0.999427841	0.000572159	1.86E-13	.	0.94123	0.11519	-0.927704399	9.719273414	277.52939	3.56927	0.355	0.168	T	0.971	0.715	D	0.893	0.659	P	0.000	0.843	D	1	0.810	D	2.455	0.715	M	-0.03	0.631	T	-1.2	0.305	N	0.733	0.731	-0.377	0.728	T	0.424	0.768	T	0.022	0.445	T	4.390	0.588	24.1	0.997	0.803	0.993	0.946	D	c	0.772	0.773	1.000	0.747	0.732	0.924	0	5.6	0.849	7.902	0.860	0.935	0.490	1.000	0.715	1.000	0.888	19.669	0.959	Dbl homology (DH) domain	.	.	0.5	64	15	14	50647379	chr14:50647379	C	G	64	PASS	DP=15;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	51289873	51289873	G	-	ncRNA_intronic	LOC105370489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	81	14	51289872	chr14:51289872	TG	T	88	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	52481092	52481092	G	C	exonic	NID2	.	synonymous SNV	NID2:NM_007361:exon16:c.C3333G:p.L1111L	6.95E-07	0.999989562	9.74E-06	.	0.75123	0.20667	3.602297049	99.53408823	1392.55812	6.9826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	14	52481092	chr14:52481092	G	C	.	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	59113339	59113339	G	C	exonic	DACT1	.	synonymous SNV	DACT1:NM_001079520:exon4:c.G1887C:p.V629V,DACT1:NM_016651:exon4:c.G1998C:p.V666V	0.816597553	0.183214244	0.000188203	DISEASE: Neural tube defects (NTD) [MIM:182940]: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy. Failure of neural tube closure can occur at any level of the embryonic axis. Common NTD forms include anencephaly, myelomeningocele and spina bifida, which result from the failure of fusion in the cranial and spinal region of the neural tube. NTDs have a multifactorial etiology encompassing both genetic and environmental components. {ECO:0000269|PubMed:22610794}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.15217	0.12544	0.202129237	67.42745931	2431.69074	9.16027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	592	14	59113339	chr14:59113339	G	C	.	PASS	DP=592;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	59931147	59931147	G	A	exonic	GPR135	.	synonymous SNV	GPR135:NM_022571:exon1:c.C798T:p.T266T	0.003932041	0.644923881	0.351144078	.	0.05073	.	.	.	520.54112	4.65898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	193	14	59931147	chr14:59931147	G	A	54	PASS	DP=193;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	63848889	63848889	A	-	intronic	PPP2R5E	.	.	.	0.999433464	0.000566533	2.65E-09	.	0.55655	0.14896	-0.405853867	26.23260203	8.32866	0.3049	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	41	14	63848888	chr14:63848888	GA	G	41	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	64989352	64989395	ATGTCAGCATAAAAAAAAGTGGTAGGAAAACTCTAAAACCTCGA	-	exonic	ZBTB1	.	frameshift deletion	ZBTB1:NM_001123329:exon2:c.1130_1173del:p.I380Kfs*2,ZBTB1:NM_014950:exon2:c.1130_1173del:p.I380Kfs*2	0.973423964	0.026569485	6.55E-06	.	0.46339	0.10423	-0.247889024	35.98726115	429.66774	4.32847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.79	15	14	64989351	chr14:64989351	GATGTCAGCATAAAAAAAAGTGGTAGGAAAACTCTAAAACCTCGA	G	11.79	PASS	DP=15;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	65009434	65009434	G	A	exonic	HSPA2	.	nonsynonymous SNV	HSPA2:NM_021979:exon1:c.G1867A:p.G623S	.	.	.	.	0.63859	.	0.130533008	63.35810333	148.46704	2.65691	0.163	0.234	T	0.016	0.161	B	0.001	0.040	B	0.304	0.040	N	0.993	0.238	N	2.045	0.562	M	5.41	0.010	T	-0.62	0.183	N	0.379	0.439	-0.852	0.519	T	0.008	0.028	T	0.015	0.360	T	1.400	0.231	12.79	0.955	0.264	0.863	0.453	D	c	-0.273	-0.158	1.000	0.747	0.767	0.994	0	3.55	0.396	4.548	0.602	0.122	0.211	1.000	0.715	0.893	0.376	8.157	0.302	Heat shock protein 70kD, C-terminal domain	.	.	0.5	91	185	14	65009434	chr14:65009434	G	A	91	PASS	DP=185;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	65266521	65266521	G	T	exonic	SPTB	.	synonymous SNV	SPTB:NM_000347:exon8:c.C1008A:p.G336G,SPTB:NM_001024858:exon8:c.C1008A:p.G336G	0.999999748	2.52E-07	2.52E-22	DISEASE: Elliptocytosis 3 (EL3) [MIM:182870]: A Rhesus-unlinked form of hereditary elliptocytosis, a genetically heterogeneous, autosomal dominant hematologic disorder. It is characterized by variable hemolytic anemia and elliptical or oval red cell shape. {ECO:0000269|PubMed:1975598, ECO:0000269|PubMed:7883966, ECO:0000269|PubMed:8018926, ECO:0000269|PubMed:8226774}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spherocytosis 2 (SPH2) [MIM:616649]: An autosomal dominant form of hereditary spherocytosis, a group of hematologic disorders characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. Clinical manifestations include chronic hemolytic anemia, jaundice, and splenomegaly, with variable severity. {ECO:0000269|PubMed:19538529, ECO:0000269|PubMed:8102379}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.31324	0.33019	-2.640400656	0.778485492	7634.17972	18.78025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	204	14	65266521	chr14:65266521	G	T	.	PASS	DP=204;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
14	69619703	69619705	CCG	-	UTR5	DCAF5	NM_001284206:c.-8_-10delCGG;NM_003861:c.-8_-10delCGG;NM_001284208:c.-8_-10delCGG	.	.	0.999968932	3.11E-05	2.25E-12	.	0.58383	0.10764	-1.105907904	6.86482661	58.69346	1.55207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	28	14	69619702	chr14:69619702	ACCG	A	42	PASS	DP=28;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	70714144	70714144	A	G	ncRNA_exonic	ADAM21P1	.	.	.	.	.	.	.	.	0.09205	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	79	14	70714144	chr14:70714144	A	G	78	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	72941318	72941318	-	T	intronic	RGS6	.	.	.	0.801361183	0.198636867	1.95E-06	.	0.44756	0.09798	-0.670411825	15.61689078	74.87042	1.81038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	304	14	72941317	chr14:72941317	GT	GTT,G	80	PASS	DP=304;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
14	72941318	72941318	T	-	intronic	RGS6	.	.	.	0.801361183	0.198636867	1.95E-06	.	0.44756	0.09798	-0.670411825	15.61689078	74.87042	1.81038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	304	14	72941317	chr14:72941317	GT	GTT,G	80	PASS	DP=304;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
14	74876120	74876120	G	T	exonic	SYNDIG1L	.	nonsynonymous SNV	SYNDIG1L:NM_001105579:exon2:c.C328A:p.Q110K	0.003664182	0.629708936	0.366626881	.	0.14052	.	0.571462851	81.99457419	795.52044	5.55885	1.0	0.010	T	0.008	0.135	B	0.011	0.145	B	0.684	0.061	N	1	0.090	N	2.135	0.597	M	-3.63	0.951	D	-0.64	0.187	N	0.169	0.204	-0.221	0.772	T	0.721	0.905	D	0.037	0.575	D	-1.358	0.020	0.004	0.562	0.054	0.437	0.269	N	c	-0.604	-0.574	0.999	0.371	0.615	0.372	0	3.69	0.413	2.897	0.481	0.994	0.605	0.344	0.255	0.004	0.083	13.224	0.592	.	.	.	0.5	.	57	14	74876120	chr14:74876120	G	T	.	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	74876234	74876234	A	T	exonic	SYNDIG1L	.	nonsynonymous SNV	SYNDIG1L:NM_001105579:exon2:c.T214A:p.C72S	0.003664182	0.629708936	0.366626881	.	0.14052	.	0.571462851	81.99457419	795.52044	5.55885	0.054	0.386	T	0.015	0.158	B	0.002	0.063	B	0.000	0.504	D	0.559	0.322	D	1.95	0.526	M	-3.57	0.949	D	0.07	0.381	N	0.321	0.466	0.162	0.853	D	0.656	0.880	D	0.067	0.703	D	1.292	0.220	12.23	0.800	0.126	0.977	0.762	D	c	-0.399	-0.235	1.000	0.747	0.657	0.484	0	3.28	0.365	4.515	0.600	0.082	0.190	1.000	0.715	0.996	0.625	9.099	0.356	.	.	.	0.5	.	42	14	74876234	chr14:74876234	A	T	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	74970076	74970076	G	A	exonic	LTBP2	.	synonymous SNV	LTBP2:NM_000428:exon33:c.C4734T:p.D1578D	0.018734688	0.981265309	2.42E-09	DISEASE: Glaucoma 3, primary congenital, D (GLC3D) [MIM:613086]: An autosomal recessive form of primary congenital glaucoma (PCG). PCG is characterized by marked increase of intraocular pressure at birth or early childhood, large ocular globes (buphthalmos) and corneal edema. It results from developmental defects of the trabecular meshwork and anterior chamber angle of the eye that prevent adequate drainage of aqueous humor. {ECO:0000269|PubMed:19361779}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma (MSPKA) [MIM:251750]: A rare disease characterized by smaller and more spherical lenses than normal bilaterally, an increased anteroposterior thickness of the lens, and highly myopic eyes. Lens dislocation or subluxation may occur, leading to defective accommodation. {ECO:0000269|PubMed:20617341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Weill-Marchesani syndrome 3 (WMS3) [MIM:614819]: A rare connective tissue disorder characterized by short stature, brachydactyly, joint stiffness, and eye abnormalities including microspherophakia, ectopia lentis, severe myopia and glaucoma. {ECO:0000269|PubMed:22539340}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.34261	0.09147	-1.545648077	3.290870488	1221.56268	6.60795	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	83	14	74970076	chr14:74970076	G	A	.	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	75388240	75388240	C	A	exonic	RPS6KL1	.	nonsynonymous SNV	RPS6KL1:NM_031464:exon2:c.G5T:p.S2I	0.000674281	0.9788712	0.020454519	.	0.10194	.	0.04598748	57.47817882	4892.98014	14.2268	0.0	0.912	D	0.998	0.715	D	0.991	0.807	D	0.011	0.298	N	0.993	0.238	N	2.39	0.691	M	0.01	0.625	T	-3.15	0.895	D	0.458	0.510	-0.860	0.513	T	0.248	0.617	T	0.061	0.683	D	5.601	0.763	26.5	0.995	0.703	0.788	0.386	D	c	0.270	0.224	1.000	0.458	0.660	0.495	0	3.26	0.363	2.273	0.428	0.852	0.362	1.000	0.715	0.781	0.330	6.163	0.195	.	.	.	0.5	79	392	14	75388240	chr14:75388240	C	A	79	PASS	DP=392;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	80320318	80320318	-	T	intronic	NRXN3	.	.	.	0.999855501	0.000144499	1.92E-11	.	0.61924	0.11925	-1.548724932	3.273177636	47.34272	1.33505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	288	14	80320317	chr14:80320317	AT	ATT,A	89	PASS	DP=288;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	80320318	80320318	T	-	intronic	NRXN3	.	.	.	0.999855501	0.000144499	1.92E-11	.	0.61924	0.11925	-1.548724932	3.273177636	47.34272	1.33505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	288	14	80320317	chr14:80320317	AT	ATT,A	89	PASS	DP=288;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	81574701	81574701	T	C	intronic	TSHR	.	.	.	5.80E-06	0.879485782	0.120508415	DISEASE: Note=Defects in TSHR are found in patients affected by hyperthyroidism with different etiologies. Somatic, constitutively activating TSHR mutations and/or constitutively activating G(s)alpha mutations have been identified in toxic thyroid nodules (TTNs) that are the predominant cause of hyperthyroidism in iodine deficient areas. These mutations lead to TSH independent activation of the cAMP cascade resulting in thyroid growth and hormone production. TSHR mutations are found in autonomously functioning thyroid nodules (AFTN), toxic multinodular goiter (TMNG) and hyperfunctioning thyroid adenomas (HTA). TMNG encompasses a spectrum of different clinical entities, ranging from a single hyperfunctioning nodule within an enlarged thyroid, to multiple hyperfunctioning areas scattered throughout the gland. HTA are discrete encapsulated neoplasms characterized by TSH- independent autonomous growth, hypersecretion of thyroid hormones, and TSH suppression. Defects in TSHR are also a cause of thyroid neoplasms (papillary and follicular cancers).; DISEASE: Note=Autoantibodies against TSHR are directly responsible for the pathogenesis and hyperthyroidism of Graves disease. Antibody interaction with TSHR results in an uncontrolled receptor stimulation.; DISEASE: Hypothyroidism, congenital, non-goitrous, 1 (CHNG1) [MIM:275200]: A non-autoimmune condition characterized by resistance to thyroid-stimulating hormone (TSH) leading to increased levels of plasma TSH and low levels of thyroid hormone. It presents variable severity depending on the completeness of the defect. Most patients are euthyroid and asymptomatic, with a normal sized thyroid gland. Only a subset of patients develop hypothyroidism and present a hypoplastic thyroid gland. {ECO:0000269|PubMed:10720030, ECO:0000269|PubMed:11095460, ECO:0000269|PubMed:11442002, ECO:0000269|PubMed:12050212, ECO:0000269|PubMed:14725684, ECO:0000269|PubMed:15531543, ECO:0000269|PubMed:7528344, ECO:0000269|PubMed:8954020, ECO:0000269|PubMed:9100579, ECO:0000269|PubMed:9185526, ECO:0000269|PubMed:9329388}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial gestational hyperthyroidism (HTFG) [MIM:603373]: A condition characterized by abnormally high levels of serum thyroid hormones occurring during early pregnancy. {ECO:0000269|PubMed:9854118}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hyperthyroidism, non-autoimmune (HTNA) [MIM:609152]: A condition characterized by abnormally high levels of serum thyroid hormones, thyroid hyperplasia, goiter and lack of anti-thyroid antibodies. Typical features of Graves disease such as exophthalmia, myxedema, antibodies anti-TSH receptor and lymphocytic infiltration of the thyroid gland are absent. {ECO:0000269|PubMed:10199795, ECO:0000269|PubMed:10852462, ECO:0000269|PubMed:11081252, ECO:0000269|PubMed:11127522, ECO:0000269|PubMed:11201847, ECO:0000269|PubMed:11517004, ECO:0000269|PubMed:11549687, ECO:0000269|PubMed:15163335, ECO:0000269|PubMed:7800007, ECO:0000269|PubMed:7920658, ECO:0000269|PubMed:8636266, ECO:0000269|PubMed:8964822, ECO:0000269|PubMed:9349581, ECO:0000269|PubMed:9360555, ECO:0000269|PubMed:9398746, ECO:0000269|PubMed:9589634}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.19628	0.35681	0.005534202	54.09884407	850.31473	5.69844	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	13	14	81574701	chr14:81574701	T	C	71	PASS	DP=13;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	81953889	81953889	-	A	intronic	SEL1L	.	.	.	0.704308255	0.295691491	2.53E-07	.	0.3657	0.18583	0.154398214	64.73814579	162.19537	2.7815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	37	14	81953889	chr14:81953889	G	GA	62	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	86088953	86088953	C	A	exonic	FLRT2	.	synonymous SNV	FLRT2:NM_001346143:exon2:c.C1095A:p.P365P,FLRT2:NM_001346144:exon2:c.C1095A:p.P365P,FLRT2:NM_001346145:exon2:c.C1095A:p.P365P,FLRT2:NM_001346146:exon2:c.C1095A:p.P365P,FLRT2:NM_013231:exon2:c.C1095A:p.P365P	0.894038334	0.105747558	0.000214108	.	0.2241	0.11009	-0.044015879	50.44821892	1227.80506	6.62629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	115	320	14	86088953	chr14:86088953	C	A	115	PASS	DP=320;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	89629000	89629000	C	A	exonic	FOXN3	.	nonsynonymous SNV	FOXN3:NM_005197:exon6:c.G1165T:p.D389Y,FOXN3:NM_001085471:exon7:c.G1231T:p.D411Y	0.90779936	0.092051233	0.000149407	.	0.74209	0.17554	-0.356299879	29.31115829	47.54211	1.33837	0.002	0.721	D	0.997	0.689	D	0.863	0.596	P	0.000	0.491	D	0.999	0.462	D	2.395	0.694	M	-0.02	0.629	T	-3.17	0.650	D	0.739	0.736	-0.309	0.747	T	0.383	0.739	T	0.061	0.684	D	5.522	0.750	26.3	0.994	0.620	0.996	0.980	D	c	0.748	0.758	1.000	0.747	0.707	0.730	0	5.95	0.964	7.883	0.857	0.066	0.173	1.000	0.715	0.928	0.402	19.988	0.973	.	.	.	0.5	.	131	14	89629000	chr14:89629000	C	A	.	PASS	DP=131;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	91467521	91467521	-	A	intronic	RPS6KA5	.	.	.	0.999801807	0.000198193	4.15E-11	.	0.66327	0.31031	-0.178111357	40.44585987	117.20806	2.35411	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	214	14	91467521	chr14:91467521	G	GA	58	PASS	DP=214;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	93650551	93650551	T	C	exonic	MOAP1	.	nonsynonymous SNV	MOAP1:NM_022151:exon3:c.A37G:p.M13V	0.001403636	0.663920629	0.334675734	.	0.19634	0.15764	0.639420866	83.8995046	91.52402	2.05748	0.014	0.531	D	0.987	0.600	D	0.945	0.664	D	.	.	.	0.999	0.214	N	2.475	0.721	M	2.5	0.144	T	-3.44	0.674	D	0.495	0.541	-1.093	0.050	T	0.073	0.295	T	0.007	0.188	T	2.392	0.349	18.77	0.964	0.292	0.339	0.247	N	c	0.142	-0.034	1.000	0.747	0.789	0.998	0	2.26	0.273	1.397	0.339	1.060	0.767	0.957	0.332	0.005	0.090	6.767	0.226	.	.	.	0.5	58	126	14	93650551	chr14:93650551	T	C	58	PASS	DP=126;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	93705836	93705836	C	T	UTR3	BTBD7	NM_001002860:c.*2783G>A;NM_001289133:c.*2783G>A	.	.	0.682366257	0.317633428	3.16E-07	.	0.4057	.	-0.947938165	9.341825902	455.53339	4.4332	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	14	93705836	chr14:93705836	C	T	.	PASS	DP=47;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	94088721	94088721	C	T	exonic	UNC79	.	synonymous SNV	UNC79:NM_020818:exon30:c.C4611T:p.L1537L,UNC79:NM_001346218:exon31:c.C5292T:p.L1764L	1	2.61E-11	1.21E-30	.	0.13734	0.1172	-1.113491624	6.634819533	491.26186	4.56078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	14	94088721	chr14:94088721	C	T	.	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	94703987	94703987	G	-	exonic	PPP4R4	.	frameshift deletion	PPP4R4:NM_001348142:exon8:c.574delG:p.E192Kfs*20,PPP4R4:NM_058237:exon8:c.817delG:p.E273Kfs*20,PPP4R4:NM_001348144:exon9:c.496delG:p.E166Kfs*20,PPP4R4:NM_001348143:exon10:c.496delG:p.E166Kfs*20	0.005674255	0.994325407	3.39E-07	.	0.10634	0.08878	-1.085675268	7.147912243	115.24346	2.33468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	32	14	94703986	chr14:94703986	TG	T	51	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	99637948	99637948	T	-	UTR3	BCL11B	NM_022898:c.*2540delA;NM_138576:c.*2540delA;NM_001282238:c.*2540delA;NM_001282237:c.*2540delA	.	.	0.929785242	0.070140307	7.45E-05	.	0.70076	0.16232	.	.	29.1619	0.93217	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	317	14	99637947	chr14:99637947	AT	A	82	PASS	DP=317;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
14	100594926	100594926	-	C	exonic	EVL	.	frameshift insertion	EVL:NM_001330221:exon6:c.553dupC:p.P188Tfs*107,EVL:NM_016337:exon6:c.559dupC:p.P190Tfs*107	0.99261527	0.007384449	2.82E-07	.	0.74284	0.16663	-0.359940251	28.93371078	237.51255	3.32761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	458	14	100594926	chr14:100594926	G	GC	94	PASS	DP=458;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
14	100594948	100594948	C	T	exonic	EVL	.	nonsynonymous SNV	EVL:NM_001330221:exon6:c.C574T:p.P192S,EVL:NM_016337:exon6:c.C580T:p.P194S	0.99261527	0.007384449	2.82E-07	.	0.74284	0.16663	-0.359940251	28.93371078	237.51255	3.32761	0.376	0.912	T	0.78	0.423	P	0.265	0.383	B	0.000	0.481	D	1.000	0.488	D	2.74	0.803	M	-0.78	0.736	T	-4.61	0.795	D	0.28	0.489	-0.396	0.722	T	0.353	0.717	T	0.220	0.878	D	4.071	0.547	23.7	0.997	0.828	0.990	0.895	D	c	0.264	0.301	1.000	0.747	0.672	0.522	0	3.87	0.437	7.005	0.759	0.781	0.315	1.000	0.715	0.994	0.587	14.989	0.709	.	.	.	0.5	65	188	14	100594948	chr14:100594948	C	T	65	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
14	102302491	102302491	T	-	intronic	PPP2R5C	.	.	.	0.997672663	0.00232732	1.68E-08	.	0.16008	0.12741	0.018483465	55.44939844	1821.40468	7.87398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	321	14	102302490	chr14:102302490	GT	G,GTT	128	PASS	DP=321;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	0/2
14	102302491	102302491	-	T	intronic	PPP2R5C	.	.	.	0.997672663	0.00232732	1.68E-08	.	0.16008	0.12741	0.018483465	55.44939844	1821.40468	7.87398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	128	321	14	102302490	chr14:102302490	GT	G,GTT	128	PASS	DP=321;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	0/2
14	102771215	102771223	CCTCAAGCT	-	intronic	MOK	.	.	.	5.96E-17	0.001830666	0.998169334	.	0.14379	.	1.023320772	91.04741684	2990.39023	10.37744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	73	14	102771214	chr14:102771214	CCCTCAAGCT	C	69	PASS	DP=73;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	102801998	102801998	T	-	intronic	ZNF839	.	.	.	9.19E-05	0.935142117	0.064765993	.	0.0931	.	1.495467846	95.37626799	1511.89021	7.22302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	73	14	102801997	chr14:102801997	CT	C	56	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	104136556	104136591	GTAAAAGAGGGAAGTACAAAGAAGCAGAGCCGTTGT	-	exonic	KLC1	.	nonframeshift deletion	KLC1:NM_001130107:exon7:c.923_958del:p.G311_R322del,KLC1:NM_005552:exon7:c.923_958del:p.G311_R322del,KLC1:NM_182923:exon7:c.923_958del:p.G311_R322del	0.514955332	0.485012289	3.24E-05	.	0.2206	0.15408	-0.492218069	22.35786742	40.10824	1.17876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	23.97	61	14	104136555	chr14:104136555	GGTAAAAGAGGGAAGTACAAAGAAGCAGAGCCGTTGT	G	23.97	PASS	DP=61;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	104515928	104515928	T	-	intronic	TDRD9	.	.	.	3.82E-07	0.999438651	0.000560967	.	0.12943	0.10013	-0.191064116	39.27813163	513.83114	4.63761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	404	14	104515927	chr14:104515927	CT	C	83	PASS	DP=404;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	105181013	105181013	G	-	exonic	INF2	.	frameshift deletion	INF2:NM_001031714:exon21:c.3514delG:p.E1172Rfs*26,INF2:NM_022489:exon21:c.3514delG:p.E1172Rfs*26	0.999083288	0.000916712	7.09E-11	DISEASE: Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:20023659, ECO:0000269|PubMed:21258034, ECO:0000269|PubMed:21866090, ECO:0000269|PubMed:22971997, ECO:0000269|PubMed:25165188}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease, dominant, intermediate type, E (CMTDIE) [MIM:614455]: A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. The dominant intermediate type E is characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec. Patients additionally manifest focal segmental glomerulonephritis, proteinuria, progression to end- stage renal disease, and a characteristic histologic pattern on renal biopsy. {ECO:0000269|PubMed:22187985, ECO:0000269|PubMed:24174593, ECO:0000269|PubMed:24750328, ECO:0000269|PubMed:25165188, ECO:0000269|PubMed:25676889}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	-0.033100763	50.56027365	2152.91209	8.53891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	30.54	29	14	105181012	chr14:105181012	TGAGGAC	TAGGAC,T	30.54	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	105181013	105181018	GAGGAC	-	exonic	INF2	.	nonframeshift deletion	INF2:NM_001031714:exon21:c.3514_3519del:p.D1175_E1176del,INF2:NM_022489:exon21:c.3514_3519del:p.D1175_E1176del	0.999083288	0.000916712	7.09E-11	DISEASE: Focal segmental glomerulosclerosis 5 (FSGS5) [MIM:613237]: A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. {ECO:0000269|PubMed:20023659, ECO:0000269|PubMed:21258034, ECO:0000269|PubMed:21866090, ECO:0000269|PubMed:22971997, ECO:0000269|PubMed:25165188}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Charcot-Marie-Tooth disease, dominant, intermediate type, E (CMTDIE) [MIM:614455]: A form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. The dominant intermediate type E is characterized by clinical and pathologic features intermediate between demyelinating and axonal peripheral neuropathies, and motor median nerve conduction velocities ranging from 25 to 45 m/sec. Patients additionally manifest focal segmental glomerulonephritis, proteinuria, progression to end- stage renal disease, and a characteristic histologic pattern on renal biopsy. {ECO:0000269|PubMed:22187985, ECO:0000269|PubMed:24174593, ECO:0000269|PubMed:24750328, ECO:0000269|PubMed:25165188, ECO:0000269|PubMed:25676889}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	-0.033100763	50.56027365	2152.91209	8.53891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	30.54	29	14	105181012	chr14:105181012	TGAGGAC	TAGGAC,T	30.54	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	105196230	105196230	A	C	exonic	ADSSL1	.	nonsynonymous SNV	ADSSL1:NM_199165:exon1:c.A1C:p.M1L	0.000383323	0.990043419	0.009573258	.	0.25728	0.15503	-0.020150552	52.25288983	212.40167	3.1447	0.072	0.349	T	0.003	0.102	B	0.0	0.013	B	.	.	.	0.000	0.810	P	.	.	.	1.09	0.392	T	0.1	0.058	N	0.026	0.008	-0.939	0.429	T	0.000	0.000	T	.	.	.	-1.742	0.012	0.002	0.594	0.061	0.011	0.040	N	c	-1.464	-1.611	1.000	0.747	0.403	0.052	0	-0.317	0.120	-1.196	0.031	-1.937	0.005	0.040	0.208	0.001	0.043	.	.	.	ENSG00000184990.8|ENSG00000184990.8|ENSG00000185100.6|ENSG00000185100.6|ENSG00000184990.8|ENSG00000185100.6|ENSG00000185100.6|ENSG00000185100.6|ENSG00000185100.6|ENSG00000185100.6|ENSG00000258430.1|ENSG00000179627.9|ENSG00000142208.11	Artery_Aorta|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Lung|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Testis|Thyroid|Thyroid|Thyroid	0.5	146	94	14	105196230	chr14:105196230	A	C	146	PASS	DP=94;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	105242966	105242966	T	C	intronic	AKT1	.	.	.	0.980206587	0.019792772	6.41E-07	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:17611497}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Note=Genetic variations in AKT1 may play a role in susceptibility to ovarian cancer.; DISEASE: Proteus syndrome (PROTEUSS) [MIM:176920]: A highly variable, severe disorder of asymmetric and disproportionate overgrowth of body parts, connective tissue nevi, epidermal nevi, dysregulated adipose tissue, and vascular malformations. Many features of Proteus syndrome overlap with other overgrowth syndromes. {ECO:0000269|PubMed:21793738}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cowden syndrome 6 (CWS6) [MIM:615109]: A form of Cowden syndrome, a hamartomatous polyposis syndrome with age-related penetrance. Cowden syndrome is characterized by hamartomatous lesions affecting derivatives of ectodermal, mesodermal and endodermal layers, macrocephaly, facial trichilemmomas (benign tumors of the hair follicle infundibulum), acral keratoses, papillomatous papules, and elevated risk for development of several types of malignancy, particularly breast carcinoma in women and thyroid carcinoma in both men and women. Colon cancer and renal cell carcinoma have also been reported. Hamartomas can be found in virtually every organ, but most commonly in the skin, gastrointestinal tract, breast and thyroid. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99568	0.9996	-1.001120478	8.321538099	12.57291	0.45861	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	159	14	105242966	chr14:105242966	T	C	90	PASS	DP=159;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
14	105344239	105344239	G	A	exonic	CEP170B	.	nonsynonymous SNV	CEP170B:NM_015005:exon3:c.G3A:p.M1I,CEP170B:NM_001112726:exon4:c.G213A:p.M71I	0.87050986	0.12948953	6.11E-07	.	0.17272	.	-1.690488621	2.600849257	961.44284	6.00066	0.048	0.538	D	0.009	0.163	B	0.012	0.149	B	0.032	0.251	N	1	0.810	D	-0.84	0.015	N	1.52	0.307	T	0.5	0.030	N	0.128	0.146	-1.080	0.073	T	0.026	0.112	T	0.011	0.279	T	2.085	0.312	16.76	0.977	0.348	0.247	0.222	N	c	-0.796	-0.668	0.999	0.377	0.707	0.730	0	2.61	0.301	0.594	0.235	0.902	0.416	0.997	0.399	0.992	0.562	5.009	0.136	Forkhead-associated (FHA) domain|SMAD/FHA domain	.	.	0.5	.	84	14	105344239	chr14:105344239	G	A	.	PASS	DP=84;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	105412138	105412138	A	G	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.T9350C:p.L3117P,AHNAK2:NM_138420:exon7:c.T9650C:p.L3217P	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.114	0.286	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-2.045	0.002	N	6.64	0.005	T	2.0	0.004	N	0.055	0.037	-1.036	0.187	T	0.001	0.002	T	.	.	.	0.084	0.102	3.433	0.304	0.017	0.001	0.005	N	c	-1.613	-1.536	0.000	0.061	0.476	0.093	0	2.59	0.300	-0.281	0.084	-0.582	0.045	0.000	0.063	0.000	0.016	5.350	0.152	.	.	.	0.5	116	433	14	105412138	chr14:105412138	A	G	116	PASS	DP=433;AN=4	GT	./.	0/1	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
14	105412163	105412163	C	G	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.G9325C:p.V3109L,AHNAK2:NM_138420:exon7:c.G9625C:p.V3209L	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.393	0.107	T	0.008	0.135	B	0.007	0.121	B	.	.	.	1	0.090	N	1.435	0.361	L	5.31	0.011	T	-0.93	0.249	N	0.117	0.129	-0.900	0.481	T	0.003	0.010	T	0.003	0.077	T	0.072	0.101	3.314	0.791	0.122	0.029	0.077	N	c	-1.262	-1.364	0.000	0.059	0.476	0.093	0	-2.26	0.064	-5.015	0.002	-4.746	0.000	0.000	0.063	0.000	0.016	0.886	0.012	.	.	.	0.5	76	648	14	105412163	chr14:105412163	C	G,A	76	PASS	DP=648;AN=4	GT	./.	./.	./.	./.	0/1	0/2	./.	./.	./.	./.	./.	./.
14	105412163	105412163	C	A	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.G9325T:p.V3109L,AHNAK2:NM_138420:exon7:c.G9625T:p.V3209L	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.393	0.107	T	0.008	0.135	B	0.007	0.121	B	.	.	.	1	0.090	N	1.435	0.361	L	5.31	0.011	T	-0.93	0.249	N	0.117	0.129	-0.900	0.481	T	0.003	0.010	T	0.003	0.078	T	0.444	0.137	6.990	0.806	0.128	0.020	0.060	N	c	-1.262	-1.364	0.000	0.059	0.476	0.093	0	-2.26	0.064	-5.015	0.002	-4.746	0.000	0.000	0.063	0.000	0.016	0.886	0.012	.	.	.	0.5	76	648	14	105412163	chr14:105412163	C	G,A	76	PASS	DP=648;AN=4	GT	./.	./.	./.	./.	0/1	0/2	./.	./.	./.	./.	./.	./.
14	105418538	105418538	C	T	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.G2950A:p.V984M,AHNAK2:NM_138420:exon7:c.G3250A:p.V1084M	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.535	0.069	T	0.229	0.288	B	0.09	0.283	B	.	.	.	1	0.198	N	0.52	0.136	N	5.57	0.009	T	-0.62	0.183	N	0.106	0.112	-0.928	0.444	T	0.003	0.009	T	0.008	0.226	T	1.040	0.194	10.88	0.977	0.350	0.012	0.042	N	c	-1.369	-1.465	0.000	0.054	0.707	0.730	0	-1.55	0.081	-1.942	0.016	-0.014	0.131	0.000	0.063	0.033	0.150	4.125	0.095	.	.	.	0.5	85	589	14	105418538	chr14:105418538	C	T	85	PASS	DP=589;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
14	105954731	105954731	C	T	intronic	CRIP1	.	.	.	0.00135796	0.422344924	0.576297116	.	0.16635	0.11262	0.281220278	71.07808445	288.32797	3.63595	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	14	105954731	chr14:105954731	C	T	.	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	106095799	106095799	C	A	intergenic	MIR8071-2;MIR8071-2	dist=8282;dist=10706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	354	14	106095799	chr14:106095799	C	A	.	PASS	DP=354;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	106109683	106109683	C	T	intergenic	MIR8071-2;ELK2AP	dist=3114;dist=26231	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	263	14	106109683	chr14:106109683	C	T	.	PASS	DP=263;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	106137413	106137413	-	A	ncRNA_intronic	ELK2AP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	370	14	106137412	chr14:106137412	GA	GAA,GAAA,G	69	PASS	DP=370;AN=4	GT	././.	././.	././.	0/1/.	././.	././.	0/3	././.	././.	././.	././.	././.
14	106137413	106137413	-	AA	ncRNA_intronic	ELK2AP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	370	14	106137412	chr14:106137412	GA	GAA,GAAA,G	69	PASS	DP=370;AN=4	GT	././.	././.	././.	0/1/.	././.	././.	0/3	././.	././.	././.	././.	././.
14	106137413	106137413	A	-	ncRNA_intronic	ELK2AP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	370	14	106137412	chr14:106137412	GA	GAA,GAAA,G	69	PASS	DP=370;AN=4	GT	././.	././.	././.	0/1/.	././.	././.	0/3	././.	././.	././.	././.	././.
14	106206603	106206603	A	G	intergenic	ELK2AP;MIR4507	dist=67459;dist=117690	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	391	14	106206603	chr14:106206603	A	G	138	PASS	DP=391;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	106206606	106206606	A	G	intergenic	ELK2AP;MIR4507	dist=67462;dist=117687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	386	14	106206606	chr14:106206606	A	G	142	PASS	DP=386;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
14	106237769	106237769	T	C	intergenic	ELK2AP;MIR4507	dist=98625;dist=86524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	816	14	106237769	chr14:106237769	T	C	129	PASS	DP=816;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
14	106452718	106452718	G	T	intergenic	ADAM6;LINC00226	dist=14360;dist=291551	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	344	14	106452718	chr14:106452718	G	T	85	PASS	DP=344;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	106494322	106494322	C	A	intergenic	ADAM6;LINC00226	dist=55964;dist=249947	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	319	14	106494322	chr14:106494322	C	A	91	PASS	DP=319;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
14	106579211	106579211	A	T	intergenic	ADAM6;LINC00226	dist=140853;dist=165058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	160	14	106579211	chr14:106579211	A	T	.	PASS	DP=160;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
14	106725332	106725332	C	T	intergenic	ADAM6;LINC00226	dist=286974;dist=18937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	288	14	106725332	chr14:106725332	C	T	98	PASS	DP=288;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	20084006	20084006	A	G	intergenic	NONE;CHEK2P2	dist=NONE;dist=403991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	214	15	20084006	chr15:20084006	A	G	132	PASS	DP=214;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	20362867	20362867	T	C	intergenic	NONE;CHEK2P2	dist=NONE;dist=125130	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	393	15	20362867	chr15:20362867	T	C	114	PASS	DP=393;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	20434040	20434040	T	A	intergenic	NONE;CHEK2P2	dist=NONE;dist=53957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	177	15	20434040	chr15:20434040	T	A	.	PASS	DP=177;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	20450149	20450149	T	C	intergenic	NONE;CHEK2P2	dist=NONE;dist=37848	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	1311	15	20450149	chr15:20450149	T	C	92	PASS	DP=1311;AN=4	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	20450231	20450231	C	A	intergenic	NONE;CHEK2P2	dist=NONE;dist=37766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	394	15	20450231	chr15:20450231	C	A	.	PASS	DP=394;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	20453992	20453992	T	C	intergenic	NONE;CHEK2P2	dist=NONE;dist=34005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	985	15	20453992	chr15:20453992	T	C	.	PASS	DP=985;AN=4	GT	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.
15	20489389	20489389	G	C	ncRNA_intronic	CHEK2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	175	15	20489389	chr15:20489389	G	C	63	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	20495286	20495286	A	C	ncRNA_intronic	CHEK2P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	234	15	20495286	chr15:20495286	A	C	148	PASS	DP=234;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	20876452	20876452	G	A	ncRNA_exonic	NBEAP1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	15	20876452	chr15:20876452	G	A	.	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	21051204	21051270	TCAGGTTTTCTGCTCTTCCTTTGTGGAATTAATCCATCATCACCATTGCCAGCACTGGCACCATTAG	-	exonic	POTEB;POTEB2;POTEB3	.	frameshift deletion	POTEB2:NM_001277303:exon9:c.1190_1256del:p.T397Kfs*38,POTEB:NM_001277304:exon9:c.1190_1256del:p.T397Kfs*38,POTEB3:NM_207355:exon10:c.1190_1256del:p.T397Kfs*38	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	62	15	21051203	chr15:21051203	TTCAGGTTTTCTGCTCTTCCTTTGTGGAATTAATCCATCATCACCATTGCCAGCACTGGCACCATTAG	T	60	PASS	DP=62;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	21938082	21938082	G	A	ncRNA_exonic	LOC646214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	72	15	21938082	chr15:21938082	G	A	.	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	22298164	22298164	G	T	ncRNA_intronic	LINC02203;LOC101927079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	154	15	22298164	chr15:22298164	G	T	109	PASS	DP=154;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	22368600	22368600	G	C	exonic;splicing	OR4M2;LINC02203	NR_015416:exon9:c.1264+1G>C	nonsynonymous SNV	OR4M2:NM_001004719:exon1:c.G25C:p.V9L	.	.	.	.	.	.	.	.	.	.	0.006	0.614	D	0.258	0.297	B	0.126	0.311	B	0.001	0.424	D	0.780	0.293	N	2.505	0.732	M	5.64	0.008	T	-2.37	0.522	N	0.395	0.454	-1.133	0.017	T	0.006	0.021	T	0.004	0.091	T	2.568	0.370	19.90	0.990	0.492	0.632	0.318	D	c	-0.194	-0.226	0.999	0.383	0.487	0.133	0	2.5	0.292	0.492	0.220	0.681	0.295	0.094	0.225	0.584	0.286	10.808	0.455	.	.	.	0.5	92	141	15	22368600	chr15:22368600	G	C	92	PASS	DP=141;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	22413972	22413972	C	A	ncRNA_exonic	OR4N3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	177	15	22413972	chr15:22413972	C	A	.	PASS	DP=177;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	22448402	22448402	G	T	ncRNA_exonic	IGHV1OR15-1;LOC102724760	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	288	15	22448402	chr15:22448402	G	T	.	PASS	DP=288;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	22483137	22483137	G	A	intergenic	IGHV1OR15-3;MIR1268A	dist=16590;dist=30092	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	178	15	22483137	chr15:22483137	G	A	.	PASS	DP=178;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	22743235	22743235	A	G	exonic	GOLGA6L1;GOLGA6L22	.	synonymous SNV	GOLGA6L1:NM_001001413:exon8:c.A1620G:p.R540R,GOLGA6L22:NM_001271664:exon10:c.A1584G:p.R528R	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	94	15	22743235	chr15:22743235	A	G	81	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	23108906	23108906	T	C	ncRNA_intronic	LOC283683	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	275	15	23108906	chr15:23108906	T	C	82	PASS	DP=275;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	23262117	23262117	T	G	ncRNA_intronic	GOLGA8IP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	235	15	23262117	chr15:23262117	T	G	96	PASS	DP=235;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	23410615	23410615	T	C	intronic	GOLGA6L22	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	259	15	23410615	chr15:23410615	T	C	.	PASS	DP=259;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	23605348	23605348	C	A	ncRNA_intronic	GOLGA8S	.	.	.	0.004662616	0.877542935	0.117794449	.	.	.	.	.	7996.64766	19.29597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	304	15	23605348	chr15:23605348	C	A	.	PASS	DP=304;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	23690415	23690415	-	TGTGC	intronic	GOLGA6L2	.	.	.	8.97E-06	0.322765802	0.677225227	.	.	.	.	.	13588.28081	25.3545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	33	15	23690415	chr15:23690415	T	TTGTGC	59	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
15	24921380	24921380	G	A	exonic	NPAP1	.	nonsynonymous SNV	NPAP1:NM_018958:exon1:c.G366A:p.M122I	0.273009366	0.721810072	0.005180563	.	0.05519	0.05806	3.546886998	99.49280491	286.08933	3.62008	0.082	0.332	T	0.001	0.067	B	0.0	0.013	B	0.005	0.010	N	1	0.090	N	0	0.065	N	3.37	0.059	T	-0.84	0.229	N	0.057	0.040	-0.978	0.356	T	0.009	0.034	T	0.000	0.001	T	-1.330	0.021	0.004	0.729	0.098	0.001	0.009	N	c	-1.563	-1.664	0.069	0.155	0.487	0.133	0	-3.13	0.049	-0.735	0.050	0.535	0.282	0.000	0.063	0.009	0.108	0.246	0.002	.	.	.	0.5	.	202	15	24921380	chr15:24921380	G	A	.	PASS	DP=202;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	25417793	25417793	G	A	ncRNA_exonic	SNORD115-2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	15	25417793	chr15:25417793	G	A	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	25432640	25432640	G	T	ncRNA_intronic	SNHG14	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	69	15	25432640	chr15:25432640	G	T	119	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	28419774	28419774	C	T	intronic	HERC2	.	.	.	1	3.99E-17	4.70E-51	DISEASE: Mental retardation, autosomal recessive 38 (MRT38) [MIM:615516]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT38 is characterized by global developmental delay affecting motor, speech, adaptive, and social development. Patients manifest autistic features, aggression, self-injury, impulsivity, and distractibility. {ECO:0000269|PubMed:23065719}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24532	0.21556	-5.985628431	0.047180939	2166.06955	8.56756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	422	15	28419774	chr15:28419774	C	T	113	PASS	DP=422;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	28419779	28419779	A	G	intronic	HERC2	.	.	.	1	3.99E-17	4.70E-51	DISEASE: Mental retardation, autosomal recessive 38 (MRT38) [MIM:615516]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT38 is characterized by global developmental delay affecting motor, speech, adaptive, and social development. Patients manifest autistic features, aggression, self-injury, impulsivity, and distractibility. {ECO:0000269|PubMed:23065719}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24532	0.21556	-5.985628431	0.047180939	2166.06955	8.56756	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	383	15	28419779	chr15:28419779	A	G	123	PASS	DP=383;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	28878923	28878923	-	T	intergenic	HERC2P11;HERC2P9	dist=44537;dist=20665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	155	15	28878923	chr15:28878923	A	AT	76	PASS	DP=155;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	30850264	30850264	G	C	intergenic	LOC100288203;DNM1P50	dist=67748;dist=10537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	250	15	30850264	chr15:30850264	G	C	144	PASS	DP=250;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	31093624	31093624	C	G	intergenic	LOC100288637;HERC2P10	dist=28415;dist=16615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	350	15	31093624	chr15:31093624	C	G	67	PASS	DP=350;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	31233063	31233063	A	C	UTR3	MTMR10	NM_017762:c.*610T>G	.	.	0.035049797	0.964614838	0.000335366	.	0.04354	.	0.378498378	75.58386412	720.47875	5.32943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	39	15	31233063	chr15:31233063	A	C	78	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	32716905	32716905	A	C	ncRNA_intronic	ULK4P1;ULK4P2;ULK4P3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	15	32716905	chr15:32716905	A	C	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	33923502	33923502	-	T	intronic	RYR3	.	.	.	0.999999945	5.48E-08	8.09E-38	.	0.32508	0.17005	-5.868890763	0.058976174	4624.36471	13.6808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	19	15	33923502	chr15:33923502	A	AT	44	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	34642927	34642927	C	A	exonic	NUTM1	.	synonymous SNV	NUTM1:NM_001284293:exon3:c.C802A:p.R268R,NUTM1:NM_001284292:exon4:c.C832A:p.R278R,NUTM1:NM_175741:exon4:c.C748A:p.R250R	0.005981126	0.993096368	0.000922506	DISEASE: Note=A chromosomal aberration involving NUT is found in a rare, aggressive, and lethal carcinoma arising in midline organs of young people. Translocation t(15;19)(q14;p13) with BRD4 which produces a BRD4-NUT fusion protein. {ECO:0000269|PubMed:12543779}.; DISEASE: Note=A chromosomal aberration involving NUT is found in a rare, aggressive, and lethal carcinoma arising in midline organs of young people. Translocation t(15;9)(q14;q34) with BRD3 which produces a BRD3-NUT fusion protein. {ECO:0000269|PubMed:12543779}.; 	0.10314	0.08894	1.431149089	95.02241095	2356.45511	9.00213	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	15	34642927	chr15:34642927	C	A	.	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	35046595	35046595	T	A	intronic	GJD2	.	.	.	0.1177216	0.856017325	0.026261075	.	0.33289	0.19444	-0.271755481	34.31823543	43.42131	1.25398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	529	15	35046595	chr15:35046595	T	A	125	PASS	DP=529;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	35273705	35273705	T	C	exonic	ZNF770	.	nonsynonymous SNV	ZNF770:NM_014106:exon3:c.A1931G:p.Y644C	0.827513247	0.1723277	0.000159054	.	0.37639	0.0946	-0.442665927	24.53408823	53.00521	1.44576	0.037	0.430	D	1.0	0.899	D	0.979	0.728	D	0.000	0.481	D	0.891	0.279	N	1.005	0.253	L	2.26	0.176	T	-2.57	0.555	D	0.813	0.801	-1.077	0.078	T	0.076	0.306	T	0.011	0.278	T	4.350	0.582	24.1	0.997	0.820	0.957	0.654	D	c	0.578	0.600	1.000	0.747	0.672	0.522	0	5.27	0.737	3.059	0.494	1.061	0.807	1.000	0.715	1.000	0.888	15.350	0.740	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	64	60	15	35273705	chr15:35273705	T	C	64	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
15	35385329	35385329	C	T	intergenic	ZNF770;ANP32AP1	dist=104832;dist=144198	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	361	15	35385329	chr15:35385329	C	T	.	PASS	DP=361;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	35385345	35385347	GGC	-	intergenic	ZNF770;ANP32AP1	dist=104848;dist=144180	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	284	15	35385344	chr15:35385344	AGGC	A	99	PASS	DP=284;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	40951700	40951700	T	-	intronic	KNL1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	199	15	40951699	chr15:40951699	CT	C	68	PASS	DP=199;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	41021637	41021638	GT	-	intronic	RAD51	.	.	.	0.990418088	0.00957928	2.63E-06	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10807537}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Mirror movements 2 (MRMV2) [MIM:614508]: A disorder characterized by contralateral involuntary movements that mirror voluntary ones. While mirror movements are occasionally found in young children, persistence beyond the age of 10 is abnormal. Mirror movements occur more commonly in the upper extremities. {ECO:0000269|PubMed:22305526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99998	0.9588	-0.139478553	43.29440906	27.3455	0.88074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	37	15	41021636	chr15:41021636	GGT	G	60	PASS	DP=37;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	41793794	41793794	G	A	intronic	ITPKA	.	.	.	0.821022369	0.17811602	0.000861612	.	0.21376	0.12708	.	.	45.24026	1.29149	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	15	41793794	chr15:41793794	G	A	.	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	41862354	41862436	GGTAAGGGGATGGGGATGTGGAGGGAGAGGCAGGTAATGATGAAAGACCTTGGAGCTGACCCCAAATCCTGGGTTTTCCTTTA	-	exonic	TYRO3	.	frameshift deletion	TYRO3:NM_001330264:exon10:c.1247delG:p.Q417Kfs*42,TYRO3:NM_006293:exon10:c.1382delG:p.Q462Kfs*42	0.761822543	0.238176797	6.60E-07	.	0.26568	0.24002	-0.817464788	11.97806086	1530.51507	7.27014	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	368	15	41862353	chr15:41862353	GGGTAAGGGGATGGGGATGTGGAGGGAGAGGCAGGTAATGATGAAAGACCTTGGAGCTGACCCCAAATCCTGGGTTTTCCTTTA	G	68	PASS	DP=368;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	42144979	42144979	C	-	intronic	SPTBN5	.	.	.	1.09E-70	6.32E-11	1	.	0.16852	0.12091	.	.	13728.76893	25.43136	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	221	15	42144978	chr15:42144978	GC	G	78	PASS	DP=221;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	42438404	42438404	C	G	exonic	PLA2G4F	.	synonymous SNV	PLA2G4F:NM_213600:exon14:c.G1455C:p.A485A	1.40E-09	0.985845067	0.014154932	.	0.06296	0.09823	1.32640619	94.10238264	1110.4377	6.37148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	192	15	42438404	chr15:42438404	C	G	124	PASS	DP=192;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	43512886	43512886	C	T	intronic	EPB42	.	.	.	1.56E-07	0.955587191	0.044412653	DISEASE: Spherocytosis 5 (SPH5) [MIM:612690]: Spherocytosis is a hematologic disorder leading to chronic hemolytic anemia and characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. Absence of band 4.2 associated with spur or target erythrocytes has also been reported. {ECO:0000269|PubMed:10406914, ECO:0000269|PubMed:1558976, ECO:0000269|PubMed:7772513, ECO:0000269|PubMed:7819064, ECO:0000269|PubMed:8547071, ECO:0000269|PubMed:8547605}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.41009	0.12721	-0.194700582	39.24274593	150.84156	2.68319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	130	15	43512886	chr15:43512886	C	T	.	PASS	DP=130;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	43622483	43622483	C	A	exonic	LCMT2	.	nonsynonymous SNV	LCMT2:NM_014793:exon1:c.G205T:p.A69S	7.27E-08	0.268667513	0.731332415	.	0.07788	0.11769	-0.042196577	50.49539986	231.36801	3.28766	0.504	0.076	T	0.506	0.354	P	0.281	0.386	B	0.052	0.229	N	1	0.810	D	1.445	0.365	L	1.9	0.235	T	0.34	0.038	N	0.264	0.321	-1.123	0.022	T	0.047	0.201	T	0.024	0.472	T	2.050	0.307	16.53	0.832	0.141	0.946	0.614	D	c	-0.343	-0.246	1.000	0.747	0.006	0.001	3	4.63	0.570	3.175	0.503	0.049	0.161	1.000	0.715	0.311	0.239	12.395	0.545	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	95	515	15	43622483	chr15:43622483	C	A	95	PASS	DP=515;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	43638146	43638146	G	T	exonic	ADAL	.	nonsynonymous SNV	ADAL:NM_001012969:exon8:c.G520T:p.V174F,ADAL:NM_001159280:exon9:c.G520T:p.V174F,ADAL:NM_001324364:exon9:c.G520T:p.V174F,ADAL:NM_001324365:exon9:c.G520T:p.V174F,ADAL:NM_001324366:exon9:c.G520T:p.V174F,ADAL:NM_001324367:exon9:c.G520T:p.V174F,ADAL:NM_001324368:exon9:c.G520T:p.V174F	8.52E-09	0.044008879	0.955991112	.	0.06081	0.11351	0.260991686	70.25831564	135.20538	2.52983	0.001	0.784	D	0.993	0.657	D	0.971	0.742	D	0.000	0.843	D	1	0.810	D	3.35	0.913	M	-3.72	0.954	D	-4.13	0.759	D	0.976	0.980	1.058	0.983	D	0.936	0.979	D	0.446	0.943	D	6.431	0.887	29.8	0.996	0.738	0.986	0.846	D	c	0.943	0.904	1.000	0.747	0.732	0.924	0	5.87	0.942	7.503	0.803	1.048	0.713	1.000	0.715	0.987	0.523	18.072	0.893	Adenosine/AMP deaminase domain|Metal-dependent hydrolase	.	.	0.5	.	58	15	43638146	chr15:43638146	G	T	.	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	43903130	43903130	C	T	exonic	STRC	.	nonsynonymous SNV	STRC:NM_153700:exon14:c.G3359A:p.C1120Y	0.005321845	0.994633321	4.48E-05	DISEASE: Deafness, autosomal recessive, 16 (DFNB16) [MIM:603720]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:11687802}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness-infertility syndrome (DIS) [MIM:611102]: Characterized by deafness and infertility and is caused by large contiguous gene deletions at 15q15.3 that removes both STRC and CATSPER2 genes. {ECO:0000269|PubMed:17098888}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14418	.	.	.	4206.67564	12.90457	0.009	0.574	D	0.997	0.689	D	0.991	0.782	D	0.001	0.425	D	1	0.810	D	0.975	0.246	L	-1.24	0.790	T	-1.08	0.281	N	0.798	0.788	-0.133	0.793	T	0.447	0.783	T	0.074	0.719	D	5.878	0.806	27.4	0.997	0.771	0.939	0.593	D	c	0.433	0.414	0.005	0.108	0.554	0.246	0	4.13	0.475	3.425	0.523	0.850	0.350	1.000	0.715	0.993	0.574	12.075	0.528	.	.	.	0.5	.	35	15	43903130	chr15:43903130	C	T	.	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	44085843	44085843	T	C	exonic	SERF2	.	synonymous SNV	SERF2:NM_001199875:exon3:c.T186C:p.H62H	0.138975962	0.779592802	0.081431235	.	0.24204	0.11262	.	.	2084.12462	8.40921	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	421	15	44085843	chr15:44085843	T	C	76	PASS	DP=421;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	45123755	45123755	-	C	ncRNA_exonic	SORD2P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	216	15	45123755	chr15:45123755	G	GC	97	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	45400207	45400207	G	A	intronic	DUOX2	.	.	.	1.90E-37	3.81E-06	0.999996187	DISEASE: Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200]: A disorder due to a defective conversion of accumulated iodide to organically bound iodine. The iodide organification defect can be partial or complete. {ECO:0000269|PubMed:12110737, ECO:0000269|PubMed:16134168, ECO:0000269|PubMed:16322276, ECO:0000269|PubMed:20187165}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15059	0.21524	0.227640447	68.52441614	1216.76018	6.60084	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	219	15	45400207	chr15:45400207	G	A	65	PASS	DP=219;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	49117125	49117125	-	T	UTR3	SHC4	NM_203349:c.*1042_*1043insA	.	.	1.17E-05	0.988149866	0.011838437	.	0.29902	0.12806	-0.709045403	14.673272	251.32202	3.41544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	106	21	15	49117125	chr15:49117125	G	GT	106	PASS	DP=21;AN=2	GT	1/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	50754454	50754454	T	-	intronic	USP8	.	.	.	0.999982629	1.74E-05	2.23E-14	.	0.21578	0.12146	0.402364592	76.45081387	805.90942	5.59333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	65	15	50754453	chr15:50754453	CT	C	59	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	55880103	55880103	C	-	UTR5	PYGO1	NM_001330326:c.-22delG	.	.	0.956651522	0.043239764	0.000108714	.	0.08925	0.11665	0.196671391	67.19155461	345.47846	3.94247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	738	15	55880102	chr15:55880102	TC	T	89	PASS	DP=738;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	56435086	56435086	G	A	exonic	RFX7	.	synonymous SNV	RFX7:NM_022841:exon4:c.C291T:p.A97A	0.999680946	0.000319054	1.32E-10	.	0.76512	0.10256	.	.	372.49082	4.07209	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	15	56435086	chr15:56435086	G	A	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	58985103	58985103	G	A	ncRNA_exonic	HSP90AB4P	.	.	.	.	.	.	.	0.20153	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	156	15	58985103	chr15:58985103	G	A	81	PASS	DP=156;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	59912374	59912374	-	T	downstream	GCNT3	dist=164	.	.	4.04E-09	0.054399435	0.945600561	.	0.11221	0.09788	0.446457185	77.97829677	58.26865	1.54572	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	160	15	59912374	chr15:59912374	A	AT	70	PASS	DP=160;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	59981640	59981640	C	A	UTR5	BNIP2	NM_001320674:c.-1G>T;NM_004330:c.-1G>T	.	.	1.69E-05	0.671754446	0.328228624	.	0.59599	0.12477	-0.336073593	30.55555556	3900.56272	12.33278	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	282	15	59981640	chr15:59981640	C	A	.	PASS	DP=282;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	62167156	62167156	A	-	intronic	VPS13C	.	.	.	1.86E-37	0.999996999	3.00E-06	.	0.21113	0.1084	-0.811192082	12.07832036	3785.30625	12.05677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	194	15	62167155	chr15:62167155	CA	C	73	PASS	DP=194;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	63127921	63127921	G	A	intronic	TLN2	.	.	.	0.999853231	0.000146769	3.85E-21	.	0.30553	0.44698	-3.469503166	0.353857042	2221.48407	8.67915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	188	15	63127921	chr15:63127921	G	A	.	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	63447893	63447893	C	G	exonic	RPS27L	.	nonsynonymous SNV	RPS27L:NM_015920:exon3:c.G153C:p.Q51H	0.335851902	0.603407942	0.060740156	.	0.35212	0.08617	0.101211609	60.95777306	22.08009	0.7413	0.008	0.599	D	0.977	0.566	D	0.926	0.644	D	0.000	0.843	D	0.999	0.463	D	.	.	.	.	.	.	-4.7	0.806	D	0.937	0.931	-0.385	0.725	T	0.364	0.725	T	0.027	0.500	D	4.623	0.619	24.5	0.997	0.795	0.876	0.469	D	c	0.429	0.400	1.000	0.747	0.660	0.490	0	2.71	0.310	4.090	0.572	0.935	0.490	1.000	0.715	0.997	0.653	9.976	0.408	Ribosomal protein S27e, zinc-binding domain|Zinc-binding ribosomal protein	.	.	0.5	59	54	15	63447893	chr15:63447893	C	G	59	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	66629410	66629411	AC	-	exonic	TIPIN	.	stopgain	TIPIN:NM_001289986:exon7:c.488_489del:p.C163fs*0,TIPIN:NM_017858:exon8:c.791_792del:p.C264fs*0	0.009832085	0.942185447	0.047982468	.	0.80134	0.08685	0.72761005	86.08162302	1665.32698	7.53505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.27	22	15	66629409	chr15:66629409	TAC	T	12.27	PASS	DP=22;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
15	66786707	66786709	GAG	-	UTR3	SNAPC5	NM_001329615:c.*67_*65delCTC;NM_001329614:c.*67_*65delCTC;NM_001329613:c.*67_*65delCTC	.	.	1.40E-05	0.125603911	0.874382068	.	0.08216	0.11262	-0.09720619	46.20193442	24.24987	0.79777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	29	15	66786706	chr15:66786706	TGAG	T	79	PASS	DP=29;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
15	71256253	71256253	A	G	exonic	LRRC49	.	synonymous SNV	LRRC49:NM_001199017:exon9:c.A918G:p.L306L,LRRC49:NM_017691:exon9:c.A903G:p.L301L,LRRC49:NM_001199018:exon10:c.A771G:p.L257L,LRRC49:NM_001284357:exon10:c.A873G:p.L291L	0.446510312	0.553478597	1.11E-05	.	0.18522	0.11023	-0.666770504	15.86459071	4621.78815	13.66012	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	59	15	71256253	chr15:71256253	A	G	91	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	73996200	73996200	G	T	exonic	CD276	.	nonsynonymous SNV	CD276:NM_001329629:exon4:c.G496T:p.A166S,CD276:NM_001024736:exon5:c.G934T:p.A312S	2.02E-05	0.709451017	0.290528763	.	0.09767	0.14799	0.450099045	78.01958009	6835.12654	17.61125	0.774	0.033	T	0.008	0.135	B	0.022	0.184	B	0.323	0.142	N	1	0.090	N	-0.52	0.025	N	-0.04	0.633	T	0.47	0.031	N	0.114	0.124	-1.002	0.294	T	0.060	0.250	T	0.018	0.401	T	-1.326	0.021	0.004	0.719	0.095	0.214	0.212	N	c	-1.310	-1.255	1.000	0.517	0.713	0.817	0	0.246	0.147	-0.062	0.115	0.905	0.419	0.000	0.063	0.162	0.208	4.847	0.128	Immunoglobulin V-set domain|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	269	15	73996200	chr15:73996200	G	T	.	PASS	DP=269;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	74327470	74327470	G	C	UTR3	PML	NM_033240:c.*473G>C	.	.	0.937511029	0.062486698	2.27E-06	DISEASE: Note=A chromosomal aberration involving PML may be a cause of acute promyelocytic leukemia (APL). Translocation t(15;17)(q21;q21) with RARA. The PML breakpoints (type A and type B) lie on either side of an alternatively spliced exon. {ECO:0000269|PubMed:1652369, ECO:0000269|PubMed:1720570}.; 	0.13603	0.57235	0.148734569	64.11889597	74.41273	1.8023	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	576	15	74327470	chr15:74327470	G	C	92	PASS	DP=576;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	74368297	74368297	C	G	exonic	GOLGA6A	.	nonsynonymous SNV	GOLGA6A:NM_001038640:exon8:c.G594C:p.Q198H	0.224411354	0.739591664	0.035996982	.	.	0.07726	.	.	525.23752	4.67589	0.099	0.306	T	0.966	0.542	D	0.891	0.614	P	.	.	.	1	0.090	N	2.4	0.697	M	1.85	0.245	T	-2.28	0.508	N	0.036	0.016	-1.040	0.172	T	0.079	0.313	T	.	.	.	1.002	0.190	10.67	0.970	0.314	0.001	0.007	N	c	-0.614	-0.905	0.000	0.052	0.554	0.246	0	-1.05	0.095	-1.640	0.021	-0.440	0.057	0.000	0.063	0.000	0.016	5.104	0.140	.	.	.	0.5	123	114	15	74368297	chr15:74368297	C	G	123	PASS	DP=114;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
15	75221479	75221480	TA	-	exonic	COX5A	.	frameshift deletion	COX5A:NM_004255:exon2:c.194_195del:p.I65Rfs*6	0.324238693	0.61012662	0.065634687	.	0.12532	0.28848	-0.163345027	41.24793583	8.88764	0.32735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	42	15	75221478	chr15:75221478	CTA	C	56	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	75649171	75649171	C	T	exonic	MAN2C1	.	nonsynonymous SNV	MAN2C1:NM_001256496:exon20:c.G2323A:p.G775S,MAN2C1:NM_001256494:exon22:c.G2671A:p.G891S,MAN2C1:NM_001256495:exon22:c.G2620A:p.G874S,MAN2C1:NM_006715:exon22:c.G2620A:p.G874S	2.94E-25	0.000435876	0.999564124	.	0.25399	0.26675	-0.095604385	46.20783204	574.28122	4.86436	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	3.83	0.957	H	-3.04	0.924	D	-5.38	0.849	D	0.66	0.975	1.026	0.977	D	0.913	0.971	D	0.546	0.958	D	6.534	0.900	31	0.998	0.919	0.978	0.769	D	c	0.714	0.549	1.000	0.747	0.707	0.730	0	4.17	0.481	5.910	0.695	0.934	0.450	1.000	0.715	0.336	0.243	12.617	0.558	Galactose mutarotase-like domain|Glycosyl hydrolase family 38, C-terminal;Glycoside hydrolase 38/57, N-terminal domain	.	.	0.5	.	117	15	75649171	chr15:75649171	C	T	.	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	75651720	75651720	G	-	exonic	MAN2C1	.	frameshift deletion	MAN2C1:NM_001256496:exon15:c.1698delC:p.T567Pfs*13,MAN2C1:NM_001256494:exon17:c.2008delC:p.H670Tfs*34,MAN2C1:NM_001256495:exon17:c.1995delC:p.T666Pfs*13,MAN2C1:NM_006715:exon17:c.1995delC:p.T666Pfs*13	2.94E-25	0.000435876	0.999564124	.	0.25399	0.26675	-0.095604385	46.20783204	574.28122	4.86436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	251	15	75651719	chr15:75651719	TG	T	53	PASS	DP=251;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	75981256	75981256	G	T	exonic	CSPG4	.	nonsynonymous SNV	CSPG4:NM_001897:exon3:c.C2150A:p.A717E	8.90E-05	0.999905547	5.48E-06	.	0.14288	0.14191	0.347031518	73.79098844	3644.03559	11.72399	0.417	0.099	T	0.808	0.433	P	0.274	0.383	B	0.433	0.127	N	1	0.090	N	2.6	0.763	M	1.79	0.255	T	-0.4	0.138	N	0.377	0.437	-1.081	0.072	T	0.051	0.217	T	0.010	0.255	T	-0.941	0.034	0.021	0.756	0.108	0.778	0.380	D	c	-0.083	-0.098	0.992	0.328	0.598	0.340	0	4.56	0.555	4.615	0.607	0.970	0.593	0.998	0.411	0.049	0.163	10.038	0.411	.	.	.	0.5	.	190	15	75981256	chr15:75981256	G	T	.	PASS	DP=190;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	76074518	76074518	T	G	intergenic	MIR4313;UBE2Q2	dist=19862;dist=61109	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	59	15	76074518	chr15:76074518	T	G	113	PASS	DP=59;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	76463300	76463300	G	T	intronic	TMEM266	.	.	.	.	.	.	.	0.25737	.	0.20030965	67.3566879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	86	15	76463300	chr15:76463300	G	T	.	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	78207569	78207569	G	A	ncRNA_exonic	LOC645752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	149	15	78207569	chr15:78207569	G	A	.	PASS	DP=149;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
15	78397503	78397503	-	T	UTR3	CIB2	NM_001301224:c.*149_*150insA;NM_001271889:c.*149_*150insA;NM_001271888:c.*149_*150insA;NM_006383:c.*149_*150insA	.	.	0.000468493	0.667683033	0.331848474	DISEASE: Usher syndrome 1J (USH1J) [MIM:614869]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:23023331}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40943	0.13588	-0.293801652	32.93819297	57.97419	1.53939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	178	15	78397503	chr15:78397503	G	GT	108	PASS	DP=178;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	79025018	79025018	C	A	intergenic	CHRNB4;LOC646938	dist=91431;dist=19361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	200	15	79025018	chr15:79025018	C	A	.	PASS	DP=200;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	80430026	80430026	-	T	UTR3	ZFAND6	NM_001242918:c.*56_*57insT;NM_001242917:c.*56_*57insT;NM_001242912:c.*56_*57insT;NM_001242911:c.*56_*57insT;NM_019006:c.*56_*57insT;NM_001242913:c.*56_*57insT;NM_001242914:c.*56_*57insT;NM_001242916:c.*56_*57insT;NM_001242915:c.*56_*57insT;NM_001242919:c.*56_*57insT	.	.	0.218468573	0.743621706	0.037909721	.	0.59679	0.11302	0.058937498	58.26256192	29.26317	0.93658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	169	15	80430026	chr15:80430026	G	GT	61	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	81627146	81627146	G	T	exonic	TMC3	.	nonsynonymous SNV	TMC3:NM_001080532:exon21:c.C2374A:p.P792T	9.78E-16	0.396541992	0.603458008	.	0.05595	0.12437	1.478915028	95.29370134	1882.26477	7.98006	0.109	0.295	T	0.001	0.067	B	0.002	0.063	B	0.738	0.098	N	1	0.090	N	1.19	0.302	L	-0.22	0.665	T	-2.89	0.606	D	0.059	0.043	-0.982	0.346	T	0.120	0.419	T	0.026	0.487	D	-0.170	0.078	1.266	0.935	0.228	0.098	0.153	N	c	-0.895	-0.938	1.000	0.480	0.497	0.185	0	-1.64	0.078	0.717	0.253	0.143	0.228	0.282	0.249	0.008	0.104	1.798	0.029	.	.	.	0.5	93	291	15	81627146	chr15:81627146	G	T	93	PASS	DP=291;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
15	83658674	83658674	G	-	exonic	FAM103A1	.	frameshift deletion	FAM103A1:NM_031452:exon4:c.212delG:p.W73Gfs*53	0.828445215	0.167913869	0.003640916	.	0.0914	0.10748	0.25917371	70.05779665	177.4953	2.89591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	56	15	83658673	chr15:83658673	TG	T	93	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	89416087	89416087	A	T	intronic	ACAN	.	.	.	0.999993945	6.06E-06	1.71E-15	DISEASE: Spondyloepiphyseal dysplasia type Kimberley (SEDK) [MIM:608361]: Spondyloepiphyseal dysplasias are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. The autosomal dominant SEDK is associated with premature degenerative arthropathy. {ECO:0000269|PubMed:16080123}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondyloepimetaphyseal dysplasia aggrecan type (SEMD- ACAN) [MIM:612813]: A bone disease characterized by severe short stature, macrocephaly, severe midface hypoplasia, short neck, barrel chest and brachydactyly. The radiological findings comprise long bones with generalized irregular epiphyses with widened metaphyses, especially at the knees, platyspondyly, and multiple cervical-vertebral clefts. {ECO:0000269|PubMed:19110214}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteochondritis dissecans short stature and early-onset osteoarthritis (OD) [MIM:165800]: A type of osteochondritis defined as a separation of cartilage and subchondral bone from the surrounding tissue, primarily affecting the knee, ankle and elbow joints. It is clinically characterized by multiple osteochondritic lesions in knees and/or hips and/or elbows, disproportionate short stature and early-onset osteoarthritis. {ECO:0000269|PubMed:20137779}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3407	0.5702	1.284310712	93.77211607	15528.89086	26.89264	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	15	89416087	chr15:89416087	A	T	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
15	89421327	89421327	A	G	exonic	HAPLN3	.	synonymous SNV	HAPLN3:NM_178232:exon5:c.T957C:p.G319G,HAPLN3:NM_001307952:exon6:c.T1143C:p.G381G	3.92E-06	0.370376544	0.629619539	.	0.1436	0.10628	-0.354480518	29.42911064	4444.58352	13.35637	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	178	155	15	89421327	chr15:89421327	A	G	178	PASS	DP=155;AN=2	GT	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	89876718	89876718	G	C	exonic	POLG	.	nonsynonymous SNV	POLG:NM_001126131:exon2:c.C268G:p.Q90E,POLG:NM_002693:exon2:c.C268G:p.Q90E	4.12E-05	0.99995541	3.35E-06	DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 1 (PEOA1) [MIM:157640]: A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. {ECO:0000269|PubMed:12210792, ECO:0000269|PubMed:15351195, ECO:0000269|PubMed:15534189, ECO:0000269|PubMed:17420318, ECO:0000269|PubMed:18575922}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive, 1 (PEOB1) [MIM:258450]: A severe form of progressive external ophthalmoplegia, a disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. It is clinically more heterogeneous than the autosomal dominant forms. {ECO:0000269|PubMed:11431686, ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:12707443, ECO:0000269|PubMed:12872260, ECO:0000269|PubMed:12975295, ECO:0000269|PubMed:14635118, ECO:0000269|PubMed:15349879, ECO:0000269|PubMed:15351195, ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15917273, ECO:0000269|PubMed:16401742, ECO:0000269|PubMed:16621917, ECO:0000269|PubMed:16634032, ECO:0000269|PubMed:16639411}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]: A systemic disorder resulting from mitochondrial dysfunction associated with mitochondrial depletion in skeletal muscle and peripheral nerve tissue. The clinical triad of symptoms consists of sensory ataxic neuropathy, dysarthria, and ophthalmoparesis. However, the phenotype varies widely, even within the same family, and can also include myopathy, seizures, and hearing loss. An atypical form of the disease is characterized by headaches and/or seizures manifesting in childhood or adolescence, followed by development of cerebellar and sensory ataxia, dysarthria, progressive external ophthalmoplegia, and myoclonus in early adulthood. {ECO:0000269|PubMed:12565911, ECO:0000269|PubMed:14745080, ECO:0000269|PubMed:15477547, ECO:0000269|PubMed:15824347, ECO:0000269|PubMed:15917273, ECO:0000269|PubMed:16080118, ECO:0000269|PubMed:16621917, ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:16919951}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mitochondrial DNA depletion syndrome 4A (MTDPS4A) [MIM:203700]: An autosomal recessive hepatocerebral syndrome due to mitochondrial dysfunction. The typical course of the disease includes severe developmental delay, intractable seizures, liver failure, and death in childhood. Refractory seizures, cortical blindness, progressive liver dysfunction, and acute liver failure after exposure to valproic acid are considered diagnostic features. The neuropathological hallmarks are neuronal loss, spongiform degeneration, and astrocytosis of the visual cortex. Liver biopsy results show steatosis, often progressing to cirrhosis. {ECO:0000269|PubMed:15122711, ECO:0000269|PubMed:15689359, ECO:0000269|PubMed:15929042, ECO:0000269|PubMed:16621917, ECO:0000269|PubMed:16639411, ECO:0000269|PubMed:18828154}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mitochondrial DNA depletion syndrome 4B (MTDPS4B) [MIM:613662]: An autosomal recessive progressive multisystem disorder due to mitochondrial dysfunction. It is clinically characterized by chronic gastrointestinal dysmotility and pseudo- obstruction, cachexia, progressive external ophthalmoplegia, axonal sensory ataxic neuropathy, and muscle weakness. {ECO:0000269|PubMed:12825077, ECO:0000269|PubMed:19307547}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:18828154}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23758	0.34185	-0.031281682	50.5779665	540.1607	4.73561	1.0	0.010	T	0.0	0.026	B	0.001	0.040	B	0.927	0.075	N	0.997	0.229	N	0.77	0.194	N	-3.9	0.960	D	-0.47	0.152	N	0.055	0.037	-0.333	0.741	T	0.617	0.865	D	0.092	0.759	D	-0.940	0.034	0.021	0.884	0.174	0.343	0.248	N	c	-0.916	-0.831	1.000	0.747	0.840	1.000	0	1.39	0.212	0.414	0.207	-0.730	0.036	0.150	0.234	0.805	0.338	2.669	0.047	.	.	.	0.5	42	36	15	89876718	chr15:89876718	G	C	42	PASS	DP=36;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	90838939	90838939	G	A	intergenic	NGRN;GABARAPL3	dist=23496;dist=50824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	73	15	90838939	chr15:90838939	G	A	.	PASS	DP=73;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	91185111	91185111	G	C	ncRNA_intronic	CRTC3-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	435	15	91185111	chr15:91185111	G	C	76	PASS	DP=435;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
15	91527977	91527977	C	T	exonic	PRC1	.	synonymous SNV	PRC1:NM_001267580:exon2:c.G90A:p.G30G,PRC1:NM_003981:exon2:c.G90A:p.G30G,PRC1:NM_199413:exon2:c.G90A:p.G30G	0.01597584	0.984015149	9.01E-06	.	0.68082	0.15466	-0.200157416	39.11299835	294.41154	3.66477	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	15	91527977	chr15:91527977	C	T	.	PASS	DP=26;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	98516888	98516888	T	C	UTR3	ARRDC4	NM_183376:c.*2471T>C	.	.	0.000815443	0.931074843	0.068109713	.	0.61153	0.10975	0.463046108	78.58575136	4696.45685	13.81768	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	102	15	98516888	chr15:98516888	T	C	113	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
15	99504134	99504134	-	C	UTR3	IGF1R	NM_001291858:c.*3463_*3464insC;NM_000875:c.*3463_*3464insC	.	.	0.55297426	0.4470257	4.02E-08	DISEASE: Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450]: A disorder characterized by intrauterine growth retardation, poor postnatal growth and increased plasma IGF1 levels. {ECO:0000269|PubMed:14657428, ECO:0000269|PubMed:15928254}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99531	0.86203	-1.71613166	2.494692144	156.15124	2.73123	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	570	15	99504134	chr15:99504134	G	GC	100	PASS	DP=570;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
15	101562089	101562089	G	A	exonic	LRRK1	.	synonymous SNV	LRRK1:NM_024652:exon14:c.G1779A:p.Q593Q	1.59E-05	0.999984068	2.20E-08	.	0.13723	0.10871	-1.611828042	2.972399151	4789.19708	14.03707	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	15	101562089	chr15:101562089	G	A	.	PASS	DP=26;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
15	102185369	102185369	A	-	intronic	TM2D3	.	.	.	0.000338995	0.597218902	0.402442103	.	0.1174	0.11255	0.350995466	74.37485256	80.9731	1.90334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	101	15	102185368	chr15:102185368	TA	T,TAA	62	PASS	DP=101;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	102185369	102185369	-	A	intronic	TM2D3	.	.	.	0.000338995	0.597218902	0.402442103	.	0.1174	0.11255	0.350995466	74.37485256	80.9731	1.90334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	101	15	102185368	chr15:102185368	TA	T,TAA	62	PASS	DP=101;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
15	102516373	102516373	C	T	ncRNA_exonic	WASH3P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	171	1076	15	102516373	chr15:102516373	C	T	171	PASS	DP=1076;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	74287	74287	C	G	ncRNA_exonic	WASIR2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	771	16	74287	chr16:74287	C	G	124	PASS	DP=771;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	628970	628970	C	T	intronic	PIGQ	.	.	.	3.39E-10	0.16521487	0.83478513	.	0.12183	0.14652	0.07895234	59.21207832	128.11911	2.46745	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	16	628970	chr16:628970	C	T	.	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	697898	697898	C	T	intronic	MCRIP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	16	697898	chr16:697898	C	T	.	PASS	DP=48;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	705131	705131	T	-	exonic	WDR90	.	frameshift deletion	WDR90:NM_145294:exon14:c.1540delT:p.F515Lfs*30	4.02E-46	1.08E-08	0.999999989	.	0.12488	.	0.973706547	90.28072659	5541.15698	15.39276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	782	16	705130	chr16:705130	CT	C	69	PASS	DP=782;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	0/1
16	1036706	1036706	A	C	UTR3	SOX8	NM_014587:c.*1320A>C	.	.	0.87370846	0.124658748	0.001632792	.	0.14736	.	.	.	35.61411	1.0723	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	16	1036706	chr16:1036706	A	C	.	PASS	DP=42;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	1379810	1379810	-	A	intergenic	UBE2I;BAIAP3	dist=2791;dist=3796	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	208	16	1379810	chr16:1379810	G	GA	94	PASS	DP=208;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	1382899	1382899	-	A	upstream	BAIAP3	dist=707	.	.	2.21E-19	0.088488031	0.911511969	.	0.29593	0.09988	-2.150176731	1.468506723	719.07294	5.32413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	860	16	1382898	chr16:1382898	GA	GAA,G	72	PASS	DP=860;AN=6	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/2	0/1
16	1382899	1382899	A	-	upstream	BAIAP3	dist=707	.	.	2.21E-19	0.088488031	0.911511969	.	0.29593	0.09988	-2.150176731	1.468506723	719.07294	5.32413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	860	16	1382898	chr16:1382898	GA	GAA,G	72	PASS	DP=860;AN=6	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/2	0/1
16	1402200	1402200	G	T	intronic	GNPTG	.	.	.	6.00E-08	0.243287932	0.756712008	DISEASE: Mucolipidosis type III complementation group C (MLIIIC) [MIM:252605]: Autosomal recessive disease of lysosomal hydrolase trafficking. Unlike the related diseases, mucolipidosis II and IIIA, the enzyme affected in mucolipidosis IIIC (GlcNAc- phosphotransferase) retains full transferase activity on synthetic substrates but lacks activity on lysosomal hydrolases. Typical clinical findings include stiffness of the hands and shoulders, claw-hand deformity, scoliosis, short stature, coarse facies, and mild mental retardation. Radiographically, severe dysostosis multiplex of the hip is characteristic and frequently disabling. The clinical diagnosis can be confirmed by finding elevated serum lysosomal enzyme levels and/or decreased lysosomal enzyme levels in cultured fibroblasts. {ECO:0000269|PubMed:10712439, ECO:0000269|PubMed:15532026, ECO:0000269|PubMed:24316125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in GNPTG have been suggested to play a role in susceptibility to persistent stuttering. Stuttering is a common speech disorder characterized by repetitions, prolongations, and interruptions in the flow of speech. {ECO:0000269|PubMed:20147709}.; 	0.11006	0.14352	-0.334253673	30.70299599	52.40877	1.43216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	265	16	1402200	chr16:1402200	G	T	124	PASS	DP=265;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	1435440	1435440	C	T	intronic	UNKL	.	.	.	0.098857019	0.86639236	0.034750621	.	0.24267	.	.	.	179.13605	2.9076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	1026	16	1435440	chr16:1435440	C	T	84	PASS	DP=1026;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	1716121	1716121	C	G	exonic	CRAMP1	.	nonsynonymous SNV	CRAMP1:NM_020825:exon14:c.C2800G:p.L934V	.	.	.	.	0.14109	0.7741	-1.256630467	5.343241331	.	.	0.549	0.066	T	0.001	0.067	B	0.006	0.112	B	0.073	0.214	N	0.996	0.243	N	1.01	0.254	L	.	.	.	-0.28	0.116	N	0.065	0.051	-1.010	0.269	T	0.045	0.194	T	0.001	0.010	T	1.086	0.198	11.14	0.970	0.314	0.674	0.332	D	c	-0.606	-0.402	0.063	0.153	0.707	0.730	0	2.11	0.262	0.557	0.230	0.848	0.348	0.862	0.304	0.999	0.750	10.344	0.429	.	.	.	0.5	127	1503	16	1716121	chr16:1716121	C	G	127	PASS	DP=1503;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	1808124	1808190	CTCTGTGCGTCGCTGGACTCGCCAGGGGAGTTCTCAGGTGAGTATCTCACTCTCCTGTCTGTCTCCC	-	exonic	MAPK8IP3	.	nonframeshift deletion	MAPK8IP3:NM_001318852:exon9:c.1217_1228del:p.G406_S409del,MAPK8IP3:NM_015133:exon9:c.1214_1225del:p.G405_S408del	0.999999971	2.91E-08	9.42E-20	.	0.31764	0.18911	-2.649793416	0.766690257	619.3755	5.02096	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	24.15	20	16	1808123	chr16:1808123	TCTCTGTGCGTCGCTGGACTCGCCAGGGGAGTTCTCAGGTGAGTATCTCACTCTCCTGTCTGTCTCCC	T	24.15	PASS	DP=20;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	1813737	1813737	G	A	exonic	MAPK8IP3	.	nonsynonymous SNV	MAPK8IP3:NM_001040439:exon16:c.G1957A:p.G653S,MAPK8IP3:NM_001318852:exon17:c.G1978A:p.G660S,MAPK8IP3:NM_015133:exon17:c.G1975A:p.G659S	0.999999971	2.91E-08	9.42E-20	.	0.31764	0.18911	-2.649793416	0.766690257	619.3755	5.02096	0.041	0.419	D	0.999	0.899	D	0.899	0.916	P	0.000	0.629	D	1	0.810	D	2.725	0.800	M	0.77	0.496	T	-5.19	0.836	D	0.538	0.576	-0.361	0.732	T	0.313	0.683	T	0.530	0.956	D	4.995	0.672	25.1	0.998	0.875	0.982	0.799	D	c	0.665	0.586	1.0	0.983	0.840	1.000	0	4.82	0.615	9.852	0.984	0.898	0.412	1.000	0.715	0.901	0.381	17.511	0.876	.	.	.	0.5	97	118	16	1813737	chr16:1813737	G	A	97	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	1821328	1821328	G	A	exonic	NME3	.	nonsynonymous SNV	NME3:NM_002513:exon2:c.C130T:p.R44C	2.37E-06	0.086504203	0.913493423	.	0.27797	0.18492	.	.	94.46567	2.09186	0.019	0.501	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.56	0.992	H	0.31	0.586	T	-7.42	0.948	D	0.763	0.780	0.057	0.834	D	0.454	0.787	T	0.762	0.981	D	6.809	0.925	32	0.995	0.663	0.927	0.560	D	c	0.741	0.609	1.000	0.747	0.767	0.994	0	3.61	0.403	6.192	0.718	0.881	0.386	1.000	0.715	0.998	0.697	11.253	0.481	.	.	.	0.5	.	55	16	1821328	chr16:1821328	G	A	.	PASS	DP=55;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	2028523	2028523	C	-	intronic	TBL3	.	.	.	1.54E-06	0.998145068	0.001853396	.	0.16182	0.11544	-0.338129542	30.07784855	1241.80468	6.65189	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	539	16	2028522	chr16:2028522	AC	A	80	PASS	DP=539;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	2030628	2030628	C	T	intronic	NOXO1	.	.	.	3.17E-11	0.011808231	0.988191769	.	0.0626	0.1393	0.240763792	69.36777542	563.1205	4.81832	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	743	16	2030628	chr16:2030628	C	T	76	PASS	DP=743;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	2235420	2235420	A	C	intronic	CASKIN1	.	.	.	0.999956295	4.37E-05	1.04E-12	.	0.23556	0.11347	.	.	504.89212	4.61185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	476	16	2235420	chr16:2235420	A	C	.	PASS	DP=476;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	2348569	2348569	C	A	intronic	ABCA3	.	.	.	7.48E-08	0.999990122	9.80E-06	DISEASE: Pulmonary surfactant metabolism dysfunction 3 (SMDP3) [MIM:610921]: A rare lung disorder due to impaired surfactant homeostasis. It is characterized by alveolar filling with floccular material that stains positive using the periodic acid- Schiff method and is derived from surfactant phospholipids and protein components. Excessive lipoproteins accumulation in the alveoli results in severe respiratory distress. {ECO:0000269|PubMed:15044640}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13416	0.16987	-1.477690451	3.709601321	188.10316	2.97844	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	16	2348569	chr16:2348569	C	A	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	2653674	2653674	G	A	ncRNA_exonic	LOC652276	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	1228	16	2653674	chr16:2653674	G	A	94	PASS	DP=1228;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	2837452	2837452	T	C	upstream	PRSS33	dist=744	.	.	0.000160244	0.439783392	0.560056365	.	0.05419	.	.	.	451.00798	4.41353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	505	16	2837452	chr16:2837452	T	C	147	PASS	DP=505;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	2837462	2837462	C	T	upstream	PRSS33	dist=754	.	.	0.000160244	0.439783392	0.560056365	.	0.05419	.	.	.	451.00798	4.41353	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	233	16	2837462	chr16:2837462	C	T	119	PASS	DP=233;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	4013844	4013844	A	-	UTR3	ADCY9	NM_001116:c.*1932delT	.	.	0.974310442	0.025689508	4.99E-08	.	0.1617	0.17928	-1.780505741	2.282377919	630.16158	5.05923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	167	16	4013843	chr16:4013843	GA	G	99	PASS	DP=167;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	5037498	5037498	-	G	intronic	SEC14L5	.	.	.	6.57E-10	0.408296631	0.591703368	.	0.15183	.	-1.703090605	2.535975466	83.7768	1.94866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	64	16	5037498	chr16:5037498	T	TG	99	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	5040768	5040768	G	T	exonic	SEC14L5	.	nonsynonymous SNV	SEC14L5:NM_014692:exon5:c.G346T:p.V116F	6.57E-10	0.408296631	0.591703368	.	0.15183	.	-1.703090605	2.535975466	83.7768	1.94866	0.001	0.784	D	1.0	0.899	D	0.997	0.850	D	0.000	0.537	D	1	0.810	D	2.79	0.817	M	2.21	0.184	T	-4.03	0.743	D	0.729	0.728	-0.781	0.563	T	0.148	0.475	T	0.058	0.674	D	6.411	0.885	29.7	0.996	0.712	0.984	0.824	D	c	0.865	0.784	1.000	0.747	0.615	0.372	0	4.37	0.517	9.492	0.969	1.048	0.713	1.000	0.715	0.953	0.430	17.101	0.865	PRELI/MSF1 domain	.	.	0.5	.	50	16	5040768	chr16:5040768	G	T	.	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	9856337	9856337	C	A	UTR3	GRIN2A	NM_001134408:c.*875G>T;NM_001134407:c.*669G>T;NM_000833:c.*669G>T	.	.	0.998044808	0.001955191	4.49E-10	DISEASE: Epilepsy, focal, with speech disorder and with or without mental retardation (FESD) [MIM:245570]: A highly variable neurologic disorder with features ranging from severe early-onset seizures associated with delayed psychomotor development, persistent speech difficulties, and mental retardation to a more benign entity characterized by childhood onset of mild or asymptomatic seizures associated with transient speech difficulties followed by remission of seizures in adolescence and normal psychomotor development. The disorder encompasses several clinical entities, including Landau-Kleffner syndrome, epileptic encephalopathy with continuous spike and wave during slow-wave sleep, autosomal dominant rolandic epilepsy, mental retardation and speech dyspraxia, and benign epilepsy with centrotemporal spikes. {ECO:0000269|PubMed:20890276, ECO:0000269|PubMed:23033978, ECO:0000269|PubMed:23933818, ECO:0000269|PubMed:23933819, ECO:0000269|PubMed:23933820, ECO:0000269|PubMed:24504326, ECO:0000269|PubMed:24903190}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving GRIN2A has been found in a family with epilepsy and neurodevelopmental defects. Translocation t(16;17)(p13.2;q11.2).; DISEASE: Note=GRIN2A somatic mutations have been frequently found in cutaneous malignant melanoma, suggesting that the glutamate signaling pathway may play a role in the pathogenesis of melanoma. {ECO:0000269|PubMed:21499247, ECO:0000269|PubMed:24455489}.; 	0.37855	0.47307	-1.455091209	3.886529842	119.73741	2.38246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	16	9856337	chr16:9856337	C	A	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	11121098	11121098	A	T	intronic	CLEC16A	.	.	.	0.010138957	0.989843481	1.76E-05	.	0.33524	0.17783	-1.010461444	8.197688134	250.55243	3.41106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	69	16	11121098	chr16:11121098	A	T	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	14863935	14863935	G	-	intergenic	NPIPA3;ABCC6P2	dist=4620;dist=52354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	1630	16	14863934	chr16:14863934	TG	T	93	PASS	DP=1630;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	14976507	14976507	G	T	exonic	NOMO1	.	synonymous SNV	NOMO1:NM_014287:exon26:c.G3084T:p.R1028R	.	.	.	.	.	0.1005	.	.	534.93703	4.71517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	1099	16	14976507	chr16:14976507	G	T	133	PASS	DP=1099;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	15159105	15159105	G	-	exonic	RRN3	.	frameshift deletion	RRN3:NM_001301064:exon15:c.1587delC:p.F530Sfs*7,RRN3:NM_018427:exon16:c.1677delC:p.F560Sfs*7	0.00047458	0.998071537	0.001453883	.	0.09916	0.13442	0.378498378	75.58386412	586.40473	4.91226	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.76	55	16	15159104	chr16:15159104	AG	A	21.76	PASS	DP=55;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	15474951	15474951	C	T	intergenic	NPIPA5;MPV17L	dist=2800;dist=14660	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	215	16	15474951	chr16:15474951	C	T	88	PASS	DP=215;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	15474958	15474958	-	A	intergenic	NPIPA5;MPV17L	dist=2807;dist=14653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	314	16	15474957	chr16:15474957	TA	TAA,T	70	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	15474958	15474958	A	-	intergenic	NPIPA5;MPV17L	dist=2807;dist=14653	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	314	16	15474957	chr16:15474957	TA	TAA,T	70	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	16281079	16281079	C	A	intronic	ABCC6	.	.	.	1.45E-06	0.99998186	1.67E-05	DISEASE: Pseudoxanthoma elasticum (PXE) [MIM:264800]: A multisystem disorder characterized by accumulation of mineralized and fragmented elastic fibers in the skin, vascular walls, and Burch membrane in the eye. Clinically, patients exhibit characteristic lesions of the posterior segment of the eye including peau d'orange, angioid streaks, and choroidal neovascularizations, of the skin including soft, ivory colored papules in a reticular pattern that predominantly affect the neck and large flexor surfaces, and of the cardiovascular system with peripheral and coronary arterial occlusive disease as well as gastrointestinal bleedings. {ECO:0000269|PubMed:10811882, ECO:0000269|PubMed:10835642, ECO:0000269|PubMed:10954200, ECO:0000269|PubMed:11427982, ECO:0000269|PubMed:11536079, ECO:0000269|PubMed:11702217, ECO:0000269|PubMed:15086542, ECO:0000269|PubMed:15098239, ECO:0000269|PubMed:15459974, ECO:0000269|PubMed:16086317, ECO:0000269|PubMed:17617515, ECO:0000269|PubMed:19339160, ECO:0000269|PubMed:20034067, ECO:0000269|PubMed:25615550}. Note=The disease is caused by mutations affecting the gene represented in this entry. Homozygous or compound heterozygous ABCC6 mutations have been found in the overwhelming majority of cases. Individuals carrying heterozygous mutations express limited manifestations of the pseudoxanthoma elasticum phenotype.; DISEASE: Arterial calcification of infancy, generalized, 2 (GACI2) [MIM:614473]: A severe autosomal recessive disorder characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation. The disorder is often fatal within the first 6 months of life because of myocardial ischemia resulting in refractory heart failure. {ECO:0000269|PubMed:22209248}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1251	.	0.626356326	83.53974994	2678.20897	9.73052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	84	16	16281079	chr16:16281079	C	A	.	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	16457549	16457549	C	T	ncRNA_intronic	PKD1P4-NPIPA8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	136	16	16457549	chr16:16457549	C	T	.	PASS	DP=136;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	18437726	18437726	C	A	ncRNA_exonic	LOC100288162;PKD1P4-NPIPA8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	351	16	18437726	chr16:18437726	C	A	.	PASS	DP=351;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	18482153	18482153	G	T	ncRNA_exonic	PKD1P5-LOC105376752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	599	16	18482153	chr16:18482153	G	T	120	PASS	DP=599;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	18820575	18820575	G	A	UTR3	SMG1	NM_015092:c.*316C>T	.	.	1	4.40E-14	1.05E-36	.	.	.	-2.975494782	0.542580797	910.18577	5.86659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	201	16	18820575	chr16:18820575	G	A	74	PASS	DP=201;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	18869474	18869474	-	A	intronic	SMG1	.	.	.	1	4.40E-14	1.05E-36	.	.	.	-2.975494782	0.542580797	910.18577	5.86659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	468	16	18869474	chr16:18869474	G	GA	60	PASS	DP=468;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	18872151	18872151	-	A	intronic	SMG1	.	.	.	1	4.40E-14	1.05E-36	.	.	.	-2.975494782	0.542580797	910.18577	5.86659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	376	16	18872151	chr16:18872151	T	TA	102	PASS	DP=376;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	19080213	19080213	-	A	intronic	COQ7	.	.	.	4.68E-05	0.416968957	0.582984257	.	0.15929	0.14294	-0.115612493	45.12856806	146.5872	2.6373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	713	16	19080213	chr16:19080213	T	TA	101	PASS	DP=713;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/1
16	21823156	21823156	A	G	ncRNA_exonic	RRN3P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	35	16	21823156	chr16:21823156	A	G	80	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	22574742	22574742	G	T	ncRNA_intronic	LOC653786	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	396	16	22574742	chr16:22574742	G	T	125	PASS	DP=396;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	22574745	22574745	C	T	ncRNA_intronic	LOC653786	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	402	16	22574745	chr16:22574745	C	T	123	PASS	DP=402;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	23702685	23702685	G	T	exonic	ERN2	.	nonsynonymous SNV	ERN2:NM_001308220:exon19:c.C2282A:p.A761E,ERN2:NM_033266:exon20:c.C2438A:p.A813E	1.79E-15	0.517166148	0.482833852	.	0.37292	0.11979	-1.697674421	2.583156405	1512.87602	7.22771	0.991	0.030	T	0.002	0.349	B	0.012	0.360	B	0.001	0.403	N	0.540	0.314	N	1.595	0.408	L	1.58	0.291	T	-0.93	0.249	N	0.264	0.321	-1.057	0.126	T	0.046	0.199	T	0.010	0.263	T	1.702	0.266	14.42	0.941	0.237	0.893	0.494	D	c	-0.441	-0.289	1.000	0.747	0.676	0.548	0	4.83	0.617	1.374	0.337	1.048	0.713	0.601	0.275	0.985	0.512	13.880	0.630	KEN domain;KEN domain|PUG domain	.	.	0.5	90	618	16	23702685	chr16:23702685	G	T	90	PASS	DP=618;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	28354353	28354353	T	G	exonic	NPIPB6	.	nonsynonymous SNV	NPIPB6:NM_001282524:exon7:c.A853C:p.T285P	0.636136512	0.335207165	0.028656323	.	.	.	.	.	364.15712	4.03989	1.0	0.010	T	0.001	0.067	B	0.0	0.013	B	.	.	.	1	0.090	P	-2.05	0.002	N	1.83	0.248	T	4.72	0.000	N	0.045	0.025	-1.037	0.182	T	0.011	0.041	T	.	.	.	-3.438	0.000	0.001	0.069	0.000	0.000	0.002	N	c	-2.800	-2.809	0.142	0.173	0.638	0.428	0	.	.	-4.246	0.003	-4.857	0.000	0.001	0.137	0.000	0.016	.	.	.	.	.	0.5	74	38	16	28354353	chr16:28354353	T	G	74	PASS	DP=38;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	28617595	28617595	A	G	intronic	SULT1A1	.	.	.	2.24E-09	0.073319455	0.926680543	.	0.09968	0.40709	-0.156065314	42.16206653	63.72574	1.63669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	74	16	28617595	chr16:28617595	A	G	105	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	28618446	28618446	T	C	intronic	SULT1A1	.	.	.	2.24E-09	0.073319455	0.926680543	.	0.09968	0.40709	-0.156065314	42.16206653	63.72574	1.63669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	100	16	28618446	chr16:28618446	T	C	132	PASS	DP=100;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	28906289	28906289	C	A	intronic	ATP2A1	.	.	.	7.04E-09	0.998563754	0.001436239	DISEASE: Brody myopathy (BRM) [MIM:601003]: A disorder of muscle function that is characterized by painless muscle cramping and exercise-induced impairment of muscle relaxation. {ECO:0000269|PubMed:10914677}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78274	.	-1.392555112	4.269874971	168.67085	2.83491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	54	16	28906289	chr16:28906289	C	A	.	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	29376056	29376056	T	A	ncRNA_exonic	SNX29P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	16	29376056	chr16:29376056	T	A	.	PASS	DP=38;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	29624821	29624821	C	T	ncRNA_exonic	SMG1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	903	16	29624821	chr16:29624821	C	T	110	PASS	DP=903;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	29817529	29817529	C	G	intronic	MAZ	.	.	.	0.953969622	0.045904111	0.000126268	.	0.32161	0.20668	.	.	18.8914	0.6524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	175	16	29817529	chr16:29817529	C	G	58	PASS	DP=175;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	29824634	29824634	C	G	exonic	PRRT2	.	nonsynonymous SNV	PRRT2:NM_001256442:exon2:c.C259G:p.L87V,PRRT2:NM_001256443:exon2:c.C259G:p.L87V,PRRT2:NM_145239:exon2:c.C259G:p.L87V	0.301735693	0.679146035	0.019118272	DISEASE: Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]: An autosomal dominant neurologic condition characterized by recurrent and brief attacks of abnormal involuntary movements, triggered by sudden voluntary movement. These attacks usually have onset during childhood or early adulthood and can involve dystonic postures, chorea, or athetosis. {ECO:0000269|PubMed:22101681, ECO:0000269|PubMed:22120146, ECO:0000269|PubMed:22131361, ECO:0000269|PubMed:22209761}. Note=The disease is caused by mutations affecting the gene represented in this entry. Disease- causing mutations that produce truncation of the C-terminus of the protein alter subcellular location, from plasma membrane to cytosplasm (PubMed:22101681). {ECO:0000269|PubMed:22101681}.; DISEASE: Convulsions, familial infantile, with paroxysmal choreoathetosis (ICCA) [MIM:602066]: A syndrome characterized by clinical features of benign familial infantile seizures and episodic kinesigenic dyskinesia. Benign familial infantile seizures is a disorder characterized by afebrile seizures occurring during the first year of life, without neurologic sequelae. Paroxysmal choreoathetosis is a disorder of involuntary movements characterized by attacks that occur spontaneously or are induced by a variety of stimuli. {ECO:0000269|PubMed:22243967}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Seizures, benign familial infantile 2 (BFIS2) [MIM:605751]: An autosomal dominant disorder in which afebrile seizures occur in clusters during the first year of life, without neurologic sequelae. {ECO:0000269|PubMed:22243967, ECO:0000269|PubMed:22399141, ECO:0000269|PubMed:22623405}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30697	0.08082	0.549415813	81.38122199	216.41438	3.17873	0.038	0.574	D	0.59	0.372	P	0.328	0.402	B	0.522	0.117	N	0.860	0.283	N	1.75	0.456	L	-0.48	0.726	T	-1.36	0.338	N	0.233	0.285	-0.849	0.520	T	0.226	0.590	T	0.040	0.592	D	1.157	0.206	11.52	0.989	0.478	0.213	0.211	N	c	-0.277	-0.215	1.000	0.747	0.767	0.994	0	4.25	0.495	-0.066	0.115	0.935	0.490	0.002	0.151	0.404	0.255	12.335	0.542	.	.	.	0.5	134	570	16	29824634	chr16:29824634	C	G	134	PASS	DP=570;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	29825016	29825016	C	-	exonic	PRRT2	.	frameshift deletion	PRRT2:NM_001256442:exon2:c.641delC:p.R217Efs*11,PRRT2:NM_001256443:exon2:c.641delC:p.R217Efs*11,PRRT2:NM_145239:exon2:c.641delC:p.R217Efs*11	0.301735693	0.679146035	0.019118272	DISEASE: Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]: An autosomal dominant neurologic condition characterized by recurrent and brief attacks of abnormal involuntary movements, triggered by sudden voluntary movement. These attacks usually have onset during childhood or early adulthood and can involve dystonic postures, chorea, or athetosis. {ECO:0000269|PubMed:22101681, ECO:0000269|PubMed:22120146, ECO:0000269|PubMed:22131361, ECO:0000269|PubMed:22209761}. Note=The disease is caused by mutations affecting the gene represented in this entry. Disease- causing mutations that produce truncation of the C-terminus of the protein alter subcellular location, from plasma membrane to cytosplasm (PubMed:22101681). {ECO:0000269|PubMed:22101681}.; DISEASE: Convulsions, familial infantile, with paroxysmal choreoathetosis (ICCA) [MIM:602066]: A syndrome characterized by clinical features of benign familial infantile seizures and episodic kinesigenic dyskinesia. Benign familial infantile seizures is a disorder characterized by afebrile seizures occurring during the first year of life, without neurologic sequelae. Paroxysmal choreoathetosis is a disorder of involuntary movements characterized by attacks that occur spontaneously or are induced by a variety of stimuli. {ECO:0000269|PubMed:22243967}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Seizures, benign familial infantile 2 (BFIS2) [MIM:605751]: An autosomal dominant disorder in which afebrile seizures occur in clusters during the first year of life, without neurologic sequelae. {ECO:0000269|PubMed:22243967, ECO:0000269|PubMed:22399141, ECO:0000269|PubMed:22623405}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30697	0.08082	0.549415813	81.38122199	216.41438	3.17873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	149	16	29825015	chr16:29825015	GC	G	97	PASS	DP=149;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	29855814	29855814	G	C	exonic	MVP	.	nonsynonymous SNV	MVP:NM_001293204:exon10:c.G1635C:p.W545C,MVP:NM_005115:exon11:c.G1635C:p.W545C,MVP:NM_017458:exon11:c.G1635C:p.W545C	0.007448525	0.991880268	0.000671207	.	0.12911	0.21917	-0.813834387	12.05472989	340.52664	3.91613	0.018	0.506	D	1.0	0.899	D	0.992	0.790	D	0.000	0.843	D	1	0.810	D	2.825	0.825	M	0.68	0.520	T	-12.08	0.996	D	0.812	0.910	-0.404	0.719	T	0.341	0.707	T	0.056	0.667	D	6.650	0.912	32	0.991	0.532	0.989	0.890	D	c	0.902	0.876	1.000	0.747	0.732	0.924	0	5.91	0.952	8.171	0.895	1.048	0.713	1.000	0.715	1.000	0.888	17.799	0.884	Shoulder domain	.	.	0.5	101	187	16	29855814	chr16:29855814	G	C	101	PASS	DP=187;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	29889679	29889679	A	G	exonic	SEZ6L2	.	synonymous SNV	SEZ6L2:NM_001114100:exon8:c.T1299C:p.Y433Y,SEZ6L2:NM_001243333:exon9:c.T1509C:p.Y503Y,SEZ6L2:NM_001114099:exon10:c.T1431C:p.Y477Y,SEZ6L2:NM_001243332:exon10:c.T1641C:p.Y547Y,SEZ6L2:NM_012410:exon10:c.T1431C:p.Y477Y,SEZ6L2:NM_201575:exon10:c.T1641C:p.Y547Y	0.13015316	0.869807213	3.96E-05	.	0.53499	0.10324	-1.124330456	6.575843359	637.27687	5.07921	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	195	16	29889679	chr16:29889679	A	G	120	PASS	DP=195;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	29922505	29922505	G	-	intronic	KCTD13	.	.	.	0.791960934	0.206734677	0.00130439	.	0.38266	0.08839	-0.339715008	30.06605331	12.10685	0.43891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	69	16	29922504	chr16:29922504	AG	A	41	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	30007664	30007664	-	A	exonic	INO80E	.	frameshift insertion	INO80E:NM_001304562:exon1:c.34dupA:p.Y15Ifs*50,INO80E:NM_001304563:exon1:c.34dupA:p.Y15Ifs*50,INO80E:NM_173618:exon1:c.34dupA:p.Y15Ifs*50	0.017414685	0.891403715	0.0911816	.	0.18786	0.11011	-0.073340031	48.11866006	41.31906	1.20769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	424	16	30007664	chr16:30007664	C	CA	70	PASS	DP=424;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	30041821	30041821	C	-	exonic	FAM57B	.	frameshift deletion	FAM57B:NM_031478:exon1:c.28delG:p.V10Wfs*111	0.285736246	0.692579589	0.021684165	.	0.32096	.	-0.405853867	26.23260203	517.79767	4.6525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	845	16	30041820	chr16:30041820	AC	A	79	PASS	DP=845;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	31008054	31008054	C	T	exonic	STX1B	.	nonsynonymous SNV	STX1B:NM_052874:exon7:c.G487A:p.E163K	0.944474733	0.05548414	4.11E-05	DISEASE: Generalized epilepsy with febrile seizures plus 9 (GEFSP9) [MIM:616172]: An autosomal dominant neurologic disorder characterized by febrile and/or afebrile seizures manifesting in early childhood. Seizure are variable and include generalized tonic-clonic, atonic, myoclonic, complex partial, and absence types. Most patients have remission of seizures later in childhood with no residual neurologic deficits. Rarely, patients may show mild developmental delay or mild intellectual disabilities. {ECO:0000269|PubMed:25362483}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22761	0.14229	-0.163345027	41.24793583	5.61252	0.20995	0.001	0.784	D	0.613	0.418	P	0.319	0.399	B	0.000	0.629	D	1	0.810	D	2.33	0.670	M	0.28	0.591	T	-3.86	0.726	D	0.923	0.918	-0.219	0.772	T	0.297	0.669	T	0.085	0.745	D	5.918	0.812	27.5	0.999	0.983	0.992	0.920	D	c	0.605	0.609	1.0	0.983	0.789	0.998	0	4.76	0.600	7.867	0.854	0.870	0.379	1.000	0.715	0.995	0.604	16.694	0.851	Syntaxin, N-terminal domain|t-SNARE	.	.	0.5	85	556	16	31008054	chr16:31008054	C	T	85	PASS	DP=556;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	31177199	31177199	G	A	intergenic	PRSS36;FUS	dist=15784;dist=14232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	16	31177199	chr16:31177199	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	31196420	31196420	C	T	exonic	FUS	.	synonymous SNV	FUS:NM_001170634:exon6:c.C681T:p.G227G,FUS:NM_001170937:exon6:c.C672T:p.G224G,FUS:NM_004960:exon6:c.C684T:p.G228G	0.999963786	3.62E-05	3.26E-12	DISEASE: Note=A chromosomal aberration involving FUS is found in a patient with malignant myxoid liposarcoma. Translocation t(12;16)(q13;p11) with DDIT3. {ECO:0000269|PubMed:7503811}.; DISEASE: Note=A chromosomal aberration involving FUS is a cause of acute myeloid leukemia (AML). Translocation t(16;21)(p11;q22) with ERG. {ECO:0000269|PubMed:8187069}.; DISEASE: Angiomatoid fibrous histiocytoma (AFH) [MIM:612160]: A distinct variant of malignant fibrous histiocytoma that typically occurs in children and adolescents and is manifest by nodular subcutaneous growth. Characteristic microscopic features include lobulated sheets of histiocyte-like cells intimately associated with areas of hemorrhage and cystic pseudovascular spaces, as well as a striking cuffing of inflammatory cells, mimicking a lymph node metastasis. {ECO:0000269|PubMed:11063792}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving FUS is found in a patient with angiomatoid fibrous histiocytoma. Translocation t(12;16)(q13;p11.2) with ATF1 generates a chimeric FUS/ATF1 protein. {ECO:0000269|PubMed:11063792}.; DISEASE: Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia (ALS6) [MIM:608030]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. {ECO:0000269|PubMed:19251627, ECO:0000269|PubMed:19251628, ECO:0000269|PubMed:19861302, ECO:0000269|PubMed:20124201}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tremor, hereditary essential 4 (ETM4) [MIM:614782]: A common movement disorder mainly characterized by postural tremor of the arms. Head, legs, trunk, voice, jaw, and facial muscles also may be involved. The condition can be aggravated by emotions, hunger, fatigue and temperature extremes, and may cause a functional disability or even incapacitation. Inheritance is autosomal dominant. {ECO:0000269|PubMed:22863194}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42621	0.49093	-1.001120478	8.321538099	78.86065	1.87589	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	550	16	31196420	chr16:31196420	C	T	.	PASS	DP=550;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	31368547	31368547	C	A	intronic	ITGAX	.	.	.	6.11E-05	0.999936982	1.90E-06	.	0.09861	.	-0.915030414	9.837225761	3879.17486	12.28742	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	88	16	31368547	chr16:31368547	C	A	.	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	32007110	32007110	G	C	intergenic	ZNF267;LOC102723753	dist=78481;dist=156323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	575	16	32007110	chr16:32007110	G	C	.	PASS	DP=575;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	32133768	32133768	G	C	intergenic	ZNF267;LOC102723753	dist=205139;dist=29665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	166	547	16	32133768	chr16:32133768	G	C	166	PASS	DP=547;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	32170666	32170666	T	A	ncRNA_splicing	LOC102723753	NR_135178:exon19:c.3089-2A>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	523	16	32170666	chr16:32170666	T	A	93	PASS	DP=523;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	32859230	32859230	C	A	intergenic	TP53TG3;SLC6A10P	dist=171780;dist=29567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	1286	16	32859230	chr16:32859230	C	A	92	PASS	DP=1286;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	32883398	32883398	C	A	intergenic	TP53TG3;SLC6A10P	dist=195948;dist=5399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	772	16	32883398	chr16:32883398	C	A	92	PASS	DP=772;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	32890992	32890992	G	T	ncRNA_exonic	SLC6A10P	.	.	.	.	.	.	.	0.09544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	297	16	32890992	chr16:32890992	G	T	92	PASS	DP=297;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	32891453	32891453	G	T	ncRNA_intronic	SLC6A10P	.	.	.	.	.	.	.	0.09544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	1710	16	32891453	chr16:32891453	G	T	121	PASS	DP=1710;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	32916782	32916782	G	A	intergenic	SLC6A10P;TP53TG3B	dist=20319;dist=288801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	512	16	32916782	chr16:32916782	G	A	84	PASS	DP=512;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	32928588	32928591	CCGG	-	intergenic	SLC6A10P;TP53TG3B	dist=32125;dist=276992	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	163	691	16	32928587	chr16:32928587	TCCGG	T	163	PASS	DP=691;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	33366720	33366720	A	G	intergenic	LOC390705;ENPP7P13	dist=68018;dist=205124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	159	469	16	33366720	chr16:33366720	A	G	159	PASS	DP=469;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	33402192	33402192	G	T	intergenic	LOC390705;ENPP7P13	dist=103490;dist=169652	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	149	16	33402192	chr16:33402192	G	T	116	PASS	DP=149;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	33539535	33539535	T	C	intergenic	LOC390705;ENPP7P13	dist=240833;dist=32309	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	191	16	33539535	chr16:33539535	T	C	134	PASS	DP=191;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	33752655	33752655	G	T	intergenic	ENPP7P13;LINC00273	dist=165913;dist=208397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	290	16	33752655	chr16:33752655	G	T	.	PASS	DP=290;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	47117444	47117444	G	A	exonic	NETO2	.	synonymous SNV	NETO2:NM_001201477:exon9:c.C1245T:p.Y415Y,NETO2:NM_018092:exon9:c.C1266T:p.Y422Y	0.158399551	0.841464188	0.000136261	.	0.17156	0.11389	-0.404032746	26.53338051	133.98421	2.51752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	183	16	47117444	chr16:47117444	G	A	.	PASS	DP=183;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	47533805	47533805	G	T	exonic	PHKB	.	nonsynonymous SNV	PHKB:NM_000293:exon3:c.G305T:p.R102M,PHKB:NM_001031835:exon4:c.G284T:p.R95M	3.16E-10	0.999792045	0.000207954	DISEASE: Glycogen storage disease 9B (GSD9B) [MIM:261750]: A metabolic disorder characterized by hepatomegaly, only slightly elevated transaminases and plasma lipids, clinical improvement with increasing age, and remarkably no clinical muscle involvement. Biochemical observations suggest that this mild phenotype is caused by an incomplete holoenzyme that lacks the beta subunit, but that may possess residual activity. {ECO:0000269|PubMed:9402963}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.34561	0.21599	0.367380537	74.74050484	834.92029	5.65576	0.029	0.721	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	2.8	0.819	M	-2.88	0.915	D	-4.84	0.824	D	0.465	0.784	0.990	0.970	D	0.887	0.963	D	.	.	.	6.297	0.870	29.1	0.963	0.287	0.993	0.948	D	c	0.894	0.826	1.0	0.983	0.706	0.609	0	4.79	0.608	9.964	0.990	1.048	0.713	1.000	0.715	0.973	0.468	17.891	0.887	Six-hairpin glycosidase-like	.	.	0.5	92	264	16	47533805	chr16:47533805	G	T	92	PASS	DP=264;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	49671746	49671746	C	A	exonic	ZNF423	.	nonsynonymous SNV	ZNF423:NM_001330533:exon2:c.G966T:p.Q322H,ZNF423:NM_001271620:exon4:c.G1137T:p.Q379H,ZNF423:NM_015069:exon4:c.G1317T:p.Q439H	0.990468533	0.00953136	1.06E-07	DISEASE: Nephronophthisis 14 (NPHP14) [MIM:614844]: An autosomal recessive disorder manifesting as infantile-onset kidney disease, cerebellar vermis hypoplasia, and situs inversus. Nephronophthisis is a progressive tubulo-interstitial kidney disorder histologically characterized by modifications of the tubules with thickening of the basement membrane, interstitial fibrosis and, in the advanced stages, medullary cysts. {ECO:0000269|PubMed:22863007}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Joubert syndrome 19 (JBTS19) [MIM:614844]: A form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). JBTS19 patients have polycystic kidney disease, Leber congenital amaurosis, cerebellar vermis hypoplasia, and breathing abnormality. {ECO:0000269|PubMed:22863007}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.57996	0.12164	-2.203192877	1.362349611	308.99952	3.74292	0.029	0.457	D	0.026	0.181	B	0.02	0.179	B	0.000	0.843	D	0.998	0.445	D	0.55	0.145	N	2.91	0.100	T	-1.56	0.377	N	0.373	0.434	-0.970	0.373	T	0.016	0.067	T	0.013	0.326	T	2.081	0.311	16.73	0.984	0.403	0.934	0.580	D	c	-0.114	0.088	1.000	0.517	0.707	0.730	0	5.05	0.674	3.820	0.551	0.852	0.362	1.000	0.715	1.000	0.888	6.563	0.215	.	.	.	0.5	66	303	16	49671746	chr16:49671746	C	A	66	PASS	DP=303;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	50117908	50117908	G	A	exonic	HEATR3	.	nonsynonymous SNV	HEATR3:NM_001329731:exon7:c.G409A:p.E137K,HEATR3:NM_182922:exon8:c.G1102A:p.E368K,HEATR3:NM_001329729:exon9:c.G751A:p.E251K,HEATR3:NM_001329730:exon9:c.G751A:p.E251K	0.000127665	0.990470629	0.009401706	.	0.10176	.	0.110306132	62.00165133	346.43566	3.94743	0.0	0.912	D	1.0	0.899	D	0.984	0.807	D	0.000	0.843	D	1	0.810	D	2.72	0.798	M	1.48	0.317	T	-3.5	0.681	D	0.975	0.976	-0.751	0.579	T	0.222	0.585	T	0.080	0.734	D	7.392	0.950	34	0.999	0.991	0.995	0.968	D	c	0.923	0.923	1.000	0.747	0.732	0.924	0	6.03	0.978	9.140	0.937	1.048	0.713	1.000	0.715	1.000	0.888	20.575	0.994	.	.	.	0.5	.	30	16	50117908	chr16:50117908	G	A	.	PASS	DP=30;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	53934612	53934612	G	C	intronic	FTO	.	.	.	0.011344576	0.986864609	0.001790815	DISEASE: Growth retardation, developmental delay, and facial dysmorphism (GDFD) [MIM:612938]: A severe polymalformation syndrome characterized by postnatal growth retardation, microcephaly, severe psychomotor delay, functional brain deficits and characteristic facial dysmorphism. In some patients, structural brain malformations, cardiac defects, genital anomalies, and cleft palate are observed. Early death occurs by the age of 3 years. {ECO:0000269|PubMed:19559399}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Obesity (OBESITY) [MIM:601665]: A condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat. {ECO:0000269|PubMed:26287746}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A pathogenic intronic FTO variation (rs1421085) disrupts an evolutionarily conserved motif for ARID5B binding. Loss of ARID5B binding results in overexpression of two genes distal to FTO, IRX3 and IRX5. IRX3 and IRX5 overexpression shifts pre-adipocytes differentiation from brown to white fat cells, resulting in increased lipid storage and loss of mitochondrial thermogenesis. {ECO:0000269|PubMed:26287746}.; 	0.42596	0.28005	-0.288341872	33.41589998	98.07425	2.14102	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	110	16	53934612	chr16:53934612	G	C	69	PASS	DP=110;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	54966439	54966439	G	T	exonic	IRX5	.	nonsynonymous SNV	IRX5:NM_001252197:exon2:c.G279T:p.M93I,IRX5:NM_005853:exon2:c.G279T:p.M93I	.	.	.	DISEASE: Hamamy syndrome (HMMS) [MIM:611174]: A syndrome characterized by severe hypertelorism, upslanting palpebral fissures, brachycephaly, abnormal ears, sloping shoulders, enamel hypoplasia, and osteopenia with repeated fractures. Additional features include myopia, mild to moderate sensorineural hearing loss, gonadal anomalies and borderline intelligence. {ECO:0000269|PubMed:22581230}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66381	0.13039	.	.	1652.69996	7.51371	0.154	0.309	T	0.063	0.219	B	0.168	0.335	B	0.000	0.843	D	1	0.810	D	0.82	0.209	L	0.34	0.592	T	-2.07	0.558	N	0.51	0.570	-0.820	0.539	T	0.188	0.540	T	0.019	0.410	T	2.204	0.326	17.54	0.992	0.553	0.895	0.497	D	c	0.119	0.267	1.000	0.747	0.598	0.340	0	4.68	0.582	6.624	0.739	0.953	0.551	1.000	0.715	0.994	0.587	16.332	0.828	.	.	.	0.5	99	241	16	54966439	chr16:54966439	G	T	99	PASS	DP=241;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	54967692	54967692	G	C	exonic	IRX5	.	nonsynonymous SNV	IRX5:NM_001252197:exon3:c.G1356C:p.L452F,IRX5:NM_005853:exon3:c.G1359C:p.L453F	.	.	.	DISEASE: Hamamy syndrome (HMMS) [MIM:611174]: A syndrome characterized by severe hypertelorism, upslanting palpebral fissures, brachycephaly, abnormal ears, sloping shoulders, enamel hypoplasia, and osteopenia with repeated fractures. Additional features include myopia, mild to moderate sensorineural hearing loss, gonadal anomalies and borderline intelligence. {ECO:0000269|PubMed:22581230}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66381	0.13039	.	.	1652.69996	7.51371	0.045	0.912	D	0.998	0.715	D	0.996	0.832	D	0.001	0.434	D	1	0.810	D	1.04	0.263	L	0.15	0.608	T	-1.07	0.475	N	0.369	0.431	-0.567	0.662	T	0.296	0.668	T	0.022	0.446	T	2.369	0.346	18.62	0.986	0.426	0.941	0.598	D	c	0.604	0.608	1.000	0.747	0.598	0.340	0	4.77	0.603	5.274	0.652	1.048	0.713	1.000	0.715	1.000	0.888	17.973	0.890	.	.	.	0.5	.	158	16	54967692	chr16:54967692	G	C	.	PASS	DP=158;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	55824470	55824470	C	A	intergenic	CES1P1;CES1	dist=15644;dist=12294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	516	16	55824470	chr16:55824470	C	A	105	PASS	DP=516;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	55866900	55866900	T	C	intronic	CES1	.	.	.	6.77E-14	0.00837054	0.99162946	.	0.4719	0.33344	1.912614283	97.42863883	1302.69006	6.79071	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	46	16	55866900	chr16:55866900	T	C	103	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
16	56281373	56281373	G	-	intronic	GNAO1	.	.	.	0.984288177	0.015702972	8.85E-06	DISEASE: Epileptic encephalopathy, early infantile, 17 (EIEE17) [MIM:615473]: A severe neurologic disorder characterized by onset of intractable seizures in the first weeks or months of life and usually associated with EEG abnormalities. Affected infants have very poor psychomotor development and may have brain abnormalities, such as cerebral atrophy or thin corpus callosum. Some patients may show involuntary movements. {ECO:0000269|PubMed:23993195}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24762	0.17859	-0.736552314	13.93606983	11.79169	0.42714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	34	16	56281372	chr16:56281372	TG	T	52	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	57054540	57054540	C	T	intronic	NLRC5	.	.	.	6.72E-05	0.999932818	2.78E-09	.	0.07927	0.08967	0.514279338	80.30195801	898.09245	5.83754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	16	57054540	chr16:57054540	C	T	.	PASS	DP=59;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	57101244	57101244	A	G	intronic	NLRC5	.	.	.	6.72E-05	0.999932818	2.78E-09	.	0.07927	0.08967	0.514279338	80.30195801	898.09245	5.83754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	57	16	57101244	chr16:57101244	A	G	70	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	58021306	58021306	C	G	exonic	TEPP	.	synonymous SNV	TEPP:NM_199046:exon8:c.C873G:p.V291V,TEPP:NM_199456:exon8:c.C792G:p.V264V	6.80E-05	0.729947501	0.269984542	.	.	.	-0.069700724	48.54328851	39.64027	1.16858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	91	16	58021306	chr16:58021306	C	G	85	PASS	DP=91;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	64294574	64294574	-	A	intergenic	NONE;CDH11	dist=NONE;dist=683083	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	53	16	64294574	chr16:64294574	T	TA	78	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	66920308	66920308	-	T	UTR3	PDP2	NM_020786:c.*531_*532insT;NM_001329934:c.*531_*532insT;NM_001329928:c.*531_*532insT;NM_001329932:c.*531_*532insT;NM_001329929:c.*531_*532insT;NM_001329933:c.*531_*532insT;NM_001329931:c.*531_*532insT;NM_001329930:c.*531_*532insT	.	.	1.86E-05	0.45419908	0.545782308	.	.	.	-0.933156985	9.54824251	36.00648	1.08197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	97	16	66920308	chr16:66920308	C	CT	53	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	66967592	66967592	C	T	exonic	FAM96B	.	synonymous SNV	FAM96B:NM_016062:exon3:c.G273A:p.P91P	0.002103752	0.510385152	0.487511096	.	0.24177	0.10692	0.013025609	54.62962963	7.86023	0.28897	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	16	66967592	chr16:66967592	C	T	.	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	66969542	66969542	C	T	exonic	CES2	.	nonsynonymous SNV	CES2:NM_003869:exon1:c.C196T:p.R66W,CES2:NM_198061:exon1:c.C196T:p.R66W	1.08E-10	0.162085408	0.837914592	.	0.07261	0.14132	-0.863377021	10.84571833	45.73853	1.29986	0.124	0.279	T	0.995	0.657	D	0.676	0.515	P	.	.	.	1.000	0.090	N	0.55	0.145	N	-0.3	0.679	T	-2.65	0.567	D	0.242	0.296	-0.951	0.408	T	0.129	0.438	T	0.029	0.517	D	1.099	0.200	11.21	0.994	0.618	0.041	0.094	N	c	-1.062	-1.295	1.000	0.747	0.789	0.998	0	-6.52	0.017	-3.195	0.006	0.069	0.176	0.000	0.063	0.021	0.135	0.429	0.004	Alpha/Beta hydrolase fold|Carboxylesterase, type B	.	.	0.5	79	886	16	66969542	chr16:66969542	C	T	79	PASS	DP=886;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
16	67208152	67208152	C	A	exonic	NOL3	.	stopgain	NOL3:NM_001185057:exon2:c.C80A:p.S27X,NOL3:NM_001276309:exon2:c.C80A:p.S27X,NOL3:NM_001276311:exon2:c.C80A:p.S27X,NOL3:NM_003946:exon2:c.C80A:p.S27X,NOL3:NM_001276307:exon4:c.C80A:p.S27X,NOL3:NM_001276312:exon4:c.C80A:p.S27X,NOL3:NM_001276319:exon4:c.C266A:p.S89X	0.000536476	0.458633926	0.540829599	DISEASE: Myoclonus, familial cortical (FCM) [MIM:614937]: An autosomal dominant neurologic condition characterized by adult onset of cortical myoclonus manifest as involuntary jerks or movements affecting the face and limbs. Affected individuals can also experience falls without seizure activity or loss of consciousness. {ECO:0000269|PubMed:22926851}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08489	0.13982	0.125076652	62.7388535	82.97218	1.93512	.	.	.	.	.	.	.	.	.	0.000	0.469	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.485	0.963	35	0.990	0.507	0.577	0.302	D	c	0.635	0.447	1.0	0.983	0.726	0.872	0	4.95	0.648	2.836	0.476	0.925	0.434	0.990	0.367	0.765	0.326	13.69	0.619	CARD domain|Death-like domain	.	.	0.5	96	244	16	67208152	chr16:67208152	C	A	96	PASS	DP=244;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	67300017	67300019	GAG	-	exonic	SLC9A5	.	nonframeshift deletion	SLC9A5:NM_001323972:exon14:c.1804_1806del:p.E607del,SLC9A5:NM_001323973:exon15:c.2104_2106del:p.E707del,SLC9A5:NM_001323974:exon15:c.1219_1221del:p.E412del,SLC9A5:NM_001323975:exon15:c.1222_1224del:p.E413del,SLC9A5:NM_004594:exon15:c.2107_2109del:p.E708del	0.036251926	0.963735021	1.31E-05	.	0.32414	0.12612	-0.865195027	10.79853739	86.06036	1.98043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	49	16	67300016	chr16:67300016	TGAG	T	59	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	67470052	67470052	-	C	intronic	HSD11B2	.	.	.	0.244955465	0.724823672	0.030220863	.	0.7257	0.64394	-0.47017169	23.25430526	28.64779	0.91706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	154	16	67470052	chr16:67470052	G	GC	45	PASS	DP=154;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
16	67660381	67660381	C	T	intronic	CTCF	.	.	.	0.997924958	0.002075029	1.27E-08	DISEASE: Mental retardation, autosomal dominant 21 (MRD21) [MIM:615502]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Additional MRD21 features include short stature, microcephaly, and developmental delay. {ECO:0000269|PubMed:23746550}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78428	0.25142	-0.293801652	32.93819297	9.66001	0.35497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	90	16	67660381	chr16:67660381	C	T	.	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	68057932	68057932	G	-	intronic	DUS2	.	.	.	0.000272032	0.999072268	0.0006557	.	0.08346	0.11249	-0.400392389	26.85185185	261.28866	3.47039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.23	39	16	68057931	chr16:68057931	TG	T	18.23	PASS	DP=39;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	68386042	68386042	T	G	intronic	PRMT7	.	.	.	8.31E-09	0.895222115	0.104777876	.	0.04723	0.11983	-1.903381992	1.94621373	52.71496	1.43803	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	172	16	68386042	chr16:68386042	T	G	86	PASS	DP=172;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	69499982	69499982	T	-	UTR3	CYB5B	NM_030579:c.*3559delT	.	.	0.25957799	0.713647973	0.026774037	.	0.23716	0.10842	-0.207437529	38.2814343	80.36516	1.8944	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	116	16	69499981	chr16:69499981	CT	C	76	PASS	DP=116;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	69776180	69776180	C	T	UTR3	NOB1	NM_014062:c.*55G>A	.	.	8.61E-08	0.292883367	0.707116547	.	0.12273	.	-0.154246007	42.22694032	2859.41631	10.11657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	1009	16	69776180	chr16:69776180	C	T	149	PASS	DP=1009;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	69988359	69988359	A	G	exonic	CLEC18A	.	synonymous SNV	CLEC18A:NM_001136214:exon4:c.A339G:p.L113L,CLEC18A:NM_001271197:exon4:c.A339G:p.L113L,CLEC18A:NM_182619:exon4:c.A339G:p.L113L	0.144113695	0.778785582	0.077100722	.	.	.	.	.	3437.51904	11.25783	.	.	.	.	.	.	.	.	.	.	.	.	0.000	0.588	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.764	0.167	9.239	0.305	0.017	0.026	0.071	N	c	-0.605	-0.680	0.001	0.080	0.554	0.246	0	1.97	0.252	0.164	0.162	-0.026	0.128	0.993	0.376	0.084	0.183	4.761	0.124	.	ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157322.12|ENSG00000157322.12|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000223496.1|ENSG00000196696.8|ENSG00000261556.4|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000223496.1|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000261556.4|ENSG00000223496.1|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000196696.8|ENSG00000157335.15|ENSG00000157322.12|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000261556.4|ENSG00000223496.1|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157335.15|ENSG00000157322.12|ENSG00000157322.12|ENSG00000196696.8|ENSG00000157322.12|ENSG00000157335.15|ENSG00000196696.8|ENSG00000157322.12|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8|ENSG00000196696.8|ENSG00000157322.12|ENSG00000223496.1|ENSG00000157335.15|ENSG00000196696.8	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Adrenal_Gland|Adrenal_Gland|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Aorta|Artery_Coronary|Artery_Tibial|Artery_Tibial|Artery_Tibial|Artery_Tibial|Artery_Tibial|Brain_Caudate_basal_ganglia|Brain_Cerebellum|Brain_Cortex|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Colon_Transverse|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Heart_Left_Ventricle|Heart_Left_Ventricle|Lung|Lung|Lung|Lung|Lung|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Ovary|Pancreas|Pancreas|Pancreas|Pancreas|Prostate|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Small_Intestine_Terminal_Ileum|Spleen|Spleen|Stomach|Stomach|Testis|Testis|Testis|Thyroid|Thyroid|Thyroid|Thyroid|Vagina|Whole_Blood|Whole_Blood|Whole_Blood|Whole_Blood	0.5	129	134	16	69988359	chr16:69988359	A	G	129	PASS	DP=134;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	70165914	70165914	T	C	intronic	PDPR	.	.	.	4.85E-08	0.989391133	0.010608819	.	.	0.11815	0.874458024	88.88888889	1513.23821	7.22888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	135	16	70165914	chr16:70165914	T	C	.	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	71887095	71887095	C	T	UTR3	ATXN1L	NM_001137675:c.*1382C>T	.	.	.	.	.	.	.	.	0.637604436	83.77565464	1685.42189	7.56537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	122	16	71887095	chr16:71887095	C	T	90	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	71967795	71967795	G	C	intronic	PKD1L3	.	.	.	.	.	.	.	.	0.11058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	60	16	71967795	chr16:71967795	G	C	71	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	72820886	72820886	C	T	UTR3	ZFHX3	NM_006885:c.*177G>A;NM_001164766:c.*177G>A	.	.	1	1.41E-10	8.85E-27	.	0.74579	0.15507	-4.263203714	0.117952347	6032.74571	16.21079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	115	16	72820886	chr16:72820886	C	T	.	PASS	DP=115;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	74372596	74372596	-	A	ncRNA_intronic	LOC283922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.95	37	16	74372596	chr16:74372596	C	CA	13.95	PASS	DP=37;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	74922137	74922137	T	A	exonic	WDR59	.	nonsynonymous SNV	WDR59:NM_030581:exon22:c.A2276T:p.Q759L	3.44E-11	0.995036935	0.004963065	.	0.21989	0.10981	-1.256630467	5.343241331	409.53463	4.24211	0.202	0.202	T	0.244	0.481	B	0.049	0.612	B	0.000	0.843	D	1	0.810	D	1.5	0.380	L	-0.35	0.686	T	-1.63	0.391	N	0.838	0.825	-0.514	0.681	T	0.347	0.712	T	0.032	0.543	D	3.417	0.469	23.0	0.988	0.454	0.989	0.890	D	c	0.261	0.375	1.000	0.747	0.732	0.924	0	5.77	0.910	4.161	0.577	1.061	0.807	1.000	0.715	0.998	0.697	16.099	0.809	.	.	.	0.5	.	42	16	74922137	chr16:74922137	T	A	.	PASS	DP=42;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	75238153	75238153	C	A	exonic	CTRB2	.	nonsynonymous SNV	CTRB2:NM_001025200:exon7:c.G698T:p.W233L	0.283515253	0.630328734	0.086156013	.	0.02971	0.33983	.	.	23.4963	0.78152	0.005	0.654	D	1.0	0.899	D	0.992	0.790	D	0.000	0.629	U	1	0.810	D	2.71	0.795	M	-3.3	0.938	D	-10.4	0.992	D	0.929	0.923	1.010	0.974	D	0.893	0.964	D	0.522	0.955	D	5.375	0.728	25.9	0.987	0.438	0.975	0.748	D	c	0.684	0.600	1.000	0.747	0.554	0.283	0	4.33	0.509	6.100	0.709	0.803	0.325	1.000	0.715	0.973	0.468	16.809	0.855	Peptidase S1, PA clan|Serine proteases, trypsin domain	.	.	0.5	120	558	16	75238153	chr16:75238153	C	A	120	PASS	DP=558;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	75269958	75269958	-	CA	intronic	BCAR1	.	.	.	0.992956578	0.007043171	2.51E-07	.	0.47335	.	1.53037684	95.51191319	778.41129	5.52069	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	19	16	75269958	chr16:75269958	C	CCA	60	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
16	75327731	75327731	-	A	UTR3	CFDP1	NM_006324:c.*118_*119insT	.	.	0.084939582	0.90532901	0.009731408	.	0.69235	0.12239	-0.115612493	45.12856806	45.52056	1.29597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	24	16	75327731	chr16:75327731	G	GA	43	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
16	84035871	84035871	G	T	intronic	NECAB2	.	.	.	.	.	.	.	0.13866	0.11297	-0.126743121	44.0905874	2833.50108	10.05093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	78	16	84035871	chr16:84035871	G	T	.	PASS	DP=78;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
16	84218459	84218459	C	A	exonic	TAF1C	.	stopgain	TAF1C:NM_001243156:exon2:c.G136T:p.E46X,TAF1C:NM_005679:exon2:c.G136T:p.E46X	3.23E-11	0.472377146	0.527622854	.	0.24194	0.0925	0.593325282	82.46048596	1956.88534	8.14058	.	.	.	.	.	.	.	.	.	0.173	0.031	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.443	0.472	23.0	0.894	0.182	0.010	0.037	N	c	-0.490	-0.957	1.000	0.747	0.731	0.878	0	-7.45	0.012	-2.252	0.013	-2.251	0.004	0.000	0.063	0.003	0.074	2.072	0.034	.	.	.	0.5	.	273	16	84218459	chr16:84218459	C	A	.	PASS	DP=273;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	86600947	86600947	G	T	exonic	FOXC2	.	nonsynonymous SNV	FOXC2:NM_005251:exon1:c.G6T:p.Q2H	.	.	.	DISEASE: Lymphedema-distichiasis (LYD) [MIM:153400]: A disorder characterized by primary limb lymphedema associated with distichiasis (double rows of eyelashes, with extra eyelashes growing from the Meibomian gland orifices). Swelling of the extremities, due to altered lymphatic flow, usually appears in late childhood or puberty. Most affected individuals have ocular findings including corneal irritation, recurrent conjunctivitis, and photophobia. Drooping of the upper eyelid (ptosis) is a variable feature of the lymphedema-distichiasis syndrome, occurring in about 30% of patients. {ECO:0000269|PubMed:11078474, ECO:0000269|PubMed:11371511, ECO:0000269|PubMed:11499682}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.38597	0.23829	.	.	50.82093	1.40445	0.0	0.912	D	0.999	0.764	D	0.99	0.774	D	0.615	0.057	U	0.994	0.422	D	2.015	0.552	M	-4.1	0.967	D	-3.49	0.680	D	0.725	0.724	0.608	0.920	D	0.914	0.972	D	0.585	0.963	D	5.864	0.804	27.3	0.996	0.740	0.975	0.751	D	c	0.453	0.349	1.000	0.747	0.623	0.393	0	1.4	0.213	6.207	0.719	0.952	0.539	1.000	0.715	1.000	0.888	8.527	0.323	.	.	.	0.5	103	527	16	86600947	chr16:86600947	G	T	103	PASS	DP=527;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	86612457	86612457	G	-	exonic	FOXL1	.	frameshift deletion	FOXL1:NM_005250:exon1:c.128delG:p.A44Pfs*219	0.063930237	0.726767174	0.209302589	.	0.73079	.	.	.	70.601	1.74883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	363	16	86612456	chr16:86612456	CG	C	124	PASS	DP=363;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	87936017	87936017	G	C	intronic	CA5A	.	.	.	0.010723138	0.946445827	0.042831035	DISEASE: Hyperammonemia due to carbonic anhydrase VA deficiency (CA5AD) [MIM:615751]: An autosomal recessive inborn error of metabolism, clinically characterized by infantile hyperammonemic encephalopathy. Metabolic abnormalities include hypoglycemia, hyperlactatemia, metabolic acidosis and respiratory alkalosis. {ECO:0000269|PubMed:24530203}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11209	0.10917	-0.001743238	53.85114414	62.38928	1.61312	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	82	16	87936017	chr16:87936017	G	C	71	PASS	DP=82;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	88123963	88123963	C	-	intergenic	BANP;LOC400553	dist=13039;dist=9052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	543	16	88123962	chr16:88123962	GC	G	96	PASS	DP=543;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	88499564	88499564	C	A	exonic	ZNF469	.	nonsynonymous SNV	ZNF469:NM_001127464:exon2:c.C5602A:p.P1868T	.	.	.	.	.	.	.	.	3862.54073	12.24999	0.0	0.912	D	0.767	0.418	P	0.344	0.408	B	.	.	.	1	0.090	N	1.7	0.440	L	2.21	0.184	T	-2.63	0.564	D	0.305	0.365	-1.052	0.139	T	0.025	0.107	T	0.411	0.936	D	3.911	0.527	23.5	0.952	0.257	0.044	0.098	N	c	-0.393	-0.436	0.443	0.205	0.646	0.450	0	3.49	0.389	0.033	0.135	0.807	0.329	0.000	0.063	0.045	0.161	2.867	0.052	.	.	.	0.5	.	222	16	88499564	chr16:88499564	C	A	.	PASS	DP=222;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	88874632	88874632	C	G	exonic	CDT1	.	synonymous SNV	CDT1:NM_030928:exon10:c.C1587G:p.L529L	7.76E-09	0.14754679	0.852453202	DISEASE: Meier-Gorlin syndrome 4 (MGORS4) [MIM:613804]: A syndrome characterized by bilateral microtia, aplasia/hypoplasia of the patellae, and severe intrauterine and postnatal growth retardation with short stature and poor weight gain. Additional clinical findings include anomalies of cranial sutures, microcephaly, apparently low-set and simple ears, microstomia, full lips, highly arched or cleft palate, micrognathia, genitourinary tract anomalies, and various skeletal anomalies. While almost all cases have primordial dwarfism with substantial prenatal and postnatal growth retardation, not all cases have microcephaly, and microtia and absent/hypoplastic patella are absent in some. Despite the presence of microcephaly, intellect is usually normal. {ECO:0000269|PubMed:21358631, ECO:0000269|PubMed:21358632}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.96985	0.14861	1.18495331	92.84029252	248.60148	3.39744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	174	16	88874632	chr16:88874632	C	G	99	PASS	DP=174;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
16	89017426	89017426	C	A	exonic	LOC100129697	.	nonsynonymous SNV	LOC100129697:NM_001290330:exon2:c.C900A:p.D300E	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	758	16	89017426	chr16:89017426	C	A	.	PASS	DP=758;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	89293717	89293717	G	C	exonic	ZNF778	.	nonsynonymous SNV	ZNF778:NM_182531:exon6:c.G937C:p.E313Q,ZNF778:NM_001201407:exon7:c.G1021C:p.E341Q	1.63E-15	0.003467761	0.996532239	.	.	.	1.302520887	93.9195565	439.77574	4.37018	0.325	0.133	T	0.041	0.210	B	0.052	0.280	B	.	.	.	1	0.090	N	1.195	0.303	L	2.21	0.184	T	-0.71	0.202	N	0.113	0.186	-0.992	0.320	T	0.031	0.133	T	0.001	0.007	T	0.336	0.126	6.040	0.525	0.047	0.010	0.039	N	c	-0.964	-1.071	0.106	0.165	0.566	0.321	0	1.13	0.197	-0.251	0.088	0.635	0.291	0.000	0.063	0.001	0.043	8.198	0.304	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	77	61	16	89293717	chr16:89293717	G	C	77	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	89661967	89661967	C	T	exonic	CPNE7	.	nonsynonymous SNV	CPNE7:NM_153636:exon14:c.C1495T:p.L499F,CPNE7:NM_014427:exon16:c.C1720T:p.L574F	1.63E-13	0.026868774	0.973131226	.	0.10022	.	-1.343026423	4.647322482	1754.91457	7.73074	0.183	0.373	T	0.096	0.277	B	0.106	0.296	B	0.000	0.629	D	0.876	0.356	D	1.975	0.537	M	1.35	0.346	T	-2.13	0.483	N	0.469	0.519	-0.963	0.387	T	0.087	0.337	T	0.026	0.494	D	2.331	0.341	18.37	0.743	0.103	0.913	0.530	D	c	-0.475	-0.497	1.000	0.517	0.706	0.609	0	2.58	0.299	2.284	0.429	0.848	0.348	0.965	0.337	0.205	0.218	12.567	0.555	Copine|von Willebrand factor, type A	.	.	0.5	102	417	16	89661967	chr16:89661967	C	T	102	PASS	DP=417;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
16	89804335	89804336	CT	-	UTR3	FANCA	NM_001286167:c.*771_*770delAG;NM_000135:c.*674_*673delAG	.	.	2.08E-34	0.000122619	0.999877381	DISEASE: Fanconi anemia, complementation group A (FANCA) [MIM:227650]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:10094191, ECO:0000269|PubMed:10210316, ECO:0000269|PubMed:10521298, ECO:0000269|PubMed:10807541, ECO:0000269|PubMed:11091222, ECO:0000269|PubMed:17924555, ECO:0000269|PubMed:9371798, ECO:0000269|PubMed:9399890, ECO:0000269|PubMed:9929978}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23385	0.24341	-0.101294944	45.66525124	1788.01434	7.80511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	499	16	89804334	chr16:89804334	CCT	C	87	PASS	DP=499;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	89839766	89839766	G	C	exonic	FANCA	.	nonsynonymous SNV	FANCA:NM_000135:exon22:c.C1927G:p.P643A,FANCA:NM_001286167:exon22:c.C1927G:p.P643A	2.08E-34	0.000122619	0.999877381	DISEASE: Fanconi anemia, complementation group A (FANCA) [MIM:227650]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:10094191, ECO:0000269|PubMed:10210316, ECO:0000269|PubMed:10521298, ECO:0000269|PubMed:10807541, ECO:0000269|PubMed:11091222, ECO:0000269|PubMed:17924555, ECO:0000269|PubMed:9371798, ECO:0000269|PubMed:9399890, ECO:0000269|PubMed:9929978}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23385	0.24341	-0.101294944	45.66525124	1788.01434	7.80511	0.453	0.107	T	0.002	0.090	B	0.001	0.040	B	0.510	0.118	N	1	0.090	P	0.97	0.241	L	-1.74	0.834	D	-2.45	0.535	N	0.065	0.246	-1.101	0.040	T	0.000	0.000	T	.	.	.	-1.202	0.025	0.006	0.374	0.024	0.033	0.083	N	c	-1.452	-1.469	0.022	0.134	0.707	0.730	0	-2.44	0.061	0.074	0.144	-0.701	0.038	0.000	0.063	0.002	0.062	2.101	0.034	.	ENSG00000187741.10|ENSG00000204991.6|ENSG00000204991.6|ENSG00000187741.10|ENSG00000204991.6|ENSG00000204991.6|ENSG00000258947.2|ENSG00000141002.14|ENSG00000204991.6|ENSG00000178773.10|ENSG00000187741.10|ENSG00000204991.6|ENSG00000204991.6|ENSG00000204991.6|ENSG00000187741.10|ENSG00000187741.10|ENSG00000204991.6|ENSG00000187741.10|ENSG00000140995.12|ENSG00000204991.6|ENSG00000003249.9|ENSG00000204991.6|ENSG00000256390.1|ENSG00000204991.6|ENSG00000256390.1	Adipose_Subcutaneous|Adipose_Subcutaneous|Artery_Aorta|Artery_Tibial|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Testis|Testis|Whole_Blood	0.5	65	136	16	89839766	chr16:89839766	G	C	65	PASS	DP=136;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
16	89986075	89986075	G	T	exonic	MC1R	.	nonsynonymous SNV	MC1R:NM_002386:exon1:c.G409T:p.A137S	3.25E-07	0.052370692	0.947628983	DISEASE: Melanoma, cutaneous malignant 5 (CMM5) [MIM:613099]: A malignant neoplasm of melanocytes, arising de novo or from a pre- existing benign nevus, which occurs most often in the skin but also may involve other sites. {ECO:0000269|PubMed:17434924, ECO:0000269|PubMed:19338054}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	.	0.68939	0.34168906	73.72611465	1416.53832	7.03613	0.012	0.654	D	0.7	0.399	P	0.519	0.463	P	0.001	0.392	U	0.994	0.236	N	3.31	0.908	M	2.11	0.199	T	-2.03	0.466	N	0.058	0.332	-1.056	0.128	T	0.082	0.323	T	0.015	0.355	T	4.232	0.567	23.9	0.996	0.738	0.669	0.330	D	c	-0.007	-0.082	1.000	0.747	0.615	0.372	0	1.64	0.228	2.657	0.461	0.091	0.195	0.997	0.399	0.004	0.083	9.907	0.404	GPCR, rhodopsin-like, 7TM	.	.	0.5	.	69	16	89986075	chr16:89986075	G	T	.	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
16	90001773	90001773	C	T	exonic	TUBB3	.	nonsynonymous SNV	TUBB3:NM_001197181:exon4:c.C698T:p.P233L,TUBB3:NM_006086:exon4:c.C914T:p.P305L	0.960789307	0.039126002	8.47E-05	DISEASE: Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]: A congenital ocular motility disorder marked by restrictive ophthalmoplegia affecting extraocular muscles innervated by the oculomotor and/or trochlear nerves. It is clinically characterized by anchoring of the eyes in downward gaze, ptosis, and backward tilt of the head. Congenital fibrosis of extraocular muscles type 3 presents as a non-progressive, autosomal dominant disorder with variable expression. Patients may be bilaterally or unilaterally affected, and their oculo-motility defects range from complete ophthalmoplegia (with the eyes fixed in a hypo- and exotropic position), to mild asymptomatic restrictions of ocular movement. Ptosis, refractive error, amblyopia, and compensatory head positions are associated with the more severe forms of the disorder. In some cases, the ocular phenotype is accompanied by additional features including developmental delay, corpus callosum agenesis, basal ganglia dysmorphism, facial weakness, polyneuropathy. {ECO:0000269|PubMed:20074521}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039]: A disorder of aberrant neuronal migration and disturbed axonal guidance. Affected individuals have mild to severe mental retardation, strabismus, axial hypotonia, and spasticity. Brain imaging shows variable malformations of cortical development, including polymicrogyria, gyral disorganization, and fusion of the basal ganglia, as well as thin corpus callosum, hypoplastic brainstem, and dysplastic cerebellar vermis. Extraocular muscles are not involved. {ECO:0000269|PubMed:20829227}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.70074	-0.758599262	13.32861524	8.39665	0.30705	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.559	D	1	0.810	D	4.065	0.972	H	-1.94	0.849	D	-7.73	0.957	D	0.778	0.770	0.954	0.965	D	0.836	0.945	D	0.708	0.976	D	6.729	0.919	32	0.997	0.816	0.989	0.879	D	c	0.867	0.760	1.000	0.747	0.707	0.730	0	4.6	0.564	7.819	0.846	0.935	0.490	1.000	0.715	0.110	0.193	17.363	0.872	Tubulin/FtsZ, 2-layer sandwich domain|Tubulin/FtsZ, C-terminal;Tubulin/FtsZ, GTPase domain	.	.	0.5	.	405	16	90001773	chr16:90001773	C	T	.	PASS	DP=405;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	982599	982599	T	A	exonic	ABR	.	nonsynonymous SNV	ABR:NM_001092:exon5:c.A560T:p.K187M,ABR:NM_001159746:exon6:c.A533T:p.K178M,ABR:NM_001322840:exon6:c.A533T:p.K178M,ABR:NM_001322841:exon6:c.A1448T:p.K483M,ABR:NM_021962:exon6:c.A671T:p.K224M	0.999949479	5.05E-05	1.49E-12	.	0.59342	.	-1.03976177	7.802547771	211.79342	3.13829	0.002	0.721	D	0.979	0.764	D	0.905	0.736	P	0.000	0.629	D	0.999	0.453	D	2.725	0.800	M	-0.13	0.648	T	-3.2	0.658	D	0.556	0.686	-0.257	0.762	T	0.405	0.755	T	0.115	0.795	D	6.051	0.833	28.0	0.996	0.750	0.982	0.806	D	c	0.593	0.532	1.000	0.747	0.767	0.994	0	4.12	0.473	5.317	0.654	0.964	0.580	1.000	0.715	1.000	0.888	9.380	0.373	Dbl homology (DH) domain	.	.	0.5	.	55	17	982599	chr17:982599	T	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	1012138	1012138	-	C	intronic	ABR	.	.	.	0.999949479	5.05E-05	1.49E-12	.	0.59342	.	-1.03976177	7.802547771	211.79342	3.13829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	285	17	1012138	chr17:1012138	G	GC	57	PASS	DP=285;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	1359255	1359255	C	T	exonic	CRK	.	nonsynonymous SNV	CRK:NM_005206:exon1:c.G157A:p.E53K,CRK:NM_016823:exon1:c.G157A:p.E53K	0.864536311	0.135055982	0.000407707	.	0.73088	0.53296	-0.339715008	30.06605331	5.16406	0.19181	0.002	0.721	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	1.305	0.328	L	1.82	0.885	T	-3.75	0.711	D	0.463	0.753	-1.044	0.161	T	0.131	0.443	T	0.835	0.987	D	6.949	0.934	33	0.999	0.992	0.933	0.577	D	c	0.689	0.684	1.0	0.983	0.442	0.072	0	4.93	0.643	7.593	0.818	0.907	0.419	1.000	0.715	0.998	0.697	16.011	0.801	SH2 domain	.	.	0.5	.	65	17	1359255	chr17:1359255	C	T	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	1641029	1641029	G	A	UTR3	WDR81	NM_001163673:c.*50G>A;NM_152348:c.*50G>A;NM_001163811:c.*50G>A;NM_001163809:c.*50G>A	.	.	1.26E-05	0.997783337	0.002204062	.	0.26554	.	-1.758449269	2.335456476	3904.13594	12.33658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	258	17	1641029	chr17:1641029	G	A	.	PASS	DP=258;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	3838567	3838567	G	A	exonic	ATP2A3	.	synonymous SNV	ATP2A3:NM_005173:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174953:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174954:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174955:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174956:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174957:exon17:c.C2529T:p.Y843Y,ATP2A3:NM_174958:exon17:c.C2529T:p.Y843Y	0.06445003	0.935544655	5.31E-06	.	0.12887	0.19795	-1.471735692	3.739089408	775.92328	5.51515	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	266	17	3838567	chr17:3838567	G	A	65	PASS	DP=266;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	3969786	3969816	CTTCTGCTTCATTCCCCAGGCTCATCAGGGA	-	exonic	ZZEF1	.	frameshift deletion	ZZEF1:NM_015113:exon28:c.4174_4204del:p.S1392Kfs*9	0.999923091	7.69E-05	6.61E-24	.	0.3881	0.10288	-3.376061946	0.389242746	5318.26057	15.07421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	15.7	27	17	3969785	chr17:3969785	TCTTCTGCTTCATTCCCCAGGCTCATCAGGGA	T	15.7	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	3976075	3976075	C	G	intronic	ZZEF1	.	.	.	0.999923091	7.69E-05	6.61E-24	.	0.3881	0.10288	-3.376061946	0.389242746	5318.26057	15.07421	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	21	17	3976075	chr17:3976075	C	G	58	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	4173433	4173433	-	A	UTR3	UBE2G1	NM_003342:c.*2415_*2416insT	.	.	0.745694457	0.252001968	0.002303575	.	0.70845	0.18619	0.013025609	54.62962963	2.97356	0.10769	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	34	17	4173433	chr17:4173433	T	TA	78	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	4750525	4750525	-	TTCA	intronic	MINK1	.	.	.	0.999984022	1.60E-05	7.45E-16	.	0.46968	0.13857	-1.456898556	3.862939372	2119.37505	8.47592	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	20	17	4750525	chr17:4750525	G	GTTCA	58	PASS	DP=20;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	5118249	5118249	G	A	exonic	SCIMP	.	nonsynonymous SNV	SCIMP:NM_001271842:exon4:c.C233T:p.P78L,SCIMP:NM_001319190:exon4:c.C233T:p.P78L,SCIMP:NM_207103:exon4:c.C254T:p.P85L	0.012575344	0.855696202	0.131728455	.	0.1304	.	-0.163345027	41.24793583	10.11893	0.36946	.	.	.	0.946	0.514	P	0.324	0.413	B	0.001	0.425	N	0.995	0.426	D	2.045	0.562	M	.	.	.	.	.	.	0.424	0.544	-0.885	0.494	T	0.133	0.446	T	0.010	0.257	T	5.229	0.706	25.6	0.998	0.866	0.830	0.418	D	c	0.145	0.124	0.017	0.130	0.707	0.730	0	4.06	0.464	2.724	0.467	1.048	0.713	1.000	0.715	0.769	0.327	9.318	0.369	.	.	.	0.5	.	59	17	5118249	chr17:5118249	G	A	.	PASS	DP=59;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	6665416	6665416	G	T	intronic	XAF1	.	.	.	2.07E-08	0.073341496	0.926658483	.	0.05763	0.08526	0.995816767	90.62278839	600.13477	4.95792	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	17	6665416	chr17:6665416	G	T	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	6920052	6920052	G	A	ncRNA_intronic	MIR497HG;RNASEK-C17orf49	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	114	17	6920052	chr17:6920052	G	A	.	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	6978296	6978296	G	T	UTR3	CLEC10A	NM_006344:c.*77C>A;NM_182906:c.*77C>A;NM_001330070:c.*77C>A	.	.	4.25E-08	0.203022746	0.796977211	.	0.05732	0.1098	1.218120595	93.15876386	329.25844	3.85744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	166	17	6978296	chr17:6978296	G	T	.	PASS	DP=166;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	7323892	7323892	G	T	intronic	SPEM1	.	.	.	0.023453063	0.913435787	0.06311115	.	0.03702	.	0.485092724	79.37603208	739.00476	5.3966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	141	17	7323892	chr17:7323892	G	T	86	PASS	DP=141;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	7578179	7578179	C	A	exonic	TP53	.	stopgain	TP53:NM_001126115:exon2:c.G274T:p.E92X,TP53:NM_001126116:exon2:c.G274T:p.E92X,TP53:NM_001126117:exon2:c.G274T:p.E92X,TP53:NM_001276697:exon2:c.G193T:p.E65X,TP53:NM_001276698:exon2:c.G193T:p.E65X,TP53:NM_001276699:exon2:c.G193T:p.E65X,TP53:NM_001126118:exon5:c.G553T:p.E185X,TP53:NM_000546:exon6:c.G670T:p.E224X,TP53:NM_001126112:exon6:c.G670T:p.E224X,TP53:NM_001126113:exon6:c.G670T:p.E224X,TP53:NM_001126114:exon6:c.G670T:p.E224X,TP53:NM_001276695:exon6:c.G553T:p.E185X,TP53:NM_001276696:exon6:c.G553T:p.E185X,TP53:NM_001276760:exon6:c.G553T:p.E185X,TP53:NM_001276761:exon6:c.G553T:p.E185X	0.912222953	0.087750328	2.67E-05	DISEASE: Note=TP53 is found in increased amounts in a wide variety of transformed cells. TP53 is frequently mutated or inactivated in about 60% of cancers. TP53 defects are found in Barrett metaplasia a condition in which the normally stratified squamous epithelium of the lower esophagus is replaced by a metaplastic columnar epithelium. The condition develops as a complication in approximately 10% of patients with chronic gastroesophageal reflux disease and predisposes to the development of esophageal adenocarcinoma.; DISEASE: Esophageal cancer (ESCR) [MIM:133239]: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Li-Fraumeni syndrome (LFS) [MIM:151623]: Autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:10484981, ECO:0000269|PubMed:1565144, ECO:0000269|PubMed:1737852, ECO:0000269|PubMed:1933902, ECO:0000269|PubMed:1978757, ECO:0000269|PubMed:2259385, ECO:0000269|PubMed:7887414, ECO:0000269|PubMed:8825920, ECO:0000269|PubMed:9452042}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Papilloma of choroid plexus (CPP) [MIM:260500]: A benign tumor of neuroectodermal origin that generally occurs in childhood, but has also been reported in adults. Although generally found within the ventricular system, choroid plexus papillomas can arise ectopically in the brain parenchyma or disseminate throughout the neuraxis. Patients present with signs and symptoms of increased intracranial pressure including headache, hydrocephalus, papilledema, nausea, vomiting, cranial nerve deficits, gait impairment, and seizures. {ECO:0000269|PubMed:12085209}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Adrenocortical carcinoma (ADCC) [MIM:202300]: A malignant neoplasm of the adrenal cortex and a rare childhood tumor. It occurs with increased frequency in patients with Beckwith- Wiedemann syndrome and Li-Fraumeni syndrome. {ECO:0000269|PubMed:11481490}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Basal cell carcinoma 7 (BCC7) [MIM:614740]: A common malignant skin neoplasm that typically appears on hair-bearing skin, most commonly on sun-exposed areas. It is slow growing and rarely metastasizes, but has potentialities for local invasion and destruction. It usually develops as a flat, firm, pale area that is small, raised, pink or red, translucent, shiny, and waxy, and the area may bleed following minor injury. Tumor size can vary from a few millimeters to several centimeters in diameter. {ECO:0000269|PubMed:21946351}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.99999	0.9998	-0.247889024	35.98726115	15.3263	0.55115	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.787	0.978	38	0.997	0.804	0.970	0.719	D	c	0.919	0.728	0.695	0.226	0.732	0.924	0	3.13	0.349	4.159	0.577	0.852	0.362	1.000	0.715	0.992	0.562	12.988	0.578	p53, DNA-binding domain|p53-like transcription factor, DNA-binding|p53/RUNT-type transcription factor, DNA-binding domain	.	.	0.5	69	188	17	7578179	chr17:7578179	C	A	69	PASS	DP=188;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	7751192	7751192	C	T	exonic	KDM6B	.	nonsynonymous SNV	KDM6B:NM_001080424:exon11:c.C1586T:p.P529L,KDM6B:NM_001348716:exon11:c.C1586T:p.P529L	0.999994425	5.58E-06	2.83E-16	.	0.20577	0.12653	-1.31556435	4.794762916	5734.22375	15.68691	0.0	0.912	D	0.014	0.156	B	0.006	0.112	B	0.330	0.141	N	0.686	0.333	D	0.345	0.112	N	3.16	0.077	T	0.15	0.053	N	0.143	0.168	-0.992	0.321	T	0.013	0.048	T	0.015	0.354	T	0.288	0.122	5.572	0.920	0.207	0.543	0.293	D	c	-0.874	-0.797	0.097	0.163	0.615	0.372	0	1.06	0.193	0.637	0.242	0.736	0.307	0.000	0.063	0.796	0.335	7.492	0.265	.	.	.	0.5	.	45	17	7751192	chr17:7751192	C	T	.	PASS	DP=45;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	8025659	8025671	ACCCGGGGGCTCC	-	exonic	HES7	.	frameshift deletion	HES7:NM_001165967:exon3:c.216_226del:p.E73Rfs*97,HES7:NM_032580:exon3:c.216_226del:p.E73Gfs*92	0.78288357	0.210284915	0.006831516	DISEASE: Spondylocostal dysostosis 4, autosomal recessive (SCDO4) [MIM:613686]: A rare condition of variable severity characterized by vertebral and costal anomalies. The main feature include dwarfism, vertebral fusion, hemivertebrae, posterior rib fusion, reduced rib number, and other rib malformations. {ECO:0000269|PubMed:18775957, ECO:0000269|PubMed:20087400}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27407	0.1136	.	.	14.20939	0.51375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.18	34	17	8025658	chr17:8025658	TACCCGGGGGCTCC	T	13.18	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	8093806	8093806	C	-	upstream	BORCS6	dist=242	.	.	.	.	.	.	0.38193	0.10905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	215	17	8093805	chr17:8093805	AC	A	65	PASS	DP=215;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	9086212	9086212	C	G	intronic	NTN1	.	.	.	.	.	.	.	0.95071	0.25454	-0.626318434	17.03231894	24.88991	0.81675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	157	17	9086212	chr17:9086212	C	G	.	PASS	DP=157;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	9497478	9497478	-	T	intronic	CFAP52	.	.	.	.	.	.	.	0.04801	0.09789	-0.617221851	17.44515216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	100	17	9497478	chr17:9497478	C	CT	64	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	10219247	10219247	G	T	exonic	MYH13	.	nonsynonymous SNV	MYH13:NM_003802:exon28:c.C3834A:p.N1278K	1.89E-29	0.014239931	0.985760069	.	0.48597	0.1881	-0.635977455	16.74333569	5547.032	15.40045	0.057	0.379	T	0.06	0.217	B	0.314	0.398	B	.	.	.	0.982	0.250	N	2.39	0.691	M	-1.11	0.775	T	-1.37	0.340	N	0.092	0.143	-0.238	0.767	T	0.522	0.822	D	0.072	0.714	D	4.382	0.587	24.1	0.998	0.882	0.361	0.252	N	c	-0.290	-0.338	0.000	0.012	0.497	0.185	0	1.08	0.194	-0.472	0.066	0.939	0.529	0.000	0.063	1.000	0.888	8.421	0.317	Myosin tail	.	.	0.5	.	89	17	10219247	chr17:10219247	G	T	.	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	10247303	10247303	G	T	exonic	MYH13	.	nonsynonymous SNV	MYH13:NM_003802:exon16:c.C1708A:p.P570T	1.89E-29	0.014239931	0.985760069	.	0.48597	0.1881	-0.635977455	16.74333569	5547.032	15.40045	0.048	0.400	D	0.003	0.102	B	0.22	0.361	B	.	.	.	0.985	0.247	N	1.465	0.370	L	-2.18	0.867	D	-2.52	0.547	D	0.197	0.306	0.032	0.829	D	0.676	0.888	D	0.068	0.705	D	1.967	0.297	16.00	0.957	0.270	0.235	0.219	N	c	-0.610	-0.697	0.000	0.012	0.487	0.133	0	-0.255	0.123	0.009	0.130	0.900	0.413	0.000	0.063	0.983	0.502	16.651	0.850	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	95	359	17	10247303	chr17:10247303	G	T	95	PASS	DP=359;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	10417160	10417160	C	A	exonic	MYH1	.	nonsynonymous SNV	MYH1:NM_005963:exon8:c.G719T:p.R240M	1.29E-29	0.041852309	0.958147691	.	0.69127	0.30625	-1.080656478	7.248171739	785.49267	5.53734	0.0	0.912	D	0.999	0.764	D	0.986	0.754	D	0.000	0.481	U	1	0.810	D	2.995	0.861	M	-2.47	0.890	D	-4.87	0.812	D	0.951	0.947	0.981	0.969	D	0.885	0.962	D	0.205	0.870	D	6.732	0.919	32	0.965	0.296	0.959	0.663	D	c	1.028	0.958	1.0	0.983	0.534	0.214	0	5.58	0.843	7.875	0.855	0.935	0.490	1.000	0.715	1.000	0.888	19.947	0.972	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	65	173	17	10417160	chr17:10417160	C	A	65	PASS	DP=173;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	10552000	10552000	-	T	intronic	MYH3	.	.	.	3.60E-13	0.999999918	8.17E-08	DISEASE: Arthrogryposis, distal, 2A (DA2A) [MIM:193700]: A form of distal arthrogryposis, a disease characterized by congenital joint contractures that mainly involve two or more distal parts of the limbs, in the absence of a primary neurological or muscle disease. DA2A is characterized by contractures of the hands and feet, oropharyngeal abnormalities, scoliosis, and a distinctive face that includes a very small oral orifice, puckered lips, and an H- shaped dimple of the chin. {ECO:0000269|PubMed:16642020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Arthrogryposis, distal, 2B (DA2B) [MIM:601680]: A form of distal arthrogryposis, a disease characterized by congenital joint contractures that mainly involve two or more distal parts of the limbs, in the absence of a primary neurological or muscle disease. DA2B is characterized by contractures of the hands and feet, and a distinctive face characterized by prominent nasolabial folds, small mouth and downslanting palpebral fissures. {ECO:0000269|PubMed:16642020}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Arthrogryposis, distal, 8 (DA8) [MIM:178110]: A form of distal arthrogryposis, a disease characterized by congenital joint contractures that mainly involve two or more distal parts of the limbs, in the absence of a primary neurological or muscle disease. {ECO:0000269|PubMed:25957469}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43095	0.21181	-1.554570334	3.225996697	602.04688	4.96558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	33	17	10552000	chr17:10552000	A	AT	76	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	11697016	11697016	A	-	intronic	DNAH9	.	.	.	1.37E-35	0.999999244	7.56E-07	.	0.20972	0.11901	0.45554211	78.06086341	11534.8129	23.18197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	27	17	11697015	chr17:11697015	GA	G	64	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	16097866	16097866	A	G	exonic	NCOR1	.	synonymous SNV	NCOR1:NM_001190438:exon1:c.T18C:p.Y6Y,NCOR1:NM_001190440:exon1:c.T18C:p.Y6Y,NCOR1:NM_006311:exon2:c.T18C:p.Y6Y	0.999999999	7.43E-10	7.08E-30	.	0.57767	0.62451	-2.137013188	1.49799481	297.95501	3.68236	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	77	17	16097866	chr17:16097866	A	G	76	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	16344524	16344524	A	-	ncRNA_exonic	LRRC75A-AS1	.	.	.	.	.	.	.	0.01204	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	20	17	16344523	chr17:16344523	CA	C	57	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	17707151	17707151	G	A	exonic	RAI1	.	nonsynonymous SNV	RAI1:NM_030665:exon4:c.G5647A:p.A1883T	0.999136112	0.000863888	6.14E-11	DISEASE: Smith-Magenis syndrome (SMS) [MIM:182290]: Characterized by congenital mental retardation associated with development and growth delays. Affected persons have characteristic behavioral abnormalities, including self-injurious behaviors and sleep disturbance, and distinct craniofacial and skeletal anomalies. {ECO:0000269|PubMed:11404004, ECO:0000269|PubMed:12652298}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13693	0.11743	-3.683732498	0.253597547	223.68182	3.23449	0.0	0.912	D	0.999	0.764	D	0.995	0.818	D	.	.	.	1.000	0.810	D	4.17	0.977	H	-0.97	0.757	T	-3.46	0.677	D	0.668	0.791	0.488	0.904	D	0.663	0.883	D	0.358	0.925	D	7.132	0.943	34	0.965	0.295	0.994	0.953	D	c	0.983	0.925	1.000	0.747	0.707	0.730	0	5.46	0.799	9.735	0.980	1.048	0.713	1.000	0.715	0.997	0.653	18.908	0.924	Zinc finger, PHD-type	.	.	0.5	84	330	17	17707151	chr17:17707151	G	A	84	PASS	DP=330;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	18150558	18150558	G	A	exonic	FLII	.	synonymous SNV	FLII:NM_001256265:exon20:c.C2436T:p.A812A,FLII:NM_001256264:exon21:c.C2568T:p.A856A,FLII:NM_002018:exon21:c.C2601T:p.A867A	3.31E-06	0.999991566	5.12E-06	.	0.32333	0.23356	-2.936657799	0.554376032	332.27693	3.87529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	152	17	18150558	chr17:18150558	G	A	59	PASS	DP=152;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	18286711	18286711	G	A	intronic	EVPLL	.	.	.	2.73E-08	0.085818228	0.914181744	.	.	.	0.858082312	88.55862232	308.50866	3.73819	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	17	18286711	chr17:18286711	G	A	.	PASS	DP=24;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	19091405	19091405	C	G	intergenic	LOC79999;LOC79999	dist=25468;dist=27538	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	1738	17	19091405	chr17:19091405	C	G	147	PASS	DP=1738;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	19350020	19350049	CCGCGGCCTTGGCCCCGGCCCCGTCCACGG	-	intergenic	RNF112;SLC47A1	dist=29431;dist=87118	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	117	17	19350019	chr17:19350019	TCCGCGGCCTTGGCCCCGGCCCCGTCCACGG	T	133	PASS	DP=117;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	19651700	19651700	-	A	UTR5	ALDH3A1	NM_000691:c.-3259_-3258insT;NM_001330150:c.-4982_-4981insT	.	.	1.33E-12	0.012994368	0.987005632	.	0.38989	.	0.113945049	62.14319415	3022.02935	10.43597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	228	17	19651700	chr17:19651700	G	GA	53	PASS	DP=228;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	20354747	20354747	-	CT	intronic	LGALS9B	.	.	.	.	.	.	.	.	.	.	.	1350.76308	6.90243	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	93	17	20354747	chr17:20354747	C	CCT	116	PASS	DP=93;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	20416895	20416895	A	C	intergenic	KRT16P3;CDRT15L2	dist=9084;dist=66142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	957	17	20416895	chr17:20416895	A	C	126	PASS	DP=957;AN=4	GT	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.
17	20769722	20769722	A	T	intronic	CCDC144NL	.	.	.	8.14E-06	0.171830686	0.828161171	.	.	.	1.26585432	93.59518754	271.43253	3.53005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	403	17	20769722	chr17:20769722	A	T	.	PASS	DP=403;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	0/1
17	21030283	21030283	C	A	UTR5	DHRS7B	NM_015510:c.-2C>A	.	.	4.76E-08	0.117359366	0.882640587	.	0.1878	0.08946	-0.049474214	50.01179523	36.48054	1.09338	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	136	17	21030283	chr17:21030283	C	A	.	PASS	DP=136;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	21205359	21205364	GGGGCT	-	intronic	MAP2K3	.	.	.	0.000496053	0.968531857	0.03097209	DISEASE: Note=Defects in MAP2K3 may be involved in colon cancer.; 	0.23537	0.33997	0.108486928	61.90728946	81.19169	1.90782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	75	17	21205358	chr17:21205358	GGGGGCT	G	132	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	21216758	21216758	-	CTTC	intronic	MAP2K3	.	.	.	0.000496053	0.968531857	0.03097209	DISEASE: Note=Defects in MAP2K3 may be involved in colon cancer.; 	0.23537	0.33997	0.108486928	61.90728946	81.19169	1.90782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	82	17	21216758	chr17:21216758	G	GCTTC	117	PASS	DP=82;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	21216846	21216846	G	C	exonic	MAP2K3	.	synonymous SNV	MAP2K3:NM_002756:exon11:c.G870C:p.L290L,MAP2K3:NM_145109:exon11:c.G957C:p.L319L,MAP2K3:NM_001316332:exon12:c.G870C:p.L290L	0.000496053	0.968531857	0.03097209	DISEASE: Note=Defects in MAP2K3 may be involved in colon cancer.; 	0.23537	0.33997	0.108486928	61.90728946	81.19169	1.90782	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	146	144	17	21216846	chr17:21216846	G	C	146	PASS	DP=144;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	25640358	25640358	T	G	UTR3	WSB1	NM_001348350:c.*963T>G;NM_134265:c.*963T>G;NM_015626:c.*963T>G	.	.	0.92319404	0.076786985	1.90E-05	.	0.35908	0.18099	-0.448125345	24.19202642	3046.97495	10.4928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	17	25640358	chr17:25640358	T	G	.	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	25783897	25783897	G	A	intergenic	TBC1D3P5;KSR1	dist=25248;dist=15139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	176	17	25783897	chr17:25783897	G	A	.	PASS	DP=176;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	25910015	25910015	-	C	exonic	KSR1	.	frameshift insertion	KSR1:NM_014238:exon5:c.454dupC:p.P155Tfs*21	0.609182271	0.390802697	1.50E-05	.	0.30789	0.15135	.	.	702.71821	5.27148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	466	17	25910015	chr17:25910015	G	GC	79	PASS	DP=466;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	25974223	25974223	G	-	intronic	LGALS9	.	.	.	0.00139054	0.964148727	0.034460733	.	0.13572	0.22025	0.797386419	87.53833451	2358.5758	9.00919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	164	17	25974222	chr17:25974222	AG	A	59	PASS	DP=164;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	26087768	26087768	G	A	exonic	NOS2	.	nonsynonymous SNV	NOS2:NM_000625:exon24:c.C2891T:p.A964V	7.26E-09	0.998625922	0.00137407	.	0.17004	0.94961	-1.675620402	2.689313517	2728.58132	9.84685	0.12	0.279	T	0.005	0.119	B	0.006	0.112	B	0.013	0.291	N	0.587	0.324	D	1.93	0.516	L	1.31	0.354	T	-2.45	0.535	N	0.488	0.535	-0.743	0.584	T	0.185	0.535	T	0.018	0.394	T	3.324	0.458	22.9	0.996	0.712	0.852	0.440	D	c	0.145	0.025	0.009	0.118	0.622	0.393	0	2.57	0.298	2.612	0.458	-0.294	0.082	0.999	0.424	0.020	0.134	9.485	0.379	FAD-binding, type 1|Ferredoxin reductase-type FAD-binding domain|Riboflavin synthase-like beta-barrel;Ferredoxin reductase-type FAD-binding domain|Riboflavin synthase-like beta-barrel	.	.	0.5	.	324	17	26087768	chr17:26087768	G	A	.	PASS	DP=324;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	26087772	26087772	T	G	splicing	NOS2	NM_000625:exon24:c.2889-2A>C	.	.	7.26E-09	0.998625922	0.00137407	.	0.17004	0.94961	-1.675620402	2.689313517	2728.58132	9.84685	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3.536	0.483	23.1	0.988	0.455	0.949	0.624	D	c	0.783	0.547	0.987	0.311	0.056	0.006	0	4.59	0.561	5.197	0.648	0.964	0.580	1.000	0.715	0.033	0.150	13.201	0.590	.	.	.	0.5	.	311	17	26087772	chr17:26087772	T	G	.	PASS	DP=311;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	26522835	26522835	T	-	UTR3	NLK	NM_016231:c.*1173delT	.	.	0.998934347	0.001065641	1.24E-08	.	0.96706	0.16306	-0.494039303	22.09247464	16.84134	0.5932	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	169	17	26522834	chr17:26522834	AT	A	89	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	27419327	27419327	C	A	intronic	MYO18A	.	.	.	0.999417504	0.000582496	3.26E-16	.	0.45342	0.14389	-1.618952458	2.895730125	551.10541	4.7741	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	70	17	27419327	chr17:27419327	C	A	.	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	28886747	28886747	G	T	intronic	TBC1D29	.	.	.	8.25E-05	0.321646341	0.678271175	.	0.07418	.	0.215080721	67.91696155	10.20934	0.37212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	398	17	28886747	chr17:28886747	G	T	.	PASS	DP=398;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	28999185	28999185	A	-	intergenic	LOC107133515;SUZ12P1	dist=34701;dist=37441	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	226	17	28999184	chr17:28999184	GA	G	59	PASS	DP=226;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	29349022	29349022	C	T	exonic	LOC107984974	.	synonymous SNV	LOC107984974:NM_001350575:exon2:c.C147T:p.I49I,LOC107984974:NM_001350578:exon2:c.C147T:p.I49I,LOC107984974:NM_001350579:exon2:c.C147T:p.I49I	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	17	29349022	chr17:29349022	C	T	.	PASS	DP=25;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	29482988	29482988	-	T	intronic	NF1	.	.	.	0.999999846	1.54E-07	1.06E-27	DISEASE: Neurofibromatosis 1 (NF1) [MIM:162200]: A disease characterized by patches of skin pigmentation (cafe-au-lait spots), Lisch nodules of the iris, tumors in the peripheral nervous system and fibromatous skin tumors. Individuals with the disorder have increased susceptibility to the development of benign and malignant tumors. {ECO:0000269|PubMed:10220149, ECO:0000269|PubMed:10336779, ECO:0000269|PubMed:10607834, ECO:0000269|PubMed:10712197, ECO:0000269|PubMed:10980545, ECO:0000269|PubMed:11258625, ECO:0000269|PubMed:11735023, ECO:0000269|PubMed:11857752, ECO:0000269|PubMed:12522551, ECO:0000269|PubMed:12552569, ECO:0000269|PubMed:12746402, ECO:0000269|PubMed:1302608, ECO:0000269|PubMed:15060124, ECO:0000269|PubMed:15146469, ECO:0000269|PubMed:15520408, ECO:0000269|PubMed:15523642, ECO:0000269|PubMed:15948193, ECO:0000269|PubMed:17160901, ECO:0000269|PubMed:2114220, ECO:0000269|PubMed:21838856, ECO:0000269|PubMed:23758643, ECO:0000269|PubMed:24413922, ECO:0000269|PubMed:7981679, ECO:0000269|PubMed:8081387, ECO:0000269|PubMed:8544190, ECO:0000269|PubMed:8807336, ECO:0000269|PubMed:8834249, ECO:0000269|PubMed:9003501, ECO:0000269|PubMed:9101300, ECO:0000269|PubMed:9150739, ECO:0000269|PubMed:9298829, ECO:0000269|PubMed:9668168}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Watson syndrome (WTSN) [MIM:193520]: A syndrome characterized by the presence of pulmonary stenosis, cafe-au-lait spots, and mental retardation. It is considered as an atypical form of neurofibromatosis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial spinal neurofibromatosis (FSNF) [MIM:162210]: Considered to be an alternative form of neurofibromatosis, showing multiple spinal tumors. {ECO:0000269|PubMed:11704931}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]: Characterized by manifestations of both NF1 and Noonan syndrome (NS). NS is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. {ECO:0000269|PubMed:12707950, ECO:0000269|PubMed:16380919, ECO:0000269|PubMed:19845691}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.6001	0.90845	-3.091147521	0.471809389	198.4465	3.04463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	31	17	29482988	chr17:29482988	C	CT	40	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	29559138	29559138	G	A	exonic	NF1	.	nonsynonymous SNV	NF1:NM_000267:exon25:c.G3245A:p.G1082D,NF1:NM_001042492:exon25:c.G3245A:p.G1082D	0.999999846	1.54E-07	1.06E-27	DISEASE: Neurofibromatosis 1 (NF1) [MIM:162200]: A disease characterized by patches of skin pigmentation (cafe-au-lait spots), Lisch nodules of the iris, tumors in the peripheral nervous system and fibromatous skin tumors. Individuals with the disorder have increased susceptibility to the development of benign and malignant tumors. {ECO:0000269|PubMed:10220149, ECO:0000269|PubMed:10336779, ECO:0000269|PubMed:10607834, ECO:0000269|PubMed:10712197, ECO:0000269|PubMed:10980545, ECO:0000269|PubMed:11258625, ECO:0000269|PubMed:11735023, ECO:0000269|PubMed:11857752, ECO:0000269|PubMed:12522551, ECO:0000269|PubMed:12552569, ECO:0000269|PubMed:12746402, ECO:0000269|PubMed:1302608, ECO:0000269|PubMed:15060124, ECO:0000269|PubMed:15146469, ECO:0000269|PubMed:15520408, ECO:0000269|PubMed:15523642, ECO:0000269|PubMed:15948193, ECO:0000269|PubMed:17160901, ECO:0000269|PubMed:2114220, ECO:0000269|PubMed:21838856, ECO:0000269|PubMed:23758643, ECO:0000269|PubMed:24413922, ECO:0000269|PubMed:7981679, ECO:0000269|PubMed:8081387, ECO:0000269|PubMed:8544190, ECO:0000269|PubMed:8807336, ECO:0000269|PubMed:8834249, ECO:0000269|PubMed:9003501, ECO:0000269|PubMed:9101300, ECO:0000269|PubMed:9150739, ECO:0000269|PubMed:9298829, ECO:0000269|PubMed:9668168}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Watson syndrome (WTSN) [MIM:193520]: A syndrome characterized by the presence of pulmonary stenosis, cafe-au-lait spots, and mental retardation. It is considered as an atypical form of neurofibromatosis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial spinal neurofibromatosis (FSNF) [MIM:162210]: Considered to be an alternative form of neurofibromatosis, showing multiple spinal tumors. {ECO:0000269|PubMed:11704931}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]: Characterized by manifestations of both NF1 and Noonan syndrome (NS). NS is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. {ECO:0000269|PubMed:12707950, ECO:0000269|PubMed:16380919, ECO:0000269|PubMed:19845691}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.6001	0.90845	-3.091147521	0.471809389	198.4465	3.04463	0.145	0.251	T	0.999	0.899	D	0.971	0.832	D	0.000	0.843	D	1	0.810	D	2.215	0.627	M	3.15	0.094	T	-4.43	0.775	D	0.936	0.930	-1.162	0.007	T	0.071	0.289	T	0.861	0.989	D	3.165	0.440	22.6	0.998	0.882	0.992	0.926	D	c	0.538	0.606	1.000	0.747	0.732	0.924	0	5.35	0.762	9.493	0.969	0.998	0.613	1.000	0.715	0.998	0.697	19.059	0.930	.	.	.	0.5	.	55	17	29559138	chr17:29559138	G	A	.	PASS	DP=55;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	29701671	29701671	T	-	UTR3	NF1	NM_000267:c.*498delT;NM_001042492:c.*498delT	.	.	0.999999846	1.54E-07	1.06E-27	DISEASE: Neurofibromatosis 1 (NF1) [MIM:162200]: A disease characterized by patches of skin pigmentation (cafe-au-lait spots), Lisch nodules of the iris, tumors in the peripheral nervous system and fibromatous skin tumors. Individuals with the disorder have increased susceptibility to the development of benign and malignant tumors. {ECO:0000269|PubMed:10220149, ECO:0000269|PubMed:10336779, ECO:0000269|PubMed:10607834, ECO:0000269|PubMed:10712197, ECO:0000269|PubMed:10980545, ECO:0000269|PubMed:11258625, ECO:0000269|PubMed:11735023, ECO:0000269|PubMed:11857752, ECO:0000269|PubMed:12522551, ECO:0000269|PubMed:12552569, ECO:0000269|PubMed:12746402, ECO:0000269|PubMed:1302608, ECO:0000269|PubMed:15060124, ECO:0000269|PubMed:15146469, ECO:0000269|PubMed:15520408, ECO:0000269|PubMed:15523642, ECO:0000269|PubMed:15948193, ECO:0000269|PubMed:17160901, ECO:0000269|PubMed:2114220, ECO:0000269|PubMed:21838856, ECO:0000269|PubMed:23758643, ECO:0000269|PubMed:24413922, ECO:0000269|PubMed:7981679, ECO:0000269|PubMed:8081387, ECO:0000269|PubMed:8544190, ECO:0000269|PubMed:8807336, ECO:0000269|PubMed:8834249, ECO:0000269|PubMed:9003501, ECO:0000269|PubMed:9101300, ECO:0000269|PubMed:9150739, ECO:0000269|PubMed:9298829, ECO:0000269|PubMed:9668168}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Watson syndrome (WTSN) [MIM:193520]: A syndrome characterized by the presence of pulmonary stenosis, cafe-au-lait spots, and mental retardation. It is considered as an atypical form of neurofibromatosis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial spinal neurofibromatosis (FSNF) [MIM:162210]: Considered to be an alternative form of neurofibromatosis, showing multiple spinal tumors. {ECO:0000269|PubMed:11704931}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]: Characterized by manifestations of both NF1 and Noonan syndrome (NS). NS is a disorder characterized by dysmorphic facial features, short stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a bleeding diathesis. {ECO:0000269|PubMed:12707950, ECO:0000269|PubMed:16380919, ECO:0000269|PubMed:19845691}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.6001	0.90845	-3.091147521	0.471809389	198.4465	3.04463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	79	17	29701670	chr17:29701670	CT	C	55	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	30263821	30263821	C	G	upstream	SUZ12	dist=208	.	.	0.999270636	0.000729363	9.92E-10	DISEASE: Note=A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. {ECO:0000269|PubMed:11371647}.; 	0.90035	.	-0.159704656	41.90846898	37.06069	1.10711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	90	17	30263821	chr17:30263821	C	G	102	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	30320861	30320861	-	T	intronic	SUZ12	.	.	.	0.999270636	0.000729363	9.92E-10	DISEASE: Note=A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. {ECO:0000269|PubMed:11371647}.; 	0.90035	.	-0.159704656	41.90846898	37.06069	1.10711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	106	17	30320860	chr17:30320860	CT	CTT,C	66	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	30320861	30320861	T	-	intronic	SUZ12	.	.	.	0.999270636	0.000729363	9.92E-10	DISEASE: Note=A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. {ECO:0000269|PubMed:11371647}.; 	0.90035	.	-0.159704656	41.90846898	37.06069	1.10711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	106	17	30320860	chr17:30320860	CT	CTT,C	66	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	30327962	30327962	A	-	UTR3	SUZ12	NM_015355:c.*1940delA;NM_001321207:c.*1940delA	.	.	0.999270636	0.000729363	9.92E-10	DISEASE: Note=A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer. {ECO:0000269|PubMed:11371647}.; 	0.90035	.	-0.159704656	41.90846898	37.06069	1.10711	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	25	17	30327961	chr17:30327961	TA	T	41	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	30621266	30621268	TCC	-	intronic	RHBDL3	.	.	.	0.001523114	0.967948766	0.03052812	.	0.1589	0.10761	-0.249709319	35.74545883	2655.56199	9.68692	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	28.53	14	17	30621265	chr17:30621265	TTCC	T	28.53	PASS	DP=14;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	33769038	33769038	C	A	exonic	SLFN13	.	nonsynonymous SNV	SLFN13:NM_144682:exon5:c.G1466T:p.R489L	8.75E-15	0.004834494	0.995165506	.	0.05976	0.06727	2.763559657	98.99740505	1954.11134	8.1348	0.635	0.051	T	0.388	0.327	B	0.083	0.277	B	0.287	0.039	N	1	0.090	P	2.24	0.636	M	4.49	0.035	T	-2.15	0.486	N	0.188	0.241	-0.948	0.414	T	0.008	0.030	T	.	.	.	0.520	0.144	7.585	0.425	0.031	0.004	0.019	N	c	-1.448	-1.614	0.119	0.168	0.707	0.730	0	-6.09	0.020	-6.973	0.001	-2.795	0.002	0.000	0.063	0.000	0.016	5.552	0.163	.	.	.	0.5	170	599	17	33769038	chr17:33769038	C	A	170	PASS	DP=599;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	36357125	36357144	AAATATATTTGAGCACTTAA	-	ncRNA_intronic	LOC440434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	200	17	36357124	chr17:36357124	TAAATATATTTGAGCACTTAA	T	68	PASS	DP=200;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	36861971	36861971	C	A	exonic	MLLT6	.	nonsynonymous SNV	MLLT6:NM_005937:exon1:c.C86A:p.A29E	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	0.448	0.342	B	0.115	0.316	B	0.005	0.332	N	0.716	0.299	N	0.625	0.159	N	.	.	.	.	.	.	0.262	0.323	-1.013	0.258	T	0.015	0.062	T	0.417	0.937	D	4.294	0.575	24.0	0.976	0.342	0.758	0.369	D	c	-0.418	-0.326	1.000	0.747	0.767	0.994	0	1.16	0.198	6.035	0.704	-0.077	0.119	1.000	0.715	0.996	0.625	11.099	0.472	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, PHD-type, conserved site|Zinc finger, RING/FYVE/PHD-type	.	.	0.5	129	1087	17	36861971	chr17:36861971	C	A	129	PASS	DP=1087;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	36875820	36875820	G	A	exonic	MLLT6	.	nonsynonymous SNV	MLLT6:NM_005937:exon13:c.G1993A:p.E665K	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	0.996	0.670	D	0.99	0.774	D	0.000	0.513	D	1	0.810	D	1.895	0.505	L	.	.	.	.	.	.	0.232	0.721	-1.157	0.008	T	0.071	0.288	T	0.008	0.223	T	4.628	0.620	24.5	0.999	0.955	0.979	0.776	D	c	0.677	0.661	1.000	0.747	0.726	0.872	0	4.73	0.593	7.708	0.835	1.029	0.652	1.000	0.715	1.000	0.888	16.627	0.848	.	.	.	0.5	.	225	17	36875820	chr17:36875820	G	A	.	PASS	DP=225;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	36880975	36880975	C	T	exonic	MLLT6	.	synonymous SNV	MLLT6:NM_005937:exon19:c.C2986T:p.L996L	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	113	17	36880975	chr17:36880975	C	T	59	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	36883483	36883483	-	T	UTR3	MLLT6	NM_005937:c.*1632_*1633insT	.	.	0.998762157	0.001237842	7.29E-10	DISEASE: Note=A chromosomal aberration involving MLLT6 is associated with acute leukemias. Translocation t(11;17)(q23;q21) with KMT2A/MLL1. The result is a rogue activator protein.; 	0.50287	0.15426	-0.020150552	52.25288983	264.58482	3.48969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	44	17	36883483	chr17:36883483	G	GT	51	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	36923775	36923775	A	C	UTR3	PIP4K2B	NM_003559:c.*2169T>G	.	.	0.989205104	0.010791372	3.52E-06	.	0.18019	0.12112	-0.049474214	50.01179523	29.81132	0.95121	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	42	17	36923775	chr17:36923775	A	C	54	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	36965911	36965911	C	A	intronic	CWC25	.	.	.	0.008010166	0.977729099	0.014260735	.	0.2055	0.10468	-0.115612493	45.12856806	76.64648	1.83775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	17	36965911	chr17:36965911	C	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	36965912	36965912	C	T	intronic	CWC25	.	.	.	0.008010166	0.977729099	0.014260735	.	0.2055	0.10468	-0.115612493	45.12856806	76.64648	1.83775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	17	36965912	chr17:36965912	C	T	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	38349645	38349645	C	T	exonic	RAPGEFL1	.	nonsynonymous SNV	RAPGEFL1:NM_001303533:exon14:c.C1387T:p.R463C,RAPGEFL1:NM_001303534:exon14:c.C1369T:p.R457C	0.874145904	0.125840265	1.38E-05	.	0.42544	.	-0.758599262	13.32861524	28.15111	0.90201	0.0	0.912	D	1.0	0.899	D	0.973	0.749	D	0.000	0.497	D	1	0.810	D	2.675	0.786	M	1.45	0.325	T	-7.14	0.941	D	0.952	0.949	-0.693	0.608	T	0.201	0.558	T	0.061	0.685	D	7.745	0.955	35	0.999	0.993	0.936	0.583	D	c	0.669	0.624	0.998	0.358	0.696	0.567	0	4.63	0.570	0.506	0.222	0.852	0.362	0.998	0.411	1.000	0.888	13.063	0.583	Ras guanine nucleotide exchange factor domain|Ras guanine-nucleotide exchange factors catalytic domain;Ras guanine nucleotide exchange factor domain|Ubiquitin-related domain	.	.	0.5	39	69	17	38349645	chr17:38349645	C	T	39	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	38644861	38644861	C	A	exonic	TNS4	.	nonsynonymous SNV	TNS4:NM_032865:exon3:c.G800T:p.R267L	0.000130733	0.997996452	0.001872815	.	0.08569	0.10973	-0.24061166	36.28214201	2886.90526	10.1786	0.174	0.225	T	0.01	0.144	B	0.009	0.133	B	0.000	0.002	N	1.000	0.090	N	0.635	0.160	N	2.13	0.196	T	-1.64	0.393	N	0.099	0.101	-1.022	0.231	T	0.034	0.148	T	0.007	0.178	T	1.838	0.282	15.21	0.879	0.170	0.184	0.201	N	c	-0.845	-0.774	1.000	0.517	0.497	0.185	0	2.35	0.280	0.509	0.223	0.060	0.166	0.000	0.063	0.994	0.587	6.436	0.209	.	.	.	0.5	.	190	17	38644861	chr17:38644861	C	A	.	PASS	DP=190;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	39021183	39021183	C	T	exonic	KRT12	.	nonsynonymous SNV	KRT12:NM_000223:exon3:c.G682A:p.V228I	9.44E-11	0.080930289	0.919069711	.	0.21898	0.21502	0.50895761	80.20169851	717.36097	5.31581	0.015	0.524	D	1.0	0.899	D	0.998	0.875	D	0.000	0.445	D	1.000	0.588	D	3.615	0.940	H	-2.54	0.895	D	-0.86	0.234	N	0.51	0.554	0.970	0.967	D	0.889	0.963	D	0.095	0.765	D	6.181	0.853	28.6	0.999	0.963	0.984	0.818	D	c	0.845	0.732	1.000	0.747	0.497	0.185	0	5.96	0.967	5.047	0.638	0.935	0.490	1.000	0.715	0.416	0.257	20.422	0.990	.	.	.	0.5	.	277	17	39021183	chr17:39021183	C	T	.	PASS	DP=277;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	39033672	39033672	-	T	intronic	KRT20	.	.	.	5.58E-06	0.672378198	0.327616222	.	0.33628	0.25521	0.176444282	66.07100731	89.49778	2.03437	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	20	17	39033672	chr17:39033672	G	GT	59	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	39203522	39203534	TGGTGTCTGAGGC	-	UTR5	KRTAP2-1	NM_001123387:c.-3_-15delGCCTCAGACACCA	.	.	.	.	.	.	0.24626	.	.	.	6079.05555	16.29512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	175	17	39203521	chr17:39203521	GTGGTGTCTGAGGC	G	108	PASS	DP=175;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	39411615	39411615	A	G	intronic	KRTAP9-9	.	.	.	0.007298706	0.536562679	0.456138614	.	.	0.10345	.	.	5752.9952	15.75321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	136	17	39411615	chr17:39411615	A	G	82	PASS	DP=136;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	39412133	39412133	C	A	exonic	KRTAP9-9	.	nonsynonymous SNV	KRTAP9-9:NM_030975:exon1:c.C496A:p.P166T,KRTAP9-9:NM_001318227:exon2:c.C511A:p.P171T	0.007298706	0.536562679	0.456138614	.	.	0.10345	.	.	5752.9952	15.75321	0.037	0.430	D	0.975	0.561	D	0.763	0.547	P	.	.	.	0.999	0.220	N	.	.	.	4.67	0.018	T	-4.87	0.812	D	0.492	0.539	-0.980	0.350	T	0.013	0.050	T	0.004	0.112	T	4.329	0.580	24.0	0.993	0.575	0.117	0.166	N	c	-0.033	-0.185	0.004	0.103	0.447	0.083	0	1.48	0.218	0.044	0.138	0.718	0.303	0.000	0.063	0.957	0.436	4.831	0.127	.	.	.	0.5	.	321	17	39412133	chr17:39412133	C	A	.	PASS	DP=321;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	39594694	39594694	G	A	intronic	KRT38	.	.	.	2.17E-05	0.724250939	0.275727343	.	0.08393	0.1123	-0.33061537	30.82094834	172.03352	2.86058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	103	92	17	39594694	chr17:39594694	G	A	103	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	39776818	39776818	A	-	intronic	KRT17	.	.	.	7.07E-06	0.722413326	0.2775796	DISEASE: Pachyonychia congenita 2 (PC2) [MIM:167210]: An autosomal dominant ectodermal dysplasia characterized by hypertrophic nail dystrophy resulting in onchyogryposis (thickening and increase in curvature of the nail), palmoplantar keratoderma and hyperhidrosis, follicular hyperkeratosis, multiple epidermal cysts, absent/sparse eyebrow and body hair, and by the presence of natal teeth. {ECO:0000269|PubMed:10571744, ECO:0000269|PubMed:11348474, ECO:0000269|PubMed:11874497, ECO:0000269|PubMed:11886499, ECO:0000269|PubMed:15102078, ECO:0000269|PubMed:15795125, ECO:0000269|PubMed:16250206, ECO:0000269|PubMed:16620218, ECO:0000269|PubMed:16625196, ECO:0000269|PubMed:17719747, ECO:0000269|PubMed:18547302, ECO:0000269|PubMed:19470054, ECO:0000269|PubMed:21326300, ECO:0000269|PubMed:23278621, ECO:0000269|PubMed:23855588, ECO:0000269|PubMed:7539673, ECO:0000269|PubMed:9008238, ECO:0000269|PubMed:9767294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Steatocystoma multiplex (SM) [MIM:184500]: Disease characterized by round or oval cystic tumors widely distributed on the back, anterior trunk, arms, scrotum, and thighs. {ECO:0000269|PubMed:16620218, ECO:0000269|PubMed:9008238, ECO:0000269|PubMed:9767294}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=KRT16 and KRT17 are coexpressed only in pathological situations such as metaplasias and carcinomas of the uterine cervix and in psoriasis vulgaris.; 	.	0.22756	-0.244249595	36.17008728	729.66866	5.36212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	325	17	39776817	chr17:39776817	GA	G	90	PASS	DP=325;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	39974642	39974642	A	G	exonic	FKBP10	.	nonsynonymous SNV	FKBP10:NM_021939:exon4:c.A590G:p.K197R	0.000807425	0.983229411	0.015963164	DISEASE: Osteogenesis imperfecta 11 (OI11) [MIM:610968]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI11 is an autosomal recessive form. {ECO:0000269|PubMed:20362275, ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bruck syndrome 1 (BRKS1) [MIM:259450]: A disease characterized by generalized osteopenia, congenital joint contractures, fragile bones with onset of fractures in infancy or early childhood, short stature, severe limb deformity, progressive scoliosis, and pterygia. {ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.44644	0.10813	-0.751322189	13.71196037	103.41854	2.19663	1.0	0.010	T	0.0	0.026	B	0.003	0.080	B	0.041	0.240	N	1	0.090	P	-1.85	0.003	N	0.82	0.481	T	1.41	0.008	N	0.036	0.016	-0.983	0.343	T	0.001	0.003	T	.	.	.	-2.128	0.006	0.001	0.143	0.003	0.204	0.208	N	c	-1.729	-1.528	0.971	0.292	0.722	0.854	0	1.37	0.211	3.252	0.509	-0.229	0.095	0.999	0.424	0.808	0.339	11.540	0.497	FKBP-type peptidyl-prolyl cis-trans isomerase domain	ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000141698.12|ENSG00000259623.1|ENSG00000141698.12	Adipose_Subcutaneous|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Lung|Muscle_Skeletal|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Thyroid|Whole_Blood	0.5	160	102	17	39974642	chr17:39974642	A	G	160	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	40370236	40370236	G	-	exonic	STAT5B	.	frameshift deletion	STAT5B:NM_012448:exon9:c.1102delC:p.Q368Rfs*1	0.99995316	4.68E-05	1.24E-12	DISEASE: Growth hormone insensitivity with immunodeficiency (GHII) [MIM:245590]: A disease characterized by short stature, growth hormone deficiency in the presence of normal to elevated circulating concentrations of growth hormone, resistance to hexogeneous growth hormone therapy, and recurrent infections. {ECO:0000269|PubMed:13679528, ECO:0000269|PubMed:15827093, ECO:0000269|PubMed:22419735}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.50895	.	-0.890882376	10.30313753	46.4952	1.31577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	581	17	40370235	chr17:40370235	TG	T	79	PASS	DP=581;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.
17	40461067	40461067	A	G	exonic	STAT5A	.	nonsynonymous SNV	STAT5A:NM_001288719:exon16:c.A1975G:p.K659E,STAT5A:NM_001288720:exon16:c.A1972G:p.K658E,STAT5A:NM_001288718:exon17:c.A2065G:p.K689E,STAT5A:NM_003152:exon18:c.A2065G:p.K689E	0.999866029	0.000133971	1.60E-11	.	0.68233	0.58998	-0.644723694	16.52512385	205.21053	3.09506	0.291	0.215	T	0.063	0.219	B	0.023	0.262	B	0.587	0.111	N	1.000	0.588	D	2.645	0.776	M	-3.96	0.962	D	-1.24	0.314	N	0.668	0.678	0.455	0.899	D	0.831	0.944	D	0.084	0.744	D	1.099	0.200	11.21	0.949	0.252	0.991	0.912	D	c	-0.155	-0.073	1.000	0.747	0.672	0.522	0	4.91	0.638	9.161	0.938	1.140	0.893	1.000	0.715	0.212	0.220	14.570	0.677	SH2 domain	.	.	0.5	98	69	17	40461067	chr17:40461067	A	G	98	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	40819937	40819937	G	A	UTR3	PLEKHH3	NM_024927:c.*208C>T	.	.	0.003760662	0.994437387	0.001801951	.	0.57588	0.09682	-0.955204708	9.170794999	149.26629	2.66346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	85	17	40819937	chr17:40819937	G	A	.	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	41960509	41960509	C	A	intronic	MPP2	.	.	.	0.002580507	0.994325869	0.003093623	.	0.58879	0.11658	-1.021348453	7.997169144	72.75543	1.7805	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	17	41960509	chr17:41960509	C	A	.	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	42143772	42143772	C	-	intronic	LSM12	.	.	.	0.931681763	0.067978307	0.000339929	.	0.4439	0.11262	0.169169615	65.33380514	36.37283	1.09024	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	644	17	42143771	chr17:42143771	AC	A	85	PASS	DP=644;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	42283996	42283996	A	-	UTR3	UBTF	NM_001076684:c.*614delT;NM_001076683:c.*614delT;NM_014233:c.*614delT	.	.	0.999998048	1.95E-06	2.65E-15	.	0.8196	0.17238	-1.155457828	6.168907761	10.71614	0.38835	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	525	17	42283995	chr17:42283995	TA	T	71	PASS	DP=525;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	43324637	43324637	C	A	UTR3	FMNL1	NM_005892:c.*412C>A	.	.	0.999687036	0.000312964	5.17E-12	.	0.38561	0.13099	-1.063626766	7.484076433	3176.17327	10.74104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	410	17	43324637	chr17:43324637	C	A	105	PASS	DP=410;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	43626397	43626397	G	C	intergenic	LRRC37A4P;MAPK8IP1P2	dist=28508;dist=51072	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	875	17	43626397	chr17:43626397	G	C	129	PASS	DP=875;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	45623336	45623336	C	T	exonic	NPEPPS	.	nonsynonymous SNV	NPEPPS:NM_006310:exon2:c.C317T:p.S106L,NPEPPS:NM_001330257:exon3:c.C305T:p.S102L	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	0.103	0.405	T	0.367	0.323	B	0.166	0.398	B	0.000	0.843	D	1	0.810	D	1.53	0.389	L	4.2	0.027	T	-2.01	0.463	N	0.565	0.607	-0.941	0.425	T	0.019	0.080	T	0.018	0.405	T	3.588	0.489	23.2	0.999	0.972	0.917	0.537	D	c	0.094	0.198	0.094	0.162	0.706	0.609	0	4.11	0.472	6.164	0.715	0.709	0.301	1.000	0.715	1.000	0.888	15.272	0.733	Peptidase M1, membrane alanine aminopeptidase, N-terminal	.	.	0.5	.	56	17	45623336	chr17:45623336	C	T	.	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	45664574	45664574	-	T	intronic	NPEPPS	.	.	.	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.23	131	17	45664573	chr17:45664573	CT	CTT,C	25.23	PASS	DP=131;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	45664574	45664574	T	-	intronic	NPEPPS	.	.	.	0.99990592	9.41E-05	6.76E-12	.	0.2064	0.20026	0.042348793	57.31304553	51.85467	1.42259	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.23	131	17	45664573	chr17:45664573	CT	CTT,C	25.23	PASS	DP=131;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	45727590	45727590	G	A	UTR5	KPNB1	NM_002265:c.-21G>A	.	.	0.999994328	5.67E-06	7.22E-15	.	0.99948	0.5595	-0.624497208	17.16206653	28.74247	0.91953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	17	45727590	chr17:45727590	G	A	.	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	46053334	46053334	A	G	exonic	CDK5RAP3	.	synonymous SNV	CDK5RAP3:NM_001278198:exon6:c.A78G:p.E26E,CDK5RAP3:NM_001278216:exon6:c.A78G:p.E26E,CDK5RAP3:NM_001278217:exon7:c.A492G:p.E164E,CDK5RAP3:NM_001278197:exon8:c.A828G:p.E276E,CDK5RAP3:NM_176096:exon8:c.A753G:p.E251E	2.87E-12	0.138474787	0.861525213	.	0.22673	0.12287	0.622829232	83.47487615	584.11515	4.90058	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	256	17	46053334	chr17:46053334	A	G	96	PASS	DP=256;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	46621803	46621803	T	-	ncRNA_intronic	HOXB-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	937	17	46621802	chr17:46621802	AT	A	87	PASS	DP=937;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	46689879	46689879	A	G	UTR3	HOXB8	NM_024016:c.*685T>C	.	.	0.444768418	0.548716697	0.006514885	.	0.70662	0.1705	0.347360312	73.97381458	275.34627	3.55414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	168	17	46689879	chr17:46689879	A	G	124	PASS	DP=168;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	47583697	47583697	C	A	exonic	NGFR	.	nonsynonymous SNV	NGFR:NM_002507:exon3:c.C245A:p.P82Q	0.238222215	0.754753803	0.007023982	.	0.45788	0.74431	-0.203796826	38.81811748	290.02902	3.64468	0.415	0.100	T	0.213	0.284	B	0.049	0.237	B	0.014	0.286	N	0.998	0.448	D	1.33	0.334	L	-2.66	0.903	D	-1.28	0.322	N	0.167	0.202	-0.342	0.738	T	0.462	0.792	T	0.086	0.747	D	2.601	0.374	20.2	0.979	0.361	0.432	0.268	N	c	-0.427	-0.265	1.000	0.517	0.696	0.567	0	4.39	0.520	2.493	0.447	0.935	0.490	0.400	0.259	1.000	0.888	15.485	0.752	TNFR/NGFR cysteine-rich region	.	.	0.5	.	276	17	47583697	chr17:47583697	C	A	.	PASS	DP=276;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	48195470	48195470	G	T	intronic	SAMD14	.	.	.	0.02026443	0.975990271	0.003745299	.	0.19905	0.10658	-0.53631094	20.53550366	50.42659	1.39709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	137	17	48195470	chr17:48195470	G	T	.	PASS	DP=137;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	48277042	48277042	C	A	intronic	COL1A1	.	.	.	0.999999999	1.02E-09	2.21E-25	DISEASE: Caffey disease (CAFFD) [MIM:114000]: Characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age. {ECO:0000269|PubMed:15864348}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome, classic type (EDS) [MIM:130000]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. {ECO:0000269|PubMed:10739762, ECO:0000269|PubMed:17211858}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome 7A (EDS7A) [MIM:130060]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. {ECO:0000269|PubMed:1634225, ECO:0000269|PubMed:16638323, ECO:0000269|PubMed:16705691, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1718984, ECO:0000269|PubMed:1737847, ECO:0000269|PubMed:17875077, ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:24682174, ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:3244312, ECO:0000269|PubMed:8223589}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. {ECO:0000269|PubMed:10627137, ECO:0000269|PubMed:1460047, ECO:0000269|PubMed:1511982, ECO:0000269|PubMed:1613761, ECO:0000269|PubMed:16566045, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:1874719, ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:1939261, ECO:0000269|PubMed:1953667, ECO:0000269|PubMed:2035536, ECO:0000269|PubMed:2036375, ECO:0000269|PubMed:2037280, ECO:0000269|PubMed:2116413, ECO:0000269|PubMed:2211725, ECO:0000269|PubMed:2339700, ECO:0000269|PubMed:2470760, ECO:0000269|PubMed:25958000, ECO:0000269|PubMed:2777764, ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:2913053, ECO:0000269|PubMed:3016737, ECO:0000269|PubMed:3108247, ECO:0000269|PubMed:3403550, ECO:0000269|PubMed:3667599, ECO:0000269|PubMed:7520724, ECO:0000269|PubMed:7679635, ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7961597, ECO:0000269|PubMed:8100209, ECO:0000269|PubMed:8349697, ECO:0000269|PubMed:8349698, ECO:0000269|PubMed:8364588, ECO:0000269|PubMed:8456808, ECO:0000269|PubMed:8786074, ECO:0000269|PubMed:9143923, ECO:0000269|Ref.47, ECO:0000269|Ref.50}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:10408781, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1770532, ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:2037280, ECO:0000269|PubMed:2511192, ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7881420, ECO:0000269|PubMed:8019571, ECO:0000269|PubMed:8364588, ECO:0000269|PubMed:8456809, ECO:0000269|PubMed:8669434, ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:9101304}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1770532, ECO:0000269|PubMed:17875077, ECO:0000269|PubMed:1988452, ECO:0000269|PubMed:2745420, ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7982948, ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8339541, ECO:0000269|PubMed:9600458}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteoporosis (OSTEOP) [MIM:166710]: A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs. {ECO:0000269|PubMed:8841196, ECO:0000269|PubMed:9535665}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving COL1A1 is found in dermatofibrosarcoma protuberans. Translocation t(17;22)(q22;q13) with PDGF.; 	0.99194	0.99087	-1.785892633	2.25878745	137.3096	2.54895	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	179	17	48277042	chr17:48277042	C	A	101	PASS	DP=179;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	48639434	48639434	T	A	ncRNA_exonic	CACNA1G-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	17	48639434	chr17:48639434	T	A	.	PASS	DP=99;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	48639445	48639445	C	T	ncRNA_exonic	CACNA1G-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	101	17	48639445	chr17:48639445	C	T	.	PASS	DP=101;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	48653397	48653397	C	-	exonic	CACNA1G	.	frameshift deletion	CACNA1G:NM_001256324:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256325:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256326:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256327:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256328:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256329:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256330:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256331:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256332:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256333:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256334:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256359:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256360:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_001256361:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_018896:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198376:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198377:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198378:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198379:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198380:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198382:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198383:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198384:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198385:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198386:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198387:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198388:exon8:c.1634delC:p.P547Lfs*16,CACNA1G:NM_198396:exon8:c.1634delC:p.P547Lfs*16	0.999996517	3.48E-06	7.46E-19	.	0.50605	0.17372	-2.374358198	1.114649682	288.88842	3.63697	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	805	17	48653396	chr17:48653396	GC	G	83	PASS	DP=805;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	48750766	48750766	C	T	intronic	ABCC3	.	.	.	2.62E-14	0.989877188	0.010122812	.	0.11549	0.27947	0.690669139	85.21467327	889.61134	5.81122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	17	48750766	chr17:48750766	C	T	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	48750768	48750768	G	T	intronic	ABCC3	.	.	.	2.62E-14	0.989877188	0.010122812	.	0.11549	0.27947	0.690669139	85.21467327	889.61134	5.81122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	17	48750768	chr17:48750768	G	T	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	48940282	48940282	-	A	UTR3	TOB1	NM_001243885:c.*58_*59insT;NM_001243877:c.*58_*59insT;NM_005749:c.*58_*59insT	.	.	0.798204384	0.196185003	0.005610612	.	0.78741	0.22085	-0.271755481	34.31823543	36.86645	1.10425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	600	17	48940281	chr17:48940281	GA	GAA,G	75	PASS	DP=600;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/2
17	48940282	48940282	A	-	UTR3	TOB1	NM_001243885:c.*59delT;NM_001243877:c.*59delT;NM_005749:c.*59delT	.	.	0.798204384	0.196185003	0.005610612	.	0.78741	0.22085	-0.271755481	34.31823543	36.86645	1.10425	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	600	17	48940281	chr17:48940281	GA	GAA,G	75	PASS	DP=600;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/2
17	56332206	56332206	C	A	exonic	LPO	.	synonymous SNV	LPO:NM_001160102:exon7:c.C891A:p.A297A,LPO:NM_006151:exon9:c.C1140A:p.A380A	2.91E-11	0.264081682	0.735918318	.	0.15837	0.32199	-1.240018202	5.461193678	1144.41107	6.45117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	17	56332206	chr17:56332206	C	A	.	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	57762403	57762403	T	-	intronic	CLTC	.	.	.	0.999999993	6.69E-09	1.07E-22	.	0.64701	0.94571	-1.3098007	4.847841472	29.64323	0.94706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	83	17	57762402	chr17:57762402	CT	C,CTT	84	PASS	DP=83;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/2
17	57762403	57762403	-	T	intronic	CLTC	.	.	.	0.999999993	6.69E-09	1.07E-22	.	0.64701	0.94571	-1.3098007	4.847841472	29.64323	0.94706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	83	17	57762402	chr17:57762402	CT	C,CTT	84	PASS	DP=83;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/2
17	58239854	58239854	C	T	intergenic	CA4;USP32	dist=2948;dist=14837	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	278	17	58239854	chr17:58239854	C	T	61	PASS	DP=278;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	58469177	58469178	TA	-	intronic	USP32	.	.	.	0.999999997	2.88E-09	5.68E-25	.	0.99543	0.10507	-2.078019896	1.580561453	184.4083	2.94681	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	111	17	58469176	chr17:58469176	TTA	T	81	PASS	DP=111;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	59465991	59465991	-	A	exonic	BCAS3	.	frameshift insertion	BCAS3:NM_001320470:exon25:c.2673dupA:p.Q895Tfs*8	0.998848202	0.001151798	1.02E-12	DISEASE: Note=A chromosomal aberration involving BCAS3 has been found in some breast carcinoma cell lines. Translocation t(17;20)(q23;q13) with BCAS4.; 	0.63691	.	-0.753139731	13.67067705	343.97696	3.93313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	51	17	59465991	chr17:59465991	G	GA	66	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	59857599	59857599	-	A	intronic	BRIP1	.	.	.	5.38E-13	0.932068251	0.067931749	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:11301010}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group J (FANCJ) [MIM:609054]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:16116423, ECO:0000269|PubMed:16116424, ECO:0000269|PubMed:20639400}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20765	0.27124	-0.637452658	16.73743808	155.97826	2.72998	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	52	17	59857599	chr17:59857599	C	CA	75	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	59974795	59974795	T	-	intronic	INTS2	.	.	.	0.999806217	0.000193783	3.25E-13	.	0.77276	0.13043	-0.620857637	17.3566879	100.80715	2.17423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	244	17	59974794	chr17:59974794	CT	C,CTTT,CTT	78	PASS	DP=244;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/3	./.
17	59974795	59974795	-	TT	intronic	INTS2	.	.	.	0.999806217	0.000193783	3.25E-13	.	0.77276	0.13043	-0.620857637	17.3566879	100.80715	2.17423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	244	17	59974794	chr17:59974794	CT	C,CTTT,CTT	78	PASS	DP=244;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/3	./.
17	59974795	59974795	-	T	intronic	INTS2	.	.	.	0.999806217	0.000193783	3.25E-13	.	0.77276	0.13043	-0.620857637	17.3566879	100.80715	2.17423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	244	17	59974794	chr17:59974794	CT	C,CTTT,CTT	78	PASS	DP=244;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/3	./.
17	60217010	60217010	G	T	intergenic	MED13;TBC1D3P2	dist=74367;dist=125057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	385	17	60217010	chr17:60217010	G	T	67	PASS	DP=385;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	60217713	60217713	G	T	intergenic	MED13;TBC1D3P2	dist=75070;dist=124354	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	303	17	60217713	chr17:60217713	G	T	.	PASS	DP=303;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	60345044	60345044	A	T	ncRNA_intronic	TBC1D3P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	286	17	60345044	chr17:60345044	A	T	.	PASS	DP=286;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	60563163	60563163	C	T	intronic	TLK2	.	.	.	0.999999806	1.94E-07	9.60E-18	.	0.36654	0.09988	-0.271755481	34.31823543	14.64528	0.52777	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	95	17	60563163	chr17:60563163	C	T	60	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	61585272	61585272	G	-	intergenic	ACE;KCNH6	dist=9531;dist=15423	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	563	17	61585271	chr17:61585271	TG	T	83	PASS	DP=563;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	61949621	61949621	G	T	exonic	CSH2	.	nonsynonymous SNV	CSH2:NM_022645:exon3:c.C234A:p.D78E,CSH2:NM_020991:exon5:c.C519A:p.D173E	0.458223921	0.515305	0.026471079	.	0.04737	0.07342	-0.139478553	43.29440906	29.18154	0.93272	0.044	0.784	D	0.887	0.715	P	0.86	0.818	P	0.002	0.009	N	1	0.810	D	2.675	0.786	M	-2.3	0.885	D	-2.76	0.634	D	0.516	0.569	-0.268	0.759	T	0.868	0.956	D	0.018	0.404	T	3.095	0.432	22.5	0.995	0.660	0.671	0.330	D	c	0.430	0.263	0.000	0.042	0.447	0.083	0	2.96	0.332	0.749	0.258	0.973	0.593	0.999	0.424	0.739	0.319	6.177	0.195	Four-helical cytokine, core|Four-helical cytokine-like, core	.	.	0.5	.	305	17	61949621	chr17:61949621	G	T	.	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	62007074	62007074	G	A	intronic	CD79B	.	.	.	0.950002657	0.049842119	0.000155224	DISEASE: Agammaglobulinemia 6, autosomal recessive (AGM6) [MIM:612692]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:17675462}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24113	0.3219	-0.449946534	24.00330267	9.1864	0.3355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	77	17	62007074	chr17:62007074	G	A	.	PASS	DP=77;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
17	62009640	62009640	G	T	UTR5	CD79B	NM_021602:c.-19C>A;NM_000626:c.-19C>A;NM_001329050:c.-19C>A;NM_001039933:c.-19C>A	.	.	0.950002657	0.049842119	0.000155224	DISEASE: Agammaglobulinemia 6, autosomal recessive (AGM6) [MIM:612692]: A primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B-cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. {ECO:0000269|PubMed:17675462}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24113	0.3219	-0.449946534	24.00330267	9.1864	0.3355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	551	17	62009640	chr17:62009640	G	T	120	PASS	DP=551;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	62223403	62223403	G	T	ncRNA_intronic	SNHG25	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	679	17	62223403	chr17:62223403	G	T	138	PASS	DP=679;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	62290515	62290515	C	A	exonic	TEX2	.	nonsynonymous SNV	TEX2:NM_001288732:exon2:c.G1063T:p.G355W,TEX2:NM_001288733:exon2:c.G1063T:p.G355W,TEX2:NM_018469:exon2:c.G1063T:p.G355W	0.44097988	0.559019647	4.74E-07	.	0.17386	0.08006	-0.946125119	9.377211607	521.90393	4.66418	0.001	0.784	D	0.999	0.764	D	0.975	0.717	D	0.000	0.843	D	0.998	0.445	D	1.67	0.430	L	0.46	0.563	T	-2.27	0.506	N	0.593	0.620	-0.538	0.673	T	0.305	0.676	T	0.053	0.654	D	6.215	0.858	28.7	0.946	0.245	0.931	0.571	D	c	0.696	0.709	1.000	0.747	0.615	0.372	0	6.03	0.978	4.527	0.600	0.935	0.490	1.000	0.715	0.912	0.389	20.557	0.993	.	.	.	0.5	.	48	17	62290515	chr17:62290515	C	A	.	PASS	DP=48;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	62502195	62502212	CTCGGTCCCGGCCGCGGT	-	exonic	DDX5	.	nonframeshift deletion	DDX5:NM_004396:exon1:c.26_43del:p.D9_R14del,DDX5:NM_001320595:exon2:c.26_43del:p.D9_R14del,DDX5:NM_001320596:exon2:c.26_43del:p.D9_R14del	0.997454099	0.00254588	2.09E-08	.	0.99513	0.25991	-0.712684326	14.49634348	217.31003	3.18659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	331	17	62502194	chr17:62502194	CCTCGGTCCCGGCCGCGGT	C	71	PASS	DP=331;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	62602763	62602763	A	-	intronic	SMURF2	.	.	.	0.999989891	1.01E-05	5.97E-15	.	0.24709	0.18339	-0.690637458	15.12149092	113.88537	2.32671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	138	17	62602762	chr17:62602762	TA	T	83	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	62817209	62817209	C	A	ncRNA_intronic	PLEKHM1P1	.	.	.	.	.	.	.	.	0.09794	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	141	17	62817209	chr17:62817209	C	A	.	PASS	DP=141;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	62852056	62852056	A	G	intronic	LRRC37A3	.	.	.	.	.	.	.	.	.	.	.	193.95095	3.02097	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	529	17	62852056	chr17:62852056	A	G	90	PASS	DP=529;AN=6	GT	./.	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	0/1	./.
17	64500758	64500758	G	A	intronic	PRKCA	.	.	.	0.952135908	0.047864044	4.76E-08	.	0.81012	0.85579	-0.334253673	30.70299599	22.99218	0.76666	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	17	64500758	chr17:64500758	G	A	.	PASS	DP=24;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
17	66251815	66251815	A	G	intronic	AMZ2	.	.	.	1.55E-08	0.116628489	0.883371495	.	0.13213	0.10068	0.507139401	80.10143902	66.56149	1.68126	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	96	17	66251815	chr17:66251815	A	G	63	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	66972250	66972250	A	T	intronic	ABCA9	.	.	.	1.28E-26	0.089815749	0.910184251	.	0.07193	.	-0.001957219	53.73319179	5531.81651	15.36212	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	13	17	66972250	chr17:66972250	A	T	82	PASS	DP=13;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.
17	71468207	71468207	C	A	intronic	SDK2	.	.	.	0.029034431	0.970965567	1.25E-09	.	0.41261	0.12096	-2.470675891	0.9849021	2484.07134	9.29974	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	510	17	71468207	chr17:71468207	C	A	127	PASS	DP=510;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	72368450	72368450	C	T	exonic	GPR142	.	nonsynonymous SNV	GPR142:NM_001331076:exon4:c.C836T:p.T279I,GPR142:NM_001331077:exon4:c.C836T:p.T279I,GPR142:NM_181790:exon4:c.C1100T:p.T367I	5.60E-05	0.689421967	0.310522078	.	.	.	-0.214928658	37.7388535	583.16278	4.89646	0.463	0.086	T	0.166	0.295	B	0.038	0.234	B	0.120	0.190	N	0.982	0.250	N	0.14	0.088	N	-0.36	0.688	T	0.17	0.051	N	0.156	0.186	-1.036	0.187	T	0.105	0.384	T	0.027	0.500	D	1.117	0.202	11.31	0.909	0.196	0.315	0.241	N	c	-0.610	-0.497	0.068	0.155	0.497	0.185	0	3.63	0.406	2.018	0.404	0.925	0.434	0.005	0.169	0.980	0.490	6.953	0.236	GPCR, rhodopsin-like, 7TM	.	.	0.5	.	206	17	72368450	chr17:72368450	C	T	.	PASS	DP=206;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	72736980	72736980	C	T	exonic	RAB37	.	nonsynonymous SNV	RAB37:NM_001006638:exon2:c.C167T:p.S56F,RAB37:NM_001163989:exon2:c.C182T:p.S61F,RAB37:NM_001330471:exon2:c.C86T:p.S29F	8.23E-05	0.76782021	0.23209752	.	0.08186	0.11813	0.040529541	57.15380986	48.09219	1.35018	0.003	0.721	D	0.884	0.473	P	0.816	0.571	P	0.000	0.449	D	0.999	0.810	D	2.03	0.557	M	-1.14	0.779	T	-3.79	0.724	D	0.38	0.440	0.185	0.857	D	0.556	0.838	D	0.226	0.881	D	5.061	0.682	25.2	0.998	0.867	0.990	0.891	D	c	0.476	0.436	1.000	0.747	0.706	0.609	0	5.1	0.688	4.832	0.622	0.921	0.432	1.000	0.715	0.999	0.750	17.296	0.870	P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	70	304	17	72736980	chr17:72736980	C	T	70	PASS	DP=304;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	73495692	73495692	C	G	UTR3	TMEM94	NM_001321149:c.*277C>G;NM_014738:c.*277C>G;NM_001351202:c.*277C>G;NM_001321148:c.*277C>G;NM_001351203:c.*277C>G	.	.	.	.	.	.	0.47515	0.13216	-2.738053399	0.684123614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	322	17	73495692	chr17:73495692	C	G	134	PASS	DP=322;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	73518210	73518210	A	T	exonic	TSEN54	.	nonsynonymous SNV	TSEN54:NM_207346:exon8:c.A1048T:p.R350W	1.76E-05	0.878799611	0.121182822	DISEASE: Pontocerebellar hypoplasia 4 (PCH4) [MIM:225753]: A disorder characterized by an abnormally small cerebellum and brainstem, severe neonatal encephalopathy, microcephaly, myoclonus and muscular hypertonia. There is a severe inferior olivary and pontine neuronal loss and a diffuse white matter gliosis. {ECO:0000269|PubMed:18711368, ECO:0000269|PubMed:21824568}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pontocerebellar hypoplasia 2A (PCH2A) [MIM:277470]: A disorder characterized by an abnormally small cerebellum and brainstem, and progressive microcephaly from birth combined with extrapyramidal dyskinesia. Severe chorea occurs and epilepsy is frequent. There are no signs of spinal cord anterior horn cells degeneration. {ECO:0000269|PubMed:18711368, ECO:0000269|PubMed:23307886}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pontocerebellar hypoplasia 5 (PCH5) [MIM:610204]: A form of pontocerebellar hypoplasia, a disorder characterized by structural defects of the pons and cerebellum. Brain MRI shows an abnormally small cerebellum and brainstem, decreased cerebral white matter, and a thin corpus callosum. {ECO:0000269|PubMed:21368912}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1309	0.10259	1.664578456	96.27860344	7072.81561	18.04186	0.001	0.784	D	0.991	0.622	D	0.726	0.533	P	0.051	0.230	N	1	0.090	N	1.79	0.469	L	0.21	0.600	T	-3.83	0.721	D	0.308	0.369	-0.625	0.638	T	0.213	0.574	T	0.050	0.643	D	0.691	0.160	8.767	0.596	0.061	0.087	0.144	N	c	-0.954	-1.235	1.000	0.427	0.706	0.609	0	-7.6	0.012	-0.258	0.087	-1.110	0.018	0.000	0.063	0.006	0.095	14.221	0.652	.	.	.	0.5	105	247	17	73518210	chr17:73518210	A	T	105	PASS	DP=247;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	74017493	74017501	CCGCCCCTG	-	intronic	EVPL	.	.	.	6.49E-14	0.99720216	0.00279784	.	0.45755	0.25979	0.769689266	86.89549422	2455.91155	9.22294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	52	17	74017492	chr17:74017492	CCCGCCCCTG	C	65	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	74017554	74017554	G	T	exonic	EVPL	.	nonsynonymous SNV	EVPL:NM_001320747:exon9:c.C1006A:p.R336S,EVPL:NM_001988:exon9:c.C1006A:p.R336S	6.49E-14	0.99720216	0.00279784	.	0.45755	0.25979	0.769689266	86.89549422	2455.91155	9.22294	0.065	0.363	T	0.023	0.176	B	0.013	0.154	B	0.105	0.197	N	0.413	0.324	P	2.135	0.597	M	1.56	0.296	T	-2.91	0.609	D	0.291	0.350	-1.003	0.291	T	0.070	0.287	T	.	.	.	3.548	0.484	23.1	0.989	0.477	0.459	0.274	N	c	-0.189	-0.094	0.027	0.138	0.487	0.133	0	3.51	0.391	1.922	0.394	0.136	0.221	0.982	0.353	0.875	0.366	6.907	0.233	.	.	.	0.5	92	143	17	74017554	chr17:74017554	G	T	92	PASS	DP=143;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	74470461	74470461	G	A	exonic	RHBDF2	.	synonymous SNV	RHBDF2:NM_001005498:exon11:c.C1458T:p.D486D,RHBDF2:NM_024599:exon12:c.C1545T:p.D515D	0.000966721	0.998509275	0.000524004	.	0.22785	0.10899	-0.367438677	28.29087049	609.30799	4.99073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	17	74470461	chr17:74470461	G	A	.	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	74476031	74476031	C	T	intronic	RHBDF2	.	.	.	0.000966721	0.998509275	0.000524004	.	0.22785	0.10899	-0.367438677	28.29087049	609.30799	4.99073	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	124	17	74476031	chr17:74476031	C	T	.	PASS	DP=124;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	74722933	74722933	G	T	UTR5	METTL23	NM_001206985:c.-6244G>T;NM_001302705:c.-2855G>T;NM_001080510:c.-2860G>T;NM_001302703:c.-2860G>T;NM_001206987:c.-6244G>T;NM_001302704:c.-6244G>T;NM_001206984:c.-2860G>T;NM_001206986:c.-6244G>T;NM_001206983:c.-2860G>T	.	.	0.113237609	0.778025357	0.108737034	DISEASE: Mental retardation, autosomal recessive 44 (MRT44) [MIM:615942]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT44 manifestations include mild to severe cognitive impairment, delayed psychomotor development, seizures in some patients, and dysmorphic features. {ECO:0000269|PubMed:24501276, ECO:0000269|PubMed:24626631}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.08223	0.349177632	74.18023119	73.16169	1.78753	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	95	17	74722933	chr17:74722933	G	T	.	PASS	DP=95;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	76001227	76001227	T	-	intronic	TNRC6C	.	.	.	0.999997824	2.18E-06	7.00E-16	.	0.32049	0.10248	-1.537897124	3.338051427	1348.87379	6.89482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	279	17	76001226	chr17:76001226	CT	C	90	PASS	DP=279;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
17	76116666	76116678	TCCCGGCCACACG	-	intronic	TMC6	.	.	.	5.08E-08	0.838066538	0.161933411	.	0.17431	0.14008	0.497836815	79.65911772	4133.48394	12.75965	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	149	90	17	76116665	chr17:76116665	CTCCCGGCCACACG	C	149	PASS	DP=90;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	76446798	76446798	G	T	exonic	DNAH17	.	nonsynonymous SNV	DNAH17:NM_173628:exon67:c.C10865A:p.T3622N	.	.	.	.	0.10041	.	.	.	8793.71322	20.21811	.	.	.	0.009	0.139	B	0.02	0.179	B	0.002	0.385	N	0.895	0.360	D	1.065	0.271	L	-0.24	0.668	T	.	.	.	0.152	0.181	-0.930	0.441	T	0.155	0.486	T	0.006	0.164	T	1.568	0.250	13.68	0.934	0.225	0.921	0.546	D	c	-0.349	-0.193	0.171	0.177	0.615	0.372	0	2.33	0.279	1.201	0.317	0.953	0.551	0.877	0.307	1.000	0.888	9.725	0.393	.	.	.	0.5	.	102	17	76446798	chr17:76446798	G	T	.	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
17	77093795	77093795	A	T	exonic	RBFOX3	.	nonsynonymous SNV	RBFOX3:NM_001350453:exon8:c.T601A:p.Y201N,RBFOX3:NM_001350451:exon9:c.T601A:p.Y201N,RBFOX3:NM_001082575:exon10:c.T601A:p.Y201N	.	.	.	.	.	.	-0.141298762	42.87567823	36.57701	1.09709	.	.	.	0.094	0.238	B	0.062	0.255	B	0.000	0.629	D	1	0.810	D	1.845	0.488	L	1.73	0.264	T	.	.	.	0.813	0.831	-1.080	0.073	T	0.053	0.223	T	0.057	0.669	D	3.998	0.538	23.6	0.956	0.267	0.996	0.978	D	c	-0.032	0.109	1.000	0.747	0.742	0.980	0	4.27	0.498	8.780	0.914	1.168	0.901	1.000	0.715	0.984	0.507	13.219	0.591	.	.	.	0.5	.	206	17	77093795	chr17:77093795	A	T	.	PASS	DP=206;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	78083795	78083795	G	T	exonic	GAA	.	stopgain	GAA:NM_000152:exon9:c.G1378T:p.E460X,GAA:NM_001079804:exon9:c.G1378T:p.E460X,GAA:NM_001079803:exon10:c.G1378T:p.E460X	4.62E-11	0.781839838	0.218160162	DISEASE: Glycogen storage disease 2 (GSD2) [MIM:232300]: A metabolic disorder with a broad clinical spectrum. The severe infantile form, or Pompe disease, presents at birth with massive accumulation of glycogen in muscle, heart and liver. Cardiomyopathy and muscular hypotonia are the cardinal features of this form whose life expectancy is less than two years. The juvenile and adult forms present as limb-girdle muscular dystrophy beginning in the lower limbs. Final outcome depends on respiratory muscle failure. Patients with the adult form can be free of clinical symptoms for most of their life but finally develop a slowly progressive myopathy. {ECO:0000269|PubMed:10189220, ECO:0000269|PubMed:10206684, ECO:0000269|PubMed:10338092, ECO:0000269|PubMed:10737124, ECO:0000269|PubMed:11071489, ECO:0000269|PubMed:11738358, ECO:0000269|PubMed:12601120, ECO:0000269|PubMed:12923862, ECO:0000269|PubMed:14643388, ECO:0000269|PubMed:14695532, ECO:0000269|PubMed:14972326, ECO:0000269|PubMed:15145338, ECO:0000269|PubMed:15668445, ECO:0000269|PubMed:16433701, ECO:0000269|PubMed:1652892, ECO:0000269|PubMed:16782080, ECO:0000269|PubMed:1684505, ECO:0000269|PubMed:16917947, ECO:0000269|PubMed:17643989, ECO:0000269|PubMed:18425781, ECO:0000269|PubMed:18429042, ECO:0000269|PubMed:1898413, ECO:0000269|PubMed:19588081, ECO:0000269|PubMed:20080426, ECO:0000269|PubMed:20350966, ECO:0000269|PubMed:21109266, ECO:0000269|PubMed:22644586, ECO:0000269|PubMed:22676651, ECO:0000269|PubMed:25681614, ECO:0000269|PubMed:7695647, ECO:0000269|PubMed:7717400, ECO:0000269|PubMed:7866409, ECO:0000269|PubMed:7881422, ECO:0000269|PubMed:7981676, ECO:0000269|PubMed:8094613, ECO:0000269|PubMed:8401535, ECO:0000269|PubMed:8834250, ECO:0000269|PubMed:9521422, ECO:0000269|PubMed:9535769, ECO:0000269|PubMed:9660056, ECO:0000269|Ref.5}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11717	0.93517	-1.159397299	6.098136353	1841.49194	7.915	.	.	.	.	.	.	.	.	.	0.000	0.629	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.180	0.989	41	0.998	0.844	0.927	0.561	D	c	1.008	0.829	1.000	0.747	0.718	0.821	0	5.41	0.782	9.349	0.964	0.953	0.551	1.000	0.715	0.784	0.331	13.497	0.607	Glycoside hydrolase superfamily	.	.	0.5	137	953	17	78083795	chr17:78083795	G	T	137	PASS	DP=953;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	78321111	78321111	C	T	exonic	RNF213	.	synonymous SNV	RNF213:NM_001256071:exon29:c.C8976T:p.D2992D	1.68E-29	0.999999941	5.86E-08	DISEASE: Moyamoya disease 2 (MYMY2) [MIM:607151]: A progressive cerebral angiopathy characterized by bilateral intracranial carotid artery stenosis and telangiectatic vessels in the region of the basal ganglia. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on cerebral angiogram. Affected individuals can develop transient ischemic attacks and/or cerebral infarction, and rupture of the collateral vessels can cause intracranial hemorrhage. Hemiplegia of sudden onset and epileptic seizures constitute the prevailing presentation in childhood, while subarachnoid bleeding occurs more frequently in adults. {ECO:0000269|PubMed:21048783, ECO:0000269|PubMed:21799892}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving ALO17 is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALK.; 	0.27678	.	1.993454751	97.65274829	3964.07552	12.4561	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	17	78321111	chr17:78321111	C	T	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	78321189	78321189	C	G	exonic	RNF213	.	nonsynonymous SNV	RNF213:NM_001256071:exon29:c.C9054G:p.I3018M	1.68E-29	0.999999941	5.86E-08	DISEASE: Moyamoya disease 2 (MYMY2) [MIM:607151]: A progressive cerebral angiopathy characterized by bilateral intracranial carotid artery stenosis and telangiectatic vessels in the region of the basal ganglia. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on cerebral angiogram. Affected individuals can develop transient ischemic attacks and/or cerebral infarction, and rupture of the collateral vessels can cause intracranial hemorrhage. Hemiplegia of sudden onset and epileptic seizures constitute the prevailing presentation in childhood, while subarachnoid bleeding occurs more frequently in adults. {ECO:0000269|PubMed:21048783, ECO:0000269|PubMed:21799892}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving ALO17 is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALK.; 	0.27678	.	1.993454751	97.65274829	3964.07552	12.4561	0.004	0.654	D	0.964	0.539	D	0.679	0.516	P	0.000	0.559	D	0.880	0.280	N	2.685	0.788	M	1.68	0.272	T	-2.44	0.534	N	0.399	0.495	-0.903	0.477	T	0.112	0.401	T	0.026	0.490	D	3.964	0.533	23.6	0.756	0.108	0.405	0.262	N	c	0.293	0.205	0.020	0.132	0.719	0.830	0	4.85	0.622	0.411	0.207	0.935	0.490	0.042	0.209	0.975	0.474	9.228	0.364	.	.	.	0.5	65	74	17	78321189	chr17:78321189	C	G	65	PASS	DP=74;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
17	79092197	79092197	A	G	UTR3	AATK	NM_001080395:c.*5T>C;NM_004920:c.*5T>C	.	.	0.806763652	0.193192255	4.41E-05	.	0.24713	0.12093	.	.	2421.6539	9.14383	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	473	17	79092197	chr17:79092197	A	G	72	PASS	DP=473;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	79092204	79092204	A	G	exonic	AATK	.	stoploss	AATK:NM_004920:exon13:c.T3814C:p.X1272R,AATK:NM_001080395:exon14:c.T4123C:p.X1375R	0.806763652	0.193192255	4.41E-05	.	0.24713	0.12093	.	.	2421.6539	9.14383	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.767	0.273	14.79	0.783	0.118	0.222	0.214	N	c	0.413	0.067	1.000	0.747	0.079	0.017	2	2.46	0.289	1.062	0.300	0.977	0.596	0.009	0.180	0.524	0.275	4.001	0.090	.	.	.	0.5	74	488	17	79092204	chr17:79092204	A	G	74	PASS	DP=488;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	79155017	79155017	C	G	ncRNA_exonic	AATK-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	223	17	79155017	chr17:79155017	C	G	109	PASS	DP=223;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	79176011	79176011	C	-	intronic	CEP131	.	.	.	.	.	.	.	0.11345	0.14275	2.688316751	98.8794527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	303	17	79176010	chr17:79176010	GC	G	71	PASS	DP=303;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
17	79246270	79246270	-	C	intronic	SLC38A10	.	.	.	4.09E-08	0.986554606	0.013445353	.	0.11386	0.09454	1.13164289	92.23873555	8935.42464	20.45812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	38	17	79246270	chr17:79246270	G	GC	109	PASS	DP=38;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
17	79507107	79507108	CG	-	UTR3	FAAP100	NM_025161:c.*738_*737delCG	.	.	.	.	.	.	0.14739	0.16001	0.363735434	74.71101675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	620	17	79507106	chr17:79507106	CCG	C	79	PASS	DP=620;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	0/1	./.
17	79683805	79683805	G	A	intronic	SLC25A10	.	.	.	0.002439368	0.928274848	0.069285784	.	0.18311	0.12721	-0.448125345	24.19202642	41.5856	1.21268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	406	17	79683805	chr17:79683805	G	A	85	PASS	DP=406;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
17	80377690	80377690	T	G	exonic	HEXDC	.	synonymous SNV	HEXDC:NM_001330542:exon2:c.T15G:p.T5T,HEXDC:NM_173620:exon2:c.T15G:p.T5T	1.59E-06	0.854020781	0.145977631	.	0.1403	.	0.560331224	81.70559094	113.59821	2.32178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	57	17	80377690	chr17:80377690	T	G	97	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
17	80887089	80887089	G	A	exonic	TBCD	.	nonsynonymous SNV	TBCD:NM_005993:exon31:c.G2794A:p.D932N	6.98E-05	0.999929838	3.18E-07	.	0.12203	0.11011	-1.453286053	3.892427459	630.24341	5.05995	0.095	0.312	T	0.007	0.158	B	0.037	0.218	B	0.030	0.254	N	1	0.090	N	2.395	0.694	M	-0.26	0.672	T	-1.57	0.379	N	0.071	0.077	-0.822	0.538	T	0.219	0.583	T	0.034	0.553	D	1.823	0.280	15.12	0.991	0.533	0.166	0.193	N	c	-0.469	-0.459	0.405	0.202	0.707	0.730	0	5.13	0.696	2.663	0.462	1.048	0.713	0.513	0.268	0.016	0.126	9.679	0.390	Armadillo-type fold|Tubulin-specific chaperone D, C-terminal;Tubulin-specific chaperone D, C-terminal	.	.	0.5	.	140	17	80887089	chr17:80887089	G	A	.	PASS	DP=140;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	49208	49208	G	A	intergenic	LOC102723376;ROCK1P1	dist=33278;dist=59857	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.25	0.791	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.269	0.120	5.391	0.711	0.092	0.191	0.203	N	n	-0.126	-0.174	0.000	0.012	0.554	0.283	0	0.109	0.138	-0.406	0.072	0.344	0.273	0.844	0.301	0.001	0.043	2.943	0.054	.	.	.	0.5	98	105	18	49208	chr18:49208	G	A	98	PASS	DP=105;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	11622602	11622602	T	C	intergenic	SLC35G4;MIR7153	dist=11991;dist=32282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	99	18	11622602	chr18:11622602	T	C	66	PASS	DP=99;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	12449301	12449301	T	-	UTR3	SPIRE1	NM_020148:c.*336delA;NM_001128627:c.*336delA;NM_001128626:c.*336delA	.	.	0.330091752	0.669881004	2.72E-05	.	0.13285	0.09444	-1.111360919	6.717386176	74.25913	1.79961	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	46	27	18	12449300	chr18:12449300	CT	C	46	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	13099601	13099601	-	T	intronic	CEP192	.	.	.	7.44E-10	0.999999897	1.02E-07	.	0.09044	0.10852	1.493675397	95.37037037	4911.21175	14.29193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	50	18	13099601	chr18:13099601	G	GT	75	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
18	13643440	13643440	G	A	intronic	LDLRAD4	.	.	.	0.377306395	0.611933101	0.010760504	.	0.53888	0.09904	-0.115612493	45.12856806	49.8811	1.38578	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	18	13643440	chr18:13643440	G	A	.	PASS	DP=38;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	13824036	13824036	C	T	intergenic	RNMT;MC5R	dist=59481;dist=1507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	693	18	13824036	chr18:13824036	C	T	131	PASS	DP=693;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
18	14173952	14173952	A	G	intergenic	ZNF519;ANKRD20A5P	dist=41463;dist=5144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	231	18	14173952	chr18:14173952	A	G	100	PASS	DP=231;AN=4	GT	0/1	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
18	14808654	14808654	T	C	intronic	ANKRD30B	.	.	.	1.49E-09	0.94288369	0.057116308	.	.	.	1.06196211	91.507431	2417.32649	9.13836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	139	18	14808654	chr18:14808654	T	C	87	PASS	DP=139;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
18	20572852	20572852	-	A	exonic	RBBP8	.	frameshift insertion	RBBP8:NM_002894:exon11:c.1063dupA:p.H358Tfs*7,RBBP8:NM_203291:exon11:c.1063dupA:p.H358Tfs*7,RBBP8:NM_203292:exon11:c.1063dupA:p.H358Tfs*7	0.000108379	0.999790809	0.000100812	DISEASE: Seckel syndrome 2 (SCKL2) [MIM:606744]: A rare autosomal recessive disorder characterized by proportionate dwarfism of prenatal onset associated with low birth weight, growth retardation, severe microcephaly with a bird-headed like appearance, and mental retardation. {ECO:0000269|PubMed:21998596}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Jawad syndrome (JWDS) [MIM:251255]: A syndrome characterized by congenital microcephaly, moderately severe mental retardation, and symmetrical digital anomalies. Digital malformations of variable degree include hallux valgus, syndactyly of toes 4 and 5, short fifth fingers, single flexion crease of fifth fingers, polydactyly and synpolydactyly. {ECO:0000269|PubMed:21998596}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Genetic variability in RBBP8 is noted as a factor in BRCA1-associated breast cancer risk (PubMed:21799032). Exhibits sensitivity to tamoxifen in certain breast cancer cell lines (PubMed:18171986). {ECO:0000269|PubMed:18171986, ECO:0000269|PubMed:21799032}.; 	0.82222	.	-0.641086234	16.6784619	66.92298	1.69043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.22	49	18	20572852	chr18:20572852	G	GA	12.22	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
18	24035449	24035449	T	-	UTR3	KCTD1	NM_198991:c.*258delA;NM_001258221:c.*258delA;NM_001142730:c.*258delA;NM_001136205:c.*258delA;NM_001351443:c.*258delA;NM_001258222:c.*258delA	.	.	0.934855731	0.064842753	0.000301517	DISEASE: Scalp-ear-nipple syndrome (SENS) [MIM:181270]: A disease characterized by aplasia cutis congenita of the scalp, breast anomalies that range from hypothelia or athelia to amastia, and minor anomalies of the external ears. Less frequent clinical characteristics include nail dystrophy, dental anomalies, cutaneous syndactyly of the digits, and renal malformations. Penetrance appears to be high, although there is substantial variable expressivity within families. {ECO:0000269|PubMed:23541344}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20055	0.11262	-0.405853867	26.23260203	261.92903	3.47336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	156	348	18	24035448	chr18:24035448	CT	C	156	PASS	DP=348;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
18	30350917	30350917	C	T	intronic	KLHL14	.	.	.	0.082722189	0.916851004	0.000426807	.	0.49787	.	-0.979072682	8.752064166	49.14169	1.37053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	129	18	30350917	chr18:30350917	C	T	.	PASS	DP=129;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
18	31432437	31432438	CA	-	UTR3	NOL4	NM_001198548:c.*369_*368delTG;NM_001282527:c.*369_*368delTG;NM_001198549:c.*369_*368delTG;NM_003787:c.*369_*368delTG;NM_001198547:c.*369_*368delTG;NM_001198546:c.*369_*368delTG	.	.	0.998788438	0.001211561	6.92E-10	.	0.33775	0.11098	-0.66859065	15.76433121	32.86908	1.01975	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	14	18	31432436	chr18:31432436	CCA	C	54	PASS	DP=14;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	34340634	34340634	G	A	exonic	FHOD3	.	nonsynonymous SNV	FHOD3:NM_001281739:exon22:c.G3913A:p.E1305K,FHOD3:NM_025135:exon23:c.G3964A:p.E1322K,FHOD3:NM_001281740:exon27:c.G4513A:p.E1505K	0.997517123	0.002482877	1.35E-12	.	0.22803	0.10389	-0.514518236	21.21962727	7901.72753	19.20257	0.098	0.308	T	0.592	0.372	P	0.254	0.374	B	0.000	0.843	D	1.000	0.588	D	1.895	0.505	L	1.44	0.369	T	-2.44	0.534	N	0.439	0.568	-1.102	0.039	T	0.071	0.288	T	0.018	0.396	T	3.289	0.454	22.8	0.998	0.874	0.995	0.962	D	c	0.117	0.227	1.000	0.747	0.758	0.990	0	5.16	0.704	9.443	0.967	1.048	0.713	1.000	0.715	0.324	0.241	15.386	0.743	Formin, FH2 domain	.	.	0.5	.	175	18	34340634	chr18:34340634	G	A	.	PASS	DP=175;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
18	34415357	34415357	-	T	intronic	KIAA1328	.	.	.	6.07E-05	0.894567113	0.105372162	.	0.32449	.	0.040529541	57.15380986	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	26	18	34415357	chr18:34415357	C	CT	50	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
18	43577703	43577703	G	A	intronic	PSTPIP2	.	.	.	0.107611557	0.892114743	0.0002737	.	0.08446	0.08464	0.060756528	58.52795471	1683.83562	7.56284	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	224	18	43577703	chr18:43577703	G	A	78	PASS	DP=224;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	44561516	44561516	C	G	exonic	ELOA2	.	synonymous SNV	ELOA2:NM_016427:exon1:c.G120C:p.T40T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	138	18	44561516	chr18:44561516	C	G	129	PASS	DP=138;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
18	55144025	55144025	A	-	UTR3	ONECUT2	NM_004852:c.*70delA	.	.	0.903998414	0.095195415	0.000806171	.	0.11843	0.18435	-0.60427181	17.74593064	16.33351	0.57897	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	9	18	55144024	chr18:55144024	GA	G	58	PASS	DP=9;AN=2	GT	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	57013193	57013193	-	T	exonic	LMAN1	.	frameshift insertion	LMAN1:NM_005570:exon8:c.912dupA:p.E305Rfs*19	0.486069839	0.513889663	4.05E-05	DISEASE: Factor V and factor VIII combined deficiency 1 (F5F8D1) [MIM:227300]: A blood coagulation disorder characterized by bleeding symptoms similar to those in hemophilia or parahemophilia, that are caused by single deficiency of FV or FVIII, respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma levels of coagulation factors V and VIII are in the range of 5 to 30% of normal. {ECO:0000269|PubMed:10090935, ECO:0000269|PubMed:19787799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1019	0.17526	-0.045835247	50.34206181	760.68404	5.46719	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	320	18	57013193	chr18:57013193	C	CT	67	PASS	DP=320;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
18	59217504	59217504	T	A	intronic	CDH20	.	.	.	0.980513136	0.019486247	6.16E-07	.	0.41102	0.0974	-0.619039275	17.39797122	686.47702	5.2313	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	41	18	59217504	chr18:59217504	T	A	107	PASS	DP=41;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	59878413	59878413	A	G	exonic	KIAA1468	.	nonsynonymous SNV	KIAA1468:NM_001346229:exon2:c.A554G:p.D185G,KIAA1468:NM_001346230:exon2:c.A554G:p.D185G,KIAA1468:NM_001346231:exon2:c.A554G:p.D185G,KIAA1468:NM_001346232:exon2:c.A554G:p.D185G,KIAA1468:NM_001346233:exon2:c.A554G:p.D185G,KIAA1468:NM_001346234:exon2:c.A554G:p.D185G,KIAA1468:NM_020854:exon2:c.A554G:p.D185G	0.99999956	4.40E-07	2.89E-18	.	0.18204	0.12098	-1.285933373	5.083746167	74.67048	1.80768	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	2.41	0.699	M	0.86	0.468	T	-5.46	0.855	D	0.91	0.900	-0.408	0.718	T	0.316	0.686	T	0.148	0.831	D	6.326	0.874	29.3	0.999	0.940	0.987	0.851	D	c	0.778	0.744	1.000	0.747	0.706	0.609	0	5.21	0.719	8.718	0.911	1.199	0.960	1.000	0.715	0.999	0.750	15.078	0.716	.	.	.	0.5	92	101	18	59878413	chr18:59878413	A	G	92	PASS	DP=101;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
18	60015409	60015409	G	A	exonic	TNFRSF11A	.	synonymous SNV	TNFRSF11A:NM_001270949:exon2:c.G84A:p.L28L,TNFRSF11A:NM_001270950:exon2:c.G84A:p.L28L,TNFRSF11A:NM_001270951:exon2:c.G84A:p.L28L,TNFRSF11A:NM_001278268:exon2:c.G84A:p.L28L,TNFRSF11A:NM_003839:exon2:c.G84A:p.L28L	0.879917354	0.120022306	6.03E-05	DISEASE: Paget disease of bone 2, early-onset (PDB2) [MIM:602080]: A form of Paget disease, a disorder of bone remodeling characterized by increased bone turnover affecting one or more sites throughout the skeleton, primarily the axial skeleton. Osteoclastic overactivity followed by compensatory osteoblastic activity leads to a structurally disorganized mosaic of bone (woven bone), which is mechanically weaker, larger, less compact, more vascular, and more susceptible to fracture than normal adult lamellar bone. {ECO:0000269|PubMed:10615125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteopetrosis, autosomal recessive 7 (OPTB7) [MIM:612301]: A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB7 is characterized by paucity of osteoclasts, suggesting a molecular defect in osteoclast development. OPTB7 is associated with hypogammaglobulinemia. {ECO:0000269|PubMed:18606301}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0838	.	0.665103516	84.6131163	577.42674	4.87253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	18	60015409	chr18:60015409	G	A	.	PASS	DP=32;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
18	60791966	60791966	T	-	UTR3	BCL2	NM_000633:c.*3892delA	.	.	0.337855764	0.602211203	0.059933033	DISEASE: Note=A chromosomal aberration involving BCL2 has been found in chronic lymphatic leukemia. Translocation t(14;18)(q32;q21) with immunoglobulin gene regions. BCL2 mutations found in non-Hodgkin lymphomas carrying the chromosomal translocation could be attributed to the Ig somatic hypermutation mechanism resulting in nucleotide transitions. {ECO:0000269|PubMed:2875799, ECO:0000269|PubMed:3285301}.; 	0.95405	0.98331	-0.185391282	39.67916962	463.55581	4.46164	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	95	18	60791965	chr18:60791965	CT	C	79	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
18	61231145	61231148	AAAT	-	intronic	SERPINB12	.	.	.	7.76E-17	0.000298875	0.999701125	.	0.64256	0.12241	0.64123826	83.97617363	445.92863	4.39516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	15.85	61	18	61231144	chr18:61231144	AAAAT	A	15.85	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
18	61325749	61325778	TTCGTTTGACTTTCCACCCAGGAGTTAATC	-	exonic	SERPINB3	.	nonframeshift deletion	SERPINB3:NM_006919:exon5:c.438_467del:p.K146_T155del	8.69E-14	0.00261773	0.99738227	.	0.3168	0.31828	2.177262001	98.07147912	707.88934	5.28346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.84	23	18	61325748	chr18:61325748	ATTCGTTTGACTTTCCACCCAGGAGTTAATC	A	10.84	PASS	DP=23;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	66358515	66358516	AA	-	exonic	TMX3	.	stopgain	TMX3:NM_001350513:exon8:c.572_573del:p.F191fs*0	0.191322508	0.808583205	9.43E-05	.	0.25561	0.11004	0.240763792	69.36777542	113.00046	2.31345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	43	18	66358514	chr18:66358514	TAA	T	109	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
18	67860479	67860479	T	A	intronic	RTTN	.	.	.	2.40E-13	0.999999994	5.97E-09	DISEASE: Polymicrogyria with seizures (PMGYS) [MIM:614833]: A disease characterized by many irregular small gyri in the brain surface and fusion of the molecular layer over multiple small gyri, which gives a festooned appearance to the cortical surface, without abnormal neuronal migration. Polymicrogyria is a heterogeneous disorder, considered to be the result of postmigratory abnormal cortical organization. PMGYS patients have moderate to severe mental retardation, poor speech, dysarthria and seizures. {ECO:0000269|PubMed:22939636}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25498	0.10307	0.18719002	66.27742392	829.75241	5.64516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	128	18	67860479	chr18:67860479	T	A	.	PASS	DP=128;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
18	77254927	77254927	A	T	intronic	NFATC1	.	.	.	0.969219888	0.030779726	3.86E-07	.	0.26703	0.65916	-1.846676608	2.052370842	1895.12903	8.00523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	144	18	77254927	chr18:77254927	A	T	.	PASS	DP=144;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
18	77464792	77464792	G	T	exonic	CTDP1	.	nonsynonymous SNV	CTDP1:NM_001202504:exon5:c.G290T:p.R97L,CTDP1:NM_001318511:exon5:c.G647T:p.R216L,CTDP1:NM_004715:exon5:c.G647T:p.R216L,CTDP1:NM_048368:exon5:c.G647T:p.R216L	0.924155319	0.075843928	7.53E-07	DISEASE: Congenital cataracts, facial dysmorphism, and neuropathy (CCFDN) [MIM:604168]: An autosomal recessive developmental disorder characterized by a complex clinical phenotype with seemingly unrelated features involving multiple organs and systems. Developmental abnormalities include congenital cataracts and microcorneae, hypomyelination of the peripheral nervous system, impaired physical growth, delayed early motor and intellectual development, facial dysmorphism and hypogonadism. Central nervous system involvement, with cerebral and spinal cord atrophy, may be the result of disrupted development with superimposed degenerative changes. Affected individuals are prone to severe rhabdomyolysis after viral infections and to serious complications related to general anesthesia (such as pulmonary edema and epileptic seizures). {ECO:0000269|PubMed:14517542}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11827	0.23034	-0.835882558	11.47676339	993.37938	6.07377	0.113	0.287	T	1.0	0.899	D	0.997	0.971	D	0.000	0.843	D	1	0.810	D	0.57	0.153	N	2.3	0.170	T	-4.51	0.782	D	0.897	0.886	-1.066	0.104	T	0.067	0.274	T	0.015	0.352	T	6.266	0.865	29.0	0.998	0.924	0.976	0.757	D	c	0.549	0.585	1.000	0.747	0.707	0.730	0	4.96	0.650	7.350	0.785	0.953	0.551	1.000	0.715	0.993	0.574	18.560	0.910	FCP1 homology domain|FCP1-like phosphatase, phosphatase domain|HAD-like domain	.	.	0.5	124	216	18	77464792	chr18:77464792	G	T	124	PASS	DP=216;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
18	77894260	77894260	-	C	exonic	ADNP2	.	frameshift insertion	ADNP2:NM_014913:exon4:c.965dupC:p.A325Cfs*58	0.346937921	0.652481031	0.000581048	.	0.17091	0.1058	-1.497391194	3.603444209	154.16578	2.71378	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	253	18	77894260	chr18:77894260	T	TC	66	PASS	DP=253;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	313545	313545	C	A	exonic	MIER2	.	stopgain	MIER2:NM_001346105:exon7:c.G646T:p.E216X,MIER2:NM_017550:exon8:c.G754T:p.E252X	0.977262863	0.022736235	9.02E-07	.	0.24964	.	-1.148192153	6.316348195	267.17865	3.50509	.	.	.	.	.	.	.	.	.	0.000	0.473	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.488	0.963	35	0.996	0.761	0.912	0.527	D	c	0.514	0.225	0.133	0.171	0.672	0.522	0	2.75	0.313	2.526	0.450	0.890	0.394	0.986	0.359	0.067	0.174	7.591	0.270	ELM2 domain	.	.	0.5	.	238	19	313545	chr19:313545	C	A	.	PASS	DP=238;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	646805	646805	C	T	downstream	RNF126	dist=721	.	.	0.774554603	0.223811494	0.001633903	.	0.14462	0.11239	-0.468351206	23.42533616	439.52593	4.36897	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	17	19	646805	chr19:646805	C	T	.	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	757412	757412	A	G	exonic	MISP	.	nonsynonymous SNV	MISP:NM_173481:exon2:c.A466G:p.S156G	1.95E-10	0.034098173	0.965901827	.	0.13168	.	-0.031281682	50.5779665	693.62656	5.25135	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.904	0.086	N	1	0.090	P	-0.82	0.015	N	0.75	0.502	T	0.42	0.034	N	0.015	0.002	-0.951	0.408	T	0.000	0.000	T	.	.	.	-1.729	0.012	0.002	0.144	0.003	0.019	0.058	N	c	-1.589	-1.521	0.002	0.092	0.581	0.326	0	-0.862	0.101	-1.156	0.032	-0.535	0.048	0.000	0.063	0.675	0.304	5.825	0.177	.	.	.	0.5	111	72	19	757412	chr19:757412	A	G	111	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	806606	806606	G	T	intronic	PTBP1	.	.	.	0.9987392	0.001260782	1.86E-08	.	0.88766	0.24759	-1.217968826	5.638122199	29.53361	0.94402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	366	19	806606	chr19:806606	G	T	.	PASS	DP=366;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	1122672	1122672	C	T	exonic	SBNO2	.	nonsynonymous SNV	SBNO2:NM_001100122:exon6:c.G728A:p.R243Q,SBNO2:NM_014963:exon9:c.G899A:p.R300Q	0.024423765	0.975552528	2.37E-05	.	0.41647	0.11239	-2.2729502	1.250294881	880.95739	5.7817	0.002	0.721	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1.000	0.548	D	2.63	0.772	M	-3.24	0.935	D	-3.56	0.688	D	0.655	0.668	1.036	0.978	D	0.902	0.968	D	0.532	0.956	D	5.231	0.707	25.6	0.999	0.985	0.989	0.886	D	c	0.627	0.501	1.000	0.747	0.672	0.522	0	4.1	0.470	7.751	0.839	0.771	0.312	1.000	0.715	0.709	0.311	15.679	0.770	P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	21	19	1122672	chr19:1122672	C	T	.	PASS	DP=21;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	1360699	1360699	G	C	exonic	MUM1	.	nonsynonymous SNV	MUM1:NM_032853:exon5:c.G782C:p.R261T	0.032092633	0.967523954	0.000383414	.	0.0715	0.13329	-0.661316159	16.02382637	285.13749	3.61395	0.069	0.355	T	0.48	0.464	P	0.062	0.460	B	0.613	0.057	N	1	0.090	N	1.87	0.498	L	1.88	0.245	T	-1.01	0.266	N	0.088	0.084	-1.043	0.163	T	0.046	0.198	T	0.017	0.380	T	2.487	0.360	19.38	0.906	0.193	0.110	0.162	N	c	-0.805	-0.992	1.000	0.747	0.742	0.982	0	-2.63	0.057	-0.138	0.103	0.898	0.412	0.000	0.063	0.002	0.062	1.389	0.021	.	.	.	0.5	.	141	19	1360699	chr19:1360699	G	C	.	PASS	DP=141;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	1371193	1371193	C	A	intronic	MUM1	.	.	.	0.032092633	0.967523954	0.000383414	.	0.0715	0.13329	-0.661316159	16.02382637	285.13749	3.61395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	261	19	1371193	chr19:1371193	C	A	62	PASS	DP=261;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	1506040	1506040	G	A	exonic	ADAMTSL5	.	synonymous SNV	ADAMTSL5:NM_213604:exon12:c.C1390T:p.L464L	3.22E-10	0.086390501	0.913609499	.	0.15136	0.10435	0.442818085	77.8544468	191.46176	3.00098	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	291	19	1506040	chr19:1506040	G	A	125	PASS	DP=291;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	1605428	1605428	C	T	UTR5	UQCR11	NM_006830:c.-20G>A	.	.	0.030503461	0.595980384	0.373516155	.	0.14335	0.14499	-0.009020804	52.8544468	8.08743	0.29633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	19	1605428	chr19:1605428	C	T	.	PASS	DP=57;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	1627481	1627481	C	A	intronic	TCF3	.	.	.	0.185647144	0.813858528	0.000494328	DISEASE: Note=Chromosomal aberrations involving TCF3 are cause of forms of pre-B-cell acute lymphoblastic leukemia (B-ALL). Translocation t(1;19)(q23;p13.3) with PBX1. TCF3-PBX1 transforms cells by constitutively activating transcription of genes regulated by PBX1 or by other members of the PBX protein family (PubMed:1967983, PubMed:1671560). Translocation t(17;19)(q22;p13.3) with HLF (PubMed:1386162). Inversion inv(19)(p13;q13) with TFPT (PubMed:10086727). {ECO:0000269|PubMed:10086727, ECO:0000269|PubMed:1386162, ECO:0000269|PubMed:1671560, ECO:0000269|PubMed:1967983}.; 	0.8525	0.49369	-0.075375604	47.26350554	1035.94021	6.18027	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	104	19	1627481	chr19:1627481	C	A	.	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	1775123	1775123	-	CGCC	intronic	ONECUT3	.	.	.	.	.	.	.	0.08086	.	.	.	9.33211	0.34246	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	58	19	1775123	chr19:1775123	T	TCGCC	105	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	1881408	1881408	A	G	exonic	ABHD17A	.	nonsynonymous SNV	ABHD17A:NM_001130111:exon2:c.T158C:p.L53S,ABHD17A:NM_031213:exon2:c.T158C:p.L53S	0.050556875	0.860043678	0.089399447	.	.	0.11236	.	.	106.70342	2.24142	0.503	0.077	T	0.0	0.067	B	0.0	0.040	B	0.939	0.076	N	1	0.090	N	-0.345	0.033	N	1.65	0.400	T	0.06	0.063	N	0.041	0.021	-0.981	0.348	T	0.017	0.071	T	.	.	.	-1.091	0.029	0.010	0.258	0.012	0.003	0.017	N	c	-1.604	-1.530	0.999	0.396	0.722	0.854	0	0.323	0.151	0.191	0.168	0.069	0.176	0.000	0.063	0.013	0.120	6.095	0.191	.	.	.	0.5	102	176	19	1881408	chr19:1881408	A	G	102	PASS	DP=176;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	2038185	2038185	C	T	UTR3	MKNK2	NM_199054:c.*1427G>A	.	.	9.34E-06	0.777281387	0.222709276	.	0.18067	0.14759	-0.576764155	18.7839113	742.98614	5.41125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	385	19	2038185	chr19:2038185	C	T	86	PASS	DP=385;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	2432366	2432366	C	T	intronic	LMNB2	.	.	.	0.995599597	0.004400324	7.95E-08	DISEASE: Partial acquired lipodystrophy (APLD) [MIM:608709]: A rare childhood disease characterized by loss of subcutaneous fat from the face and trunk. Fat deposition on the pelvic girdle and lower limbs is normal or excessive. Most frequently, onset between 5 and 15 years of age. Most affected subjects are females and some show no other abnormality, but many develop glomerulonephritis, diabetes mellitus, hyperlipidemia, and complement deficiency. Mental retardation in some cases. APLD is a sporadic disorder of unknown etiology. {ECO:0000269|PubMed:16826530, ECO:0000269|PubMed:22768673}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, progressive myoclonic 9 (EPM9) [MIM:616540]: An autosomal recessive form of progressive myoclonic epilepsy, a rare disease initially responsive to antiepileptic drugs which over time becomes refractory and can be associated with cognitive decline. EPM9 features include myoclonus, tonic-clonic seizures, ataxia, and psychomotor development. {ECO:0000269|PubMed:25954030}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.8376	0.24333	-1.129772626	6.505071951	299.25483	3.68858	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	80	19	2432366	chr19:2432366	C	T	.	PASS	DP=80;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	2476487	2476487	G	T	intronic	GADD45B	.	.	.	0.185427442	0.763426872	0.051145686	.	0.43236	0.38305	-0.031067188	51.03798066	5224.38363	14.87867	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	900	19	2476487	chr19:2476487	G	T	138	PASS	DP=900;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	3620937	3620937	C	A	intronic	CACTIN	.	.	.	0.999345096	0.0006549	3.77E-09	.	0.11116	.	-0.753139731	13.67067705	1251.44006	6.67662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	19	3620937	chr19:3620937	C	A	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	4042057	4042057	T	G	intergenic	PIAS4;ZBTB7A	dist=2673;dist=1245	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	122	19	4042057	chr19:4042057	T	G	45	PASS	DP=122;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	4294807	4294807	G	A	exonic	TMIGD2	.	nonsynonymous SNV	TMIGD2:NM_001308232:exon2:c.C53T:p.P18L,TMIGD2:NM_001169126:exon3:c.C413T:p.P138L,TMIGD2:NM_144615:exon3:c.C413T:p.P138L	0.01525187	0.878338597	0.106409533	.	0.08093	.	1.931026376	97.46992215	710.71198	5.29848	0.118	0.281	T	0.032	0.189	B	0.015	0.162	B	.	.	.	1	0.090	P	0.345	0.112	N	1.62	0.317	T	-2.87	0.603	D	0.021	0.005	-0.996	0.309	T	0.000	0.000	T	.	.	.	-0.525	0.054	0.191	0.781	0.117	0.008	0.032	N	c	-1.298	-1.427	0.000	0.042	0.516	0.203	0	-4.98	0.028	-0.450	0.068	-0.094	0.117	0.000	0.063	0.022	0.137	0.988	0.013	.	.	.	0.5	54	35	19	4294807	chr19:4294807	G	A	54	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	4472360	4472360	T	C	exonic	HDGFL2	.	nonsynonymous SNV	HDGFL2:NM_001001520:exon1:c.T13C:p.F5L,HDGFL2:NM_032631:exon1:c.T13C:p.F5L	.	.	.	.	.	.	.	.	.	.	.	.	.	0.41	0.388	B	0.241	0.408	B	0.000	0.629	N	0.995	0.423	D	1.26	0.320	L	.	.	.	.	.	.	0.231	0.453	-0.657	0.624	T	0.238	0.606	T	0.940	0.996	D	3.169	0.440	22.7	0.992	0.537	0.767	0.373	D	c	-0.128	-0.108	1.000	0.747	0.726	0.872	0	3.22	0.359	3.883	0.556	0.866	0.377	1.000	0.715	0.984	0.507	10.171	0.419	PWWP domain	.	.	0.5	68	119	19	4472360	chr19:4472360	T	C	68	PASS	DP=119;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	4508855	4508855	G	T	exonic	PLIN4	.	nonsynonymous SNV	PLIN4:NM_001080400:exon4:c.C3585A:p.H1195Q	1.66E-12	0.007710433	0.992289567	.	0.16259	0.102	5.994578529	99.85845718	9818.87991	21.57786	0.01	0.564	D	1.0	0.899	D	0.983	0.742	D	0.000	0.473	D	1.000	0.191	N	3.06	0.872	M	2.22	0.182	T	-6.83	0.930	D	0.705	0.708	-1.075	0.083	T	0.075	0.301	T	0.045	0.617	D	4.476	0.599	24.2	0.990	0.492	0.078	0.136	N	c	-0.392	-0.605	0.001	0.078	0.581	0.326	0	-1.18	0.091	-1.209	0.031	-1.161	0.017	0.004	0.165	0.040	0.157	7.974	0.291	.	.	.	0.5	82	476	19	4508855	chr19:4508855	G	T	82	PASS	DP=476;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	4511284	4511284	A	G	exonic	PLIN4	.	synonymous SNV	PLIN4:NM_001080400:exon3:c.T2646C:p.D882D	1.66E-12	0.007710433	0.992289567	.	0.16259	0.102	5.994578529	99.85845718	9818.87991	21.57786	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	111	19	4511284	chr19:4511284	A	G	82	PASS	DP=111;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	4945914	4945914	A	C	exonic	UHRF1	.	unknown	UNKNOWN	.	.	.	DISEASE: Note=Defects in UHRF1 may be a cause of cancers. Overexpressed in many different forms of human cancers, including bladder, breast, cervical, colorectal and prostate cancers, as well as pancreatic adenocarcinomas, rhabdomyosarcomas and gliomas. Plays an important role in the correlation of histone modification and gene silencing in cancer progression. Expression is associated with a poor prognosis in patients with various cancers, suggesting that it participates in cancer progression.; 	0.23883	0.15269	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	153	127	19	4945914	chr19:4945914	A	C	153	PASS	DP=127;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	5587282	5587282	G	-	exonic	SAFB2	.	frameshift deletion	SAFB2:NM_014649:exon21:c.2834delC:p.P945Rfs*48	0.999582501	0.000417499	5.16E-11	.	0.17843	0.15468	-0.929520514	9.683887709	138.84431	2.56776	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	225	19	5587281	chr19:5587281	CG	C	42	PASS	DP=225;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	5785320	5785320	C	G	intronic	DUS3L	.	.	.	2.45E-09	0.447364589	0.552635408	.	0.16355	.	-0.685180376	15.32200991	3219.59367	10.81274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	488	19	5785320	chr19:5785320	C	G	104	PASS	DP=488;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	5787245	5787245	G	A	intronic	DUS3L	.	.	.	2.45E-09	0.447364589	0.552635408	.	0.16355	.	-0.685180376	15.32200991	3219.59367	10.81274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	476	19	5787245	chr19:5787245	G	A	121	PASS	DP=476;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	6414075	6414075	-	A	UTR3	KHSRP	NM_003685:c.*47_*48insT	.	.	0.999711222	0.000288778	5.13E-10	.	0.45176	0.15486	-0.690637458	15.12149092	19.12445	0.65912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	410	19	6414075	chr19:6414075	G	GA	73	PASS	DP=410;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	0/1	./.
19	6477251	6477251	G	-	exonic	DENND1C	.	frameshift deletion	DENND1C:NM_001290331:exon6:c.359delC:p.P120Lfs*28,DENND1C:NM_024898:exon8:c.491delC:p.P164Lfs*28	0.036005999	0.963928827	6.52E-05	.	0.12173	.	1.249272484	93.46543996	1257.08513	6.68696	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.26	135	19	6477250	chr19:6477250	AG	A	25.26	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	7604754	7604754	G	A	intronic	PNPLA6	.	.	.	1.59E-08	0.999981666	1.83E-05	DISEASE: Spastic paraplegia 39, autosomal recessive (SPG39) [MIM:612020]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG39 is associated with a motor axonopathy affecting upper and lower limbs and resulting in progressive wasting of distal upper and lower extremity muscles. {ECO:0000269|PubMed:18313024, ECO:0000269|PubMed:24355708}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Boucher-Neuhauser syndrome (BNHS) [MIM:215470]: An autosomal recessive disorder characterized by spinocerebellar ataxia, hypogonadotropic hypogonadism, and visual impairment due to chorioretinal dystrophy. The age at onset is variable, but most patients develop 1 or more symptoms in the first decade of life. Chorioretinal dystrophy may not always be present. {ECO:0000269|PubMed:24355708, ECO:0000269|PubMed:25033069}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Laurence-Moon syndrome (LNMS) [MIM:245800]: An autosomal recessive syndrome characterized by progressive spinocerebellar degeneration, spastic paraplegia, mental retardation, hypogonadism, dwarfism, and chorioretinopathy. Trichomegaly is absent. {ECO:0000269|PubMed:25480986}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Oliver-McFarlane syndrome (OMCS) [MIM:275400]: A rare autosomal recessive, congenital syndrome characterized by trichomegaly, severe chorioretinal atrophy and multiple pituitary hormone deficiencies. It results in intellectual impairment and dwarfism, if untreated. Clinical features include hypogonadotropic hypogonadism during puberty, pigmentary retinal degeneration, ataxia, spastic paraplegia, and peripheral neuropathy. {ECO:0000269|PubMed:25480986}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1035	0.15862	-1.142761145	6.375324369	1325.61906	6.84406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	19	7604754	chr19:7604754	G	A	.	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	8176845	8176845	G	-	intronic	FBN3	.	.	.	1.35E-27	0.999811749	0.000188251	.	0.09923	0.13532	7.067302466	99.89384289	18901.16442	29.48902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	83	19	8176844	chr19:8176844	TG	T	72	PASS	DP=83;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	8591377	8591377	G	T	exonic	MYO1F	.	synonymous SNV	MYO1F:NM_001348355:exon24:c.C2718A:p.T906T,MYO1F:NM_012335:exon24:c.C2730A:p.T910T	0.158022191	0.841977807	1.90E-09	.	0.37121	0.20079	-1.828205761	2.123142251	209.12294	3.12186	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	458	19	8591377	chr19:8591377	G	T	114	PASS	DP=458;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	8931965	8931965	C	A	exonic	ZNF558	.	nonsynonymous SNV	ZNF558:NM_144693:exon7:c.G138T:p.E46D	0.000767127	0.768778657	0.230454216	.	0.15725	0.09863	0.330767508	73.53739089	79.11796	1.87794	0.014	0.531	D	0.015	0.158	B	0.097	0.288	B	.	.	.	1	0.810	D	2.55	0.747	M	4.38	0.023	T	-1.53	0.372	N	0.158	0.189	-0.903	0.477	T	0.008	0.028	T	0.004	0.083	T	3.538	0.483	23.1	0.993	0.588	0.471	0.277	N	c	-0.523	-0.466	0.000	0.056	0.707	0.730	0	1.98	0.252	-0.373	0.075	-0.005	0.134	0.007	0.175	0.983	0.502	7.989	0.292	Krueppel-associated box	.	.	0.5	.	202	19	8931965	chr19:8931965	C	A	.	PASS	DP=202;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	8962341	8962341	C	T	intronic	MUC16	.	.	.	.	.	.	.	0.05884	.	29.75317221	100	23894.83454	31.77381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	18	19	8962341	chr19:8962341	C	T	.	PASS	DP=18;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	9120973	9120973	G	T	intergenic	MUC16;OR1M1	dist=28955;dist=82948	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	429	19	9120973	chr19:9120973	G	T	113	PASS	DP=429;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	9297597	9297597	-	T	UTR3	OR7D2	NM_175883:c.*201_*202insT	.	.	0.092527122	0.767080495	0.140392383	.	0.12848	0.09473	-0.203796826	38.81811748	142.40142	2.6032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	63	19	9297597	chr19:9297597	C	CT	107	PASS	DP=63;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	9873861	9873861	G	A	intronic	ZNF846	.	.	.	3.75E-16	0.000756524	0.999243476	.	.	.	0.466683681	78.73908941	1291.14567	6.76427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	19	9873861	chr19:9873861	G	A	.	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	10444783	10444783	C	-	intronic	ICAM3	.	.	.	2.08E-22	1.53E-05	0.999984686	.	0.02658	0.18737	-0.042196577	50.49539986	1207.94912	6.58159	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	235	19	10444782	chr19:10444782	AC	A	58	PASS	DP=235;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	10599904	10599904	C	T	exonic	KEAP1	.	nonsynonymous SNV	KEAP1:NM_012289:exon5:c.G1672A:p.G558R,KEAP1:NM_203500:exon5:c.G1672A:p.G558R	0.251629058	0.748110764	0.000260179	.	0.23809	0.20935	-1.133409319	6.434300543	28.06422	0.90037	0.002	0.721	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	3.04	0.868	M	-1.64	0.825	D	-2.86	0.601	D	0.957	0.955	0.795	0.944	D	0.792	0.929	D	0.291	0.906	D	7.438	0.951	34	0.999	0.995	0.996	0.982	D	c	0.935	0.862	1.000	0.747	0.672	0.522	0	5.56	0.836	7.701	0.834	0.887	0.390	1.000	0.715	0.977	0.480	17.087	0.864	Galactose oxidase, beta-propeller	.	.	0.5	.	86	19	10599904	chr19:10599904	C	T	.	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	11132340	11132340	C	T	intronic	SMARCA4	.	.	.	0.999999998	2.39E-09	4.32E-23	DISEASE: Mental retardation, autosomal dominant 16 (MRD16) [MIM:614609]: A disease characterized by multiple congenital anomalies and mental retardation. Mental retardation is defined by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD16 patients manifest developmental delay, absent or hypoplastic fifth fingernails or toenails, thick eyebrows and long eyelashes, hirsutism. Additional findings include hypotonia, microcephaly, seizures, a Dandy-Walker malformation, and vision and hearing problems. {ECO:0000269|PubMed:22426308}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99989	0.50628	-2.851950648	0.601556971	107.64396	2.2526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	163	19	11132340	chr19:11132340	C	T	.	PASS	DP=163;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	11227485	11227485	C	T	intronic	LDLR	.	.	.	2.59E-16	0.058594457	0.941405543	DISEASE: Familial hypercholesterolemia (FH) [MIM:143890]: Common autosomal semi-dominant disease that affects about 1 in 500 individuals. The receptor defect impairs the catabolism of LDL, and the resultant elevation in plasma LDL-cholesterol promotes deposition of cholesterol in the skin (xanthelasma), tendons (xanthomas), and coronary arteries (atherosclerosis). {ECO:0000269|PubMed:10090484, ECO:0000269|PubMed:10206683, ECO:0000269|PubMed:10422803, ECO:0000269|PubMed:10447263, ECO:0000269|PubMed:10532689, ECO:0000269|PubMed:10660340, ECO:0000269|PubMed:10882754, ECO:0000269|PubMed:10978268, ECO:0000269|PubMed:10980548, ECO:0000269|PubMed:11298688, ECO:0000269|PubMed:11462246, ECO:0000269|PubMed:1446662, ECO:0000269|PubMed:1464748, ECO:0000269|PubMed:17142622, ECO:0000269|PubMed:17347910, ECO:0000269|PubMed:1867200, ECO:0000269|PubMed:19318025, ECO:0000269|PubMed:19319977, ECO:0000269|PubMed:22160468, ECO:0000269|PubMed:2318961, ECO:0000269|PubMed:24529145, ECO:0000269|PubMed:2569482, ECO:0000269|PubMed:2726768, ECO:0000269|PubMed:3263645, ECO:0000269|PubMed:3955657, ECO:0000269|PubMed:7550239, ECO:0000269|PubMed:7573037, ECO:0000269|PubMed:7583548, ECO:0000269|PubMed:7635461, ECO:0000269|PubMed:7635482, ECO:0000269|PubMed:7649546, ECO:0000269|PubMed:7649549, ECO:0000269|PubMed:8168830, ECO:0000269|PubMed:8347689, ECO:0000269|PubMed:8462973, ECO:0000269|PubMed:8664907, ECO:0000269|PubMed:8740918, ECO:0000269|PubMed:9026534, ECO:0000269|PubMed:9104431, ECO:0000269|PubMed:9143924, ECO:0000269|PubMed:9254862, ECO:0000269|PubMed:9259195, ECO:0000269|PubMed:9452094, ECO:0000269|PubMed:9452095, ECO:0000269|PubMed:9452118, ECO:0000269|PubMed:9654205, ECO:0000269|PubMed:9678702, ECO:0000269|PubMed:9852677, ECO:0000269|Ref.70}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42568	0.94311	-1.853858183	2.028780373	654.09994	5.13173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	19	11227485	chr19:11227485	C	T	.	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	11227498	11227498	C	T	intronic	LDLR	.	.	.	2.59E-16	0.058594457	0.941405543	DISEASE: Familial hypercholesterolemia (FH) [MIM:143890]: Common autosomal semi-dominant disease that affects about 1 in 500 individuals. The receptor defect impairs the catabolism of LDL, and the resultant elevation in plasma LDL-cholesterol promotes deposition of cholesterol in the skin (xanthelasma), tendons (xanthomas), and coronary arteries (atherosclerosis). {ECO:0000269|PubMed:10090484, ECO:0000269|PubMed:10206683, ECO:0000269|PubMed:10422803, ECO:0000269|PubMed:10447263, ECO:0000269|PubMed:10532689, ECO:0000269|PubMed:10660340, ECO:0000269|PubMed:10882754, ECO:0000269|PubMed:10978268, ECO:0000269|PubMed:10980548, ECO:0000269|PubMed:11298688, ECO:0000269|PubMed:11462246, ECO:0000269|PubMed:1446662, ECO:0000269|PubMed:1464748, ECO:0000269|PubMed:17142622, ECO:0000269|PubMed:17347910, ECO:0000269|PubMed:1867200, ECO:0000269|PubMed:19318025, ECO:0000269|PubMed:19319977, ECO:0000269|PubMed:22160468, ECO:0000269|PubMed:2318961, ECO:0000269|PubMed:24529145, ECO:0000269|PubMed:2569482, ECO:0000269|PubMed:2726768, ECO:0000269|PubMed:3263645, ECO:0000269|PubMed:3955657, ECO:0000269|PubMed:7550239, ECO:0000269|PubMed:7573037, ECO:0000269|PubMed:7583548, ECO:0000269|PubMed:7635461, ECO:0000269|PubMed:7635482, ECO:0000269|PubMed:7649546, ECO:0000269|PubMed:7649549, ECO:0000269|PubMed:8168830, ECO:0000269|PubMed:8347689, ECO:0000269|PubMed:8462973, ECO:0000269|PubMed:8664907, ECO:0000269|PubMed:8740918, ECO:0000269|PubMed:9026534, ECO:0000269|PubMed:9104431, ECO:0000269|PubMed:9143924, ECO:0000269|PubMed:9254862, ECO:0000269|PubMed:9259195, ECO:0000269|PubMed:9452094, ECO:0000269|PubMed:9452095, ECO:0000269|PubMed:9452118, ECO:0000269|PubMed:9654205, ECO:0000269|PubMed:9678702, ECO:0000269|PubMed:9852677, ECO:0000269|Ref.70}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.42568	0.94311	-1.853858183	2.028780373	654.09994	5.13173	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	19	11227498	chr19:11227498	C	T	.	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	11564715	11564715	C	G	UTR3	ELAVL3	NM_001420:c.*626G>C;NM_032281:c.*626G>C	.	.	0.822602584	0.176556392	0.000841025	.	0.39015	0.23372	-0.780646273	12.77423921	9.21155	0.33694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	505	19	11564715	chr19:11564715	C	G	69	PASS	DP=505;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	11564730	11564731	CC	-	UTR3	ELAVL3	NM_001420:c.*611_*610delGG;NM_032281:c.*611_*610delGG	.	.	0.822602584	0.176556392	0.000841025	.	0.39015	0.23372	-0.780646273	12.77423921	9.21155	0.33694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	115	19	11564729	chr19:11564729	TCC	T	69	PASS	DP=115;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	11591325	11591325	C	-	intronic	ELAVL3	.	.	.	0.822602584	0.176556392	0.000841025	.	0.39015	0.23372	-0.780646273	12.77423921	9.21155	0.33694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	368	19	11591324	chr19:11591324	AC	A	92	PASS	DP=368;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	11661058	11661058	G	C	UTR3	CNN1	NM_001308342:c.*448G>C;NM_001308341:c.*448G>C;NM_001299:c.*448G>C	.	.	0.861520643	0.138047141	0.000432216	.	0.31953	0.14336	-0.336073593	30.55555556	38.63481	1.14452	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	273	19	11661058	chr19:11661058	G	C	96	PASS	DP=273;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	11917481	11917481	C	G	exonic	ZNF491	.	nonsynonymous SNV	ZNF491:NM_152356:exon3:c.C713G:p.T238R	5.13E-07	0.405347903	0.594651584	.	0.19959	.	0.88921411	89.24274593	196.96831	3.03569	0.0	0.912	D	0.999	0.764	D	0.967	0.699	D	.	.	.	0.943	0.374	D	1.53	0.389	L	1.78	0.257	T	-4.81	0.807	D	0.171	0.214	-0.860	0.513	T	0.130	0.439	T	0.001	0.010	T	4.157	0.557	23.8	0.979	0.360	0.001	0.004	N	c	-0.249	-0.575	0.249	0.187	0.554	0.246	0	0.981	0.188	0.146	0.159	0.643	0.292	0.000	0.063	0.007	0.100	9.569	0.384	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	117	62	19	11917481	chr19:11917481	C	G	117	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
19	11978253	11978253	C	T	exonic	ZNF439	.	synonymous SNV	ZNF439:NM_152262:exon3:c.C369T:p.S123S,ZNF439:NM_001348718:exon4:c.C393T:p.S131S,ZNF439:NM_001348719:exon4:c.C384T:p.S128S,ZNF439:NM_001348721:exon4:c.C330T:p.S110S,ZNF439:NM_001348722:exon4:c.C228T:p.S76S,ZNF439:NM_001348720:exon5:c.C330T:p.S110S,ZNF439:NM_001348723:exon5:c.C228T:p.S76S	3.21E-08	0.174571486	0.825428482	.	0.20448	.	0.953537969	90.08610521	391.8226	4.16553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	19	11978253	chr19:11978253	C	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	12024208	12024208	-	T	intronic	ZNF69	.	.	.	7.35E-05	0.303763702	0.696162787	.	.	.	0.25917371	70.05779665	27.23843	0.8772	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	21	19	12024208	chr19:12024208	C	CT	44	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	12186761	12186761	A	G	exonic	ZNF844	.	nonsynonymous SNV	ZNF844:NM_001136501:exon4:c.A826G:p.T276A	1.01E-05	0.341425777	0.658564161	.	.	.	2.81877582	99.05638122	4160.71334	12.81024	0.066	0.361	T	0.363	0.322	B	0.114	0.302	B	.	.	.	0.993	0.588	P	2.02	0.555	M	1.73	0.264	T	-4.1	0.749	D	0.054	0.036	-1.012	0.262	T	0.000	0.000	T	.	.	.	2.136	0.318	17.09	0.951	0.255	0.000	0.000	N	c	-0.661	-0.780	0.001	0.082	0.776	0.995	0	1.45	0.216	3.402	0.521	0.672	0.294	0.703	0.284	0.010	0.111	6.394	0.207	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	ENSG00000214189.4|ENSG00000223547.5	Skin_Not_Sun_Exposed_Suprapubic|Thyroid	0.5	51	39	19	12186761	chr19:12186761	A	G	51	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	12430216	12430216	-	A	exonic	ZNF563	.	frameshift insertion	ZNF563:NM_145276:exon4:c.622dupT:p.W208Lfs*8	8.58E-07	0.745959735	0.254039407	.	0.19969	.	-0.179930907	40.35739561	73.78661	1.79524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	303	19	12430216	chr19:12430216	C	CA	65	PASS	DP=303;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	13064214	13064214	C	-	UTR3	RAD23A	NM_001270363:c.*351delC;NM_005053:c.*351delC;NM_001270362:c.*351delC	.	.	0.039256536	0.953968382	0.006775082	.	0.75777	0.19913	0.373041938	75.29488087	343.62896	3.93038	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	420	19	13064213	chr19:13064213	AC	A	87	PASS	DP=420;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/1
19	13209514	13209514	C	T	UTR3	NFIX	NM_002501:c.*4086C>T;NM_001271044:c.*4086C>T;NM_001271043:c.*4051C>T	.	.	0.989066455	0.010929908	3.64E-06	DISEASE: Sotos syndrome 2 (SOTOS2) [MIM:614753]: A form of Sotos syndrome, a childhood overgrowth syndrome characterized by prenatal and postnatal overgrowth, developmental delay, mental retardation, advanced bone age, and abnormal craniofacial morphology. SOTOS2 patients have macrocephaly, long narrow face, high forehead, slender habitus, scoliosis, and unusual behavior characterized especially by anxiety. {ECO:0000269|PubMed:22301465}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Marshall-Smith syndrome (MRSHSS) [MIM:602535]: A distinct malformation syndrome characterized by accelerated skeletal maturation, relative failure to thrive, respiratory difficulties, mental retardation, and unusual facies, including prominent forehead, shallow orbits, blue sclerae, depressed nasal bridge, and micrognathia. Additional skeletal findings include long and thin tubular bones, broad middle phalanges with relatively narrow distal phalanges, and scoliosis. {ECO:0000269|PubMed:20673863}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35172	0.09375	-0.273576253	33.97027601	1.20885	0.03724	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	84	19	13209514	chr19:13209514	C	T	.	PASS	DP=84;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	13318896	13318896	A	-	intronic	CACNA1A	.	.	.	1	2.24E-10	1.12E-27	DISEASE: Spinocerebellar ataxia 6 (SCA6) [MIM:183086]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA6 is an autosomal dominant cerebellar ataxia (ADCA), mainly caused by expansion of a CAG repeat in the coding region of CACNA1A. There seems to be a correlation between the repeat number and earlier onset of the disorder. {ECO:0000269|PubMed:16325861, ECO:0000269|PubMed:20682717, ECO:0000269|PubMed:8988170, ECO:0000269|PubMed:9345107}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Migraine, familial hemiplegic, 1 (FHM1) [MIM:141500]: A subtype of migraine with aura associated with ictal hemiparesis and, in some families, cerebellar ataxia and atrophy. Migraine is a disabling symptom complex of periodic headaches, usually temporal and unilateral. Headaches are often accompanied by irritability, nausea, vomiting and photophobia, preceded by constriction of the cranial arteries. Migraine with aura is characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred vision, hallucinations, vertigo, numbness and difficulty in concentrating and speaking. {ECO:0000269|PubMed:10408532, ECO:0000269|PubMed:11409427, ECO:0000269|PubMed:11439943, ECO:0000269|PubMed:15032980, ECO:0000269|PubMed:18400034, ECO:0000269|PubMed:8898206}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Episodic ataxia 2 (EA2) [MIM:108500]: An autosomal dominant disorder characterized by acetozolamide-responsive attacks of ataxia, migraine-like symptoms, interictal nystagmus, and cerebellar atrophy. {ECO:0000269|PubMed:10987655, ECO:0000269|PubMed:11176968, ECO:0000269|PubMed:11723274, ECO:0000269|PubMed:12420090, ECO:0000269|PubMed:14718690, ECO:0000269|PubMed:15173248, ECO:0000269|PubMed:15293273, ECO:0000269|PubMed:18602318, ECO:0000269|PubMed:19232643, ECO:0000269|PubMed:20129625, ECO:0000269|PubMed:21696515, ECO:0000269|PubMed:8898206, ECO:0000269|PubMed:9302278}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.58636	0.55905	-1.782298694	2.270582685	4523.77922	13.50808	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	454	19	13318895	chr19:13318895	CA	C	76	PASS	DP=454;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	14910637	14910637	-	A	exonic	OR7C1	.	frameshift insertion	OR7C1:NM_198944:exon1:c.311dupT:p.T105Hfs*16	0.22002709	0.647565891	0.132407019	.	0.04419	.	1.68481378	96.37886294	1256.02466	6.68179	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	204	19	14910637	chr19:14910637	G	GA	74	PASS	DP=204;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	15794498	15794498	G	T	exonic	CYP4F12	.	nonsynonymous SNV	CYP4F12:NM_023944:exon7:c.G843T:p.Q281H	1.18E-09	0.317322174	0.682677824	.	0.12638	0.13897	3.741799815	99.5930644	493.21153	4.56649	0.067	0.359	T	0.015	0.158	B	0.114	0.302	B	0.137	0.184	U	1	0.090	N	1.555	0.395	L	-0.42	0.695	T	-3.34	0.663	D	0.053	0.112	-0.890	0.490	T	0.184	0.533	T	0.033	0.549	D	-0.572	0.051	0.146	0.908	0.195	0.179	0.198	N	c	-1.031	-1.135	0.000	0.071	0.487	0.133	0	-1.35	0.086	-1.551	0.023	-3.501	0.001	0.000	0.063	0.000	0.016	2.707	0.048	.	.	.	0.5	100	297	19	15794498	chr19:15794498	G	T	100	PASS	DP=297;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	15905468	15905468	T	G	exonic	OR10H5	.	nonsynonymous SNV	OR10H5:NM_001004466:exon1:c.T610G:p.C204G	0.043953004	0.666138751	0.289908245	.	0.05526	0.09533	1.910792163	97.4168436	5294.08243	15.03864	0.122	0.276	T	0.998	0.715	D	0.984	0.745	D	0.000	0.537	D	1	0.090	P	-1.72	0.003	N	1.29	0.358	T	-1.9	0.443	N	0.451	0.504	-1.088	0.058	T	0.002	0.008	T	.	.	.	0.506	0.142	7.473	0.698	0.088	0.110	0.161	N	c	-0.380	-0.506	0.000	0.060	0.487	0.133	0	3.36	0.374	1.173	0.313	0.719	0.303	0.001	0.137	0.003	0.074	6.761	0.226	GPCR, rhodopsin-like, 7TM	ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267453.2|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000268673.3|ENSG00000267594.5|ENSG00000267594.5|ENSG00000268673.3	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Aorta|Artery_Tibial|Artery_Tibial|Brain_Frontal_Cortex_BA9|Breast_Mammary_Tissue|Breast_Mammary_Tissue|Colon_Sigmoid|Colon_Sigmoid|Colon_Transverse|Colon_Transverse|Esophagus_Gastroesophageal_Junction|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Lung|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Pituitary|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Stomach|Stomach|Testis|Thyroid|Thyroid	0.5	129	80	19	15905468	chr19:15905468	T	G	129	PASS	DP=80;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	15918201	15918201	A	G	exonic	OR10H1	.	nonsynonymous SNV	OR10H1:NM_013940:exon1:c.T647C:p.L216P	0.637065116	0.334487775	0.028447109	.	0.15432	0.095	0.575097644	82.1656051	2707.23222	9.78935	0.008	0.586	D	0.997	0.689	D	0.976	0.719	D	0.012	0.295	N	0.937	0.372	D	3.125	0.882	M	8.34	0.003	T	-4.7	0.798	D	0.67	0.680	-0.686	0.611	T	0.002	0.006	T	0.005	0.127	T	4.839	0.650	24.8	0.999	0.930	0.163	0.191	N	c	0.497	0.355	0.001	0.086	0.487	0.133	0	4.96	0.650	2.769	0.471	0.897	0.411	0.014	0.188	0.989	0.536	12.564	0.555	GPCR, rhodopsin-like, 7TM	.	.	0.5	132	98	19	15918201	chr19:15918201	A	G	132	PASS	DP=98;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	15918238	15918238	A	C	exonic	OR10H1	.	nonsynonymous SNV	OR10H1:NM_013940:exon1:c.T610G:p.C204G	0.637065116	0.334487775	0.028447109	.	0.15432	0.095	0.575097644	82.1656051	2707.23222	9.78935	0.097	0.309	T	0.998	0.715	D	0.984	0.745	D	0.000	0.537	D	0.955	0.379	D	-1.47	0.005	N	1.29	0.358	T	-1.92	0.446	N	0.469	0.519	-1.046	0.155	T	0.021	0.086	T	.	.	.	1.099	0.200	11.21	0.865	0.160	0.091	0.148	N	c	-0.196	-0.226	0.017	0.129	0.554	0.283	0	4.71	0.589	2.526	0.450	0.897	0.411	0.402	0.260	0.068	0.175	10.575	0.442	GPCR, rhodopsin-like, 7TM	.	.	0.5	143	106	19	15918238	chr19:15918238	A	C	143	PASS	DP=106;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	16653215	16653215	C	G	UTR5	CHERP	NM_006387:c.-26G>C	.	.	0.999988396	1.16E-05	2.04E-13	.	0.24899	0.1174	-1.087493118	7.106628922	30.28923	0.96588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	231	19	16653215	chr19:16653215	C	G	76	PASS	DP=231;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	16770215	16770215	G	A	exonic	SMIM7	.	nonsynonymous SNV	SMIM7:NM_001300925:exon3:c.C112T:p.P38S,SMIM7:NM_024104:exon3:c.C112T:p.P38S	0.417815347	0.547200563	0.03498409	.	0.22364	.	0.013025609	54.62962963	5.74285	0.21555	0.616	0.209	T	0.0	0.026	B	0.003	0.080	B	0.067	0.218	U	0.538	0.314	N	.	.	.	.	.	.	-3.89	0.728	D	0.19	0.243	-0.885	0.494	T	0.118	0.415	T	0.005	0.141	T	3.148	0.438	22.6	0.999	0.944	0.877	0.471	D	c	0.042	0.188	1.000	0.747	0.628	0.401	0	4.53	0.548	5.680	0.676	1.044	0.665	1.000	0.715	0.872	0.365	12.978	0.578	.	.	.	0.5	.	22	19	16770215	chr19:16770215	G	A	.	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	18276930	18276930	G	T	intronic	PIK3R2	.	.	.	0.939626884	0.060371032	2.08E-06	DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 (MPPH1) [MIM:603387]: A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome. {ECO:0000269|PubMed:22729224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.47036	0.41833	-0.534490515	20.70063694	216.25734	3.17643	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	0.055	0.037	.	.	.	.	.	.	.	.	.	-0.137	0.081	1.468	0.187	0.006	0.089	0.146	N	n	-0.268	-0.222	0.290	0.191	0.563	0.310	0	-6.35	0.018	-0.578	0.059	-0.982	0.023	0.000	0.063	0.001	0.043	2.325	0.039	.	.	.	0.5	.	67	19	18276930	chr19:18276930	G	T	.	PASS	DP=67;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	18390732	18390732	-	T	UTR3	JUND	NM_001286968:c.*518_*519insA;NM_005354:c.*518_*519insA	.	.	0.560887374	0.389592916	0.04951971	.	0.5238	.	.	.	36.56701	1.09595	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	56	19	18390732	chr19:18390732	A	AT	39	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	18544389	18544389	C	T	intronic	SSBP4	.	.	.	0.961658882	0.038337822	3.30E-06	.	0.20604	0.10821	-0.293801652	32.93819297	37.43039	1.11514	.	.	.	.	.	.	.	.	.	.	.	.	0.899	0.361	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.103	0.777	D	0.729	0.163	9.014	0.934	0.225	0.033	0.083	N	n	1.267	5.403	1.000	0.747	0.090	0.018	0	0.216	0.145	-0.156	0.100	0.667	0.294	0.000	0.063	0.067	0.174	4.762	0.124	.	.	.	0.5	.	29	19	18544389	chr19:18544389	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	18650239	18650239	C	T	exonic	FKBP8	.	nonsynonymous SNV	FKBP8:NM_001308373:exon4:c.G493A:p.V165M,FKBP8:NM_012181:exon4:c.G493A:p.V165M	0.978738099	0.021243272	1.86E-05	.	0.14814	0.16202	-0.578583623	18.71903751	316.31545	3.77722	0.261	0.165	T	0.068	0.468	B	0.009	0.337	B	0.000	0.497	D	0.988	0.810	D	0.835	0.211	L	0.29	0.589	T	-0.12	0.088	N	0.241	0.364	-0.844	0.524	T	0.139	0.458	T	0.022	0.453	T	2.702	0.386	20.8	0.980	0.367	0.211	0.211	N	c	-0.271	-0.271	0.012	0.122	0.707	0.730	0	3.71	0.416	0.405	0.206	0.841	0.343	0.004	0.165	0.530	0.276	13.033	0.581	FKBP-type peptidyl-prolyl cis-trans isomerase domain	.	.	0.5	108	192	19	18650239	chr19:18650239	C	T	108	PASS	DP=192;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	18700047	18700047	A	G	intronic	C19orf60	.	.	.	0.249879078	0.642082143	0.10803878	.	0.11766	.	.	.	32.748	1.01722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	151	207	19	18700047	chr19:18700047	A	G	151	PASS	DP=207;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	19431733	19431733	C	T	exonic	MAU2	.	nonsynonymous SNV	MAU2:NM_015329:exon1:c.C65T:p.A22V	0.999717755	0.000282245	9.82E-11	.	0.26949	.	-0.758599262	13.32861524	16.10564	0.57035	0.519	0.073	T	0.028	0.184	B	0.015	0.162	B	0.037	0.244	U	0.795	0.344	D	0.14	0.088	N	-1.34	0.800	T	-0.16	0.095	N	0.21	0.258	-0.674	0.617	T	0.228	0.593	T	0.108	0.785	D	3.361	0.462	22.9	0.996	0.711	0.949	0.624	D	c	-0.170	0.087	1.0	0.983	0.442	0.072	0	5.31	0.750	4.788	0.619	0.935	0.490	1.000	0.715	0.983	0.502	16.478	0.839	Tetratricopeptide-like helical domain	.	.	0.5	121	851	19	19431733	chr19:19431733	C	T	121	PASS	DP=851;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	20370250	20370250	C	A	intergenic	ZNF486;MIR1270	dist=58951;dist=139831	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	114	98	19	20370250	chr19:20370250	C	A	114	PASS	DP=98;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	20728254	20728254	C	G	exonic	ZNF737	.	nonsynonymous SNV	ZNF737:NM_001159293:exon4:c.G755C:p.S252T	1.11E-07	0.186556737	0.813443152	.	.	.	2.2177395	98.14225053	1976.98707	8.19153	1.0	0.010	T	0.0	0.026	B	0.002	0.063	B	.	.	.	0.993	0.237	N	-0.235	0.039	N	2.64	0.128	T	3.08	0.001	N	0.056	0.039	-0.951	0.408	T	0.011	0.041	T	0.001	0.015	T	-2.207	0.006	0.001	0.090	0.001	0.001	0.004	N	c	-1.873	-1.913	0.001	0.084	0.615	0.372	0	-0.2	0.125	-0.363	0.076	-0.719	0.036	0.007	0.175	0.001	0.043	5.437	0.157	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	87	100	19	20728254	chr19:20728254	C	G	87	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	21132532	21132532	T	C	exonic	ZNF85	.	synonymous SNV	ZNF85:NM_001256173:exon3:c.T1020C:p.G340G,ZNF85:NM_003429:exon4:c.T1212C:p.G404G,ZNF85:NM_001256171:exon5:c.T1302C:p.G434G	2.28E-10	0.03733675	0.962663249	.	0.16722	0.10724	2.577929865	98.74970512	348.08165	3.9535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	161	19	21132532	chr19:21132532	T	C	80	PASS	DP=161;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	21990546	21990546	T	C	exonic	ZNF43	.	nonsynonymous SNV	ZNF43:NM_001256651:exon3:c.A2098G:p.K700E,ZNF43:NM_001256654:exon3:c.A2098G:p.K700E,ZNF43:NM_001256653:exon4:c.A2320G:p.K774E,ZNF43:NM_003423:exon4:c.A2293G:p.K765E,ZNF43:NM_001256650:exon6:c.A2275G:p.K759E,ZNF43:NM_001256648:exon7:c.A2275G:p.K759E,ZNF43:NM_001256649:exon7:c.A2275G:p.K759E	2.15E-08	0.254407834	0.745592144	.	0.34703	0.07168	0.378498378	75.58386412	64.23103	1.64447	0.782	0.033	T	0.001	0.067	B	0.003	0.080	B	.	.	.	1.000	0.090	N	0.1	0.085	N	3.1	0.083	T	0.77	0.020	N	0.195	0.239	-0.929	0.442	T	0.008	0.029	T	0.001	0.005	T	0.058	0.099	3.160	0.238	0.010	0.002	0.009	N	c	-1.327	-1.311	0.001	0.083	0.651	0.465	0	0.672	0.170	-3.816	0.004	-1.599	0.009	0.000	0.063	0.003	0.074	0.178	0.001	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2;Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	80	85	19	21990546	chr19:21990546	T	C	80	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	22868521	22868521	A	G	intergenic	ZNF492;ZNF99	dist=18049;dist=66464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	196	19	22868521	chr19:22868521	A	G	80	PASS	DP=196;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	22940344	22940344	A	G	exonic	ZNF99	.	synonymous SNV	ZNF99:NM_001080409:exon4:c.T2367C:p.Y789Y	3.04E-09	0.162337151	0.837662846	.	.	.	.	.	1840.35634	7.91225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	111	106	19	22940344	chr19:22940344	A	G	111	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	22942325	22942325	G	C	exonic	ZNF99	.	nonsynonymous SNV	ZNF99:NM_001080409:exon4:c.C386G:p.A129G	3.04E-09	0.162337151	0.837662846	.	.	.	.	.	1840.35634	7.91225	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-2.115	0.002	N	3.24	0.069	T	1.63	0.006	N	0.112	0.121	-0.995	0.313	T	0.000	0.000	T	.	.	.	-1.238	0.024	0.006	0.266	0.013	0.001	0.006	N	c	-2.131	-2.096	0.000	0.012	0.487	0.133	0	-0.806	0.103	-1.663	0.021	-1.836	0.006	0.000	0.063	0.000	0.016	4.388	0.107	.	ENSG00000229676.2|ENSG00000229676.2|ENSG00000261558.1|ENSG00000229676.2	Adipose_Subcutaneous|Cells_Transformed_fibroblasts|Testis|Testis	0.5	76	21	19	22942325	chr19:22942325	G	C	76	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	24310450	24310450	A	G	exonic	ZNF254	.	nonsynonymous SNV	ZNF254:NM_001278678:exon2:c.A1393G:p.K465E,ZNF254:NM_001278663:exon3:c.A1393G:p.K465E,ZNF254:NM_001278664:exon3:c.A1429G:p.K477E,ZNF254:NM_203282:exon4:c.A1648G:p.K550E,ZNF254:NM_001278661:exon5:c.A1525G:p.K509E,ZNF254:NM_001278662:exon5:c.A1525G:p.K509E,ZNF254:NM_001278677:exon6:c.A1525G:p.K509E	9.15E-27	5.71E-07	0.999999429	.	0.18622	0.0746	0.560331224	81.70559094	1143.56	6.44823	1.0	0.010	T	0.002	0.090	B	0.004	0.093	B	.	.	.	1	0.090	N	-1.06	0.011	N	3.19	0.074	T	2.42	0.003	N	0.1	0.153	-0.929	0.443	T	0.008	0.029	T	0.000	0.002	T	-1.524	0.016	0.002	0.732	0.099	0.000	0.001	N	c	-1.448	-1.483	0.000	0.044	0.651	0.465	0	-0.481	0.114	-2.687	0.009	-0.516	0.050	0.000	0.063	0.008	0.104	4.412	0.108	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	55	124	19	24310450	chr19:24310450	A	G	55	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	33353558	33353558	C	T	intronic	SLC7A9	.	.	.	0.246082408	0.752570593	0.001347	.	0.15776	0.27325	-0.529034136	20.85987261	2700.38343	9.7809	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	63	19	33353558	chr19:33353558	C	T	.	PASS	DP=63;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	33490500	33490500	C	T	exonic	RHPN2	.	nonsynonymous SNV	RHPN2:NM_033103:exon10:c.G1217A:p.R406Q	0.000336631	0.997287291	0.002376078	.	0.1907	0.10228	0.003714825	54.06935598	5254.99892	14.95444	0.33	0.131	T	0.046	0.205	B	0.011	0.145	B	0.546	0.053	N	1	0.090	N	0.72	0.188	N	1.92	0.231	T	-1.58	0.381	N	0.045	0.025	-1.048	0.150	T	0.066	0.274	T	0.014	0.345	T	2.284	0.336	18.06	0.984	0.411	0.008	0.031	N	c	-1.114	-1.210	1.000	0.425	0.672	0.522	0	-6.97	0.015	-0.603	0.057	-0.079	0.119	0.000	0.063	0.088	0.184	3.396	0.068	BRO1 domain	.	.	0.5	109	148	19	33490500	chr19:33490500	C	T	109	PASS	DP=148;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	33490585	33490585	G	A	exonic	RHPN2	.	stopgain	RHPN2:NM_033103:exon10:c.C1132T:p.Q378X	0.000336631	0.997287291	0.002376078	.	0.1907	0.10228	0.003714825	54.06935598	5254.99892	14.95444	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.292	0.982	39	0.998	0.910	0.991	0.907	D	c	1.043	0.881	1.000	0.747	0.672	0.522	0	4.72	0.591	9.105	0.935	0.889	0.393	1.000	0.715	0.979	0.486	17.685	0.881	BRO1 domain	.	.	0.5	109	115	19	33490585	chr19:33490585	G	A	109	PASS	DP=115;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	35486903	35486903	A	G	UTR5	GRAMD1A	NM_001320036:c.-24A>G	.	.	0.568380699	0.431615022	4.28E-06	.	0.11858	0.11551	-1.017713296	8.103326256	1134.30997	6.42672	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	411	19	35486903	chr19:35486903	A	G	116	PASS	DP=411;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	35502371	35502371	C	T	intronic	GRAMD1A	.	.	.	0.568380699	0.431615022	4.28E-06	.	0.11858	0.11551	-1.017713296	8.103326256	1134.30997	6.42672	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	206	19	35502371	chr19:35502371	C	T	.	PASS	DP=206;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	35510102	35510102	G	C	exonic	GRAMD1A	.	synonymous SNV	GRAMD1A:NM_001136199:exon11:c.G1200C:p.T400T,GRAMD1A:NM_001320035:exon11:c.G519C:p.T173T,GRAMD1A:NM_001320034:exon12:c.G1221C:p.T407T,GRAMD1A:NM_020895:exon12:c.G1221C:p.T407T,GRAMD1A:NM_001320036:exon13:c.G1479C:p.T493T	0.568380699	0.431615022	4.28E-06	.	0.11858	0.11551	-1.017713296	8.103326256	1134.30997	6.42672	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	38	19	35510102	chr19:35510102	G	C	129	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.
19	35761963	35761963	-	T	intronic	USF2	.	.	.	0.992520444	0.00747812	1.44E-06	.	0.26523	0.33317	.	.	1586.84065	7.37078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	42	19	35761963	chr19:35761963	C	CT	50	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	36018407	36018407	T	C	exonic	SBSN	.	synonymous SNV	SBSN:NM_001166034:exon1:c.A777G:p.R259R	0.035145281	0.928145312	0.036709407	.	0.11115	0.09814	1.997187788	97.66454352	2531.0409	9.38563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	58	19	36018407	chr19:36018407	T	C	108	PASS	DP=58;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
19	36122319	36122319	G	T	intronic	RBM42	.	.	.	0.759889531	0.239708836	0.000401633	.	0.204	0.11141	-0.293801652	32.93819297	28.6708	0.91789	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	263	19	36122319	chr19:36122319	G	T	75	PASS	DP=263;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	36211475	36211475	C	T	exonic	KMT2B	.	nonsynonymous SNV	KMT2B:NM_014727:exon3:c.C1226T:p.P409L	0.999999997	2.55E-09	2.07E-24	.	0.69282	0.10507	-5.294103076	0.064873791	1636.68668	7.47877	0.003	0.682	D	0.998	0.715	D	0.981	0.736	D	.	.	.	0.988	0.408	D	0.345	0.112	N	-2.33	0.879	D	-1.52	0.370	N	0.413	0.508	0.045	0.831	D	0.545	0.833	D	0.500	0.952	D	2.537	0.366	19.71	0.986	0.424	0.875	0.468	D	c	0.170	0.151	1.000	0.747	0.696	0.567	0	3.55	0.396	3.033	0.492	0.919	0.430	0.921	0.317	0.931	0.405	10.809	0.455	.	.	.	0.5	.	161	19	36211475	chr19:36211475	C	T	.	PASS	DP=161;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	36322509	36322509	G	A	intronic	NPHS1	.	.	.	7.72E-11	0.998432314	0.001567686	DISEASE: Nephrotic syndrome 1 (NPHS1) [MIM:256300]: A form of nephrotic syndrome, a renal disease clinically characterized by severe proteinuria, resulting in complications such as hypoalbuminemia, hyperlipidemia and edema. Kidney biopsies show non-specific histologic changes such as focal segmental glomerulosclerosis and diffuse mesangial proliferation. Some affected individuals have an inherited steroid-resistant form and progress to end-stage renal failure. {ECO:0000269|PubMed:10652016, ECO:0000269|PubMed:11317351, ECO:0000269|PubMed:17290294, ECO:0000269|PubMed:18503012, ECO:0000269|PubMed:18614772, ECO:0000269|PubMed:20172850, ECO:0000269|PubMed:22009864, ECO:0000269|PubMed:22565185, ECO:0000269|PubMed:9660941, ECO:0000269|PubMed:9915943}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.53507	0.683343061	84.94928049	3107.13056	10.6062	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	225	19	36322509	chr19:36322509	G	A	126	PASS	DP=225;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	36487002	36487002	G	T	UTR3	SDHAF1	NM_001042631:c.*478G>T	.	.	0.106593834	0.5920706	0.301335566	.	.	.	.	.	13.08923	0.47642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	115	19	36487002	chr19:36487002	G	T	83	PASS	DP=115;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	36632054	36632054	C	T	exonic	CAPNS1	.	synonymous SNV	CAPNS1:NM_001003962:exon2:c.C141T:p.G47G,CAPNS1:NM_001302632:exon2:c.C141T:p.G47G,CAPNS1:NM_001749:exon2:c.C141T:p.G47G	0.00012438	0.955664809	0.044210811	.	0.08365	0.34122	-0.273576253	33.97027601	297.0565	3.67821	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	180	19	36632054	chr19:36632054	C	T	.	PASS	DP=180;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	36821265	36821265	-	T	ncRNA_exonic	LINC00665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	750	19	36821265	chr19:36821265	A	AT	82	PASS	DP=750;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	38850231	38850231	C	T	intronic	CATSPERG	.	.	.	1.31E-11	0.754237373	0.245762627	.	0.21807	.	-0.657684922	16.09459778	542.61244	4.74222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	418	19	38850231	chr19:38850231	C	T	106	PASS	DP=418;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	38924410	38924410	G	A	UTR5	RYR1	NM_000540:c.-60G>A;NM_001042723:c.-60G>A	.	.	1.61E-07	0.999999839	2.45E-26	DISEASE: Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomal dominant pharmacogenetic disorder of skeletal muscle and is one of the main causes of death due to anesthesia. In susceptible people, an MH episode can be triggered by all commonly used inhalational anesthetics such as halothane and by depolarizing muscle relaxants such as succinylcholine. The clinical features of the myopathy are hyperthermia, accelerated muscle metabolism, contractures, metabolic acidosis, tachycardia and death, if not treated with the postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can be determined with the 'in vitro' contracture test (IVCT): observing the magnitude of contractures induced in strips of muscle tissue by caffeine alone and halothane alone. Patients with normal response are MH normal (MHN), those with abnormal response to caffeine alone or halothane alone are MH equivocal (MHE(C) and MHE(H) respectively). {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10484775, ECO:0000269|PubMed:10612851, ECO:0000269|PubMed:10823104, ECO:0000269|PubMed:10888602, ECO:0000269|PubMed:11241852, ECO:0000269|PubMed:11389482, ECO:0000269|PubMed:11525881, ECO:0000269|PubMed:11575529, ECO:0000269|PubMed:11928716, ECO:0000269|PubMed:12059893, ECO:0000269|PubMed:12066726, ECO:0000269|PubMed:12123492, ECO:0000269|PubMed:12208234, ECO:0000269|PubMed:12411788, ECO:0000269|PubMed:12709367, ECO:0000269|PubMed:12883402, ECO:0000269|PubMed:1354642, ECO:0000269|PubMed:14732627, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:15221887, ECO:0000269|PubMed:15448513, ECO:0000269|PubMed:16163667, ECO:0000269|PubMed:1774074, ECO:0000269|PubMed:19191329, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:20681998, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24013571, ECO:0000269|PubMed:7751854, ECO:0000269|PubMed:7849712, ECO:0000269|PubMed:7881417, ECO:0000269|PubMed:8012359, ECO:0000269|PubMed:9066328, ECO:0000269|PubMed:9138151, ECO:0000269|PubMed:9389851, ECO:0000269|PubMed:9450902, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Central core disease of muscle (CCD) [MIM:117000]: Autosomal dominant congenital myopathy, but a severe autosomal recessive form also exists. Both clinical and histological variability is observed. Affected individuals typically display hypotonia and proximal muscle weakness in infancy, leading to the delay of motor milestones. The clinical course of the disorder is usually slow or nonprogressive in adulthood, and the severity of the symptoms may vary from normal to significant muscle weakness. Microscopic examination of CCD-affected skeletal muscle reveals a predominance of type I fibers containing amorphous-looking areas (cores) that do not stain with oxidative and phosphorylase histochemical techniques. {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10097181, ECO:0000269|PubMed:11113224, ECO:0000269|PubMed:11709545, ECO:0000269|PubMed:11741831, ECO:0000269|PubMed:12112081, ECO:0000269|PubMed:12136074, ECO:0000269|PubMed:12565913, ECO:0000269|PubMed:12566385, ECO:0000269|PubMed:12937085, ECO:0000269|PubMed:14670767, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:17204054, ECO:0000269|PubMed:17226826, ECO:0000269|PubMed:18253926, ECO:0000269|PubMed:18312400, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:21674524, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24561095, ECO:0000269|PubMed:7829078, ECO:0000269|PubMed:8220422, ECO:0000269|PubMed:8220423, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]: Clinically heterogeneous neuromuscular disorder. General features include neonatal hypotonia, delayed motor development, and generalized muscle weakness and amyotrophy, which may progress slowly or remain stable. Muscle biopsy shows multiple, poorly circumscribed, short areas of sarcomere disorganization and mitochondria depletion (areas termed minicores) in most muscle fibers. Typically, no dystrophic signs, such as muscle fiber necrosis or regeneration or significant endomysial fibrosis, are present in multiminicore disease. {ECO:0000269|PubMed:12719381, ECO:0000269|PubMed:16380615}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:20583297}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in RYR1 may be a cause of Samaritan myopathy, a congenital myopathy with benign course. Patients display severe hypotonia and respiratory distress at birth. Unlike other congenital myopathies, the health status constantly improves and patients are minimally affected at adulthood.; 	0.22212	.	-8.291678111	0.005897617	2142.38985	8.51518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	73	19	38924410	chr19:38924410	G	A	.	PASS	DP=73;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	39227910	39227910	C	T	exonic	CAPN12	.	synonymous SNV	CAPN12:NM_144691:exon10:c.G1248A:p.A416A	7.48E-20	0.000491944	0.999508056	.	0.38998	0.11824	-0.523584927	20.93654164	2537.68423	9.40302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	152	19	39227910	chr19:39227910	C	T	.	PASS	DP=152;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	39423227	39423227	C	A	exonic	MRPS12	.	nonsynonymous SNV	MRPS12:NM_021107:exon2:c.C304A:p.L102M,MRPS12:NM_033362:exon3:c.C304A:p.L102M,MRPS12:NM_033363:exon3:c.C304A:p.L102M	0.010426267	0.612392219	0.377181514	.	0.31923	0.17492	-0.139478553	43.29440906	162.82289	2.78572	0.001	0.784	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.08	0.973	H	0.56	0.546	T	-2.0	0.461	N	0.687	0.729	0.351	0.884	D	0.526	0.824	D	0.054	0.658	D	5.459	0.741	26.1	0.996	0.736	0.944	0.609	D	c	0.909	0.778	1.0	0.983	0.719	0.830	0	5.85	0.936	5.987	0.700	0.925	0.434	1.000	0.715	0.977	0.480	17.651	0.880	Nucleic acid-binding, OB-fold	.	.	0.5	111	635	19	39423227	chr19:39423227	C	A	111	PASS	DP=635;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	39978801	39978801	C	G	exonic	TIMM50	.	nonsynonymous SNV	TIMM50:NM_001329559:exon8:c.C458G:p.P153R,TIMM50:NM_001001563:exon9:c.C1106G:p.P369R	0.442656937	0.557064432	0.000278631	.	0.15447	0.10784	-0.045835247	50.34206181	685.25632	5.2276	0.236	0.179	T	0.002	0.156	B	0.005	0.121	B	0.001	0.409	D	0.795	0.344	D	0.015	0.080	N	2.23	0.181	T	3.42	0.001	N	0.227	0.278	-1.018	0.242	T	0.024	0.101	T	0.005	0.137	T	2.418	0.352	18.94	0.225	0.009	0.912	0.527	D	c	-0.128	0.081	0.857	0.251	0.707	0.730	0	4.96	0.650	2.818	0.475	0.852	0.362	0.999	0.424	0.997	0.653	10.696	0.449	FCP1 homology domain|HAD-like domain	.	.	0.5	118	134	19	39978801	chr19:39978801	C	G	118	PASS	DP=134;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	40368733	40368733	G	C	exonic	FCGBP	.	synonymous SNV	FCGBP:NM_003890:exon28:c.C12615G:p.L4205L	.	.	.	.	0.54275	.	.	.	18359.5916	28.93384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	339	19	40368733	chr19:40368733	G	C	136	PASS	DP=339;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	40512005	40512005	C	G	exonic	ZNF546	.	synonymous SNV	ZNF546:NM_001297763:exon4:c.C9G:p.P3P,ZNF546:NM_178544:exon4:c.C87G:p.P29P	2.54E-10	0.439925615	0.560074385	.	0.1624	.	0.606246644	82.93229535	1927.87071	8.08022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	51	19	40512005	chr19:40512005	C	G	97	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	40747818	40747818	C	A	intronic	AKT2	.	.	.	0.997816207	0.002183722	7.10E-08	DISEASE: Note=Defects in AKT2 are a cause of susceptibility to breast cancer (BC). AKT2 promotes metastasis of tumor cells without affecting the latency of tumor development. With AKT3, plays also a pivotal role in the biology of glioblastoma.; DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:15166380, ECO:0000269|PubMed:19164855}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hypoinsulinemic hypoglycemia with hemihypertrophy (HIHGHH) [MIM:240900]: A disorder characterized by hypoglycemia, low insulin levels, low serum levels of ketone bodies and branched-chain amino acids, left-sided hemihypertrophy, neonatal macrosomia, reduced consciousness and hypoglycemic seizures. {ECO:0000269|PubMed:21979934}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.91994	0.55644	-0.648365105	16.35999056	17.52078	0.61489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	624	19	40747818	chr19:40747818	C	A	124	PASS	DP=624;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	41062902	41062902	-	C	intronic	SPTBN4	.	.	.	.	.	.	.	0.16131	0.15197	-1.824619408	2.129039868	5101.64368	14.64602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	89	19	41062902	chr19:41062902	A	AC	144	PASS	DP=89;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	41074106	41074106	C	T	exonic	SPTBN4	.	nonsynonymous SNV	SPTBN4:NM_020971:exon31:c.C6874T:p.R2292W	.	.	.	.	0.16131	0.15197	-1.824619408	2.129039868	5101.64368	14.64602	0.0	0.912	D	0.997	0.764	D	0.551	0.575	P	0.000	0.473	U	0.965	0.385	D	0	0.065	N	-1.43	0.807	T	-1.74	0.412	N	0.457	0.509	-0.090	0.803	T	0.452	0.786	T	0.271	0.899	D	7.746	0.955	35	0.999	0.951	0.825	0.414	D	c	0.066	0.080	1.000	0.747	0.598	0.340	0	3.64	0.407	1.957	0.398	0.004	0.136	1.000	0.715	0.117	0.195	13.106	0.585	.	.	.	0.5	94	650	19	41074106	chr19:41074106	C	T	94	PASS	DP=650;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	41285972	41285972	C	G	exonic	RAB4B	.	stopgain	RAB4B:NM_016154:exon2:c.C65G:p.S22X	0.940202326	0.059554587	0.000243086	.	0.37331	0.11262	-0.538132194	20.26421326	2.81543	0.10018	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.035	0.972	37	0.994	0.638	0.988	0.864	D	c	1.153	1.008	1.000	0.747	0.732	0.924	0	5.38	0.772	7.846	0.851	0.807	0.329	1.000	0.715	1.000	0.888	17.959	0.889	P-loop containing nucleoside triphosphate hydrolase|Small GTP-binding protein domain	.	.	0.5	69	45	19	41285972	chr19:41285972	C	G	69	PASS	DP=45;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	41354606	41354606	G	T	exonic	CYP2A6	.	synonymous SNV	CYP2A6:NM_000762:exon3:c.C406A:p.R136R	2.18E-06	0.708893749	0.291104073	.	0.23228	0.52146	0.295774947	71.64425572	375.34434	4.08402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	157	19	41354606	chr19:41354606	G	T	.	PASS	DP=157;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	41354661	41354661	T	C	exonic	CYP2A6	.	synonymous SNV	CYP2A6:NM_000762:exon3:c.A351G:p.V117V	2.18E-06	0.708893749	0.291104073	.	0.23228	0.52146	0.295774947	71.64425572	375.34434	4.08402	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	130	160	19	41354661	chr19:41354661	T	C	130	PASS	DP=160;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	41533087	41533087	T	C	intergenic	CYP2B6;CYP2A13	dist=8786;dist=61269	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	206	19	41533087	chr19:41533087	T	C	90	PASS	DP=206;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	41533181	41533181	A	G	intergenic	CYP2B6;CYP2A13	dist=8880;dist=61175	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	403	19	41533181	chr19:41533181	A	G	122	PASS	DP=403;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	41633855	41633855	G	T	exonic	CYP2F1	.	synonymous SNV	CYP2F1:NM_000774:exon10:c.G1344T:p.L448L	2.76E-05	0.771523766	0.228448673	.	.	.	1.003094668	90.77022883	5472.61938	15.24169	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	295	19	41633855	chr19:41633855	G	T	.	PASS	DP=295;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	42351672	42351672	G	A	exonic	DMRTC2	.	nonsynonymous SNV	DMRTC2:NM_001040283:exon2:c.G176A:p.R59H	0.726527694	0.272884882	0.000587423	.	.	0.0851	-0.514264485	21.41424864	37.06083	1.1074	0.318	0.136	T	0.637	0.899	P	0.142	0.875	B	0.020	0.272	N	0.994	0.421	D	0.52	0.136	N	.	.	.	-3.31	0.659	D	0.904	0.894	-0.716	0.597	T	0.274	0.646	T	0.005	0.125	T	4.402	0.589	24.1	0.916	0.203	0.885	0.481	D	c	0.292	0.328	0.827	0.246	0.497	0.185	0	4.29	0.502	2.205	0.422	1.045	0.669	1.000	0.715	1.000	0.888	12.978	0.578	DM DNA-binding domain	.	.	0.5	.	151	19	42351672	chr19:42351672	G	A	.	PASS	DP=151;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	42594356	42594356	-	T	UTR3	POU2F2	NM_001247994:c.*1400_*1401insA;NM_002698:c.*1347_*1348insA;NM_001207025:c.*1347_*1348insA	.	.	0.97379428	0.026199392	6.33E-06	.	0.49246	0.27788	-0.538132194	20.26421326	113.2753	2.31761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.53	104	19	42594356	chr19:42594356	A	AT	14.53	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	42595035	42595035	G	-	UTR3	POU2F2	NM_001247994:c.*722delC;NM_002698:c.*669delC;NM_001207025:c.*669delC	.	.	0.97379428	0.026199392	6.33E-06	.	0.49246	0.27788	-0.538132194	20.26421326	113.2753	2.31761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	38	19	42595034	chr19:42595034	TG	T	41	PASS	DP=38;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	42752834	42752834	C	T	exonic	ERF	.	nonsynonymous SNV	ERF:NM_001301035:exon4:c.G1205A:p.C402Y,ERF:NM_001308402:exon4:c.G1205A:p.C402Y,ERF:NM_001312656:exon4:c.G1205A:p.C402Y,ERF:NM_006494:exon4:c.G1430A:p.C477Y	0.807144401	0.19263935	0.000216249	DISEASE: Craniosynostosis 4 (CRS4) [MIM:600775]: A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability. {ECO:0000269|PubMed:23354439}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.63786	0.13887	-0.424258538	25.56027365	41.74458	1.21591	0.002	0.721	D	0.969	0.548	D	0.895	0.617	P	0.003	0.356	U	1.000	0.588	D	1.87	0.498	L	1.8	0.263	T	-3.06	0.630	D	0.85	0.837	-1.033	0.196	T	0.108	0.393	T	0.019	0.413	T	4.988	0.671	25.1	0.994	0.637	0.949	0.625	D	c	0.546	0.521	1.000	0.448	0.672	0.522	0	4.25	0.495	3.419	0.522	0.837	0.341	1.000	0.715	0.995	0.604	12.374	0.544	.	.	.	0.5	71	310	19	42752834	chr19:42752834	C	T	71	PASS	DP=310;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	42755585	42755585	T	G	intronic	ERF	.	.	.	0.807144401	0.19263935	0.000216249	DISEASE: Craniosynostosis 4 (CRS4) [MIM:600775]: A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability. {ECO:0000269|PubMed:23354439}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.63786	0.13887	-0.424258538	25.56027365	41.74458	1.21591	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	19	42755585	chr19:42755585	T	G	.	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	43439858	43439858	G	T	exonic	PSG7	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	0.723	0.405	P	0.739	0.538	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.097	0.207	.	.	.	.	.	.	.	.	.	0.665	0.157	8.593	0.606	0.063	0.002	0.013	N	n	-0.375	-0.222	0.007	0.115	0.054	0.004	0	-1.38	0.085	-2.555	0.010	-1.058	0.020	0.000	0.063	0.000	0.016	2.002	0.032	Immunoglobulin V-set domain|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	87	297	19	43439858	chr19:43439858	G	T	87	PASS	DP=297;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	43593534	43593534	G	C	intergenic	PSG2;PSG5	dist=6641;dist=78361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	388	19	43593534	chr19:43593534	G	C	108	PASS	DP=388;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	43697581	43697581	C	T	intronic	PSG4	.	.	.	7.90E-10	0.142725513	0.857274486	.	.	.	2.180909934	98.08327436	470.5539	4.48902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	123	19	43697581	chr19:43697581	C	T	91	PASS	DP=123;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	43763145	43763145	G	A	exonic	PSG9	.	synonymous SNV	PSG9:NM_001301707:exon3:c.C573T:p.P191P,PSG9:NM_002784:exon4:c.C852T:p.P284P	2.75E-14	0.004925661	0.995074339	.	0.24972	.	1.607548084	95.91884879	1896.34765	8.00804	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	661	19	43763145	chr19:43763145	G	A	86	PASS	DP=661;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	44098881	44098881	G	-	intronic	IRGQ	.	.	.	0.001197228	0.956861915	0.041940857	.	0.11132	0.10002	0.174625237	65.9648502	46.00143	1.30616	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	155	337	19	44098880	chr19:44098880	AG	A	155	PASS	DP=337;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	44981013	44981013	G	C	exonic	ZNF180	.	nonsynonymous SNV	ZNF180:NM_001278508:exon4:c.C1610G:p.S537C,ZNF180:NM_001288761:exon4:c.C656G:p.S219C,ZNF180:NM_001288762:exon4:c.C656G:p.S219C,ZNF180:NM_001278509:exon5:c.C1604G:p.S535C,ZNF180:NM_001288759:exon5:c.C1682G:p.S561C,ZNF180:NM_001291633:exon5:c.C1604G:p.S535C,ZNF180:NM_013256:exon5:c.C1685G:p.S562C,ZNF180:NM_001288760:exon7:c.C656G:p.S219C	7.36E-06	0.73046946	0.269523183	.	0.16058	.	1.157431179	92.60438783	5752.00612	15.73654	0.002	0.721	D	1.0	0.899	D	0.98	0.732	D	0.001	0.405	N	0.976	0.253	N	1.655	0.426	L	4.67	0.018	T	-4.15	0.753	D	0.429	0.485	-1.188	0.003	T	0.026	0.110	T	0.008	0.204	T	4.854	0.652	24.9	0.989	0.475	0.000	0.001	N	c	0.671	0.609	0.997	0.353	0.660	0.495	0	5.23	0.725	2.093	0.411	0.998	0.613	0.032	0.204	0.996	0.625	11.128	0.474	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	76	54	19	44981013	chr19:44981013	G	C	76	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	45185796	45185796	G	-	intronic	CEACAM19	.	.	.	5.78E-07	0.248356946	0.751642477	.	0.14148	.	-0.003562597	53.72729417	225.41131	3.24667	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	215	19	45185795	chr19:45185795	TG	T	65	PASS	DP=215;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	45375202	45375202	C	G	exonic	NECTIN2	.	nonsynonymous SNV	NECTIN2:NM_001042724:exon3:c.C571G:p.P191A,NECTIN2:NM_002856:exon3:c.C571G:p.P191A	.	.	.	.	0.11419	0.17465	0.556689353	81.63481953	.	.	0.043	0.413	D	0.847	0.448	P	0.725	0.532	P	0.002	0.373	N	0.993	0.417	D	1.005	0.253	L	-0.79	0.737	T	-5.3	0.892	D	0.45	0.508	-0.417	0.715	T	0.379	0.736	T	0.030	0.525	D	1.601	0.254	13.85	0.991	0.528	0.352	0.250	N	c	0.046	0.003	0.810	0.243	0.672	0.522	0	4.42	0.526	0.679	0.248	0.932	0.445	0.227	0.244	0.877	0.367	12.389	0.545	CD80-like, immunoglobulin C2-set|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	128	107	19	45375202	chr19:45375202	C	G	128	PASS	DP=107;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	45419456	45419456	C	A	exonic	APOC1	.	nonsynonymous SNV	APOC1:NM_001321065:exon3:c.C68A:p.P23Q,APOC1:NM_001645:exon3:c.C68A:p.P23Q,APOC1:NM_001321066:exon4:c.C68A:p.P23Q	0.050738273	0.691173387	0.25808834	.	0.0944	0.47132	-0.053113545	49.38664779	30.95619	0.97866	.	.	.	0.997	0.689	D	0.957	0.682	D	0.001	0.428	D	1	0.810	D	.	.	.	1.34	0.732	T	.	.	.	0.342	0.403	-0.998	0.304	T	0.160	0.495	T	0.124	0.806	D	5.320	0.720	25.8	0.988	0.467	0.773	0.377	D	c	0.261	0.178	1.000	0.404	0.635	0.413	0	3.29	0.366	1.860	0.388	0.903	0.418	0.895	0.311	0.921	0.396	8.289	0.309	.	.	.	0.5	.	64	19	45419456	chr19:45419456	C	A	.	PASS	DP=64;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	45683434	45683434	G	-	UTR3	BLOC1S3	NM_212550:c.*271delG	.	.	0.01842977	0.494019384	0.487550846	DISEASE: Hermansky-Pudlak syndrome 8 (HPS8) [MIM:614077]: A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. {ECO:0000269|PubMed:16385460}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0538	0.23912	.	.	73.74289	1.79457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	20.31	35	19	45683433	chr19:45683433	TG	T	20.31	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	45684896	45684938	TCCGATCCCAGCTCTGGTCCCTCAGCCGCATTCATATTTACTC	-	UTR3	BLOC1S3	NM_212550:c.*1733_*1775delTCCGATCCCAGCTCTGGTCCCTCAGCCGCATTCATATTTACTC	.	.	0.01842977	0.494019384	0.487550846	DISEASE: Hermansky-Pudlak syndrome 8 (HPS8) [MIM:614077]: A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. {ECO:0000269|PubMed:16385460}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.0538	0.23912	.	.	73.74289	1.79457	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.67	22	19	45684895	chr19:45684895	TTCCGATCCCAGCTCTGGTCCCTCAGCCGCATTCATATTTACTC	T	10.67	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	45973823	45973824	GT	-	intronic	FOSB	.	.	.	0.852916177	0.146576388	0.000507435	.	0.56755	0.4303	-0.117432389	44.89266336	34.12794	1.04651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	203	19	45973822	chr19:45973822	GGT	G	74	PASS	DP=203;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	45998165	45998165	G	-	exonic	RTN2	.	frameshift deletion	RTN2:NM_005619:exon3:c.178delC:p.R60Gfs*2,RTN2:NM_206900:exon3:c.178delC:p.R60Gfs*2	0.636179982	0.363808153	1.19E-05	.	0.58971	.	-0.200157416	39.11299835	92.63069	2.06891	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	686	19	45998164	chr19:45998164	CG	C	84	PASS	DP=686;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	46265029	46265029	C	T	exonic	BHMG1	.	synonymous SNV	BHMG1:NM_001310124:exon12:c.C1338T:p.S446S	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	66	19	46265029	chr19:46265029	C	T	108	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	47603106	47603106	A	G	intronic	ZC3H4	.	.	.	0.999999772	2.28E-07	1.41E-17	.	0.40007	.	-1.320975027	4.777070064	637.42325	5.07993	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	36	19	47603106	chr19:47603106	A	G	52	PASS	DP=36;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	47656347	47656347	-	T	intronic	SAE1	.	.	.	0.988952422	0.011043848	3.73E-06	.	0.6322	0.12546	-0.380166007	27.88393489	72.606	1.77749	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	165	19	47656347	chr19:47656347	C	CT	92	PASS	DP=165;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	48197667	48197667	C	T	exonic	BICRA	.	nonsynonymous SNV	BICRA:NM_015711:exon8:c.C2579T:p.P860L	.	.	.	.	.	.	.	.	.	.	0.053	0.388	T	0.741	0.410	P	0.04	0.225	B	.	.	.	0.822	0.288	N	1.7	0.440	L	1.47	0.320	T	-0.37	0.132	N	0.297	0.357	-1.073	0.088	T	0.030	0.130	T	0.538	0.957	D	2.044	0.306	16.49	0.822	0.136	0.134	0.177	N	c	-0.418	-0.431	0.074	0.157	0.646	0.450	0	2.11	0.262	0.256	0.180	0.739	0.307	0.023	0.197	0.003	0.074	4.790	0.125	.	.	.	0.5	.	81	19	48197667	chr19:48197667	C	T	.	PASS	DP=81;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	48198672	48198672	C	G	exonic	BICRA	.	nonsynonymous SNV	BICRA:NM_015711:exon10:c.C3127G:p.P1043A	.	.	.	.	.	.	.	.	.	.	0.022	0.486	D	0.93	0.498	P	0.758	0.545	P	.	.	.	0.895	0.278	N	0.895	0.225	L	1.49	0.315	T	-1.27	0.320	N	0.149	0.176	-1.058	0.123	T	0.084	0.330	T	0.034	0.559	D	1.885	0.287	15.50	0.983	0.398	0.779	0.381	D	c	0.077	0.037	0.959	0.284	0.696	0.567	0	3.35	0.373	0.904	0.279	0.807	0.329	0.010	0.182	0.974	0.471	10.533	0.440	.	.	.	0.5	67	127	19	48198672	chr19:48198672	C	G	67	PASS	DP=127;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	48533848	48533848	A	-	intronic	CABP5	.	.	.	0.004220803	0.864684114	0.131095083	.	0.35156	0.12664	1.216305531	93.13517339	1299.91454	6.78329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	159	19	48533847	chr19:48533847	GA	G,GAA	92	PASS	DP=159;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	0/1
19	48533848	48533848	-	A	intronic	CABP5	.	.	.	0.004220803	0.864684114	0.131095083	.	0.35156	0.12664	1.216305531	93.13517339	1299.91454	6.78329	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	159	19	48533847	chr19:48533847	GA	G,GAA	92	PASS	DP=159;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	0/1
19	48660232	48660232	G	A	intronic	LIG1	.	.	.	0.017705097	0.982287161	7.74E-06	.	0.97979	0.38753	0.36555769	74.7287096	466.53831	4.47469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	88	19	48660232	chr19:48660232	G	A	.	PASS	DP=88;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	48801293	48801293	G	A	exonic	CCDC114	.	nonsynonymous SNV	CCDC114:NM_144577:exon12:c.C1355T:p.P452L	0.002706897	0.936351114	0.060941988	DISEASE: Ciliary dyskinesia, primary, 20 (CILD20) [MIM:615067]: A disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia. Patients may exhibit randomization of left-right body asymmetry and situs inversus, due to dysfunction of monocilia at the embryonic node. Primary ciliary dyskinesia associated with situs inversus is referred to as Kartagener syndrome. Unlike other forms of CILD characterized by reduced fertility, patients with CILD20 do not appear to be infertile. {ECO:0000269|PubMed:23261302, ECO:0000269|PubMed:23261303}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09978	.	1.42749112	94.99292286	2463.6872	9.24341	0.229	0.183	T	0.059	0.216	B	0.013	0.154	B	.	.	.	1	0.090	N	0.345	0.112	N	1.94	0.227	T	-4.15	0.753	D	0.096	0.097	-0.969	0.374	T	0.021	0.086	T	0.009	0.249	T	0.522	0.144	7.596	0.403	0.028	0.018	0.056	N	c	-1.182	-1.203	0.002	0.091	0.646	0.450	0	-0.14	0.127	0.017	0.132	0.953	0.551	0.001	0.137	0.070	0.176	3.658	0.077	.	.	.	0.5	89	574	19	48801293	chr19:48801293	G	A	89	PASS	DP=574;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	49207731	49207731	C	T	UTR3	FUT2	NM_001097638:c.*486C>T;NM_000511:c.*486C>T	.	.	5.47E-12	0.004200172	0.995799828	.	0.05184	.	0.823072022	88.03963199	10077.22821	21.87521	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	19	49207731	chr19:49207731	C	T	.	PASS	DP=25;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	49316502	49316502	C	-	exonic	HSD17B14	.	frameshift deletion	HSD17B14:NM_016246:exon9:c.743delG:p.G248Vfs*32	0.001372525	0.963567036	0.035060439	.	0.21207	.	0.927856124	89.70276008	1316.53203	6.82371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	38	19	49316501	chr19:49316501	AC	A	45	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	49468728	49468728	A	T	UTR5	FTL	NM_000146:c.-37A>T	.	.	0.000458653	0.427809813	0.571731534	DISEASE: Hereditary hyperferritinemia-cataract syndrome (HHCS) [MIM:600886]: An autosomal dominant disease characterized by elevated level of ferritin in serum and tissues, and early-onset bilateral cataract. {ECO:0000269|PubMed:19176363}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurodegeneration with brain iron accumulation 3 (NBIA3) [MIM:606159]: A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. It is characterized by a variety of neurological signs including parkinsonism, ataxia, corticospinal signs, mild non-progressive cognitive deficit and episodic psychosis. It is linked with decreased serum ferritin levels. {ECO:0000269|PubMed:16116125}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: L-ferritin deficiency (LFTD) [MIM:615604]: A condition characterized by low levels of ferritin in serum and tissues in the absence of other hematological symptoms. Seizures and mild neuropsychologic impairment may manifest in individuals with complete ferritin deficiency. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08288	0.64843	-0.163345027	41.24793583	10.88019	0.39394	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	803	19	49468728	chr19:49468728	A	T	125	PASS	DP=803;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	49550848	49550848	-	TG	downstream	CGB8	dist=47	.	.	0.091777955	0.569050721	0.339171324	.	.	0.0808	.	.	2.44485	0.08929	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	471	19	49550848	chr19:49550848	C	CTG	71	PASS	DP=471;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	49552005	49552005	T	C	UTR5	CGB8	NM_033183:c.-9A>G	.	.	0.091777955	0.569050721	0.339171324	.	.	0.0808	.	.	2.44485	0.08929	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	461	19	49552005	chr19:49552005	T	C	91	PASS	DP=461;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	49558211	49558211	T	G	exonic	CGB7	.	nonsynonymous SNV	CGB7:NM_033142:exon2:c.A70C:p.M24L	0.013101838	0.660375879	0.326522282	.	0.13856	0.10426	.	.	1267.08809	6.70772	0.731	0.038	T	.	.	.	.	.	.	0.985	0.079	N	1	0.090	N	.	.	.	1.18	0.377	T	-0.25	0.110	N	0.162	0.195	-1.021	0.234	T	0.000	0.000	T	.	.	.	-1.685	0.013	0.002	0.447	0.034	0.000	0.003	N	c	-0.919	-1.061	0.226	0.184	0.677	0.550	0	0.946	0.186	2.839	0.477	-0.104	0.116	0.727	0.287	0.001	0.043	5.899	0.181	.	ENSG00000196337.6|ENSG00000196337.6|ENSG00000196337.6|ENSG00000196337.6|ENSG00000104827.12|ENSG00000189052.6|ENSG00000196337.6|ENSG00000189052.6|ENSG00000213030.4|ENSG00000189052.6|ENSG00000196337.6|ENSG00000213030.4|ENSG00000196337.6	Cells_Transformed_fibroblasts|Esophagus_Mucosa|Lung|Muscle_Skeletal|Pancreas|Prostate|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Testis	0.5	111	216	19	49558211	chr19:49558211	T	G	111	PASS	DP=216;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	49558667	49558667	T	C	UTR5	CGB7	NM_033142:c.-35A>G	.	.	0.013101838	0.660375879	0.326522282	.	0.13856	0.10426	.	.	1267.08809	6.70772	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	152	327	19	49558667	chr19:49558667	T	C	152	PASS	DP=327;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	49558678	49558678	T	G	UTR5	CGB7	NM_033142:c.-46A>C	.	.	0.013101838	0.660375879	0.326522282	.	0.13856	0.10426	.	.	1267.08809	6.70772	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	653	19	49558678	chr19:49558678	T	G	135	PASS	DP=653;AN=4	GT	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.
19	49606750	49606750	C	-	intronic	SNRNP70	.	.	.	0.993095086	0.006904675	2.39E-07	.	0.54826	0.24974	.	.	34.51837	1.05414	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	582	19	49606749	chr19:49606749	TC	T	80	PASS	DP=582;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	0/1
19	49982165	49982165	-	C	splicing	FLT3LG	NM_001278638:exon6:c.97-1->C;NM_001204502:exon6:c.343-1->C;NM_001459:exon6:c.343-1->C;NM_001278637:exon6:c.97-1->C;NM_001204503:exon5:c.343-1->C	.	.	0.950828698	0.049022409	0.000148893	.	0.24328	0.14299	-0.560178693	19.30879925	10.2966	0.3755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	289	19	49982165	chr19:49982165	G	GC	89	PASS	DP=289;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	50180555	50180556	CG	-	exonic	PRMT1	.	frameshift deletion	PRMT1:NM_001207042:exon1:c.18_19del:p.A7Efs*14,PRMT1:NM_001536:exon1:c.18_19del:p.A7Efs*12,PRMT1:NM_198318:exon1:c.18_19del:p.A7Efs*14	0.993587787	0.006411228	9.85E-07	.	0.91947	0.4592	-0.560178693	19.30879925	19.62667	0.67361	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	50	19	50180554	chr19:50180554	CCG	C	42	PASS	DP=50;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	50216195	50216195	G	T	intronic	CPT1C	.	.	.	0.000284628	0.999590886	0.000124486	.	0.20362	.	-0.705410796	14.77942911	101.01814	2.17533	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	167	19	50216195	chr19:50216195	G	T	92	PASS	DP=167;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	50463670	50463670	T	G	exonic	SIGLEC11	.	nonsynonymous SNV	SIGLEC11:NM_001135163:exon3:c.A469C:p.K157Q,SIGLEC11:NM_052884:exon3:c.A469C:p.K157Q	2.64E-08	0.478412852	0.521587121	.	0.07542	0.08273	0.846940207	88.47605567	1686.30736	7.57044	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.069	0.216	N	1	0.090	P	-3.23	0.000	N	4.04	0.032	T	2.48	0.002	N	0.021	0.005	-0.964	0.385	T	0.000	0.000	T	.	.	.	-1.721	0.012	0.002	0.118	0.002	0.000	0.002	N	c	-1.667	-1.590	0.001	0.075	0.487	0.133	0	-0.577	0.111	-0.136	0.103	-0.590	0.045	0.000	0.063	0.001	0.043	1.928	0.031	Immunoglobulin-like domain|Immunoglobulin-like fold	ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161643.8|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161643.8|ENSG00000105053.6|ENSG00000105053.6|ENSG00000221125.1|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161640.11|ENSG00000161643.8|ENSG00000161640.11	Adipose_Subcutaneous|Adipose_Visceral_Omentum|Adrenal_Gland|Artery_Aorta|Artery_Tibial|Breast_Mammary_Tissue|Colon_Transverse|Esophagus_Mucosa|Lung|Lung|Skin_Sun_Exposed_Lower_leg|Spleen|Testis|Testis|Testis|Testis|Thyroid|Thyroid|Whole_Blood	0.5	155	305	19	50463670	chr19:50463670	T	G	155	PASS	DP=305;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	50764680	50764680	C	T	intronic	MYH14	.	.	.	0.999847921	0.000152079	6.12E-17	DISEASE: Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:15015131, ECO:0000269|PubMed:16222661}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peripheral neuropathy, myopathy, hoarseness, and hearing loss (PNMHH) [MIM:614369]: A complex phenotype of progressive peripheral neuropathy and distal myopathy, with later onset of hoarseness and hearing loss. Affected individuals develop distal muscle weakness at a mean age of 10.6 years, followed by progressive atrophy of these muscles. The lower limbs are more severely affected than the upper limbs, and the muscle weakness first affects anterior leg muscles and later posterior leg muscles. {ECO:0000269|PubMed:21480433}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22477	0.14506	-2.236665977	1.309271054	1826.33006	7.88079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	19	50764680	chr19:50764680	C	T	.	PASS	DP=42;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	50838423	50838423	A	T	ncRNA_exonic	NAPSB	.	.	.	.	.	.	.	0.02668	0.05504	-0.073340031	48.11866006	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	222	19	50838423	chr19:50838423	A	T	.	PASS	DP=222;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	50912139	50912139	G	A	exonic	POLD1	.	nonsynonymous SNV	POLD1:NM_001308632:exon14:c.G1951A:p.G651R,POLD1:NM_001256849:exon15:c.G1873A:p.G625R,POLD1:NM_002691:exon15:c.G1873A:p.G625R	0.001807011	0.998149838	4.32E-05	DISEASE: Colorectal cancer 10 (CRCS10) [MIM:612591]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:23263490, ECO:0000269|PubMed:24501277}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL) [MIM:615381]: An autosomal dominant systemic disorder characterized by prominent loss of subcutaneous fat, metabolic abnormalities including insulin resistance and diabetes mellitus, sclerodermatous skin, and a facial appearance characterized by mandibular hypoplasia. Sensorineural deafness occurs late in the first or second decades of life. {ECO:0000269|PubMed:23770608}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.96379	0.4561	-0.828637633	11.54163718	551.71434	4.7781	0.226	0.185	T	0.177	0.273	B	0.052	0.241	B	0.016	0.281	N	1.000	0.548	D	2.18	0.615	M	2.36	0.161	T	-2.45	0.535	N	0.663	0.674	-1.111	0.030	T	0.047	0.200	T	0.023	0.464	T	4.438	0.594	24.2	0.898	0.185	0.940	0.596	D	c	-0.075	0.005	0.923	0.267	0.707	0.730	0	4.69	0.584	5.751	0.681	1.048	0.713	1.000	0.715	0.011	0.114	16.771	0.853	DNA-directed DNA polymerase, family B, multifunctional domain	.	.	0.5	112	362	19	50912139	chr19:50912139	G	A	112	PASS	DP=362;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	50978722	50978722	G	T	exonic	FAM71E1	.	synonymous SNV	FAM71E1:NM_001308429:exon3:c.C399A:p.L133L	0.006132393	0.737056923	0.256810684	.	0.18198	.	0.194852702	67.03231894	119.58351	2.38015	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	234	19	50978722	chr19:50978722	G	T	.	PASS	DP=234;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	51274851	51274851	A	C	exonic	GPR32	.	nonsynonymous SNV	GPR32:NM_001506:exon1:c.A994C:p.T332P	7.91E-05	0.315038766	0.68488214	.	0.0893	.	0.108486928	61.90728946	99.68741	2.16289	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	-1.72	0.003	N	1.24	0.367	T	3.88	0.001	N	0.074	0.064	-0.995	0.312	T	0.030	0.131	T	.	.	.	-1.311	0.022	0.004	0.827	0.139	0.001	0.005	N	c	-1.513	-1.493	0.002	0.089	0.497	0.185	0	-0.781	0.104	0.074	0.144	-0.869	0.028	0.000	0.063	0.757	0.323	3.651	0.077	.	.	.	0.5	91	43	19	51274851	chr19:51274851	A	C	91	PASS	DP=43;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	51729578	51729596	CCCAACAACTGGTATCTTT	-	exonic	CD33	.	frameshift deletion	CD33:NM_001082618:exon3:c.330_348del:p.P111Qfs*37,CD33:NM_001177608:exon4:c.711_729del:p.P238Qfs*37,CD33:NM_001772:exon4:c.711_729del:p.P238Qfs*37	2.31E-05	0.497999066	0.501977871	.	0.03502	0.08119	2.289361599	98.30738382	1143.30228	6.44529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	25	19	51729577	chr19:51729577	ACCCAACAACTGGTATCTTT	A	97	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	51919120	51919120	A	G	UTR5	LOC100129083	NM_001256795:c.-159A>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	118	139	19	51919120	chr19:51919120	A	G	118	PASS	DP=139;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	52000670	52000670	G	T	exonic	SIGLEC12	.	nonsynonymous SNV	SIGLEC12:NM_033329:exon5:c.C1081A:p.L361I,SIGLEC12:NM_053003:exon6:c.C1435A:p.L479I	1.54E-10	0.197090502	0.802909498	.	0.06344	.	2.337125365	98.40174569	3066.99793	10.53027	0.177	0.222	T	0.706	0.472	P	0.33	0.480	B	0.306	0.040	U	1	0.090	N	2.785	0.815	M	3.43	0.055	T	-0.98	0.260	N	0.096	0.097	-1.025	0.221	T	0.033	0.142	T	0.002	0.046	T	0.807	0.171	9.507	0.765	0.111	0.005	0.023	N	c	-0.930	-1.201	0.006	0.112	0.487	0.133	0	-1.22	0.090	-0.683	0.052	-0.201	0.102	0.000	0.063	0.001	0.043	2.514	0.043	Immunoglobulin-like fold	.	.	0.5	81	218	19	52000670	chr19:52000670	G	T	81	PASS	DP=218;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	52570221	52570221	G	C	exonic	ZNF841	.	nonsynonymous SNV	ZNF841:NM_001321349:exon5:c.C566G:p.T189R,ZNF841:NM_001136499:exon7:c.C914G:p.T305R	4.05E-08	0.34953153	0.650468429	.	.	.	0.619191319	83.36282142	706.42123	5.27971	0.263	0.235	T	1.0	0.899	D	0.997	0.850	D	.	.	.	1	0.090	N	1.22	0.307	L	2.46	0.149	T	-3.02	0.626	D	0.247	0.309	-1.056	0.128	T	0.048	0.206	T	0.001	0.021	T	1.654	0.260	14.15	0.955	0.265	0.042	0.096	N	c	-0.590	-0.824	0.002	0.091	0.707	0.730	0	1.1	0.195	-5.418	0.001	-0.281	0.084	0.000	0.063	0.000	0.016	2.756	0.049	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	85	133	19	52570221	chr19:52570221	G	C	85	PASS	DP=133;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	53014793	53014793	G	T	exonic	ZNF578	.	nonsynonymous SNV	ZNF578:NM_001099694:exon6:c.G1159T:p.V387L	8.81E-14	0.002639121	0.997360879	.	.	.	1.047190339	91.34229771	336.42783	3.89648	.	.	.	0.002	0.090	B	0.001	0.040	B	.	.	.	1	0.090	N	0.01	0.080	N	2.49	0.145	T	.	.	.	0.078	0.097	-1.016	0.249	T	0.036	0.157	T	0.001	0.004	T	-0.021	0.092	2.389	0.760	0.109	0.014	0.047	N	c	-1.326	-1.434	0.000	0.029	0.487	0.133	0	-2.57	0.059	-3.182	0.006	-2.389	0.003	0.000	0.063	0.000	0.016	3.497	0.072	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	71	92	19	53014793	chr19:53014793	G	T	71	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	53209576	53209576	T	C	exonic	ZNF611	.	synonymous SNV	ZNF611:NM_001161500:exon5:c.A732G:p.S244S,ZNF611:NM_001161501:exon5:c.A525G:p.S175S,ZNF611:NM_001161499:exon6:c.A732G:p.S244S,ZNF611:NM_030972:exon7:c.A732G:p.S244S	1.16E-17	0.000188316	0.999811684	.	0.14705	.	0.806491657	87.72705827	2377.17021	9.04647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	19	53209576	chr19:53209576	T	C	.	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	53418644	53418644	-	GG	intronic	ZNF888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	142	250	19	53418644	chr19:53418644	A	AGG	142	PASS	DP=250;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
19	53805222	53805222	T	G	intergenic	BIRC8;ZNF845	dist=10347;dist=31750	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	62	19	53805222	chr19:53805222	T	G	89	PASS	DP=62;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	53818738	53818738	-	G	intergenic	BIRC8;ZNF845	dist=23863;dist=18234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	22.12	139	19	53818738	chr19:53818738	T	TG	22.12	PASS	DP=139;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	53905458	53905458	C	T	intronic	ZNF765;ZNF765-ZNF761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	101	19	53905458	chr19:53905458	C	T	.	PASS	DP=101;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	53990021	53990021	A	G	intronic	ZNF813	.	.	.	8.50E-10	0.079646859	0.92035314	.	0.08121	.	1.35769336	94.43854683	2208.34827	8.65139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	141	99	19	53990021	chr19:53990021	A	G	141	PASS	DP=99;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	54245839	54245839	-	GT	ncRNA_exonic	MIR520H	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	45	19	54245839	chr19:54245839	A	AGT	98	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	54545085	54545085	A	-	intronic	VSTM1	.	.	.	4.39E-09	0.057039085	0.94296091	.	0.04548	.	0.084621747	60.31493277	1238.62841	6.64471	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	17	19	54545084	chr19:54545084	GA	G	54	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	54649671	54649671	T	-	exonic	CNOT3	.	frameshift deletion	CNOT3:NM_014516:exon9:c.729delT:p.S245Afs*89	0.999967222	3.28E-05	2.56E-12	.	0.73088	0.10155	-0.598810865	18.13517339	98.27185	2.1432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	438	19	54649670	chr19:54649670	CT	C	87	PASS	DP=438;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	./.	0/1	./.	./.	./.
19	54745682	54745682	C	T	exonic	LILRA6;LILRB3	.	nonsynonymous SNV	LILRB3:NM_001081450:exon4:c.G428A:p.R143Q,LILRB3:NM_001320960:exon4:c.G428A:p.R143Q,LILRB3:NM_006864:exon4:c.G428A:p.R143Q,LILRA6:NM_024318:exon4:c.G419A:p.R140Q	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	205	19	54745682	chr19:54745682	C	T	.	PASS	DP=205;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	54759055	54759055	C	-	intronic	LILRB5	.	.	.	7.17E-12	0.124265917	0.875734083	.	0.05934	0.06828	0.786269343	87.29063458	2895.36837	10.19483	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	145	19	54759054	chr19:54759054	AC	A	44	PASS	DP=145;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
19	54778505	54778505	C	G	UTR3	LILRB2	NM_001278403:c.*32G>C;NM_001278404:c.*32G>C;NM_005874:c.*32G>C;NM_001080978:c.*32G>C;NM_001278405:c.*220G>C	.	.	7.83E-06	0.979376847	0.020615324	.	0.31832	.	2.831581484	99.08586931	3895.89182	12.31761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	433	19	54778505	chr19:54778505	C	G	110	PASS	DP=433;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	54782405	54782405	C	G	exonic	LILRB2	.	nonsynonymous SNV	LILRB2:NM_001278404:exon6:c.G619C:p.G207R,LILRB2:NM_001278405:exon6:c.G967C:p.G323R,LILRB2:NM_001278406:exon6:c.G967C:p.G323R,LILRB2:NM_001080978:exon7:c.G967C:p.G323R,LILRB2:NM_001278403:exon7:c.G967C:p.G323R,LILRB2:NM_005874:exon7:c.G967C:p.G323R	7.83E-06	0.979376847	0.020615324	.	0.31832	.	2.831581484	99.08586931	3895.89182	12.31761	0.254	0.203	T	0.709	0.401	P	0.439	0.439	B	0.114	0.027	N	1	0.090	N	0.08	0.083	N	5.79	0.007	T	-1.54	0.373	N	0.152	0.276	-0.988	0.331	T	0.003	0.009	T	0.003	0.057	T	-0.286	0.069	0.714	0.677	0.082	0.002	0.010	N	c	-1.095	-1.318	0.999	0.381	0.447	0.083	0	-3.77	0.040	-1.813	0.018	-1.204	0.016	0.000	0.063	0.000	0.016	0.771	0.009	Immunoglobulin-like domain;Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	115	409	19	54782405	chr19:54782405	C	G	115	PASS	DP=409;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	54802380	54802394	CCCTTAGGACCCCCA	-	intronic	LILRA3	.	.	.	0.002925351	0.941785239	0.055289411	.	0.06888	.	3.561548721	99.50460014	1102.81114	6.34939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	125	19	54802379	chr19:54802379	TCCCTTAGGACCCCCA	T	69	PASS	DP=125;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	54802435	54802435	G	A	intronic	LILRA3	.	.	.	0.002925351	0.941785239	0.055289411	.	0.06888	.	3.561548721	99.50460014	1102.81114	6.34939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	88	19	54802435	chr19:54802435	G	A	.	PASS	DP=88;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	55106288	55106288	A	C	exonic	LILRA1	.	nonsynonymous SNV	LILRA1:NM_001278319:exon3:c.A229C:p.I77L,LILRA1:NM_001278318:exon4:c.A229C:p.I77L,LILRA1:NM_006863:exon4:c.A229C:p.I77L	1.54E-16	0.000861763	0.999138237	.	0.03809	.	2.539299607	98.72021703	2966.18722	10.32448	0.384	0.165	T	0.0	0.026	B	0.0	0.063	B	0.222	0.035	N	1	0.090	N	-2.02	0.002	N	5.83	0.007	T	0.68	0.022	N	0.035	0.202	-0.917	0.459	T	0.001	0.003	T	.	.	.	-1.537	0.016	0.002	0.802	0.126	0.000	0.002	N	c	-1.960	-1.968	1.000	0.517	0.610	0.352	0	-1.94	0.071	-3.526	0.005	-1.428	0.011	0.000	0.063	0.000	0.016	4.396	0.107	Immunoglobulin subtype|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold;Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	90	273	19	55106288	chr19:55106288	A	C	90	PASS	DP=273;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	55278630	55278630	G	C	intergenic	KIR2DL3;LOC101928804	dist=14126;dist=2244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	128	19	55278630	chr19:55278630	G	C	101	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	55278668	55278668	C	G	intergenic	KIR2DL3;LOC101928804	dist=14164;dist=2206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.169	0.079	1.273	0.398	0.027	0.015	0.050	N	n	-0.207	-0.202	0.000	0.012	0.054	0.004	0	-0.381	0.118	0.263	0.181	0.397	0.275	0.328	0.253	0.006	0.095	4.532	0.113	.	.	.	0.5	88	102	19	55278668	chr19:55278668	C	G	88	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	55341459	55341459	C	G	intronic	KIR3DL1	.	.	.	9.78E-06	0.552285382	0.447704835	.	0.05806	.	3.335364374	99.43382873	2335.80145	8.95125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	140	701	19	55341459	chr19:55341459	C	G	140	PASS	DP=701;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	55602970	55602970	A	C	intronic	PPP1R12C	.	.	.	0.462120927	0.537869226	9.85E-06	.	0.29098	0.10482	-1.03794674	7.832035858	344.728	3.93807	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	19	55602970	chr19:55602970	A	C	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	55698866	55698866	G	A	intronic	PTPRH	.	.	.	5.10E-29	7.03E-05	0.999929729	.	0.0771	.	1.111434312	92.06770465	5182.51875	14.81765	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	19	19	55698866	chr19:55698866	G	A	.	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
19	55795460	55795460	G	-	upstream	BRSK1	dist=74	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	604	19	55795459	chr19:55795459	CG	C	58	PASS	DP=604;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	55828098	55828098	G	A	intronic	TMEM150B	.	.	.	4.55E-06	0.22830469	0.771690758	.	.	.	-0.093566408	46.7386176	27.38398	0.88237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	146	19	55828098	chr19:55828098	G	A	87	PASS	DP=146;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	56372787	56372787	G	T	exonic	NLRP4	.	nonsynonymous SNV	NLRP4:NM_134444:exon4:c.G1892T:p.C631F	5.16E-05	0.992920234	0.007028169	.	0.07498	0.09698	0.216698013	67.92285916	73.01576	1.78351	0.001	0.784	D	1.0	0.899	D	0.988	0.764	D	.	.	.	0.738	0.338	D	1.44	0.361	L	-2.46	0.889	D	-9.24	0.983	D	0.485	0.533	0.463	0.900	D	0.740	0.911	D	0.063	0.689	D	2.952	0.415	22.1	0.990	0.488	0.530	0.290	D	c	0.012	-0.157	0.000	0.038	0.554	0.246	0	2.34	0.279	0.890	0.277	0.108	0.203	0.209	0.242	0.174	0.211	4.969	0.134	Leucine-rich repeat domain, L domain-like	.	.	0.5	.	46	19	56372787	chr19:56372787	G	T	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
19	56736012	56736012	A	G	intronic	ZSCAN5A	.	.	.	0.081218246	0.90832008	0.010461674	.	0.0921	.	-0.088107893	47.06298655	564.39042	4.82371	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	444	19	56736012	chr19:56736012	A	G	127	PASS	DP=444;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
19	58002859	58002859	T	C	exonic	ZNF419	.	synonymous SNV	ZNF419:NM_001098492:exon2:c.T57C:p.D19D,ZNF419:NM_001098493:exon2:c.T54C:p.D18D,ZNF419:NM_001098495:exon2:c.T57C:p.D19D,ZNF419:NM_001098496:exon2:c.T54C:p.D18D,ZNF419:NM_001291745:exon2:c.T57C:p.D19D,ZNF419:NM_001098491:exon3:c.T96C:p.D32D,ZNF419:NM_001098494:exon3:c.T96C:p.D32D,ZNF419:NM_001291743:exon3:c.T93C:p.D31D,ZNF419:NM_024691:exon3:c.T93C:p.D31D	2.08E-06	0.460864739	0.539133182	.	0.22698	0.08472	1.578193463	95.76551073	91.77944	2.06141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	43	19	58002859	chr19:58002859	T	C	52	PASS	DP=43;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
19	58063707	58063707	C	G	intronic	ZNF550	.	.	.	1.52E-10	0.015432932	0.984567068	.	0.13325	.	0.643056625	84.05284265	61.39768	1.59674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	59	19	58063707	chr19:58063707	C	G	57	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
19	58084294	58084294	G	A	exonic	ZNF416	.	synonymous SNV	ZNF416:NM_017879:exon4:c.C978T:p.Y326Y	0.000574204	0.896616643	0.102809153	.	0.0469	.	-0.666770504	15.86459071	44.10909	1.26615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	189	19	58084294	chr19:58084294	G	A	41	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
19	58118572	58118572	A	G	exonic	ZNF530	.	nonsynonymous SNV	ZNF530:NM_020880:exon3:c.A1679G:p.N560S,ZNF530:NM_001321981:exon4:c.A1580G:p.N527S	1.74E-10	0.114407016	0.885592984	.	0.08489	.	1.820761234	97.009908	298.54254	3.68443	1.0	0.010	T	0.006	0.126	B	0.002	0.063	B	.	.	.	1	0.090	N	-1.34	0.007	N	3.21	0.071	T	2.18	0.003	N	0.01	0.001	-0.935	0.434	T	0.004	0.013	T	0.001	0.011	T	-2.277	0.005	0.001	0.157	0.004	0.041	0.094	N	c	-1.774	-1.775	0.003	0.100	0.563	0.310	0	-2.9	0.053	-2.862	0.008	-1.267	0.014	0.000	0.063	0.000	0.016	2.216	0.037	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2|Zinc finger, C2H2-like	.	.	0.5	91	135	19	58118572	chr19:58118572	A	G	91	PASS	DP=135;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
19	58446550	58446550	G	A	UTR5	ZNF418	NM_133460:c.-1360C>T;NM_001317027:c.-2687C>T;NM_001317030:c.-7257C>T	.	.	4.09E-21	0.000634817	0.999365183	.	0.14679	.	0.07167258	59.15899976	147.26502	2.64424	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	686	19	58446550	chr19:58446550	G	A	.	PASS	DP=686;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
20	307644	307644	C	T	UTR3	SOX12	NM_006943:c.*128C>T	.	.	.	.	.	.	0.28694	.	.	.	119.21572	2.37593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	20	307644	chr20:307644	C	T	.	PASS	DP=32;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	309111	309111	G	T	UTR3	SOX12	NM_006943:c.*1595G>T	.	.	.	.	.	.	0.28694	.	.	.	119.21572	2.37593	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	20	309111	chr20:309111	G	T	.	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	2124496	2124496	G	T	UTR3	STK35	NM_080836:c.*104G>T	.	.	0.918199526	0.081264275	0.000536199	.	0.19968	0.11306	.	.	1408.18303	7.0104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	355	20	2124496	chr20:2124496	G	T	84	PASS	DP=355;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	3026937	3026937	G	-	intronic	MRPS26	.	.	.	0.187857588	0.762148525	0.049993888	.	0.10007	0.08706	.	.	10.24285	0.37333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	452	20	3026936	chr20:3026936	CG	C	69	PASS	DP=452;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	4158180	4158180	A	T	exonic	SMOX	.	nonsynonymous SNV	SMOX:NM_001270691:exon3:c.A391T:p.I131F,SMOX:NM_175839:exon3:c.A391T:p.I131F,SMOX:NM_175840:exon3:c.A391T:p.I131F,SMOX:NM_175841:exon3:c.A391T:p.I131F,SMOX:NM_175842:exon3:c.A391T:p.I131F	0.837563766	0.162301151	0.000135083	.	0.6224	0.41186	-1.153638777	6.233781552	43.62644	1.25665	0.004	0.682	D	0.999	0.899	D	0.966	0.875	D	0.000	0.843	D	1.000	0.588	D	2.455	0.715	M	-3.0	0.922	D	-3.25	0.655	D	0.597	0.623	0.571	0.915	D	0.803	0.934	D	0.171	0.849	D	4.809	0.645	24.8	0.989	0.484	0.923	0.551	D	c	0.156	0.178	1.000	0.517	0.706	0.609	0	3.0	0.336	3.496	0.528	1.194	0.916	1.000	0.715	0.993	0.574	8.313	0.311	Amine oxidase|FAD/NAD(P)-binding domain	.	.	0.5	93	237	20	4158180	chr20:4158180	A	T	93	PASS	DP=237;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	5155828	5155828	G	T	splicing	CDS2	NM_003818:exon3:c.195-1G>T	.	.	6.78E-05	0.977355656	0.022576536	.	0.08157	0.08152	-0.315847836	31.68789809	624.29254	5.04006	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.201	0.702	25.5	0.995	0.686	0.998	0.992	D	c	1.213	1.054	1.000	0.747	0.140	0.025	0	5.1	0.688	9.972	0.991	1.048	0.713	1.000	0.715	0.880	0.369	17.433	0.874	.	.	.	0.5	.	36	20	5155828	chr20:5155828	G	T	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	5974276	5974276	A	G	exonic	MCM8	.	nonsynonymous SNV	MCM8:NM_001281522:exon17:c.A2224G:p.R742G,MCM8:NM_001281520:exon18:c.A2365G:p.R789G,MCM8:NM_001281521:exon18:c.A2485G:p.R829G,MCM8:NM_032485:exon18:c.A2365G:p.R789G,MCM8:NM_182802:exon18:c.A2317G:p.R773G	1.93E-10	0.954436717	0.045563282	DISEASE: Premature ovarian failure 10 (POF10) [MIM:612885]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:25437880}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24617	0.19778	1.407269618	94.78650625	3710.46351	11.88891	0.022	0.486	D	0.214	0.305	B	0.139	0.319	B	0.000	0.843	D	0.999	0.466	D	2.395	0.694	M	4.08	0.030	T	-3.62	0.695	D	0.857	0.872	-0.994	0.315	T	0.017	0.069	T	0.017	0.384	T	4.539	0.608	24.3	0.994	0.619	0.941	0.599	D	c	0.118	0.272	0.701	0.227	0.732	0.924	0	5.82	0.927	4.299	0.586	1.199	0.960	1.000	0.715	1.000	0.888	12.092	0.528	MCM domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	78	62	20	5974276	chr20:5974276	A	G	78	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	9498657	9498657	-	CTGCCAGCAGGAGGGGC	intronic	LAMP5	.	.	.	3.84E-08	0.10400326	0.895996702	.	0.42339	.	0.260991686	70.25831564	2514.20203	9.34534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	40	20	9498657	chr20:9498657	T	TCTGCCAGCAGGAGGGGC	119	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
20	13140618	13140618	T	-	intronic	SPTLC3	.	.	.	0.00275524	0.994428189	0.002816571	.	0.10462	0.1278	-0.224023033	37.4321774	214.55753	3.15939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	25	20	13140617	chr20:13140617	CT	C	68	PASS	DP=25;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	20029070	20029070	C	T	exonic	CRNKL1	.	nonsynonymous SNV	CRNKL1:NM_001278628:exon4:c.G372A:p.M124I,CRNKL1:NM_001278625:exon5:c.G819A:p.M273I,CRNKL1:NM_001278626:exon5:c.G3A:p.M1I,CRNKL1:NM_001278627:exon5:c.G3A:p.M1I,CRNKL1:NM_016652:exon5:c.G855A:p.M285I	0.881981247	0.118018734	1.96E-08	.	0.29171	0.17515	1.049013545	91.34819533	676.59451	5.19663	0.029	0.457	D	0.771	0.425	P	0.549	0.511	P	0.000	0.843	D	1	0.810	D	3.08	0.875	M	1.37	0.342	T	-2.76	0.589	D	0.874	0.862	-0.723	0.593	T	0.223	0.587	T	0.015	0.354	T	5.003	0.673	25.1	0.997	0.777	0.982	0.805	D	c	0.719	0.751	1.000	0.747	0.732	0.924	0	6.07	0.987	6.160	0.715	0.935	0.490	1.000	0.715	1.000	0.888	20.659	0.996	Tetratricopeptide repeat-containing domain|Tetratricopeptide-like helical domain	.	.	0.5	.	17	20	20029070	chr20:20029070	C	T	.	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	21143813	21143813	-	T	intronic	KIZ	.	.	.	.	.	.	DISEASE: Retinitis pigmentosa 69 (RP69) [MIM:615780]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:24680887}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.03855	0.06663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	145	20	21143813	chr20:21143813	A	AT	62	PASS	DP=145;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
20	21493013	21493013	C	-	exonic	NKX2-2	.	frameshift deletion	NKX2-2:NM_002509:exon2:c.370delG:p.D124Tfs*59	0.337334272	0.648129386	0.014536342	.	0.48097	0.24974	0.505321956	80.00707714	296.89141	3.67718	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	933	20	21493012	chr20:21493012	TC	T	79	PASS	DP=933;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	21695452	21695452	C	A	UTR3	PAX1	NM_006192:c.*11C>A;NM_001257096:c.*252C>A	.	.	0.616084026	0.382224632	0.001691342	DISEASE: Otofaciocervical syndrome 2 (OFC2) [MIM:615560]: A disorder characterized by facial dysmorphism, cup-shaped low-set ears, preauricular fistulas, hearing loss, branchial defects, skeletal anomalies including vertebral defects, low-set clavicles, winged scapulae, sloping shoulders, and mild intellectual disability. {ECO:0000269|PubMed:23851939}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.80187	0.30248	0.350995466	74.37485256	224.51285	3.24104	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	81	20	21695452	chr20:21695452	C	A	.	PASS	DP=81;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	23066469	23066469	C	-	exonic	CD93	.	frameshift deletion	CD93:NM_012072:exon1:c.361delG:p.E121Rfs*78	7.82E-10	0.075948416	0.924051584	.	0.15486	0.28768	-0.148789446	42.29771172	256.90385	3.44823	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	586	20	23066468	chr20:23066468	TC	T	95	PASS	DP=586;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	23584198	23584198	A	T	exonic	CST9	.	synonymous SNV	CST9:NM_001008693:exon2:c.T429A:p.G143G	0.095109295	0.769080073	0.135810632	.	0.08285	0.10564	0.505321956	80.00707714	973.5092	6.03439	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	64	20	23584198	chr20:23584198	A	T	.	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	23667683	23667683	C	G	intronic	CST4	.	.	.	7.30E-06	0.161904959	0.838087741	.	0.09154	0.1077	0.262810045	70.43524416	20.08609	0.68634	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	281	20	23667683	chr20:23667683	C	G	117	PASS	DP=281;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
20	29449550	29449550	T	C	intergenic	NONE;LINC01597	dist=NONE;dist=64034	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	398	20	29449550	chr20:29449550	T	C	93	PASS	DP=398;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	29449597	29449597	G	A	intergenic	NONE;LINC01597	dist=NONE;dist=63987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	440	20	29449597	chr20:29449597	G	A	109	PASS	DP=440;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	29516584	29516584	G	T	ncRNA_exonic	LINC01597	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	310	20	29516584	chr20:29516584	G	T	.	PASS	DP=310;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	29625873	29625873	A	C	ncRNA_exonic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	0.002	0.721	D	0.837	0.444	P	0.783	0.556	P	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	-2.77	0.587	D	0.799	0.789	-0.879	0.499	T	0.181	0.529	T	.	.	.	3.765	0.509	23.4	0.993	0.591	0.844	0.432	D	c	0.345	0.056	0.999	0.397	0.675	0.547	0	1.68	0.231	1.417	0.342	0.675	0.295	1.000	0.715	0.098	0.188	7.376	0.258	Actin cross-linking	.	.	0.5	78	54	20	29625873	chr20:29625873	A	C	78	PASS	DP=54;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	29625895	29625895	G	A	ncRNA_exonic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	0.001	0.784	D	0.552	0.363	P	0.369	0.417	B	0.000	0.843	D	1.000	0.588	D	.	.	.	.	.	.	-6.2	0.904	D	0.781	0.772	-0.738	0.586	T	0.181	0.529	T	.	.	.	2.983	0.419	22.2	0.998	0.854	0.915	0.534	D	c	-0.048	-0.115	1.000	0.500	0.675	0.547	0	1.68	0.231	8.688	0.909	0.597	0.287	1.000	0.715	0.392	0.253	9.356	0.371	Actin cross-linking	.	.	0.5	84	54	20	29625895	chr20:29625895	G	A	84	PASS	DP=54;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	29628229	29628229	-	A	ncRNA_exonic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	515	20	29628229	chr20:29628229	G	GA	124	PASS	DP=515;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	29628263	29628263	A	G	ncRNA_exonic	FRG1BP;FRG1DP	.	.	.	.	.	.	.	.	.	.	.	.	.	0.307	0.141	T	0.0	0.067	B	0.018	0.206	B	0.000	0.843	D	0.634	0.328	D	.	.	.	.	.	.	-0.57	0.172	N	0.489	0.536	-1.056	0.127	T	0.055	0.231	T	0.001	0.003	T	1.583	0.252	13.76	0.942	0.239	0.631	0.317	D	c	-0.318	-0.243	1.000	0.489	0.752	0.988	0	2.08	0.260	4.712	0.613	0.666	0.294	1.000	0.715	0.993	0.574	3.866	0.085	Actin cross-linking	.	.	0.5	155	752	20	29628263	chr20:29628263	A	G	155	PASS	DP=752;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	29628335	29628335	A	T	ncRNA_intronic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	180	233	20	29628335	chr20:29628335	A	T	180	PASS	DP=233;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	29632643	29632643	T	C	ncRNA_exonic	FRG1BP	.	.	.	.	.	.	.	0.12824	.	.	.	.	.	0.027	0.465	D	0.481	0.349	P	0.317	0.399	B	0.000	0.843	U	1	0.810	D	.	.	.	.	.	.	-4.78	0.805	D	0.829	0.817	-0.847	0.522	T	0.162	0.498	T	.	.	.	4.063	0.546	23.7	0.990	0.494	0.869	0.460	D	c	0.008	-0.014	1.000	0.747	0.675	0.547	0	1.44	0.215	6.853	0.751	0.574	0.285	1.000	0.715	0.999	0.750	6.983	0.237	.	.	.	0.5	120	200	20	29632643	chr20:29632643	T	C	120	PASS	DP=200;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	31035145	31035145	C	T	UTR3	NOL4L	NM_001256798:c.*254G>A;NM_001351680:c.*454G>A;NM_080616:c.*254G>A	.	.	.	.	.	.	0.66654	0.11152	-1.045216355	7.661004954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.308	0.068	0.637	0.658	0.076	0.813	0.404	D	c	-0.518	-0.527	0.814	0.244	0.295	0.044	0	1.83	0.242	1.587	0.360	-0.429	0.058	1.000	0.715	0.155	0.206	7.611	0.271	.	.	.	0.5	.	34	20	31035145	chr20:31035145	C	T	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	32256055	32256055	G	-	UTR3	ACTL10	NM_001024675:c.*14delG	.	.	0.001052601	0.375410156	0.623537243	.	0.16929	.	.	.	42.92503	1.24244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	185	20	32256054	chr20:32256054	TG	T	73	PASS	DP=185;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
20	32298283	32298283	C	T	intronic	PXMP4	.	.	.	0.604956427	0.38624188	0.008801693	.	0.1038	0.10278	0.527368849	80.73248408	67.7056	1.70224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	76	20	32298283	chr20:32298283	C	T	.	PASS	DP=76;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	32664877	32664877	C	T	exonic	RALY	.	synonymous SNV	RALY:NM_007367:exon7:c.C654T:p.G218G,RALY:NM_016732:exon8:c.C702T:p.G234G	0.55457384	0.442614262	0.002811898	.	0.18001	0.13451	-0.093566408	46.7386176	666.56385	5.16662	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	328	20	32664877	chr20:32664877	C	T	60	PASS	DP=328;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	32972827	32972827	T	-	intronic	ITCH	.	.	.	0.999990177	9.82E-06	5.57E-15	DISEASE: Autoimmune disease, multisystem, with facial dysmorphism (ADMFD) [MIM:613385]: A disorder characterized by organomegaly, failure to thrive, developmental delay, dysmorphic features and autoimmune inflammatory cell infiltration of the lungs, liver and gut. {ECO:0000269|PubMed:20170897}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59377	0.08471	-1.089312628	7.047652748	40.17092	1.18051	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	43	20	32972826	chr20:32972826	AT	A	59	PASS	DP=43;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
20	33232046	33232046	G	T	intronic	PIGU	.	.	.	0.813069113	0.186732529	0.000198358	.	0.17799	0.11142	-0.402212257	26.7338995	75.12131	1.81375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	72	20	33232046	chr20:33232046	G	T	83	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	33422076	33422076	A	G	ncRNA_exonic	HMGB3P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	28	20	33422076	chr20:33422076	A	G	43	PASS	DP=28;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	33565481	33565481	G	A	exonic	MYH7B	.	nonsynonymous SNV	MYH7B:NM_020884:exon4:c.G52A:p.E18K	1.33E-23	0.792349353	0.207650647	.	0.15291	0.32389	-0.893455413	10.17338995	2287.01575	8.85125	0.665	0.046	T	.	.	.	.	.	.	.	.	.	0.999	0.219	N	.	.	.	-2.03	0.856	D	-0.06	0.079	N	0.134	0.155	-0.556	0.666	T	0.458	0.789	T	0.101	0.775	D	3.523	0.481	23.1	0.996	0.734	0.487	0.280	N	c	0.741	0.543	1.000	0.517	0.554	0.283	0	4.25	0.495	2.248	0.426	0.847	0.346	1.000	0.715	0.903	0.383	7.002	0.238	.	.	.	0.5	.	56	20	33565481	chr20:33565481	G	A	.	PASS	DP=56;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	34147998	34147998	A	G	ncRNA_exonic	FER1L4	.	.	.	.	.	.	.	0.06122	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	30	20	34147998	chr20:34147998	A	G	101	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.
20	34855890	34855890	G	T	intergenic	AAR2;DLGAP4	dist=11027;dist=38355	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	129	20	34855890	chr20:34855890	G	T	.	PASS	DP=129;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	35390803	35390803	A	-	intronic	DSN1	.	.	.	1.72E-06	0.659001624	0.340996652	.	0.08232	0.07785	-0.139478553	43.29440906	80.07637	1.892	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	165	20	35390802	chr20:35390802	CA	C	63	PASS	DP=165;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	36642083	36642083	G	A	exonic	TTI1	.	stopgain	TTI1:NM_001303457:exon2:c.C136T:p.Q46X,TTI1:NM_014657:exon3:c.C136T:p.Q46X	0.000238871	0.9958859	0.003875229	.	0.18744	0.09392	-0.523584927	20.93654164	285.45946	3.61803	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.198	0.973	37	0.998	0.856	0.992	0.928	D	c	1.092	0.968	1.000	0.747	0.722	0.854	0	5.33	0.756	8.813	0.915	1.048	0.713	1.000	0.715	1.000	0.888	18.192	0.897	Armadillo-type fold	.	.	0.5	.	29	20	36642083	chr20:36642083	G	A	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	37590929	37590929	T	C	upstream	DHX35	dist=52	.	.	9.69E-11	0.973981761	0.026018239	.	0.27324	0.09942	-0.328796968	30.86223166	2233.3121	8.70874	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	590	20	37590929	chr20:37590929	T	C	121	PASS	DP=590;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	40744702	40744702	C	A	intronic	PTPRT	.	.	.	0.999998893	1.11E-06	2.26E-19	.	0.39705	0.11014	-1.027089224	7.873319179	360.34688	4.01687	0.017	0.512	D	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	1.3	0.356	T	-0.02	0.073	N	0.276	0.334	-1.019	0.241	T	0.110	0.397	T	0.031	0.533	D	2.427	0.353	19.00	0.985	0.412	0.658	0.326	D	c	0.048	0.054	0.000	0.029	0.487	0.133	0	1.64	0.228	1.715	0.374	0.935	0.490	1.000	0.715	1.000	0.888	5.047	0.137	PTP type protein phosphatase|Protein-tyrosine phosphatase-like	.	.	0.5	.	19	20	40744702	chr20:40744702	C	A	.	PASS	DP=19;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	43384782	43384782	C	A	exonic	RIMS4	.	nonsynonymous SNV	RIMS4:NM_001205317:exon6:c.G806T:p.R269L,RIMS4:NM_182970:exon6:c.G803T:p.R268L	0.952765435	0.047099891	0.000134674	.	0.27845	0.11729	-0.339715008	30.06605331	3.85321	0.1438	0.0	0.912	D	0.621	0.380	P	0.523	0.465	P	0.000	0.629	D	1.000	0.588	D	1.845	0.488	L	1.58	0.291	T	-6.09	0.899	D	0.674	0.683	-1.017	0.248	T	0.097	0.363	T	0.028	0.511	D	4.818	0.647	24.8	0.998	0.893	0.962	0.680	D	c	0.258	0.297	1.000	0.747	0.696	0.567	0	4.0	0.455	6.086	0.708	0.935	0.490	1.000	0.715	0.995	0.604	13.251	0.593	.	.	.	0.5	69	417	20	43384782	chr20:43384782	C	A	69	PASS	DP=417;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	43961750	43961750	C	A	intronic	SDC4	.	.	.	0.011803491	0.847335334	0.140861176	.	0.26113	0.20685	-0.161524709	41.6430762	2463.14431	9.23969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	20	43961750	chr20:43961750	C	A	.	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	43976991	43976991	A	G	exonic	SDC4	.	nonsynonymous SNV	SDC4:NM_002999:exon1:c.T34C:p.F12L	0.011803491	0.847335334	0.140861176	.	0.26113	0.20685	-0.161524709	41.6430762	2463.14431	9.23969	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.354	0.043	N	1	0.588	P	-1.905	0.002	N	1.72	0.266	T	1.24	0.010	N	0.044	0.024	-0.934	0.436	T	0.000	0.000	T	.	.	.	1.585	0.252	13.77	0.784	0.119	0.065	0.124	N	c	-1.092	-0.869	1.000	0.747	0.564	0.319	0	1.9	0.247	0.261	0.181	0.088	0.194	0.995	0.385	0.796	0.335	5.835	0.177	.	.	.	0.5	105	84	20	43976991	chr20:43976991	A	G	105	PASS	DP=84;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	44513293	44513293	A	G	UTR3	ZSWIM1	NM_080603:c.*604A>G	.	.	8.44E-05	0.537074216	0.46284137	.	0.21057	.	0.374860183	75.43052607	362.6889	4.03314	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	321	20	44513293	chr20:44513293	A	G	83	PASS	DP=321;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	44539841	44539841	G	A	exonic	PLTP	.	synonymous SNV	PLTP:NM_001242920:exon3:c.C150T:p.T50T,PLTP:NM_006227:exon3:c.C150T:p.T50T,PLTP:NM_182676:exon3:c.C150T:p.T50T	0.000142042	0.962665909	0.037192049	.	0.36337	0.21599	-0.440847477	24.59896202	193.00501	3.01119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	762	20	44539841	chr20:44539841	G	A	125	PASS	DP=762;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	46294828	46294828	T	C	intronic	SULF2	.	.	.	0.878046241	0.121953654	1.05E-07	.	0.1472	.	-1.591018721	3.084453881	835.17771	5.65739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	85	20	46294828	chr20:46294828	T	C	73	PASS	DP=85;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	46294864	46294864	A	G	intronic	SULF2	.	.	.	0.878046241	0.121953654	1.05E-07	.	0.1472	.	-1.591018721	3.084453881	835.17771	5.65739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	169	20	46294864	chr20:46294864	A	G	97	PASS	DP=169;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	48439582	48439582	-	T	intronic	SLC9A8	.	.	.	2.82E-05	0.983591566	0.016380268	.	0.06517	0.15107	-0.666770504	15.86459071	202.63697	3.07202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	35	20	48439582	chr20:48439582	A	AT	71	PASS	DP=35;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	50721372	50721372	C	T	intronic	ZFP64	.	.	.	0.005189853	0.968804042	0.026006106	.	0.60912	0.11612	0.45192103	78.03727294	242.73747	3.36359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	193	20	50721372	chr20:50721372	C	T	.	PASS	DP=193;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	51588866	51588868	GAG	-	upstream	TSHZ2	dist=78	.	.	0.406843773	0.5927903	0.000365927	.	0.13647	0.11806	-0.916836882	9.831328143	361.35552	4.02303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	203	20	51588865	chr20:51588865	AGAG	A	119	PASS	DP=203;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
20	53208380	53208380	T	G	intronic	DOK5	.	.	.	0.043981192	0.950317262	0.005701547	.	0.48741	0.11878	-0.582225231	18.44184949	47.86079	1.34382	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	78	20	53208380	chr20:53208380	T	G	60	PASS	DP=78;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	55012547	55012547	G	T	exonic	CASS4	.	nonsynonymous SNV	CASS4:NM_001164115:exon2:c.G364T:p.G122W,CASS4:NM_020356:exon2:c.G364T:p.G122W,CASS4:NM_001164116:exon3:c.G364T:p.G122W	0.296175209	0.702950464	0.000874326	.	0.12766	0.08393	-0.10469683	45.64755839	558.21824	4.79883	0.026	0.469	D	0.961	0.670	D	0.72	0.617	P	0.987	0.079	N	1.000	0.090	N	2.125	0.592	M	2.5	0.217	T	-1.84	0.431	N	0.344	0.405	-1.021	0.232	T	0.091	0.348	T	0.015	0.353	T	3.884	0.524	23.5	0.984	0.409	0.041	0.095	N	c	-0.159	-0.364	1.000	0.404	0.554	0.283	0	0.396	0.155	-0.627	0.056	0.138	0.222	0.000	0.063	0.486	0.268	2.216	0.037	.	.	.	0.5	.	77	20	55012547	chr20:55012547	G	T	.	PASS	DP=77;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	55099658	55099658	G	T	intronic	GCNT7	.	.	.	.	.	.	.	0.03282	.	.	.	752.86612	5.44146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	97	20	55099658	chr20:55099658	G	T	.	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	55984073	55984073	T	C	UTR3	RBM38	NM_017495:c.*1171T>C;NM_001291780:c.*1171T>C;NM_183425:c.*1470T>C	.	.	0.859282996	0.138553757	0.002163247	.	0.16014	0.11106	0.43736446	77.56546355	461.24812	4.45359	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	249	20	55984073	chr20:55984073	T	C	.	PASS	DP=249;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	56941976	56941976	A	-	UTR3	RAB22A	NM_020673:c.*7217delA	.	.	0.685129848	0.313970859	0.000899293	.	0.13239	0.12253	-0.207437529	38.2814343	9.37183	0.34486	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	11	20	56941975	chr20:56941975	CA	C	53	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
20	57569709	57569709	C	T	exonic	NELFCD	.	nonsynonymous SNV	NELFCD:NM_198976:exon15:c.C1778T:p.S593F	0.20597781	0.793941076	8.11E-05	.	0.20699	0.42266	-1.199555187	5.761972163	20.6141	0.70093	.	.	.	0.99	0.615	D	0.856	0.592	P	0.000	0.843	D	1	0.810	D	1.1	0.281	L	.	.	.	.	.	.	0.465	0.884	-0.548	0.669	T	0.259	0.630	T	0.006	0.172	T	7.250	0.947	34	0.998	0.905	0.994	0.950	D	c	0.608	0.641	1.000	0.747	0.646	0.442	0	5.15	0.702	6.897	0.753	0.932	0.445	1.000	0.715	0.995	0.604	18.977	0.927	.	.	.	0.5	.	35	20	57569709	chr20:57569709	C	T	.	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	58411528	58411528	G	A	intronic	PHACTR3	.	.	.	0.971713289	0.028286398	3.13E-07	.	0.42756	0.10156	-0.220384297	37.6032083	240.61752	3.35156	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	20	58411528	chr20:58411528	G	A	.	PASS	DP=46;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
20	60892812	60892812	C	A	exonic	LAMA5	.	nonsynonymous SNV	LAMA5:NM_005560:exon54:c.G7262T:p.R2421L	0.943037981	0.056962019	9.75E-22	.	0.70971	.	3.125188892	99.28049068	9086.1435	20.60876	0.247	0.173	T	0.08	0.230	B	0.051	0.240	B	0.986	0.079	U	1	0.090	N	2.125	0.592	M	2.9	0.101	T	-2.57	0.555	D	0.1	0.103	-0.969	0.374	T	0.021	0.091	T	0.028	0.505	D	3.729	0.505	23.3	0.950	0.253	0.146	0.183	N	c	-1.149	-1.191	1.000	0.454	0.707	0.730	0	-3.58	0.043	-1.086	0.035	-1.185	0.016	0.000	0.063	0.370	0.249	10.203	0.421	Laminin alpha, domain I	.	.	0.5	.	95	20	60892812	chr20:60892812	C	A	.	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	60901732	60901732	C	A	splicing	LAMA5	NM_005560:exon40:c.5298+1G>T	.	.	0.943037981	0.056962019	9.75E-22	.	0.70971	.	3.125188892	99.28049068	9086.1435	20.60876	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.602	0.763	26.5	0.995	0.692	0.985	0.832	D	c	1.082	0.912	1.000	0.747	0.156	0.027	0	5.12	0.693	7.047	0.761	0.855	0.374	1.000	0.715	0.902	0.382	18.601	0.912	.	.	.	0.5	.	244	20	60901732	chr20:60901732	C	A	.	PASS	DP=244;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	61461737	61461737	C	A	exonic	COL9A3	.	nonsynonymous SNV	COL9A3:NM_001853:exon23:c.C1187A:p.P396H	3.25E-05	0.999944225	2.33E-05	DISEASE: Multiple epiphyseal dysplasia 3 (EDM3) [MIM:600969]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:10090888}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:11308397, ECO:0000269|PubMed:25381065}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Susceptibility to intervertebral disk disease is conferred by variant p.Arg103Trp (PubMed:11308397). {ECO:0000269|PubMed:11308397}.; 	0.4977	.	0.611719262	82.96768106	2646.06911	9.64989	0.137	0.259	T	0.975	0.561	D	0.815	0.570	P	0.048	0.233	N	0.958	0.262	N	2.825	0.825	M	-2.79	0.910	D	-1.32	0.330	N	0.231	0.283	0.164	0.853	D	0.780	0.925	D	0.330	0.918	D	4.813	0.646	24.8	0.987	0.441	0.340	0.247	N	c	0.232	0.102	0.997	0.351	0.696	0.567	0	3.04	0.340	0.071	0.143	0.852	0.362	0.000	0.063	0.557	0.281	4.047	0.092	.	.	.	0.5	.	328	20	61461737	chr20:61461737	C	A	.	PASS	DP=328;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	61942764	61942764	G	T	exonic	COL20A1	.	nonsynonymous SNV	COL20A1:NM_020882:exon12:c.G1412T:p.R471L	1.27E-24	0.001031378	0.998968622	.	0.0925	0.08222	-0.374974929	28.11983958	1065.33487	6.25837	0.354	0.127	T	0.657	0.400	P	0.171	0.378	B	0.943	0.083	N	1	0.090	N	2.105	0.586	M	0.34	0.582	T	-2.6	0.559	D	0.123	0.138	-0.998	0.306	T	0.124	0.429	T	0.035	0.560	D	0.445	0.137	6.998	0.909	0.196	0.097	0.152	N	c	-0.865	-1.012	0.001	0.075	0.581	0.326	0	-0.893	0.100	0.837	0.270	-0.450	0.056	0.000	0.063	0.004	0.083	8.845	0.341	Fibronectin type III|Immunoglobulin-like fold	.	.	0.5	.	251	20	61942764	chr20:61942764	G	T	.	PASS	DP=251;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	62203414	62203414	T	C	intronic	HELZ2	.	.	.	1.26E-09	0.999300381	0.000699618	.	.	.	-0.147490202	42.30360934	4463.72358	13.40473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	376	20	62203414	chr20:62203414	T	C	.	PASS	DP=376;AN=4	GT	./.	0/1	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
20	62551351	62551351	G	C	intronic	DNAJC5	.	.	.	0.858492459	0.139312429	0.002195113	DISEASE: Ceroid lipofuscinosis, neuronal, 4B (CLN4B) [MIM:162350]: An adult-onset neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. CLN4B has no visual involvement and is characterized by seizures and other neurologic symptoms. {ECO:0000269|PubMed:21820099, ECO:0000269|PubMed:22073189, ECO:0000269|PubMed:22235333, ECO:0000269|PubMed:22978711}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17855	0.11262	-0.339715008	30.06605331	3.7021	0.13784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	342	20	62551351	chr20:62551351	G	C	124	PASS	DP=342;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
20	62843465	62843465	G	T	exonic	MYT1	.	synonymous SNV	MYT1:NM_004535:exon9:c.G1491T:p.V497V	0.999871802	0.000128198	5.88E-13	.	0.9384	0.11581	-1.631512986	2.848549186	268.65953	3.51606	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	78	20	62843465	chr20:62843465	G	T	.	PASS	DP=78;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	9865857	9865857	A	G	intergenic	MIR3687-2;TEKT4P2	dist=39594;dist=41332	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	384	21	9865857	chr21:9865857	A	G	144	PASS	DP=384;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	10862749	10862749	A	T	intergenic	TEKT4P2;TPTE	dist=894155;dist=43438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	936	21	10862749	chr21:10862749	A	T	93	PASS	DP=936;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	10906989	10906989	C	T	exonic	TPTE	.	synonymous SNV	TPTE:NM_001290224:exon19:c.G1158A:p.R386R,TPTE:NM_199260:exon22:c.G1458A:p.R486R,TPTE:NM_199259:exon23:c.G1518A:p.R506R,TPTE:NM_199261:exon24:c.G1572A:p.R524R	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	148	511	21	10906989	chr21:10906989	C	T	148	PASS	DP=511;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	10935044	10935044	T	C	intronic	TPTE	.	.	.	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	225	21	10935044	chr21:10935044	T	C	110	PASS	DP=225;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	10942644	10942644	A	-	intronic	TPTE	.	.	.	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	620	21	10942643	chr21:10942643	CA	C	83	PASS	DP=620;AN=4	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/1	./.
21	10951205	10951205	G	C	intronic	TPTE	.	.	.	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	124	21	10951205	chr21:10951205	G	C	93	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
21	10959812	10959812	A	-	intronic	TPTE	.	.	.	5.11E-31	2.42E-06	0.99999758	.	.	0.0587	2.938206407	99.1507431	179.24136	2.90847	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	321	21	10959811	chr21:10959811	CA	C	87	PASS	DP=321;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
21	11021097	11021097	G	T	intronic	BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	95	21	11021097	chr21:11021097	G	T	94	PASS	DP=95;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	11047490	11047490	C	A	UTR3	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:c.*227G>T;NM_182481:c.*227G>T;NM_181704:c.*442G>T;NM_182484:c.*442G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	119	21	11047490	chr21:11047490	C	A	.	PASS	DP=119;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	11047491	11047491	C	A	UTR3	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:c.*226G>T;NM_182481:c.*226G>T;NM_181704:c.*441G>T;NM_182484:c.*441G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	119	21	11047491	chr21:11047491	C	A	.	PASS	DP=119;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	11049621	11049621	G	A	exonic	BAGE2;BAGE3	.	stopgain	BAGE3:NM_182481:exon4:c.C280T:p.R94X,BAGE2:NM_182482:exon4:c.C280T:p.R94X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	291	21	11049621	chr21:11049621	G	A	104	PASS	DP=291;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	11049623	11049623	T	C	splicing	BAGE2;BAGE3;BAGE4;BAGE5	NM_182482:exon4:c.280-2A>G;NM_182481:exon4:c.280-2A>G;NM_181704:exon4:c.285-2A>G;NM_181704:exon4:UTR3;NM_182484:exon4:c.284-2A>G;NM_182484:exon4:UTR3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	377	21	11049623	chr21:11049623	T	C	121	PASS	DP=377;AN=4	GT	0/1	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	11058061	11058061	T	C	UTR3	BAGE	NM_001187:c.*367A>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	253	21	11058061	chr21:11058061	T	C	104	PASS	DP=253;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
21	11058353	11058353	T	C	intronic	BAGE;BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	744	21	11058353	chr21:11058353	T	C	123	PASS	DP=744;AN=4	GT	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.	./.
21	14414818	14414818	C	T	ncRNA_intronic	ANKRD30BP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	314	21	14414818	chr21:14414818	C	T	95	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
21	14439391	14439391	C	T	ncRNA_intronic	ANKRD30BP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	45	21	14439391	chr21:14439391	C	T	66	PASS	DP=45;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	14485395	14485395	C	T	ncRNA_intronic	ANKRD30BP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	171	344	21	14485395	chr21:14485395	C	T	171	PASS	DP=344;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	14722780	14722780	A	G	intergenic	ANKRD30BP2;MIR3156-3	dist=232209;dist=55925	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	133	21	14722780	chr21:14722780	A	G	72	PASS	DP=133;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	14756846	14756846	C	A	intergenic	ANKRD30BP2;MIR3156-3	dist=266275;dist=21859	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	21	14756846	chr21:14756846	C	A	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	18924237	18924237	T	G	exonic	CXADR	.	synonymous SNV	CXADR:NM_001207063:exon3:c.T381G:p.G127G,CXADR:NM_001207064:exon3:c.T381G:p.G127G,CXADR:NM_001207066:exon3:c.T381G:p.G127G,CXADR:NM_001338:exon3:c.T381G:p.G127G	0.342891275	0.654169916	0.00293881	.	.	0.2281	-0.005381972	53.50908233	105.35884	2.22286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	173	21	18924237	chr21:18924237	T	G	100	PASS	DP=173;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
21	26979725	26979725	C	A	exonic	MRPL39	.	synonymous SNV	MRPL39:NM_017446:exon1:c.G63T:p.G21G,MRPL39:NM_080794:exon1:c.G63T:p.G21G	0.000718692	0.980539319	0.01874199	.	0.14902	0.11367	0.222355725	68.44184949	95.66892	2.11384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	544	21	26979725	chr21:26979725	C	A	.	PASS	DP=544;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	30433909	30433909	A	-	intronic	CCT8	.	.	.	0.98279276	0.017206786	4.54E-07	.	0.89566	0.47642	-0.246069119	36.06982779	254.13959	3.42911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	17	21	30433908	chr21:30433908	CA	C	44	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	31874286	31874286	G	A	exonic	KRTAP19-5	.	synonymous SNV	KRTAP19-5:NM_181611:exon1:c.C123T:p.Y41Y	0.005182713	0.465959289	0.528857998	.	0.07982	.	-0.229483771	36.86010852	22.09493	0.74262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	861	21	31874286	chr21:31874286	G	A	100	PASS	DP=861;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
21	32253409	32253409	A	T	exonic	KRTAP11-1	.	stopgain	KRTAP11-1:NM_175858:exon1:c.T435A:p.C145X	0.00426873	0.662516423	0.333214847	.	0.22409	0.09008	0.659651797	84.35362114	3007.85811	10.41393	.	.	.	.	.	.	.	.	.	0.012	0.291	N	1.000	0.548	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	9.303	0.962	35	0.989	0.474	0.164	0.192	N	c	0.137	-0.081	0.000	0.029	0.487	0.133	0	0.372	0.153	0.081	0.146	-0.546	0.048	0.645	0.279	0.981	0.494	8.509	0.322	.	.	.	0.5	.	83	21	32253409	chr21:32253409	A	T	.	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	32508223	32508223	C	A	intronic	TIAM1	.	.	.	0.999932006	6.80E-05	1.04E-15	.	0.48136	0.33272	-0.913225292	9.843123378	5001.55165	14.43752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	298	21	32508223	chr21:32508223	C	A	72	PASS	DP=298;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	32554907	32554907	C	A	exonic	TIAM1	.	synonymous SNV	TIAM1:NM_003253:exon16:c.G2718T:p.L906L	0.999932006	6.80E-05	1.04E-15	.	0.48136	0.33272	-0.913225292	9.843123378	5001.55165	14.43752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	21	32554907	chr21:32554907	C	A	.	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	33078562	33078562	T	A	intronic	SCAF4	.	.	.	0.999999693	3.07E-07	5.92E-18	.	0.7639	0.10408	-1.214341017	5.67940552	104.06406	2.20474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	103	21	33078562	chr21:33078562	T	A	79	PASS	DP=103;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
21	33078569	33078569	G	A	intronic	SCAF4	.	.	.	0.999999693	3.07E-07	5.92E-18	.	0.7639	0.10408	-1.214341017	5.67940552	104.06406	2.20474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	21	33078569	chr21:33078569	G	A	.	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
21	35446629	35446629	-	A	intronic	MRPS6;SLC5A3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	310	21	35446629	chr21:35446629	T	TA	77	PASS	DP=310;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
21	36265324	36265324	T	-	intronic	RUNX1	.	.	.	0.449323607	0.549373498	0.001302896	DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of M2 type acute myeloid leukemia (AML-M2). Translocation t(8;21)(q22;q22) with RUNX1T1.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of therapy-related myelodysplastic syndrome (T-MDS). Translocation t(3;21)(q26;q22) with EAP or MECOM.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with EAP or MECOM.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is found in childhood acute lymphoblastic leukemia (ALL). Translocation t(12;21)(p13;q22) with TEL. The translocation fuses the 3'-end of TEL to the alternate 5'-exon of AML-1H.; DISEASE: Note=A chromosomal aberration involving RUNX1 is found in acute leukemia. Translocation t(11,21)(q13;q22) that forms a MACROD1-RUNX1 fusion protein.; DISEASE: Familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399]: Autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia. {ECO:0000269|PubMed:10508512}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is found in therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein.; DISEASE: Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelomonocytic leukemia. Inversion inv(21)(q21;q22) with USP16.; 	0.71814	0.72461	-0.227663163	37.11370606	85.67689	1.97553	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	167	21	36265323	chr21:36265323	CT	C	117	PASS	DP=167;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
21	38092248	38092248	A	-	intronic	SIM2	.	.	.	0.178825369	0.820642349	0.000532282	.	0.36242	0.24747	-0.198338176	39.17197452	2208.64464	8.65301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	107	21	38092247	chr21:38092247	GA	G	87	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
21	38132055	38132055	T	C	exonic	HLCS	.	nonsynonymous SNV	HLCS:NM_000411:exon10:c.A1768G:p.M590V,HLCS:NM_001242784:exon10:c.A1768G:p.M590V,HLCS:NM_001242785:exon10:c.A1768G:p.M590V	0.486548324	0.513252415	0.000199261	.	0.07149	0.25106	-0.591542347	18.24722812	151.46286	2.69061	0.348	0.124	T	0.002	0.090	B	0.007	0.121	B	0.112	0.194	N	1.000	0.192	N	0.735	0.189	N	-3.32	0.939	D	-1.09	0.283	N	0.178	0.218	-0.471	0.697	T	0.400	0.751	T	0.042	0.603	D	0.448	0.137	7.021	0.640	0.072	0.097	0.152	N	c	-1.260	-1.285	1.000	0.747	0.638	0.428	0	-8.42	0.008	0.029	0.134	0.008	0.138	0.007	0.175	0.987	0.523	2.446	0.042	Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL), catalytic domain	.	.	0.5	.	50	21	38132055	chr21:38132055	T	C	.	PASS	DP=50;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
21	40559106	40559106	C	T	exonic	BRWD1	.	nonsynonymous SNV	BRWD1:NM_018963:exon42:c.G6809A:p.R2270Q	0.999999462	5.38E-07	6.53E-23	.	0.64569	0.10719	-0.821412236	11.77164426	5050.46205	14.54368	0.0	0.912	D	0.999	0.764	D	0.766	0.548	P	0.013	0.291	N	0.584	0.324	D	2.725	0.800	M	0.2	0.601	T	-1.06	0.277	N	0.371	0.463	-0.432	0.710	T	0.320	0.689	T	0.019	0.408	T	7.195	0.945	34	0.999	0.999	0.844	0.432	D	c	0.604	0.593	1.000	0.747	0.615	0.372	0	5.64	0.864	3.427	0.523	0.935	0.490	0.992	0.373	1.000	0.888	18.257	0.899	.	.	.	0.5	.	42	21	40559106	chr21:40559106	C	T	.	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	40714775	40714775	C	T	UTR3	HMGN1	NM_004965:c.*263G>A	.	.	0.425365462	0.541410677	0.033223861	.	0.46691	0.07886	0.3032669	72.009908	414.2321	4.26339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	21	40714775	chr21:40714775	C	T	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	41741065	41741142	CTCCGGTGTATCGATGCCGCGTGATGCAGCGGTAGTTATACAATCCATCTTCATTCTGTACATCTTTAATATACAAGG	-	exonic	DSCAM	.	nonframeshift deletion	DSCAM:NM_001271534:exon4:c.539_616del:p.A180_G205del,DSCAM:NM_001389:exon4:c.539_616del:p.A180_G205del	1	1.62E-10	1.24E-26	.	0.15662	0.10818	-3.289804051	0.430526067	213.32232	3.15158	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	11	21	41741064	chr21:41741064	TCTCCGGTGTATCGATGCCGCGTGATGCAGCGGTAGTTATACAATCCATCTTCATTCTGTACATCTTTAATATACAAGG	T	41	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
21	43291488	43291488	G	A	intronic	PRDM15	.	.	.	0.753744615	0.246255384	1.22E-09	.	0.0747	0.10154	-2.001084103	1.733899505	875.44322	5.75655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	71	21	43291488	chr21:43291488	G	A	.	PASS	DP=71;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	43299197	43299197	G	A	exonic	PRDM15	.	nonsynonymous SNV	PRDM15:NM_022115:exon2:c.C155T:p.A52V	0.753744615	0.246255384	1.22E-09	.	0.0747	0.10154	-2.001084103	1.733899505	875.44322	5.75655	0.069	0.355	T	0.099	0.241	B	0.01	0.139	B	.	.	.	1	0.810	D	0	0.065	N	2.89	0.102	T	-0.21	0.103	N	0.088	0.084	-0.985	0.337	T	0.014	0.056	T	0.270	0.899	D	3.673	0.498	23.3	0.996	0.732	0.002	0.010	N	c	-0.654	-0.578	1.000	0.747	0.623	0.393	0	1.37	0.211	0.388	0.203	-0.175	0.105	0.643	0.279	0.996	0.625	8.310	0.310	.	.	.	0.5	.	55	21	43299197	chr21:43299197	G	A	.	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	44524456	44524456	G	A	exonic	U2AF1;U2AF1L5	.	nonsynonymous SNV	U2AF1:NM_001025203:exon2:c.C101T:p.S34F,U2AF1L5:NM_001320646:exon2:c.C101T:p.S34F,U2AF1L5:NM_001320648:exon2:c.C101T:p.S34F,U2AF1L5:NM_001320650:exon2:c.C16T:p.L6F,U2AF1:NM_006758:exon2:c.C101T:p.S34F	.	.	.	.	.	.	.	.	.	.	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	3.875	0.960	H	0.88	0.460	T	-5.64	0.869	D	0.87	0.858	0.082	0.839	D	0.410	0.759	T	0.127	0.810	D	6.826	0.927	32	0.999	0.935	0.981	0.797	D	c	1.044	0.963	1.0	0.983	0.722	0.854	0	5.47	0.803	9.053	0.933	1.044	0.665	1.000	0.715	1.000	0.888	19.317	0.942	Zinc finger, CCCH-type	.	.	0.5	.	87	21	44524456	chr21:44524456	G	A	.	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
21	46306770	46306770	C	T	exonic	ITGB2	.	nonsynonymous SNV	ITGB2:NM_000211:exon15:c.G2128A:p.A710T,ITGB2:NM_001127491:exon15:c.G2128A:p.A710T,ITGB2:NM_001303238:exon15:c.G1921A:p.A641T	3.88E-05	0.997791391	0.002169845	DISEASE: Leukocyte adhesion deficiency 1 (LAD1) [MIM:116920]: LAD1 patients have recurrent bacterial infections and their leukocytes are deficient in a wide range of adhesion-dependent functions. {ECO:0000269|PubMed:1346613, ECO:0000269|PubMed:1347532, ECO:0000269|PubMed:1352501, ECO:0000269|PubMed:1590804, ECO:0000269|PubMed:1694220, ECO:0000269|PubMed:1968911, ECO:0000269|PubMed:20529581, ECO:0000269|PubMed:20549317, ECO:0000269|PubMed:7509236, ECO:0000269|PubMed:7686755, ECO:0000269|PubMed:9884339}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2445	0.53069	-1.03070223	7.861523944	113.69861	2.32291	0.003	0.682	D	0.857	0.453	P	0.461	0.446	P	.	.	.	1.000	0.588	D	3.045	0.869	M	-2.83	0.913	D	-2.28	0.516	N	0.234	0.415	0.710	0.933	D	0.759	0.918	D	0.100	0.773	D	5.324	0.720	25.8	0.995	0.706	0.895	0.498	D	c	0.250	0.152	1.000	0.747	0.672	0.522	0	4.83	0.617	3.667	0.540	0.036	0.152	0.991	0.370	0.002	0.062	15.399	0.744	.	.	.	0.5	88	458	21	46306770	chr21:46306770	C	T	88	PASS	DP=458;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	46554694	46554694	G	A	intronic	ADARB1	.	.	.	0.843939347	0.155939433	0.00012122	.	0.28156	0.13431	-0.800872469	12.33191791	35.57047	1.07201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	21	46554694	chr21:46554694	G	A	.	PASS	DP=39;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	46842366	46842366	T	A	ncRNA_exonic	COL18A1-AS1	.	.	.	.	.	.	.	0.1043	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	630	21	46842366	chr21:46842366	T	A	133	PASS	DP=630;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
21	46945700	46945700	C	-	intronic	SLC19A1	.	.	.	0.0123881	0.952273227	0.035338672	.	0.0749	.	-0.286522835	33.47487615	1149.843	6.46099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	310	21	46945699	chr21:46945699	TC	T	95	PASS	DP=310;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
21	46957709	46957709	G	A	exonic	SLC19A1	.	synonymous SNV	SLC19A1:NM_001205206:exon2:c.C165T:p.P55P,SLC19A1:NM_194255:exon2:c.C165T:p.P55P	0.0123881	0.952273227	0.035338672	.	0.0749	.	-0.286522835	33.47487615	1149.843	6.46099	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	21	46957709	chr21:46957709	G	A	.	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
21	47614405	47614405	C	A	exonic	LSS	.	nonsynonymous SNV	LSS:NM_001145437:exon19:c.G1748T:p.R583L,LSS:NM_001001438:exon20:c.G1988T:p.R663L,LSS:NM_001145436:exon20:c.G1955T:p.R652L,LSS:NM_002340:exon20:c.G1988T:p.R663L	0.000604838	0.999353008	4.22E-05	.	0.09964	0.38626	0.540106923	81.09813635	1845.09003	7.92325	0.152	0.327	T	0.995	0.670	D	0.805	0.566	P	0.000	0.843	D	1	0.810	D	2.755	0.808	M	1.97	0.221	T	-4.99	0.829	D	0.796	0.824	-1.141	0.013	T	0.078	0.312	T	0.045	0.620	D	5.650	0.770	26.7	0.996	0.740	0.965	0.692	D	c	0.480	0.465	1.000	0.747	0.707	0.730	0	5.07	0.680	7.647	0.825	0.935	0.490	1.000	0.715	0.289	0.235	18.434	0.905	Squalene cyclase, C-terminal|Terpene synthase, conserved site|Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid;Squalene cyclase, C-terminal|Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid	.	.	0.5	.	79	21	47614405	chr21:47614405	C	A	.	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	18213570	18213570	-	A	intronic	BEND2	.	.	.	0.34821659	0.651208166	0.000575244	.	0.04574	0.05824	0.687150476	85.17928757	177.40866	2.89504	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	29	X	18213570	chrX:18213570	G	GA	50	PASS	DP=29;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	19037766	19037766	C	A	exonic	ADGRG2	.	nonsynonymous SNV	ADGRG2:NM_001184835:exon12:c.G547T:p.V183F,ADGRG2:NM_001079860:exon13:c.G595T:p.V199F,ADGRG2:NM_001184836:exon13:c.G589T:p.V197F,ADGRG2:NM_001184837:exon13:c.G571T:p.V191F,ADGRG2:NM_001079859:exon14:c.G619T:p.V207F,ADGRG2:NM_001184833:exon14:c.G613T:p.V205F,ADGRG2:NM_001079858:exon15:c.G661T:p.V221F,ADGRG2:NM_001184834:exon15:c.G661T:p.V221F,ADGRG2:NM_005756:exon15:c.G652T:p.V218F	.	.	.	.	0.53967	0.10442	0.510776592	80.23708422	.	.	0.208	0.327	T	0.0	0.026	B	0.0	0.063	B	0.725	0.099	N	1	0.090	N	1.24	0.311	L	1.46	0.334	T	-1.66	0.424	N	0.16	0.193	-1.014	0.257	T	0.033	0.143	T	0.003	0.067	T	1.348	0.226	12.52	0.931	0.222	0.015	0.050	N	.	.	.	0.749	0.233	.	.	.	-0.717	0.106	-0.715	0.051	-0.415	0.060	0.002	0.151	0.910	0.387	0.727	0.009	.	.	.	0.5	.	33	X	19037766	chrX:19037766	C	A	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	22012649	22012649	-	T	UTR3	SMS	NM_004595:c.*180_*181insT;NM_001258423:c.*180_*181insT	.	.	0.921460277	0.078440686	9.90E-05	DISEASE: X-linked syndromic mental retardation Snyder-Robinson type (MRXSSR) [MIM:309583]: Characterized by moderate intellectual deficit, hypotonia, an unsteady gait, osteoporosis, kyphoscoliosis and facial asymmetry. Transmission is X-linked recessive. {ECO:0000269|PubMed:14508504, ECO:0000269|PubMed:22612257}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.58047	0.10879	-0.295622497	32.61972163	8.98969	0.33022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	247	X	22012649	chrX:22012649	G	GT	76	PASS	DP=247;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/1
X	23724764	23724764	G	A	exonic	ACOT9	.	nonsynonymous SNV	ACOT9:NM_001330259:exon9:c.C616T:p.L206F,ACOT9:NM_001033583:exon10:c.C796T:p.L266F,ACOT9:NM_001037171:exon11:c.C823T:p.L275F	1.91E-05	0.889292965	0.110687943	.	0.14996	0.09121	0.439181676	77.69521113	204.02566	3.08375	0.028	0.477	D	1.0	0.899	D	0.998	0.916	D	0.000	0.843	D	1.000	0.588	D	3.125	0.882	M	1.34	0.350	T	-3.36	0.665	D	0.747	0.778	-0.537	0.673	T	0.251	0.621	T	0.621	0.967	D	6.515	0.898	31	0.999	0.963	0.986	0.846	D	.	.	.	1.000	0.747	.	.	.	5.51	0.817	7.557	0.811	1.045	0.669	1.000	0.715	0.978	0.483	11.891	0.517	HotDog domain;HotDog domain|Hotdog acyl-CoA thioesterase (ACOT)-type domain	.	.	0.5	.	33	X	23724764	chrX:23724764	G	A	.	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	30715762	30715762	-	A	intronic	GK	.	.	.	0.90325865	0.096734397	6.95E-06	.	.	0.4441	-0.273576253	33.97027601	4.23799	0.15391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	51	X	30715762	chrX:30715762	G	GA	58	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
X	36178819	36178819	C	A	exonic	CFAP47	.	nonsynonymous SNV	CFAP47:NM_001304548:exon39:c.C5959A:p.P1987T	.	.	.	.	0.06402	.	0.371224249	75.12384996	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.282	0.121	5.518	0.584	0.058	0.735	0.357	D	.	.	.	0.000	0.064	.	.	.	2.99	0.335	3.862	0.555	-0.046	0.123	0.992	0.373	0.035	0.152	9.479	0.379	.	.	.	0.5	.	54	X	36178819	chrX:36178819	C	A	.	PASS	DP=54;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	37028770	37028770	C	A	exonic	FAM47C	.	nonsynonymous SNV	FAM47C:NM_001013736:exon1:c.C2287A:p.R763S	0.057797311	0.86697678	0.075225909	.	0.03714	.	1.76190403	96.75041283	797.36508	5.56605	0.602	0.056	T	0.048	0.207	B	0.011	0.145	B	.	.	.	1	0.090	N	1.32	0.331	L	2.06	0.205	T	-1.64	0.393	N	0.058	0.041	-0.957	0.398	T	0.029	0.123	T	0.001	0.005	T	-1.075	0.029	0.011	0.164	0.004	0.004	0.020	N	.	.	.	0.001	0.077	.	.	.	-1.85	0.073	0.201	0.169	-3.068	0.001	0.000	0.063	0.000	0.016	6.232	0.198	.	.	.	0.5	84	483	X	37028770	chrX:37028770	C	A	84	PASS	DP=483;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	37028880	37028880	C	A	exonic	FAM47C	.	synonymous SNV	FAM47C:NM_001013736:exon1:c.C2397A:p.L799L	0.057797311	0.86697678	0.075225909	.	0.03714	.	1.76190403	96.75041283	797.36508	5.56605	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	436	X	37028880	chrX:37028880	C	A	125	PASS	DP=436;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	38214650	38214650	-	A	intronic	OTC	.	.	.	0.9810179	0.01896801	1.41E-05	DISEASE: Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]: An X-linked disorder of the urea cycle which causes a form of hyperammonemia. Mutations with no residual enzyme activity are always expressed in hemizygote males by a very severe neonatal hyperammonemic coma that generally proves to be fatal. Heterozygous females are either asymptomatic or express orotic aciduria spontaneously or after protein intake. The disorder is treatable with supplemental dietary arginine and low protein diet. The arbitrary classification of patients into the 'neonatal' group (clinical hyperammonemia in the first few days of life) and 'late' onset (clinical presentation after the neonatal period) has been used to differentiate severe from mild forms. {ECO:0000269|PubMed:10070627, ECO:0000269|PubMed:10502831, ECO:0000269|PubMed:10737985, ECO:0000269|PubMed:11793483, ECO:0000269|PubMed:1480464, ECO:0000269|PubMed:1671317, ECO:0000269|PubMed:1721894, ECO:0000269|PubMed:2347583, ECO:0000269|PubMed:2474822, ECO:0000269|PubMed:3170748, ECO:0000269|PubMed:7474905, ECO:0000269|PubMed:7951259, ECO:0000269|PubMed:8019569, ECO:0000269|PubMed:8081373, ECO:0000269|PubMed:8081398, ECO:0000269|PubMed:8099056, ECO:0000269|PubMed:8530002, ECO:0000269|PubMed:8807340, ECO:0000269|PubMed:8830175, ECO:0000269|PubMed:8956038, ECO:0000269|PubMed:8956045, ECO:0000269|PubMed:9143919, ECO:0000269|PubMed:9266388, ECO:0000269|PubMed:9286441, ECO:0000269|PubMed:9452024, ECO:0000269|PubMed:9452049, ECO:0000269|PubMed:9452065, ECO:0000269|Ref.32, ECO:0000269|Ref.43}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22278	0.85665	0.082802743	60.09082331	1072.1412	6.27812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	107	X	38214650	chrX:38214650	T	TA	67	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
X	38240577	38240577	-	T	intronic	OTC	.	.	.	0.9810179	0.01896801	1.41E-05	DISEASE: Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250]: An X-linked disorder of the urea cycle which causes a form of hyperammonemia. Mutations with no residual enzyme activity are always expressed in hemizygote males by a very severe neonatal hyperammonemic coma that generally proves to be fatal. Heterozygous females are either asymptomatic or express orotic aciduria spontaneously or after protein intake. The disorder is treatable with supplemental dietary arginine and low protein diet. The arbitrary classification of patients into the 'neonatal' group (clinical hyperammonemia in the first few days of life) and 'late' onset (clinical presentation after the neonatal period) has been used to differentiate severe from mild forms. {ECO:0000269|PubMed:10070627, ECO:0000269|PubMed:10502831, ECO:0000269|PubMed:10737985, ECO:0000269|PubMed:11793483, ECO:0000269|PubMed:1480464, ECO:0000269|PubMed:1671317, ECO:0000269|PubMed:1721894, ECO:0000269|PubMed:2347583, ECO:0000269|PubMed:2474822, ECO:0000269|PubMed:3170748, ECO:0000269|PubMed:7474905, ECO:0000269|PubMed:7951259, ECO:0000269|PubMed:8019569, ECO:0000269|PubMed:8081373, ECO:0000269|PubMed:8081398, ECO:0000269|PubMed:8099056, ECO:0000269|PubMed:8530002, ECO:0000269|PubMed:8807340, ECO:0000269|PubMed:8830175, ECO:0000269|PubMed:8956038, ECO:0000269|PubMed:8956045, ECO:0000269|PubMed:9143919, ECO:0000269|PubMed:9266388, ECO:0000269|PubMed:9286441, ECO:0000269|PubMed:9452024, ECO:0000269|PubMed:9452049, ECO:0000269|PubMed:9452065, ECO:0000269|Ref.32, ECO:0000269|Ref.43}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.22278	0.85665	0.082802743	60.09082331	1072.1412	6.27812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	70	X	38240577	chrX:38240577	C	CT	52	PASS	DP=70;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	39932250	39932250	C	G	exonic	BCOR	.	nonsynonymous SNV	BCOR:NM_001123383:exon4:c.G2349C:p.K783N,BCOR:NM_001123384:exon4:c.G2349C:p.K783N,BCOR:NM_001123385:exon4:c.G2349C:p.K783N,BCOR:NM_017745:exon4:c.G2349C:p.K783N	0.999945621	5.44E-05	8.78E-12	.	0.36796	0.1257	-3.028489223	0.507195093	113.75272	2.32443	0.002	0.721	D	0.985	0.592	D	0.809	0.568	P	.	.	.	0.981	0.397	D	1.935	0.520	L	2.39	0.157	T	-1.77	0.535	N	0.083	0.077	-1.088	0.058	T	0.045	0.193	T	0.017	0.389	T	3.528	0.482	23.1	0.998	0.859	0.962	0.679	D	.	.	.	1.000	0.747	.	.	.	2.7	0.309	1.318	0.330	0.925	0.434	1.000	0.715	0.995	0.604	4.778	0.125	.	.	.	0.5	88	64	X	39932250	chrX:39932250	C	G	88	PASS	DP=64;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	40962052	40962052	T	-	intronic	USP9X	.	.	.	1	2.36E-11	2.78E-27	.	0.58131	0.10304	-1.618506764	2.925218212	35.92323	1.07855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	51	X	40962051	chrX:40962051	CT	C	73	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	41092154	41092154	C	T	UTR3	USP9X	NM_001039591:c.*377C>T;NM_001039590:c.*377C>T	.	.	1	2.36E-11	2.78E-27	.	0.58131	0.10304	-1.618506764	2.925218212	35.92323	1.07855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	X	41092154	chrX:41092154	C	T	.	PASS	DP=34;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	44494322	44494322	C	T	intergenic	FUNDC1;DUSP21	dist=92101;dist=208927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	395	X	44494322	chrX:44494322	C	T	85	PASS	DP=395;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	45606437	45606437	C	G	ncRNA_exonic	MIR222	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	54	X	45606437	chrX:45606437	C	G	60	PASS	DP=54;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	47460695	47460744	AAATTCCTAGAAAGACACAAACTACAAAAACTGACTCAGTAAGAAATGGA	-	intronic	SYN1	.	.	.	0.879529753	0.120170955	0.000299292	DISEASE: Epilepsy X-linked, with variable learning disabilities and behavior disorders (XELBD) [MIM:300491]: A neurologic disorder characterized by variable combinations of epilepsy, learning difficulties, macrocephaly, and aggressive behavior. {ECO:0000269|PubMed:14985377}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66764	0.6282	.	.	164.73159	2.80346	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.06	27	X	47460694	chrX:47460694	CAAATTCCTAGAAAGACACAAACTACAAAAACTGACTCAGTAAGAAATGGA	C	18.06	PASS	DP=27;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	47494977	47494977	-	A	UTR3	ELK1	NM_001114123:c.*1250_*1251insT;NM_001257168:c.*1371_*1372insT;NM_005229:c.*1250_*1251insT	.	.	0.756057874	0.234569302	0.009372824	.	0.99996	0.15613	0.327131069	73.27199811	572.0593	4.85348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	386	X	47494976	chrX:47494976	GA	GAA,G	88	PASS	DP=386;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/1
X	47494977	47494977	A	-	UTR3	ELK1	NM_001114123:c.*1251delT;NM_001257168:c.*1372delT;NM_005229:c.*1251delT	.	.	0.756057874	0.234569302	0.009372824	.	0.99996	0.15613	0.327131069	73.27199811	572.0593	4.85348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	386	X	47494976	chrX:47494976	GA	GAA,G	88	PASS	DP=386;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/1
X	48136935	48136935	G	T	intergenic	SSX1;SSX9	dist=10056;dist=24050	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	168	X	48136935	chrX:48136935	G	T	.	PASS	DP=168;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	48661515	48661515	-	T	intronic	HDAC6	.	.	.	0.999920798	7.92E-05	2.20E-11	DISEASE: Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia (CDP-PBHM) [MIM:300863]: A disease characterized by chondrodysplasia, severe platyspondyly, hydrocephaly, and facial features with microphthalmia. Bone abnormalities include a distinctive metaphyseal cupping of the metacarpals, metatarsals, and phalanges. Affected females show a milder phenotype with small stature, sometimes associated with body asymmetry and mild mental retardation. {ECO:0000269|PubMed:20181727}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1462	0.18896	0.069852974	59.10592121	228.99662	3.26923	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	86	X	48661515	chrX:48661515	C	CT	68	PASS	DP=86;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
X	57620213	57620213	C	G	exonic	ZXDB	.	nonsynonymous SNV	ZXDB:NM_007157:exon1:c.C1732G:p.L578V	0.842955569	0.154160523	0.002883908	.	0.06264	0.09943	.	.	96.86419	2.12723	0.126	0.272	T	0.997	0.689	D	0.978	0.725	D	0.000	0.481	D	0.950	0.377	D	2.73	0.801	M	3.01	0.091	T	-1.43	0.352	N	0.35	0.411	-1.122	0.022	T	0.048	0.205	T	0.020	0.426	T	0.986	0.188	10.58	0.978	0.353	0.940	0.595	D	.	.	.	1.000	0.747	.	.	.	2.96	0.332	3.684	0.542	0.887	0.390	1.000	0.715	0.997	0.653	8.628	0.329	.	.	.	0.5	.	57	X	57620213	chrX:57620213	C	G	.	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
X	63409795	63409795	G	A	exonic	AMER1	.	synonymous SNV	AMER1:NM_152424:exon2:c.C3372T:p.Y1124Y	0.953441253	0.046553393	5.35E-06	.	.	0.08523	-0.394936437	27.02878037	88.95926	2.02444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	X	63409795	chrX:63409795	G	A	.	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	70767720	70767720	C	T	ncRNA_intronic	BCYRN1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	X	70767720	chrX:70767720	C	T	.	PASS	DP=37;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	70823980	70823980	T	C	exonic	GCNA	.	nonsynonymous SNV	GCNA:NM_052957:exon8:c.T853C:p.S285P	.	.	.	.	.	.	.	.	.	.	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	-0.55	0.024	N	1.55	0.299	T	-0.32	0.123	N	0.057	0.040	-1.021	0.234	T	0.032	0.137	T	0.007	0.198	T	-2.254	0.005	0.001	0.117	0.002	0.003	0.016	N	.	.	.	0.917	0.265	.	.	.	-0.28	0.122	-2.462	0.011	-3.315	0.001	0.000	0.063	0.000	0.016	4.696	0.121	.	.	.	0.5	.	106	X	70823980	chrX:70823980	T	C	.	PASS	DP=106;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	70979225	70979246	CGCGTGCACATGTGCGCGCGCG	-	intergenic	BCYRN1;CXorf49	dist=30263;dist=3894	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	139	X	70979224	chrX:70979224	ACGCGTGCACATGTGCGCGCGCG	A	61	PASS	DP=139;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
X	71372288	71372288	G	A	intronic	FLJ44635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	X	71372288	chrX:71372288	G	A	.	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	73072090	73072090	-	A	ncRNA_exonic	XIST	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	300	X	73072090	chrX:73072090	G	GA	71	PASS	DP=300;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
X	76918818	76918818	A	G	intronic	ATRX	.	.	.	0.999999982	1.77E-08	2.33E-22	DISEASE: Alpha-thalassemia mental retardation syndrome, X-linked (ATRX) [MIM:301040]: A disorder characterized by severe psychomotor retardation, facial dysmorphism, urogenital abnormalities, and alpha-thalassemia. An essential phenotypic trait are hemoglobin H erythrocyte inclusions. {ECO:0000269|PubMed:10204841, ECO:0000269|PubMed:10417298, ECO:0000269|PubMed:10660327, ECO:0000269|PubMed:10995512, ECO:0000269|PubMed:12116232, ECO:0000269|PubMed:16955409, ECO:0000269|PubMed:7697714, ECO:0000269|PubMed:8968741, ECO:0000269|PubMed:9043863, ECO:0000269|PubMed:9326931}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, X-linked, syndromic, with hypotonic facies 1 (MRXSHF1) [MIM:309580]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSHF1 is a syndromic mental retardation. Clinical features include severe mental retardation, dysmorphic facies, and a highly skewed X-inactivation pattern in carrier women. Other more variable features include hypogonadism, deafness, renal anomalies, and mild skeletal defects. {ECO:0000269|PubMed:10398237, ECO:0000269|PubMed:10751095, ECO:0000269|PubMed:11050622, ECO:0000269|PubMed:15565397, ECO:0000269|PubMed:16222662, ECO:0000269|PubMed:8630485}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Alpha-thalassemia myelodysplasia syndrome (ATMDS) [MIM:300448]: A disorder characterized by hypochromic, microcytic red blood cells, hemoglobin H detected in peripheral blood, and multilineage myelodysplasia. {ECO:0000269|PubMed:12858175}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.56316	-0.925889687	9.754659118	107.54684	2.25148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	112	X	76918818	chrX:76918818	A	G	60	PASS	DP=112;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
X	84534441	84534441	-	A	intronic	POF1B	.	.	.	0.000181225	0.972919214	0.026899561	DISEASE: Premature ovarian failure 2B (POF2B) [MIM:300604]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:16773570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14231	0.41445	0.92967242	89.79122435	227.93995	3.26029	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	79	X	84534441	chrX:84534441	G	GA	51	PASS	DP=79;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
X	86958351	86958351	A	G	intergenic	KLHL4;CPXCR1	dist=33301;dist=1043875	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	55	X	86958351	chrX:86958351	A	G	72	PASS	DP=55;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	96171455	96171455	C	T	exonic	DIAPH2	.	synonymous SNV	DIAPH2:NM_006729:exon8:c.C751T:p.L251L,DIAPH2:NM_007309:exon8:c.C751T:p.L251L	0.9991191	0.0008809	6.44E-11	DISEASE: Premature ovarian failure 2A (POF2A) [MIM:300511]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:9497258}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.56881	0.27299	-0.999300439	8.368719038	38.85136	1.15117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	94	X	96171455	chrX:96171455	C	T	59	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	96171478	96171479	AC	-	exonic	DIAPH2	.	frameshift deletion	DIAPH2:NM_006729:exon8:c.774_775del:p.L258Ffs*6,DIAPH2:NM_007309:exon8:c.774_775del:p.L258Ffs*6	0.9991191	0.0008809	6.44E-11	DISEASE: Premature ovarian failure 2A (POF2A) [MIM:300511]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:9497258}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.56881	0.27299	-0.999300439	8.368719038	38.85136	1.15117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	99	X	96171477	chrX:96171477	TAC	T	58	PASS	DP=99;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	96171499	96171499	C	-	exonic	DIAPH2	.	frameshift deletion	DIAPH2:NM_006729:exon8:c.795delC:p.K267Nfs*4,DIAPH2:NM_007309:exon8:c.795delC:p.K267Nfs*3	0.9991191	0.0008809	6.44E-11	DISEASE: Premature ovarian failure 2A (POF2A) [MIM:300511]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:9497258}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.56881	0.27299	-0.999300439	8.368719038	38.85136	1.15117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	85	X	96171498	chrX:96171498	AC	A	61	PASS	DP=85;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	99924370	99924370	C	T	intronic	SRPX2	.	.	.	0.962529393	0.037467495	3.11E-06	DISEASE: Rolandic epilepsy with speech dyspraxia and mental retardation X-linked (RESDX) [MIM:300643]: A condition characterized by the association of rolandic seizures with oral and speech dyspraxia, and mental retardation. Rolandic seizures occur during a period of significant brain maturation. During this time, dysfunction of neural network activities such as focal discharges may be associated with specific developmental disabilities resulting in specific cognitive impairments of language, visuo-spatial abilities or attention. {ECO:0000269|PubMed:16497722}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30928	0.13849	0.174625237	65.9648502	51.08082	1.40844	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	139	X	99924370	chrX:99924370	C	T	.	PASS	DP=139;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	101095525	101095525	C	A	exonic	NXF5	.	nonsynonymous SNV	NXF5:NM_032946:exon10:c.G644T:p.W215L	0.004207845	0.961305373	0.034486781	DISEASE: Note=A chromosomal aberration involving NXF5 has been observed in one patient with a syndromic form of mental retardation and short stature. Pericentric inversion inv(X)(p21.1;q22) that interrupts NXF5. {ECO:0000269|PubMed:11566096}.; 	0.1981	.	1.929210393	97.45812692	107.8307	2.25521	0.115	0.285	T	1.0	0.899	D	0.954	0.677	D	0.000	0.629	U	0.998	0.441	D	3.165	0.888	M	0.42	0.570	T	-11.95	0.996	D	0.405	0.476	-0.774	0.567	T	0.233	0.599	T	0.022	0.447	T	5.034	0.678	25.2	0.985	0.421	0.903	0.511	D	.	.	.	0.000	0.046	.	.	.	1.86	0.244	5.252	0.650	0.691	0.297	1.000	0.715	0.512	0.273	9.331	0.370	Leucine-rich repeat domain, L domain-like	.	.	0.5	.	126	X	101095525	chrX:101095525	C	A	.	PASS	DP=126;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	102528736	102528806	CTGCTGGTAACAAGAGTGACACCTAAAGGAAAGTATCAGCTTAAGGTTAAAGCACATAGGCCGGCAAATGC	-	UTR3	TCEAL5	NM_001012979:c.*135_*65delGCATTTGCCGGCCTATGTGCTTTAACCTTAAGCTGATACTTTCCTTTAGGTGTCACTCTTGTTACCAGCAG	.	.	0.666797567	0.310905197	0.022297235	.	0.10123	.	0.191216164	66.57230479	730.81358	5.36747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	32.99	25	X	102528735	chrX:102528735	TCTGCTGGTAACAAGAGTGACACCTAAAGGAAAGTATCAGCTTAAGGTTAAAGCACATAGGCCGGCAAATGC	T	32.99	PASS	DP=25;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	105201339	105201339	G	A	UTR3	NRK	NM_198465:c.*1747G>A	.	.	0.763369951	0.236629918	1.31E-07	.	0.3258	0.31202	.	.	2428.62657	9.15478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	X	105201339	chrX:105201339	G	A	.	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	107408103	107408103	G	C	intronic	COL4A6	.	.	.	0.990988266	0.009011734	6.37E-12	DISEASE: Note=Deletions covering the N-terminal regions of COL4A5 and COL4A6, which are localized in a head-to-head manner, are found in the chromosome Xq22.3 centromeric deletion syndrome. This results in a phenotype with features of diffuse leiomyomatosis and Alport syndrome (DL-ATS).; DISEASE: Deafness, X-linked, 6 (DFNX6) [MIM:300914]: A non- syndromic form of sensorineural hearing loss with prelingual onset. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:23714752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14684	0.07461	0.36555769	74.7287096	361.2174	4.02247	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	184	X	107408103	chrX:107408103	G	C	.	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	108780404	108780404	C	G	UTR5	NXT2	NM_001242618:c.-939C>G	.	.	0.777280518	0.215400937	0.007318545	.	0.0023	0.02889	0.013025609	54.62962963	1.49817	0.05093	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	276	X	108780404	chrX:108780404	C	G	85	PASS	DP=276;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
X	109561058	109561060	CCG	-	exonic	AMMECR1	.	nonframeshift deletion	AMMECR1:NM_001025580:exon1:c.240_242del:p.G82del,AMMECR1:NM_015365:exon1:c.240_242del:p.G82del	0.910792997	0.088538552	0.00066845	DISEASE: Alport syndrome with mental retardation, midface hypoplasia and elliptocytosis (ATS-MR) [MIM:300194]: A X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, sensorineural hearing loss, mental retardation, midface hypoplasia and elliptocytosis. {ECO:0000269|PubMed:10049589}. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.89609	0.33817	-0.09720619	46.20193442	15.37972	0.5519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	80	X	109561057	chrX:109561057	CCCG	C	45	PASS	DP=80;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	114468474	114468476	CCG	-	exonic	LRCH2	.	nonframeshift deletion	LRCH2:NM_001243963:exon1:c.129_131del:p.G44del,LRCH2:NM_020871:exon1:c.129_131del:p.G44del	0.915538079	0.08443772	2.42E-05	.	0.16063	0.09365	-0.007201372	53.19061099	42.20239	1.22827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	110	X	114468473	chrX:114468473	CCCG	C	104	PASS	DP=110;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	118722385	118722385	G	A	UTR3	NKRF	NM_017544:c.*930C>T;NM_001173487:c.*930C>T;NM_001173488:c.*930C>T	.	.	0.955812168	0.044073795	0.000114037	.	0.48621	0.20971	-0.538132194	20.26421326	17.80669	0.62232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	X	118722385	chrX:118722385	G	A	.	PASS	DP=26;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	118722401	118722401	T	A	UTR3	NKRF	NM_017544:c.*914A>T;NM_001173487:c.*914A>T;NM_001173488:c.*914A>T	.	.	0.955812168	0.044073795	0.000114037	.	0.48621	0.20971	-0.538132194	20.26421326	17.80669	0.62232	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	49	X	118722401	chrX:118722401	T	A	58	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	118774740	118774740	C	T	exonic	SEPT6	.	synonymous SNV	SEPT6:NM_015129:exon6:c.G702A:p.P234P,SEPT6:NM_145799:exon6:c.G702A:p.P234P,SEPT6:NM_145800:exon6:c.G702A:p.P234P,SEPT6:NM_145802:exon6:c.G702A:p.P234P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	147	X	118774740	chrX:118774740	C	T	58	PASS	DP=147;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
X	119658624	119658624	-	T	UTR3	CUL4B	NM_003588:c.*1991_*1992insA;NM_001330624:c.*1991_*1992insA;NM_001079872:c.*1991_*1992insA	.	.	0.999846678	0.000153322	1.10E-10	DISEASE: Mental retardation, X-linked, syndromic, 15 (MRXS15) [MIM:300354]: A syndromic form of X-linked mental retardation characterized by severe intellectual deficit associated with short stature, craniofacial dysmorphism, small testes, muscle wasting in lower legs, kyphosis, joint hyperextensibility, pes cavus, small feet, and abnormalities of the toes. Additional neurologic manifestations include speech delay and impairment, tremor, seizures, gait ataxia, hyperactivity and decreased attention span. {ECO:0000269|PubMed:17236139, ECO:0000269|PubMed:17273978, ECO:0000269|PubMed:19377476, ECO:0000269|PubMed:20002452}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87445	0.12121	-0.361761279	28.6329323	9.19638	0.33598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	113	124	X	119658624	chrX:119658624	C	CT	113	PASS	DP=124;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
X	122585463	122585463	G	A	intronic	GRIA3	.	.	.	0.998653778	0.001346218	4.42E-09	DISEASE: Mental retardation, X-linked 94 (MRX94) [MIM:300699]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non- syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. MRX94 patients have moderate mental retardation. Other variable features are macrocephaly, seizures, myoclonic jerks, autistic behavior, asthenic body habitus, distal muscle weakness and hyporeflexia. {ECO:0000269|PubMed:17989220}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40491	0.17596	-0.115612493	45.12856806	18.51356	0.64055	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	77	X	122585463	chrX:122585463	G	A	.	PASS	DP=77;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	122648526	122648526	G	T	intergenic	GRIA3;THOC2	dist=23760;dist=85886	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	158	X	122648526	chrX:122648526	G	T	90	PASS	DP=158;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	128927042	128927042	T	C	exonic	SASH3	.	synonymous SNV	SASH3:NM_018990:exon7:c.T879C:p.N293N	0.891377605	0.108394024	0.000228371	.	0.3591	0.26327	-0.448125345	24.19202642	28.8003	0.92063	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	60	X	128927042	chrX:128927042	T	C	.	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	129354353	129354354	TT	-	exonic	ZNF280C	.	frameshift deletion	ZNF280C:NM_017666:exon13:c.1496_1497del:p.K499Rfs*50	0.992273042	0.007726643	3.15E-07	.	0.1424	.	-0.492218069	22.35786742	14.15249	0.5125	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.32	27	X	129354352	chrX:129354352	CTT	C	11.32	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	129536209	129536209	C	-	intronic	RBMX2	.	.	.	0.772803906	0.225526116	0.001669978	.	0.0606	0.39625	0.170987912	65.5579146	19.54878	0.67128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	891	X	129536208	chrX:129536208	AC	A	119	PASS	DP=891;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.
X	129546192	129546192	A	G	intronic	RBMX2	.	.	.	0.772803906	0.225526116	0.001669978	.	0.0606	0.39625	0.170987912	65.5579146	19.54878	0.67128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	291	X	129546192	chrX:129546192	A	G	110	PASS	DP=291;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
X	129630630	129630630	T	C	ncRNA_exonic	FAM45BP	.	.	.	.	.	.	.	.	0.06956	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	89	X	129630630	chrX:129630630	T	C	53	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
X	132351100	132351100	G	A	exonic	TFDP3	.	synonymous SNV	TFDP3:NM_016521:exon1:c.C1188T:p.D396D	2.30E-06	0.085066935	0.91493076	.	0.05413	0.05691	0.729426781	86.17008728	225.71159	3.2476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	X	132351100	chrX:132351100	G	A	.	PASS	DP=30;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	134556298	134556300	CGG	-	UTR3	SMIM10L2A	NM_203306:c.*5_*7delCGG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	71	X	134556297	chrX:134556297	CCGG	C	44	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
X	135960119	135960119	C	T	exonic	RBMX	.	nonsynonymous SNV	RBMX:NM_002139:exon4:c.G343A:p.G115R	0.948299697	0.051665932	3.44E-05	DISEASE: Mental retardation, X-linked, syndromic, 11 (MRXS11) [MIM:300238]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS11 patients manifest moderate intellectual disability and craniofacial dysmorphism. {ECO:0000269|PubMed:25256757}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26116	.	0.325313577	73.11276244	16.97983	0.59829	0.089	0.342	T	0.991	0.899	D	0.86	0.832	P	0.000	0.559	U	0.000	0.810	P	2.015	0.552	M	-1.02	0.763	T	-3.62	0.703	D	0.791	0.782	0.130	0.847	D	0.585	0.851	D	.	.	.	5.659	0.771	26.7	0.999	0.995	0.968	0.710	D	.	.	.	1.000	0.747	.	.	.	5.65	0.868	5.492	0.664	0.931	0.441	1.000	0.715	1.000	0.888	16.982	0.861	Nucleotide-binding alpha-beta plait domain	.	.	0.5	107	159	X	135960119	chrX:135960119	C	T	107	PASS	DP=159;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	135960146	135960146	-	AA	exonic	RBMX	.	frameshift insertion	RBMX:NM_002139:exon4:c.315_316insTT:p.P106Ffs*31	0.948299697	0.051665932	3.44E-05	DISEASE: Mental retardation, X-linked, syndromic, 11 (MRXS11) [MIM:300238]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS11 patients manifest moderate intellectual disability and craniofacial dysmorphism. {ECO:0000269|PubMed:25256757}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.26116	.	0.325313577	73.11276244	16.97983	0.59829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	155	X	135960146	chrX:135960146	G	GAA	104	PASS	DP=155;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
X	140008321	140008321	C	T	downstream	MIR320D2	dist=16	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	65	X	140008321	chrX:140008321	C	T	59	PASS	DP=65;AN=2	GT	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	153287315	153287315	G	-	UTR3	MECP2	NM_004992:c.*8503delC	.	.	0.698089048	0.298098137	0.003812815	DISEASE: Angelman syndrome (AS) [MIM:105830]: A neurodevelopmental disorder characterized by severe motor and intellectual retardation, ataxia, frequent jerky limb movements and flapping of the arms and hands, hypotonia, seizures, absence of speech, frequent smiling and episodes of paroxysmal laughter, open-mouthed expression revealing the tongue. {ECO:0000269|PubMed:11283202}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, X-linked, syndromic, 13 (MRXS13) [MIM:300055]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS13 patients manifest mental retardation associated with other variable features such as spasticity, episodes of manic depressive psychosis, increased tone and macroorchidism. {ECO:0000269|PubMed:10986043, ECO:0000269|PubMed:11007980, ECO:0000269|PubMed:11309367, ECO:0000269|PubMed:11805248, ECO:0000269|PubMed:11885030, ECO:0000269|PubMed:12161600, ECO:0000269|PubMed:12325019, ECO:0000269|PubMed:12615169, ECO:0000269|PubMed:16966553}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Rett syndrome (RTT) [MIM:312750]: An X-linked dominant neurodevelopmental disorder, and one of the most common causes of mental retardation in females. Patients appear to develop normally until 6 to 18 months of age, then gradually lose speech and purposeful hand movements, and develop microcephaly, seizures, autism, ataxia, mental retardation and stereotypic hand movements. After initial regression, the condition stabilizes and patients usually survive into adulthood. {ECO:0000269|PubMed:10508514, ECO:0000269|PubMed:10577905, ECO:0000269|PubMed:10745042, ECO:0000269|PubMed:10767337, ECO:0000269|PubMed:10814719, ECO:0000269|PubMed:10944854, ECO:0000269|PubMed:10991688, ECO:0000269|PubMed:10991689, ECO:0000269|PubMed:11055898, ECO:0000269|PubMed:11241840, ECO:0000269|PubMed:11269512, ECO:0000269|PubMed:11283202, ECO:0000269|PubMed:11376998, ECO:0000269|PubMed:11402105, ECO:0000269|PubMed:11706982, ECO:0000269|PubMed:11738883, ECO:0000269|PubMed:12161600, ECO:0000269|PubMed:12567420, ECO:0000269|PubMed:12966522, ECO:0000269|PubMed:12966523, ECO:0000269|PubMed:15034579, ECO:0000269|PubMed:15057977}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Autism, X-linked 3 (AUTSX3) [MIM:300496]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:12770674}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Encephalopathy, neonatal severe, due to MECP2 mutations (ENS-MECP2) [MIM:300673]: A neurodevelopmental disorder characterized by severe neonatal encephalopathy, developmental delay, mental retardation, microcephaly, seizures. Additional features include respiratory insufficiency and central hypoventilation, gastroesophageal reflux, axial hypotonia, hyperreflexia and dyskinetic movements. {ECO:0000269|PubMed:11238684}. Note=The disease is caused by mutations affecting the gene represented in this entry. The MECP2 gene is mutated in Rett syndrome, a severe neurodevelopmental disorder that almost always occurs in females. Although it was first thought that MECP2 mutations causing Rett syndrome were lethal in males, later reports identified a severe neonatal encephalopathy in surviving male sibs of patients with Rett syndrome. Additional reports have confirmed a severe phenotype in males with Rett syndrome-associated MECP2 mutations.; DISEASE: Mental retardation, X-linked, syndromic, Lubs type (MRXSL) [MIM:300260]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSL patients manifest mental retardation associated with variable features. They include swallowing dysfunction and gastroesophageal reflux with secondary recurrent respiratory infections, hypotonia, mild myopathy and characteristic facies such as downslanting palpebral fissures, hypertelorism and a short nose with a low nasal bridge. {ECO:0000269|PubMed:16080119}. Note=The disease is caused by mutations affecting the gene represented in this entry. Increased dosage of MECP2 due to gene duplication appears to be responsible for the mental retardation phenotype.; 	0.43937	0.69428	-0.885424753	10.4623732	83.03146	1.93651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	109	59	X	153287314	chrX:153287314	TG	T	109	PASS	DP=59;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
X	153290176	153290176	-	T	UTR3	MECP2	NM_004992:c.*5641_*5642insA	.	.	0.698089048	0.298098137	0.003812815	DISEASE: Angelman syndrome (AS) [MIM:105830]: A neurodevelopmental disorder characterized by severe motor and intellectual retardation, ataxia, frequent jerky limb movements and flapping of the arms and hands, hypotonia, seizures, absence of speech, frequent smiling and episodes of paroxysmal laughter, open-mouthed expression revealing the tongue. {ECO:0000269|PubMed:11283202}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, X-linked, syndromic, 13 (MRXS13) [MIM:300055]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXS13 patients manifest mental retardation associated with other variable features such as spasticity, episodes of manic depressive psychosis, increased tone and macroorchidism. {ECO:0000269|PubMed:10986043, ECO:0000269|PubMed:11007980, ECO:0000269|PubMed:11309367, ECO:0000269|PubMed:11805248, ECO:0000269|PubMed:11885030, ECO:0000269|PubMed:12161600, ECO:0000269|PubMed:12325019, ECO:0000269|PubMed:12615169, ECO:0000269|PubMed:16966553}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Rett syndrome (RTT) [MIM:312750]: An X-linked dominant neurodevelopmental disorder, and one of the most common causes of mental retardation in females. Patients appear to develop normally until 6 to 18 months of age, then gradually lose speech and purposeful hand movements, and develop microcephaly, seizures, autism, ataxia, mental retardation and stereotypic hand movements. After initial regression, the condition stabilizes and patients usually survive into adulthood. {ECO:0000269|PubMed:10508514, ECO:0000269|PubMed:10577905, ECO:0000269|PubMed:10745042, ECO:0000269|PubMed:10767337, ECO:0000269|PubMed:10814719, ECO:0000269|PubMed:10944854, ECO:0000269|PubMed:10991688, ECO:0000269|PubMed:10991689, ECO:0000269|PubMed:11055898, ECO:0000269|PubMed:11241840, ECO:0000269|PubMed:11269512, ECO:0000269|PubMed:11283202, ECO:0000269|PubMed:11376998, ECO:0000269|PubMed:11402105, ECO:0000269|PubMed:11706982, ECO:0000269|PubMed:11738883, ECO:0000269|PubMed:12161600, ECO:0000269|PubMed:12567420, ECO:0000269|PubMed:12966522, ECO:0000269|PubMed:12966523, ECO:0000269|PubMed:15034579, ECO:0000269|PubMed:15057977}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Autism, X-linked 3 (AUTSX3) [MIM:300496]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:12770674}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Encephalopathy, neonatal severe, due to MECP2 mutations (ENS-MECP2) [MIM:300673]: A neurodevelopmental disorder characterized by severe neonatal encephalopathy, developmental delay, mental retardation, microcephaly, seizures. Additional features include respiratory insufficiency and central hypoventilation, gastroesophageal reflux, axial hypotonia, hyperreflexia and dyskinetic movements. {ECO:0000269|PubMed:11238684}. Note=The disease is caused by mutations affecting the gene represented in this entry. The MECP2 gene is mutated in Rett syndrome, a severe neurodevelopmental disorder that almost always occurs in females. Although it was first thought that MECP2 mutations causing Rett syndrome were lethal in males, later reports identified a severe neonatal encephalopathy in surviving male sibs of patients with Rett syndrome. Additional reports have confirmed a severe phenotype in males with Rett syndrome-associated MECP2 mutations.; DISEASE: Mental retardation, X-linked, syndromic, Lubs type (MRXSL) [MIM:300260]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSL patients manifest mental retardation associated with variable features. They include swallowing dysfunction and gastroesophageal reflux with secondary recurrent respiratory infections, hypotonia, mild myopathy and characteristic facies such as downslanting palpebral fissures, hypertelorism and a short nose with a low nasal bridge. {ECO:0000269|PubMed:16080119}. Note=The disease is caused by mutations affecting the gene represented in this entry. Increased dosage of MECP2 due to gene duplication appears to be responsible for the mental retardation phenotype.; 	0.43937	0.69428	-0.885424753	10.4623732	83.03146	1.93651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	181	X	153290176	chrX:153290176	G	GT	82	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
X	153881436	153881436	C	-	intronic	CTAG2	.	.	.	0.005954387	0.494134005	0.499911607	.	0.13765	.	0.905808022	89.4373673	99.89657	2.16581	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	73	X	153881435	chrX:153881435	GC	G	75	PASS	DP=73;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	1500507	1500507	G	T	exonic	TPO	.	stopgain	TPO:NM_175722:exon11:c.G1837T:p.G613X,TPO:NM_001206745:exon12:c.G2185T:p.G729X,TPO:NM_175719:exon12:c.G2185T:p.G729X,TPO:NM_175721:exon12:c.G2356T:p.G786X,TPO:NM_000547:exon13:c.G2356T:p.G786X,TPO:NM_001206744:exon13:c.G2356T:p.G786X	1.36E-07	0.988057948	0.011941916	DISEASE: Note=An alternative splicing in the thyroperoxidase mRNA can cause Graves' disease.; DISEASE: Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500]: A disorder due to defective conversion of accumulated iodide to organically bound iodine. The iodide organification defect can be partial or complete. {ECO:0000269|PubMed:10084596, ECO:0000269|PubMed:10468986, ECO:0000269|PubMed:11061528, ECO:0000269|PubMed:11415848, ECO:0000269|PubMed:11874711, ECO:0000269|PubMed:11916616, ECO:0000269|PubMed:12213873, ECO:0000269|PubMed:12490071, ECO:0000269|PubMed:12843174, ECO:0000269|PubMed:12864797, ECO:0000269|PubMed:12938097, ECO:0000269|PubMed:16284446, ECO:0000269|PubMed:16684826, ECO:0000269|PubMed:7550241, ECO:0000269|PubMed:9024270, ECO:0000269|PubMed:9924196}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18628	0.48162	-0.14151689	42.36258552	2837.88244	10.06894	.	.	.	.	.	.	.	.	.	0.043	0.238	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.455	0.983	39	0.992	0.537	0.808	0.401	D	c	0.767	0.513	0.998	0.359	0.581	0.326	0	4.2	0.486	3.523	0.530	0.902	0.416	0.994	0.380	0.007	0.100	14.183	0.650	Sushi/SCR/CCP domain	.	.	0.5	.	94	2	1500507	chr2:1500507	G	T	.	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	1893021	1893021	C	G	exonic	MYT1L	.	nonsynonymous SNV	MYT1L:NM_001303052:exon16:c.G2512C:p.D838H,MYT1L:NM_001329845:exon16:c.G2512C:p.D838H,MYT1L:NM_001329846:exon16:c.G2506C:p.D836H,MYT1L:NM_001329847:exon16:c.G2506C:p.D836H,MYT1L:NM_001329848:exon16:c.G2506C:p.D836H,MYT1L:NM_001329849:exon16:c.G2506C:p.D836H,MYT1L:NM_001329851:exon16:c.G2512C:p.D838H,MYT1L:NM_001329852:exon16:c.G2506C:p.D836H,MYT1L:NM_015025:exon16:c.G2506C:p.D836H,MYT1L:NM_001329844:exon17:c.G2512C:p.D838H	0.999963989	3.60E-05	6.51E-13	.	0.30683	0.11638	-1.506435464	3.544468035	525.36937	4.67655	0.003	0.682	D	0.652	0.395	P	0.382	0.421	B	0.005	0.328	N	0.997	0.433	D	0.695	0.181	N	0.73	0.507	T	-1.15	0.295	N	0.245	0.355	-0.960	0.392	T	0.094	0.356	T	0.010	0.259	T	4.432	0.593	24.2	0.995	0.687	0.994	0.953	D	c	0.194	0.324	1.000	0.747	0.487	0.133	0	5.01	0.663	5.405	0.659	0.807	0.329	1.000	0.715	0.137	0.201	18.279	0.900	Myelin transcription factor 1	.	.	0.5	.	33	2	1893021	chr2:1893021	C	G	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	1983507	1983507	T	C	exonic	MYT1L	.	nonsynonymous SNV	MYT1L:NM_001303052:exon6:c.A43G:p.K15E,MYT1L:NM_001329845:exon6:c.A43G:p.K15E,MYT1L:NM_001329846:exon6:c.A43G:p.K15E,MYT1L:NM_001329847:exon6:c.A43G:p.K15E,MYT1L:NM_001329848:exon6:c.A43G:p.K15E,MYT1L:NM_001329849:exon6:c.A43G:p.K15E,MYT1L:NM_001329851:exon6:c.A43G:p.K15E,MYT1L:NM_001329852:exon6:c.A43G:p.K15E,MYT1L:NM_015025:exon6:c.A43G:p.K15E,MYT1L:NM_001329844:exon7:c.A43G:p.K15E	0.999963989	3.60E-05	6.51E-13	.	0.30683	0.11638	-1.506435464	3.544468035	525.36937	4.67655	0.003	0.682	D	0.956	0.559	P	0.899	0.676	P	0.000	0.843	D	1.000	0.537	D	2.625	0.771	M	0.02	0.623	T	-2.59	0.558	D	0.792	0.782	-0.299	0.750	T	0.360	0.722	T	0.029	0.519	D	4.511	0.604	24.3	0.996	0.723	0.965	0.695	D	c	0.634	0.634	1.000	0.517	0.487	0.133	0	5.1	0.688	6.281	0.725	0.913	0.425	1.000	0.715	1.000	0.888	15.192	0.726	.	.	.	0.5	.	227	2	1983507	chr2:1983507	T	C	.	PASS	DP=227;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	3488595	3488595	G	C	intergenic	TRAPPC12;ADI1	dist=5253;dist=13095	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	431	2	3488595	chr2:3488595	G	C	86	PASS	DP=431;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	5834716	5834716	-	T	UTR3	SOX11	NM_003108:c.*537_*538insT	.	.	0.343767037	0.598619703	0.05761326	.	0.41352	0.15395	.	.	8.44037	0.30871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	292	2	5834716	chr2:5834716	A	AT	78	PASS	DP=292;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	10095020	10095020	-	T	intronic	GRHL1	.	.	.	0.983150779	0.016849134	8.72E-08	.	0.18056	0.20109	-0.113792788	45.25831564	1942.58495	8.11174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	173	2	10095020	chr2:10095020	G	GT	64	PASS	DP=173;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	10139226	10139226	C	-	intronic	GRHL1	.	.	.	0.983150779	0.016849134	8.72E-08	.	0.18056	0.20109	-0.113792788	45.25831564	1942.58495	8.11174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	152	2	10139225	chr2:10139225	AC	A	100	PASS	DP=152;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	12164729	12164729	A	T	ncRNA_intronic	MIR3681HG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	326	2	12164729	chr2:12164729	A	T	74	PASS	DP=326;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	15536509	15536509	-	A	intronic	NBAS	.	.	.	1.89E-25	0.999906723	9.33E-05	DISEASE: Infantile liver failure syndrome 2 (ILFS2) [MIM:616483]: A form of infantile liver failure syndrome, a life-threatening disorder of hepatic function that manifests with acute liver failure in the first few months of life. Clinical features include anemia, renal tubulopathy, developmental delay, seizures, failure to thrive, and liver steatosis and fibrosis. {ECO:0000269|PubMed:26073778}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=NBAS mutations have been found in a multisystem disease affecting the liver, eye, immune system, connective tissue, and bone. Clinical manifestations include a progeroid appearance, short stature, slender bones, epiphyseal dysplasia with multiple phalangeal pseudo-epiphyses, cervical instability, myelopathy, elevated transaminases, hypogammaglobulinemia, reduced natural killer cells, Pelger-Huet anomaly of granulocytes, and in some cases retinal dystrophy and optic atrophy. {ECO:0000269|PubMed:26286438}.; 	.	.	-0.224542487	37.33191791	2659.86206	9.69933	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	145	2	15536509	chr2:15536509	G	GA	74	PASS	DP=145;AN=4	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	15769813	15769813	G	-	exonic	DDX1	.	frameshift deletion	DDX1:NM_004939:exon24:c.1963delG:p.E655Rfs*7	0.998606607	0.001393393	1.97E-10	.	0.33127	0.49952	-0.600630256	18.06440198	70.55865	1.7475	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	12	2	15769812	chr2:15769812	CG	C	62	PASS	DP=12;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	25497908	25497908	G	A	exonic	DNMT3A	.	nonsynonymous SNV	DNMT3A:NM_022552:exon6:c.C541T:p.R181C,DNMT3A:NM_175629:exon6:c.C541T:p.R181C	7.73E-45	8.72E-11	1	DISEASE: Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]: An overgrowth syndrome characterized by a distinctive facial appearance, tall stature and intellectual disability. Facial gestalt is characterized by a round face, heavy horizontal eyebrows and narrow palpebral fissures. Less common features include atrial septal defects, seizures, umbilical hernia, and scoliosis. {ECO:0000269|PubMed:24614070}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.88689	0.41514	-1.131590109	6.481481481	41.83604	1.21826	0.0	0.912	D	1.0	0.899	D	0.973	0.713	D	0.000	0.629	D	1	0.810	D	0.55	0.145	N	-4.25	0.971	D	-3.97	0.736	D	0.825	0.813	1.034	0.978	D	0.895	0.965	D	0.572	0.961	D	6.239	0.861	28.8	0.999	0.967	0.941	0.599	D	c	0.685	0.719	1.000	0.747	0.722	0.854	0	5.24	0.728	9.119	0.936	0.948	0.535	1.000	0.715	1.000	0.888	16.329	0.828	.	.	.	0.5	120	815	2	25497908	chr2:25497908	G	A	120	PASS	DP=815;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	25551452	25551452	C	-	intronic	DNMT3A	.	.	.	7.73E-45	8.72E-11	1	DISEASE: Tatton-Brown-Rahman syndrome (TBRS) [MIM:615879]: An overgrowth syndrome characterized by a distinctive facial appearance, tall stature and intellectual disability. Facial gestalt is characterized by a round face, heavy horizontal eyebrows and narrow palpebral fissures. Less common features include atrial septal defects, seizures, umbilical hernia, and scoliosis. {ECO:0000269|PubMed:24614070}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.88689	0.41514	-1.131590109	6.481481481	41.83604	1.21826	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	519	2	25551451	chr2:25551451	TC	T	68	PASS	DP=519;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	25830231	25830231	C	T	intronic	DTNB	.	.	.	0.000530412	0.999218122	0.000251466	.	0.59206	0.49987	-0.799052816	12.45576787	225.44054	3.24713	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	75	2	25830231	chr2:25830231	C	T	97	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	25875419	25875419	C	G	intronic	DTNB	.	.	.	0.000530412	0.999218122	0.000251466	.	0.59206	0.49987	-0.799052816	12.45576787	225.44054	3.24713	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	39	2	25875419	chr2:25875419	C	G	74	PASS	DP=39;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	28836881	28836881	-	T	intronic	PLB1	.	.	.	1.99E-56	1.22E-09	0.999999999	.	0.12087	0.11509	1.208866406	93.05850436	3555.80975	11.53022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	172	2	28836881	chr2:28836881	G	GT	66	PASS	DP=172;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	31416096	31416096	G	T	exonic	CAPN14	.	nonsynonymous SNV	CAPN14:NM_001145122:exon10:c.C1015A:p.L339M,CAPN14:NM_001321270:exon10:c.C487A:p.L163M	.	.	.	.	.	.	2.664347924	98.844067	6196.21935	16.44921	0.04	0.421	D	0.993	0.899	D	0.911	0.850	D	0.002	0.368	U	0.694	0.333	D	2.565	0.752	M	-4.48	0.976	D	-0.46	0.150	N	0.226	0.277	1.224	1.000	D	0.941	0.981	D	0.089	0.753	D	3.646	0.495	23.2	0.996	0.710	0.854	0.442	D	c	0.508	0.406	1.000	0.747	0.487	0.133	0	4.53	0.548	2.674	0.463	1.048	0.713	1.000	0.715	0.586	0.286	17.283	0.870	Peptidase C2, calpain, catalytic domain	.	.	0.5	94	260	2	31416096	chr2:31416096	G	T	94	PASS	DP=260;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	32515614	32515614	G	T	exonic	YIPF4	.	stopgain	YIPF4:NM_032312:exon2:c.G142T:p.E48X	0.019788591	0.902081655	0.078129753	.	0.25391	0.10849	0.369407109	74.95281906	43.18158	1.24746	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.498	0.975	37	0.996	0.729	0.981	0.792	D	c	0.897	0.760	1.000	0.747	0.706	0.609	0	4.48	0.538	9.020	0.931	0.953	0.551	1.000	0.715	1.000	0.888	15.872	0.788	.	.	.	0.5	.	83	2	32515614	chr2:32515614	G	T	.	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	33590558	33590558	C	T	exonic	LTBP1	.	synonymous SNV	LTBP1:NM_001166264:exon26:c.C3595T:p.L1199L,LTBP1:NM_001166266:exon26:c.C3436T:p.L1146L,LTBP1:NM_000627:exon27:c.C3721T:p.L1241L,LTBP1:NM_001166265:exon27:c.C3562T:p.L1188L,LTBP1:NM_206943:exon31:c.C4699T:p.L1567L	0.526234698	0.473765302	1.69E-11	.	0.4738	0.14744	-0.44293645	24.46921444	877.89035	5.77162	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	16	2	33590558	chr2:33590558	C	T	.	PASS	DP=16;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	36776617	36776617	T	-	UTR3	CRIM1	NM_016441:c.*773delT	.	.	0.977883079	0.022116914	6.98E-09	.	0.26394	.	-1.100469982	6.929700401	649.0811	5.11079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	95	2	36776616	chr2:36776616	CT	C	106	PASS	DP=95;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	37234400	37234400	A	T	exonic	HEATR5B	.	nonsynonymous SNV	HEATR5B:NM_019024:exon29:c.T4570A:p.Y1524N	8.10E-10	0.999999998	7.48E-10	.	0.25312	.	-2.513844451	0.914130691	1161.22267	6.48464	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	3.1	0.878	M	0.64	0.529	T	-8.7	0.976	D	0.891	0.880	-0.288	0.753	T	0.342	0.708	T	0.132	0.815	D	6.161	0.850	28.5	0.991	0.517	0.997	0.984	D	c	0.909	0.883	1.000	0.747	0.707	0.730	0	5.9	0.949	9.098	0.935	1.028	0.649	1.000	0.715	1.000	0.888	16.323	0.827	.	.	.	0.5	.	22	2	37234400	chr2:37234400	A	T	.	PASS	DP=22;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	37234444	37234444	C	T	exonic	HEATR5B	.	nonsynonymous SNV	HEATR5B:NM_019024:exon29:c.G4526A:p.G1509E	8.10E-10	0.999999998	7.48E-10	.	0.25312	.	-2.513844451	0.914130691	1161.22267	6.48464	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.629	D	1	0.810	D	2.715	0.797	M	0.59	0.540	T	-7.67	0.955	D	0.878	0.869	-0.245	0.765	T	0.402	0.753	T	0.058	0.673	D	6.938	0.934	33	0.998	0.876	0.998	0.992	D	c	0.888	0.859	1.000	0.747	0.707	0.730	0	5.78	0.914	7.706	0.835	0.807	0.329	1.000	0.715	0.942	0.416	20.012	0.974	Armadillo-type fold	.	.	0.5	.	19	2	37234444	chr2:37234444	C	T	.	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	38527398	38527399	CT	-	intronic	ATL2	.	.	.	0.980197371	0.019802499	1.30E-07	.	0.50505	0.11563	-0.067881249	48.69072895	3458.2471	11.29657	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	23	2	38527397	chr2:38527397	ACT	A	54	PASS	DP=23;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	39234343	39234343	A	-	intronic	SOS1	.	.	.	0.999999895	1.05E-07	1.77E-20	DISEASE: Noonan syndrome 4 (NS4) [MIM:610733]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. Some patients with NS4 have polyarticular villonodular synovitis. {ECO:0000269|PubMed:17143282, ECO:0000269|PubMed:17143285, ECO:0000269|PubMed:19020799, ECO:0000269|PubMed:19438935, ECO:0000269|PubMed:19953625, ECO:0000269|PubMed:20673819, ECO:0000269|PubMed:20683980, ECO:0000269|PubMed:21387466}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.72054	0.38414	-0.995664936	8.539749941	106.78667	2.24216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	184	2	39234342	chr2:39234342	TA	T	70	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	42508204	42508204	-	A	intronic	EML4	.	.	.	0.391138665	0.608861306	2.84E-08	.	0.20914	0.1283	-1.346642726	4.62962963	2437.31101	9.17493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.32	49	2	42508204	chr2:42508204	C	CA	10.32	PASS	DP=49;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	42922888	42922888	-	T	intronic	MTA3	.	.	.	0.855163472	0.144816431	2.01E-05	.	0.83041	0.14229	-0.602450568	17.91106393	51.94859	1.42352	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.94	60	2	42922888	chr2:42922888	A	AT	12.94	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	43768233	43768233	-	A	intronic	THADA	.	.	.	1.24E-28	0.003148502	0.996851498	.	0.09919	0.09816	0.448132652	77.98419439	4895.75241	14.23268	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	71	2	43768233	chr2:43768233	T	TA	51	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	43980744	43980744	-	T	intronic	PLEKHH2	.	.	.	1.79E-26	0.030270259	0.969729741	.	0.12448	0.091	-0.823216783	11.68318	2775.67326	9.94659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	17	2	43980744	chr2:43980744	C	CT	41	PASS	DP=17;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	44001334	44001334	T	A	intronic	DYNC2LI1	.	.	.	8.38E-05	0.927454684	0.072461519	.	0.0538	0.0823	1.596607091	95.87166785	1692.77547	7.58315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	121	541	2	44001334	chr2:44001334	T	A	121	PASS	DP=541;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	44445605	44445605	T	-	intronic	PPM1B	.	.	.	0.109620711	0.884012724	0.006366565	.	0.99971	0.21173	-0.490397599	22.50530786	53.58105	1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	89	2	44445604	chr2:44445604	GT	G,GTT	86	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	44445605	44445605	-	T	intronic	PPM1B	.	.	.	0.109620711	0.884012724	0.006366565	.	0.99971	0.21173	-0.490397599	22.50530786	53.58105	1.456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	89	2	44445604	chr2:44445604	GT	G,GTT	86	PASS	DP=89;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	48807976	48807976	T	C	exonic	STON1;STON1-GTF2A1L	.	synonymous SNV	STON1-GTF2A1L:NM_001198594:exon1:c.T204C:p.D68D,STON1-GTF2A1L:NM_001198593:exon2:c.T204C:p.D68D,STON1:NM_006873:exon2:c.T204C:p.D68D,STON1-GTF2A1L:NM_172311:exon2:c.T204C:p.D68D,STON1:NM_001198595:exon3:c.T204C:p.D68D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	93	27	2	48807976	chr2:48807976	T	C	93	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	48941191	48941191	T	A	exonic	LHCGR	.	nonsynonymous SNV	LHCGR:NM_000233:exon7:c.A539T:p.K180I	2.80E-08	0.490421431	0.509578541	DISEASE: Luteinizing hormone resistance (LHR) [MIM:238320]: An autosomal recessive disorder characterized by unresponsiveness to luteinizing hormone, defective sexual development in males, and defective follicular development and ovulation, amenorrhea and infertility in females. Two forms of the disorder have been defined in males. Type 1 is a severe form characterized by complete 46,XY male pseudohermaphroditism, low testosterone and high luteinizing hormone levels, total lack of responsiveness to luteinizing and chorionic gonadotropin hormones, lack of breast development, and absent development of secondary male sex characteristics. Type 2, a milder form, displays a broader range of phenotypic expression ranging from micropenis to severe hypospadias. {ECO:0000269|PubMed:12050206, ECO:0000269|PubMed:15372531, ECO:0000269|PubMed:15472221, ECO:0000269|PubMed:19551906, ECO:0000269|PubMed:7719343, ECO:0000269|PubMed:8559204, ECO:0000269|PubMed:9215288, ECO:0000269|PubMed:9514160, ECO:0000269|PubMed:9626144, ECO:0000269|PubMed:9626653}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.13036	0.42555	0.356452144	74.62845011	1328.76039	6.85266	0.034	0.574	D	1.0	0.899	D	0.999	0.916	D	0.000	0.629	D	1.000	0.810	D	0.995	0.252	L	-1.57	0.819	D	-3.84	0.823	D	0.829	0.831	0.180	0.856	D	0.618	0.865	D	0.274	0.900	D	4.738	0.635	24.7	0.995	0.706	0.939	0.593	D	c	0.638	0.645	1.000	0.489	0.487	0.133	0	5.52	0.821	5.074	0.640	1.061	0.807	1.000	0.715	0.994	0.587	14.976	0.708	Leucine-rich repeat domain, L domain-like	.	.	0.5	103	103	2	48941191	chr2:48941191	T	A	103	PASS	DP=103;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	48982646	48982646	T	A	intronic	LHCGR;STON1-GTF2A1L	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	160	2	48982646	chr2:48982646	T	A	.	PASS	DP=160;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	54756587	54756587	-	A	ncRNA_exonic	RPL23AP32	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	636	2	54756587	chr2:54756587	C	CA	83	PASS	DP=636;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	54895926	54895926	T	-	UTR3	SPTBN1	NM_003128:c.*220delT	.	.	1	5.26E-11	1.63E-28	.	0.27109	0.3714	-3.862151662	0.22410946	285.65309	3.61906	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	341	2	54895925	chr2:54895925	AT	A	87	PASS	DP=341;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	55863360	55863360	-	A	UTR3	PNPT1	NM_033109:c.*11_*12insT	.	.	0.908266843	0.091733155	2.06E-09	DISEASE: Combined oxidative phosphorylation deficiency 13 (COXPD13) [MIM:614932]: A mitochondrial disorder characterized by early onset severe encephalomyopathy, dystonia, choreoathetosis, bucofacial dyskinesias and combined mitochondrial respiratory chain deficiency. Nerve conductions velocities are decreased. Levels of plasma and cerebrospinal fluid lactate are increased. {ECO:0000269|PubMed:23084291}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 70 (DFNB70) [MIM:614934]: A form of non-syndromic deafness characterized by severe, bilateral hearing impairment with prelingual onset, resulting in inability to acquire normal speech. {ECO:0000269|PubMed:23084290}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2306	0.0952	0.135991087	63.61759849	3768.17005	12.01066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	183	2	55863360	chr2:55863360	T	TA	69	PASS	DP=183;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	61411443	61411443	G	C	intronic	AHSA2	.	.	.	5.61E-06	0.140152678	0.859841708	.	0.05809	.	-0.339715008	30.06605331	275.26294	3.55364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	71	2	61411443	chr2:61411443	G	C	102	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	61697840	61697840	-	C	UTR5	USP34	NM_014709:c.-14_-13insG	.	.	1	4.84E-19	7.26E-51	.	0.83824	0.09517	-3.59020415	0.300778485	689.89772	5.23798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	178	2	61697840	chr2:61697840	G	GC	63	PASS	DP=178;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	61765418	61765418	G	A	UTR5	XPO1	NM_003400:c.-4386C>T	.	.	0.999999567	4.33E-07	6.76E-17	.	0.99668	0.30319	-0.846787714	11.05803255	10.80842	0.392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	1363	2	61765418	chr2:61765418	G	A	106	PASS	DP=1363;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	63849547	63849547	G	A	intergenic	MDH1;UGP2	dist=15217;dist=218551	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	304	2	63849547	chr2:63849547	G	A	94	PASS	DP=304;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	66663051	66663051	C	T	intronic	MEIS1	.	.	.	0.990885197	0.009112474	2.33E-06	.	0.84073	0.23021	-0.317668748	31.45789101	129.87684	2.48316	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	2	66663051	chr2:66663051	C	T	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	69049478	69049478	G	T	exonic	ARHGAP25	.	nonsynonymous SNV	ARHGAP25:NM_001166276:exon9:c.G1186T:p.D396Y,ARHGAP25:NM_001166277:exon9:c.G1087T:p.D363Y,ARHGAP25:NM_014882:exon9:c.G1183T:p.D395Y,ARHGAP25:NM_001007231:exon10:c.G1207T:p.D403Y	0.438207321	0.561734301	5.84E-05	.	0.82588	0.12015	0.75875178	86.82472281	1845.81859	7.92463	0.031	0.450	D	0.691	0.474	P	0.131	0.511	B	0.355	0.138	N	0.997	0.253	N	2.3	0.659	M	2.73	0.196	T	-2.28	0.524	N	0.395	0.454	-1.105	0.035	T	0.047	0.201	T	0.017	0.382	T	5.039	0.678	25.2	0.987	0.445	0.652	0.324	D	c	-0.329	-0.349	0.941	0.274	0.549	0.223	0	3.56	0.397	0.735	0.256	-0.097	0.117	0.481	0.266	0.011	0.114	5.887	0.180	Rho GTPase-activating protein domain	.	.	0.5	61	240	2	69049478	chr2:69049478	G	T	61	PASS	DP=240;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	69685902	69685902	G	A	UTR3	AAK1	NM_014911:c.*17099C>T	.	.	0.999320421	0.000679579	1.69E-10	.	0.09908	0.09543	-0.664951379	15.91177164	3996.40242	12.50722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	2	69685902	chr2:69685902	G	A	.	PASS	DP=31;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	70070226	70070226	G	A	intronic	GMCL1	.	.	.	9.62E-06	0.984465206	0.015525171	.	.	0.11371	-0.448125345	24.19202642	77.54664	1.85338	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	2	70070226	chr2:70070226	G	A	.	PASS	DP=24;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	70463168	70463168	-	A	intronic	TIA1	.	.	.	0.832581092	0.167412892	6.02E-06	DISEASE: Welander distal myopathy (WDM) [MIM:604454]: An autosomal dominant disorder characterized by adult onset of distal muscle weakness predominantly affecting the distal long extensors of the hands, with slow progression to involve all small hand muscles and the lower legs. Skeletal muscle biopsy shows myopathic changes and prominent rimmed vacuoles. Rare homozygous patients showed earlier onset, faster progression, and proximal muscle involvement. {ECO:0000269|PubMed:23348830, ECO:0000269|PubMed:23401021}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.90768	0.26333	0.238945317	69.20853975	83.28929	1.94032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.64	57	2	70463168	chr2:70463168	T	TA	18.64	PASS	DP=57;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	71209708	71209708	T	A	exonic	ANKRD53	.	nonsynonymous SNV	ANKRD53:NM_001115116:exon5:c.T784A:p.F262I,ANKRD53:NM_024933:exon5:c.T784A:p.F262I	0.000455608	0.867354929	0.132189463	.	0.06661	0.09362	1.26585432	93.59518754	1459.41609	7.12227	0.1	0.390	T	1.0	0.899	D	0.998	0.875	D	0.002	0.366	N	0.984	0.408	D	0.18	0.091	N	-0.11	0.706	T	-1.19	0.342	N	0.67	0.680	-0.280	0.756	T	0.335	0.702	T	0.036	0.572	D	5.365	0.727	25.9	0.992	0.539	0.898	0.502	D	c	0.426	0.478	1.000	0.747	0.554	0.283	0	5.57	0.840	1.972	0.399	0.964	0.580	1.000	0.715	0.995	0.604	13.988	0.637	Ankyrin repeat-containing domain	.	.	0.5	.	68	2	71209708	chr2:71209708	T	A	.	PASS	DP=68;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	71869711	71869711	C	T	intronic	DYSF	.	.	.	1.00E-15	0.999999362	6.38E-07	DISEASE: Limb-girdle muscular dystrophy 2B (LGMD2B) [MIM:253601]: An autosomal recessive degenerative myopathy characterized by weakness and atrophy starting in the proximal pelvifemoral muscles, with onset in the late teens or later, massive elevation of serum creatine kinase levels and slow progression. Scapular muscle involvement is minor and not present at onset. Upper limb girdle involvement follows some years after the onset in lower limbs. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:14678801, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:16705711, ECO:0000269|PubMed:16996541, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]: A late- onset muscular dystrophy involving the distal lower limb musculature. It is characterized by weakness that initially affects the gastrocnemius muscle during early adulthood. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:11468312, ECO:0000269|PubMed:12796534, ECO:0000269|PubMed:15116377, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:15477515, ECO:0000269|PubMed:15515206, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526, ECO:0000269|Ref.26}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Distal myopathy with anterior tibial onset (DMAT) [MIM:606768]: Onset of the disorder is between 14 and 28 years of age and the anterior tibial muscles are the first muscle group to be involved. Inheritance is autosomal recessive. {ECO:0000269|PubMed:11198284}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18661	0.30664	-1.309065031	4.853739089	1760.18248	7.74393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	104	291	2	71869711	chr2:71869711	C	T	104	PASS	DP=291;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	71896341	71896341	G	A	intronic	DYSF	.	.	.	1.00E-15	0.999999362	6.38E-07	DISEASE: Limb-girdle muscular dystrophy 2B (LGMD2B) [MIM:253601]: An autosomal recessive degenerative myopathy characterized by weakness and atrophy starting in the proximal pelvifemoral muscles, with onset in the late teens or later, massive elevation of serum creatine kinase levels and slow progression. Scapular muscle involvement is minor and not present at onset. Upper limb girdle involvement follows some years after the onset in lower limbs. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:14678801, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:16705711, ECO:0000269|PubMed:16996541, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Miyoshi muscular dystrophy 1 (MMD1) [MIM:254130]: A late- onset muscular dystrophy involving the distal lower limb musculature. It is characterized by weakness that initially affects the gastrocnemius muscle during early adulthood. {ECO:0000269|PubMed:10196377, ECO:0000269|PubMed:11134403, ECO:0000269|PubMed:11468312, ECO:0000269|PubMed:12796534, ECO:0000269|PubMed:15116377, ECO:0000269|PubMed:15469449, ECO:0000269|PubMed:15477515, ECO:0000269|PubMed:15515206, ECO:0000269|PubMed:16010686, ECO:0000269|PubMed:16100712, ECO:0000269|PubMed:17287450, ECO:0000269|PubMed:18306167, ECO:0000269|PubMed:18853459, ECO:0000269|PubMed:9731526, ECO:0000269|Ref.26}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Distal myopathy with anterior tibial onset (DMAT) [MIM:606768]: Onset of the disorder is between 14 and 28 years of age and the anterior tibial muscles are the first muscle group to be involved. Inheritance is autosomal recessive. {ECO:0000269|PubMed:11198284}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.18661	0.30664	-1.309065031	4.853739089	1760.18248	7.74393	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	2	71896341	chr2:71896341	G	A	.	PASS	DP=36;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	73496111	73496111	G	A	exonic	FBXO41	.	synonymous SNV	FBXO41:NM_001080410:exon1:c.C648T:p.D216D	0.951773201	0.048220951	5.85E-06	.	0.30259	0.1115	.	.	1132.93967	6.42282	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	2	73496111	chr2:73496111	G	A	.	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	74291829	74291829	-	T	intronic	TET3	.	.	.	0.999942651	5.73E-05	1.00E-11	.	0.85759	0.1031	-1.512251235	3.479594244	432.06015	4.33811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	386	2	74291829	chr2:74291829	A	AT	75	PASS	DP=386;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	74668346	74668346	T	A	intronic	RTKN	.	.	.	0.000149538	0.992324331	0.007526131	.	0.1644	0.10277	-0.841329384	11.36470866	111.05692	2.29721	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	623	2	74668346	chr2:74668346	T	A	105	PASS	DP=623;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	74687542	74687542	-	C	exonic	WBP1	.	frameshift insertion	WBP1:NM_012477:exon4:c.545dupC:p.H185Sfs*4	0.000303097	0.803000262	0.196696641	.	.	0.10512	-0.26993514	34.59542345	86.33658	1.98463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	1241	2	74687542	chr2:74687542	G	GC	106	PASS	DP=1241;AN=4	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/1
2	85662190	85662190	G	A	exonic	SH2D6	.	nonsynonymous SNV	SH2D6:NM_201594:exon18:c.G100A:p.G34R	0.003696498	0.631606602	0.3646969	.	0.05815	.	0.459411326	78.28497287	94.15331	2.08683	0.003	0.682	D	0.997	0.689	D	0.896	0.618	P	0.365	0.136	N	0.828	0.349	D	1.83	0.482	L	-1.11	0.775	T	-2.96	0.617	D	0.244	0.298	-0.148	0.790	T	0.478	0.800	T	0.111	0.790	D	3.134	0.436	22.6	0.986	0.431	0.737	0.358	D	c	0.165	0.059	1.000	0.747	0.403	0.052	0	3.47	0.387	1.742	0.376	1.048	0.713	1.000	0.715	0.049	0.163	10.771	0.453	.	.	.	0.5	.	55	2	85662190	chr2:85662190	G	A	.	PASS	DP=55;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	87169455	87169455	-	CGGCCTCGACCTGGCGGGGCGG	intronic	RGPD1;RGPD2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	198	2	87169455	chr2:87169455	A	ACGGCCTCGACCTGGCGGGGCGG	107	PASS	DP=198;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	87355912	87355912	C	T	intergenic	LOC285074;MIR4771-2	dist=52376;dist=65997	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	87	2	87355912	chr2:87355912	C	T	105	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	89278092	89278092	G	C	intergenic	MIR4436A;NONE	dist=166124;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	243	2	89278092	chr2:89278092	G	C	.	PASS	DP=243;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	89339848	89339848	C	G	intergenic	MIR4436A;NONE	dist=227880;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	259	2	89339848	chr2:89339848	C	G	85	PASS	DP=259;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	89399635	89399635	T	G	intergenic	MIR4436A;NONE	dist=287667;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	132	260	2	89399635	chr2:89399635	T	G	132	PASS	DP=260;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	89545096	89545096	G	C	intergenic	MIR4436A;NONE	dist=433128;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	95	2	89545096	chr2:89545096	G	C	83	PASS	DP=95;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	90077766	90077766	C	G	intergenic	MIR4436A;LOC654342	dist=965798;dist=1746943	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	284	2	90077766	chr2:90077766	C	G	.	PASS	DP=284;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	90211702	90211702	C	A	intergenic	MIR4436A;LOC654342	dist=1099734;dist=1613007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	607	2	90211702	chr2:90211702	C	A	90	PASS	DP=607;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	91777719	91777719	G	A	intergenic	NONE;LOC654342	dist=NONE;dist=46990	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	144	2	91777719	chr2:91777719	G	A	.	PASS	DP=144;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	91793472	91793472	C	A	intergenic	NONE;LOC654342	dist=NONE;dist=31237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	320	2	91793472	chr2:91793472	C	A	95	PASS	DP=320;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	91795525	91795525	G	T	intergenic	NONE;LOC654342	dist=NONE;dist=29184	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	403	2	91795525	chr2:91795525	G	T	.	PASS	DP=403;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	91800687	91800687	C	A	intergenic	NONE;LOC654342	dist=NONE;dist=24022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	1383	2	91800687	chr2:91800687	C	A	94	PASS	DP=1383;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	91885985	91885985	T	C	intergenic	LOC654342;LOC101927050	dist=38010;dist=1729	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	191	2	91885985	chr2:91885985	T	C	.	PASS	DP=191;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	95940557	95940557	A	T	exonic	PROM2	.	nonsynonymous SNV	PROM2:NM_001165977:exon1:c.A224T:p.Q75L,PROM2:NM_001165978:exon1:c.A224T:p.Q75L,PROM2:NM_144707:exon1:c.A224T:p.Q75L	7.90E-08	0.994662578	0.005337343	.	0.12478	0.0927	-0.369255208	28.25548478	1092.43407	6.32455	0.002	0.721	D	0.999	0.764	D	0.984	0.745	D	0.001	0.428	D	1.000	0.495	D	2.93	0.848	M	0.81	0.485	T	-5.55	0.862	D	0.527	0.674	-0.634	0.634	T	0.268	0.640	T	0.173	0.850	D	4.590	0.615	24.4	0.993	0.575	0.707	0.344	D	c	0.400	0.310	1.000	0.747	0.609	0.351	0	4.94	0.645	2.723	0.467	1.028	0.649	0.998	0.411	0.909	0.387	10.981	0.465	.	.	.	0.5	.	90	2	95940557	chr2:95940557	A	T	.	PASS	DP=90;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	96126087	96126087	-	A	intergenic	FAHD2A;TRIM43B	dist=47208;dist=16628	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	267	2	96126087	chr2:96126087	C	CA	40	PASS	DP=267;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	96457946	96457946	T	C	intergenic	TRIM43;LINC00342	dist=192427;dist=14854	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	162	117	2	96457946	chr2:96457946	T	C	162	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	96517502	96517502	A	C	exonic	ANKRD36C	.	nonsynonymous SNV	ANKRD36C:NM_001310154:exon87:c.T6351G:p.I2117M	.	.	.	.	.	.	.	.	2676.37542	9.72635	0.038	0.427	D	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	1.27	0.361	T	0.01	0.069	N	0.067	0.112	-1.027	0.214	T	0.037	0.162	T	.	.	.	-0.910	0.035	0.025	0.253	0.012	0.004	0.021	N	c	-1.567	-1.743	0.000	0.044	0.651	0.465	0	-3.59	0.043	-0.643	0.055	-1.236	0.015	0.000	0.063	0.000	0.016	0.308	0.003	Ankyrin repeat-containing domain	.	.	0.5	110	87	2	96517502	chr2:96517502	A	C	110	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	96553678	96553678	C	-	exonic	ANKRD36C	.	frameshift deletion	ANKRD36C:NM_001310154:exon71:c.4151delG:p.G1384Efs*23	.	.	.	.	.	.	.	.	2676.37542	9.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	28	2	96553677	chr2:96553677	TC	T	58	PASS	DP=28;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	96579840	96579877	CTCTTTTCAAAATTACCTCTCCTAGTTTTTTCTCCATC	-	exonic	ANKRD36C	.	frameshift deletion	ANKRD36C:NM_001310154:exon43:c.2707_2728del:p.D903Cfs*8	.	.	.	.	.	.	.	.	2676.37542	9.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	21.82	40	2	96579839	chr2:96579839	TCTCTTTTCAAAATTACCTCTCCTAGTTTTTTCTCCATC	T	21.82	PASS	DP=40;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	96604548	96604548	T	C	intronic	ANKRD36C	.	.	.	.	.	.	.	.	.	.	.	2676.37542	9.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	362	2	96604548	chr2:96604548	T	C	112	PASS	DP=362;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	96688929	96688929	G	A	exonic	GPAT2	.	nonsynonymous SNV	GPAT2:NM_001321529:exon18:c.C1879T:p.R627C,GPAT2:NM_001321530:exon18:c.C1861T:p.R621C,GPAT2:NM_001321525:exon19:c.C2092T:p.R698C,GPAT2:NM_001321526:exon19:c.C2092T:p.R698C,GPAT2:NM_001321527:exon19:c.C2092T:p.R698C,GPAT2:NM_207328:exon19:c.C2074T:p.R692C	0.0016123	0.992339401	0.006048299	.	.	.	.	.	151.08322	2.68731	0.0	0.912	D	0.584	0.541	P	0.093	0.419	B	0.019	0.272	N	0.996	0.810	D	2.545	0.745	M	-1.38	0.803	T	-3.74	0.710	D	0.582	0.614	-0.949	0.412	T	0.008	0.029	T	.	.	.	5.499	0.747	26.2	0.998	0.926	0.830	0.418	D	c	0.320	0.409	0.270	0.189	0.713	0.817	0	5.44	0.793	2.136	0.415	1.013	0.643	1.000	0.715	0.999	0.750	16.748	0.853	.	.	.	0.5	125	156	2	96688929	chr2:96688929	G	A	125	PASS	DP=156;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	96697823	96697823	G	A	exonic	GPAT2	.	synonymous SNV	GPAT2:NM_001321525:exon3:c.C135T:p.P45P,GPAT2:NM_001321526:exon3:c.C135T:p.P45P,GPAT2:NM_001321527:exon3:c.C135T:p.P45P,GPAT2:NM_001321528:exon3:c.C135T:p.P45P,GPAT2:NM_001321529:exon3:c.C135T:p.P45P,GPAT2:NM_001321530:exon3:c.C135T:p.P45P,GPAT2:NM_207328:exon3:c.C135T:p.P45P,GPAT2:NM_001321531:exon4:c.C135T:p.P45P	0.0016123	0.992339401	0.006048299	.	.	.	.	.	151.08322	2.68731	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	172	770	2	96697823	chr2:96697823	G	A	172	PASS	DP=770;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	96780622	96780622	A	C	exonic	ADRA2B	.	nonsynonymous SNV	ADRA2B:NM_000682:exon2:c.T1267G:p.Y423D	0.000244369	0.526369151	0.473386481	DISEASE: Epilepsy, familial adult myoclonic, 2 (FAME2) [MIM:607876]: A form of cortical myoclonic tremor with epilepsy, a syndrome characterized by cortical myoclonus and variable occurrence of epileptic seizures. Usually, myoclonic tremor is the presenting symptom, characterized by tremulous finger movements and myoclonic jerks of the limbs increased by action and posture. In a minority of patients, seizures are the presenting symptom; both complex partial as well as generalized tonic clonic seizures are described. Some patients exhibit mild cognitive impairment. {ECO:0000269|PubMed:24114805}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.11107	-0.247889024	35.98726115	62.69652	1.61925	.	.	.	1.0	0.899	D	1.0	0.971	D	.	.	.	1.000	0.588	D	4.665	0.994	H	.	.	.	.	.	.	0.946	0.941	1.005	0.973	D	0.929	0.977	D	0.294	0.907	D	4.995	0.672	25.1	0.993	0.586	0.989	0.881	D	c	0.963	0.847	1.000	0.747	0.610	0.352	0	4.58	0.559	9.254	0.947	1.073	0.849	1.000	0.715	0.997	0.653	10.424	0.434	GPCR, rhodopsin-like, 7TM	.	.	0.5	.	278	2	96780622	chr2:96780622	A	C	.	PASS	DP=278;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	97317533	97317536	TCAT	-	intronic	FER1L5	.	.	.	.	.	.	.	0.16074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	96	2	97317532	chr2:97317532	CTCAT	C,CCAT	53	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	97317533	97317533	T	-	intronic	FER1L5	.	.	.	.	.	.	.	0.16074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	96	2	97317532	chr2:97317532	CTCAT	C,CCAT	53	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	97405565	97405565	C	T	intronic	LMAN2L	.	.	.	1.29E-07	0.356817103	0.643182769	.	0.21755	0.12712	-0.648365105	16.35999056	21.85645	0.73498	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	832	2	97405565	chr2:97405565	C	T	81	PASS	DP=832;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	97869878	97869878	C	A	intronic	ANKRD36	.	.	.	2.12E-19	0.086362931	0.913637069	.	.	.	.	.	4272.72254	12.99655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	78	2	97869878	chr2:97869878	C	A	.	PASS	DP=78;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	98872571	98872571	T	-	intronic	VWA3B	.	.	.	3.27E-18	0.596776822	0.403223178	DISEASE: Note=Defects in VWA3B may be a cause of cerebellar ataxia with intellectual disability. {ECO:0000269|PubMed:26157035}.; 	0.09166	.	1.322735566	94.07879217	1748.74917	7.72022	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	48	2	98872570	chr2:98872570	CT	C	54	PASS	DP=48;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	99219135	99219135	C	T	intronic	COA5	.	.	.	0.239646156	0.644552102	0.115801742	DISEASE: Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3 (CEMCOX3) [MIM:616500]: An infantile disorder with a fatal course in the first weeks of life, characterized by hypertrophic cardiomyopathy and mitochondrial complex IV deficiency. Postmortem microscopic investigations show accumulation of lipid droplets in cardiomyocytes and mitochondrial proliferation. {ECO:0000269|PubMed:21457908}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1181	.	0.057118534	57.99716914	4.99352	0.18509	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	86	2	99219135	chr2:99219135	C	T	.	PASS	DP=86;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	101437601	101437601	C	G	intronic	NPAS2	.	.	.	0.990888562	0.009111438	7.90E-10	.	0.21897	0.22837	-0.506987379	21.76810569	5079.47281	14.59455	.	.	.	0.005	0.119	B	0.003	0.080	B	.	.	.	1	0.090	P	.	.	.	0.78	0.494	T	.	.	.	0.089	0.086	-0.993	0.318	T	0.000	0.000	T	.	.	.	0.932	0.183	10.26	0.684	0.084	0.123	0.170	N	c	-0.944	-0.949	1.000	0.747	0.437	0.062	0	2.43	0.287	0.288	0.186	0.852	0.362	0.003	0.159	0.015	0.124	7.284	0.253	.	ENSG00000170485.12	Skin_Sun_Exposed_Lower_leg	0.5	147	78	2	101437601	chr2:101437601	C	G	147	PASS	DP=78;AN=2	GT	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	101640086	101640086	-	T	intronic	TBC1D8	.	.	.	5.26E-07	0.999927627	7.18E-05	.	0.16485	0.13045	-1.006844617	8.209483369	2278.58196	8.83254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	161	2	101640086	chr2:101640086	G	GT	77	PASS	DP=161;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	101881539	101881539	-	T	intronic	CNOT11	.	.	.	0.993507645	0.006491339	1.02E-06	.	0.50975	0.09076	-0.361761279	28.6329323	24.35814	0.80124	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	946	2	101881539	chr2:101881539	C	CT	105	PASS	DP=946;AN=6	GT	./.	./.	./.	./.	0/1	./.	./.	0/1	./.	./.	./.	0/1
2	108490151	108490152	TG	-	intronic	RGPD4	.	.	.	.	.	.	.	.	.	.	.	3826.98843	12.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.59	40	2	108490150	chr2:108490150	ATG	A	12.59	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	108496625	108496648	CACATGTACCCAAGTTTAAAAATT	-	intronic	RGPD4	.	.	.	.	.	.	.	.	.	.	.	3826.98843	12.16508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.32	33	2	108496624	chr2:108496624	ACACATGTACCCAAGTTTAAAAATT	A	19.32	PASS	DP=33;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	108520467	108520467	A	G	intergenic	RGPD4;SLC5A7	dist=11467;dist=82503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	94	2	108520467	chr2:108520467	A	G	98	PASS	DP=94;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	109276712	109276712	-	A	intronic	LIMS1	.	.	.	0.347565207	0.649601345	0.002833447	.	0.85268	0.14897	.	.	138.63474	2.56496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	637	2	109276712	chr2:109276712	G	GA	98	PASS	DP=637;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	109356988	109356988	G	C	exonic	RANBP2	.	nonsynonymous SNV	RANBP2:NM_006267:exon7:c.G826C:p.D276H	0.999999999	1.49E-09	4.67E-27	DISEASE: Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]: A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem. {ECO:0000269|PubMed:19118815}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by themselves are insufficient to make the phenotype fully penetrant; additional genetic and environmental factors are required (PubMed:19118815). {ECO:0000269|PubMed:19118815}.; 	0.93164	0.52169	-1.538551197	3.33215381	1024.97017	6.15454	0.004	0.654	D	0.996	0.670	D	0.831	0.578	P	.	.	.	0.951	0.377	D	2.645	0.776	M	1.53	0.304	T	-3.05	0.629	D	0.485	0.623	-0.912	0.466	T	0.126	0.432	T	0.016	0.378	T	3.831	0.517	23.4	0.994	0.618	0.996	0.976	D	c	0.721	0.716	0.972	0.293	0.707	0.730	0	4.79	0.608	9.401	0.966	1.038	0.658	1.000	0.715	1.000	0.888	11.696	0.506	Tetratricopeptide-like helical domain	.	.	0.5	115	367	2	109356988	chr2:109356988	G	C	115	PASS	DP=367;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	109365364	109365364	T	-	intronic	RANBP2	.	.	.	0.999999999	1.49E-09	4.67E-27	DISEASE: Encephalopathy, acute, infection-induced, 3 (IIAE3) [MIM:608033]: A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem. {ECO:0000269|PubMed:19118815}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by themselves are insufficient to make the phenotype fully penetrant; additional genetic and environmental factors are required (PubMed:19118815). {ECO:0000269|PubMed:19118815}.; 	0.93164	0.52169	-1.538551197	3.33215381	1024.97017	6.15454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	312	2	109365363	chr2:109365363	AT	A	72	PASS	DP=312;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	109404474	109404474	-	T	intronic	CCDC138	.	.	.	1.08E-05	0.986815955	0.013173211	.	0.15822	.	-0.464712395	23.5727766	2253.24012	8.76685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	131	2	109404474	chr2:109404474	C	CT	87	PASS	DP=131;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	109421324	109421324	-	T	intronic	CCDC138	.	.	.	1.08E-05	0.986815955	0.013173211	.	0.15822	.	-0.464712395	23.5727766	2253.24012	8.76685	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	27	2	109421324	chr2:109421324	G	GT	50	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	109960809	109960809	G	T	intronic	SH3RF3	.	.	.	0.981100872	0.018885189	1.39E-05	.	.	.	.	.	1390.76659	6.97706	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.231	0.074	0.945	0.713	0.093	0.095	0.150	N	n	-0.099	-0.182	1.000	0.473	0.054	0.004	0	0.474	0.159	1.163	0.312	0.635	0.291	0.004	0.165	0.015	0.124	5.12	0.141	.	.	.	0.5	81	288	2	109960809	chr2:109960809	G	T	81	PASS	DP=288;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	110036009	110036009	G	T	exonic	SH3RF3	.	synonymous SNV	SH3RF3:NM_001099289:exon5:c.G1314T:p.S438S	0.981100872	0.018885189	1.39E-05	.	.	.	.	.	1390.76659	6.97706	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	118	2	110036009	chr2:110036009	G	T	.	PASS	DP=118;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	111644331	111644331	A	G	intronic	ACOXL	.	.	.	6.28E-10	0.400098611	0.599901388	.	0.07205	0.07959	1.86668643	97.19863175	3441.02377	11.26674	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	83	2	111644331	chr2:111644331	A	G	86	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	112536287	112536287	G	A	exonic	ANAPC1	.	nonsynonymous SNV	ANAPC1:NM_022662:exon45:c.C5350T:p.P1784S	.	.	.	.	0.55585	0.09577	.	.	199.72138	3.0527	0.039	0.424	D	1.0	0.899	D	0.994	0.807	D	0.000	0.504	D	1	0.810	D	2.685	0.788	M	.	.	.	-1.73	0.410	N	0.535	0.574	-0.361	0.733	T	0.400	0.751	T	0.017	0.386	T	5.981	0.822	27.8	0.999	0.963	0.986	0.845	D	c	0.625	0.576	0.998	0.367	0.732	0.924	0	4.05	0.462	9.277	0.949	0.877	0.384	1.000	0.715	1.000	0.888	16.595	0.846	.	.	.	0.5	127	168	2	112536287	chr2:112536287	G	A	127	PASS	DP=168;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	112615888	112615888	C	G	exonic	ANAPC1	.	nonsynonymous SNV	ANAPC1:NM_022662:exon11:c.G1353C:p.Q451H	.	.	.	.	0.55585	0.09577	.	.	199.72138	3.0527	0.125	0.273	T	0.006	0.126	B	0.005	0.104	B	0.147	0.181	N	0.993	0.418	D	1.71	0.444	L	.	.	.	-0.9	0.242	N	0.431	0.487	-0.992	0.320	T	0.136	0.452	T	.	.	.	1.479	0.240	13.20	0.969	0.310	0.888	0.487	D	c	-0.624	-0.489	0.002	0.094	0.732	0.924	0	3.2	0.357	1.258	0.323	-0.467	0.054	1.000	0.715	0.973	0.468	7.272	0.253	.	.	.	0.5	127	281	2	112615888	chr2:112615888	C	G	127	PASS	DP=281;AN=4	GT	./.	./.	./.	./.	./.	0/1	0/1	./.	./.	./.	./.	./.
2	113138347	113138347	G	A	intronic	RGPD5;RGPD8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	128	2	113138347	chr2:113138347	G	A	.	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	113379341	113379341	-	GT	intergenic	CHCHD5;FLJ42351	dist=32724;dist=20066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	94	2	113379341	chr2:113379341	G	GGT	55	PASS	DP=94;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	113819674	113819674	G	A	intronic	IL36RN	.	.	.	0.00097234	0.584074519	0.414953141	DISEASE: Psoriasis 14, pustular (PSORS14) [MIM:614204]: A life- threatening disease defined by repeated flares of sudden onset consisting of diffuse erythematous skin eruption characterized by rapid coverage with pustules, high-grade fever, asthenia, marked leukocytosis, and elevated serum levels of C-reactive protein. {ECO:0000269|PubMed:21839423, ECO:0000269|PubMed:21848462, ECO:0000269|PubMed:22903787}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15223	0.12775	0.038710339	56.92380278	158.88685	2.75336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	157	2	113819674	chr2:113819674	G	A	.	PASS	DP=157;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	113891129	113891129	-	T	UTR3	IL1RN	NM_173841:c.*681_*682insT;NM_001318914:c.*681_*682insT;NM_173843:c.*681_*682insT;NM_000577:c.*681_*682insT;NM_173842:c.*681_*682insT	.	.	0.340218949	0.645559638	0.014221413	DISEASE: Interleukin 1 receptor antagonist deficiency (DIRA) [MIM:612852]: A rare autoinflammatory disease of skin and bone resulting in sterile multifocal osteomyelitis, periostitis, and pustulosis from birth. The term autoinflammatory disease describes a group of disorders characterized by attacks of seemingly unprovoked inflammation without significant levels of autoantibodies and autoreactive T-cells. {ECO:0000269|PubMed:19494218}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09392	0.71118	-0.692458599	14.96815287	19.76062	0.67491	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	29.42	32	2	113891129	chr2:113891129	A	AT	29.42	PASS	DP=32;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	114257573	114257573	G	T	exonic	FOXD4L1	.	nonsynonymous SNV	FOXD4L1:NM_012184:exon1:c.G740T:p.G247V	.	.	.	.	0.05795	0.07954	1.616843854	95.96013211	3262.81752	10.89654	0.14	0.256	T	1.0	0.899	D	0.994	0.807	D	.	.	.	1	0.090	N	1.545	0.392	L	-3.44	0.944	D	-1.06	0.277	N	0.155	0.185	0.049	0.832	D	0.782	0.926	D	0.038	0.580	D	1.777	0.274	14.85	0.986	0.434	0.120	0.168	N	c	-0.540	-0.763	0.000	0.012	0.598	0.340	0	1.37	0.211	-0.873	0.043	-0.397	0.063	0.000	0.063	0.001	0.043	6.523	0.213	.	.	.	0.5	110	645	2	114257573	chr2:114257573	G	T	110	PASS	DP=645;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	114415749	114415749	T	A	intergenic	RABL2A;SLC35F5	dist=14774;dist=48549	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	111	2	114415749	chr2:114415749	T	A	82	PASS	DP=111;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	119599910	119599910	C	A	UTR3	EN1	NM_001426:c.*604G>T	.	.	0.75193186	0.238255669	0.009812471	.	0.60781	0.26527	.	.	13.35248	0.48584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	88	2	119599910	chr2:119599910	C	A	.	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	119599911	119599911	C	A	UTR3	EN1	NM_001426:c.*603G>T	.	.	0.75193186	0.238255669	0.009812471	.	0.60781	0.26527	.	.	13.35248	0.48584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	2	119599911	chr2:119599911	C	A	.	PASS	DP=87;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	119739162	119739162	A	-	intronic	MARCO	.	.	.	6.42E-08	0.872393291	0.127606645	.	0.064	0.24721	-0.374708069	28.15522529	845.48074	5.68855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	30	2	119739161	chr2:119739161	GA	G	43	PASS	DP=30;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	120317539	120317539	C	T	exonic	CFAP221	.	synonymous SNV	CFAP221:NM_001271049:exon5:c.C363T:p.V121V	.	.	.	.	.	.	-0.220384297	37.6032083	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	2	120317539	chr2:120317539	C	T	.	PASS	DP=41;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	120857746	120857747	TA	-	intronic	EPB41L5	.	.	.	0.022933841	0.977065093	1.07E-06	.	0.19351	0.09111	0.04598748	57.47817882	253.06645	3.42227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	18	2	120857745	chr2:120857745	GTA	G	101	PASS	DP=18;AN=2	GT	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	128370201	128370201	G	T	intronic	MYO7B	.	.	.	6.38E-16	0.999852793	0.000147207	.	0.11748	.	1.019668216	90.92356688	5040.89055	14.51846	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	2	128370201	chr2:128370201	G	T	.	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	128412336	128412336	C	-	intronic	LIMS2	.	.	.	1.14E-05	0.585518975	0.414469626	.	0.40061	0.11748	-0.800872469	12.33191791	54.15487	1.46813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	176	2	128412335	chr2:128412335	GC	G	59	PASS	DP=176;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	128647869	128647869	C	G	intergenic	AMMECR1L;SAP130	dist=4355;dist=50922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	33	2	128647869	chr2:128647869	C	G	59	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	130832913	130832913	T	G	exonic	POTEF	.	nonsynonymous SNV	POTEF:NM_001099771:exon17:c.A2132C:p.D711A	.	.	.	.	.	.	.	.	1056.59425	6.24058	0.004	0.654	D	0.872	0.459	P	0.895	0.617	P	.	.	.	1	0.810	D	5.575	1.000	H	-4.87	0.983	D	-5.38	0.849	D	0.525	0.568	0.996	0.971	D	0.973	0.991	D	0.012	0.312	T	3.626	0.493	23.2	0.986	0.426	0.401	0.261	N	c	0.095	-0.271	0.000	0.050	0.554	0.246	0	.	.	3.012	0.490	-0.960	0.024	1.000	0.715	0.014	0.122	4.549	0.114	.	.	.	0.5	138	1364	2	130832913	chr2:130832913	T	G	138	PASS	DP=1364;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	130951848	130951848	T	C	exonic	TUBA3E	.	synonymous SNV	TUBA3E:NM_207312:exon4:c.A567G:p.L189L	0.001205278	0.846489817	0.152304904	.	0.51437	0.17173	0.378498378	75.58386412	520.54799	4.65963	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	49	2	130951848	chr2:130951848	T	C	96	PASS	DP=49;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	131377636	131377636	C	T	exonic	POTEJ	.	synonymous SNV	POTEJ:NM_001277083:exon4:c.C718T:p.L240L	.	.	.	.	.	.	.	.	1579.22659	7.35384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	209	2	131377636	chr2:131377636	C	T	117	PASS	DP=209;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	131414196	131414196	A	T	exonic	POTEJ	.	synonymous SNV	POTEJ:NM_001277083:exon15:c.A1863T:p.L621L	.	.	.	.	.	.	.	.	1579.22659	7.35384	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	163	2	131414196	chr2:131414196	A	T	.	PASS	DP=163;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	131459814	131459814	T	-	intergenic	CYP4F30P;GPR148	dist=16379;dist=26829	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	52	2	131459813	chr2:131459813	CT	C	45	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	131947396	131947396	T	-	intergenic	PLEKHB2;POTEE	dist=39971;dist=28528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	404	2	131947395	chr2:131947395	AT	A	78	PASS	DP=404;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	131976061	131976061	G	T	exonic	POTEE	.	nonsynonymous SNV	POTEE:NM_001083538:exon1:c.G86T:p.C29F	.	.	.	.	.	.	.	.	513.98926	4.63955	0.12	0.279	T	0.676	0.394	P	0.308	0.396	B	.	.	.	1	0.090	N	0.55	0.145	N	-0.97	0.757	T	-0.37	0.132	N	0.421	0.478	-0.900	0.480	T	0.209	0.569	T	0.030	0.525	D	-0.368	0.064	0.461	0.652	0.075	0.010	0.039	N	c	-0.930	-1.136	0.000	0.012	0.554	0.246	0	0.1	0.138	0.059	0.141	0.303	0.270	0.004	0.165	0.007	0.100	.	.	.	.	.	0.5	.	370	2	131976061	chr2:131976061	G	T	.	PASS	DP=370;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	131984320	131984320	C	T	intronic	POTEE	.	.	.	.	.	.	.	.	.	.	.	513.98926	4.63955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	197	2	131984320	chr2:131984320	C	T	124	PASS	DP=197;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	132121350	132121350	G	C	UTR5	WTH3DI	NM_001077637:c.-57C>G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	102	55	2	132121350	chr2:132121350	G	C	102	PASS	DP=55;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	132200282	132200282	C	G	ncRNA_exonic	NOC2LP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	300	2	132200282	chr2:132200282	C	G	120	PASS	DP=300;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	132366964	132366964	T	C	ncRNA_exonic	POTEKP	.	.	.	.	.	.	.	.	0.43916	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	217	2	132366964	chr2:132366964	T	C	126	PASS	DP=217;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	133426045	133426045	G	T	exonic	LYPD1	.	nonsynonymous SNV	LYPD1:NM_144586:exon2:c.C118A:p.P40T,LYPD1:NM_001321234:exon3:c.C166A:p.P56T	0.000238591	0.313658655	0.686102754	.	0.21654	.	0.3032669	72.009908	18.3074	0.63566	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1.000	0.810	D	2.045	0.562	M	-1.48	0.812	T	-2.85	0.600	D	0.724	0.723	0.127	0.847	D	0.525	0.823	D	0.092	0.758	D	5.793	0.792	27.1	0.998	0.897	0.972	0.733	D	c	0.730	0.775	1.0	0.983	0.652	0.477	0	5.43	0.789	8.986	0.930	1.048	0.713	1.000	0.715	0.999	0.750	17.605	0.879	Ly-6 antigen / uPA receptor -like	.	.	0.5	.	65	2	133426045	chr2:133426045	G	T	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	135870866	135870866	G	T	intronic	RAB3GAP1	.	.	.	3.66E-05	0.99995942	3.97E-06	.	0.42054	0.14874	0.202129237	67.42745931	2290.07687	8.85637	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	2	135870866	chr2:135870866	G	T	.	PASS	DP=34;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	138000119	138000119	C	T	exonic	THSD7B	.	nonsynonymous SNV	THSD7B:NM_001316349:exon10:c.C2243T:p.P748L	5.65E-06	0.999994327	1.97E-08	.	0.33549	0.08669	.	.	4772.07743	13.99787	0.047	0.403	D	0.949	0.518	P	0.756	0.544	P	0.000	0.629	D	0.999	0.810	D	1.665	0.427	L	2.16	0.192	T	-3.07	0.632	D	0.289	0.348	-1.103	0.037	T	0.103	0.381	T	0.011	0.274	T	5.488	0.745	26.2	0.987	0.449	0.322	0.243	N	c	0.239	0.226	0.000	0.056	0.638	0.428	0	4.87	0.627	0.408	0.206	0.935	0.490	0.107	0.227	0.911	0.388	17.396	0.873	.	.	.	0.5	41	69	2	138000119	chr2:138000119	C	T	41	PASS	DP=69;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	139328964	139328964	-	T	UTR3	SPOPL	NM_001001664:c.*2314_*2315insT	.	.	0.045446953	0.953443578	0.00110947	.	0.32484	0.11621	-0.0274281	51.65723048	55.42268	1.49467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	139	2	139328964	chr2:139328964	A	AT	63	PASS	DP=139;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	144008050	144008050	C	G	intronic	ARHGAP15	.	.	.	5.25E-06	0.964756522	0.035238224	.	0.77364	0.12676	-0.624497208	17.16206653	736.83485	5.38892	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	62	2	144008050	chr2:144008050	C	G	67	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	145027394	145027394	-	A	intronic	GTDC1	.	.	.	2.41E-10	0.07320236	0.92679764	.	0.15283	0.07494	-0.176292081	40.56381222	263.31779	3.48127	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.99	88	2	145027394	chr2:145027394	T	TA	13.99	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	148602603	148602603	G	A	UTR5	ACVR2A	NM_001616:c.-119G>A	.	.	0.993932262	0.006067564	1.74E-07	.	0.69088	0.23984	-0.339715008	30.06605331	11.33135	0.40758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	234	2	148602603	chr2:148602603	G	A	65	PASS	DP=234;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	152118256	152118256	G	C	UTR5	RBM43	NM_198557:c.-15C>G	.	.	0.05186677	0.861581767	0.086551463	.	0.04235	.	0.148941568	64.31941496	75.64131	1.82117	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	141	502	2	152118256	chr2:152118256	G	C	141	PASS	DP=502;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	152695190	152695191	TC	-	UTR3	CACNB4	NM_001320722:c.*443_*442delGA;NM_001145798:c.*443_*442delGA;NM_000726:c.*443_*442delGA;NM_001330115:c.*443_*442delGA;NM_001330116:c.*443_*442delGA;NM_001330114:c.*443_*442delGA;NM_001330113:c.*443_*442delGA;NM_001330117:c.*443_*442delGA;NM_001330118:c.*443_*442delGA;NM_001005747:c.*443_*442delGA;NM_001005746:c.*443_*442delGA	.	.	0.011363582	0.988273668	0.00036275	DISEASE: Juvenile myoclonic epilepsy 6 (EJM6) [MIM:607682]: A subtype of idiopathic generalized epilepsy. Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Episodic ataxia 5 (EA5) [MIM:613855]: A disorder characterized by episodes of vertigo and ataxia that last for several hours. Interictal examination show spontaneous downbeat and gaze-evoked nystagmus, mild dysarthria and truncal ataxia. {ECO:0000269|PubMed:10762541}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.19944	0.13941	0.082802743	60.09082331	22.57919	0.75555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	29	2	152695189	chr2:152695189	TTC	T	45	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	157186619	157186619	G	T	exonic	NR4A2	.	stopgain	NR4A2:NM_006186:exon3:c.C80A:p.S27X	0.991432866	0.008565133	2.00E-06	.	0.64744	0.60715	-0.626318434	17.03231894	29.24717	0.93603	.	.	.	.	.	.	.	.	.	0.010	0.301	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.397	0.967	36	0.990	0.491	0.958	0.660	D	c	0.937	0.824	1.000	0.747	0.549	0.223	0	5.43	0.789	6.401	0.730	1.048	0.713	1.000	0.715	1.000	0.888	19.013	0.928	.	.	.	0.5	.	107	2	157186619	chr2:157186619	G	T	.	PASS	DP=107;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	158721458	158721458	-	T	intronic	ACVR1	.	.	.	0.956448193	0.043547277	4.53E-06	.	0.99535	0.38424	-0.514264485	21.41424864	58.72963	1.55397	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.47	93	2	158721458	chr2:158721458	A	AT	10.47	PASS	DP=93;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	160729091	160729091	T	A	exonic	LY75;LY75-CD302	.	nonsynonymous SNV	LY75-CD302:NM_001198759:exon13:c.A1988T:p.E663V,LY75-CD302:NM_001198760:exon13:c.A1988T:p.E663V,LY75:NM_002349:exon13:c.A1988T:p.E663V	.	.	.	.	.	.	.	.	.	.	0.001	0.784	D	0.993	0.764	D	0.96	0.686	D	0.004	0.343	U	1.000	0.588	D	2.63	0.772	M	3.13	0.080	T	-5.39	0.850	D	0.49	0.545	-1.025	0.220	T	0.082	0.323	T	0.036	0.570	D	5.036	0.678	25.2	0.992	0.539	0.957	0.655	D	c	0.686	0.632	0.525	0.211	0.707	0.730	0	4.9	0.635	6.299	0.726	1.011	0.635	1.000	0.715	0.994	0.587	13.797	0.625	C-type lectin|C-type lectin fold|C-type lectin-like	.	.	0.5	.	28	2	160729091	chr2:160729091	T	A	.	PASS	DP=28;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	160958350	160958351	AA	-	intronic	ITGB6	.	.	.	1.91E-15	0.02690241	0.97309759	DISEASE: Amelogenesis imperfecta 1H (AI1H) [MIM:616221]: A disorder characterized by defective enamel formation, resulting in hypoplastic and hypomineralized tooth enamel that may be rough, pitted, and/or discolored. {ECO:0000269|PubMed:24305999, ECO:0000269|PubMed:24319098}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.49818	0.25886	-0.593358137	18.22953527	250.787	3.41252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	14	2	160958349	chr2:160958349	GAA	G	78	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.
2	166810161	166810161	-	CCCGCCCGCTCA	intronic	TTC21B	.	.	.	3.39E-22	0.098887146	0.901112854	DISEASE: Note=Ciliary dysfunction leads to a broad spectrum of disorders, collectively termed ciliopathies. Overlapping clinical features include retinal degeneration, renal cystic disease, skeletal abnormalities, fibrosis of various organ, and a complex range of anatomical and functional defects of the central and peripheral nervous system. The ciliopathy range of diseases includes Meckel-Gruber syndrome, Bardet-Biedl syndrome, Joubert syndrome, nephronophtisis, Senior-Loken syndrome, and Jeune asphyxiating thoracic dystrophy among others. TTC21B is causally associated with diverse ciliopathies, and also acts as a modifier gene across the ciliopathy spectrum. TTC21B mutations interact in trans with mutations in other ciliopathy-causing genes and contribute to disease manifestation and severity.; DISEASE: Nephronophthisis 12 (NPHP12) [MIM:613820]: An autosomal recessive disorder resulting in end-stage renal disease. It is a progressive tubulo-interstitial kidney disorder histologically characterized by modifications of the tubules with thickening of the basement membrane, interstitial fibrosis and, in the advanced stages, medullary cysts. Some patients manifest extra-renal features including retinal, skeletal and central nervous system defects. {ECO:0000269|PubMed:21258341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short-rib thoracic dysplasia 4 with or without polydactyly (SRTD4) [MIM:613819]: A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. {ECO:0000269|PubMed:21258341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bardet-Biedl syndrome (BBS) [MIM:209900]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:21258341}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Joubert syndrome 11 (JBTS11) [MIM:613820]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. {ECO:0000269|PubMed:21258341, ECO:0000269|PubMed:22425360}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.13531	0.09894	0.619029743	83.25666431	820.66154	5.62646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	122	94	2	166810161	chr2:166810161	G	GCCCGCCCGCTCA	122	PASS	DP=94;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	166929302	166929302	C	T	intronic	SCN1A	.	.	.	1	4.65E-10	1.62E-25	DISEASE: Generalized epilepsy with febrile seizures plus 2 (GEFS2) [MIM:604403]: A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity. {ECO:0000269|PubMed:10742094, ECO:0000269|PubMed:11254444, ECO:0000269|PubMed:11254445, ECO:0000269|PubMed:11524484, ECO:0000269|PubMed:11756608, ECO:0000269|PubMed:12535936, ECO:0000269|PubMed:12576172, ECO:0000269|PubMed:12919402, ECO:0000269|PubMed:14672992, ECO:0000269|PubMed:15525788, ECO:0000269|PubMed:15694566, ECO:0000269|PubMed:15715999, ECO:0000269|PubMed:16525050, ECO:0000269|PubMed:17347258, ECO:0000269|PubMed:17507202, ECO:0000269|PubMed:17561957, ECO:0000269|PubMed:17927801, ECO:0000269|PubMed:18251839, ECO:0000269|PubMed:18413471, ECO:0000269|PubMed:18566737, ECO:0000269|PubMed:19339291, ECO:0000269|PubMed:19464195, ECO:0000269|PubMed:19522081, ECO:0000269|PubMed:20117752, ECO:0000269|PubMed:20550552, ECO:0000269|PubMed:20600615, ECO:0000269|PubMed:20729507, ECO:0000269|PubMed:21248271, ECO:0000269|PubMed:21864321}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epileptic encephalopathy, early infantile, 6 (EIEE6) [MIM:607208]: A severe form of epileptic encephalopathy characterized by generalized tonic, clonic, and tonic-clonic seizures that are initially induced by fever and begin during the first year of life. Later, patients also manifest other seizure types, including absence, myoclonic, and simple and complex partial seizures. Psychomotor development delay is observed around the second year of life. Some patients manifest a borderline disease phenotype and do not necessarily fulfill all diagnostic criteria for core EIEE6. EIEE6 is considered to be the most severe phenotype within the spectrum of generalized epilepsies with febrile seizures-plus. {ECO:0000269|PubMed:11359211, ECO:0000269|PubMed:12083760, ECO:0000269|PubMed:12566275, ECO:0000269|PubMed:12754708, ECO:0000269|PubMed:12821740, ECO:0000269|PubMed:14504318, ECO:0000269|PubMed:14738421, ECO:0000269|PubMed:15087100, ECO:0000269|PubMed:15944908, ECO:0000269|PubMed:16122630, ECO:0000269|PubMed:16458823, ECO:0000269|PubMed:16713920, ECO:0000269|PubMed:17054684, ECO:0000269|PubMed:17054685, ECO:0000269|PubMed:17129991, ECO:0000269|PubMed:17347258, ECO:0000269|PubMed:17561957, ECO:0000269|PubMed:18413471, ECO:0000269|PubMed:18639757, ECO:0000269|PubMed:18930999, ECO:0000269|PubMed:19522081, ECO:0000269|PubMed:19563458, ECO:0000269|PubMed:19589774, ECO:0000269|PubMed:19783390, ECO:0000269|PubMed:20110217, ECO:0000269|PubMed:20431604, ECO:0000269|PubMed:20452746, ECO:0000269|PubMed:20522430, ECO:0000269|PubMed:20729507, ECO:0000269|PubMed:21248271, ECO:0000269|PubMed:21864321, ECO:0000269|PubMed:22092154, ECO:0000269|PubMed:22612257, ECO:0000269|PubMed:23195492}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intractable childhood epilepsy with generalized tonic- clonic seizures (ICEGTC) [MIM:607208]: A disorder characterized by generalized tonic-clonic seizures beginning usually in infancy and induced by fever. Seizures are associated with subsequent mental decline, as well as ataxia or hypotonia. ICEGTC is similar to SMEI, except for the absence of myoclonic seizures. {ECO:0000269|PubMed:12566275, ECO:0000269|PubMed:16210358, ECO:0000269|PubMed:17507202, ECO:0000269|PubMed:23195492}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Migraine, familial hemiplegic, 3 (FHM3) [MIM:609634]: A subtype of migraine associated with transient blindness in some families. Migraine is a disabling symptom complex of periodic headaches, usually temporal and unilateral. Headaches are often accompanied by irritability, nausea, vomiting and photophobia, preceded by constriction of the cranial arteries. The two major subtypes are common migraine (migraine without aura) and classic migraine (migraine with aura). Classic migraine is characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred vision, hallucinations, vertigo, numbness and difficulty in concentrating and speaking. {ECO:0000269|PubMed:16054936, ECO:0000269|PubMed:17397047, ECO:0000269|PubMed:18021921, ECO:0000269|PubMed:19332696}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Febrile seizures, familial, 3A (FEB3A) [MIM:604403]: Seizures associated with febrile episodes in childhood without any evidence of intracranial infection or defined pathologic or traumatic cause. It is a common condition, affecting 2-5% of children aged 3 months to 5 years. The majority are simple febrile seizures (generally defined as generalized onset, single seizures with a duration of less than 30 minutes). Complex febrile seizures are characterized by focal onset, duration greater than 30 minutes, and/or more than one seizure in a 24 hour period. The likelihood of developing epilepsy following simple febrile seizures is low. Complex febrile seizures are associated with a moderately increased incidence of epilepsy. {ECO:0000269|PubMed:16326807, ECO:0000269|PubMed:19522081}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=SCN1A mutations may be involved in Panayiotopoulos syndrome, a benign age-related focal seizure disorder occurring in early and mid-childhood. It is characterized by seizures, often prolonged, with predominantly autonomic symptoms, and by an electroencephalogram that shows shifting and/or multiple foci, often with occipital predominance. Autonomic seizures in Panayiotopoulos syndrome consist of episodes of disturbed autonomic function with emesis as the predominant symptom. Cardiorespiratory arrest is exceptional. {ECO:0000269|PubMed:17679682, ECO:0000269|PubMed:19339291, ECO:0000269|PubMed:19522081}.; 	0.25753	0.21408	-1.429430352	4.028072659	148.17021	2.65241	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	2	166929302	chr2:166929302	C	T	.	PASS	DP=66;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	168931640	168931640	T	A	exonic	STK39	.	nonsynonymous SNV	STK39:NM_013233:exon11:c.A1191T:p.K397N	0.999462431	0.000537568	4.72E-10	.	0.35513	0.21966	-0.337894035	30.37272942	4051.69126	12.61535	0.14	0.256	T	0.085	0.233	B	0.032	0.208	B	0.000	0.843	D	1.000	0.504	D	1.65	0.424	L	-0.79	0.737	T	-2.49	0.542	N	0.274	0.332	-0.867	0.508	T	0.253	0.624	T	0.031	0.536	D	2.931	0.413	22.0	0.997	0.778	0.895	0.498	D	c	-0.375	-0.259	0.927	0.268	0.693	0.558	0	1.73	0.235	0.292	0.186	-0.121	0.113	0.993	0.376	0.989	0.536	9.350	0.371	.	.	.	0.5	.	64	2	168931640	chr2:168931640	T	A	.	PASS	DP=64;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	169830401	169830401	C	G	intronic	ABCB11	.	.	.	2.19E-10	0.998263927	0.001736073	DISEASE: Cholestasis, progressive familial intrahepatic, 2 (PFIC2) [MIM:601847]: A disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. {ECO:0000269|PubMed:10579978, ECO:0000269|PubMed:11815775, ECO:0000269|PubMed:24969679, ECO:0000269|PubMed:9806540}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cholestasis, benign recurrent intrahepatic, 2 (BRIC2) [MIM:605479]: A disorder characterized by intermittent episodes of cholestasis without progression to liver failure. There is initial elevation of serum bile acids, followed by cholestatic jaundice which generally spontaneously resolves after periods of weeks to months. The cholestatic attacks vary in severity and duration. Patients are asymptomatic between episodes, both clinically and biochemically. {ECO:0000269|PubMed:15300568, ECO:0000269|PubMed:16039748}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10912	0.39265	-1.140954241	6.387119604	532.30214	4.70663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	41	2	169830401	chr2:169830401	C	G	43	PASS	DP=41;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	169984066	169984066	C	A	UTR3	LRP2	NM_004525:c.*1107G>T	.	.	1	1.49E-12	3.66E-46	.	0.64775	0.54233	3.324377969	99.4220335	2032.71856	8.29976	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	2	169984066	chr2:169984066	C	A	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	172582125	172582125	C	G	intronic	DYNC1I2	.	.	.	5.19E-07	0.960355697	0.039643784	.	0.2141	0.19929	-0.582225231	18.44184949	26.9112	0.86987	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	30	2	172582125	chr2:172582125	C	G	70	PASS	DP=30;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	172943939	172943939	-	T	intronic	METAP1D	.	.	.	1.56E-06	0.404676324	0.59532212	.	.	.	-0.093566408	46.7386176	1129.38456	6.41406	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	20	2	172943939	chr2:172943939	G	GT	41	PASS	DP=20;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	173341108	173341108	C	T	intronic	ITGA6	.	.	.	0.009913603	0.990086247	1.50E-07	DISEASE: Epidermolysis bullosa letalis, with pyloric atresia (EB- PA) [MIM:226730]: An autosomal recessive, frequently lethal, epidermolysis bullosa with variable involvement of skin, nails, mucosa, and with variable effects on the digestive system. It is characterized by mucocutaneous fragility, aplasia cutis congenita, and gastrointestinal atresia, which most commonly affects the pylorus. Pyloric atresia is a primary manifestation rather than a scarring process secondary to epidermolysis bullosa. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.61813	0.48979	0.249861693	69.66265629	3306.75309	10.97922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	2	173341108	chr2:173341108	C	T	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	174829848	174829848	G	A	intronic	SP3	.	.	.	0.992297744	0.007701944	3.12E-07	.	0.96279	0.19114	-0.067881249	48.69072895	885.01092	5.79517	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	2357	2	174829848	chr2:174829848	G	A	110	PASS	DP=2357;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	174908994	174908994	G	A	intergenic	LINC01960;OLA1	dist=17109;dist=28181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	230	2	174908994	chr2:174908994	G	A	65	PASS	DP=230;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	175199798	175199798	C	T	upstream	SP9	dist=23	.	.	0.498147938	0.428018312	0.07383375	.	.	.	.	.	26.65009	0.86255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	971	2	175199798	chr2:175199798	C	T	85	PASS	DP=971;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	175200556	175200556	G	T	intronic	SP9	.	.	.	0.498147938	0.428018312	0.07383375	.	.	.	.	.	26.65009	0.86255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	431	2	175200556	chr2:175200556	G	T	107	PASS	DP=431;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	175992041	175992041	T	C	intronic	ATF2	.	.	.	0.892244393	0.107746406	9.20E-06	.	0.88198	0.28104	-0.714505427	14.4019816	21.91257	0.73683	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	286	2	175992041	chr2:175992041	T	C	74	PASS	DP=286;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	176959252	176959252	G	A	exonic	HOXD13	.	nonsynonymous SNV	HOXD13:NM_000523:exon2:c.G826A:p.G276R	0.332069485	0.652799793	0.015130721	DISEASE: Synpolydactyly 1 (SPD1) [MIM:186000]: Limb malformation that shows a characteristic manifestation in both hands and feet. This condition is inherited as an autosomal dominant trait with reduced penetrance. {ECO:0000269|PubMed:12414828, ECO:0000269|PubMed:8817328}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brachydactyly D (BDD) [MIM:113200]: A form of brachydactyly. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. Brachydactyly type D is characterized by short and broad terminal phalanges of the thumbs and big toes. {ECO:0000269|PubMed:12649808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Syndactyly 5 (SDTY5) [MIM:186300]: A form of syndactyly, a congenital anomaly of the hand or foot marked by persistence of the webbing between adjacent digits that are more or less completely attached. The characteristic finding in SDTY5 is the presence of an associated metacarpal and metatarsal fusion. The metacarpals and metatarsals most commonly fused are the 4th and 5th or the 3rd and 4th. Soft tissue syndactyly usually affects the 3rd and 4th fingers and the 2nd and 3rd toes. {ECO:0000269|PubMed:17236141}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brachydactyly-syndactyly syndrome (BDSD) [MIM:610713]: A disease characterized by generalized shortening of the hands and feet, broad and short distal phalanges of the thumbs, and cutaneous syndactyly of toes 2 and 3. The limb phenotypes observed in this syndrome overlap those of brachydactyly types A4, D, E and syndactyly type 1. {ECO:0000269|PubMed:17236141}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brachydactyly E1 (BDE1) [MIM:113300]: A form of brachydactyly. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. Brachydactyly type E is characterized by shortening of the fingers mainly in the metacarpals and metatarsals. Wide variability in the number of digits affected occurs from person to person, even in the same family. Some individuals are moderately short of stature. Brachydactyly type E1 is characterized by shortening limited to fourth metacarpals and/or metatarsals. {ECO:0000269|PubMed:12649808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: VACTERL association (VACTERL) [MIM:192350]: VACTERL is an acronym for vertebral anomalies, anal atresia, congenital cardiac disease, tracheoesophageal fistula, renal anomalies, radial dysplasia, and other limb defects. {ECO:0000269|PubMed:19006232}. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.83205	0.40904	-0.095386216	46.48502005	95.62533	2.11131	0.0	0.912	D	0.999	0.764	D	0.995	0.818	D	0.000	0.629	D	1	0.810	D	2.85	0.831	M	-3.7	0.954	D	-7.39	0.947	D	0.736	0.733	1.059	0.983	D	0.931	0.977	D	0.323	0.916	D	6.386	0.882	29.5	0.999	0.992	0.989	0.876	D	c	0.936	0.880	1.0	0.983	0.598	0.340	0	4.99	0.658	9.602	0.976	1.048	0.713	1.000	0.715	0.962	0.444	18.830	0.921	Homeobox domain|Homeodomain-like	.	.	0.5	.	18	2	176959252	chr2:176959252	G	A	.	PASS	DP=18;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	176965470	176965470	G	T	exonic	HOXD12	.	nonsynonymous SNV	HOXD12:NM_021193:exon2:c.G795T:p.Q265H	0.003345917	0.610026817	0.386627266	.	0.8886	0.19255	0.395088462	76.15003539	604.16052	4.97604	0.242	0.176	T	0.126	0.253	B	0.041	0.226	B	0.000	0.559	D	0.993	0.810	D	1.06	0.271	L	-3.25	0.935	D	-1.16	0.297	N	0.435	0.490	-0.329	0.742	T	0.587	0.852	D	0.064	0.693	D	2.791	0.396	21.3	0.991	0.526	0.903	0.511	D	c	-0.349	-0.215	0.941	0.274	0.598	0.340	0	1.68	0.231	1.051	0.298	-0.189	0.103	1.000	0.715	0.975	0.474	8.264	0.308	.	.	.	0.5	.	108	2	176965470	chr2:176965470	G	T	.	PASS	DP=108;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	176973700	176973700	C	A	exonic	HOXD11	.	nonsynonymous SNV	HOXD11:NM_021192:exon2:c.C847A:p.R283S	0.013189848	0.661759099	0.325051053	.	0.23968	.	.	.	52.05051	1.42475	0.0	0.912	D	0.979	0.571	D	0.981	0.736	D	0.003	0.349	U	1	0.810	D	0.925	0.236	L	-3.95	0.962	D	-4.99	0.822	D	0.835	0.822	0.988	0.970	D	0.898	0.966	D	0.161	0.842	D	7.025	0.938	33	0.998	0.852	0.926	0.559	D	c	0.634	0.642	1.000	0.747	0.598	0.340	0	5.42	0.786	3.912	0.559	0.911	0.421	1.000	0.715	1.000	0.888	14.107	0.645	Homeobox domain|Homeodomain-like	.	.	0.5	115	268	2	176973700	chr2:176973700	C	A	115	PASS	DP=268;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	178081499	178081499	G	T	exonic	HNRNPA3	.	stopgain	HNRNPA3:NM_001330247:exon6:c.G673T:p.G225X,HNRNPA3:NM_001330248:exon6:c.G673T:p.G225X,HNRNPA3:NM_001330249:exon6:c.G739T:p.G247X,HNRNPA3:NM_001330250:exon6:c.G739T:p.G247X,HNRNPA3:NM_001330251:exon6:c.G739T:p.G247X,HNRNPA3:NM_194247:exon6:c.G739T:p.G247X	0.99264494	0.007353682	1.38E-06	.	0.36128	0.0925	-0.273576253	33.97027601	10.21749	0.3726	.	.	.	.	.	.	.	.	.	0.000	0.439	U	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.756	0.977	38	0.987	0.447	0.924	0.553	D	c	0.695	0.507	1.000	0.747	0.722	0.854	0	3.54	0.395	6.591	0.738	0.067	0.174	1.000	0.715	0.996	0.625	12.837	0.570	Nucleotide-binding alpha-beta plait domain	.	.	0.5	74	97	2	178081499	chr2:178081499	G	T	74	PASS	DP=97;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	178092595	178092595	T	C	intergenic	HNRNPA3;NFE2L2	dist=3908;dist=2436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	302	2	178092595	chr2:178092595	T	C	83	PASS	DP=302;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	178682626	178682626	C	G	exonic	PDE11A	.	nonsynonymous SNV	PDE11A:NM_001077196:exon5:c.G271C:p.D91H,PDE11A:NM_001077358:exon7:c.G529C:p.D177H,PDE11A:NM_016953:exon8:c.G1603C:p.D535H,PDE11A:NM_001077197:exon9:c.G853C:p.D285H	4.17E-31	4.13E-06	0.999995868	DISEASE: Primary pigmented nodular adrenocortical disease 2 (PPNAD2) [MIM:610475]: A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Adrenal glands show overall normal size and weight, and multiple small yellow-to-dark brown nodules surrounded by a cortex with a uniform appearance. Microscopically, there are moderate diffuse cortical hyperplasia with mostly nonpigmented nodules, multiple capsular deficits and massive circumscribed and infiltrating extra-adrenal cortical excrescences with micronodules. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269|PubMed:16767104}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23385	0.14082	0.764222299	86.86010852	1086.94608	6.31598	0.006	0.614	D	1.0	0.899	D	0.991	0.818	D	0.000	0.843	D	1	0.810	D	2.13	0.595	M	-0.27	0.674	T	-4.18	0.755	D	0.857	0.872	-0.678	0.615	T	0.313	0.683	T	0.017	0.394	T	6.515	0.898	31	0.995	0.650	0.986	0.845	D	c	0.353	0.458	1.000	0.747	0.487	0.133	0	5.58	0.843	7.834	0.848	0.920	0.431	1.000	0.715	0.996	0.625	18.355	0.903	GAF domain|GAF domain-like	.	.	0.5	82	21	2	178682626	chr2:178682626	C	G	82	PASS	DP=21;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	179321703	179321703	-	T	ncRNA_intronic	MIR548N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	351	2	179321703	chr2:179321703	A	AT	88	PASS	DP=351;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	179357189	179357189	G	A	ncRNA_intronic	MIR548N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	2	179357189	chr2:179357189	G	A	.	PASS	DP=35;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	182775402	182775402	-	T	intronic	SSFA2	.	.	.	7.68E-05	0.999757987	0.000165174	.	0.16545	0.10002	0.235100429	68.59518754	2237.71105	8.72526	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	194	2	182775402	chr2:182775402	G	GT	69	PASS	DP=194;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	183841692	183841692	A	-	intronic	NCKAP1	.	.	.	0.999999991	9.29E-09	5.84E-21	.	0.53149	0.18619	-1.199555187	5.761972163	23.37723	0.77966	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	124	244	2	183841691	chr2:183841691	GA	G	124	PASS	DP=244;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	186629349	186629349	G	A	intronic	FSIP2	.	.	.	3.22E-08	0.999967049	3.29E-05	.	0.05212	0.07622	.	.	5663.99441	15.56525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	101	40	2	186629349	chr2:186629349	G	A	101	PASS	DP=40;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	186692860	186692860	T	-	intronic	FSIP2	.	.	.	3.22E-08	0.999967049	3.29E-05	.	0.05212	0.07622	.	.	5663.99441	15.56525	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	29	2	186692859	chr2:186692859	CT	C	74	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	189393929	189393929	-	T	intronic	GULP1	.	.	.	0.67755775	0.321474383	0.000967867	.	0.49297	0.14271	-0.229483771	36.86010852	19.84674	0.67647	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	169	2	189393929	chr2:189393929	C	CT	63	PASS	DP=169;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	190925148	190925148	C	A	exonic	MSTN	.	nonsynonymous SNV	MSTN:NM_005259:exon2:c.G387T:p.M129I	0.812914736	0.186112611	0.000972653	DISEASE: Muscle hypertrophy (MSLHP) [MIM:614160]: A condition characterized by increased muscle bulk and strength. Affected individuals are exceptionally strong. {ECO:0000269|PubMed:15215484}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.83937	0.74393	0.663285274	84.55414013	913.77022	5.87603	0.271	0.160	T	0.0	0.026	B	0.0	0.013	B	0.001	0.407	D	0.830	0.287	N	0	0.065	N	-0.1	0.643	T	0.39	0.035	N	0.159	0.191	-1.014	0.256	T	0.104	0.382	T	0.017	0.383	T	0.556	0.147	7.847	0.856	0.154	0.207	0.209	N	c	-0.737	-0.579	0.991	0.323	0.487	0.133	0	4.89	0.632	0.051	0.139	0.059	0.165	0.029	0.202	0.947	0.422	6.745	0.225	Transforming growth factor-beta, N-terminal	.	.	0.5	.	60	2	190925148	chr2:190925148	C	A	.	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	196891589	196891589	C	T	exonic	DNAH7	.	nonsynonymous SNV	DNAH7:NM_018897:exon7:c.G562A:p.V188I	1.04E-47	0.815068072	0.184931928	.	0.23862	0.10363	5.09315636	99.81717386	6415.17778	16.77483	1.0	0.096	T	0.027	0.182	B	0.019	0.176	B	0.000	0.523	D	1.000	0.513	D	1.035	0.257	L	2.2	0.186	T	-0.04	0.140	N	0.328	0.471	-1.074	0.085	T	0.038	0.165	T	0.004	0.088	T	1.570	0.250	13.69	0.997	0.773	0.789	0.387	D	c	-0.416	-0.236	1.000	0.415	0.487	0.133	0	5.92	0.955	1.692	0.371	0.935	0.490	0.951	0.329	0.208	0.219	19.912	0.970	.	.	.	0.5	78	139	2	196891589	chr2:196891589	C	T	78	PASS	DP=139;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	197786924	197786924	A	G	intronic	PGAP1	.	.	.	0.008785882	0.991209738	4.38E-06	DISEASE: Mental retardation, autosomal recessive 42 (MRT42) [MIM:615802]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:24784135}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24265	.	-0.666770504	15.86459071	57.58899	1.53274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	88	39	2	197786924	chr2:197786924	A	G	88	PASS	DP=39;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	198324874	198324874	C	T	intronic	COQ10B	.	.	.	0.140032717	0.840396564	0.01957072	.	0.12177	0.11803	0.014844891	54.94810097	6.81651	0.25234	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	14	2	198324874	chr2:198324874	C	T	.	PASS	DP=14;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	198362018	198362018	T	C	exonic	HSPD1	.	synonymous SNV	HSPD1:NM_002156:exon3:c.A273G:p.K91K,HSPD1:NM_199440:exon3:c.A273G:p.K91K	0.985208244	0.01479021	1.55E-06	DISEASE: Spastic paraplegia 13, autosomal dominant (SPG13) [MIM:605280]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:11898127}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukodystrophy, hypomyelinating, 4 (HLD4) [MIM:612233]: A severe autosomal recessive hypomyelinating leukodystrophy. Clinically characterized by infantile-onset rotary nystagmus, progressive spastic paraplegia, neurologic regression, motor impairment, profound mental retardation. Death usually occurs within the first two decades of life. {ECO:0000269|PubMed:18571143}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.9786	0.9809	-0.203796826	38.81811748	89.54005	2.03508	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	14	2	198362018	chr2:198362018	T	C	73	PASS	DP=14;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	200134445	200134445	G	A	UTR3	SATB2	NM_001172509:c.*2489C>T;NM_001172517:c.*2489C>T;NM_015265:c.*2489C>T	.	.	0.999563007	0.000436992	1.41E-09	DISEASE: Note=Chromosomal aberrations involving SATB2 are found in isolated cleft palate. Translocation t(2;7); translocation t(2;11). {ECO:0000269|PubMed:12915443}.; DISEASE: Cleft palate isolated (CPI) [MIM:119540]: A congenital fissure of the soft and/or hard palate, due to faulty fusion. Isolated cleft palate is not associated with cleft lips. Some patients may manifest other craniofacial dysmorphic features, mental retardation, and osteoporosis. {ECO:0000269|PubMed:12915443, ECO:0000269|PubMed:17377962}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving SATB2 is found in a patient with classical features of Toriello-Carey syndrome. Translocation t(2;14)(q33;q22). {ECO:0000269|PubMed:19170718}.; 	0.90767	.	-0.868835007	10.65109696	18.7762	0.64879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	2	200134445	chr2:200134445	G	A	.	PASS	DP=48;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	200134452	200134452	G	A	UTR3	SATB2	NM_001172509:c.*2482C>T;NM_001172517:c.*2482C>T;NM_015265:c.*2482C>T	.	.	0.999563007	0.000436992	1.41E-09	DISEASE: Note=Chromosomal aberrations involving SATB2 are found in isolated cleft palate. Translocation t(2;7); translocation t(2;11). {ECO:0000269|PubMed:12915443}.; DISEASE: Cleft palate isolated (CPI) [MIM:119540]: A congenital fissure of the soft and/or hard palate, due to faulty fusion. Isolated cleft palate is not associated with cleft lips. Some patients may manifest other craniofacial dysmorphic features, mental retardation, and osteoporosis. {ECO:0000269|PubMed:12915443, ECO:0000269|PubMed:17377962}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving SATB2 is found in a patient with classical features of Toriello-Carey syndrome. Translocation t(2;14)(q33;q22). {ECO:0000269|PubMed:19170718}.; 	0.90767	.	-0.868835007	10.65109696	18.7762	0.64879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	2	200134452	chr2:200134452	G	A	.	PASS	DP=44;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	200136195	200136195	T	-	UTR3	SATB2	NM_001172509:c.*739delA;NM_001172517:c.*739delA;NM_015265:c.*739delA	.	.	0.999563007	0.000436992	1.41E-09	DISEASE: Note=Chromosomal aberrations involving SATB2 are found in isolated cleft palate. Translocation t(2;7); translocation t(2;11). {ECO:0000269|PubMed:12915443}.; DISEASE: Cleft palate isolated (CPI) [MIM:119540]: A congenital fissure of the soft and/or hard palate, due to faulty fusion. Isolated cleft palate is not associated with cleft lips. Some patients may manifest other craniofacial dysmorphic features, mental retardation, and osteoporosis. {ECO:0000269|PubMed:12915443, ECO:0000269|PubMed:17377962}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving SATB2 is found in a patient with classical features of Toriello-Carey syndrome. Translocation t(2;14)(q33;q22). {ECO:0000269|PubMed:19170718}.; 	0.90767	.	-0.868835007	10.65109696	18.7762	0.64879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	120	2	200136194	chr2:200136194	CT	C,CTT	57	PASS	DP=120;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/1	./.
2	200136195	200136195	-	T	UTR3	SATB2	NM_001172509:c.*738_*739insA;NM_001172517:c.*738_*739insA;NM_015265:c.*738_*739insA	.	.	0.999563007	0.000436992	1.41E-09	DISEASE: Note=Chromosomal aberrations involving SATB2 are found in isolated cleft palate. Translocation t(2;7); translocation t(2;11). {ECO:0000269|PubMed:12915443}.; DISEASE: Cleft palate isolated (CPI) [MIM:119540]: A congenital fissure of the soft and/or hard palate, due to faulty fusion. Isolated cleft palate is not associated with cleft lips. Some patients may manifest other craniofacial dysmorphic features, mental retardation, and osteoporosis. {ECO:0000269|PubMed:12915443, ECO:0000269|PubMed:17377962}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving SATB2 is found in a patient with classical features of Toriello-Carey syndrome. Translocation t(2;14)(q33;q22). {ECO:0000269|PubMed:19170718}.; 	0.90767	.	-0.868835007	10.65109696	18.7762	0.64879	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	120	2	200136194	chr2:200136194	CT	C,CTT	57	PASS	DP=120;AN=4	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	0/1	./.
2	201362423	201362423	-	T	intronic	KCTD18	.	.	.	0.000526111	0.886183067	0.113290821	.	0.22561	.	0.621009802	83.41589998	721.00753	5.33094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	102	2	201362423	chr2:201362423	C	CT	62	PASS	DP=102;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	201950166	201950166	-	T	intronic	NDUFB3	.	.	.	0.042565284	0.660300175	0.29713454	.	0.07174	.	0.21326276	67.71644256	9.41646	0.34679	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	27	2	201950166	chr2:201950166	C	CT	43	PASS	DP=27;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	202483804	202483804	C	A	exonic	C2CD6	.	nonsynonymous SNV	C2CD6:NM_001168216:exon1:c.G50T:p.R17L,C2CD6:NM_001168217:exon1:c.G50T:p.R17L,C2CD6:NM_001168221:exon1:c.G50T:p.R17L,C2CD6:NM_152525:exon1:c.G50T:p.R17L	.	.	.	.	.	.	.	.	.	.	0.019	0.518	D	0.892	0.518	P	0.253	0.418	B	0.765	0.066	N	1	0.090	N	0.695	0.181	N	0.16	0.609	T	-2.19	0.545	N	0.233	0.386	-0.916	0.461	T	0.129	0.439	T	0.028	0.508	D	3.667	0.498	23.2	0.942	0.238	0.068	0.127	N	c	-0.961	-1.208	1.000	0.467	0.422	0.057	0	-4.53	0.032	-0.948	0.040	0.069	0.176	0.000	0.063	0.001	0.043	5.306	0.150	.	.	.	0.5	113	492	2	202483804	chr2:202483804	C	A	113	PASS	DP=492;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	202978199	202978199	T	-	ncRNA_intronic	LOC729224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	328	2	202978198	chr2:202978198	GT	G	82	PASS	DP=328;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	204055840	204055840	T	C	intronic	NBEAL1	.	.	.	1.09E-10	0.999998397	1.60E-06	.	0.41452	0.09301	1.192277263	92.85208776	746.62671	5.42052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	150	2	204055840	chr2:204055840	T	C	87	PASS	DP=150;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
2	204354507	204354507	C	T	exonic	RAPH1	.	nonsynonymous SNV	RAPH1:NM_001329728:exon4:c.G532A:p.D178N,RAPH1:NM_203365:exon4:c.G532A:p.D178N,RAPH1:NM_213589:exon4:c.G532A:p.D178N	0.957851233	0.042148732	3.46E-08	.	0.25984	0.27016	-2.607452819	0.807973579	124.99766	2.43194	0.206	0.682	T	0.804	0.432	P	0.173	0.396	B	0.011	0.299	N	1.000	0.499	D	1.25	0.319	L	0.96	0.460	T	-1.6	0.416	N	0.047	0.043	-0.976	0.360	T	0.113	0.404	T	0.008	0.207	T	2.994	0.420	22.2	0.998	0.882	0.936	0.583	D	c	0.129	0.220	1.000	0.747	0.707	0.730	0	5.33	0.756	2.720	0.467	0.852	0.362	1.000	0.715	0.965	0.450	19.022	0.929	.	.	.	0.5	58	72	2	204354507	chr2:204354507	C	T	58	PASS	DP=72;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	205989177	205989177	A	-	exonic	PARD3B	.	frameshift deletion	PARD3B:NM_001302769:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_057177:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_152526:exon9:c.1292delA:p.D431Afs*5,PARD3B:NM_205863:exon9:c.1292delA:p.D431Afs*5	8.65E-08	0.999805592	0.000194321	.	0.48627	0.09509	0.126687467	62.75064874	840.37721	5.67705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	56	2	205989176	chr2:205989176	GA	G	100	PASS	DP=56;AN=2	GT	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.	./.
2	206581007	206581007	C	T	exonic	NRP2	.	synonymous SNV	NRP2:NM_003872:exon3:c.C342T:p.I114I,NRP2:NM_018534:exon3:c.C342T:p.I114I,NRP2:NM_201264:exon3:c.C342T:p.I114I,NRP2:NM_201266:exon3:c.C342T:p.I114I,NRP2:NM_201267:exon3:c.C342T:p.I114I,NRP2:NM_201279:exon3:c.C342T:p.I114I	0.00171165	0.998241695	4.67E-05	.	0.30972	0.15109	-1.080231599	7.277659825	168.69076	2.83534	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	2	206581007	chr2:206581007	C	T	.	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	206581012	206581012	C	T	exonic	NRP2	.	nonsynonymous SNV	NRP2:NM_003872:exon3:c.C347T:p.S116L,NRP2:NM_018534:exon3:c.C347T:p.S116L,NRP2:NM_201264:exon3:c.C347T:p.S116L,NRP2:NM_201266:exon3:c.C347T:p.S116L,NRP2:NM_201267:exon3:c.C347T:p.S116L,NRP2:NM_201279:exon3:c.C347T:p.S116L	0.00171165	0.998241695	4.67E-05	.	0.30972	0.15109	-1.080231599	7.277659825	168.69076	2.83534	0.007	0.632	D	0.999	0.764	D	0.903	0.623	P	0.000	0.843	D	1	0.810	D	1.91	0.513	L	2.14	0.194	T	-3.01	0.693	D	0.798	0.858	-0.964	0.385	T	0.150	0.478	T	0.106	0.782	D	7.796	0.955	35	0.999	0.997	0.968	0.710	D	c	0.880	0.892	1.0	0.983	0.758	0.990	0	6.17	0.997	7.905	0.864	0.935	0.490	1.000	0.715	0.961	0.442	20.879	0.999	CUB domain	.	.	0.5	.	61	2	206581012	chr2:206581012	C	T	.	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	208602115	208602115	-	T	intronic	CCNYL1	.	.	.	0.977770144	0.022209066	2.08E-05	.	0.62342	0.07638	-0.361761279	28.6329323	44.05929	1.26436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	25	2	208602115	chr2:208602115	A	AT	40	PASS	DP=25;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	209028006	209028006	C	A	exonic	CRYGA	.	synonymous SNV	CRYGA:NM_014617:exon2:c.G174T:p.L58L	0.000127117	0.626172346	0.373700537	.	0.16773	0.13686	0.016664174	55.21939137	30.09915	0.96006	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	326	2	209028006	chr2:209028006	C	A	96	PASS	DP=326;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	209223082	209223083	TA	-	UTR3	PIKFYVE	NM_015040:c.*3053_*3054delTA	.	.	0.979802749	0.020197251	5.32E-18	DISEASE: Corneal dystrophy, fleck (CFD) [MIM:121850]: A form of stromal corneal dystrophy characterized by numerous small white flecks scattered in all levels of the stroma, with configurations varying from semicircular to wreath-like, curvilinear, or punctate. Although CFD may occasionally cause mild photophobia, patients are typically asymptomatic and have normal vision. {ECO:0000269|PubMed:15902656}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.40145	0.43176	-1.400183431	4.163717858	374.82497	4.08231	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40.05	19	2	209223081	chr2:209223081	TTA	T	40.05	PASS	DP=19;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	210737613	210737613	G	T	exonic	UNC80	.	synonymous SNV	UNC80:NM_032504:exon23:c.G3765T:p.R1255R,UNC80:NM_182587:exon23:c.G3750T:p.R1250R	0.139839111	0.85601101	0.00414988	.	0.61288	.	0.992010122	90.49893843	987.20517	6.05851	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	340	2	210737613	chr2:210737613	G	T	68	PASS	DP=340;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	213878595	213878595	G	A	exonic	IKZF2	.	nonsynonymous SNV	IKZF2:NM_016260:exon7:c.C776T:p.P259L,IKZF2:NM_001079526:exon8:c.C698T:p.P233L	0.922956764	0.077024112	1.91E-05	.	0.91208	0.17129	0.020302773	55.60863411	105.57661	2.22656	0.011	0.599	D	0.039	0.384	B	0.051	0.310	B	0.000	0.843	D	1.000	0.810	D	1.7	0.440	L	3.14	0.079	T	-2.77	0.587	D	0.767	0.767	-1.131	0.017	T	0.033	0.140	T	0.019	0.416	T	5.945	0.816	27.6	0.996	0.728	0.979	0.777	D	c	0.267	0.431	1.000	0.747	0.628	0.401	0	5.54	0.828	6.278	0.724	1.048	0.713	1.000	0.715	1.000	0.888	15.345	0.739	.	.	.	0.5	76	212	2	213878595	chr2:213878595	G	A	76	PASS	DP=212;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	215851354	215851354	C	T	exonic	ABCA12	.	nonsynonymous SNV	ABCA12:NM_015657:exon20:c.G3121A:p.V1041I,ABCA12:NM_173076:exon28:c.G4075A:p.V1359I	2.02E-07	0.999999798	2.70E-13	DISEASE: Ichthyosis, congenital, autosomal recessive 4A (ARCI4A) [MIM:601277]: A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. {ECO:0000269|PubMed:12915478, ECO:0000269|PubMed:17508018, ECO:0000269|PubMed:18284401, ECO:0000269|PubMed:19262603, ECO:0000269|PubMed:22257947}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ichthyosis, congenital, autosomal recessive 4B (ARCI4B) [MIM:242500]: A rare, very severe form of congenital ichthyosis, in which the neonate is born with a thick covering of armor-like scales. The skin dries out to form hard diamond-shaped plaques separated by fissures, resembling 'armor plating'. The normal facial features are severely affected, with distortion of the lips (eclabion), eyelids (ectropion), ears, and nostrils. Affected babies are often born prematurely and rarely survive the perinatal period. Babies who survive into infancy and beyond develop skin changes resembling severe non-bullous congenital ichthyosiform erythroderma. {ECO:0000269|PubMed:15756637, ECO:0000269|PubMed:16675967, ECO:0000269|PubMed:16902423}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16262	0.15786	-0.299763455	32.26586459	2992.15591	10.38229	0.413	0.100	T	0.0	0.067	B	0.001	0.093	B	0.358	0.137	N	0.999	0.213	N	0.225	0.096	N	-3.24	0.935	D	-0.7	0.199	N	0.061	0.077	-0.509	0.683	T	0.545	0.833	D	0.032	0.539	D	2.069	0.310	16.65	0.968	0.308	0.210	0.210	N	c	-0.677	-0.544	0.001	0.081	0.693	0.558	0	1.25	0.204	0.583	0.234	-0.170	0.106	0.415	0.261	0.862	0.360	7.885	0.286	ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	44	2	215851354	chr2:215851354	C	T	.	PASS	DP=44;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	216967385	216967385	-	A	UTR3	TMEM169	NM_001142311:c.*2120_*2121insA;NM_001142310:c.*2120_*2121insA;NM_138390:c.*2120_*2121insA;NM_001142312:c.*2120_*2121insA	.	.	0.011784537	0.847117338	0.141098125	.	0.08509	.	-0.492218069	22.35786742	116.65375	2.34953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	162	2	216967385	chr2:216967385	G	GA	53	PASS	DP=162;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	217288388	217288388	G	C	exonic	SMARCAL1	.	nonsynonymous SNV	SMARCAL1:NM_001127207:exon6:c.G1129C:p.E377Q,SMARCAL1:NM_014140:exon6:c.G1129C:p.E377Q	0.000314359	0.999152781	0.000532861	DISEASE: Schimke immuno-osseous dysplasia (SIOD) [MIM:242900]: Causes spondyloepiphyseal dysplasia, renal dysfunction and T-cell immunodeficiency. Approximately half of all patients also exhibit hyperthyroidism, while around half also exhibit episodal cerebral ischemia. {ECO:0000269|PubMed:11799392}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06763	0.12074	-0.126743121	44.0905874	1034.25533	6.17659	0.068	0.446	T	0.425	0.336	B	0.324	0.401	B	0.000	0.559	D	0.000	0.511	P	2.56	0.750	M	-0.8	0.739	T	-1.09	0.283	N	0.108	0.397	-0.870	0.506	T	0.005	0.018	T	.	.	.	4.871	0.654	24.9	0.997	0.801	0.986	0.847	D	c	0.387	0.461	1.000	0.747	0.707	0.730	0	4.54	0.551	5.668	0.675	1.048	0.713	1.000	0.715	0.999	0.750	13.416	0.602	HARP domain	.	.	0.5	117	61	2	217288388	chr2:217288388	G	C	117	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	218723107	218723107	G	C	intronic	TNS1	.	.	.	0.924939889	0.075060111	5.03E-11	.	0.49253	0.15564	1.585596299	95.81269167	8076.56687	19.41076	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	126	135	2	218723107	chr2:218723107	G	C	126	PASS	DP=135;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	219695497	219695497	C	T	exonic	PRKAG3	.	synonymous SNV	PRKAG3:NM_017431:exon3:c.G201A:p.E67E	9.67E-05	0.939090481	0.06081282	.	0.21868	0.15227	0.268267497	70.64166077	1227.80308	6.62527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	117	2	219695497	chr2:219695497	C	T	.	PASS	DP=117;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	219745839	219745839	T	C	intronic	WNT10A	.	.	.	0.010169289	0.943911812	0.045918899	DISEASE: Note=Defects in WNT10A may be a cause of hypohidrotic/anhidrotic ectodermal dysplasia, a disorder characterized by sparse hair (atrichosis or hypotrichosis), abnormal or missing teeth and the inability to sweat due to the absence of sweat glands. Most patients carrying WNT10A mutations present with sweating anomalies. However, comparison with cases harboring mutations in the ectodysplasin pathway identifies some phenotypic differences. Dermatological features (anomalies of hair and sweat glands) are less severe in patients carrying WNT10A mutations and facial dysmorphism can be absent. The dental phenotype consists in microdontia, whereas teeth agenesis is more frequent in patients carrying mutations in the ectodysplasin pathway. {ECO:0000269|PubMed:20979233}.; DISEASE: Odonto-onycho-dermal dysplasia (OODD) [MIM:257980]: A rare autosomal recessive ectodermal dysplasia characterized by dry hair, severe hypodontia, smooth tongue with marked reduction of fungiform and filiform papillae, onychodysplasia, keratoderma and hyperhidrosis of palms and soles, and hyperkeratosis of the skin. {ECO:0000269|PubMed:17847007, ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Schopf-Schulz-Passarge syndrome (SSPS) [MIM:224750]: A rare ectodermal dysplasia, characterized chiefly by cysts of the eyelid margins, palmoplantar keratoderma, hypodontia, hypotrichosis and nail dystrophy. Multiple eyelid apocrine hidrocystomas are the hallmark of this condition, although they usually appear in adulthood. The concomitant presence of eccrine syringofibroadenoma in most patients and of other adnexal skin tumors in some affected subjects indicates that Schopf-Schulz- Passarge syndrome is a genodermatosis with skin appendage neoplasms. {ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tooth agenesis selective 4 (STHAG4) [MIM:150400]: A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). In STHAG4, the upper lateral incisors are absent or peg-shaped. {ECO:0000269|PubMed:21484994, ECO:0000269|PubMed:22581971}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24339	0.20297	.	.	263.26685	3.48077	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	84	2	219745839	chr2:219745839	T	C	95	PASS	DP=84;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	219754817	219754817	G	T	exonic	WNT10A	.	nonsynonymous SNV	WNT10A:NM_025216:exon3:c.G488T:p.R163L	0.010169289	0.943911812	0.045918899	DISEASE: Note=Defects in WNT10A may be a cause of hypohidrotic/anhidrotic ectodermal dysplasia, a disorder characterized by sparse hair (atrichosis or hypotrichosis), abnormal or missing teeth and the inability to sweat due to the absence of sweat glands. Most patients carrying WNT10A mutations present with sweating anomalies. However, comparison with cases harboring mutations in the ectodysplasin pathway identifies some phenotypic differences. Dermatological features (anomalies of hair and sweat glands) are less severe in patients carrying WNT10A mutations and facial dysmorphism can be absent. The dental phenotype consists in microdontia, whereas teeth agenesis is more frequent in patients carrying mutations in the ectodysplasin pathway. {ECO:0000269|PubMed:20979233}.; DISEASE: Odonto-onycho-dermal dysplasia (OODD) [MIM:257980]: A rare autosomal recessive ectodermal dysplasia characterized by dry hair, severe hypodontia, smooth tongue with marked reduction of fungiform and filiform papillae, onychodysplasia, keratoderma and hyperhidrosis of palms and soles, and hyperkeratosis of the skin. {ECO:0000269|PubMed:17847007, ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Schopf-Schulz-Passarge syndrome (SSPS) [MIM:224750]: A rare ectodermal dysplasia, characterized chiefly by cysts of the eyelid margins, palmoplantar keratoderma, hypodontia, hypotrichosis and nail dystrophy. Multiple eyelid apocrine hidrocystomas are the hallmark of this condition, although they usually appear in adulthood. The concomitant presence of eccrine syringofibroadenoma in most patients and of other adnexal skin tumors in some affected subjects indicates that Schopf-Schulz- Passarge syndrome is a genodermatosis with skin appendage neoplasms. {ECO:0000269|PubMed:19559398}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Tooth agenesis selective 4 (STHAG4) [MIM:150400]: A form of selective tooth agenesis, a common anomaly characterized by the congenital absence of one or more teeth. Selective tooth agenesis without associated systemic disorders has sometimes been divided into 2 types: oligodontia, defined as agenesis of 6 or more permanent teeth, and hypodontia, defined as agenesis of less than 6 teeth. The number in both cases does not include absence of third molars (wisdom teeth). In STHAG4, the upper lateral incisors are absent or peg-shaped. {ECO:0000269|PubMed:21484994, ECO:0000269|PubMed:22581971}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.24339	0.20297	.	.	263.26685	3.48077	0.155	0.241	T	0.011	0.147	B	0.03	0.205	B	0.000	0.629	D	1	0.810	D	1.655	0.426	L	-1.02	0.763	T	-2.05	0.470	N	0.491	0.538	-0.455	0.702	T	0.364	0.725	T	0.097	0.767	D	4.530	0.607	24.3	0.993	0.588	0.974	0.742	D	c	-0.012	0.096	1.000	0.747	0.707	0.730	0	4.46	0.534	6.505	0.734	0.953	0.551	1.000	0.715	0.221	0.222	16.205	0.819	.	.	.	0.5	104	566	2	219754817	chr2:219754817	G	T	104	PASS	DP=566;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	219826587	219826587	G	T	UTR3	CDK5R2	NM_003936:c.*941G>T	.	.	.	.	.	.	0.44177	0.11161	.	.	35.94	1.07912	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	156	2	219826587	chr2:219826587	G	T	.	PASS	DP=156;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	220308816	220308816	C	-	intronic	SPEG	.	.	.	0.999790422	0.000209578	9.17E-21	DISEASE: Myopathy, centronuclear, 5 (CNM5) [MIM:615959]: A form of centronuclear myopathy, a congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers. CNM5 features include severe neonatal hypotonia with respiratory insufficiency, difficulty feeding, and delayed motor development. Some patients die in infancy, and some develop dilated cardiomyopathy. {ECO:0000269|PubMed:25087613}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.41136	0.12798	-0.055373944	48.92073602	8867.59165	20.31253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	67	2	220308815	chr2:220308815	TC	T	64	PASS	DP=67;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	220435104	220435104	C	T	exonic	OBSL1	.	nonsynonymous SNV	OBSL1:NM_001173408:exon1:c.G851A:p.R284H,OBSL1:NM_001173431:exon1:c.G851A:p.R284H,OBSL1:NM_015311:exon1:c.G851A:p.R284H	6.64E-16	0.777707244	0.222292756	.	0.18328	.	-0.814205844	12.01934418	4573.34304	13.56826	0.039	0.424	D	0.994	0.899	D	0.931	0.679	D	.	.	.	1	0.810	D	1.47	0.371	L	-0.63	0.720	T	-1.54	0.381	N	0.131	0.199	-0.603	0.647	T	0.264	0.635	T	0.264	0.897	D	3.453	0.473	23.0	0.999	0.960	0.053	0.111	N	c	-0.032	-0.137	1.000	0.517	0.455	0.088	0	1.41	0.214	0.003	0.129	0.036	0.152	0.000	0.063	0.976	0.476	7.173	0.247	Immunoglobulin I-set|Immunoglobulin subtype 2|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	.	85	2	220435104	chr2:220435104	C	T	.	PASS	DP=85;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	223163291	223163291	C	T	exonic	PAX3	.	nonsynonymous SNV	PAX3:NM_000438:exon1:c.G44A:p.G15D,PAX3:NM_001127366:exon1:c.G44A:p.G15D,PAX3:NM_013942:exon1:c.G44A:p.G15D,PAX3:NM_181457:exon1:c.G44A:p.G15D,PAX3:NM_181458:exon1:c.G44A:p.G15D,PAX3:NM_181459:exon1:c.G44A:p.G15D,PAX3:NM_181460:exon1:c.G44A:p.G15D,PAX3:NM_181461:exon1:c.G44A:p.G15D	0.900856133	0.099136457	7.41E-06	DISEASE: Waardenburg syndrome 1 (WS1) [MIM:193500]: WS1 is an autosomal dominant disorder characterized by non-progressive sensorineural deafness, pigmentary disturbances such as frontal white blaze of hair, heterochromia of irides, white eyelashes, leukoderma, and wide bridge of nose owing to lateral displacement of the inner canthus of each eye (dystopia canthorum). WS1 shows variable clinical expression and some affected individuals do not manifest hearing impairment or iris pigmentation disturbances. Dystopia canthorum is the most consistent sign and is found in 98% of the patients. {ECO:0000269|PubMed:10779847, ECO:0000269|PubMed:12949970, ECO:0000269|PubMed:1303193, ECO:0000269|PubMed:1347148, ECO:0000269|PubMed:1347149, ECO:0000269|PubMed:7825605, ECO:0000269|PubMed:7833953, ECO:0000269|PubMed:7981674, ECO:0000269|PubMed:8447316, ECO:0000269|PubMed:8490648, ECO:0000269|PubMed:8533800, ECO:0000269|PubMed:8589691, ECO:0000269|PubMed:8845842, ECO:0000269|PubMed:9067759, ECO:0000269|PubMed:9452070, ECO:0000269|PubMed:9541113, ECO:0000269|Ref.34}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Waardenburg syndrome 3 (WS3) [MIM:148820]: WS3 is an autosomal dominant disorder characterized by sensorineural deafness, pigmentary disturbances, dystopia canthorum and limb anomalies such as hypoplasia of the musculoskeletal system, flexion contractures, fusion of the carpal bones, syndactylies. {ECO:0000269|PubMed:12949970, ECO:0000269|PubMed:7726174, ECO:0000269|Ref.35}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Craniofacial-deafness-hand syndrome (CDHS) [MIM:122880]: Thought to be an autosomal dominant disease which comprises absence or hypoplasia of the nasal bones, hypoplastic maxilla, small and short nose with thin nares, limited movement of the wrist, short palpebral fissures, ulnar deviation of the fingers, hypertelorism and profound sensory-neural deafness. {ECO:0000269|PubMed:8664898}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Rhabdomyosarcoma 2 (RMS2) [MIM:268220]: A form of rhabdomyosarcoma, a highly malignant tumor of striated muscle derived from primitive mesenchymal cells and exhibiting differentiation along rhabdomyoblastic lines. Rhabdomyosarcoma is one of the most frequently occurring soft tissue sarcomas and the most common in children. It occurs in four forms: alveolar, pleomorphic, embryonal and botryoidal rhabdomyosarcomas. {ECO:0000269|PubMed:8275086}. Note=The gene represented in this entry is involved in disease pathogenesis. A chromosomal aberration involving PAX3 is found in rhabdomyosarcoma. Translocation (2;13)(q35;q14) with FOXO1. The resulting protein is a transcriptional activator. {ECO:0000269|PubMed:8275086}.; DISEASE: Note=A chromosomal aberration involving PAX3 is a cause of rhabdomyosarcoma. Translocation t(2;2)(q35;p23) with NCOA1 generates the NCOA1-PAX3 oncogene consisting of the N-terminus part of PAX3 and the C-terminus part of NCOA1. The fusion protein acts as a transcriptional activator. Rhabdomyosarcoma is the most common soft tissue carcinoma in childhood, representing 5-8% of all malignancies in children. {ECO:0000269|PubMed:15313887}.; 	0.99336	0.67982	-0.001743238	53.85114414	209.24476	3.12323	0.002	0.721	D	0.136	0.363	B	0.025	0.415	B	0.015	0.283	N	0.840	0.810	N	0.345	0.112	N	-3.42	0.994	D	-1.37	0.364	N	0.338	0.420	0.980	0.969	D	0.917	0.973	D	0.668	0.972	D	3.940	0.530	23.5	0.993	0.575	0.936	0.583	D	c	-0.431	-0.278	1.000	0.747	0.437	0.062	0	3.15	0.351	1.196	0.316	0.768	0.311	0.297	0.251	0.998	0.697	11.550	0.498	.	.	.	0.5	124	594	2	223163291	chr2:223163291	C	T	124	PASS	DP=594;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	226265720	226265722	TGG	-	UTR5	NYAP2	NM_020864:c.-7877_-7875del-	.	.	0.906196258	0.093772035	3.17E-05	.	.	.	-0.020150552	52.25288983	158.7708	2.75169	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	131	47	2	226265719	chr2:226265719	CTGG	C	131	PASS	DP=47;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	228109625	228109625	-	TG	ncRNA_intronic	LOC654841	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	488	2	228109625	chr2:228109625	T	TTG	90	PASS	DP=488;AN=4	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	0/1
2	231115765	231115765	G	A	exonic	SP140	.	nonsynonymous SNV	SP140:NM_001278452:exon9:c.G968A:p.R323K,SP140:NM_001278451:exon10:c.G1046A:p.R349K,SP140:NM_007237:exon10:c.G1046A:p.R349K	2.00E-08	0.998412016	0.001587964	.	0.02782	0.06218	0.316000233	72.80018872	737.24204	5.38969	0.22	0.461	T	0.841	0.473	P	0.745	0.540	P	.	.	.	1	0.090	N	1.845	0.488	L	-0.17	0.729	T	-0.31	0.125	N	0.064	0.098	-0.880	0.498	T	0.220	0.583	T	0.011	0.276	T	-0.736	0.043	0.060	0.482	0.039	0.024	0.068	N	c	-1.109	-1.220	0.000	0.052	0.672	0.522	0	0.813	0.178	-0.009	0.126	-0.241	0.092	0.000	0.063	0.021	0.135	9.005	0.351	.	.	.	0.5	.	33	2	231115765	chr2:231115765	G	A	.	PASS	DP=33;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	231943397	231943397	C	T	exonic	PSMD1	.	nonsynonymous SNV	PSMD1:NM_001191037:exon10:c.C1096T:p.H366Y,PSMD1:NM_002807:exon10:c.C1096T:p.H366Y	0.999999203	7.97E-07	3.00E-16	.	0.94807	0.14977	-0.380166007	27.88393489	75.57454	1.81948	0.064	0.365	T	0.928	0.501	P	0.742	0.539	P	0.000	0.843	D	1	0.810	D	2.63	0.772	M	.	.	.	-5.5	0.858	D	0.959	0.957	0.009	0.824	D	0.486	0.804	T	0.052	0.651	D	4.542	0.608	24.3	0.998	0.897	0.994	0.952	D	c	0.811	0.803	1.000	0.747	0.707	0.730	0	5.68	0.880	7.841	0.850	0.800	0.324	1.000	0.715	0.995	0.604	19.784	0.964	.	.	.	0.5	.	29	2	231943397	chr2:231943397	C	T	.	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	233245026	233245026	G	A	exonic	ALPP	.	nonsynonymous SNV	ALPP:NM_001632:exon6:c.G788A:p.R263H	1.69E-06	0.862682097	0.137316218	.	0.11261	0.13673	1.35769336	94.43854683	1957.1571	8.14348	0.877	0.026	T	0.007	0.131	B	0.001	0.040	B	0.991	0.079	N	1	0.090	P	-1	0.012	N	-4.04	0.965	D	0.35	0.038	N	0.093	0.092	-0.828	0.535	T	0.002	0.006	T	.	.	.	0.356	0.128	6.224	0.762	0.110	0.008	0.032	N	c	-1.491	-1.418	0.004	0.106	0.497	0.185	0	-0.177	0.126	0.494	0.220	-0.025	0.128	0.000	0.063	0.021	0.135	7.139	0.246	Alkaline phosphatase-like, alpha/beta/alpha|Alkaline-phosphatase-like, core domain	ENSG00000244280.1|ENSG00000244280.1	Testis|Thyroid	0.5	.	175	2	233245026	chr2:233245026	G	A	.	PASS	DP=175;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	233246153	233246153	C	T	intronic	ALPP	.	.	.	1.69E-06	0.862682097	0.137316218	.	0.11261	0.13673	1.35769336	94.43854683	1957.1571	8.14348	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	175	2	233246153	chr2:233246153	C	T	.	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	234669144	234669144	G	A	exonic	UGT1A1	.	nonsynonymous SNV	UGT1A1:NM_000463:exon1:c.G211A:p.G71R	2.94E-09	0.085606144	0.914393853	DISEASE: Gilbert syndrome (GILBS) [MIM:143500]: Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints. {ECO:0000269|PubMed:11013440, ECO:0000269|PubMed:12139570, ECO:0000269|PubMed:7715297, ECO:0000269|PubMed:9627603}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Transient familial neonatal hyperbilirubinemia (HBLRTFN) [MIM:237900]: A condition characterized by excessive concentration of bilirubin in the blood, which may lead to jaundice. Breast milk jaundice is a common problem in nursing infants. {ECO:0000269|PubMed:11061796}. Note=The disease may be caused by mutations affecting the gene represented in this entry. The defect has been ascribed to various breast milk substances, but the component or combination of components that is responsible remains unclear. Defects of UGT1A1 are an underlying cause of the prolonged unconjugated hyperbilirubinemia associated with breast milk. One or more components in the milk may trigger the jaundice in infants who have such mutations. Mutations are identical to those detected in patients with Gilbert syndrome, a risk factor of neonatal non-physiologic hyperbilirubinemia and a genetic factor in fasting hyperbilirubinemia.; DISEASE: Crigler-Najjar syndrome 1 (CN1) [MIM:218800]: Patients have severe hyperbilirubinemia and usually die of kernicterus (bilirubin accumulation in the basal ganglia and brainstem nuclei) within the first year of life. CN1 inheritance is autosomal recessive. {ECO:0000269|PubMed:11013440, ECO:0000269|PubMed:15712364, ECO:0000269|PubMed:1634050, ECO:0000269|PubMed:17229650, ECO:0000269|PubMed:19830808, ECO:0000269|PubMed:23992562, ECO:0000269|PubMed:7906695, ECO:0000269|PubMed:7989045, ECO:0000269|PubMed:7989595, ECO:0000269|PubMed:8226884}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Crigler-Najjar syndrome 2 (CN2) [MIM:606785]: Patients have less severe hyperbilirubinemia and usually survive into adulthood without neurologic damage. Phenobarbital, which induces the partially deficient glucuronyl transferase, can diminish the jaundice. CN2 inheritance is autosomal dominant. {ECO:0000269|PubMed:11013440, ECO:0000269|PubMed:11370628, ECO:0000269|PubMed:12402338, ECO:0000269|PubMed:15712364, ECO:0000269|PubMed:17229650, ECO:0000269|PubMed:19830808, ECO:0000269|PubMed:23099197, ECO:0000269|PubMed:23992562, ECO:0000269|PubMed:7989595, ECO:0000269|PubMed:8276413, ECO:0000269|PubMed:8280139, ECO:0000269|PubMed:8706880, ECO:0000269|PubMed:9621515, ECO:0000269|PubMed:9639672}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.58091	-0.556537043	19.72753008	185.91297	2.96084	0.04	0.421	D	0.127	0.581	B	0.183	0.497	B	.	.	.	0.599	0.309	P	1.39	0.351	L	0.09	0.615	T	-1.77	0.486	N	0.097	0.100	-1.081	0.071	T	0.001	0.002	T	.	.	.	4.055	0.545	23.7	0.997	0.801	0.339	0.247	N	c	-0.077	-0.054	1.000	0.500	0.487	0.133	0	5.14	0.699	3.900	0.558	1.048	0.713	0.572	0.273	0.951	0.427	7.612	0.271	.	.	.	0.5	51	10	2	234669144	chr2:234669144	G	A	51	PASS	DP=10;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
2	235403512	235403512	A	-	UTR3	ARL4C	NM_001282431:c.*938delT;NM_005737:c.*1140delT	.	.	0.607389355	0.356926815	0.03568383	.	0.6781	0.1291	0.035072054	56.2514744	1.39352	0.04935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	88	2	235403511	chr2:235403511	TA	T,TAA	86	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	235403512	235403512	-	A	UTR3	ARL4C	NM_001282431:c.*937_*938insT;NM_005737:c.*1139_*1140insT	.	.	0.607389355	0.356926815	0.03568383	.	0.6781	0.1291	0.035072054	56.2514744	1.39352	0.04935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	88	2	235403511	chr2:235403511	TA	T,TAA	86	PASS	DP=88;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
2	235950107	235950107	G	A	exonic	SH3BP4	.	nonsynonymous SNV	SH3BP4:NM_014521:exon4:c.G694A:p.V232I	0.080964436	0.91686014	0.002175424	.	0.16796	0.10864	-0.72020276	14.27813163	283.16989	3.60324	0.209	0.197	T	0.0	0.026	B	0.0	0.013	B	0.018	0.276	N	1.000	0.090	N	0.145	0.088	N	2.92	0.099	T	0.02	0.068	N	0.046	0.026	-1.001	0.297	T	0.018	0.073	T	0.004	0.091	T	0.276	0.121	5.459	0.972	0.325	0.314	0.241	N	c	-0.606	-0.508	1.000	0.747	0.719	0.830	0	4.7	0.586	0.947	0.285	1.048	0.713	0.045	0.210	0.283	0.234	12.621	0.558	.	.	.	0.5	.	248	2	235950107	chr2:235950107	G	A	.	PASS	DP=248;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	235962622	235962622	G	C	UTR3	SH3BP4	NM_014521:c.*162G>C	.	.	0.080964436	0.91686014	0.002175424	.	0.16796	0.10864	-0.72020276	14.27813163	283.16989	3.60324	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	510	2	235962622	chr2:235962622	G	C	96	PASS	DP=510;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	237074910	237074910	G	T	exonic	GBX2	.	nonsynonymous SNV	GBX2:NM_001485:exon2:c.C694A:p.P232T	0.567961293	0.420206259	0.011832449	.	0.79886	0.23775	-0.229483771	36.86010852	119.9659	2.38746	0.078	0.339	T	0.003	0.102	B	0.002	0.063	B	0.001	0.397	N	1.000	0.810	D	1.525	0.387	L	-3.77	0.956	D	-1.6	0.385	N	0.179	0.227	0.087	0.839	D	0.670	0.886	D	0.131	0.814	D	0.815	0.172	9.553	0.916	0.203	0.906	0.516	D	c	-0.406	-0.242	1.000	0.747	0.685	0.552	0	3.47	0.387	1.164	0.312	0.953	0.551	0.998	0.411	0.986	0.517	13.682	0.618	Homeodomain-like	.	.	0.5	97	328	2	237074910	chr2:237074910	G	T	97	PASS	DP=328;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	238274611	238274627	CTTCTGGGCCACAAAAA	-	exonic	COL6A3	.	frameshift deletion	COL6A3:NM_057166:exon9:c.3731_3747del:p.V1244Gfs*45,COL6A3:NM_057167:exon11:c.4934_4950del:p.V1645Gfs*45,COL6A3:NM_004369:exon12:c.5552_5568del:p.V1851Gfs*45	7.79E-11	1	1.79E-10	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:10399756, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:9536084}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dystonia 27 (DYT27) [MIM:616411]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT27 is an autosomal recessive form characterized by segmental isolated dystonia involving the face, neck, bulbar muscles, and upper limbs. {ECO:0000269|PubMed:26004199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93588	0.40359	-2.550505158	0.861052135	5032.39412	14.4934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	128	2	238274610	chr2:238274610	CCTTCTGGGCCACAAAAA	C	86	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	238323052	238323052	-	A	upstream	COL6A3	dist=202	.	.	7.79E-11	1	1.79E-10	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:10399756, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:9536084}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dystonia 27 (DYT27) [MIM:616411]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT27 is an autosomal recessive form characterized by segmental isolated dystonia involving the face, neck, bulbar muscles, and upper limbs. {ECO:0000269|PubMed:26004199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93588	0.40359	-2.550505158	0.861052135	5032.39412	14.4934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	203	2	238323050	chr2:238323050	TAA	TAAA,T	87	PASS	DP=203;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	238323051	238323052	AA	-	upstream	COL6A3	dist=201	.	.	7.79E-11	1	1.79E-10	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:10399756, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:9536084}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dystonia 27 (DYT27) [MIM:616411]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT27 is an autosomal recessive form characterized by segmental isolated dystonia involving the face, neck, bulbar muscles, and upper limbs. {ECO:0000269|PubMed:26004199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93588	0.40359	-2.550505158	0.861052135	5032.39412	14.4934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	87	203	2	238323050	chr2:238323050	TAA	TAAA,T	87	PASS	DP=203;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	238632160	238632160	T	-	intronic	LRRFIP1	.	.	.	0.36551249	0.633984856	0.000502654	.	0.11014	0.08981	0.609894095	82.95588582	1129.28257	6.41308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.88	102	2	238632159	chr2:238632159	GT	G,GTT	13.88	PASS	DP=102;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	././.	././.	././.	././.	0/1/.
2	238632160	238632160	-	T	intronic	LRRFIP1	.	.	.	0.36551249	0.633984856	0.000502654	.	0.11014	0.08981	0.609894095	82.95588582	1129.28257	6.41308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.88	102	2	238632159	chr2:238632159	GT	G,GTT	13.88	PASS	DP=102;AN=2	GT	././.	././.	././.	././.	././.	././.	././.	././.	././.	././.	././.	0/1/.
2	238899036	238899036	C	T	ncRNA_intronic	UBE2F-SCLY	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	2	238899036	chr2:238899036	C	T	.	PASS	DP=48;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
2	239049486	239049486	A	T	exonic	KLHL30	.	stopgain	KLHL30:NM_198582:exon2:c.A91T:p.K31X	8.30E-11	0.039628124	0.960371876	.	0.07834	.	-0.262657925	34.93158764	2561.08705	9.45363	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.049	0.972	37	0.995	0.700	0.956	0.652	D	c	0.856	0.738	1.000	0.747	0.428	0.059	0	5.75	0.904	5.888	0.693	1.199	0.960	1.000	0.715	0.988	0.529	11.093	0.472	BTB/POZ domain|SKP1/BTB/POZ domain	.	.	0.5	110	518	2	239049486	chr2:239049486	A	T	110	PASS	DP=518;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	240323829	240323829	A	T	ncRNA_exonic	LOC101928111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	620	2	240323829	chr2:240323829	A	T	112	PASS	DP=620;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	241622318	241622318	C	A	upstream	AQP12B	dist=1	.	.	0.004358648	0.431917163	0.563724189	.	0.16011	.	.	.	3743.83383	11.95806	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	209	2	241622318	chr2:241622318	C	A	.	PASS	DP=209;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	241808307	241808307	-	C	exonic	AGXT	.	frameshift insertion	AGXT:NM_000030:exon1:c.26dupC:p.K12Qfs*155	0.003594369	0.9539627	0.042442931	DISEASE: Hyperoxaluria primary 1 (HP1) [MIM:259900]: An inborn error of glyoxylate metabolism characterized by increased excretion of oxalate and glycolate, and progressive tissue accumulation of insoluble calcium oxalate. Affected individuals are at risk for nephrolithiasis, nephrocalcinosis and early onset end-stage renal disease. {ECO:0000269|PubMed:10394939, ECO:0000269|PubMed:10453743, ECO:0000269|PubMed:10541294, ECO:0000269|PubMed:10862087, ECO:0000269|PubMed:12559847, ECO:0000269|PubMed:1301173, ECO:0000269|PubMed:1349575, ECO:0000269|PubMed:15253729, ECO:0000269|PubMed:15849466, ECO:0000269|PubMed:15961946, ECO:0000269|PubMed:15963748, ECO:0000269|PubMed:16971151, ECO:0000269|PubMed:1703535, ECO:0000269|PubMed:17495019, ECO:0000269|PubMed:2039493, ECO:0000269|PubMed:23229545, ECO:0000269|PubMed:24055001, ECO:0000269|PubMed:24934730, ECO:0000269|PubMed:26149463, ECO:0000269|PubMed:8101040, ECO:0000269|PubMed:9192270, ECO:0000269|PubMed:9604803}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.59321	0.59981	0.644875971	84.10002359	526.88786	4.68568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	1397	2	241808307	chr2:241808307	A	AC	97	PASS	DP=1397;AN=4	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	0/1	./.
2	241979571	241979571	C	T	exonic	SNED1	.	synonymous SNV	SNED1:NM_001080437:exon7:c.C1125T:p.C375C	0.98376281	0.01623719	1.33E-10	.	0.22403	0.13286	-1.379925048	4.364236848	4194.17391	12.86144	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	272	2	241979571	chr2:241979571	C	T	67	PASS	DP=272;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
2	242168924	242168924	G	A	UTR3	HDLBP	NM_001243900:c.*92C>T;NM_001320966:c.*92C>T;NM_005336:c.*92C>T;NM_001320965:c.*92C>T;NM_203346:c.*92C>T	.	.	0.999998383	1.62E-06	6.87E-17	.	0.83358	0.17552	-1.368693559	4.482189196	124.99167	2.43155	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	59	2	242168924	chr2:242168924	G	A	123	PASS	DP=59;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
2	242752382	242752382	C	A	UTR5	NEU4	NM_080741:c.-142C>A;NM_001167602:c.-3300C>A;NM_001167599:c.-142C>A	.	.	0.000277583	0.553721056	0.446001361	.	0.16791	0.22163	.	.	445.2511	4.39211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	90	505	2	242752382	chr2:242752382	C	A	90	PASS	DP=505;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
2	242925339	242925339	A	G	ncRNA_intronic	LINC01237	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	110	2	242925339	chr2:242925339	A	G	72	PASS	DP=110;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
2	243052594	243052594	C	G	ncRNA_intronic	LINC01881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	16	2	243052594	chr2:243052594	C	G	43	PASS	DP=16;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	243052596	243052596	A	G	ncRNA_intronic	LINC01881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	16	2	243052596	chr2:243052596	A	G	42	PASS	DP=16;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
2	243061143	243061143	A	G	ncRNA_exonic	LINC01881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	98	178	2	243061143	chr2:243061143	A	G	98	PASS	DP=178;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
13	19384053	19384053	A	C	intergenic	LINC00417;ANKRD20A9P	dist=69814;dist=1230	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	38	13	19384053	chr13:19384053	A	C	72	PASS	DP=38;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
13	20242494	20242494	-	ACGTACTATTTTTTTTTCTTAGACTTTCAAGAGTAGCAGAAGAGACAATAAAGGATT	intronic	MPHOSPH8	.	.	.	0.930242309	0.069757082	6.08E-07	.	0.10351	0.09166	-0.242430445	36.22906346	300.14804	3.69378	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	127	96	13	20242494	chr13:20242494	C	CACGTACTATTTTTTTTTCTTAGACTTTCAAGAGTAGCAGAAGAGACAATAAAGGATT	127	PASS	DP=96;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
13	20302531	20302531	C	T	intronic	PSPC1	.	.	.	0.99260702	0.007392697	2.82E-07	.	0.15131	0.1143	-0.405853867	26.23260203	58.28959	1.54636	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	13	20302531	chr13:20302531	C	T	.	PASS	DP=49;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
13	20413021	20413021	T	C	exonic	ZMYM5	.	nonsynonymous SNV	ZMYM5:NM_001039650:exon5:c.A691G:p.T231A,ZMYM5:NM_001142684:exon5:c.A691G:p.T231A	0.200378135	0.7895718	0.010050066	.	0.06748	0.07051	0.485092724	79.37603208	1157.52256	6.47872	0.041	0.477	D	0.048	0.207	B	0.013	0.158	B	0.004	0.342	N	0.999	0.588	P	0	0.065	N	1.01	0.411	T	0.31	0.058	N	0.061	0.109	-1.076	0.081	T	0.000	0.001	T	.	.	.	0.786	0.169	9.378	0.947	0.247	0.822	0.412	D	c	-0.835	-0.761	0.992	0.326	0.732	0.924	0	-0.334	0.120	0.570	0.232	-0.595	0.044	0.996	0.391	0.001	0.043	4.843	0.128	.	ENSG00000196199.9|ENSG00000196199.9|ENSG00000121390.13|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000196199.9|ENSG00000215572.2|ENSG00000196199.9	Artery_Aorta|Artery_Tibial|Artery_Tibial|Cells_Transformed_fibroblasts|Esophagus_Mucosa|Esophagus_Muscularis|Lung|Muscle_Skeletal|Nerve_Tibial|Pancreas|Skin_Not_Sun_Exposed_Suprapubic|Stomach|Testis|Thyroid	0.5	129	63	13	20413021	chr13:20413021	T	C	129	PASS	DP=63;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
13	25542289	25542289	A	G	ncRNA_intronic	TPTE2P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	61	13	25542289	chr13:25542289	A	G	45	PASS	DP=61;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
13	27830553	27830553	-	T	ncRNA_intronic	RPL21P28	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	45	13	27830553	chr13:27830553	C	CT	50	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	32882912	32882912	-	T	intronic	ZAR1L	.	.	.	.	.	.	.	.	.	0.301449681	71.80938901	237.81878	3.33	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	134	62	13	32882912	chr13:32882912	G	GT	134	PASS	DP=62;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	1/0	./.	./.	./.	./.
13	32907536	32907536	T	-	intronic	BRCA2	.	.	.	2.21E-15	0.999975298	2.47E-05	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.97144	0.70346	3.731883424	99.58716678	775.59808	5.51436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	39	13	32907535	chr13:32907535	CT	C	77	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
13	32911888	32911888	A	G	exonic	BRCA2	.	synonymous SNV	BRCA2:NM_000059:exon11:c.A3396G:p.K1132K	2.21E-15	0.999975298	2.47E-05	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.97144	0.70346	3.731883424	99.58716678	775.59808	5.51436	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	39	13	32911888	chr13:32911888	A	G	95	PASS	DP=39;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
13	39435552	39435552	-	T	intronic	FREM2	.	.	.	1.25E-07	0.999999873	1.59E-09	DISEASE: Fraser syndrome (FRASS) [MIM:219000]: Multisystem malformation usually comprising cryptophthalmos, cutaneous syndactyly, ear abnormalities, renal agenesis and congenital heart defects. {ECO:0000269|PubMed:15838507}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.4129	0.11172	-0.632876892	16.77282378	10803.546	22.53898	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	131	13	39435552	chr13:39435552	C	CT	80	PASS	DP=131;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
13	46148944	46148944	G	-	intronic	ERICH6B	.	.	.	.	.	.	.	.	.	2.710287147	98.93842887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	15	13	46148943	chr13:46148943	TG	T	61	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	46946629	46946629	G	T	UTR5	RUBCNL	NM_001286762:c.-19C>A;NM_001349772:c.-19C>A;NM_025113:c.-19C>A;NM_001286761:c.-19C>A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	13	46946629	chr13:46946629	G	T	.	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	50235208	50235208	-	A	exonic	EBPL	.	stopgain	EBPL:NM_032565:exon4:c.516dupT:p.N173fs*0	0.038853333	0.838493275	0.122653391	.	0.05028	0.0701	-0.141298762	42.87567823	28.87736	0.92255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	189	13	50235208	chr13:50235208	T	TA	66	PASS	DP=189;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
13	50570574	50570574	T	-	ncRNA_exonic	MIR3613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	38	13	50570573	chr13:50570573	CT	C	62	PASS	DP=38;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
13	50570604	50570604	-	A	ncRNA_exonic	MIR3613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	128	13	50570604	chr13:50570604	C	CA	91	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
13	50746845	50746845	C	G	ncRNA_exonic	ST13P4	.	.	.	.	.	.	.	.	0.29632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	128	13	50746845	chr13:50746845	C	G	53	PASS	DP=128;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	80095144	80095144	T	-	intronic	NDFIP2	.	.	.	0.80187873	0.196982259	0.001139011	.	0.14456	0.10625	0.327131069	73.27199811	599.78046	4.95722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	47	13	13	80095143	chr13:80095143	CT	C	47	PASS	DP=13;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
13	98018868	98018868	A	-	intronic	MBNL2	.	.	.	0.900896117	0.09892387	0.000180013	.	0.05644	0.07965	-0.293801652	32.93819297	21.49435	0.72448	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	179	13	98018867	chr13:98018867	TA	T	75	PASS	DP=179;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
13	98634738	98634738	T	-	intronic	IPO5	.	.	.	0.999998737	1.26E-06	3.77E-17	.	0.97485	0.23683	-0.909290275	10.03184713	1001.72714	6.09631	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	42	13	98634737	chr13:98634737	AT	A	76	PASS	DP=42;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
13	99461555	99461555	-	T	intronic	DOCK9	.	.	.	0.999999307	6.93E-07	2.96E-21	.	0.35485	0.10142	-2.778633322	0.672328379	918.16821	5.89066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	178	13	99461555	chr13:99461555	G	GT	63	PASS	DP=178;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
13	100635045	100635045	T	-	exonic	ZIC2	.	frameshift deletion	ZIC2:NM_007129:exon1:c.727delT:p.F244Sfs*12	.	.	.	DISEASE: Holoprosencephaly 5 (HPE5) [MIM:609637]: A structural anomaly of the brain, in which the developing forebrain fails to correctly separate into right and left hemispheres. Holoprosencephaly is genetically heterogeneous and associated with several distinct facies and phenotypic variability. {ECO:0000269|PubMed:11285244, ECO:0000269|PubMed:15221788, ECO:0000269|PubMed:19177455}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87813	0.23021	.	.	382.0785	4.12056	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	931	13	100635044	chr13:100635044	CT	C	83	PASS	DP=931;AN=4	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	0/1	./.
13	100637893	100637893	G	T	exonic	ZIC2	.	nonsynonymous SNV	ZIC2:NM_007129:exon3:c.G1556T:p.G519V	.	.	.	DISEASE: Holoprosencephaly 5 (HPE5) [MIM:609637]: A structural anomaly of the brain, in which the developing forebrain fails to correctly separate into right and left hemispheres. Holoprosencephaly is genetically heterogeneous and associated with several distinct facies and phenotypic variability. {ECO:0000269|PubMed:11285244, ECO:0000269|PubMed:15221788, ECO:0000269|PubMed:19177455}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87813	0.23021	.	.	382.0785	4.12056	0.006	0.614	D	0.11	0.246	B	0.012	0.149	B	0.006	0.320	N	1.000	0.480	D	0.805	0.203	L	-1.22	0.788	T	-0.66	0.191	N	0.354	0.415	-0.658	0.624	T	0.265	0.636	T	0.850	0.988	D	3.223	0.447	22.7	0.981	0.380	0.790	0.388	D	c	-0.233	-0.118	1.000	0.517	0.543	0.218	0	2.81	0.318	4.421	0.594	0.779	0.314	1.000	0.715	0.991	0.552	10.976	0.465	.	.	.	0.5	88	234	13	100637893	chr13:100637893	G	T	88	PASS	DP=234;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
13	102047543	102047543	G	T	exonic	NALCN	.	synonymous SNV	NALCN:NM_001350748:exon3:c.C282A:p.G94G,NALCN:NM_001350749:exon3:c.C282A:p.G94G,NALCN:NM_001350750:exon3:c.C282A:p.G94G,NALCN:NM_001350751:exon3:c.C282A:p.G94G,NALCN:NM_052867:exon3:c.C282A:p.G94G	0.000169004	0.999830996	3.03E-11	DISEASE: Hypotonia, infantile, with psychomotor retardation and characteristic facies (IHPRF) [MIM:615419]: A neurodegenerative disease characterized by variable degrees of hypotonia, speech impairment, intellectual disability, pyramidal signs, subtle facial dysmorphism, and chronic constipation. Some patients manifest neuroaxonal dystrophy, optic atrophy, unmyelinated axons and spheroid bodies in tissue biopsies. {ECO:0000269|PubMed:23749988, ECO:0000269|PubMed:24075186}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital contractures of the limbs and face, hypotonia, and developmental delay (CLIFAHDD) [MIM:616266]: A disease characterized by congenital contractures of the limbs and face, resulting in characteristic facial features, abnormal tone, most commonly manifested as hypotonia, and variable degrees of developmental delay. {ECO:0000269|PubMed:25683120}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43129	0.10307	-1.611264137	2.984194385	137.54866	2.55255	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	51	13	102047543	chr13:102047543	G	T	.	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	102106265	102106265	C	A	exonic	ITGBL1	.	synonymous SNV	ITGBL1:NM_001271755:exon2:c.C130A:p.R44R,ITGBL1:NM_004791:exon2:c.C130A:p.R44R	0.170877824	0.828540578	0.000581598	.	0.17697	0.12974	0.64123826	83.97617363	1434.7471	7.07106	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	13	102106265	chr13:102106265	C	A	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	108518516	108518518	GCC	-	exonic	FAM155A	.	nonframeshift deletion	FAM155A:NM_001080396:exon1:c.427_429del:p.G143del	0.800415326	0.199346781	0.000237893	.	0.22573	.	-0.005381972	53.50908233	761.08845	5.47031	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	114	13	108518515	chr13:108518515	TGCC	T	83	PASS	DP=114;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
13	111371701	111371701	A	T	exonic	ING1	.	stopgain	ING1:NM_001267728:exon2:c.A211T:p.K71X,ING1:NM_005537:exon2:c.A691T:p.K231X,ING1:NM_198217:exon2:c.A130T:p.K44X,ING1:NM_198218:exon2:c.A55T:p.K19X,ING1:NM_198219:exon2:c.A262T:p.K88X	0.011435702	0.979963341	0.008600957	DISEASE: Squamous cell carcinoma of the head and neck (HNSCC) [MIM:275355]: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. {ECO:0000269|PubMed:10866301}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.78935	0.17351	-0.512444034	21.55579146	154.20317	2.71419	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.978	0.988	40	0.995	0.707	0.991	0.918	D	c	0.884	0.760	1.000	0.747	0.632	0.406	0	5.14	0.699	8.731	0.912	1.053	0.755	1.000	0.715	1.000	0.888	14.967	0.707	Inhibitor of growth protein, N-terminal histone-binding	.	.	0.5	88	302	13	111371701	chr13:111371701	A	T	88	PASS	DP=302;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
13	111522059	111522059	G	T	ncRNA_exonic	LINC00346	.	.	.	.	.	.	.	.	.	.	.	328.50602	3.85367	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	338	13	111522059	chr13:111522059	G	T	83	PASS	DP=338;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
13	113473599	113473600	AT	-	intronic	ATP11A	.	.	.	0.967333743	0.032666257	3.07E-11	.	0.22056	0.10642	-1.605857744	3.007784855	269.18999	3.51905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	138	71	13	113473598	chr13:113473598	CAT	C	138	PASS	DP=71;AN=2	GT	./.	./.	./.	1/0	./.	./.	./.	./.	./.	./.	./.	./.
13	114762066	114762066	G	T	exonic	RASA3	.	synonymous SNV	RASA3:NM_001320822:exon21:c.C1986A:p.G662G,RASA3:NM_007368:exon21:c.C2082A:p.G694G,RASA3:NM_001320821:exon23:c.C933A:p.G311G	0.000433959	0.999498118	6.79E-05	.	0.20897	0.10415	-1.657176494	2.736494456	205.03169	3.0937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	229	13	114762066	chr13:114762066	G	T	.	PASS	DP=229;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
13	114806428	114806428	C	A	intronic	RASA3	.	.	.	0.000433959	0.999498118	6.79E-05	.	0.20897	0.10415	-1.657176494	2.736494456	205.03169	3.0937	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	149	13	114806428	chr13:114806428	C	A	96	PASS	DP=149;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	16255875	16255875	G	T	downstream	POTEH	dist=457	.	.	.	.	.	.	0.04666	0.08864	.	.	531.82086	4.70466	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	184	22	16255875	chr22:16255875	G	T	.	PASS	DP=184;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	17054314	17054314	G	T	intergenic	OR11H1;CCT8L2	dist=604510;dist=17334	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	22	17054314	chr22:17054314	G	T	.	PASS	DP=47;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	17073410	17073410	G	C	exonic	CCT8L2	.	nonsynonymous SNV	CCT8L2:NM_014406:exon1:c.C31G:p.L11V	0.001833343	0.720145372	0.278021284	.	0.44923	.	0.314179756	72.75300778	163.41963	2.7912	0.264	0.163	T	0.98	0.574	D	0.91	0.629	D	0.180	0.171	U	1	0.090	N	1.1	0.281	L	0.49	0.558	T	-0.34	0.127	N	0.24	0.294	-1.012	0.262	T	0.120	0.420	T	0.007	0.174	T	2.263	0.333	17.92	0.991	0.522	0.094	0.150	N	c	-0.383	-0.510	0.002	0.091	0.487	0.133	0	2.0	0.254	0.694	0.250	0.569	0.285	0.483	0.266	0.026	0.142	7.483	0.264	.	.	.	0.5	95	514	22	17073410	chr22:17073410	G	C	95	PASS	DP=514;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	17378322	17378322	T	C	intergenic	HSFY1P1;GAB4	dist=68097;dist=64505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	125	620	22	17378322	chr22:17378322	T	C	125	PASS	DP=620;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
22	17395212	17395212	G	T	intergenic	HSFY1P1;GAB4	dist=84987;dist=47615	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	324	22	17395212	chr22:17395212	G	T	95	PASS	DP=324;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	18166016	18166072	AAGAAATTTTATTAAAAGTTAAAACTGAAATTGAAGAAGAGCTAAAATCTCTGGACA	-	exonic	BCL2L13	.	nonframeshift deletion	BCL2L13:NM_001270726:exon2:c.230_286del:p.L80_I98del,BCL2L13:NM_001270727:exon2:c.230_286del:p.L80_I98del,BCL2L13:NM_001270732:exon3:c.158_214del:p.L56_I74del,BCL2L13:NM_001270734:exon3:c.158_214del:p.L56_I74del,BCL2L13:NM_001270735:exon3:c.158_214del:p.L56_I74del,BCL2L13:NM_015367:exon3:c.158_214del:p.L56_I74del	0.070274402	0.916561026	0.013164572	.	0.0591	.	0.50895761	80.20169851	191.37406	3.0001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	92	22	18166015	chr22:18166015	CAAGAAATTTTATTAAAAGTTAAAACTGAAATTGAAGAAGAGCTAAAATCTCTGGACA	C	54	PASS	DP=92;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	18861064	18861064	T	C	ncRNA_exonic	LINC01663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	133	2254	22	18861064	chr22:18861064	T	C	133	PASS	DP=2254;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	19396044	19396044	T	C	exonic	HIRA	.	nonsynonymous SNV	HIRA:NM_003325:exon3:c.A173G:p.N58S	0.999998171	1.83E-06	4.58E-16	.	0.94243	0.2323	-1.374132436	4.429110639	37.48735	1.116	0.28	0.193	T	0.154	0.265	B	0.085	0.279	B	0.000	0.843	D	1	0.810	D	0.16	0.090	N	-0.35	0.686	T	-2.33	0.516	N	0.069	0.103	-0.929	0.442	T	0.145	0.469	T	0.013	0.319	T	1.210	0.211	11.80	0.972	0.323	0.894	0.495	D	c	-0.208	0.028	1.0	0.983	0.707	0.730	0	5.5	0.813	2.917	0.483	1.061	0.807	1.000	0.715	1.000	0.888	15.776	0.779	WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain	.	.	0.5	94	181	22	19396044	chr22:19396044	T	C	94	PASS	DP=181;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	19841975	19841975	C	A	UTR5	GNB1L;RTL10	NM_053004:c.-33097G>T;NM_024627:c.-2191G>T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	176	1207	22	19841975	chr22:19841975	C	A	176	PASS	DP=1207;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	20104472	20104472	C	T	UTR5	TRMT2A	NM_182984:c.-43G>A;NM_022727:c.-43G>A;NM_001257994:c.-43G>A;NM_001331039:c.-43G>A	.	.	1.31E-05	0.954123928	0.045863013	.	.	0.10123	-0.949752638	9.32413305	192.14774	3.00453	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	73	22	20104472	chr22:20104472	C	T	58	PASS	DP=73;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	20295384	20295384	C	-	intergenic	RTN4R;DGCR6L	dist=39568;dist=6377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	493	22	20295383	chr22:20295383	GC	G	92	PASS	DP=493;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	20847401	20847401	C	A	intronic	KLHL22	.	.	.	0.702611047	0.297235373	0.00015358	.	0.52594	0.11209	-1.199555187	5.761972163	26.86408	0.8677	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	22	20847401	chr22:20847401	C	A	.	PASS	DP=31;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	21057355	21057355	T	C	ncRNA_exonic	TMEM191A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	135	1138	22	21057355	chr22:21057355	T	C	135	PASS	DP=1138;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	21354970	21354970	C	G	exonic	THAP7	.	nonsynonymous SNV	THAP7:NM_030573:exon3:c.G343C:p.A115P,THAP7:NM_001008695:exon4:c.G343C:p.A115P	0.029327855	0.923633046	0.047039099	.	0.37131	0.10994	.	.	76.37465	1.83233	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.888	0.087	N	1	0.090	P	-0.345	0.033	N	-3.75	0.955	D	0.94	0.015	N	0.024	0.007	-0.977	0.357	T	0.000	0.000	T	.	.	.	-0.669	0.046	0.085	0.483	0.040	0.009	0.036	N	c	-1.868	-1.808	1.000	0.747	0.628	0.401	0	0.539	0.163	0.097	0.149	-0.760	0.034	0.004	0.165	0.000	0.016	3.205	0.062	.	.	.	0.5	188	177	22	21354970	chr22:21354970	C	G	188	PASS	DP=177;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	21356777	21356777	G	A	ncRNA_exonic	THAP7-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	531	22	21356777	chr22:21356777	G	A	.	PASS	DP=531;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	21363454	21363454	G	C	ncRNA_exonic	THAP7-AS1;TUBA3FP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	219	22	21363454	chr22:21363454	G	C	.	PASS	DP=219;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	21470329	21470329	C	A	ncRNA_intronic	BCRP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	242	22	21470329	chr22:21470329	C	A	.	PASS	DP=242;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	21470406	21470406	C	T	ncRNA_intronic	BCRP2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	578	22	21470406	chr22:21470406	C	T	.	PASS	DP=578;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	21532831	21532831	C	A	ncRNA_intronic	FAM230B	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	99	944	22	21532831	chr22:21532831	C	A	99	PASS	DP=944;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	21579692	21579692	A	G	exonic	GGT2	.	nonsynonymous SNV	GGT2:NM_001351304:exon6:c.T152C:p.L51S	0.80481651	0.190051731	0.005131759	.	.	0.11718	.	.	1425.85016	7.053	1.0	0.010	T	.	.	.	.	.	.	.	.	.	1.000	0.200	N	.	.	.	3.62	0.044	T	5.21	0.000	N	0.138	0.166	-0.931	0.441	T	0.003	0.009	T	.	.	.	-0.658	0.047	0.090	0.247	0.011	0.007	0.029	N	c	-1.088	-1.002	0.000	0.050	0.554	0.246	0	1.7	0.232	6.366	0.728	-0.114	0.115	1.000	0.715	0.314	0.240	6.475	0.211	Nucleophile aminohydrolases, N-terminal	.	.	0.5	76	93	22	21579692	chr22:21579692	A	G	76	PASS	DP=93;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	21583596	21583597	CT	-	intronic	GGT2	.	.	.	0.80481651	0.190051731	0.005131759	.	.	0.11718	.	.	1425.85016	7.053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	83	22	21583595	chr22:21583595	ACT	A	105	PASS	DP=83;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	22041874	22041874	G	A	intronic	PPIL2	.	.	.	0.027492987	0.97240894	9.81E-05	.	0.24149	0.11289	-0.596992387	18.18825195	85.07728	1.96609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	22	22041874	chr22:22041874	G	A	.	PASS	DP=26;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	22664079	22664079	T	G	ncRNA_intronic	BMS1P20	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	123	342	22	22664079	chr22:22664079	T	G	123	PASS	DP=342;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	22664091	22664091	G	A	ncRNA_intronic	BMS1P20	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	116	381	22	22664091	chr22:22664091	G	A	116	PASS	DP=381;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	23101568	23101568	T	G	intergenic	GGTLC2;MIR650	dist=111200;dist=63702	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	82	22	23101568	chr22:23101568	T	G	.	PASS	DP=82;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
22	23653813	23653813	T	G	intronic	BCR	.	.	.	0.999967225	3.28E-05	1.05E-13	DISEASE: Leukemia, chronic myeloid (CML) [MIM:608232]: A clonal myeloproliferative disorder of a pluripotent stem cell with a specific cytogenetic abnormality, the Philadelphia chromosome (Ph), involving myeloid, erythroid, megakaryocytic, B-lymphoid, and sometimes T-lymphoid cells, but not marrow fibroblasts. {ECO:0000269|PubMed:2407300, ECO:0000269|PubMed:3107980, ECO:0000269|PubMed:3540951}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Note=A chromosomal aberration involving BCR has been found in patients with chronic myeloid leukemia. Translocation t(9;22)(q34;q11) with ABL1. The translocation produces a BCR-ABL found also in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). {ECO:0000269|PubMed:3107980, ECO:0000269|PubMed:7665185}.; 	0.27882	0.76444	-1.253015116	5.360934183	625.45504	5.04431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	163	736	22	23653813	chr22:23653813	T	G	163	PASS	DP=736;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
22	23656859	23656859	T	C	exonic	BCR	.	synonymous SNV	BCR:NM_021574:exon21:c.T3552C:p.P1184P,BCR:NM_004327:exon22:c.T3684C:p.P1228P	0.999967225	3.28E-05	1.05E-13	DISEASE: Leukemia, chronic myeloid (CML) [MIM:608232]: A clonal myeloproliferative disorder of a pluripotent stem cell with a specific cytogenetic abnormality, the Philadelphia chromosome (Ph), involving myeloid, erythroid, megakaryocytic, B-lymphoid, and sometimes T-lymphoid cells, but not marrow fibroblasts. {ECO:0000269|PubMed:2407300, ECO:0000269|PubMed:3107980, ECO:0000269|PubMed:3540951}. Note=The gene represented in this entry is involved in disease pathogenesis.; DISEASE: Note=A chromosomal aberration involving BCR has been found in patients with chronic myeloid leukemia. Translocation t(9;22)(q34;q11) with ABL1. The translocation produces a BCR-ABL found also in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). {ECO:0000269|PubMed:3107980, ECO:0000269|PubMed:7665185}.; 	0.27882	0.76444	-1.253015116	5.360934183	625.45504	5.04431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	136	331	22	23656859	chr22:23656859	T	C	136	PASS	DP=331;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	23959752	23959752	G	A	intronic	DRICH1	.	.	.	.	.	.	.	.	.	1.282454727	93.71313989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	168	22	23959752	chr22:23959752	G	A	84	PASS	DP=168;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	23982696	23982696	-	C	ncRNA_intronic	GUSBP11	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	314	22	23982696	chr22:23982696	T	TC	76	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	24656656	24656656	A	G	ncRNA_intronic	POM121L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	250	22	24656656	chr22:24656656	A	G	110	PASS	DP=250;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
22	24658397	24658397	C	T	ncRNA_exonic	POM121L9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	498	22	24658397	chr22:24658397	C	T	107	PASS	DP=498;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	25574407	25574407	A	G	intronic	KIAA1671	.	.	.	.	.	.	.	.	.	.	.	239.04669	3.34052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	144	311	22	25574407	chr22:25574407	A	G	144	PASS	DP=311;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
22	25715733	25715733	G	C	ncRNA_splicing	IGLL3P	NR_029395:exon3:c.216-1G>C	.	.	.	.	.	.	0.05956	0.07001	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	170	22	25715733	chr22:25715733	G	C	.	PASS	DP=170;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	26422845	26422845	C	A	exonic	MYO18B	.	stopgain	MYO18B:NM_001318245:exon43:c.C6908A:p.S2303X,MYO18B:NM_032608:exon43:c.C6905A:p.S2302X	2.61E-15	0.99999606	3.94E-06	.	0.16167	0.10792	1.205427351	93.02311866	5231.65918	14.90607	.	.	.	.	.	.	.	.	.	0.005	0.329	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.780	0.978	38	0.991	0.513	0.308	0.240	N	c	0.235	-0.047	0.697	0.226	0.554	0.246	0	3.57	0.399	2.155	0.417	0.935	0.490	0.057	0.215	0.282	0.234	8.680	0.332	.	.	.	0.5	.	53	22	26422845	chr22:26422845	C	A	.	PASS	DP=53;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	26747134	26747134	G	T	exonic	SEZ6L	.	nonsynonymous SNV	SEZ6L:NM_001184773:exon12:c.G2524T:p.G842W,SEZ6L:NM_001184774:exon12:c.G2524T:p.G842W,SEZ6L:NM_001184775:exon12:c.G2524T:p.G842W,SEZ6L:NM_001184777:exon12:c.G2524T:p.G842W,SEZ6L:NM_021115:exon12:c.G2524T:p.G842W	0.928831047	0.071168823	1.30E-07	.	0.30074	0.11342	-2.032105599	1.686718566	1299.61065	6.78117	0.0	0.912	D	0.998	0.899	D	0.995	0.916	D	0.000	0.537	D	1	0.810	D	3.54	0.933	H	-0.75	0.733	T	-6.85	0.940	D	0.925	0.938	0.692	0.931	D	0.701	0.897	D	0.358	0.925	D	6.576	0.904	31	0.996	0.753	0.983	0.813	D	c	0.936	0.817	1.000	0.747	0.554	0.246	0	4.54	0.551	9.459	0.968	1.024	0.645	1.000	0.715	0.997	0.653	16.502	0.840	Sushi/SCR/CCP domain	.	.	0.5	91	305	22	26747134	chr22:26747134	G	T	91	PASS	DP=305;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	27019121	27019121	C	A	intronic	CRYBA4	.	.	.	6.69E-08	0.257581927	0.742418006	DISEASE: Cataract 23 (CTRCT23) [MIM:610425]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT23 is a zonular cataract. Zonular or lamellar cataracts are opacities, broad or narrow, usually consisting of powdery white dots affecting only certain layers or zones between the cortex and nucleus of an otherwise clear lens. The opacity may be so dense as to render the entire central region of the lens completely opaque, or so translucent that vision is hardly if at all impeded. Zonular cataracts generally do not involve the embryonic nucleus, though sometimes they involve the fetal nucleus. Usually sharply separated from a clear cortex outside them, they may have projections from their outer edges known as riders or spokes. {ECO:0000269|PubMed:16960806}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.20946	0.13306	0.21689899	68.12927577	150.50912	2.67784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	22	27019121	chr22:27019121	C	A	.	PASS	DP=52;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	28191059	28191059	A	-	intronic	MN1	.	.	.	.	.	.	DISEASE: Note=A chromosomal aberration involving MN1 may be a cause of acute myeloid leukemia (AML). Translocation t(12;22)(p13;q11) with ETV6. {ECO:0000269|PubMed:7731705}.; DISEASE: Note=Defects in MN1 involved in the development of meningiomas, slowly growing benign tumors derived from the arachnoidal cap cells of the leptomeninges, the soft coverings of the brain and spinal cord. Meningiomas are believed to be the most common primary tumors of the central nervous system in man. {ECO:0000269|PubMed:7731706}.; 	0.29108	.	.	.	959.02985	5.99624	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	175	22	28191058	chr22:28191058	GA	G	77	PASS	DP=175;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	29130347	29130347	-	T	intronic	CHEK2	.	.	.	1.18E-15	0.005518936	0.994481064	DISEASE: Li-Fraumeni syndrome 2 (LFS2) [MIM:609265]: A highly penetrant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed (PubMed:8118819 and PubMed:8718514) and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers. {ECO:0000269|PubMed:11719428}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Prostate cancer (PC) [MIM:176807]: A malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma. {ECO:0000269|PubMed:12533788}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Osteogenic sarcoma (OSRC) [MIM:259500]: A sarcoma originating in bone-forming cells, affecting the ends of long bones. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:12094328, ECO:0000269|PubMed:21618645, ECO:0000269|PubMed:25619829}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. {ECO:0000269|PubMed:12094328}.; 	0.98514	0.65565	-0.134019284	43.90776126	138.54243	2.56375	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	101	15	22	29130347	chr22:29130347	G	GT	101	PASS	DP=15;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	1/1	./.	./.	./.	./.
22	30374873	30374873	T	-	intronic	MTMR3	.	.	.	0.994951612	0.005048388	3.77E-11	.	0.241	0.11999	-0.902027742	10.1556971	326.83215	3.84289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	11	22	30374872	chr22:30374872	CT	C	42	PASS	DP=11;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	30772228	30772228	-	T	ncRNA_intronic	KIAA1656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.94	84	22	30772228	chr22:30772228	C	CT,CTT	12.94	PASS	DP=84;AN=2	GT	././.	././.	././.	././.	././.	././.	0/1/.	././.	././.	././.	././.	././.
22	30772228	30772228	-	TT	ncRNA_intronic	KIAA1656	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.94	84	22	30772228	chr22:30772228	C	CT,CTT	12.94	PASS	DP=84;AN=2	GT	././.	././.	././.	././.	././.	././.	0/1/.	././.	././.	././.	././.	././.
22	31524444	31524444	C	A	intronic	INPP5J	.	.	.	6.43E-12	0.062187285	0.937812715	.	0.4443	0.14051	-0.224023033	37.4321774	1180.94022	6.52336	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	425	22	31524444	chr22:31524444	C	A	84	PASS	DP=425;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	31859660	31859660	G	C	intronic	EIF4ENIF1	.	.	.	0.999689054	0.000310946	1.03E-12	.	0.37607	0.23099	-0.973616687	8.8995046	113.80534	2.32557	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	68	94	22	31859660	chr22:31859660	G	C	68	PASS	DP=94;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	32211320	32211320	G	A	intronic	DEPDC5	.	.	.	0.999999934	6.60E-08	9.62E-24	DISEASE: Note=Inactivating mutations and truncating deletions in the genes encoding GATOR1 proteins, including DEPDC5, are detected in glioblastoma and ovarian tumors and are associated with loss of heterozygosity events. Inactivation of GATOR1 proteins promotes constitutive localization of mTORC1 to the lysosomal membrane and blocks mTORC1 inactivation following amino acid withdrawal (PubMed:23723238). {ECO:0000269|PubMed:23723238}.; 	0.19403	0.09278	-1.115293937	6.623024298	895.81677	5.83244	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	22	32211320	chr22:32211320	G	A	.	PASS	DP=28;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	32650200	32650200	C	T	exonic	SLC5A4	.	nonsynonymous SNV	SLC5A4:NM_014227:exon2:c.G136A:p.A46T	2.60E-13	0.125757351	0.874242649	.	0.08441	0.1124	0.736704836	86.32932295	914.47301	5.88119	0.017	0.512	D	0.228	0.288	B	0.206	0.354	B	0.000	0.843	D	0.000	0.588	P	2.89	0.840	M	-2.33	0.879	D	-1.68	0.401	N	0.167	0.207	-0.909	0.470	T	0.003	0.009	T	.	.	.	4.996	0.672	25.1	0.995	0.702	0.940	0.597	D	c	-0.113	-0.109	0.000	0.064	0.554	0.246	0	3.19	0.356	0.590	0.235	0.038	0.153	0.998	0.411	0.133	0.200	12.082	0.528	.	.	.	0.5	95	45	22	32650200	chr22:32650200	C	T	95	PASS	DP=45;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	32756652	32756652	A	G	exonic	RFPL3	.	nonsynonymous SNV	RFPL3:NM_001098535:exon2:c.A787G:p.S263G,RFPL3:NM_006604:exon3:c.A700G:p.S234G	0.000158443	0.437571789	0.562269768	.	0.04317	.	0.687150476	85.17928757	1089.79284	6.32074	0.219	0.190	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	N	0.935	0.237	L	0.12	0.611	T	-0.28	0.116	N	0.056	0.078	-1.028	0.211	T	0.108	0.392	T	.	.	.	-1.537	0.016	0.002	0.517	0.045	0.000	0.002	N	c	-1.461	-1.545	0.003	0.100	0.549	0.223	0	0.115	0.139	-0.551	0.061	-1.073	0.019	0.000	0.063	0.004	0.083	6.122	0.193	B30.2/SPRY domain|Concanavalin A-like lectin/glucanase domain|SPRY domain	.	.	0.5	125	410	22	32756652	chr22:32756652	A	G	125	PASS	DP=410;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	35659263	35659263	T	-	intronic	HMGXB4	.	.	.	0.218813415	0.780833648	0.000352936	.	0.88512	0.11014	-0.492218069	22.35786742	1952.80292	8.13335	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	104	22	35659262	chr22:35659262	AT	A	50	PASS	DP=104;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	36113816	36113816	A	-	upstream	APOL5	dist=103	.	.	1.01E-08	0.170032073	0.829967917	.	0.05935	.	0.887394731	89.18966737	7067.29	18.01366	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	117	22	36113815	chr22:36113815	GA	G	59	PASS	DP=117;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	37334329	37334329	G	T	exonic	CSF2RB	.	nonsynonymous SNV	CSF2RB:NM_000395:exon14:c.G2479T:p.G827C	0.001866652	0.997129945	0.001003402	DISEASE: Pulmonary surfactant metabolism dysfunction 5 (SMDP5) [MIM:614370]: A rare lung disorder due to impaired surfactant homeostasis. It is characterized by alveolar filling with floccular material that stains positive using the periodic acid- Schiff method and is derived from surfactant phospholipids and protein components. Excessive lipoproteins accumulation in the alveoli results in severe respiratory distress. {ECO:0000269|PubMed:21075760}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.3108	0.24942	-1.076610636	7.324840764	1096.75329	6.34077	0.002	0.721	D	1.0	0.899	D	0.991	0.782	D	0.158	0.177	N	1.000	0.090	N	1.79	0.469	L	-2.8	0.939	D	-3.26	0.665	D	0.466	0.532	0.141	0.849	D	0.807	0.935	D	0.066	0.700	D	5.638	0.768	26.6	0.997	0.821	0.586	0.304	D	c	0.136	-0.026	0.975	0.295	0.732	0.924	0	1.96	0.251	2.718	0.467	0.141	0.225	0.937	0.323	0.435	0.260	6.269	0.200	.	.	.	0.5	95	635	22	37334329	chr22:37334329	G	T	95	PASS	DP=635;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	37462130	37462130	A	T	exonic	TMPRSS6	.	nonsynonymous SNV	TMPRSS6:NM_001289001:exon18:c.T2399A:p.V800E,TMPRSS6:NM_153609:exon18:c.T2426A:p.V809E,TMPRSS6:NM_001289000:exon19:c.T2465A:p.V822E	3.34E-06	0.99700676	0.002989896	DISEASE: Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200]: Key features include congenital hypochromic microcytic anemia, very low mean corpuscular erythrocyte volume, low transferrin saturation, abnormal iron absorption characterized by no hematologic improvement following treatment with oral iron, and abnormal iron utilization characterized by a sluggish, incomplete response to parenteral iron. {ECO:0000269|PubMed:18408718, ECO:0000269|PubMed:18603562, ECO:0000269|PubMed:19357398, ECO:0000269|PubMed:19592582, ECO:0000269|PubMed:19708871, ECO:0000269|PubMed:19747362, ECO:0000269|PubMed:20232450, ECO:0000269|PubMed:20704562, ECO:0000269|PubMed:21618415, ECO:0000269|PubMed:22581667, ECO:0000269|PubMed:25156943, ECO:0000269|PubMed:25588876}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations leading to abrogation of TMPRSS6 activity are associated with IRIDA due to elevated levels of hepcidin, a negative regulator of plasma iron pool (PubMed:20232450). {ECO:0000269|PubMed:20232450}.; 	0.11488	0.1454	0.589672374	82.36022647	395.53283	4.17829	0.083	0.342	T	0.041	0.200	B	0.011	0.145	B	0.944	0.076	N	0.691	0.302	N	0.93	0.236	L	-3.26	0.936	D	-0.17	0.096	N	0.317	0.409	-0.276	0.757	T	0.555	0.838	D	0.242	0.888	D	2.647	0.379	20.5	0.958	0.272	0.751	0.365	D	c	-0.722	-0.588	0.607	0.218	0.615	0.372	0	2.31	0.277	0.890	0.277	0.119	0.209	0.939	0.324	0.945	0.419	3.410	0.069	Peptidase S1, PA clan|Serine proteases, trypsin domain	.	.	0.5	119	182	22	37462130	chr22:37462130	A	T	119	PASS	DP=182;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	37707028	37707028	G	-	splicing	CYTH4	NM_001318024:exon10:c.638-1G>-;NM_013385:exon10:c.809-1G>-	.	.	0.572494882	0.42740411	0.000101009	.	0.24327	0.12192	0.086440867	60.47416844	260.30767	3.46595	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	60	22	37707027	chr22:37707027	AG	A	44	PASS	DP=60;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	37768968	37768971	GTGC	-	UTR3	ELFN2	NM_052906:c.*144_*141delGCAC	.	.	0.849015287	0.150440504	0.000544209	.	0.18208	.	-1.835411529	2.081858929	137.02578	2.54496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	71	22	37768967	chr22:37768967	TGTGC	T	42	PASS	DP=71;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	37768971	37768971	C	T	UTR3	ELFN2	NM_052906:c.*141G>A	.	.	0.849015287	0.150440504	0.000544209	.	0.18208	.	-1.835411529	2.081858929	137.02578	2.54496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	91	743	22	37768971	chr22:37768971	C	T	91	PASS	DP=743;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	37771139	37771139	C	A	exonic	ELFN2	.	nonsynonymous SNV	ELFN2:NM_052906:exon3:c.G436T:p.A146S	0.849015287	0.150440504	0.000544209	.	0.18208	.	-1.835411529	2.081858929	137.02578	2.54496	0.111	0.290	T	0.989	0.609	D	0.907	0.627	P	0.000	0.843	D	1	0.810	D	1.09	0.274	L	0.56	0.546	T	-1.05	0.275	N	0.457	0.509	-0.628	0.637	T	0.269	0.641	T	0.035	0.560	D	4.486	0.601	24.3	0.994	0.648	0.993	0.939	D	c	0.605	0.586	1.000	0.747	0.701	0.575	0	4.66	0.577	7.796	0.843	0.823	0.336	1.000	0.715	1.000	0.888	17.923	0.888	Leucine-rich repeat domain, L domain-like	.	.	0.5	.	46	22	37771139	chr22:37771139	C	A	.	PASS	DP=46;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	37771523	37771523	C	A	exonic	ELFN2	.	nonsynonymous SNV	ELFN2:NM_052906:exon3:c.G52T:p.G18C	0.849015287	0.150440504	0.000544209	.	0.18208	.	-1.835411529	2.081858929	137.02578	2.54496	0.032	0.446	D	0.979	0.571	D	0.635	0.501	P	0.169	0.174	N	1	0.090	N	1.445	0.365	L	0.64	0.529	T	-3.6	0.693	D	0.471	0.521	-0.927	0.446	T	0.165	0.503	T	0.042	0.603	D	3.682	0.500	23.3	0.990	0.505	0.343	0.248	N	c	0.041	-0.054	0.999	0.396	0.646	0.450	0	4.52	0.546	1.359	0.335	0.852	0.362	0.003	0.159	0.091	0.185	13.204	0.590	.	.	.	0.5	.	100	22	37771523	chr22:37771523	C	A	.	PASS	DP=100;AN=2	GT	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.
22	37964453	37964453	G	A	exonic	CDC42EP1	.	nonsynonymous SNV	CDC42EP1:NM_152243:exon3:c.G802A:p.G268S	1.06E-05	0.197795982	0.802193447	.	0.08861	0.10603	-0.442665927	24.53408823	193.55365	3.0183	0.369	0.116	T	0.0	0.026	B	0.001	0.040	B	.	.	.	1	0.090	N	0.345	0.112	N	1.59	0.288	T	0.21	0.048	N	0.159	0.191	-0.985	0.339	T	0.025	0.108	T	0.003	0.064	T	-0.512	0.055	0.205	0.349	0.022	0.171	0.195	N	c	-1.455	-1.501	1.000	0.747	0.672	0.522	0	-0.736	0.105	0.126	0.155	-1.241	0.015	0.000	0.063	0.000	0.016	3.638	0.076	.	.	.	0.5	.	88	22	37964453	chr22:37964453	G	A	.	PASS	DP=88;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	38203338	38203338	-	CCC	UTR3	H1F0	NM_005318:c.*1202_*1203insCCC	.	.	0.154802582	0.635588541	0.209608877	.	0.85024	0.20751	-0.053113545	49.38664779	8.17863	0.30157	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	52	22	38203338	chr22:38203338	T	TCCC	106	PASS	DP=52;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	38254768	38254768	-	T	intronic	EIF3L	.	.	.	0.938813614	0.061184231	2.16E-06	.	0.10378	0.12326	-0.758599262	13.32861524	8.36913	0.30609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	113	22	38254768	chr22:38254768	G	GT	62	PASS	DP=113;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.
22	38523469	38523469	C	A	intronic	PLA2G6	.	.	.	2.66E-08	0.901102432	0.098897542	DISEASE: Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]: A neurodegenerative disease characterized by pathologic axonal swelling and spheroid bodies in the central nervous system. Onset is within the first 2 years of life with death by age 10 years. {ECO:0000269|PubMed:16783378, ECO:0000269|PubMed:17033970, ECO:0000269|PubMed:23749988}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Parkinson disease 14 (PARK14) [MIM:612953]: An adult- onset progressive neurodegenerative disorder characterized by parkinsonism, dystonia, severe cognitive decline, cerebral and cerebellar atrophy and absent iron in the basal ganglia on magnetic resonance imaging. {ECO:0000269|PubMed:18570303}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16881	0.17642	-1.591018721	3.084453881	148.63297	2.65978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	103	22	38523469	chr22:38523469	C	A	.	PASS	DP=103;AN=2	GT	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.
22	38543532	38543532	G	-	intronic	PLA2G6	.	.	.	2.66E-08	0.901102432	0.098897542	DISEASE: Neurodegeneration with brain iron accumulation 2A (NBIA2A) [MIM:256600]: A neurodegenerative disease characterized by pathologic axonal swelling and spheroid bodies in the central nervous system. Onset is within the first 2 years of life with death by age 10 years. {ECO:0000269|PubMed:16783378, ECO:0000269|PubMed:17033970, ECO:0000269|PubMed:23749988}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Parkinson disease 14 (PARK14) [MIM:612953]: An adult- onset progressive neurodegenerative disorder characterized by parkinsonism, dystonia, severe cognitive decline, cerebral and cerebellar atrophy and absent iron in the basal ganglia on magnetic resonance imaging. {ECO:0000269|PubMed:18570303}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.16881	0.17642	-1.591018721	3.084453881	148.63297	2.65978	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	48	22	38543531	chr22:38543531	TG	T	53	PASS	DP=48;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	38995742	38995742	G	A	intronic	FAM227A	.	.	.	.	.	.	.	.	.	.	.	358.7527	4.01183	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	22	38995742	chr22:38995742	G	A	.	PASS	DP=66;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	39496323	39496325	AAC	-	exonic	APOBEC3H	.	nonframeshift deletion	APOBEC3H:NM_001166002:exon2:c.40_42del:p.N15del,APOBEC3H:NM_001166003:exon2:c.40_42del:p.N15del,APOBEC3H:NM_001166004:exon2:c.40_42del:p.N15del,APOBEC3H:NM_181773:exon2:c.40_42del:p.N15del	0.637623187	0.355699123	0.00667769	.	0.03807	0.11857	0.705562627	85.52724699	3553.79975	11.52391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	129	75	22	39496322	chr22:39496322	TAAC	T	129	PASS	DP=75;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	39496336	39496336	G	T	exonic	APOBEC3H	.	nonsynonymous SNV	APOBEC3H:NM_001166002:exon2:c.G53T:p.R18L,APOBEC3H:NM_001166003:exon2:c.G53T:p.R18L,APOBEC3H:NM_001166004:exon2:c.G53T:p.R18L,APOBEC3H:NM_181773:exon2:c.G53T:p.R18L	0.637623187	0.355699123	0.00667769	.	0.03807	0.11857	0.705562627	85.52724699	3553.79975	11.52391	0.142	0.270	T	0.989	0.609	D	0.925	0.643	D	.	.	.	1	0.090	P	1.845	0.488	L	0.04	0.634	T	-2.22	0.501	N	0.173	0.210	-1.017	0.247	T	0.000	0.000	T	.	.	.	2.007	0.302	16.25	0.986	0.437	0.019	0.058	N	c	-0.661	-0.923	1.000	0.517	0.560	0.301	0	-0.212	0.125	-0.116	0.106	-0.317	0.077	0.000	0.063	0.000	0.016	5.159	0.143	Cytidine and deoxycytidylate deaminases, zinc-binding	ENSG00000226024.1|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000226024.1|ENSG00000239713.3|ENSG00000239713.3|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000128394.12|ENSG00000239713.3|ENSG00000226024.1|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000226024.1|ENSG00000239713.3|ENSG00000226024.1|ENSG00000226024.1|ENSG00000243811.3|ENSG00000239713.3|ENSG00000239713.3|ENSG00000226024.1|ENSG00000239713.3|ENSG00000239713.3|ENSG00000239713.3	Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Subcutaneous|Adipose_Visceral_Omentum|Artery_Aorta|Artery_Tibial|Artery_Tibial|Breast_Mammary_Tissue|Cells_Transformed_fibroblasts|Cells_Transformed_fibroblasts|Colon_Sigmoid|Esophagus_Mucosa|Esophagus_Mucosa|Esophagus_Muscularis|Esophagus_Muscularis|Esophagus_Muscularis|Heart_Atrial_Appendage|Heart_Left_Ventricle|Lung|Lung|Muscle_Skeletal|Nerve_Tibial|Nerve_Tibial|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Thyroid|Vagina	0.5	127	76	22	39496336	chr22:39496336	G	T	127	PASS	DP=76;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.	0/1
22	39910495	39910517	TTTTGTTACCCAACTCTTCCTAT	-	UTR3	MIEF1	NM_019008:c.*167_*189delTTTTGTTACCCAACTCTTCCTAT	.	.	0.062893833	0.921465906	0.015640262	.	0.12261	0.09986	0.420771676	77.15852795	1019.99486	6.14357	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	17.15	17	22	39910494	chr22:39910494	ATTTTGTTACCCAACTCTTCCTAT	A	17.15	PASS	DP=17;AN=2	GT	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	42475821	42475821	G	T	exonic	SMDT1	.	nonsynonymous SNV	SMDT1:NM_033318:exon1:c.G49T:p.G17W	0.163350133	0.639606461	0.197043405	.	0.17181	0.10294	-0.273576253	33.97027601	12.90089	0.47023	0.002	0.721	D	0.02	0.170	B	0.013	0.154	B	0.027	0.259	N	1.000	0.201	N	2.245	0.637	M	0.72	0.510	T	-0.06	0.079	N	0.337	0.398	-0.959	0.394	T	0.103	0.379	T	0.025	0.485	D	2.541	0.367	19.73	0.967	0.300	0.360	0.252	N	c	-1.126	-1.142	1.000	0.747	0.442	0.072	0	0.547	0.163	0.972	0.288	-0.806	0.032	0.865	0.305	0.000	0.016	2.209	0.037	.	.	.	0.5	108	678	22	42475821	chr22:42475821	G	T	108	PASS	DP=678;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
22	42557280	42557280	G	A	UTR3	TCF20	NM_005650:c.*129C>T;NM_181492:c.*67C>T	.	.	0.999977934	2.21E-05	4.00E-14	.	0.33163	0.19448	-2.552652857	0.8492569	1856.84901	7.94395	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	314	22	42557280	chr22:42557280	G	A	.	PASS	DP=314;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
22	42898666	42898666	C	-	ncRNA_intronic	SERHL	.	.	.	.	.	.	.	0.10684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	110	310	22	42898665	chr22:42898665	GC	G	110	PASS	DP=310;AN=4	GT	./.	0/1	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	44276728	44276728	G	A	exonic	PNPLA5	.	stopgain	PNPLA5:NM_001177675:exon7:c.C895T:p.Q299X,PNPLA5:NM_138814:exon9:c.C1237T:p.Q413X	9.38E-07	0.317699047	0.682300015	.	0.17953	0.09445	0.576916344	82.25406936	1541.98025	7.28556	.	.	.	.	.	.	.	.	.	.	.	.	0.810	0.346	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8.992	0.961	35	0.967	0.301	0.113	0.163	N	c	0.037	-0.331	0.035	0.142	0.615	0.352	0	2.1	0.261	1.248	0.322	1.048	0.713	0.057	0.215	0.008	0.104	8.910	0.345	.	.	.	0.5	.	65	22	44276728	chr22:44276728	G	A	.	PASS	DP=65;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	44696688	44696688	C	A	intronic	KIAA1644	.	.	.	0.676861238	0.318457206	0.004681556	.	.	.	-0.139478553	43.29440906	142.92745	2.60644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	94	109	22	44696688	chr22:44696688	C	A	94	PASS	DP=109;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	45728562	45728562	C	T	exonic	FAM118A	.	nonsynonymous SNV	FAM118A:NM_001349915:exon5:c.C686T:p.A229V,FAM118A:NM_001349913:exon6:c.C908T:p.A303V,FAM118A:NM_001349914:exon6:c.C911T:p.A304V,FAM118A:NM_017911:exon6:c.C908T:p.A303V,FAM118A:NM_001104595:exon7:c.C908T:p.A303V,FAM118A:NM_001349916:exon8:c.C950T:p.A317V	0.591868565	0.406055484	0.002075951	.	0.10583	0.09201	-0.001743238	53.85114414	52.56756	1.43555	0.103	0.301	T	0.518	0.356	P	0.129	0.312	B	0.020	0.270	N	0.978	0.394	D	0.975	0.246	L	1.49	0.315	T	-0.28	0.116	N	0.492	0.573	-1.101	0.040	T	0.050	0.213	T	0.006	0.157	T	2.171	0.322	17.32	0.997	0.785	0.906	0.516	D	c	-0.143	-0.043	1.000	0.480	0.707	0.730	0	4.7	0.586	4.701	0.613	0.852	0.362	0.970	0.340	1.000	0.888	16.225	0.820	.	.	.	0.5	50	51	22	45728562	chr22:45728562	C	T	50	PASS	DP=51;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	46447677	46447756	GAGCCCTGGGTTTGGGCTGAGCGCGGTAGCTCATACCTGTAATTCCAGCACATTGGGAGGCCGAGGCAGGAAGATTGCAT	-	exonic	PRR34	.	frameshift deletion	PRR34:NM_018280:exon2:c.368_447del:p.H123Lfs*35	.	.	.	.	0.07675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	29	22	46447676	chr22:46447676	AGAGCCCTGGGTTTGGGCTGAGCGCGGTAGCTCATACCTGTAATTCCAGCACATTGGGAGGCCGAGGCAGGAAGATTGCAT	A	50	PASS	DP=29;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.
22	46505189	46505189	C	T	ncRNA_exonic	MIRLET7BHG	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	383	22	46505189	chr22:46505189	C	T	77	PASS	DP=383;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
22	46685382	46685382	G	T	exonic	TTC38	.	nonsynonymous SNV	TTC38:NM_017931:exon12:c.G1166T:p.G389V	5.70E-10	0.382156005	0.617843995	.	.	0.09803	0.913082291	89.54352442	574.23128	4.86368	0.037	0.430	D	0.999	0.764	D	0.975	0.717	D	0.000	0.843	D	1	0.810	D	3.295	0.906	M	0.61	0.535	T	-5.81	0.882	D	0.664	0.675	-0.203	0.776	T	0.346	0.711	T	0.033	0.549	D	4.886	0.656	24.9	0.997	0.825	0.939	0.592	D	c	0.652	0.520	1.000	0.747	0.635	0.413	0	4.77	0.603	6.884	0.752	1.048	0.713	1.000	0.715	0.103	0.190	15.297	0.735	.	.	.	0.5	148	582	22	46685382	chr22:46685382	G	T	148	PASS	DP=582;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	49147663	49147663	-	T	UTR3	FAM19A5	NM_001082967:c.*2004_*2005insT;NM_015381:c.*2004_*2005insT	.	.	0.310031382	0.617806909	0.07216171	.	0.13152	.	0.347360312	73.97381458	13.36073	0.48609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	434	22	49147663	chr22:49147663	A	AT	83	PASS	DP=434;AN=2	GT	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.	./.
22	50312802	50312818	CCCTCGACCTGGGCTCG	-	intronic	CRELD2	.	.	.	4.96E-08	0.220198053	0.779801898	.	0.23727	0.10908	0.801024817	87.65628686	1620.87519	7.44658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	147	99	22	50312801	chr22:50312801	ACCCTCGACCTGGGCTCG	A	147	PASS	DP=99;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
22	50927718	50927718	C	T	exonic	MIOX	.	nonsynonymous SNV	MIOX:NM_017584:exon7:c.C580T:p.H194Y	4.60E-12	0.014039927	0.985960073	.	0.17947	0.12797	-0.200157416	39.11299835	99.70995	2.16398	0.0	0.912	D	1.0	0.899	D	0.998	0.875	D	0.000	0.843	D	1	0.810	D	.	.	.	.	.	.	-5.8	0.881	D	0.813	0.874	0.368	0.886	D	0.578	0.848	D	0.084	0.743	D	5.840	0.800	27.3	0.997	0.820	0.976	0.754	D	c	0.774	0.669	1.000	0.747	0.581	0.326	0	5.14	0.699	3.575	0.534	0.865	0.377	1.000	0.715	0.950	0.426	16.098	0.809	.	.	.	0.5	58	55	22	50927718	chr22:50927718	C	T	58	PASS	DP=55;AN=2	GT	./.	./.	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.
22	51193209	51193209	T	G	intergenic	ACR;RPL23AP82	dist=9482;dist=2305	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	106	146	22	51193209	chr22:51193209	T	G	106	PASS	DP=146;AN=2	GT	./.	./.	./.	./.	./.	0/1	./.	./.	./.	./.	./.	./.
22	51193798	51193798	G	A	intergenic	ACR;RPL23AP82	dist=10071;dist=1716	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	119	276	22	51193798	chr22:51193798	G	A	119	PASS	DP=276;AN=2	GT	./.	0/1	./.	./.	./.	./.	./.	./.	./.	./.	./.	./.
